<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1987-08-13" modified="2017-12-20" version="261">
<accession>P04637</accession>
<accession>Q15086</accession>
<accession>Q15087</accession>
<accession>Q15088</accession>
<accession>Q16535</accession>
<accession>Q16807</accession>
<accession>Q16808</accession>
<accession>Q16809</accession>
<accession>Q16810</accession>
<accession>Q16811</accession>
<accession>Q16848</accession>
<accession>Q2XN98</accession>
<accession>Q3LRW1</accession>
<accession>Q3LRW2</accession>
<accession>Q3LRW3</accession>
<accession>Q3LRW4</accession>
<accession>Q3LRW5</accession>
<accession>Q86UG1</accession>
<accession>Q8J016</accession>
<accession>Q99659</accession>
<accession>Q9BTM4</accession>
<accession>Q9HAQ8</accession>
<accession>Q9NP68</accession>
<accession>Q9NPJ2</accession>
<accession>Q9NZD0</accession>
<accession>Q9UBI2</accession>
<accession>Q9UQ61</accession>
<name>P53_HUMAN</name>
<protein>
<recommendedName>
<fullName>Cellular tumor antigen p53</fullName>
</recommendedName>
<alternativeName>
<fullName>Antigen NY-CO-13</fullName>
</alternativeName>
<alternativeName>
<fullName>Phosphoprotein p53</fullName>
</alternativeName>
<alternativeName>
<fullName>Tumor suppressor p53</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">TP53</name>
<name type="synonym">P53</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1985" name="EMBO J." volume="4" first="1251" last="1255">
<title>Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.</title>
<authorList>
<person name="Zakut-Houri R."/>
<person name="Bienz-Tadmor B."/>
<person name="Givol D."/>
<person name="Oren M."/>
</authorList>
<dbReference type="PubMed" id="4006916"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1986" name="Mol. Cell. Biol." volume="6" first="1379" last="1385">
<title>Characterization of the human p53 gene.</title>
<authorList>
<person name="Lamb P."/>
<person name="Crawford L."/>
</authorList>
<dbReference type="PubMed" id="2946935"/>
<dbReference type="DOI" id="10.1128/MCB.6.5.1379"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1)</scope>
<scope>VARIANT GLY-76</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1985" name="Mol. Cell. Biol." volume="5" first="1601" last="1610">
<title>Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53.</title>
<authorList>
<person name="Harlow E."/>
<person name="Williamson N.M."/>
<person name="Ralston R."/>
<person name="Helfman D.M."/>
<person name="Adams T.E."/>
</authorList>
<dbReference type="PubMed" id="3894933"/>
<dbReference type="DOI" id="10.1128/MCB.5.7.1601"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1986" name="Mol. Cell. Biol." volume="6" first="4650" last="4656">
<title>Molecular basis for heterogeneity of the human p53 protein.</title>
<authorList>
<person name="Harris N."/>
<person name="Brill E."/>
<person name="Shohat O."/>
<person name="Prokocimer M."/>
<person name="Wolf D."/>
<person name="Arai N."/>
<person name="Rotter V."/>
</authorList>
<dbReference type="PubMed" id="3025664"/>
<dbReference type="DOI" id="10.1128/MCB.6.12.4650"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1988" name="Gene" volume="70" first="245" last="252">
<title>A variation in the structure of the protein-coding region of the human p53 gene.</title>
<authorList>
<person name="Buchman V.L."/>
<person name="Chumakov P.M."/>
<person name="Ninkina N.N."/>
<person name="Samarina O.P."/>
<person name="Georgiev G.P."/>
</authorList>
<dbReference type="PubMed" id="2905688"/>
<dbReference type="DOI" id="10.1016/0378-1119(88)90196-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1991" name="EMBO J." volume="10" first="2879" last="2887">
<title>p53 is frequently mutated in Burkitt's lymphoma cell lines.</title>
<authorList>
<person name="Farrell P.J."/>
<person name="Allan G."/>
<person name="Shanahan F."/>
<person name="Vousden K.H."/>
<person name="Crook T."/>
</authorList>
<dbReference type="PubMed" id="1915267"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS SPORADIC CANCERS</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1993" name="Radiat. Res." volume="134" first="349" last="354">
<title>Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs.</title>
<authorList>
<person name="Allalunis-Turner M.J."/>
<person name="Barron G.M."/>
<person name="Day R.S. III"/>
<person name="Dobler K.D."/>
<person name="Mirzayans R."/>
</authorList>
<dbReference type="PubMed" id="8316628"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT LYS-286</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="3361" last="3370">
<title>Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity.</title>
<authorList>
<person name="Chang N.-S."/>
<person name="Pratt N."/>
<person name="Heath J."/>
<person name="Schultz L."/>
<person name="Sleve D."/>
<person name="Carey G.B."/>
<person name="Zevotek N."/>
</authorList>
<dbReference type="PubMed" id="11058590"/>
<dbReference type="DOI" id="10.1074/jbc.M007140200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INTERACTION WITH WWOX</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2005" name="Genes Dev." volume="19" first="2122" last="2137">
<title>p53 isoforms can regulate p53 transcriptional activity.</title>
<authorList>
<person name="Bourdon J.C."/>
<person name="Fernandes K."/>
<person name="Murray-Zmijewski F."/>
<person name="Liu G."/>
<person name="Diot A."/>
<person name="Xirodimas D.P."/>
<person name="Saville M.K."/>
<person name="Lane D.P."/>
</authorList>
<dbReference type="PubMed" id="16131611"/>
<dbReference type="DOI" id="10.1101/gad.1339905"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 7; 8 AND 9)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>ALTERNATIVE PROMOTER USAGE</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>INDUCTION</scope>
<scope>VARIANT ARG-72</scope>
<source>
<tissue>Colon</tissue>
</source>
</reference>
<reference key="10">
<citation type="submission" date="1991-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Chumakov P.M."/>
<person name="Almazov V.P."/>
<person name="Jenkins J.R."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="11">
<citation type="submission" date="1997-03" db="EMBL/GenBank/DDBJ databases">
<title>P53 genomic sequence. Corrections and polymorphism.</title>
<authorList>
<person name="Rozemuller E.H."/>
<person name="Tilanus M.G.J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="12">
<citation type="submission" date="2004-11" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS SER-47; LYS-339 AND ALA-366</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="Radiat. Res." volume="154" first="473" last="476">
<title>Human TP53 from the malignant glioma-derived cell lines M059J and M059K has a cancer-associated mutation in exon 8.</title>
<authorList>
<person name="Anderson C.W."/>
<person name="Allalunis-Turner M.J."/>
</authorList>
<dbReference type="PubMed" id="11023613"/>
<dbReference type="DOI" id="10.1667/0033-7587(2000)154[0473:HTFTMG]2.0.CO;2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT LYS-286</scope>
</reference>
<reference key="14">
<citation type="submission" date="2002-03" db="EMBL/GenBank/DDBJ databases">
<title>Identification of a tumor-rejection antigen recognized by HLA-B46 restricted CTL.</title>
<authorList>
<person name="Azuma K."/>
<person name="Shichijo S."/>
<person name="Itoh K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS HIS-273 AND SER-309</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT ARG-72</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1045" last="1049">
<title>DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Adams D.J."/>
<person name="Sharpe T."/>
<person name="Harrow J."/>
<person name="Lupski J.R."/>
<person name="Nicholson C."/>
<person name="Searle S.M."/>
<person name="Wilming L."/>
<person name="Young S.K."/>
<person name="Abouelleil A."/>
<person name="Allen N.R."/>
<person name="Bi W."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Bugalter B.E."/>
<person name="Butler J."/>
<person name="Chang J.L."/>
<person name="Chen C.-K."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="Cuomo C.A."/>
<person name="de Jong P.J."/>
<person name="DeCaprio D."/>
<person name="Dewar K."/>
<person name="FitzGerald M."/>
<person name="Gilbert J."/>
<person name="Gibson R."/>
<person name="Gnerre S."/>
<person name="Goldstein S."/>
<person name="Grafham D.V."/>
<person name="Grocock R."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hart E."/>
<person name="Norman C.H."/>
<person name="Humphray S."/>
<person name="Jaffe D.B."/>
<person name="Jones M."/>
<person name="Kamal M."/>
<person name="Khodiyar V.K."/>
<person name="LaButti K."/>
<person name="Laird G."/>
<person name="Lehoczky J."/>
<person name="Liu X."/>
<person name="Lokyitsang T."/>
<person name="Loveland J."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews L."/>
<person name="Mauceli E."/>
<person name="McCarroll S.A."/>
<person name="Mihalev A.H."/>
<person name="Mudge J."/>
<person name="Nguyen C."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Osoegawa K."/>
<person name="Schwartz D.C."/>
<person name="Shaw-Smith C."/>
<person name="Stankiewicz P."/>
<person name="Steward C."/>
<person name="Swarbreck D."/>
<person name="Venkataraman V."/>
<person name="Whittaker C.A."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Bradley A."/>
<person name="Hubbard T."/>
<person name="Birren B.W."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16625196"/>
<dbReference type="DOI" id="10.1038/nature04689"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="17">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT ARG-72</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT ALA-278</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="15836" last="15841">
<title>Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin.</title>
<authorList>
<person name="Kanashiro C.A."/>
<person name="Schally A.V."/>
<person name="Groot K."/>
<person name="Armatis P."/>
<person name="Bernardino A.L."/>
<person name="Varga J.L."/>
</authorList>
<dbReference type="PubMed" id="14660794"/>
<dbReference type="DOI" id="10.1073/pnas.2536558100"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-379 (ISOFORM 1)</scope>
<scope>VARIANTS ASN-139 AND PRO-155</scope>
<source>
<tissue>Lung carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="1984" name="EMBO J." volume="3" first="3257" last="3262">
<title>Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene.</title>
<authorList>
<person name="Matlashewski G."/>
<person name="Lamb P."/>
<person name="Pim D."/>
<person name="Peacock J."/>
<person name="Crawford L."/>
<person name="Benchimol S."/>
</authorList>
<dbReference type="PubMed" id="6396087"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 101-393</scope>
</reference>
<reference key="21">
<citation type="submission" date="2003-09" db="EMBL/GenBank/DDBJ databases">
<title>Study on the effect of tumor suppressor gene p53 in arsenism patients.</title>
<authorList>
<person name="Pan X.L."/>
<person name="Zhang A.H."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 126-185</scope>
</reference>
<reference key="22">
<citation type="submission" date="2003-08" db="EMBL/GenBank/DDBJ databases">
<title>Detection of P53 gene mutations and serum p53 antibodies associated with cigarette smoking.</title>
<authorList>
<person name="Nimri L.F."/>
<person name="Owais W."/>
<person name="Momani E."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 261-298</scope>
<scope>VARIANT GLN-282</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="23">
<citation type="submission" date="1996-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Filippini G."/>
<person name="Soldati G."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 262-306</scope>
<scope>VARIANT VAL-262</scope>
<source>
<tissue>Ovarian adenocarcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="submission" date="1999-12" db="EMBL/GenBank/DDBJ databases">
<title>Mutation detection utilizing a novel PCR approach for amplification of the p53 gene from microdissected tissue: application to archival tumor samples.</title>
<authorList>
<person name="Thompson-Hehir J."/>
<person name="Davies M.P.A."/>
<person name="Green J.A."/>
<person name="Halliwell N."/>
<person name="Joyce K.A."/>
<person name="Salisbury J."/>
<person name="Sibson D.R."/>
<person name="Vergote I."/>
<person name="Walker C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 225-260</scope>
<source>
<tissue>Glial cell</tissue>
<tissue>Glial tumor</tissue>
</source>
</reference>
<reference key="25">
<citation type="submission" date="2000-03" db="EMBL/GenBank/DDBJ databases">
<title>Bcl6 and P53 gene mutations in tonsillar B cells.</title>
<authorList>
<person name="Yavuz A.S."/>
<person name="Farner N.L."/>
<person name="Yavuz S."/>
<person name="Grammer A.C."/>
<person name="Girschick H.J."/>
<person name="Lipsky P.E."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 225-260</scope>
</reference>
<reference key="26">
<citation type="submission" date="2003-04" db="EMBL/GenBank/DDBJ databases">
<title>Allelic variant in intron 9 of TP53 gene.</title>
<authorList>
<person name="Pinto E.M."/>
<person name="Mendonca B.B."/>
<person name="Latronico A.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 332-366</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1990" name="Oncogene" volume="5" first="423" last="426">
<title>The p53 nuclear localisation signal is structurally linked to a p34cdc2 kinase motif.</title>
<authorList>
<person name="Addison C."/>
<person name="Jenkins J.R."/>
<person name="Sturzbecher H.-W."/>
</authorList>
<dbReference type="PubMed" id="2156209"/>
</citation>
<scope>NUCLEAR LOCALIZATION SIGNAL</scope>
<scope>MUTAGENESIS OF LYS-319; LYS-320 AND LYS-321</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1990" name="Proc. Natl. Acad. Sci. U.S.A." volume="87" first="4766" last="4770">
<title>Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2.</title>
<authorList>
<person name="Bischoff J.R."/>
<person name="Friedman P.N."/>
<person name="Marshak D.R."/>
<person name="Prives C."/>
<person name="Beach D."/>
</authorList>
<dbReference type="PubMed" id="2141171"/>
<dbReference type="DOI" id="10.1073/pnas.87.12.4766"/>
</citation>
<scope>PHOSPHORYLATION BY P60/CDC2 AND CYCLIN B/CDC2</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1991" name="Mol. Cell. Biol." volume="11" first="1598" last="1606">
<title>The tumor suppressor p53 is bound to RNA by a stable covalent linkage.</title>
<authorList>
<person name="Samad A."/>
<person name="Carroll R.B."/>
</authorList>
<dbReference type="PubMed" id="1705009"/>
<dbReference type="DOI" id="10.1128/MCB.11.3.1598"/>
</citation>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1991" name="Mol. Cell. Biol." volume="11" first="1996" last="2003">
<title>Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen.</title>
<authorList>
<person name="Scheidtmann K.H."/>
<person name="Mumby M.C."/>
<person name="Rundell K."/>
<person name="Walter G."/>
</authorList>
<dbReference type="PubMed" id="1848668"/>
<dbReference type="DOI" id="10.1128/MCB.11.4.1996"/>
</citation>
<scope>DEPHOSPHORYLATION BY PP2A</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1996" name="Oncogene" volume="12" first="813" last="818">
<title>The human tumour suppressor gene p53 is alternatively spliced in normal cells.</title>
<authorList>
<person name="Flaman J.-M."/>
<person name="Waridel F."/>
<person name="Estreicher A."/>
<person name="Vannier A."/>
<person name="Limacher J.-M."/>
<person name="Gilbert D."/>
<person name="Iggo R."/>
<person name="Frebourg T."/>
</authorList>
<dbReference type="PubMed" id="8632903"/>
</citation>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1996" name="Oncogene" volume="12" first="921" last="930">
<title>Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus.</title>
<authorList>
<person name="Shaw P."/>
<person name="Freeman J."/>
<person name="Bovey R."/>
<person name="Iggo R."/>
</authorList>
<dbReference type="PubMed" id="8632915"/>
</citation>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1997" name="Mol. Cell. Biol." volume="17" first="7220" last="7229">
<title>p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner.</title>
<authorList>
<person name="Ko L.J."/>
<person name="Shieh S.-Y."/>
<person name="Chen X."/>
<person name="Jayaraman L."/>
<person name="Tamai K."/>
<person name="Taya Y."/>
<person name="Prives C."/>
<person name="Pan Z.-Q."/>
</authorList>
<dbReference type="PubMed" id="9372954"/>
<dbReference type="DOI" id="10.1128/MCB.17.12.7220"/>
</citation>
<scope>PHOSPHORYLATION AT SER-33</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1998" name="Oncogene" volume="17" first="2733" last="2741">
<title>Regulation of CAK kinase activity by p53.</title>
<authorList>
<person name="Schneider E."/>
<person name="Montenarh M."/>
<person name="Wagner P."/>
</authorList>
<dbReference type="PubMed" id="9840937"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202504"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN COMPLEX WITH CAK</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="6462" last="6471">
<title>Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.</title>
<authorList>
<person name="Gostissa M."/>
<person name="Hengstermann A."/>
<person name="Fogal V."/>
<person name="Sandy P."/>
<person name="Schwarz S.E."/>
<person name="Scheffner M."/>
<person name="Del Sal G."/>
</authorList>
</citation>
<scope>SUMOYLATION AT LYS-386</scope>
<scope>MUTAGENESIS OF LYS-386</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1999" name="FEBS Lett." volume="463" first="312" last="316">
<title>Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15.</title>
<authorList>
<person name="Dumaz N."/>
<person name="Milne D.M."/>
<person name="Meek D.W."/>
</authorList>
<dbReference type="PubMed" id="10606744"/>
<dbReference type="DOI" id="10.1016/S0014-5793(99)01647-6"/>
</citation>
<scope>PHOSPHORYLATION AT THR-18 BY CSNK1D/CK1</scope>
</reference>
<reference key="37">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="32699" last="32703">
<title>A bipartite nuclear localization signal is required for p53 nuclear import regulated by a carboxyl-terminal domain.</title>
<authorList>
<person name="Liang S.H."/>
<person name="Clarke M.F."/>
</authorList>
<dbReference type="PubMed" id="10551826"/>
<dbReference type="DOI" id="10.1074/jbc.274.46.32699"/>
</citation>
<scope>BIPARTITE NUCLEAR LOCALIZATION SIGNAL</scope>
<scope>CHARACTERIZATION OF VARIANT ASN-305</scope>
</reference>
<reference key="38">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="13777" last="13782">
<title>Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.</title>
<authorList>
<person name="Chehab N.H."/>
<person name="Malikzay A."/>
<person name="Stavridi E.S."/>
<person name="Halazonetis T.D."/>
</authorList>
<dbReference type="PubMed" id="10570149"/>
<dbReference type="DOI" id="10.1073/pnas.96.24.13777"/>
</citation>
<scope>PHOSPHORYLATION AT SER-15 AND SER-20</scope>
<scope>INDUCTION BY DNA DAMAGE</scope>
<scope>CHARACTERIZATION OF LFS VARIANT HIS-273</scope>
<scope>MUTAGENESIS OF THR-18; SER-20 AND 22-LEU-TRP-23</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PML AND MDM2</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="8945" last="8951">
<title>Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.</title>
<authorList>
<person name="Fang S."/>
<person name="Jensen J.P."/>
<person name="Ludwig R.L."/>
<person name="Vousden K.H."/>
<person name="Weissman A.M."/>
</authorList>
<dbReference type="PubMed" id="10722742"/>
<dbReference type="DOI" id="10.1074/jbc.275.12.8945"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2000" name="J. Mol. Biol." volume="295" first="853" last="864">
<title>Post-translational modification of p53 protein in response to ionizing radiation analyzed by mass spectrometry.</title>
<authorList>
<person name="Abraham J."/>
<person name="Kelly J."/>
<person name="Thibault P."/>
<person name="Benchimol S."/>
</authorList>
<dbReference type="PubMed" id="10656795"/>
<dbReference type="DOI" id="10.1006/jmbi.1999.3415"/>
</citation>
<scope>ACETYLATION AT LYS-373 AND LYS-382</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2000" name="J. Mol. Biol." volume="300" first="503" last="518">
<title>The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.</title>
<authorList>
<person name="Luciani M.G."/>
<person name="Hutchins J.R.A."/>
<person name="Zheleva D."/>
<person name="Hupp T.R."/>
</authorList>
<dbReference type="PubMed" id="10884347"/>
<dbReference type="DOI" id="10.1006/jmbi.2000.3830"/>
</citation>
<scope>PHOSPHORYLATION AT SER-315 AND SER-392 BY CDK2</scope>
<scope>MUTAGENESIS OF LYS-382; LEU-383 AND PHE-385</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2000" name="Nat. Cell Biol." volume="2" first="730" last="736">
<title>The function of PML in p53-dependent apoptosis.</title>
<authorList>
<person name="Guo A."/>
<person name="Salomoni P."/>
<person name="Luo J."/>
<person name="Shih A."/>
<person name="Zhong S."/>
<person name="Gu W."/>
<person name="Pandolfi P.P."/>
</authorList>
<dbReference type="PubMed" id="11025664"/>
<dbReference type="DOI" id="10.1038/35036365"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PML</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2000" name="Oncogene" volume="19" first="188" last="199">
<title>p53 is involved in the p120E4F-mediated growth arrest.</title>
<authorList>
<person name="Sandy P."/>
<person name="Gostissa M."/>
<person name="Fogal V."/>
<person name="Cecco L.D."/>
<person name="Szalay K."/>
<person name="Rooney R.J."/>
<person name="Schneider C."/>
<person name="Del Sal G."/>
</authorList>
<dbReference type="PubMed" id="10644996"/>
<dbReference type="DOI" id="10.1038/sj.onc.1203250"/>
</citation>
<scope>INTERACTION WITH E4F1</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2000" name="Oncogene" volume="19" first="3656" last="3664">
<title>The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein.</title>
<authorList>
<person name="Lopez-Borges S."/>
<person name="Lazo P.A."/>
</authorList>
<dbReference type="PubMed" id="10951572"/>
<dbReference type="DOI" id="10.1038/sj.onc.1203709"/>
</citation>
<scope>PHOSPHORYLATION AT THR-18</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2001" name="Antioxid. Redox Signal." volume="3" first="611" last="623">
<title>Zinc binding and redox control of p53 structure and function.</title>
<authorList>
<person name="Hainaut P."/>
<person name="Mann K."/>
</authorList>
<dbReference type="PubMed" id="11554448"/>
<dbReference type="DOI" id="10.1089/15230860152542961"/>
</citation>
<scope>REVIEW ON ZINC-BINDING PROPERTIES</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2001" name="Biochem. Biophys. Res. Commun." volume="287" first="562" last="567">
<title>Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line.</title>
<authorList>
<person name="Imamura K."/>
<person name="Ogura T."/>
<person name="Kishimoto A."/>
<person name="Kaminishi M."/>
<person name="Esumi H."/>
</authorList>
<dbReference type="PubMed" id="11554766"/>
<dbReference type="DOI" id="10.1006/bbrc.2001.5627"/>
</citation>
<scope>PHOSPHORYLATION AT SER-15</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2001" name="Cell" volume="107" first="149" last="159">
<title>hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.</title>
<authorList>
<person name="Vaziri H."/>
<person name="Dessain S.K."/>
<person name="Ng Eaton E."/>
<person name="Imai S."/>
<person name="Frye R.A."/>
<person name="Pandita T.K."/>
<person name="Guarente L."/>
<person name="Weinberg R.A."/>
</authorList>
<dbReference type="PubMed" id="11672523"/>
<dbReference type="DOI" id="10.1016/S0092-8674(01)00527-X"/>
</citation>
<scope>DEACETYLATION AT LYS-382 BY SIRT1</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="1510" last="1515">
<title>p53 amino acids 339-346 represent the minimal p53 repression domain.</title>
<authorList>
<person name="Hong T.M."/>
<person name="Chen J.J."/>
<person name="Peck K."/>
<person name="Yang P.C."/>
<person name="Wu C.W."/>
</authorList>
<dbReference type="PubMed" id="11007800"/>
<dbReference type="DOI" id="10.1074/jbc.M008231200"/>
</citation>
<scope>MINIMAL REPRESSION DOMAIN</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="36194" last="36199">
<title>Reactive oxygen species-induced phosphorylation of p53 on serine 20 is mediated in part by polo-like kinase-3.</title>
<authorList>
<person name="Xie S."/>
<person name="Wang Q."/>
<person name="Wu H."/>
<person name="Cogswell J."/>
<person name="Lu L."/>
<person name="Jhanwar-Uniyal M."/>
<person name="Dai W."/>
</authorList>
<dbReference type="PubMed" id="11447225"/>
<dbReference type="DOI" id="10.1074/jbc.M104157200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-20 BY PLK3</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="43305" last="43312">
<title>Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway.</title>
<authorList>
<person name="Xie S."/>
<person name="Wu H."/>
<person name="Wang Q."/>
<person name="Cogswell J.P."/>
<person name="Husain I."/>
<person name="Conn C."/>
<person name="Stambrook P."/>
<person name="Jhanwar-Uniyal M."/>
<person name="Dai W."/>
</authorList>
<dbReference type="PubMed" id="11551930"/>
<dbReference type="DOI" id="10.1074/jbc.M106050200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-20 BY PLK3</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="12654" last="12659">
<title>SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting.</title>
<authorList>
<person name="Rodriguez M.S."/>
<person name="Dargemont C."/>
<person name="Hay R.T."/>
</authorList>
<dbReference type="PubMed" id="11124955"/>
<dbReference type="DOI" id="10.1074/jbc.M009476200"/>
</citation>
<scope>SUMOYLATION AT LYS-386</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF PHE-385; LYS-386; THR-387 AND GLU-388</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="44003" last="44011">
<title>Cloning and characterization of a p53-related protein kinase expressed in interleukin-2-activated cytotoxic T-cells, epithelial tumor cell lines, and the testes.</title>
<authorList>
<person name="Abe Y."/>
<person name="Matsumoto S."/>
<person name="Wei S."/>
<person name="Nezu K."/>
<person name="Miyoshi A."/>
<person name="Kito K."/>
<person name="Ueda N."/>
<person name="Shigemoto K."/>
<person name="Hitsumoto Y."/>
<person name="Nikawa J."/>
<person name="Enomoto Y."/>
</authorList>
<dbReference type="PubMed" id="11546806"/>
<dbReference type="DOI" id="10.1074/jbc.M105669200"/>
</citation>
<scope>PHOSPHORYLATION BY PRPK</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2001" name="Mol. Cell" volume="7" first="283" last="292">
<title>A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1.</title>
<authorList>
<person name="Keller D.M."/>
<person name="Zeng X."/>
<person name="Wang Y."/>
<person name="Zhang Q.H."/>
<person name="Kapoor M."/>
<person name="Shu H."/>
<person name="Goodman R."/>
<person name="Lozano G."/>
<person name="Zhao Y."/>
<person name="Lu H."/>
</authorList>
<dbReference type="PubMed" id="11239457"/>
<dbReference type="DOI" id="10.1016/S1097-2765(01)00176-9"/>
</citation>
<scope>PHOSPHORYLATION AT SER-392</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2002" name="Cell" volume="111" first="1041" last="1054">
<title>Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde.</title>
<authorList>
<person name="Hu M."/>
<person name="Li P."/>
<person name="Li M."/>
<person name="Li W."/>
<person name="Yao T."/>
<person name="Wu J.-W."/>
<person name="Gu W."/>
<person name="Cohen R.E."/>
<person name="Shi Y."/>
</authorList>
<dbReference type="PubMed" id="12507430"/>
<dbReference type="DOI" id="10.1016/S0092-8674(02)01199-6"/>
</citation>
<scope>INTERACTION WITH USP7</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="2951" last="2957">
<title>Differential effect of ik3-1/cables on p53- and p73-induced cell death.</title>
<authorList>
<person name="Tsuji K."/>
<person name="Mizumoto K."/>
<person name="Yamochi T."/>
<person name="Nishimoto I."/>
<person name="Matsuoka M."/>
</authorList>
<dbReference type="PubMed" id="11706030"/>
<dbReference type="DOI" id="10.1074/jbc.M108535200"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH CABLES1 AND TP73</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="32020" last="32028">
<title>Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo.</title>
<authorList>
<person name="Kim E.-J."/>
<person name="Park J.-S."/>
<person name="Um S.-J."/>
</authorList>
<dbReference type="PubMed" id="11925430"/>
<dbReference type="DOI" id="10.1074/jbc.M200153200"/>
</citation>
<scope>INTERACTION WITH HIPK2</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2002" name="Nat. Cell Biol." volume="4" first="1" last="10">
<title>Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2.</title>
<authorList>
<person name="Hofmann T.G."/>
<person name="Moeller A."/>
<person name="Sirma H."/>
<person name="Zentgraf H."/>
<person name="Taya Y."/>
<person name="Droege W."/>
<person name="Will H."/>
<person name="Schmitz M.L."/>
</authorList>
<dbReference type="PubMed" id="11740489"/>
<dbReference type="DOI" id="10.1038/ncb715"/>
</citation>
<scope>INTERACTION WITH HIPK2</scope>
<scope>PHOSPHORYLATION AT SER-46</scope>
<scope>MUTAGENESIS OF SER-46 AND LYS-382</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2002" name="Nat. Cell Biol." volume="4" first="11" last="19">
<title>Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.</title>
<authorList>
<person name="D'Orazi G."/>
<person name="Cecchinelli B."/>
<person name="Bruno T."/>
<person name="Manni I."/>
<person name="Higashimoto Y."/>
<person name="Saito S."/>
<person name="Gostissa M."/>
<person name="Coen S."/>
<person name="Marchetti A."/>
<person name="Del Sal G."/>
<person name="Piaggio G."/>
<person name="Fanciulli M."/>
<person name="Appella E."/>
<person name="Soddu S."/>
</authorList>
<dbReference type="PubMed" id="11780126"/>
<dbReference type="DOI" id="10.1038/ncb714"/>
</citation>
<scope>INTERACTION WITH HIPK2</scope>
<scope>PHOSPHORYLATION AT SER-46</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="2373" last="2378">
<title>p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.</title>
<authorList>
<person name="Shiseki M."/>
<person name="Nagashima M."/>
<person name="Pedeux R.M."/>
<person name="Kitahama-Shiseki M."/>
<person name="Miura K."/>
<person name="Okamura S."/>
<person name="Onogi H."/>
<person name="Higashimoto Y."/>
<person name="Appella E."/>
<person name="Yokota J."/>
<person name="Harris C.C."/>
</authorList>
<dbReference type="PubMed" id="12750254"/>
</citation>
<scope>INTERACTION WITH ING4</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="25568" last="25576">
<title>Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305.</title>
<authorList>
<person name="Wang Y.H."/>
<person name="Tsay Y.G."/>
<person name="Tan B.C."/>
<person name="Lo W.Y."/>
<person name="Lee S.C."/>
</authorList>
<dbReference type="PubMed" id="12724314"/>
<dbReference type="DOI" id="10.1074/jbc.M212574200"/>
</citation>
<scope>ACETYLATION AT LYS-305</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="33134" last="33141">
<title>The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation.</title>
<authorList>
<person name="Louria-Hayon I."/>
<person name="Grossman T."/>
<person name="Sionov R.V."/>
<person name="Alsheich O."/>
<person name="Pandolfi P.P."/>
<person name="Haupt Y."/>
</authorList>
<dbReference type="PubMed" id="12810724"/>
<dbReference type="DOI" id="10.1074/jbc.M301264200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CHEK2 AND PML</scope>
<scope>UBIQUITINATION BY MDM2</scope>
<scope>PHOSPHORYLATION AT SER-20</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="37722" last="37729">
<title>TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity.</title>
<authorList>
<person name="Tomasini R."/>
<person name="Samir A.A."/>
<person name="Carrier A."/>
<person name="Isnardon D."/>
<person name="Cecchinelli B."/>
<person name="Soddu S."/>
<person name="Malissen B."/>
<person name="Dagorn J.-C."/>
<person name="Iovanna J.L."/>
<person name="Dusetti N.J."/>
</authorList>
<dbReference type="PubMed" id="12851404"/>
<dbReference type="DOI" id="10.1074/jbc.M301979200"/>
</citation>
<scope>INTERACTION WITH TP53INP1</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="6396" last="6405">
<title>Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination.</title>
<authorList>
<person name="O'Keefe K."/>
<person name="Li H."/>
<person name="Zhang Y."/>
</authorList>
<dbReference type="PubMed" id="12944468"/>
<dbReference type="DOI" id="10.1128/MCB.23.18.6396-6405.2003"/>
</citation>
<scope>NUCLEOCYTOPLASMIC SHUTTLING</scope>
<scope>NUCLEAR EXPORT SIGNAL</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="5431" last="5436">
<title>Characterization of cells and gene-targeted mice deficient for the p53-binding kinase homeodomain-interacting protein kinase 1 (HIPK1).</title>
<authorList>
<person name="Kondo S."/>
<person name="Lu Y."/>
<person name="Debbas M."/>
<person name="Lin A.W."/>
<person name="Sarosi I."/>
<person name="Itie A."/>
<person name="Wakeham A."/>
<person name="Tuan J."/>
<person name="Saris C."/>
<person name="Elliott G."/>
<person name="Ma W."/>
<person name="Benchimol S."/>
<person name="Lowe S.W."/>
<person name="Mak T.W."/>
<person name="Thukral S.K."/>
</authorList>
<dbReference type="PubMed" id="12702766"/>
<dbReference type="DOI" id="10.1073/pnas.0530308100"/>
</citation>
<scope>INTERACTION WITH HIPK1</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2004" name="Biochem. J." volume="380" first="605" last="610">
<title>Alternative reading frame protein (ARF)-independent function of CARF (collaborator of ARF) involves its interactions with p53: evidence for a novel p53-activation pathway and its negative feedback control.</title>
<authorList>
<person name="Hasan M.K."/>
<person name="Yaguchi T."/>
<person name="Minoda Y."/>
<person name="Hirano T."/>
<person name="Taira K."/>
<person name="Wadhwa R."/>
<person name="Kaul S.C."/>
</authorList>
<dbReference type="PubMed" id="15109303"/>
<dbReference type="DOI" id="10.1042/BJ20040337"/>
</citation>
<scope>INTERACTION WITH CDKN2AIP</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2004" name="Cell" volume="117" first="735" last="748">
<title>Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53.</title>
<authorList>
<person name="An W."/>
<person name="Kim J."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="15186775"/>
<dbReference type="DOI" id="10.1016/j.cell.2004.05.009"/>
</citation>
<scope>INTERACTION WITH HRMT1L2; EP300 AND CARM1</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2004" name="J. Mol. Biol." volume="339" first="313" last="325">
<title>The Ankrd2 protein, a link between the sarcomere and the nucleus in skeletal muscle.</title>
<authorList>
<person name="Kojic S."/>
<person name="Medeot E."/>
<person name="Guccione E."/>
<person name="Krmac H."/>
<person name="Zara I."/>
<person name="Martinelli V."/>
<person name="Valle G."/>
<person name="Faulkner G."/>
</authorList>
<dbReference type="PubMed" id="15136035"/>
<dbReference type="DOI" id="10.1016/j.jmb.2004.03.071"/>
</citation>
<scope>INTERACTION WITH ANKRD2</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2004" name="Mol. Cell" volume="13" first="867" last="878">
<title>Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression.</title>
<authorList>
<person name="Li H.-H."/>
<person name="Li A.G."/>
<person name="Sheppard H.M."/>
<person name="Liu X."/>
</authorList>
<dbReference type="PubMed" id="15053879"/>
<dbReference type="DOI" id="10.1016/S1097-2765(04)00123-6"/>
</citation>
<scope>PHOSPHORYLATION AT THR-55</scope>
<scope>MUTAGENESIS OF THR-55</scope>
<scope>INTERACTION WITH TAF1</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2004" name="Mol. Cell" volume="13" first="879" last="886">
<title>A dynamic role of HAUSP in the p53-Mdm2 pathway.</title>
<authorList>
<person name="Li M."/>
<person name="Brooks C.L."/>
<person name="Kon N."/>
<person name="Gu W."/>
</authorList>
<dbReference type="PubMed" id="15053880"/>
<dbReference type="DOI" id="10.1016/S1097-2765(04)00157-1"/>
</citation>
<scope>DEUBIQUITINATION BY USP7</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="7987" last="7997">
<title>Regulation of human p53 activity and cell localization by alternative splicing.</title>
<authorList>
<person name="Ghosh A."/>
<person name="Stewart D."/>
<person name="Matlashewski G."/>
</authorList>
<dbReference type="PubMed" id="15340061"/>
<dbReference type="DOI" id="10.1128/MCB.24.18.7987-7997.2004"/>
</citation>
<scope>ALTERNATIVE SPLICING (ISOFORM 4)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2004" name="Nature" volume="432" first="353" last="360">
<title>Regulation of p53 activity through lysine methylation.</title>
<authorList>
<person name="Chuikov S."/>
<person name="Kurash J.K."/>
<person name="Wilson J.R."/>
<person name="Xiao B."/>
<person name="Justin N."/>
<person name="Ivanov G.S."/>
<person name="McKinney K."/>
<person name="Tempst P."/>
<person name="Prives C."/>
<person name="Gamblin S.J."/>
<person name="Barlev N.A."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="15525938"/>
<dbReference type="DOI" id="10.1038/nature03117"/>
</citation>
<scope>METHYLATION AT LYS-372</scope>
<scope>MUTAGENESIS OF LYS-372</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="55" last="62">
<title>Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.</title>
<authorList>
<person name="Katayama H."/>
<person name="Sasai K."/>
<person name="Kawai H."/>
<person name="Yuan Z.M."/>
<person name="Bondaruk J."/>
<person name="Suzuki F."/>
<person name="Fujii S."/>
<person name="Arlinghaus R.B."/>
<person name="Czerniak B.A."/>
<person name="Sen S."/>
</authorList>
<dbReference type="PubMed" id="14702041"/>
<dbReference type="DOI" id="10.1038/ng1279"/>
</citation>
<scope>INTERACTION WITH AURKA</scope>
<scope>PHOSPHORYLATION AT SER-315</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2005" name="Genes Dev." volume="19" first="2912" last="2924">
<title>NIR is a novel INHAT repressor that modulates the transcriptional activity of p53.</title>
<authorList>
<person name="Hublitz P."/>
<person name="Kunowska N."/>
<person name="Mayer U.P."/>
<person name="Muller J.M."/>
<person name="Heyne K."/>
<person name="Yin N."/>
<person name="Fritzsche C."/>
<person name="Poli C."/>
<person name="Miguet L."/>
<person name="Schupp I.W."/>
<person name="van Grunsven L.A."/>
<person name="Potiers N."/>
<person name="van Dorsselaer A."/>
<person name="Metzger E."/>
<person name="Roemer K."/>
<person name="Schule R."/>
</authorList>
<dbReference type="PubMed" id="16322561"/>
<dbReference type="DOI" id="10.1101/gad.351205"/>
</citation>
<scope>INTERACTION WITH NOC2L</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="16019" last="16029">
<title>Tumor suppressor SMAR1 activates and stabilizes p53 through its arginine-serine-rich motif.</title>
<authorList>
<person name="Jalota-Badhwar A."/>
<person name="Singh K."/>
<person name="Pavithra L."/>
<person name="Kaul-Ghanekar R."/>
<person name="Jameel S."/>
<person name="Chattopadhyay S."/>
</authorList>
<dbReference type="PubMed" id="15701641"/>
<dbReference type="DOI" id="10.1074/jbc.M413200200"/>
</citation>
<scope>INTERACTION WITH BANP</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-15</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="25008" last="25021">
<title>Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53.</title>
<authorList>
<person name="Golubovskaya V.M."/>
<person name="Finch R."/>
<person name="Cance W.G."/>
</authorList>
<dbReference type="PubMed" id="15855171"/>
<dbReference type="DOI" id="10.1074/jbc.M414172200"/>
</citation>
<scope>INTERACTION WITH PTK2/FAK1</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="43100" last="43108">
<title>WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53.</title>
<authorList>
<person name="Chang N.-S."/>
<person name="Doherty J."/>
<person name="Ensign A."/>
<person name="Schultz L."/>
<person name="Hsu L.-J."/>
<person name="Hong Q."/>
</authorList>
<dbReference type="PubMed" id="16219768"/>
<dbReference type="DOI" id="10.1074/jbc.M505590200"/>
</citation>
<scope>INTERACTION WITH WWOX</scope>
<scope>MUTAGENESIS OF SER-46</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2005" name="Mol. Cell" volume="18" first="283" last="293">
<title>AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.</title>
<authorList>
<person name="Jones R.G."/>
<person name="Plas D.R."/>
<person name="Kubek S."/>
<person name="Buzzai M."/>
<person name="Mu J."/>
<person name="Xu Y."/>
<person name="Birnbaum M.J."/>
<person name="Thompson C.B."/>
</authorList>
<dbReference type="PubMed" id="15866171"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.03.027"/>
</citation>
<scope>PHOSPHORYLATION AT SER-15</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="10701" last="10708">
<title>LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.</title>
<authorList>
<person name="Zeng P.Y."/>
<person name="Berger S.L."/>
</authorList>
<dbReference type="PubMed" id="17108107"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-06-0999"/>
</citation>
<scope>INTERACTION WITH STK11/LKB1</scope>
<scope>PHOSPHORYLATION AT SER-15 AND SER-392</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2006" name="FEBS J." volume="273" first="2487" last="2504">
<title>The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines.</title>
<authorList>
<person name="Blanco S."/>
<person name="Klimcakova L."/>
<person name="Vega F.M."/>
<person name="Lazo P.A."/>
</authorList>
<dbReference type="PubMed" id="16704422"/>
<dbReference type="DOI" id="10.1111/j.1742-4658.2006.05256.x"/>
</citation>
<scope>PHOSPHORYLATION AT THR-18</scope>
</reference>
<reference key="80">
<citation type="journal article" date="2006" name="FEBS Lett." volume="580" first="305" last="310">
<title>Protein kinase A phosphorylates and regulates dimerization of 14-3-3 epsilon.</title>
<authorList>
<person name="Gu Y.-M."/>
<person name="Jin Y.-H."/>
<person name="Choi J.-K."/>
<person name="Baek K.-H."/>
<person name="Yeo C.-Y."/>
<person name="Lee K.-Y."/>
</authorList>
<dbReference type="PubMed" id="16376338"/>
<dbReference type="DOI" id="10.1016/j.febslet.2005.12.024"/>
</citation>
<scope>INTERACTION WITH YWHAZ</scope>
</reference>
<reference key="81">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="5734" last="5740">
<title>Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage.</title>
<authorList>
<person name="Yoshida K."/>
<person name="Liu H."/>
<person name="Miki Y."/>
</authorList>
<dbReference type="PubMed" id="16377624"/>
<dbReference type="DOI" id="10.1074/jbc.M512074200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-46</scope>
<scope>INTERACTION WITH PRKCG</scope>
</reference>
<reference key="82">
<citation type="journal article" date="2006" name="Nature" volume="444" first="629" last="632">
<title>Repression of p53 activity by Smyd2-mediated methylation.</title>
<authorList>
<person name="Huang J."/>
<person name="Perez-Burgos L."/>
<person name="Placek B.J."/>
<person name="Sengupta R."/>
<person name="Richter M."/>
<person name="Dorsey J.A."/>
<person name="Kubicek S."/>
<person name="Opravil S."/>
<person name="Jenuwein T."/>
<person name="Berger S.L."/>
</authorList>
<dbReference type="PubMed" id="17108971"/>
<dbReference type="DOI" id="10.1038/nature05287"/>
</citation>
<scope>METHYLATION AT LYS-370</scope>
<scope>MUTAGENESIS OF LYS-370</scope>
</reference>
<reference key="83">
<citation type="journal article" date="2006" name="Nat. Cell Biol." volume="8" first="855" last="862">
<title>Critical role for Daxx in regulating Mdm2.</title>
<authorList>
<person name="Tang J."/>
<person name="Qu L.K."/>
<person name="Zhang J."/>
<person name="Wang W."/>
<person name="Michaelson J.S."/>
<person name="Degenhardt Y.Y."/>
<person name="El-Deiry W.S."/>
<person name="Yang X."/>
</authorList>
<dbReference type="PubMed" id="16845383"/>
<dbReference type="DOI" id="10.1038/ncb1442"/>
</citation>
<scope>INTERACTION WITH DAXX</scope>
</reference>
<reference key="84">
<citation type="journal article" date="2006" name="Nat. Struct. Mol. Biol." volume="13" first="140" last="146">
<title>Structural basis for the methylation site specificity of SET7/9.</title>
<authorList>
<person name="Couture J.-F."/>
<person name="Collazo E."/>
<person name="Hauk G."/>
<person name="Trievel R.C."/>
</authorList>
<dbReference type="PubMed" id="16415881"/>
<dbReference type="DOI" id="10.1038/nsmb1045"/>
</citation>
<scope>MOTIF</scope>
<scope>METHYLATION AT LYS-372</scope>
</reference>
<reference key="85">
<citation type="journal article" date="2006" name="Nucleic Acids Res." volume="34" first="6640" last="6652">
<title>Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expression.</title>
<authorList>
<person name="Budhram-Mahadeo V.S."/>
<person name="Bowen S."/>
<person name="Lee S."/>
<person name="Perez-Sanchez C."/>
<person name="Ensor E."/>
<person name="Morris P.J."/>
<person name="Latchman D.S."/>
</authorList>
<dbReference type="PubMed" id="17145718"/>
<dbReference type="DOI" id="10.1093/nar/gkl878"/>
</citation>
<scope>INTERACTION WITH POU4F2</scope>
</reference>
<reference key="86">
<citation type="journal article" date="2007" name="Cell" volume="128" first="295" last="308">
<title>PRAK is essential for ras-induced senescence and tumor suppression.</title>
<authorList>
<person name="Sun P."/>
<person name="Yoshizuka N."/>
<person name="New L."/>
<person name="Moser B.A."/>
<person name="Li Y."/>
<person name="Liao R."/>
<person name="Xie C."/>
<person name="Chen J."/>
<person name="Deng Q."/>
<person name="Yamout M."/>
<person name="Dong M.Q."/>
<person name="Frangou C.G."/>
<person name="Yates J.R. III"/>
<person name="Wright P.E."/>
<person name="Han J."/>
</authorList>
<dbReference type="PubMed" id="17254968"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.11.050"/>
</citation>
<scope>PHOSPHORYLATION AT SER-37</scope>
<scope>MUTAGENESIS OF SER-37</scope>
</reference>
<reference key="87">
<citation type="journal article" date="2007" name="Cell" volume="130" first="624" last="637">
<title>Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation.</title>
<authorList>
<person name="Das S."/>
<person name="Raj L."/>
<person name="Zhao B."/>
<person name="Kimura Y."/>
<person name="Bernstein A."/>
<person name="Aaronson S.A."/>
<person name="Lee S.W."/>
</authorList>
<dbReference type="PubMed" id="17719541"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.06.013"/>
</citation>
<scope>INTERACTION WITH ZNF385A</scope>
<scope>CHARACTERIZATION OF VARIANTS ALA-143; HIS-175 AND PRO-175</scope>
</reference>
<reference key="88">
<citation type="journal article" date="2007" name="EMBO J." volume="26" first="113" last="122">
<title>Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'.</title>
<authorList>
<person name="Yamasaki S."/>
<person name="Yagishita N."/>
<person name="Sasaki T."/>
<person name="Nakazawa M."/>
<person name="Kato Y."/>
<person name="Yamadera T."/>
<person name="Bae E."/>
<person name="Toriyama S."/>
<person name="Ikeda R."/>
<person name="Zhang L."/>
<person name="Fujitani K."/>
<person name="Yoo E."/>
<person name="Tsuchimochi K."/>
<person name="Ohta T."/>
<person name="Araya N."/>
<person name="Fujita H."/>
<person name="Aratani S."/>
<person name="Eguchi K."/>
<person name="Komiya S."/>
<person name="Maruyama I."/>
<person name="Higashi N."/>
<person name="Sato M."/>
<person name="Senoo H."/>
<person name="Ochi T."/>
<person name="Yokoyama S."/>
<person name="Amano T."/>
<person name="Kim J."/>
<person name="Gay S."/>
<person name="Fukamizu A."/>
<person name="Nishioka K."/>
<person name="Tanaka K."/>
<person name="Nakajima T."/>
</authorList>
<dbReference type="PubMed" id="17170702"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601490"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>INTERACTION WITH SYVN1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="89">
<citation type="journal article" date="2007" name="EMBO J." volume="26" first="402" last="411">
<title>A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55.</title>
<authorList>
<person name="Li H.H."/>
<person name="Cai X."/>
<person name="Shouse G.P."/>
<person name="Piluso L.G."/>
<person name="Liu X."/>
</authorList>
<dbReference type="PubMed" id="17245430"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601519"/>
</citation>
<scope>INTERACTION WITH PPP2CA; PPP2R1A; PPP2R2A AND PPP2R5C</scope>
</reference>
<reference key="90">
<citation type="journal article" date="2007" name="FEBS Lett." volume="581" first="4943" last="4948">
<title>SVH-B interacts directly with p53 and suppresses the transcriptional activity of p53.</title>
<authorList>
<person name="Zhou X."/>
<person name="Yang G."/>
<person name="Huang R."/>
<person name="Chen X."/>
<person name="Hu G."/>
</authorList>
<dbReference type="PubMed" id="17904127"/>
<dbReference type="DOI" id="10.1016/j.febslet.2007.09.025"/>
</citation>
<scope>INTERACTION WITH ARMC10</scope>
</reference>
<reference key="91">
<citation type="journal article" date="2007" name="FEBS Lett." volume="581" first="5649" last="5657">
<title>Novel homeodomain-interacting protein kinase family member, HIPK4, phosphorylates human p53 at serine 9.</title>
<authorList>
<person name="Arai S."/>
<person name="Matsushita A."/>
<person name="Du K."/>
<person name="Yagi K."/>
<person name="Okazaki Y."/>
<person name="Kurokawa R."/>
</authorList>
<dbReference type="PubMed" id="18022393"/>
<dbReference type="DOI" id="10.1016/j.febslet.2007.11.022"/>
</citation>
<scope>PHOSPHORYLATION AT SER-9</scope>
</reference>
<reference key="92">
<citation type="journal article" date="2007" name="Genomics" volume="89" first="756" last="768">
<title>Nine-amino-acid transactivation domain: establishment and prediction utilities.</title>
<authorList>
<person name="Piskacek S."/>
<person name="Gregor M."/>
<person name="Nemethova M."/>
<person name="Grabner M."/>
<person name="Kovarik P."/>
<person name="Piskacek M."/>
</authorList>
<dbReference type="PubMed" id="17467953"/>
<dbReference type="DOI" id="10.1016/j.ygeno.2007.02.003"/>
</citation>
<scope>DOMAIN</scope>
</reference>
<reference key="93">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="3273" last="3281">
<title>CARPs are ubiquitin ligases that promote MDM2-independent p53 and phospho-p53ser20 degradation.</title>
<authorList>
<person name="Yang W."/>
<person name="Rozan L.M."/>
<person name="McDonald E.R. III"/>
<person name="Navaraj A."/>
<person name="Liu J.J."/>
<person name="Matthew E.M."/>
<person name="Wang W."/>
<person name="Dicker D.T."/>
<person name="El-Deiry W.S."/>
</authorList>
<dbReference type="PubMed" id="17121812"/>
<dbReference type="DOI" id="10.1074/jbc.M610793200"/>
</citation>
<scope>INTERACTION WITH RFFL AND RNF34</scope>
</reference>
<reference key="94">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="11969" last="11981">
<title>The notch regulator MAML1 interacts with p53 and functions as a coactivator.</title>
<authorList>
<person name="Zhao Y."/>
<person name="Katzman R.B."/>
<person name="Delmolino L.M."/>
<person name="Bhat I."/>
<person name="Zhang Y."/>
<person name="Gurumurthy C.B."/>
<person name="Germaniuk-Kurowska A."/>
<person name="Reddi H.V."/>
<person name="Solomon A."/>
<person name="Zeng M.S."/>
<person name="Kung A."/>
<person name="Ma H."/>
<person name="Gao Q."/>
<person name="Dimri G."/>
<person name="Stanculescu A."/>
<person name="Miele L."/>
<person name="Wu L."/>
<person name="Griffin J.D."/>
<person name="Wazer D.E."/>
<person name="Band H."/>
<person name="Band V."/>
</authorList>
<dbReference type="PubMed" id="17317671"/>
<dbReference type="DOI" id="10.1074/jbc.M608974200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MAML1</scope>
</reference>
<reference key="95">
<citation type="journal article" date="2007" name="J. Cell Sci." volume="120" first="2259" last="2271">
<title>Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.</title>
<authorList>
<person name="Lee J.-H."/>
<person name="Kim H.-S."/>
<person name="Lee S.-J."/>
<person name="Kim K.-T."/>
</authorList>
<dbReference type="PubMed" id="17591690"/>
<dbReference type="DOI" id="10.1242/jcs.03468"/>
</citation>
<scope>PHOSPHORYLATION AT SER-15; SER-33 AND SER-46</scope>
<scope>INTERACTION WITH CDK5</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="96">
<citation type="journal article" date="2007" name="Mol. Biol. Cell" volume="18" first="1701" last="1709">
<title>Dynamic regulation of p53 subnuclear localization and senescence by MORC3.</title>
<authorList>
<person name="Takahashi K."/>
<person name="Yoshida N."/>
<person name="Murakami N."/>
<person name="Kawata K."/>
<person name="Ishizaki H."/>
<person name="Tanaka-Okamoto M."/>
<person name="Miyoshi J."/>
<person name="Zinn A.R."/>
<person name="Shime H."/>
<person name="Inoue N."/>
</authorList>
<dbReference type="PubMed" id="17332504"/>
<dbReference type="DOI" id="10.1091/mbc.E06-08-0747"/>
</citation>
<scope>INTERACTION WITH MORC3</scope>
</reference>
<reference key="97">
<citation type="journal article" date="2007" name="Mol. Cell" volume="25" first="725" last="738">
<title>DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage.</title>
<authorList>
<person name="Taira N."/>
<person name="Nihira K."/>
<person name="Yamaguchi T."/>
<person name="Miki Y."/>
<person name="Yoshida K."/>
</authorList>
<dbReference type="PubMed" id="17349958"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.02.007"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-46</scope>
<scope>MUTAGENESIS OF SER-46</scope>
</reference>
<reference key="98">
<citation type="journal article" date="2007" name="Nature" volume="449" first="105" last="108">
<title>p53 is regulated by the lysine demethylase LSD1.</title>
<authorList>
<person name="Huang J."/>
<person name="Sengupta R."/>
<person name="Espejo A.B."/>
<person name="Lee M.G."/>
<person name="Dorsey J.A."/>
<person name="Richter M."/>
<person name="Opravil S."/>
<person name="Shiekhattar R."/>
<person name="Bedford M.T."/>
<person name="Jenuwein T."/>
<person name="Berger S.L."/>
</authorList>
<dbReference type="PubMed" id="17805299"/>
<dbReference type="DOI" id="10.1038/nature06092"/>
</citation>
<scope>DEMETHYLATION BY KDM1A</scope>
</reference>
<reference key="99">
<citation type="journal article" date="2007" name="Mol. Cell" volume="27" first="636" last="646">
<title>Modulation of p53 function by SET8-mediated methylation at lysine 382.</title>
<authorList>
<person name="Shi X."/>
<person name="Kachirskaia I."/>
<person name="Yamaguchi H."/>
<person name="West L.E."/>
<person name="Wen H."/>
<person name="Wang E.W."/>
<person name="Dutta S."/>
<person name="Appella E."/>
<person name="Gozani O."/>
</authorList>
<dbReference type="PubMed" id="17707234"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.07.012"/>
</citation>
<scope>METHYLATION AT LYS-382</scope>
<scope>MUTAGENESIS OF LYS-382</scope>
</reference>
<reference key="100">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="101">
<citation type="journal article" date="2008" name="Biochem. Biophys. Res. Commun." volume="368" first="690" last="695">
<title>Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53.</title>
<authorList>
<person name="Jin Y.H."/>
<person name="Kim Y.J."/>
<person name="Kim D.W."/>
<person name="Baek K.H."/>
<person name="Kang B.Y."/>
<person name="Yeo C.Y."/>
<person name="Lee K.Y."/>
</authorList>
<dbReference type="PubMed" id="18249187"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2008.01.114"/>
</citation>
<scope>ACETYLATION</scope>
<scope>DEACETYLATION BY SIRT2</scope>
</reference>
<reference key="102">
<citation type="journal article" date="2008" name="Cell. Signal." volume="20" first="1671" last="1678">
<title>Histone methyltransferase protein SETD2 interacts with p53 and selectively regulates its downstream genes.</title>
<authorList>
<person name="Xie P."/>
<person name="Tian C."/>
<person name="An L."/>
<person name="Nie J."/>
<person name="Lu K."/>
<person name="Xing G."/>
<person name="Zhang L."/>
<person name="He F."/>
</authorList>
<dbReference type="PubMed" id="18585004"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2008.05.012"/>
</citation>
<scope>INTERACTION WITH SETD2</scope>
</reference>
<reference key="103">
<citation type="journal article" date="2008" name="Mol. Cell" volume="29" first="9" last="22">
<title>Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation.</title>
<authorList>
<person name="Lim S.T."/>
<person name="Chen X.L."/>
<person name="Lim Y."/>
<person name="Hanson D.A."/>
<person name="Vo T.T."/>
<person name="Howerton K."/>
<person name="Larocque N."/>
<person name="Fisher S.J."/>
<person name="Schlaepfer D.D."/>
<person name="Ilic D."/>
</authorList>
<dbReference type="PubMed" id="18206965"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.11.031"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="104">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="448" last="456">
<title>Serine 15 phosphorylation of p53 directs its interaction with B56gamma and the tumor suppressor activity of B56gamma-specific protein phosphatase 2A.</title>
<authorList>
<person name="Shouse G.P."/>
<person name="Cai X."/>
<person name="Liu X."/>
</authorList>
<dbReference type="PubMed" id="17967874"/>
<dbReference type="DOI" id="10.1128/MCB.00983-07"/>
</citation>
<scope>INTERACTION WITH PPP2CA; PPP2R1A AND PPP2R5C</scope>
<scope>PHOSPHORYLATION AT SER-15 BY ATM</scope>
<scope>MUTAGENESIS OF SER-15</scope>
</reference>
<reference key="105">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="106">
<citation type="journal article" date="2009" name="EMBO J." volume="28" first="2100" last="2113">
<title>Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis.</title>
<authorList>
<person name="Lee E.-W."/>
<person name="Lee M.-S."/>
<person name="Camus S."/>
<person name="Ghim J."/>
<person name="Yang M.-R."/>
<person name="Oh W."/>
<person name="Ha N.-C."/>
<person name="Lane D.P."/>
<person name="Song J."/>
</authorList>
<dbReference type="PubMed" id="19536131"/>
<dbReference type="DOI" id="10.1038/emboj.2009.164"/>
</citation>
<scope>INTERACTION WITH MKRN1</scope>
<scope>MUTAGENESIS OF 291-LYS-LYS-292</scope>
<scope>UBIQUITINATION AT LYS-291 AND LYS-292 BY MKRN1</scope>
</reference>
<reference key="107">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="18588" last="18592">
<title>Plk1-mediated phosphorylation of Topors regulates p53 stability.</title>
<authorList>
<person name="Yang X."/>
<person name="Li H."/>
<person name="Zhou Z."/>
<person name="Wang W.H."/>
<person name="Deng A."/>
<person name="Andrisani O."/>
<person name="Liu X."/>
</authorList>
<dbReference type="PubMed" id="19473992"/>
<dbReference type="DOI" id="10.1074/jbc.C109.001560"/>
</citation>
<scope>UBIQUITINATION BY TOPORS</scope>
</reference>
<reference key="108">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="34545" last="34552">
<title>MTA1 coregulator regulates p53 stability and function.</title>
<authorList>
<person name="Li D.Q."/>
<person name="Divijendra Natha Reddy S."/>
<person name="Pakala S.B."/>
<person name="Wu X."/>
<person name="Zhang Y."/>
<person name="Rayala S.K."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="19837670"/>
<dbReference type="DOI" id="10.1074/jbc.M109.056499"/>
</citation>
<scope>INTERACTION WITH MTA1 AND RFWD2</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="109">
<citation type="journal article" date="2009" name="J. Virol." volume="83" first="12388" last="12398">
<title>Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein.</title>
<authorList>
<person name="Hwang E.S."/>
<person name="Zhang Z."/>
<person name="Cai H."/>
<person name="Huang D.Y."/>
<person name="Huong S.M."/>
<person name="Cha C.Y."/>
<person name="Huang E.S."/>
</authorList>
<dbReference type="PubMed" id="19776115"/>
<dbReference type="DOI" id="10.1128/JVI.00304-09"/>
</citation>
<scope>INTERACTION WITH HHV-5 PROTEIN UL123</scope>
</reference>
<reference key="110">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="10195" last="10200">
<title>JFK, a Kelch domain-containing F-box protein, links the SCF complex to p53 regulation.</title>
<authorList>
<person name="Sun L."/>
<person name="Shi L."/>
<person name="Li W."/>
<person name="Yu W."/>
<person name="Liang J."/>
<person name="Zhang H."/>
<person name="Yang X."/>
<person name="Wang Y."/>
<person name="Li R."/>
<person name="Yao X."/>
<person name="Yi X."/>
<person name="Shang Y."/>
</authorList>
<dbReference type="PubMed" id="19509332"/>
<dbReference type="DOI" id="10.1073/pnas.0901864106"/>
</citation>
<scope>INTERACTION WITH FBXO42</scope>
</reference>
<reference key="111">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="11612" last="11616">
<title>Trim24 targets endogenous p53 for degradation.</title>
<authorList>
<person name="Allton K."/>
<person name="Jain A.K."/>
<person name="Herz H.M."/>
<person name="Tsai W.W."/>
<person name="Jung S.Y."/>
<person name="Qin J."/>
<person name="Bergmann A."/>
<person name="Johnson R.L."/>
<person name="Barton M.C."/>
</authorList>
<dbReference type="PubMed" id="19556538"/>
<dbReference type="DOI" id="10.1073/pnas.0813177106"/>
</citation>
<scope>FUNCTION</scope>
<scope>UBIQUITINATION</scope>
<scope>INTERACTION WITH TRIM24</scope>
</reference>
<reference key="112">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-381 AND LYS-382</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="113">
<citation type="journal article" date="2010" name="Cell" volume="140" first="384" last="396">
<title>USP10 regulates p53 localization and stability by deubiquitinating p53.</title>
<authorList>
<person name="Yuan J."/>
<person name="Luo K."/>
<person name="Zhang L."/>
<person name="Cheville J.C."/>
<person name="Lou Z."/>
</authorList>
<dbReference type="PubMed" id="20096447"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.12.032"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP10</scope>
</reference>
<reference key="114">
<citation type="journal article" date="2010" name="Cell" volume="142" first="409" last="419">
<title>A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response.</title>
<authorList>
<person name="Huarte M."/>
<person name="Guttman M."/>
<person name="Feldser D."/>
<person name="Garber M."/>
<person name="Koziol M.J."/>
<person name="Kenzelmann-Broz D."/>
<person name="Khalil A.M."/>
<person name="Zuk O."/>
<person name="Amit I."/>
<person name="Rabani M."/>
<person name="Attardi L.D."/>
<person name="Regev A."/>
<person name="Lander E.S."/>
<person name="Jacks T."/>
<person name="Rinn J.L."/>
</authorList>
<dbReference type="PubMed" id="20673990"/>
<dbReference type="DOI" id="10.1016/j.cell.2010.06.040"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="115">
<citation type="journal article" date="2010" name="Cell. Mol. Life Sci." volume="67" first="1105" last="1118">
<title>Isoform specific phosphorylation of p53 by protein kinase CK1.</title>
<authorList>
<person name="Venerando A."/>
<person name="Marin O."/>
<person name="Cozza G."/>
<person name="Bustos V.H."/>
<person name="Sarno S."/>
<person name="Pinna L.A."/>
</authorList>
<dbReference type="PubMed" id="20041275"/>
<dbReference type="DOI" id="10.1007/s00018-009-0236-7"/>
</citation>
<scope>PHOSPHORYLATION AT SER-20 BY CSNK1D/CK1</scope>
</reference>
<reference key="116">
<citation type="journal article" date="2010" name="FEBS Lett." volume="584" first="2231" last="2236">
<title>p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma.</title>
<authorList>
<person name="Lim S.O."/>
<person name="Kim H."/>
<person name="Jung G."/>
</authorList>
<dbReference type="PubMed" id="20385133"/>
<dbReference type="DOI" id="10.1016/j.febslet.2010.04.006"/>
</citation>
<scope>INTERACTION WITH SNAI1</scope>
<scope>CHARACTERIZATION OF VARIANTS LEU-110; PRO-155; HIS-175; SER-232; SER-249; HIS-273 AND TRP-282</scope>
<scope>MUTAGENESIS OF ARG-248</scope>
</reference>
<reference key="117">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="1743" last="1753">
<title>Pyk2 inhibition of p53 as an adaptive and intrinsic mechanism facilitating cell proliferation and survival.</title>
<authorList>
<person name="Lim S.T."/>
<person name="Miller N.L."/>
<person name="Nam J.O."/>
<person name="Chen X.L."/>
<person name="Lim Y."/>
<person name="Schlaepfer D.D."/>
</authorList>
<dbReference type="PubMed" id="19880522"/>
<dbReference type="DOI" id="10.1074/jbc.M109.064212"/>
</citation>
<scope>INTERACTION WITH PTK2B/PYK2 AND MDM2</scope>
<scope>UBIQUITINATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="118">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="9636" last="9641">
<title>G9a and Glp methylate lysine 373 in the tumor suppressor p53.</title>
<authorList>
<person name="Huang J."/>
<person name="Dorsey J."/>
<person name="Chuikov S."/>
<person name="Perez-Burgos L."/>
<person name="Zhang X."/>
<person name="Jenuwein T."/>
<person name="Reinberg D."/>
<person name="Berger S.L."/>
</authorList>
<dbReference type="PubMed" id="20118233"/>
<dbReference type="DOI" id="10.1074/jbc.M109.062588"/>
</citation>
<scope>METHYLATION AT LYS-373</scope>
<scope>MUTAGENESIS OF LYS-373</scope>
</reference>
<reference key="119">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="18122" last="18122">
<authorList>
<person name="Huang J."/>
<person name="Dorsey J."/>
<person name="Chuikov S."/>
<person name="Perez-Burgos L."/>
<person name="Zhang X."/>
<person name="Jenuwein T."/>
<person name="Reinberg D."/>
<person name="Berger S.L."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="120">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="12823" last="12830">
<title>G-protein-coupled receptor kinase 5 phosphorylates p53 and inhibits DNA damage-induced apoptosis.</title>
<authorList>
<person name="Chen X."/>
<person name="Zhu H."/>
<person name="Yuan M."/>
<person name="Fu J."/>
<person name="Zhou Y."/>
<person name="Ma L."/>
</authorList>
<dbReference type="PubMed" id="20124405"/>
<dbReference type="DOI" id="10.1074/jbc.M109.094243"/>
</citation>
<scope>PHOSPHORYLATION AT THR-55</scope>
<scope>INTERACTION WITH GRK5</scope>
</reference>
<reference key="121">
<citation type="journal article" date="2010" name="Nat. Cell Biol." volume="12" first="380" last="389">
<title>BRD7 is a candidate tumour suppressor gene required for p53 function.</title>
<authorList>
<person name="Drost J."/>
<person name="Mantovani F."/>
<person name="Tocco F."/>
<person name="Elkon R."/>
<person name="Comel A."/>
<person name="Holstege H."/>
<person name="Kerkhoven R."/>
<person name="Jonkers J."/>
<person name="Voorhoeve P.M."/>
<person name="Agami R."/>
<person name="Del Sal G."/>
</authorList>
<dbReference type="PubMed" id="20228809"/>
<dbReference type="DOI" id="10.1038/ncb2038"/>
</citation>
<scope>INTERACTION WITH BRD7</scope>
<scope>ACETYLATION AT LYS-382</scope>
</reference>
<reference key="122">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="4579" last="4584">
<title>RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage.</title>
<authorList>
<person name="Fu X."/>
<person name="Yucer N."/>
<person name="Liu S."/>
<person name="Li M."/>
<person name="Yi P."/>
<person name="Mu J.J."/>
<person name="Yang T."/>
<person name="Chu J."/>
<person name="Jung S.Y."/>
<person name="O'Malley B.W."/>
<person name="Gu W."/>
<person name="Qin J."/>
<person name="Wang Y."/>
</authorList>
<dbReference type="PubMed" id="20173098"/>
<dbReference type="DOI" id="10.1073/pnas.0912094107"/>
</citation>
<scope>UBIQUITINATION BY RFWD3</scope>
</reference>
<reference key="123">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="14280" last="14285">
<title>Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence.</title>
<authorList>
<person name="Burrows A.E."/>
<person name="Smogorzewska A."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="20660729"/>
<dbReference type="DOI" id="10.1073/pnas.1009559107"/>
</citation>
<scope>INTERACTION WITH BRD7</scope>
</reference>
<reference key="124">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="125">
<citation type="journal article" date="2011" name="Cell Cycle" volume="10" first="3284" last="3299">
<title>NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor.</title>
<authorList>
<person name="Mori T."/>
<person name="Ikeda D.D."/>
<person name="Fukushima T."/>
<person name="Takenoshita S."/>
<person name="Kochi H."/>
</authorList>
<dbReference type="PubMed" id="21952639"/>
<dbReference type="DOI" id="10.4161/cc.10.19.17176"/>
</citation>
<scope>INTERACTION WITH UHRF2</scope>
</reference>
<reference key="126">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="2236" last="2244">
<title>Aurora B interacts with NIR-p53, leading to p53 phosphorylation in its DNA-binding domain and subsequent functional suppression.</title>
<authorList>
<person name="Wu L."/>
<person name="Ma C.A."/>
<person name="Zhao Y."/>
<person name="Jain A."/>
</authorList>
<dbReference type="PubMed" id="20959462"/>
<dbReference type="DOI" id="10.1074/jbc.M110.174755"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH AURKB AND NOC2L</scope>
<scope>PHOSPHORYLATION AT SER-183; SER-269 AND THR-284</scope>
<scope>CHARACTERIZATION OF VARIANT ALA-284</scope>
<scope>MUTAGENESIS OF SER-183 AND SER-269</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="127">
<citation type="journal article" date="2011" name="Nat. Genet." volume="43" first="1098" last="1103">
<title>A germline variant in the TP53 polyadenylation signal confers cancer susceptibility.</title>
<authorList>
<person name="Stacey S.N."/>
<person name="Sulem P."/>
<person name="Jonasdottir A."/>
<person name="Masson G."/>
<person name="Gudmundsson J."/>
<person name="Gudbjartsson D.F."/>
<person name="Magnusson O.T."/>
<person name="Gudjonsson S.A."/>
<person name="Sigurgeirsson B."/>
<person name="Thorisdottir K."/>
<person name="Ragnarsson R."/>
<person name="Benediktsdottir K.R."/>
<person name="Nexo B.A."/>
<person name="Tjonneland A."/>
<person name="Overvad K."/>
<person name="Rudnai P."/>
<person name="Gurzau E."/>
<person name="Koppova K."/>
<person name="Hemminki K."/>
<person name="Corredera C."/>
<person name="Fuentelsaz V."/>
<person name="Grasa P."/>
<person name="Navarrete S."/>
<person name="Fuertes F."/>
<person name="Garcia-Prats M.D."/>
<person name="Sanambrosio E."/>
<person name="Panadero A."/>
<person name="De Juan A."/>
<person name="Garcia A."/>
<person name="Rivera F."/>
<person name="Planelles D."/>
<person name="Soriano V."/>
<person name="Requena C."/>
<person name="Aben K.K."/>
<person name="van Rossum M.M."/>
<person name="Cremers R.G."/>
<person name="van Oort I.M."/>
<person name="van Spronsen D.J."/>
<person name="Schalken J.A."/>
<person name="Peters W.H."/>
<person name="Helfand B.T."/>
<person name="Donovan J.L."/>
<person name="Hamdy F.C."/>
<person name="Badescu D."/>
<person name="Codreanu O."/>
<person name="Jinga M."/>
<person name="Csiki I.E."/>
<person name="Constantinescu V."/>
<person name="Badea P."/>
<person name="Mates I.N."/>
<person name="Dinu D.E."/>
<person name="Constantin A."/>
<person name="Mates D."/>
<person name="Kristjansdottir S."/>
<person name="Agnarsson B.A."/>
<person name="Jonsson E."/>
<person name="Barkardottir R.B."/>
<person name="Einarsson G.V."/>
<person name="Sigurdsson F."/>
<person name="Moller P.H."/>
<person name="Stefansson T."/>
<person name="Valdimarsson T."/>
<person name="Johannsson O.T."/>
<person name="Sigurdsson H."/>
<person name="Jonsson T."/>
<person name="Jonasson J.G."/>
<person name="Tryggvadottir L."/>
<person name="Rice T."/>
<person name="Hansen H.M."/>
<person name="Xiao Y."/>
<person name="Lachance D.H."/>
<person name="O'Neill B.P."/>
<person name="Kosel M.L."/>
<person name="Decker P.A."/>
<person name="Thorleifsson G."/>
<person name="Johannsdottir H."/>
<person name="Helgadottir H.T."/>
<person name="Sigurdsson A."/>
<person name="Steinthorsdottir V."/>
<person name="Lindblom A."/>
<person name="Sandler R.S."/>
<person name="Keku T.O."/>
<person name="Banasik K."/>
<person name="Jorgensen T."/>
<person name="Witte D.R."/>
<person name="Hansen T."/>
<person name="Pedersen O."/>
<person name="Jinga V."/>
<person name="Neal D.E."/>
<person name="Catalona W.J."/>
<person name="Wrensch M."/>
<person name="Wiencke J."/>
<person name="Jenkins R.B."/>
<person name="Nagore E."/>
<person name="Vogel U."/>
<person name="Kiemeney L.A."/>
<person name="Kumar R."/>
<person name="Mayordomo J.I."/>
<person name="Olafsson J.H."/>
<person name="Kong A."/>
<person name="Thorsteinsdottir U."/>
<person name="Rafnar T."/>
<person name="Stefansson K."/>
</authorList>
<dbReference type="PubMed" id="21946351"/>
<dbReference type="DOI" id="10.1038/ng.926"/>
</citation>
<scope>INVOLVEMENT IN BCC7</scope>
</reference>
<reference key="128">
<citation type="journal article" date="2011" name="Oncogene" volume="30" first="2933" last="2942">
<title>A new role of NUAK1: directly phosphorylating p53 and regulating cell proliferation.</title>
<authorList>
<person name="Hou X."/>
<person name="Liu J.E."/>
<person name="Liu W."/>
<person name="Liu C.Y."/>
<person name="Liu Z.Y."/>
<person name="Sun Z.Y."/>
</authorList>
<dbReference type="PubMed" id="21317932"/>
<dbReference type="DOI" id="10.1038/onc.2011.19"/>
</citation>
<scope>INTERACTION WITH NUAK1</scope>
<scope>PHOSPHORYLATION AT SER-15 AND SER-392</scope>
</reference>
<reference key="129">
<citation type="journal article" date="2012" name="Cell" volume="149" first="1536" last="1548">
<title>p53 opens the mitochondrial permeability transition pore to trigger necrosis.</title>
<authorList>
<person name="Vaseva A.V."/>
<person name="Marchenko N.D."/>
<person name="Ji K."/>
<person name="Tsirka S.E."/>
<person name="Holzmann S."/>
<person name="Moll U.M."/>
</authorList>
<dbReference type="PubMed" id="22726440"/>
<dbReference type="DOI" id="10.1016/j.cell.2012.05.014"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PPIF</scope>
</reference>
<reference key="130">
<citation type="journal article" date="2012" name="Cell Cycle" volume="11" first="407" last="417">
<title>The RAX/PACT-PKR stress response pathway promotes p53 sumoylation and activation, leading to G(1) arrest.</title>
<authorList>
<person name="Bennett R.L."/>
<person name="Pan Y."/>
<person name="Christian J."/>
<person name="Hui T."/>
<person name="May W.S. Jr."/>
</authorList>
<dbReference type="PubMed" id="22214662"/>
<dbReference type="DOI" id="10.4161/cc.11.2.18999"/>
</citation>
<scope>INTERACTION WITH UBC9</scope>
<scope>PHOSPHORYLATION AT SER-392</scope>
<scope>SUMOYLATION AT LYS-386</scope>
</reference>
<reference key="131">
<citation type="journal article" date="2012" name="Cell Death Differ." volume="19" first="1613" last="1622">
<title>Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses.</title>
<authorList>
<person name="Lee S."/>
<person name="Kim J.Y."/>
<person name="Kim Y.J."/>
<person name="Seok K.O."/>
<person name="Kim J.H."/>
<person name="Chang Y.J."/>
<person name="Kang H.Y."/>
<person name="Park J.H."/>
</authorList>
<dbReference type="PubMed" id="22522597"/>
<dbReference type="DOI" id="10.1038/cdd.2012.40"/>
</citation>
<scope>INTERACTION WITH NOP53</scope>
</reference>
<reference key="132">
<citation type="journal article" date="2012" name="Eur. J. Immunol." volume="42" first="3405" last="3415">
<title>ZNF385B is characteristically expressed in germinal center B cells and involved in B-cell apoptosis.</title>
<authorList>
<person name="Iijima K."/>
<person name="Yamada H."/>
<person name="Miharu M."/>
<person name="Imadome K."/>
<person name="Miyagawa Y."/>
<person name="Akimoto S."/>
<person name="Kobayashi K."/>
<person name="Okita H."/>
<person name="Nakazawa A."/>
<person name="Fujiwara S."/>
<person name="Fujimoto J."/>
<person name="Kiyokawa N."/>
</authorList>
<dbReference type="PubMed" id="22945289"/>
<dbReference type="DOI" id="10.1002/eji.201242530"/>
</citation>
<scope>INTERACTION WITH ZNF385B</scope>
</reference>
<reference key="133">
<citation type="journal article" date="2012" name="Nat. Struct. Mol. Biol." volume="19" first="916" last="924">
<title>PHF20 is an effector protein of p53 double lysine methylation that stabilizes and activates p53.</title>
<authorList>
<person name="Cui G."/>
<person name="Park S."/>
<person name="Badeaux A.I."/>
<person name="Kim D."/>
<person name="Lee J."/>
<person name="Thompson J.R."/>
<person name="Yan F."/>
<person name="Kaneko S."/>
<person name="Yuan Z."/>
<person name="Botuyan M.V."/>
<person name="Bedford M.T."/>
<person name="Cheng J.Q."/>
<person name="Mer G."/>
</authorList>
<dbReference type="PubMed" id="22864287"/>
<dbReference type="DOI" id="10.1038/nsmb.2353"/>
</citation>
<scope>METHYLATION AT LYS-370 AND LYS-382</scope>
</reference>
<reference key="134">
<citation type="journal article" date="2013" name="Nat. Commun." volume="4" first="2444" last="2444">
<title>p53 regulates Period2 expression and the circadian clock.</title>
<authorList>
<person name="Miki T."/>
<person name="Matsumoto T."/>
<person name="Zhao Z."/>
<person name="Lee C.C."/>
</authorList>
<dbReference type="PubMed" id="24051492"/>
<dbReference type="DOI" id="10.1038/ncomms3444"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="135">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="3895" last="3900">
<title>MOZ increases p53 acetylation and premature senescence through its complex formation with PML.</title>
<authorList>
<person name="Rokudai S."/>
<person name="Laptenko O."/>
<person name="Arnal S.M."/>
<person name="Taya Y."/>
<person name="Kitabayashi I."/>
<person name="Prives C."/>
</authorList>
<dbReference type="PubMed" id="23431171"/>
<dbReference type="DOI" id="10.1073/pnas.1300490110"/>
</citation>
<scope>INTERACTION WITH KAT6A</scope>
<scope>ACETYLATION AT LYS-120 AND LYS-382</scope>
</reference>
<reference key="136">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="E5282" last="E5291">
<title>Disruption of FAT10-MAD2 binding inhibits tumor progression.</title>
<authorList>
<person name="Theng S.S."/>
<person name="Wang W."/>
<person name="Mah W.C."/>
<person name="Chan C."/>
<person name="Zhuo J."/>
<person name="Gao Y."/>
<person name="Qin H."/>
<person name="Lim L."/>
<person name="Chong S.S."/>
<person name="Song J."/>
<person name="Lee C.G."/>
</authorList>
<dbReference type="PubMed" id="25422469"/>
<dbReference type="DOI" id="10.1073/pnas.1403383111"/>
</citation>
<scope>INTERACTION WITH UBD</scope>
</reference>
<reference key="137">
<citation type="journal article" date="2015" name="Cell. Physiol. Biochem." volume="35" first="237" last="245">
<title>RNF125 is a ubiquitin-protein ligase that promotes p53 degradation.</title>
<authorList>
<person name="Yang L."/>
<person name="Zhou B."/>
<person name="Li X."/>
<person name="Lu Z."/>
<person name="Li W."/>
<person name="Huo X."/>
<person name="Miao Z."/>
</authorList>
<dbReference type="PubMed" id="25591766"/>
<dbReference type="DOI" id="10.1159/000369691"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="138">
<citation type="journal article" date="2016" name="Oncogene" volume="35" first="69" last="82">
<title>PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53.</title>
<authorList>
<person name="Wimmer P."/>
<person name="Berscheminski J."/>
<person name="Blanchette P."/>
<person name="Groitl P."/>
<person name="Branton P.E."/>
<person name="Hay R.T."/>
<person name="Dobner T."/>
<person name="Schreiner S."/>
</authorList>
<dbReference type="PubMed" id="25772236"/>
<dbReference type="DOI" id="10.1038/onc.2015.63"/>
</citation>
<scope>INTERACTION WITH HADV5 E1B-55K</scope>
</reference>
<reference key="139">
<citation type="journal article" date="2016" name="Oncotarget" volume="7" first="47687" last="47698">
<title>LACE1 interacts with p53 and mediates its mitochondrial translocation and apoptosis.</title>
<authorList>
<person name="Cesnekova J."/>
<person name="Spacilova J."/>
<person name="Hansikova H."/>
<person name="Houstek J."/>
<person name="Zeman J."/>
<person name="Stiburek L."/>
</authorList>
<dbReference type="PubMed" id="27323408"/>
<dbReference type="DOI" id="10.18632/oncotarget.9959"/>
</citation>
<scope>INTERACTION WITH AFG1L</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="140">
<citation type="journal article" date="1994" name="Science" volume="265" first="386" last="391">
<title>High-resolution structure of the oligomerization domain of p53 by multidimensional NMR.</title>
<authorList>
<person name="Clore G.M."/>
<person name="Omichinski J.G."/>
<person name="Sakaguchi K."/>
<person name="Zambrano N."/>
<person name="Sakamoto H."/>
<person name="Appella E."/>
<person name="Gronenborn A.M."/>
</authorList>
<dbReference type="PubMed" id="8023159"/>
<dbReference type="DOI" id="10.1126/science.8023159"/>
</citation>
<scope>STRUCTURE BY NMR OF 319-360</scope>
</reference>
<reference key="141">
<citation type="journal article" date="1994" name="Nat. Struct. Biol." volume="1" first="877" last="890">
<title>Solution structure of the tetrameric minimum transforming domain of p53.</title>
<authorList>
<person name="Lee W."/>
<person name="Harvey T.S."/>
<person name="Yin Y."/>
<person name="Yau P."/>
<person name="Litchfield D."/>
<person name="Arrowsmith C.H."/>
</authorList>
<dbReference type="PubMed" id="7773777"/>
<dbReference type="DOI" id="10.1038/nsb1294-877"/>
</citation>
<scope>STRUCTURE BY NMR OF 325-355</scope>
</reference>
<reference key="142">
<citation type="journal article" date="1997" name="EMBO J." volume="16" first="6230" last="6236">
<title>Hydrophobic side-chain size is a determinant of the three-dimensional structure of the p53 oligomerization domain.</title>
<authorList>
<person name="McCoy M."/>
<person name="Stavridi E.S."/>
<person name="Waterman J.L."/>
<person name="Wieczorek A.M."/>
<person name="Opella S.J."/>
<person name="Halazonetis T.D."/>
</authorList>
<dbReference type="PubMed" id="9321402"/>
<dbReference type="DOI" id="10.1093/emboj/16.20.6230"/>
</citation>
<scope>STRUCTURE BY NMR OF 326-354</scope>
</reference>
<reference key="143">
<citation type="journal article" date="1994" name="Science" volume="265" first="346" last="355">
<title>Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.</title>
<authorList>
<person name="Cho Y."/>
<person name="Gorina S."/>
<person name="Jeffrey P.D."/>
<person name="Pavletich N.P."/>
</authorList>
<dbReference type="PubMed" id="8023157"/>
<dbReference type="DOI" id="10.1126/science.8023157"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 94-289</scope>
</reference>
<reference key="144">
<citation type="journal article" date="1995" name="Science" volume="267" first="1498" last="1502">
<title>Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.</title>
<authorList>
<person name="Jeffrey P.D."/>
<person name="Gorina S."/>
<person name="Pavletich N.P."/>
</authorList>
<dbReference type="PubMed" id="7878469"/>
<dbReference type="DOI" id="10.1126/science.7878469"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 325-356</scope>
</reference>
<reference key="145">
<citation type="journal article" date="1996" name="Science" volume="274" first="948" last="953">
<title>Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.</title>
<authorList>
<person name="Kussie P.H."/>
<person name="Gorina S."/>
<person name="Marechal V."/>
<person name="Elenbaas B."/>
<person name="Moreau J."/>
<person name="Levine A.J."/>
<person name="Pavletich N.P."/>
</authorList>
<dbReference type="PubMed" id="8875929"/>
<dbReference type="DOI" id="10.1126/science.274.5289.948"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 13-29 IN COMPLEX WITH MDM2</scope>
</reference>
<reference key="146">
<citation type="journal article" date="1996" name="Science" volume="274" first="1001" last="1005">
<title>Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2.</title>
<authorList>
<person name="Gorina S."/>
<person name="Pavletich N.P."/>
</authorList>
<dbReference type="PubMed" id="8875926"/>
<dbReference type="DOI" id="10.1126/science.274.5289.1001"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 97-287 IN COMPLEX WITH 53BP2</scope>
</reference>
<reference key="147">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="1291" last="1296">
<title>Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations.</title>
<authorList>
<person name="Joerger A.C."/>
<person name="Allen M.D."/>
<person name="Fersht A.R."/>
</authorList>
<dbReference type="PubMed" id="14534297"/>
<dbReference type="DOI" id="10.1074/jbc.M309732200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 94-312 IN COMPLEX WITH ZINC IONS</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="148">
<citation type="journal article" date="2006" name="Mol. Cell" volume="22" first="741" last="753">
<title>Structural basis of DNA recognition by p53 tetramers.</title>
<authorList>
<person name="Kitayner M."/>
<person name="Rozenberg H."/>
<person name="Kessler N."/>
<person name="Rabinovich D."/>
<person name="Shaulov L."/>
<person name="Haran T.E."/>
<person name="Shakked Z."/>
</authorList>
<dbReference type="PubMed" id="16793544"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.05.015"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 94-293 IN COMPLEX WITH DNA AND ZINC IONS</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="149">
<citation type="journal article" date="2006" name="Nat. Struct. Mol. Biol." volume="13" first="285" last="291">
<title>Molecular recognition of p53 and MDM2 by USP7/HAUSP.</title>
<authorList>
<person name="Sheng Y."/>
<person name="Saridakis V."/>
<person name="Sarkari F."/>
<person name="Duan S."/>
<person name="Wu T."/>
<person name="Arrowsmith C.H."/>
<person name="Frappier L."/>
</authorList>
<dbReference type="PubMed" id="16474402"/>
<dbReference type="DOI" id="10.1038/nsmb1067"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 358-367 IN COMPLEX WITH USP7</scope>
<scope>INTERACTION WITH USP7</scope>
</reference>
<reference key="150">
<citation type="journal article" date="2006" name="PLoS Biol." volume="4" first="228" last="239">
<title>Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway.</title>
<authorList>
<person name="Hu M."/>
<person name="Gu L."/>
<person name="Li M."/>
<person name="Jeffrey P.D."/>
<person name="Gu W."/>
<person name="Shi Y."/>
</authorList>
<dbReference type="PubMed" id="16402859"/>
<dbReference type="DOI" id="10.1371/journal.pbio.0040027"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 360-368 IN COMPLEX WITH USP7</scope>
<scope>MUTAGENESIS OF PRO-359; GLY-361 AND SER-362</scope>
<scope>INTERACTION WITH USP7</scope>
</reference>
<reference key="151">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="37725" last="37732">
<title>The MBT repeats of L3MBTL1 link SET8-mediated p53 methylation at lysine 382 to target gene repression.</title>
<authorList>
<person name="West L.E."/>
<person name="Roy S."/>
<person name="Lachmi-Weiner K."/>
<person name="Hayashi R."/>
<person name="Shi X."/>
<person name="Appella E."/>
<person name="Kutateladze T.G."/>
<person name="Gozani O."/>
</authorList>
<dbReference type="PubMed" id="20870725"/>
<dbReference type="DOI" id="10.1074/jbc.M110.139527"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 377-386</scope>
<scope>METHYLATION AT LYS-382</scope>
<scope>MUTAGENESIS OF LYS-382</scope>
<scope>INTERACTION WITH L3MBTL1</scope>
</reference>
<reference key="152">
<citation type="journal article" date="1993" name="Science" volume="262" first="1980" last="1981">
<title>p53: at the crossroads of molecular carcinogenesis and risk assessment.</title>
<authorList>
<person name="Harris C.C."/>
</authorList>
<dbReference type="PubMed" id="8266092"/>
<dbReference type="DOI" id="10.1126/science.8266092"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="153">
<citation type="journal article" date="1991" name="Science" volume="253" first="49" last="53">
<title>p53 mutations in human cancers.</title>
<authorList>
<person name="Hoolstein M."/>
<person name="Sidransky D."/>
<person name="Vogelstein B."/>
<person name="Harris C.C."/>
</authorList>
<dbReference type="PubMed" id="1905840"/>
<dbReference type="DOI" id="10.1126/science.1905840"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="154">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="7" first="202" last="213">
<title>Database of mutations in the p53 and APC tumor suppressor genes designed to facilitate molecular epidemiological analyses.</title>
<authorList>
<person name="de Vries E.M.G."/>
<person name="Ricke D.O."/>
<person name="de Vries T.N."/>
<person name="Hartmann A."/>
<person name="Blaszyk H."/>
<person name="Liao D."/>
<person name="Soussi T."/>
<person name="Kovach J.S."/>
<person name="Sommer S.S."/>
</authorList>
<dbReference type="PubMed" id="8829653"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)7:3&lt;202::AID-HUMU4>3.3.CO;2-5"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="155">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="15056" last="15061">
<title>Structural basis for understanding oncogenic p53 mutations and designing rescue drugs.</title>
<authorList>
<person name="Joerger A.C."/>
<person name="Ang H.C."/>
<person name="Fersht A.R."/>
</authorList>
<dbReference type="PubMed" id="17015838"/>
<dbReference type="DOI" id="10.1073/pnas.0607286103"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 94-312 IN COMPLEX WITH ZINC IONS</scope>
</reference>
<reference key="156">
<citation type="journal article" date="2008" name="Acta Crystallogr. D" volume="64" first="471" last="477">
<title>Impact of low-frequency hotspot mutation R282Q on the structure of p53 DNA-binding domain as revealed by crystallography at 1.54 angstroms resolution.</title>
<authorList>
<person name="Tu C."/>
<person name="Tan Y.H."/>
<person name="Shaw G."/>
<person name="Zhou Z."/>
<person name="Bai Y."/>
<person name="Luo R."/>
<person name="Ji X."/>
</authorList>
<dbReference type="PubMed" id="18453682"/>
<dbReference type="DOI" id="10.1107/S0907444908003338"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.54 ANGSTROMS) OF 94-292 OF VARIANT GLN-282</scope>
</reference>
<reference key="157">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10360" last="10365">
<title>Targeted rescue of a destabilized mutant of p53 by an in silico screened drug.</title>
<authorList>
<person name="Boeckler F.M."/>
<person name="Joerger A.C."/>
<person name="Jaggi G."/>
<person name="Rutherford T.J."/>
<person name="Veprintsev D.B."/>
<person name="Fersht A.R."/>
</authorList>
<dbReference type="PubMed" id="18650397"/>
<dbReference type="DOI" id="10.1073/pnas.0805326105"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 94-312 OF VARIANT CYS-202 IN COMPLEX WITH ZINC IONS AND PHIKAN083</scope>
</reference>
<reference key="158">
<citation type="journal article" date="2009" name="J. Mol. Biol." volume="385" first="249" last="265">
<title>Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.</title>
<authorList>
<person name="Suad O."/>
<person name="Rozenberg H."/>
<person name="Brosh R."/>
<person name="Diskin-Posner Y."/>
<person name="Kessler N."/>
<person name="Shimon L.J."/>
<person name="Frolow F."/>
<person name="Liran A."/>
<person name="Rotter V."/>
<person name="Shakked Z."/>
</authorList>
<dbReference type="PubMed" id="18996393"/>
<dbReference type="DOI" id="10.1016/j.jmb.2008.10.063"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.2 ANGSTROMS) OF 94-293 OF VARIANT SER-249 IN COMPLEX WITH DNA</scope>
</reference>
<reference key="159">
<citation type="journal article" date="2009" name="Protein Eng. Des. Sel." volume="22" first="421" last="430">
<title>Stabilising the DNA-binding domain of p53 by rational design of its hydrophobic core.</title>
<authorList>
<person name="Khoo K.H."/>
<person name="Joerger A.C."/>
<person name="Freund S.M."/>
<person name="Fersht A.R."/>
</authorList>
<dbReference type="PubMed" id="19515728"/>
<dbReference type="DOI" id="10.1093/protein/gzp018"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 94-310 IN COMPLEX WITH ZINC IONS</scope>
</reference>
<reference key="160">
<citation type="journal article" date="2010" name="Chem. Biol." volume="17" first="46" last="56">
<title>Toward the rational design of p53-stabilizing drugs: probing the surface of the oncogenic Y220C mutant.</title>
<authorList>
<person name="Basse N."/>
<person name="Kaar J.L."/>
<person name="Settanni G."/>
<person name="Joerger A.C."/>
<person name="Rutherford T.J."/>
<person name="Fersht A.R."/>
</authorList>
<dbReference type="PubMed" id="20142040"/>
<dbReference type="DOI" id="10.1016/j.chembiol.2009.12.011"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 94-312 OF VARIANT CYS-220 IN COMPLEX WITH ZINC IONS</scope>
</reference>
<reference key="161">
<citation type="journal article" date="2010" name="Nat. Struct. Mol. Biol." volume="17" first="423" last="429">
<title>Diversity in DNA recognition by p53 revealed by crystal structures with Hoogsteen base pairs.</title>
<authorList>
<person name="Kitayner M."/>
<person name="Rozenberg H."/>
<person name="Rohs R."/>
<person name="Suad O."/>
<person name="Rabinovich D."/>
<person name="Honig B."/>
<person name="Shakked Z."/>
</authorList>
<dbReference type="PubMed" id="20364130"/>
<dbReference type="DOI" id="10.1038/nsmb.1800"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 94-293 IN COMPLEX WITH DNA AND ZINC IONS</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="162">
<citation type="journal article" date="1991" name="Hum. Genet." volume="86" first="369" last="370">
<title>Characterization of a frequent polymorphism in the coding sequence of the Tp53 gene in colonic cancer patients and a control population.</title>
<authorList>
<person name="Olschwang S."/>
<person name="Laurent-Puig P."/>
<person name="Vassal A."/>
<person name="Salmon R.-J."/>
<person name="Thomas G."/>
</authorList>
<dbReference type="PubMed" id="1999338"/>
<dbReference type="DOI" id="10.1007/BF00201836"/>
</citation>
<scope>VARIANT ARG-72</scope>
</reference>
<reference key="163">
<citation type="journal article" date="1991" name="Cancer Res." volume="51" first="6385" last="6387">
<title>A germ line mutation in exon 5 of the p53 gene in an extended cancer family.</title>
<authorList>
<person name="Law J.C."/>
<person name="Strong L.C."/>
<person name="Chidambaram A."/>
<person name="Ferrell R.E."/>
</authorList>
<dbReference type="PubMed" id="1933902"/>
</citation>
<scope>VARIANT LFS THR-133</scope>
</reference>
<reference key="164">
<citation type="journal article" date="1990" name="Science" volume="250" first="1233" last="1238">
<title>Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.</title>
<authorList>
<person name="Malkin D."/>
<person name="Li F.P."/>
<person name="Strong L.C."/>
<person name="Fraumeni J.F. Jr."/>
<person name="Nelson C.E."/>
<person name="Kim D.H."/>
<person name="Kassel J."/>
<person name="Gryka M.A."/>
<person name="Bischoff F.Z."/>
<person name="Tainsky M.A."/>
<person name="Friend S.H."/>
</authorList>
<dbReference type="PubMed" id="1978757"/>
<dbReference type="DOI" id="10.1126/science.1978757"/>
</citation>
<scope>VARIANTS LFS CYS-245; TRP-248; PRO-252 AND LYS-258</scope>
</reference>
<reference key="165">
<citation type="journal article" date="1990" name="Nature" volume="348" first="747" last="749">
<title>Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.</title>
<authorList>
<person name="Srivastava S."/>
<person name="Zou Z."/>
<person name="Pirollo K."/>
<person name="Blattner W."/>
<person name="Chang E.H."/>
</authorList>
<dbReference type="PubMed" id="2259385"/>
<dbReference type="DOI" id="10.1038/348747a0"/>
</citation>
<scope>VARIANT LFS ASP-245</scope>
</reference>
<reference key="166">
<citation type="journal article" date="1992" name="J. Clin. Invest." volume="89" first="640" last="647">
<title>Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.</title>
<authorList>
<person name="Felix C.A."/>
<person name="Nau M.M."/>
<person name="Takahashi T."/>
<person name="Mitsudomi T."/>
<person name="Chiba I."/>
<person name="Poplack D.G."/>
<person name="Reaman G.H."/>
<person name="Cole D.E."/>
<person name="Letterio J.J."/>
<person name="Whang-Peng J."/>
<person name="Knutsen T."/>
<person name="Minna J.D."/>
</authorList>
<dbReference type="PubMed" id="1737852"/>
<dbReference type="DOI" id="10.1172/JCI115630"/>
</citation>
<scope>VARIANT LFS LEU-272</scope>
</reference>
<reference key="167">
<citation type="journal article" date="1992" name="N. Engl. J. Med." volume="326" first="1309" last="1315">
<title>Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.</title>
<authorList>
<person name="Malkin D."/>
<person name="Jolly K.W."/>
<person name="Barbier N."/>
<person name="Look A.T."/>
<person name="Friend S.H."/>
<person name="Gebhardt M.C."/>
<person name="Andersen T.I."/>
<person name="Boerresen A.-L."/>
<person name="Li F.P."/>
<person name="Garber J."/>
<person name="Strong L.C."/>
</authorList>
<dbReference type="PubMed" id="1565144"/>
<dbReference type="DOI" id="10.1056/NEJM199205143262002"/>
</citation>
<scope>VARIANTS LFS HIS-273 AND VAL-325</scope>
</reference>
<reference key="168">
<citation type="journal article" date="1990" name="Oncogene" volume="5" first="893" last="899">
<title>Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.</title>
<authorList>
<person name="Bartek J."/>
<person name="Iggo R."/>
<person name="Gannon J."/>
<person name="Lane D.P."/>
</authorList>
<dbReference type="PubMed" id="1694291"/>
</citation>
<scope>VARIANTS SPORADIC CANCERS GLN-132; SER-249; LYS-280 AND LYS-285</scope>
</reference>
<reference key="169">
<citation type="journal article" date="1990" name="Proc. Natl. Acad. Sci. U.S.A." volume="87" first="7555" last="7559">
<title>p53 mutations in colorectal cancer.</title>
<authorList>
<person name="Rodrigues N.R."/>
<person name="Rowan A."/>
<person name="Smith M.E.F."/>
<person name="Kerr I.B."/>
<person name="Bodmer W.F."/>
<person name="Gannon J.V."/>
<person name="Lane D.P."/>
</authorList>
<dbReference type="PubMed" id="1699228"/>
<dbReference type="DOI" id="10.1073/pnas.87.19.7555"/>
</citation>
<scope>VARIANTS SPORADIC CANCERS PHE-241 AND HIS-273</scope>
</reference>
<reference key="170">
<citation type="journal article" date="1990" name="Proc. Natl. Acad. Sci. U.S.A." volume="87" first="9958" last="9961">
<title>Frequent mutation of the p53 gene in human esophageal cancer.</title>
<authorList>
<person name="Hollstein M.C."/>
<person name="Metcalf R.A."/>
<person name="Welsh J.A."/>
<person name="Montesano R."/>
<person name="Harris C.C."/>
</authorList>
<dbReference type="PubMed" id="2263646"/>
<dbReference type="DOI" id="10.1073/pnas.87.24.9958"/>
</citation>
<scope>VARIANTS SPORADIC CANCER VAL-154; VAL-245; GLN-248; LEU-278 AND SER-278</scope>
</reference>
<reference key="171">
<citation type="journal article" date="1991" name="Biochem. Biophys. Res. Commun." volume="177" first="901" last="906">
<title>Mutations of the P53 gene, including an intronic point mutation, in colorectal tumors.</title>
<authorList>
<person name="Ishioka C."/>
<person name="Sato T."/>
<person name="Gamoh M."/>
<person name="Suzuki T."/>
<person name="Shibata H."/>
<person name="Kanamaru R."/>
<person name="Wakui A."/>
<person name="Yamazaki T."/>
</authorList>
<dbReference type="PubMed" id="1647768"/>
<dbReference type="DOI" id="10.1016/0006-291X(91)90623-F"/>
</citation>
<scope>VARIANTS SPORADIC CANCERS</scope>
</reference>
<reference key="172">
<citation type="journal article" date="1991" name="Cancer Res." volume="51" first="4495" last="4499">
<title>p53 gene mutations in Barrett's epithelium and esophageal cancer.</title>
<authorList>
<person name="Casson A.G."/>
<person name="Mukhopadhyay T."/>
<person name="Cleary K.R."/>
<person name="Ro J.Y."/>
<person name="Levin B."/>
<person name="Roth J.A."/>
</authorList>
<dbReference type="PubMed" id="1868473"/>
</citation>
<scope>VARIANTS SPORADIC CANCERS LEU-152; ALA-155; HIS-175; PHE-176 AND HIS-273</scope>
</reference>
<reference key="173">
<citation type="journal article" date="1991" name="Nature" volume="350" first="427" last="428">
<title>Mutational hotspot in the p53 gene in human hepatocellular carcinomas.</title>
<authorList>
<person name="Hsu I.C."/>
<person name="Metcalf R.A."/>
<person name="Sun T."/>
<person name="Welsh J.A."/>
<person name="Wang N.J."/>
<person name="Harris C.C."/>
</authorList>
<dbReference type="PubMed" id="1849234"/>
<dbReference type="DOI" id="10.1038/350427a0"/>
</citation>
<scope>VARIANTS SPORADIC CANCERS IN CHINA</scope>
</reference>
<reference key="174">
<citation type="journal article" date="1991" name="Nature" volume="350" first="429" last="431">
<title>Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.</title>
<authorList>
<person name="Bressac B."/>
<person name="Kew M."/>
<person name="Wands J."/>
<person name="Ozturk M."/>
</authorList>
<dbReference type="PubMed" id="1672732"/>
<dbReference type="DOI" id="10.1038/350429a0"/>
</citation>
<scope>VARIANTS SPORADIC CANCERS IN SOUTH AFRICA</scope>
</reference>
<reference key="175">
<citation type="journal article" date="1992" name="Cancer Res." volume="52" first="5997" last="6000">
<title>Frequent p53 mutations in head and neck cancer.</title>
<authorList>
<person name="Somers K.D."/>
<person name="Merrick M.A."/>
<person name="Lopez M.E."/>
<person name="Incognito L.S."/>
<person name="Schechter G.L."/>
<person name="Casey G."/>
</authorList>
<dbReference type="PubMed" id="1394225"/>
</citation>
<scope>VARIANTS SPORADIC CANCERS PHE-176; PHE-242; CYS-245; LEU-248 AND HIS-273</scope>
</reference>
<reference key="176">
<citation type="journal article" date="1992" name="EMBO J." volume="11" first="3935" last="3940">
<title>Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens.</title>
<authorList>
<person name="Crook T."/>
<person name="Vousden K.H."/>
</authorList>
<dbReference type="PubMed" id="1327751"/>
</citation>
<scope>VARIANTS SPORADIC CANCERS</scope>
</reference>
<reference key="177">
<citation type="journal article" date="1992" name="Int. J. Cancer" volume="52" first="867" last="872">
<title>The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma.</title>
<authorList>
<person name="Sakai E."/>
<person name="Rikimaru K."/>
<person name="Ueda M."/>
<person name="Matsumoto Y."/>
<person name="Ishii N."/>
<person name="Enomoto S."/>
<person name="Yamamoto H."/>
<person name="Tsuchida N."/>
</authorList>
<dbReference type="PubMed" id="1459726"/>
<dbReference type="DOI" id="10.1002/ijc.2910520606"/>
</citation>
<scope>VARIANTS SPORADIC CANCERS CYS-205; GLU-281 AND LYS-285</scope>
</reference>
<reference key="178">
<citation type="journal article" date="1992" name="Hum. Mol. Genet." volume="1" first="207" last="208">
<title>A novel mutation in the p53 gene in a Burkitt's lymphoma cell line.</title>
<authorList>
<person name="Bhatia K."/>
<person name="Guiterrez M.I."/>
<person name="Magrath I.T."/>
</authorList>
<dbReference type="PubMed" id="1303181"/>
<dbReference type="DOI" id="10.1093/hmg/1.3.207"/>
</citation>
<scope>VARIANT PRO-HIS-PRO-178 INS</scope>
</reference>
<reference key="179">
<citation type="journal article" date="1992" name="Oncogene" volume="7" first="2161" last="2167">
<title>p53 mutations in Raji cells: characterization and localization relative to other Burkitt's lymphomas.</title>
<authorList>
<person name="Duthu A."/>
<person name="Debuire B."/>
<person name="Romano J.W."/>
<person name="Ehrhart J.C."/>
<person name="Fiscella M."/>
<person name="May E."/>
<person name="Appella E."/>
<person name="May P."/>
</authorList>
<dbReference type="PubMed" id="1437144"/>
</citation>
<scope>VARIANTS SPORADIC CANCERS</scope>
</reference>
<reference key="180">
<citation type="journal article" date="1992" name="Proc. Natl. Acad. Sci. U.S.A." volume="89" first="6516" last="6520">
<title>An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma.</title>
<authorList>
<person name="Sun Y."/>
<person name="Hegamyer G."/>
<person name="Heng Y.-J."/>
<person name="Hildesheim A."/>
<person name="Chen J.-Y."/>
<person name="Chen I.-H."/>
<person name="Cao Y."/>
<person name="Yao K.-T."/>
<person name="Colburn N.H."/>
</authorList>
<dbReference type="PubMed" id="1631151"/>
<dbReference type="DOI" id="10.1073/pnas.89.14.6516"/>
</citation>
<scope>VARIANT SPORADIC CANCER THR-280</scope>
</reference>
<reference key="181">
<citation type="journal article" date="1993" name="Am. J. Pathol." volume="142" first="1131" last="1139">
<title>p53 alterations in human squamous cell carcinomas and carcinoma cell lines.</title>
<authorList>
<person name="Caamano J."/>
<person name="Zhang S.Y."/>
<person name="Rosvold E.A."/>
<person name="Bauer B."/>
<person name="Klein-Szanto A.J.P."/>
</authorList>
<dbReference type="PubMed" id="7682763"/>
</citation>
<scope>VARIANTS SPORADIC CANCERS SER-151; PRO-156; LYS-174; ARG-194; CYS-220; GLN-248; LEU-248 AND HIS-273</scope>
</reference>
<reference key="182">
<citation type="journal article" date="1993" name="Cancer Res." volume="53" first="4477" last="4480">
<title>The incidence of p53 mutations increases with progression of head and neck cancer.</title>
<authorList>
<person name="Boyle J.O."/>
<person name="Hakim J."/>
<person name="Koch W."/>
<person name="van der Riet P."/>
<person name="Hruban R.H."/>
<person name="Roa R.A."/>
<person name="Correo R."/>
<person name="Eby Y.J."/>
<person name="Ruppert J.M."/>
<person name="Sidransky D."/>
</authorList>
<dbReference type="PubMed" id="8402617"/>
</citation>
<scope>VARIANTS SPORADIC CANCERS</scope>
</reference>
<reference key="183">
<citation type="journal article" date="1993" name="Oncogene" volume="8" first="2213" last="2220">
<title>Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors.</title>
<authorList>
<person name="Hamelin R."/>
<person name="Jego N."/>
<person name="Laurent-Puig P."/>
<person name="Vidaud M."/>
<person name="Thomas G."/>
</authorList>
<dbReference type="PubMed" id="8336944"/>
</citation>
<scope>VARIANTS SPORADIC CANCERS</scope>
</reference>
<reference key="184">
<citation type="journal article" date="1994" name="Cancer Res." volume="54" first="1298" last="1304">
<title>Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.</title>
<authorList>
<person name="Birch J.M."/>
<person name="Hartley A.L."/>
<person name="Tricker K.J."/>
<person name="Prosser J."/>
<person name="Condie A."/>
<person name="Kelsey A.M."/>
<person name="Harris M."/>
<person name="Jones P.H."/>
<person name="Binchy A."/>
<person name="Crowther D."/>
<person name="Craft A.W."/>
<person name="Eden O.B."/>
<person name="Evans D.G.R."/>
<person name="Thompson E."/>
<person name="Mann J.R."/>
<person name="Martin J."/>
<person name="Mitchell E.L.D."/>
<person name="Santibanez-Koref M.F."/>
</authorList>
<dbReference type="PubMed" id="8118819"/>
</citation>
<scope>VARIANTS</scope>
<scope>INVOLVEMENT IN LFL</scope>
</reference>
<reference key="185">
<citation type="journal article" date="1994" name="EMBO J." volume="13" first="2535" last="2544">
<title>A temperature-sensitive mutant of human p53.</title>
<authorList>
<person name="Zhang W."/>
<person name="Guo X.-Y."/>
<person name="Hu G.-Y."/>
<person name="Liu W.-B."/>
<person name="Shay J.W."/>
<person name="Deisseroth A.B."/>
</authorList>
<dbReference type="PubMed" id="8013454"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT ALA-143</scope>
</reference>
<reference key="186">
<citation type="journal article" date="1995" name="Am. J. Hum. Genet." volume="56" first="608" last="615">
<title>Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.</title>
<authorList>
<person name="Frebourg T."/>
<person name="Barbier N."/>
<person name="Yan Y.-X."/>
<person name="Garber J.E."/>
<person name="Dreyfus M."/>
<person name="Fraumeni J.F. Jr."/>
<person name="Li F.P."/>
<person name="Friend S.H."/>
</authorList>
<dbReference type="PubMed" id="7887414"/>
</citation>
<scope>VARIANTS LFS HIS-175; ARG-193; GLN-248; CYS-273 AND TYR-275</scope>
</reference>
<reference key="187">
<citation type="journal article" date="1995" name="Cancer Surv." volume="25" first="101" last="124">
<title>Germline mutations in the TP53 gene.</title>
<authorList>
<person name="Eeles R.A."/>
</authorList>
<dbReference type="PubMed" id="8718514"/>
</citation>
<scope>VARIANTS</scope>
<scope>INVOLVEMENT IN LFL</scope>
</reference>
<reference key="188">
<citation type="journal article" date="1995" name="J. Med. Genet." volume="32" first="942" last="945">
<title>An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53.</title>
<authorList>
<person name="Varley J.M."/>
<person name="McGrown G."/>
<person name="Thorncroft M."/>
<person name="Tricker K.J."/>
<person name="Teare M.D."/>
<person name="Santibanez-Koref M.F."/>
<person name="Houlston R.S."/>
<person name="Martin J."/>
<person name="Birch J.M."/>
<person name="Evans D.G.R."/>
</authorList>
<dbReference type="PubMed" id="8825920"/>
<dbReference type="DOI" id="10.1136/jmg.32.12.942"/>
</citation>
<scope>VARIANT LFS HIS-175</scope>
</reference>
<reference key="189">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="7" first="109" last="113">
<title>Molecular analysis of the TP53 gene in Barrett's adenocarcinoma.</title>
<authorList>
<person name="Audrezet M.-P."/>
<person name="Robaszkiewicz M."/>
<person name="Mercier B."/>
<person name="Nousbaum J.-B."/>
<person name="Hardy E."/>
<person name="Bail J.-P."/>
<person name="Volant A."/>
<person name="Lozac'H P."/>
<person name="Gouerou H."/>
<person name="Ferec C."/>
</authorList>
<dbReference type="PubMed" id="8829627"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)7:2&lt;109::AID-HUMU4>3.3.CO;2-0"/>
</citation>
<scope>VARIANTS SPORADIC CANCERS PHE-176; SER-245; TRP-248; TRP-282 AND GLN-286</scope>
</reference>
<reference key="190">
<citation type="journal article" date="1997" name="Hum. Mutat." volume="9" first="348" last="355">
<title>Single-step DGGE-based mutation scanning of the p53 gene: application to genetic diagnosis of colorectal cancer.</title>
<authorList>
<person name="Guldberg P."/>
<person name="Nedergaard T."/>
<person name="Nielsen H.J."/>
<person name="Olsen A.C."/>
<person name="Ahrenkiel V."/>
<person name="Zeuthen J."/>
</authorList>
<dbReference type="PubMed" id="9101296"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1997)9:4&lt;348::AID-HUMU8>3.0.CO;2-1"/>
</citation>
<scope>VARIANTS SPORADIC CANCERS</scope>
</reference>
<reference key="191">
<citation type="journal article" date="1997" name="Oncogene" volume="15" first="2877" last="2881">
<title>Drastic genetic instability of tumors and normal tissues in Turcot syndrome.</title>
<authorList>
<person name="Miyaki M."/>
<person name="Nishio J."/>
<person name="Konishi M."/>
<person name="Kikuchi-Yanoshita R."/>
<person name="Tanaka K."/>
<person name="Muraoka M."/>
<person name="Nagato M."/>
<person name="Chong J.-M."/>
<person name="Koike M."/>
<person name="Terada T."/>
<person name="Kawahara Y."/>
<person name="Fukutome A."/>
<person name="Tomiyama J."/>
<person name="Chuganji Y."/>
<person name="Momoi M."/>
<person name="Utsunomiya J."/>
</authorList>
<dbReference type="PubMed" id="9419979"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201668"/>
</citation>
<scope>VARIANT SPORADIC CANCER ILE-157</scope>
</reference>
<reference key="192">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="11" first="39" last="44">
<title>Detection of p53 gene mutations in oral squamous cell carcinomas of a black African population sample.</title>
<authorList>
<person name="van Rensburg E.J."/>
<person name="Engelbrecht S."/>
<person name="van Heerden W.F.P."/>
<person name="Kotze M.J."/>
<person name="Raubenheimer E.J."/>
</authorList>
<dbReference type="PubMed" id="9450901"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1998)11:1&lt;39::AID-HUMU6>3.0.CO;2-G"/>
</citation>
<scope>VARIANTS SER-152; ILE-169; PHE-176; THR-195; CYS-220; ILE-230; CYS-273 AND SER-278</scope>
</reference>
<reference key="193">
<citation type="journal article" date="1998" name="Hum. Mutat. Suppl." volume="1" first="S58" last="S61">
<title>A germline missense mutation R337C in exon 10 of the human p53 gene.</title>
<authorList>
<person name="Luca J.W."/>
<person name="Strong L.C."/>
<person name="Hansen M.F."/>
</authorList>
<dbReference type="PubMed" id="9452042"/>
</citation>
<scope>VARIANT NON-CLASSICAL LFS CYS-337</scope>
</reference>
<reference key="194">
<citation type="journal article" date="1999" name="Cancer Genet. Cytogenet." volume="113" first="145" last="151">
<title>Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family.</title>
<authorList>
<person name="Gueran S."/>
<person name="Tunca Y."/>
<person name="Imirzalioglu N."/>
</authorList>
<dbReference type="PubMed" id="10484981"/>
<dbReference type="DOI" id="10.1016/S0165-4608(98)00276-3"/>
</citation>
<scope>VARIANT LFS ILE-292</scope>
</reference>
<reference key="195">
<citation type="journal article" date="2000" name="Adv. Cancer Res." volume="77" first="81" last="137">
<title>p53 and human cancer: the first ten thousand mutations.</title>
<authorList>
<person name="Hainaut P."/>
<person name="Hollstein M."/>
</authorList>
<dbReference type="PubMed" id="10549356"/>
</citation>
<scope>VARIANTS</scope>
</reference>
<reference key="196">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="9330" last="9335">
<title>An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.</title>
<authorList>
<person name="Ribeiro R.C."/>
<person name="Sandrini F."/>
<person name="Figueiredo B."/>
<person name="Zambetti G.P."/>
<person name="Michalkiewicz E."/>
<person name="Lafferty A.R."/>
<person name="DeLacerda L."/>
<person name="Rabin M."/>
<person name="Cadwell C."/>
<person name="Sampaio G."/>
<person name="Cat I."/>
<person name="Stratakis C.A."/>
<person name="Sandrini R."/>
</authorList>
<dbReference type="PubMed" id="11481490"/>
<dbReference type="DOI" id="10.1073/pnas.161479898"/>
</citation>
<scope>VARIANT ADCC HIS-337</scope>
</reference>
<reference key="197">
<citation type="journal article" date="2002" name="Br. J. Cancer" volume="86" first="1592" last="1596">
<title>Investigations on a clinically and functionally unusual and novel germline p53 mutation.</title>
<authorList>
<person name="Rutherford J."/>
<person name="Chu C.E."/>
<person name="Duddy P.M."/>
<person name="Charlton R.S."/>
<person name="Chumas P."/>
<person name="Taylor G.R."/>
<person name="Lu X."/>
<person name="Barnes D.M."/>
<person name="Camplejohn R.S."/>
</authorList>
<dbReference type="PubMed" id="12085209"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6600269"/>
</citation>
<scope>INVOLVEMENT IN CPP</scope>
</reference>
<reference key="198">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] LEU-134; PHE-157; CYS-163; HIS-175; ARG-177; ARG-193; PRO-213; PHE-241; PHE-242; GLN-248; TRP-248; SER-249; TRP-267; LYS-271; CYS-273; HIS-273; LEU-273; SER-278; ILE-280 AND HIS-281</scope>
</reference>
<reference key="199">
<citation type="journal article" date="2007" name="Breast Cancer Res." volume="9" first="R5" last="R5">
<title>Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas.</title>
<authorList>
<person name="Chanock S.J."/>
<person name="Burdett L."/>
<person name="Yeager M."/>
<person name="Llaca V."/>
<person name="Langeroed A."/>
<person name="Presswalla S."/>
<person name="Kaaresen R."/>
<person name="Strausberg R.L."/>
<person name="Gerhard D.S."/>
<person name="Kristensen V."/>
<person name="Perou C.M."/>
<person name="Boerresen-Dale A.-L."/>
</authorList>
<dbReference type="PubMed" id="17224074"/>
<dbReference type="DOI" id="10.1186/bcr1637"/>
</citation>
<scope>VARIANTS PRO-110; VAL-113; VAL-138; CYS-163; HIS-163; THR-195; MET-216; ALA-241; MET-249; SER-251; TYR-259 AND CYS-273</scope>
</reference>
<reference key="200">
<citation type="journal article" date="2007" name="Hum. Mutat." volume="28" first="622" last="629">
<title>Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.</title>
<authorList>
<person name="Petitjean A."/>
<person name="Mathe E."/>
<person name="Kato S."/>
<person name="Ishioka C."/>
<person name="Tavtigian S.V."/>
<person name="Hainaut P."/>
<person name="Olivier M."/>
</authorList>
<dbReference type="PubMed" id="17311302"/>
<dbReference type="DOI" id="10.1002/humu.20495"/>
</citation>
<scope>VARIANTS</scope>
</reference>
<reference key="201">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1324" last="1334">
<title>DBC1 functions as a tumor suppressor by regulating p53 stability.</title>
<authorList>
<person name="Qin B."/>
<person name="Minter-Dykhouse K."/>
<person name="Yu J."/>
<person name="Zhang J."/>
<person name="Liu T."/>
<person name="Zhang H."/>
<person name="Lee S."/>
<person name="Kim J."/>
<person name="Wang L."/>
<person name="Lou Z."/>
</authorList>
<dbReference type="PubMed" id="25732823"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.01.066"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT SPORADIC CANCER LYS-280</scope>
<scope>UBIQUITINATION</scope>
<scope>PROTEASOMAL DEGRADATION</scope>
<scope>INTERACTION WITH CCAR2</scope>
</reference>
<comment type="function">
<text evidence="32 45 58 59 91 93 113 129 131 141 145 165">Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seem to have to effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492).</text>
</comment>
<comment type="cofactor">
<cofactor>
<name>Zn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29105"/>
</cofactor>
<text>Binds 1 zinc ion per subunit.</text>
</comment>
<comment type="subunit">
<text evidence="20 44 45 46 49 53 54 56 57 58 63 64 67 69 70 71 72 74 76 77 81 83 85 86 87 89 91 92 96 98 99 100 104 105 107 110 111 112 113 114 116 117 122 123 125 126 127 128 130 131 132 136 137 138 141 143 144 146 148 149 150 159 160 165">Interacts with AXIN1. Probably part of a complex consisting of TP53, HIPK2 and AXIN1 (By similarity). Binds DNA as a homotetramer. Interacts with histone acetyltransferases EP300 and methyltransferases HRMT1L2 and CARM1, and recruits them to promoters. In vitro, the interaction of TP53 with cancer-associated/HPV (E6) viral proteins leads to ubiquitination and degradation of TP53 giving a possible model for cell growth regulation. This complex formation requires an additional factor, E6-AP, which stably associates with TP53 in the presence of E6. Interacts (via C-terminus) with TAF1; when TAF1 is part of the TFIID complex. Interacts with ING4; this interaction may be indirect. Found in a complex with CABLES1 and TP73. Interacts with HIPK1, HIPK2, and TP53INP1. Interacts with WWOX. May interact with HCV core protein. Interacts with USP7 and SYVN1. Interacts with HSP90AB1. Interacts with CHD8; leading to recruit histone H1 and prevent transactivation activity (By similarity). Interacts with ARMC10, BANP, CDKN2AIP, NUAK1, STK11/LKB1, UHRF2 and E4F1. Interacts with YWHAZ; the interaction enhances TP53 transcriptional activity. Phosphorylation of YWHAZ on 'Ser-58' inhibits this interaction. Interacts (via DNA-binding domain) with MAML1 (via N-terminus). Interacts with MKRN1. Interacts with PML (via C-terminus). Interacts with MDM2; leading to ubiquitination and proteasomal degradation of TP53. Directly interacts with FBXO42; leading to ubiquitination and degradation of TP53. Interacts (phosphorylated at Ser-15 by ATM) with the phosphatase PP2A-PPP2R5C holoenzyme; regulates stress-induced TP53-dependent inhibition of cell proliferation. Interacts with PPP2R2A. Interacts with AURKA, DAXX, BRD7 and TRIM24. Interacts (when monomethylated at Lys-382) with L3MBTL1. Isoform 1 interacts with isoform 2 and with isoform 4. Interacts with GRK5. Binds to the CAK complex (CDK7, cyclin H and MAT1) in response to DNA damage. Interacts with CDK5 in neurons. Interacts with AURKB, SETD2, UHRF2 and NOC2L. Interacts (via N-terminus) with PTK2/FAK1; this promotes ubiquitination by MDM2. Interacts with PTK2B/PYK2; this promotes ubiquitination by MDM2. Interacts with PRKCG. Interacts with PPIF; the association implicates preferentially tetrameric TP53, is induced by oxidative stress and is impaired by cyclosporin A (CsA). Interacts with human cytomegalovirus/HHV-5 protein UL123. Interacts with SNAI1; the interaction induces SNAI1 degradation via MDM2-mediated ubiquitination and inhibits SNAI1-induced cell invasion. Interacts with KAT6A. Interacts with UBC9. Interacts with ZNF385B; the interaction is direct. Interacts (via DNA-binding domain) with ZNF385A; the interaction is direct and enhances p53/TP53 transactivation functions on cell-cycle arrest target genes, resulting in growth arrest. Interacts with ANKRD2. Interacts with RFFL and RNF34; involved in p53/TP53 ubiquitination. Interacts with MTA1 and RFWD2. Interacts with CCAR2 (via N-terminus). Interacts (via N-terminus) with human adenovirus 5 E1B-55K protein; this interaction leads to the inhibition of TP53 function and/or its degradation (PubMed:25772236). Interacts with MORC3 (PubMed:17332504). Interacts (via C-terminus) with POU4F2 isoform 1 (via C-terminus) (PubMed:17145718). Interacts (via oligomerization region) with NOP53; the interaction is direct and may prevent the MDM2-mediated proteasomal degradation of TP53 (PubMed:22522597). Interacts with AFG1L; mediates mitochondrial translocation of TP53 (PubMed:27323408). Interacts with UBD (PubMed:25422469).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-366083"/>
<organismsDiffer>false</organismsDiffer>
<experiments>24</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-617698">
<id>P03070</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>19</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-6838571">
<id>P26663</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-7210801">
<id>Q7L7W2</id>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-6863726">
<id>Q8QW27</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-745226">
<id>Q13155</id>
<label>AIMP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-711158">
<id>O95376</id>
<label>ARIH2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-743313">
<id>P49407</id>
<label>ARRB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-4303019">
<id>P29066</id>
<label>Arrb1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-540797">
<id>Q9UBL3</id>
<label>ASH2L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-15980880">
<id>O95352-2</id>
<label>ATG7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-710484">
<id>O15169</id>
<label>AXIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-744695">
<id>Q8N9N5</id>
<label>BANP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-77694">
<id>P10415</id>
<label>BCL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-287195">
<id>Q07817-1</id>
<label>BCL2L1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>26</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-712838">
<id>P11274</id>
<label>BCR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-711810">
<id>O14503</id>
<label>BHLHE40</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-79792">
<id>P51587</id>
<label>BRCA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-711221">
<id>Q9NPI1</id>
<label>BRD7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-710091">
<id>Q9BX70</id>
<label>BTBD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-307461">
<id>Q9Y297</id>
<label>BTRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-604411">
<id>Q9ESJ1</id>
<label>Cables1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-711501">
<id>Q9BWC9</id>
<label>CCDC106</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-375077">
<id>P38936</id>
<label>CDKN1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-969696">
<id>P17676</id>
<label>CEBPB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-81215">
<id>Q92793</id>
<label>CREBBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-296306">
<id>P45481</id>
<label>Crebbp</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-286709">
<id>P55060</id>
<label>CSE1L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-347804">
<id>P68400</id>
<label>CSNK2A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-308606">
<id>Q14999</id>
<label>CUL7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-311123">
<id>Q8IWT3</id>
<label>CUL9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-949911">
<id>Q9P0U4</id>
<label>CXXC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-77321">
<id>Q9UER7</id>
<label>DAXX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-746012">
<id>Q92841</id>
<label>DDX17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-351962">
<id>P17844</id>
<label>DDX5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-528367">
<id>Q9NRR4</id>
<label>DROSHA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-2924519">
<id>Q9BV47</id>
<label>DUSP26</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-740850">
<id>O14641</id>
<label>DVL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1177242">
<id>P03126</id>
<label>E6</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1186926">
<id>P06463</id>
<label>E6</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-447295">
<id>Q09472</id>
<label>EP300</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>20</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1646991">
<id>P15036</id>
<label>ETS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1047804">
<id>Q86XK2</id>
<label>FBXO11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1644164">
<id>O43524</id>
<label>FOXO3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-373586">
<id>P49841</id>
<label>GSK3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-715539">
<id>P32780</id>
<label>GTF2H1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-301834">
<id>Q13547</id>
<label>HDAC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-692891">
<id>Q86Z02</id>
<label>HIPK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-389432">
<id>P09429</id>
<label>HMGB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-304185">
<id>P61978</id>
<label>HNRNPK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-7060731">
<id>P61978-2</id>
<label>HNRNPK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-8659">
<id>P02829</id>
<label>HSP82</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-354912">
<id>P34931</id>
<label>HSPA1L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-354932">
<id>P38646</id>
<label>HSPA9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-352682">
<id>P04792</id>
<label>HSPB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-466029">
<id>P42858</id>
<label>HTT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-625934">
<id>Q7Z6Z7</id>
<label>HUWE1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-6273540">
<id>Q16666-2</id>
<label>IFI16</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-8064290">
<id>Q08619</id>
<label>Ifi205b</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-81266">
<id>O14920</id>
<label>IKBKB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-747509">
<id>Q9UHH9</id>
<label>IP6K2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-8464037">
<id>Q6NYC1</id>
<label>JMJD6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-399080">
<id>Q92993</id>
<label>KAT5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-896414">
<id>Q9H7Z6</id>
<label>KAT8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-15599570">
<id>O60341-1</id>
<label>KDM1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-2689959">
<id>Q8IZD2</id>
<label>KMT2E</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-711505">
<id>Q16363</id>
<label>LAMA4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-5650739">
<id>P43356</id>
<label>MAGEA2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-5651487">
<id>Q9UBF1</id>
<label>MAGEC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-764611">
<id>P46821</id>
<label>MAP1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-298304">
<id>Q15759</id>
<label>MAPK11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1201460">
<id>Q8IW41</id>
<label>MAPKAPK5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-389668">
<id>Q00987</id>
<label>MDM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>91</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-398437">
<id>O15151</id>
<label>MDM4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>19</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-373524">
<id>Q9UHC7</id>
<label>MKRN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-821405">
<id>O75970</id>
<label>MPDZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-8045030">
<id>P04731</id>
<label>MT1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-346967">
<id>P19338</id>
<label>NCL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-80830">
<id>Q9Y618</id>
<label>NCOR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-389739">
<id>P23511</id>
<label>NFYA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-389728">
<id>P25208</id>
<label>NFYB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-751547">
<id>Q9Y3T9</id>
<label>NOC2L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-740992">
<id>O60936</id>
<label>NOL3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-78579">
<id>P06748</id>
<label>NPM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-354150">
<id>P06748-1</id>
<label>NPM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-3910729">
<id>Q15466</id>
<label>NR0B2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-721550">
<id>P22736</id>
<label>NR4A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-2371631">
<id>O43847</id>
<label>NRDC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-9522973">
<id>P89055</id>
<label>NSP1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1046789">
<id>O60285</id>
<label>NUAK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-915016">
<id>P49757</id>
<label>NUMB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1058491">
<id>Q96FW1</id>
<label>OTUB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-81968">
<id>Q8TEW0</id>
<label>PARD3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-355676">
<id>P09874</id>
<label>PARP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-536853">
<id>Q96KB5</id>
<label>PBK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-354213">
<id>P35232</id>
<label>PHB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-629434">
<id>O75925</id>
<label>PIAS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-348555">
<id>O75928</id>
<label>PIAS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-473160">
<id>Q8N2W9</id>
<label>PIAS4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-714158">
<id>Q13526</id>
<label>PIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-476768">
<id>P53350</id>
<label>PLK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-295890">
<id>P29590</id>
<label>PML</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-5544229">
<id>P30405</id>
<label>PPIF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-356289">
<id>P36873-1</id>
<label>PPP1CC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-5550163">
<id>Q8WUF5</id>
<label>PPP1R13L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-302388">
<id>P30153</id>
<label>PPP2R1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1266156">
<id>Q13362</id>
<label>PPP2R5C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-704279">
<id>Q05655</id>
<label>PRKCD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-355546">
<id>P61289</id>
<label>PSME3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-702142">
<id>Q05397</id>
<label>PTK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-297202">
<id>Q06609</id>
<label>RAD51</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-632552">
<id>Q06330</id>
<label>RBPJ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-947779">
<id>Q96PM5</id>
<label>RCHY1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-2129159">
<id>Q6PCD5</id>
<label>RFWD3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-351193">
<id>P23396</id>
<label>RPS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-752324">
<id>Q8N488</id>
<label>RYBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-743686">
<id>P23297</id>
<label>S100A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-752230">
<id>P29034</id>
<label>S100A2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-717058">
<id>P26447</id>
<label>S100A4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-458391">
<id>P04271</id>
<label>S100B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-348298">
<id>Q15424</id>
<label>SAFB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1268586">
<id>Q8WTS6</id>
<label>SETD7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-476295">
<id>P31947</id>
<label>SFN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-347218">
<id>Q96ST3</id>
<label>SIN3A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
<label>SIRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>18</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1802585">
<id>Q923E4</id>
<label>Sirt1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1040141">
<id>Q15796</id>
<label>SMAD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1055671">
<id>Q9NRG4</id>
<label>SMYD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-15612527">
<id>Q8R5A0</id>
<label>Smyd2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1045459">
<id>O95863</id>
<label>SNAI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-6672525">
<id>Q06945</id>
<label>SOX4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-298336">
<id>P08047</id>
<label>SP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-465059">
<id>Q12772</id>
<label>SREBF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-539478">
<id>Q96SB4</id>
<label>SRPK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-80140">
<id>P63165</id>
<label>SUMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-947849">
<id>Q86TM6</id>
<label>SYVN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-355371">
<id>P20226</id>
<label>TBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-533224">
<id>P15884</id>
<label>TCF4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-717460">
<id>Q96GM8</id>
<label>TOE1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-396540">
<id>Q12888</id>
<label>TP53BP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-8022649">
<id>Q12888-1</id>
<label>TP53BP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>17</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-77642">
<id>Q13625</id>
<label>TP53BP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-2337775">
<id>Q9H3D4</id>
<label>TP63</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-2338025">
<id>O88898</id>
<label>Tp63</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1783169">
<id>P13693</id>
<label>TPT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-2130378">
<id>O15164</id>
<label>TRIM24</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1797287">
<id>Q15672</id>
<label>TWIST1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-6123119">
<id>P26687</id>
<label>Twist1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-3390054">
<id>P0CG48</id>
<label>UBC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-954357">
<id>Q05086</id>
<label>UBE3A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-625304">
<id>Q96PU4</id>
<label>UHRF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-2513638">
<id>Q9H9J4</id>
<label>USP42</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-9118105">
<id>Q9H9J4-2</id>
<label>USP42</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-302474">
<id>Q93009</id>
<label>USP7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>18</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-286357">
<id>P11473</id>
<label>VDR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1769146">
<id>Q99986</id>
<label>VRK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-368417">
<id>Q14191</id>
<label>WRN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-355867">
<id>O14980</id>
<label>XPO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-353208">
<id>P12956</id>
<label>XRCC6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-359832">
<id>P61981</id>
<label>YWHAG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-3923307">
<id>Q8TAQ5</id>
<label>ZNF420</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-366083"/>
<interactant intactId="EBI-1782562">
<id>Q9PST7</id>
<label>znf585b</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>PML body</location>
</subcellularLocation>
<subcellularLocation>
<location>Endoplasmic reticulum</location>
</subcellularLocation>
<subcellularLocation>
<location>Mitochondrion matrix</location>
</subcellularLocation>
<text evidence="150">Interaction with BANP promotes nuclear localization. Recruited into PML bodies together with CHEK2. Translocates to mitochondria upon oxidative stress. Translocates to mitochondria in response to mitomycin C treatment (PubMed:27323408).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Predominantly nuclear but localizes to the cytoplasm when expressed with isoform 4.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Localized mainly in the nucleus with minor staining in the cytoplasm.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Localized in the nucleus in most cells but found in the cytoplasm in some cells.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 4</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Predominantly nuclear but translocates to the cytoplasm following cell stress.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 7</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Localized mainly in the nucleus with minor staining in the cytoplasm.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 8</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Localized in both nucleus and cytoplasm in most cells. In some cells, forms foci in the nucleus that are different from nucleoli.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 9</molecule>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative promoter"/>
<event type="alternative splicing"/>
<isoform>
<id>P04637-1</id>
<name>1</name>
<name>p53</name>
<name>p53alpha</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P04637-2</id>
<name>2</name>
<name>I9RET</name>
<name>p53beta</name>
<sequence type="described" ref="VSP_006535 VSP_006536"/>
<text>Expressed in quiescent lymphocytes. Seems to be non-functional. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.</text>
</isoform>
<isoform>
<id>P04637-3</id>
<name>3</name>
<name>p53gamma</name>
<sequence type="described" ref="VSP_040560 VSP_040561"/>
<text>Expressed in quiescent lymphocytes. Seems to be non-functional. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.</text>
</isoform>
<isoform>
<id>P04637-4</id>
<name>4</name>
<name>Del40-p53</name>
<name>Del40-p53alpha</name>
<name>p47</name>
<sequence type="described" ref="VSP_040832"/>
</isoform>
<isoform>
<id>P04637-5</id>
<name>5</name>
<name>Del40-p53beta</name>
<sequence type="described" ref="VSP_040832 VSP_006535 VSP_006536"/>
</isoform>
<isoform>
<id>P04637-6</id>
<name>6</name>
<name>Del40-p53gamma</name>
<sequence type="described" ref="VSP_040832 VSP_040560 VSP_040561"/>
</isoform>
<isoform>
<id>P04637-7</id>
<name>7</name>
<name>Del133-p53</name>
<name>Del133-p53alpha</name>
<sequence type="described" ref="VSP_040833"/>
<text>Produced by alternative promoter usage.</text>
</isoform>
<isoform>
<id>P04637-8</id>
<name>8</name>
<name>Del133-p53beta</name>
<sequence type="described" ref="VSP_040833 VSP_006535 VSP_006536"/>
<text>Produced by alternative promoter usage and alternative splicing.</text>
</isoform>
<isoform>
<id>P04637-9</id>
<name>9</name>
<name>Del133-p53gamma</name>
<sequence type="described" ref="VSP_040833 VSP_040560 VSP_040561"/>
<text>Produced by alternative promoter usage and alternative splicing.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="66">Ubiquitous. Isoforms are expressed in a wide range of normal tissues but in a tissue-dependent manner. Isoform 2 is expressed in most normal tissues but is not detected in brain, lung, prostate, muscle, fetal brain, spinal cord and fetal liver. Isoform 3 is expressed in most normal tissues but is not detected in lung, spleen, testis, fetal brain, spinal cord and fetal liver. Isoform 7 is expressed in most normal tissues but is not detected in prostate, uterus, skeletal muscle and breast. Isoform 8 is detected only in colon, bone marrow, testis, fetal brain and intestine. Isoform 9 is expressed in most normal tissues but is not detected in brain, heart, lung, fetal liver, salivary gland, breast or intestine.</text>
</comment>
<comment type="induction">
<text evidence="24 66">Up-regulated in response to DNA damage. Isoform 2 is not induced in tumor cells in response to stress.</text>
</comment>
<comment type="domain">
<text evidence="95">The nuclear export signal acts as a transcriptional repression domain. The TADI and TADII motifs (residues 17 to 25 and 48 to 56) correspond both to 9aaTAD motifs which are transactivation domains present in a large number of yeast and animal transcription factors.</text>
</comment>
<comment type="PTM">
<text evidence="27 125 144">Acetylated. Acetylation of Lys-382 by CREBBP enhances transcriptional activity. Deacetylation of Lys-382 by SIRT1 impairs its ability to induce proapoptotic program and modulate cell senescence. Deacetylation by SIRT2 impairs its ability to induce transcription activation in a AKT-dependent manner.</text>
</comment>
<comment type="PTM">
<text evidence="20 24 25 29 30 34 35 37 38 39 40 41 45 53 54 63 65 71 75 82 83 90 93 96 100 101 119 122 131 132 133 137 161">Phosphorylation on Ser residues mediates transcriptional activation. Phosphorylated by HIPK1 (By similarity). Phosphorylation at Ser-9 by HIPK4 increases repression activity on BIRC5 promoter. Phosphorylated on Thr-18 by VRK1. Phosphorylated on Ser-20 by CHEK2 in response to DNA damage, which prevents ubiquitination by MDM2. Phosphorylated on Ser-20 by PLK3 in response to reactive oxygen species (ROS), promoting p53/TP53-mediated apoptosis. Phosphorylated on Thr-55 by TAF1, which promotes MDM2-mediated degradation. Phosphorylated on Ser-33 by CDK7 in a CAK complex in response to DNA damage. Phosphorylated on Ser-46 by HIPK2 upon UV irradiation. Phosphorylation on Ser-46 is required for acetylation by CREBBP. Phosphorylated on Ser-392 following UV but not gamma irradiation. Phosphorylated on Ser-15 upon ultraviolet irradiation; which is enhanced by interaction with BANP. Phosphorylated by NUAK1 at Ser-15 and Ser-392; was initially thought to be mediated by STK11/LKB1 but it was later shown that it is indirect and that STK11/LKB1-dependent phosphorylation is probably mediated by downstream NUAK1 (PubMed:21317932). It is unclear whether AMP directly mediates phosphorylation at Ser-15. Phosphorylated on Thr-18 by isoform 1 and isoform 2 of VRK2. Phosphorylation on Thr-18 by isoform 2 of VRK2 results in a reduction in ubiquitination by MDM2 and an increase in acetylation by EP300. Stabilized by CDK5-mediated phosphorylation in response to genotoxic and oxidative stresses at Ser-15, Ser-33 and Ser-46, leading to accumulation of p53/TP53, particularly in the nucleus, thus inducing the transactivation of p53/TP53 target genes. Phosphorylated by DYRK2 at Ser-46 in response to genotoxic stress. Phosphorylated at Ser-315 and Ser-392 by CDK2 in response to DNA-damage.</text>
</comment>
<comment type="PTM">
<text>Dephosphorylated by PP2A-PPP2R5C holoenzyme at Thr-55. SV40 small T antigen inhibits the dephosphorylation by the AC form of PP2A.</text>
</comment>
<comment type="PTM">
<text evidence="156">May be O-glycosylated in the C-terminal basic region. Studied in EB-1 cell line.</text>
</comment>
<comment type="PTM">
<text evidence="28 45 55 59 87 102 109 112 113 116 117 120 124 147 148">Ubiquitinated by MDM2 and SYVN1, which leads to proteasomal degradation (PubMed:10722742, PubMed:12810724, PubMed:15340061, PubMed:17170702, PubMed:19880522). Ubiquitinated by RFWD3, which works in cooperation with MDM2 and may catalyze the formation of short polyubiquitin chains on p53/TP53 that are not targeted to the proteasome (PubMed:10722742, PubMed:12810724, PubMed:20173098). Ubiquitinated by MKRN1 at Lys-291 and Lys-292, which leads to proteasomal degradation (PubMed:19536131). Deubiquitinated by USP10, leading to its stabilization (PubMed:20096447). Ubiquitinated by TRIM24, RFFL, RNF34 and RNF125, which leads to proteasomal degradation (PubMed:19556538). Ubiquitination by TOPORS induces degradation (PubMed:19473992). Deubiquitination by USP7, leading to stabilization (PubMed:15053880). Isoform 4 is monoubiquitinated in an MDM2-independent manner (PubMed:15340061). Ubiquitinated by RFWD2, which leads to proteasomal degradation (PubMed:19837670). Ubiquitination and subsequent proteasomal degradation is negatively regulated by CCAR2 (PubMed:25732823).</text>
</comment>
<comment type="PTM">
<text>Monomethylated at Lys-372 by SETD7, leading to stabilization and increased transcriptional activation. Monomethylated at Lys-370 by SMYD2, leading to decreased DNA-binding activity and subsequent transcriptional regulation activity. Lys-372 monomethylation prevents interaction with SMYD2 and subsequent monomethylation at Lys-370. Dimethylated at Lys-373 by EHMT1 and EHMT2. Monomethylated at Lys-382 by KMT5A, promoting interaction with L3MBTL1 and leading to repress transcriptional activity. Dimethylation at Lys-370 and Lys-382 diminishes p53 ubiquitination, through stabilizing association with the methyl reader PHF20. Demethylation of dimethylated Lys-370 by KDM1A prevents interaction with TP53BP1 and represses TP53-mediated transcriptional activation.</text>
</comment>
<comment type="PTM">
<text evidence="33 137 171">Sumoylated with SUMO1. Sumoylated at Lys-386 by UBC9.</text>
</comment>
<comment type="disease">
<text>TP53 is found in increased amounts in a wide variety of transformed cells. TP53 is frequently mutated or inactivated in about 60% of cancers. TP53 defects are found in Barrett metaplasia a condition in which the normally stratified squamous epithelium of the lower esophagus is replaced by a metaplastic columnar epithelium. The condition develops as a complication in approximately 10% of patients with chronic gastroesophageal reflux disease and predisposes to the development of esophageal adenocarcinoma.</text>
</comment>
<comment type="disease">
<disease id="DI-01537">
<name>Esophageal cancer</name>
<acronym>ESCR</acronym>
<description>A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage.</description>
<dbReference type="MIM" id="133239"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="22 62 94 108 115 139 153 157 164">
<disease id="DI-01904">
<name>Li-Fraumeni syndrome</name>
<acronym>LFS</acronym>
<description>Autosomal dominant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers.</description>
<dbReference type="MIM" id="151623"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-01696">
<name>Squamous cell carcinoma of the head and neck</name>
<acronym>HNSCC</acronym>
<description>A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes.</description>
<dbReference type="MIM" id="275355"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease">
<disease id="DI-02205">
<name>Lung cancer</name>
<acronym>LNCR</acronym>
<description>A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis.</description>
<dbReference type="MIM" id="211980"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="42">
<disease id="DI-01346">
<name>Papilloma of choroid plexus</name>
<acronym>CPP</acronym>
<description>A benign tumor of neuroectodermal origin that generally occurs in childhood, but has also been reported in adults. Although generally found within the ventricular system, choroid plexus papillomas can arise ectopically in the brain parenchyma or disseminate throughout the neuraxis. Patients present with signs and symptoms of increased intracranial pressure including headache, hydrocephalus, papilledema, nausea, vomiting, cranial nerve deficits, gait impairment, and seizures.</description>
<dbReference type="MIM" id="260500"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="36">
<disease id="DI-02740">
<name>Adrenocortical carcinoma</name>
<acronym>ADCC</acronym>
<description>A malignant neoplasm of the adrenal cortex and a rare childhood tumor. It occurs with increased frequency in patients with Beckwith-Wiedemann syndrome and Li-Fraumeni syndrome.</description>
<dbReference type="MIM" id="202300"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="135">
<disease id="DI-03503">
<name>Basal cell carcinoma 7</name>
<acronym>BCC7</acronym>
<description>A common malignant skin neoplasm that typically appears on hair-bearing skin, most commonly on sun-exposed areas. It is slow growing and rarely metastasizes, but has potentialities for local invasion and destruction. It usually develops as a flat, firm, pale area that is small, raised, pink or red, translucent, shiny, and waxy, and the area may bleed following minor injury. Tumor size can vary from a few millimeters to several centimeters in diameter.</description>
<dbReference type="MIM" id="614740"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="173">Belongs to the p53 family.</text>
</comment>
<comment type="online information" name="IARC TP53 mutation database">
<link uri="http://p53.iarc.fr/"/>
<text>Somatic and germline TP53 mutations in human cancers</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/P53ID88.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/tp53/"/>
</comment>
<comment type="online information" name="SHMPD">
<link uri="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&amp;genename=TP53"/>
<text>The Singapore human mutation and polymorphism database</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/P53"/>
<text>P53 entry</text>
</comment>
<dbReference type="EMBL" id="X02469">
<property type="protein sequence ID" value="CAA26306.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M13121">
<property type="protein sequence ID" value="AAA59987.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M13112">
<property type="protein sequence ID" value="AAA59987.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M13113">
<property type="protein sequence ID" value="AAA59987.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M13114">
<property type="protein sequence ID" value="AAA59987.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M13115">
<property type="protein sequence ID" value="AAA59987.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M13116">
<property type="protein sequence ID" value="AAA59987.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M13117">
<property type="protein sequence ID" value="AAA59987.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M13118">
<property type="protein sequence ID" value="AAA59987.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M13119">
<property type="protein sequence ID" value="AAA59987.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M13120">
<property type="protein sequence ID" value="AAA59987.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="K03199">
<property type="protein sequence ID" value="AAA59989.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M14694">
<property type="protein sequence ID" value="AAA61211.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M14695">
<property type="protein sequence ID" value="AAA61212.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M22898">
<property type="protein sequence ID" value="AAA59988.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M22882">
<property type="protein sequence ID" value="AAA59988.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M22883">
<property type="protein sequence ID" value="AAA59988.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M22884">
<property type="protein sequence ID" value="AAA59988.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M22887">
<property type="protein sequence ID" value="AAA59988.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M22888">
<property type="protein sequence ID" value="AAA59988.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M22894">
<property type="protein sequence ID" value="AAA59988.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M22895">
<property type="protein sequence ID" value="AAA59988.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M22896">
<property type="protein sequence ID" value="AAA59988.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M22897">
<property type="protein sequence ID" value="AAA59988.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X01405">
<property type="protein sequence ID" value="CAA25652.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X60011">
<property type="protein sequence ID" value="CAA42626.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X60012">
<property type="protein sequence ID" value="CAA42627.1"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X60013">
<property type="protein sequence ID" value="CAA42628.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X60014">
<property type="protein sequence ID" value="CAA42629.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X60015">
<property type="protein sequence ID" value="CAA42630.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X60016">
<property type="protein sequence ID" value="CAA42631.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X60017">
<property type="protein sequence ID" value="CAA42632.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X60018">
<property type="protein sequence ID" value="CAA42633.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X60019">
<property type="protein sequence ID" value="CAA42634.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X60020">
<property type="protein sequence ID" value="CAA42635.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF307851">
<property type="protein sequence ID" value="AAG28785.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ186648">
<property type="protein sequence ID" value="ABA29753.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ186649">
<property type="protein sequence ID" value="ABA29754.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ186650">
<property type="protein sequence ID" value="ABA29755.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ186651">
<property type="protein sequence ID" value="ABA29756.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ186652">
<property type="protein sequence ID" value="ABA29757.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ191317">
<property type="protein sequence ID" value="ABB80262.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ286964">
<property type="protein sequence ID" value="ABB80266.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X54156">
<property type="protein sequence ID" value="CAA38095.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U94788">
<property type="protein sequence ID" value="AAC12971.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY838896">
<property type="protein sequence ID" value="AAV80424.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF135121">
<property type="protein sequence ID" value="AAD28535.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF135120">
<property type="protein sequence ID" value="AAD28535.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF136271">
<property type="protein sequence ID" value="AAD28628.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF136270">
<property type="protein sequence ID" value="AAD28628.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB082923">
<property type="protein sequence ID" value="BAC16799.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK312568">
<property type="protein sequence ID" value="BAG35463.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC007421">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC087388">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471108">
<property type="protein sequence ID" value="EAW90143.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471108">
<property type="protein sequence ID" value="EAW90144.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC003596">
<property type="protein sequence ID" value="AAH03596.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY429684">
<property type="protein sequence ID" value="AAR10356.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY390341">
<property type="protein sequence ID" value="AAQ90158.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY359814">
<property type="protein sequence ID" value="AAR13239.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U63714">
<property type="protein sequence ID" value="AAB39322.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209136">
<property type="protein sequence ID" value="AAF36362.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209128">
<property type="protein sequence ID" value="AAF36354.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209129">
<property type="protein sequence ID" value="AAF36355.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209130">
<property type="protein sequence ID" value="AAF36356.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209131">
<property type="protein sequence ID" value="AAF36357.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209132">
<property type="protein sequence ID" value="AAF36358.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209133">
<property type="protein sequence ID" value="AAF36359.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209134">
<property type="protein sequence ID" value="AAF36360.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209135">
<property type="protein sequence ID" value="AAF36361.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209148">
<property type="protein sequence ID" value="AAF36374.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209149">
<property type="protein sequence ID" value="AAF36375.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209150">
<property type="protein sequence ID" value="AAF36376.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209151">
<property type="protein sequence ID" value="AAF36377.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209152">
<property type="protein sequence ID" value="AAF36378.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209153">
<property type="protein sequence ID" value="AAF36379.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209154">
<property type="protein sequence ID" value="AAF36380.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209155">
<property type="protein sequence ID" value="AAF36381.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209156">
<property type="protein sequence ID" value="AAF36382.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF210309">
<property type="protein sequence ID" value="AAF63442.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF210308">
<property type="protein sequence ID" value="AAF63442.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF210310">
<property type="protein sequence ID" value="AAF63443.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF240684">
<property type="protein sequence ID" value="AAK76358.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF240685">
<property type="protein sequence ID" value="AAK76359.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY270155">
<property type="protein sequence ID" value="AAP30003.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11118.1">
<molecule id="P04637-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45605.1">
<molecule id="P04637-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45606.1">
<molecule id="P04637-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS73966.1">
<molecule id="P04637-7"/>
</dbReference>
<dbReference type="CCDS" id="CCDS73967.1">
<molecule id="P04637-9"/>
</dbReference>
<dbReference type="CCDS" id="CCDS73968.1">
<molecule id="P04637-8"/>
</dbReference>
<dbReference type="CCDS" id="CCDS73969.1">
<molecule id="P04637-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS73970.1">
<molecule id="P04637-6"/>
</dbReference>
<dbReference type="CCDS" id="CCDS73971.1">
<molecule id="P04637-5"/>
</dbReference>
<dbReference type="PIR" id="A25224">
<property type="entry name" value="DNHU53"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000537.3">
<molecule id="P04637-1"/>
<property type="nucleotide sequence ID" value="NM_000546.5"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001119584.1">
<molecule id="P04637-1"/>
<property type="nucleotide sequence ID" value="NM_001126112.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001119585.1">
<molecule id="P04637-3"/>
<property type="nucleotide sequence ID" value="NM_001126113.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001119586.1">
<molecule id="P04637-2"/>
<property type="nucleotide sequence ID" value="NM_001126114.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001119587.1">
<molecule id="P04637-7"/>
<property type="nucleotide sequence ID" value="NM_001126115.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001119588.1">
<molecule id="P04637-8"/>
<property type="nucleotide sequence ID" value="NM_001126116.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001119589.1">
<molecule id="P04637-9"/>
<property type="nucleotide sequence ID" value="NM_001126117.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001119590.1">
<molecule id="P04637-4"/>
<property type="nucleotide sequence ID" value="NM_001126118.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001263624.1">
<molecule id="P04637-6"/>
<property type="nucleotide sequence ID" value="NM_001276695.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001263625.1">
<molecule id="P04637-5"/>
<property type="nucleotide sequence ID" value="NM_001276696.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001263626.1">
<property type="nucleotide sequence ID" value="NM_001276697.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001263627.1">
<property type="nucleotide sequence ID" value="NM_001276698.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001263628.1">
<property type="nucleotide sequence ID" value="NM_001276699.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001263689.1">
<molecule id="P04637-4"/>
<property type="nucleotide sequence ID" value="NM_001276760.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001263690.1">
<molecule id="P04637-4"/>
<property type="nucleotide sequence ID" value="NM_001276761.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.437460"/>
<dbReference type="UniGene" id="Hs.740601"/>
<dbReference type="PDB" id="1A1U">
<property type="method" value="NMR"/>
<property type="chains" value="A/C=324-358"/>
</dbReference>
<dbReference type="PDB" id="1AIE">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=326-356"/>
</dbReference>
<dbReference type="PDB" id="1C26">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=325-356"/>
</dbReference>
<dbReference type="PDB" id="1DT7">
<property type="method" value="NMR"/>
<property type="chains" value="X/Y=367-388"/>
</dbReference>
<dbReference type="PDB" id="1GZH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/C=95-292"/>
</dbReference>
<dbReference type="PDB" id="1H26">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.24"/>
<property type="chains" value="E=376-386"/>
</dbReference>
<dbReference type="PDB" id="1HS5">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=324-357"/>
</dbReference>
<dbReference type="PDB" id="1JSP">
<property type="method" value="NMR"/>
<property type="chains" value="A=367-386"/>
</dbReference>
<dbReference type="PDB" id="1KZY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=95-289"/>
</dbReference>
<dbReference type="PDB" id="1MA3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="B=372-389"/>
</dbReference>
<dbReference type="PDB" id="1OLG">
<property type="method" value="NMR"/>
<property type="chains" value="A/B/C/D=319-360"/>
</dbReference>
<dbReference type="PDB" id="1OLH">
<property type="method" value="NMR"/>
<property type="chains" value="A/B/C/D=319-360"/>
</dbReference>
<dbReference type="PDB" id="1PES">
<property type="method" value="NMR"/>
<property type="chains" value="A/B/C/D=325-355"/>
</dbReference>
<dbReference type="PDB" id="1PET">
<property type="method" value="NMR"/>
<property type="chains" value="A/B/C/D=325-355"/>
</dbReference>
<dbReference type="PDB" id="1SAE">
<property type="method" value="NMR"/>
<property type="chains" value="A/B/C/D=319-360"/>
</dbReference>
<dbReference type="PDB" id="1SAF">
<property type="method" value="NMR"/>
<property type="chains" value="A/B/C/D=319-360"/>
</dbReference>
<dbReference type="PDB" id="1SAK">
<property type="method" value="NMR"/>
<property type="chains" value="A/B/C/D=319-360"/>
</dbReference>
<dbReference type="PDB" id="1SAL">
<property type="method" value="NMR"/>
<property type="chains" value="A/B/C/D=319-360"/>
</dbReference>
<dbReference type="PDB" id="1TSR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/C=94-312"/>
</dbReference>
<dbReference type="PDB" id="1TUP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/C=94-312"/>
</dbReference>
<dbReference type="PDB" id="1UOL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="1XQH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="B/F=369-377"/>
</dbReference>
<dbReference type="PDB" id="1YC5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="B=372-389"/>
</dbReference>
<dbReference type="PDB" id="1YCQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="B=13-29"/>
</dbReference>
<dbReference type="PDB" id="1YCR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="B=15-29"/>
</dbReference>
<dbReference type="PDB" id="1YCS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=94-292"/>
</dbReference>
<dbReference type="PDB" id="2AC0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B/C/D=94-293"/>
</dbReference>
<dbReference type="PDB" id="2ADY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=94-293"/>
</dbReference>
<dbReference type="PDB" id="2AHI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/B/C/D=94-293"/>
</dbReference>
<dbReference type="PDB" id="2ATA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/C/D=94-293"/>
</dbReference>
<dbReference type="PDB" id="2B3G">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="B=33-60"/>
</dbReference>
<dbReference type="PDB" id="2BIM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.98"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="2BIN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=94-312"/>
</dbReference>
<dbReference type="PDB" id="2BIO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=94-312"/>
</dbReference>
<dbReference type="PDB" id="2BIP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=94-312"/>
</dbReference>
<dbReference type="PDB" id="2BIQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=94-312"/>
</dbReference>
<dbReference type="PDB" id="2F1X">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=359-368"/>
</dbReference>
<dbReference type="PDB" id="2FEJ">
<property type="method" value="NMR"/>
<property type="chains" value="A=94-297"/>
</dbReference>
<dbReference type="PDB" id="2FOJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="B=361-367"/>
</dbReference>
<dbReference type="PDB" id="2FOO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="B=358-363"/>
</dbReference>
<dbReference type="PDB" id="2GS0">
<property type="method" value="NMR"/>
<property type="chains" value="B=20-73"/>
</dbReference>
<dbReference type="PDB" id="2H1L">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.16"/>
<property type="chains" value="M/N/O/P/Q/R/S/T/U/V/W/X=92-292"/>
</dbReference>
<dbReference type="PDB" id="2H2D">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="B=372-389"/>
</dbReference>
<dbReference type="PDB" id="2H2F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="B=372-389"/>
</dbReference>
<dbReference type="PDB" id="2H4F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="D=372-389"/>
</dbReference>
<dbReference type="PDB" id="2H4H">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.99"/>
<property type="chains" value="B=372-389"/>
</dbReference>
<dbReference type="PDB" id="2H4J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="D=372-389"/>
</dbReference>
<dbReference type="PDB" id="2H59">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="D/E=372-389"/>
</dbReference>
<dbReference type="PDB" id="2J0Z">
<property type="method" value="NMR"/>
<property type="chains" value="A/B/C/D=326-356"/>
</dbReference>
<dbReference type="PDB" id="2J10">
<property type="method" value="NMR"/>
<property type="chains" value="A/B/C/D=326-356"/>
</dbReference>
<dbReference type="PDB" id="2J11">
<property type="method" value="NMR"/>
<property type="chains" value="A/B/C/D=326-356"/>
</dbReference>
<dbReference type="PDB" id="2J1W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="2J1X">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="2J1Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.69"/>
<property type="chains" value="A/B/C/D=94-293"/>
</dbReference>
<dbReference type="PDB" id="2J1Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="2J20">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="2J21">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="2K8F">
<property type="method" value="NMR"/>
<property type="chains" value="B=1-39"/>
</dbReference>
<dbReference type="PDB" id="2L14">
<property type="method" value="NMR"/>
<property type="chains" value="B=13-61"/>
</dbReference>
<dbReference type="PDB" id="2LY4">
<property type="method" value="NMR"/>
<property type="chains" value="B=1-93"/>
</dbReference>
<dbReference type="PDB" id="2MEJ">
<property type="method" value="NMR"/>
<property type="chains" value="B=96-312"/>
</dbReference>
<dbReference type="PDB" id="2MWO">
<property type="method" value="NMR"/>
<property type="chains" value="B=363-377"/>
</dbReference>
<dbReference type="PDB" id="2MWP">
<property type="method" value="NMR"/>
<property type="chains" value="B=376-387"/>
</dbReference>
<dbReference type="PDB" id="2MWY">
<property type="method" value="NMR"/>
<property type="chains" value="B=15-29"/>
</dbReference>
<dbReference type="PDB" id="2MZD">
<property type="method" value="NMR"/>
<property type="chains" value="B=35-59"/>
</dbReference>
<dbReference type="PDB" id="2OCJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A/B/C/D=94-312"/>
</dbReference>
<dbReference type="PDB" id="2PCX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.54"/>
<property type="chains" value="A=94-292"/>
</dbReference>
<dbReference type="PDB" id="2RUK">
<property type="method" value="NMR"/>
<property type="chains" value="A=41-62"/>
</dbReference>
<dbReference type="PDB" id="2VUK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="2WGX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="2X0U">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="2X0V">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="2X0W">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="2XWR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.68"/>
<property type="chains" value="A/B=89-293"/>
</dbReference>
<dbReference type="PDB" id="2YBG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B/C/D=94-293"/>
</dbReference>
<dbReference type="PDB" id="2YDR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="P=144-154"/>
</dbReference>
<dbReference type="PDB" id="2Z5S">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="P/Q/R=15-29"/>
</dbReference>
<dbReference type="PDB" id="2Z5T">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="P/Q/R=15-29"/>
</dbReference>
<dbReference type="PDB" id="3D05">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=94-293"/>
</dbReference>
<dbReference type="PDB" id="3D06">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.20"/>
<property type="chains" value="A=94-293"/>
</dbReference>
<dbReference type="PDB" id="3D07">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=94-293"/>
</dbReference>
<dbReference type="PDB" id="3D08">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=94-293"/>
</dbReference>
<dbReference type="PDB" id="3D09">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=94-293"/>
</dbReference>
<dbReference type="PDB" id="3D0A">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B/C/D=94-293"/>
</dbReference>
<dbReference type="PDB" id="3DAB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="B/D/F/H=15-29"/>
</dbReference>
<dbReference type="PDB" id="3DAC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="B/P=17-37"/>
</dbReference>
<dbReference type="PDB" id="3IGK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=94-293"/>
</dbReference>
<dbReference type="PDB" id="3IGL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=94-293"/>
</dbReference>
<dbReference type="PDB" id="3KMD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A/B/C/D=92-291"/>
</dbReference>
<dbReference type="PDB" id="3KZ8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.91"/>
<property type="chains" value="A/B=94-293"/>
</dbReference>
<dbReference type="PDB" id="3LW1">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.28"/>
<property type="chains" value="P=385-393"/>
</dbReference>
<dbReference type="PDB" id="3OQ5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="D/E=377-386"/>
</dbReference>
<dbReference type="PDB" id="3PDH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="D=372-389"/>
</dbReference>
<dbReference type="PDB" id="3Q01">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=94-356"/>
</dbReference>
<dbReference type="PDB" id="3Q05">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/C/D=94-356"/>
</dbReference>
<dbReference type="PDB" id="3Q06">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B/C/D=96-354"/>
</dbReference>
<dbReference type="PDB" id="3SAK">
<property type="method" value="NMR"/>
<property type="chains" value="A/B/C/D=319-360"/>
</dbReference>
<dbReference type="PDB" id="3TG5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="B=365-375"/>
</dbReference>
<dbReference type="PDB" id="3TS8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B/C/D=94-356"/>
</dbReference>
<dbReference type="PDB" id="3ZME">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.35"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="4AGL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="4AGM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.52"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="4AGN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="4AGO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="4AGP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="4AGQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.42"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="4BUZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="P=379-386"/>
</dbReference>
<dbReference type="PDB" id="4BV2">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="E/H=376-388"/>
</dbReference>
<dbReference type="PDB" id="4HFZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.69"/>
<property type="chains" value="B/D=15-29"/>
</dbReference>
<dbReference type="PDB" id="4HJE">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.91"/>
<property type="chains" value="A/B/C/D=92-291"/>
</dbReference>
<dbReference type="PDB" id="4IBQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B/C/D=94-293"/>
</dbReference>
<dbReference type="PDB" id="4IBS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.78"/>
<property type="chains" value="A/B/C/D=94-293"/>
</dbReference>
<dbReference type="PDB" id="4IBT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A/B/C/D=94-293"/>
</dbReference>
<dbReference type="PDB" id="4IBU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A/B/C/D=94-293"/>
</dbReference>
<dbReference type="PDB" id="4IBV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=94-293"/>
</dbReference>
<dbReference type="PDB" id="4IBW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A=94-293"/>
</dbReference>
<dbReference type="PDB" id="4IBY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="A/B=94-293"/>
</dbReference>
<dbReference type="PDB" id="4IBZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.92"/>
<property type="chains" value="A/B/C/D=94-293"/>
</dbReference>
<dbReference type="PDB" id="4IJT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.78"/>
<property type="chains" value="A=94-293"/>
</dbReference>
<dbReference type="PDB" id="4KVP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A/B/C/D=94-312"/>
</dbReference>
<dbReference type="PDB" id="4LO9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/C/D=94-312"/>
</dbReference>
<dbReference type="PDB" id="4LOE">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/B/C/D=94-312"/>
</dbReference>
<dbReference type="PDB" id="4LOF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=94-312"/>
</dbReference>
<dbReference type="PDB" id="4MZI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.25"/>
<property type="chains" value="A=94-292"/>
</dbReference>
<dbReference type="PDB" id="4MZR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C/D=94-388"/>
</dbReference>
<dbReference type="PDB" id="4QO1">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.92"/>
<property type="chains" value="B=92-312"/>
</dbReference>
<dbReference type="PDB" id="4RP6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="Z=252-258"/>
</dbReference>
<dbReference type="PDB" id="4RP7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.58"/>
<property type="chains" value="Z=253-258"/>
</dbReference>
<dbReference type="PDB" id="4X34">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="C/D=377-386"/>
</dbReference>
<dbReference type="PDB" id="4XR8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="C/D=94-292"/>
</dbReference>
<dbReference type="PDB" id="4ZZJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.74"/>
<property type="chains" value="B=379-383"/>
</dbReference>
<dbReference type="PDB" id="5A7B">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="5AB9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.36"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="5ABA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.62"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="5AOI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.78"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="5AOJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.47"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="5AOK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.35"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="5AOL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="5AOM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.74"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="5BUA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.81"/>
<property type="chains" value="A=94-293"/>
</dbReference>
<dbReference type="PDB" id="5ECG">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=95-312"/>
</dbReference>
<dbReference type="PDB" id="5G4M">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.38"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="5G4N">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.35"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="5G4O">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.48"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="5HOU">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-61"/>
</dbReference>
<dbReference type="PDB" id="5HP0">
<property type="method" value="NMR"/>
<property type="chains" value="A=37-61"/>
</dbReference>
<dbReference type="PDB" id="5HPD">
<property type="method" value="NMR"/>
<property type="chains" value="A=2-61"/>
</dbReference>
<dbReference type="PDB" id="5LAP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.42"/>
<property type="chains" value="A/B=94-312"/>
</dbReference>
<dbReference type="PDB" id="5LGY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.92"/>
<property type="chains" value="A/B/C/D=94-291"/>
</dbReference>
<dbReference type="PDB" id="5MHC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.20"/>
<property type="chains" value="P=382-393"/>
</dbReference>
<dbReference type="PDB" id="5MOC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="P=382-393"/>
</dbReference>
<dbReference type="PDB" id="5UN8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.13"/>
<property type="chains" value="E/F/G/H=144-154"/>
</dbReference>
<dbReference type="PDBsum" id="1A1U"/>
<dbReference type="PDBsum" id="1AIE"/>
<dbReference type="PDBsum" id="1C26"/>
<dbReference type="PDBsum" id="1DT7"/>
<dbReference type="PDBsum" id="1GZH"/>
<dbReference type="PDBsum" id="1H26"/>
<dbReference type="PDBsum" id="1HS5"/>
<dbReference type="PDBsum" id="1JSP"/>
<dbReference type="PDBsum" id="1KZY"/>
<dbReference type="PDBsum" id="1MA3"/>
<dbReference type="PDBsum" id="1OLG"/>
<dbReference type="PDBsum" id="1OLH"/>
<dbReference type="PDBsum" id="1PES"/>
<dbReference type="PDBsum" id="1PET"/>
<dbReference type="PDBsum" id="1SAE"/>
<dbReference type="PDBsum" id="1SAF"/>
<dbReference type="PDBsum" id="1SAK"/>
<dbReference type="PDBsum" id="1SAL"/>
<dbReference type="PDBsum" id="1TSR"/>
<dbReference type="PDBsum" id="1TUP"/>
<dbReference type="PDBsum" id="1UOL"/>
<dbReference type="PDBsum" id="1XQH"/>
<dbReference type="PDBsum" id="1YC5"/>
<dbReference type="PDBsum" id="1YCQ"/>
<dbReference type="PDBsum" id="1YCR"/>
<dbReference type="PDBsum" id="1YCS"/>
<dbReference type="PDBsum" id="2AC0"/>
<dbReference type="PDBsum" id="2ADY"/>
<dbReference type="PDBsum" id="2AHI"/>
<dbReference type="PDBsum" id="2ATA"/>
<dbReference type="PDBsum" id="2B3G"/>
<dbReference type="PDBsum" id="2BIM"/>
<dbReference type="PDBsum" id="2BIN"/>
<dbReference type="PDBsum" id="2BIO"/>
<dbReference type="PDBsum" id="2BIP"/>
<dbReference type="PDBsum" id="2BIQ"/>
<dbReference type="PDBsum" id="2F1X"/>
<dbReference type="PDBsum" id="2FEJ"/>
<dbReference type="PDBsum" id="2FOJ"/>
<dbReference type="PDBsum" id="2FOO"/>
<dbReference type="PDBsum" id="2GS0"/>
<dbReference type="PDBsum" id="2H1L"/>
<dbReference type="PDBsum" id="2H2D"/>
<dbReference type="PDBsum" id="2H2F"/>
<dbReference type="PDBsum" id="2H4F"/>
<dbReference type="PDBsum" id="2H4H"/>
<dbReference type="PDBsum" id="2H4J"/>
<dbReference type="PDBsum" id="2H59"/>
<dbReference type="PDBsum" id="2J0Z"/>
<dbReference type="PDBsum" id="2J10"/>
<dbReference type="PDBsum" id="2J11"/>
<dbReference type="PDBsum" id="2J1W"/>
<dbReference type="PDBsum" id="2J1X"/>
<dbReference type="PDBsum" id="2J1Y"/>
<dbReference type="PDBsum" id="2J1Z"/>
<dbReference type="PDBsum" id="2J20"/>
<dbReference type="PDBsum" id="2J21"/>
<dbReference type="PDBsum" id="2K8F"/>
<dbReference type="PDBsum" id="2L14"/>
<dbReference type="PDBsum" id="2LY4"/>
<dbReference type="PDBsum" id="2MEJ"/>
<dbReference type="PDBsum" id="2MWO"/>
<dbReference type="PDBsum" id="2MWP"/>
<dbReference type="PDBsum" id="2MWY"/>
<dbReference type="PDBsum" id="2MZD"/>
<dbReference type="PDBsum" id="2OCJ"/>
<dbReference type="PDBsum" id="2PCX"/>
<dbReference type="PDBsum" id="2RUK"/>
<dbReference type="PDBsum" id="2VUK"/>
<dbReference type="PDBsum" id="2WGX"/>
<dbReference type="PDBsum" id="2X0U"/>
<dbReference type="PDBsum" id="2X0V"/>
<dbReference type="PDBsum" id="2X0W"/>
<dbReference type="PDBsum" id="2XWR"/>
<dbReference type="PDBsum" id="2YBG"/>
<dbReference type="PDBsum" id="2YDR"/>
<dbReference type="PDBsum" id="2Z5S"/>
<dbReference type="PDBsum" id="2Z5T"/>
<dbReference type="PDBsum" id="3D05"/>
<dbReference type="PDBsum" id="3D06"/>
<dbReference type="PDBsum" id="3D07"/>
<dbReference type="PDBsum" id="3D08"/>
<dbReference type="PDBsum" id="3D09"/>
<dbReference type="PDBsum" id="3D0A"/>
<dbReference type="PDBsum" id="3DAB"/>
<dbReference type="PDBsum" id="3DAC"/>
<dbReference type="PDBsum" id="3IGK"/>
<dbReference type="PDBsum" id="3IGL"/>
<dbReference type="PDBsum" id="3KMD"/>
<dbReference type="PDBsum" id="3KZ8"/>
<dbReference type="PDBsum" id="3LW1"/>
<dbReference type="PDBsum" id="3OQ5"/>
<dbReference type="PDBsum" id="3PDH"/>
<dbReference type="PDBsum" id="3Q01"/>
<dbReference type="PDBsum" id="3Q05"/>
<dbReference type="PDBsum" id="3Q06"/>
<dbReference type="PDBsum" id="3SAK"/>
<dbReference type="PDBsum" id="3TG5"/>
<dbReference type="PDBsum" id="3TS8"/>
<dbReference type="PDBsum" id="3ZME"/>
<dbReference type="PDBsum" id="4AGL"/>
<dbReference type="PDBsum" id="4AGM"/>
<dbReference type="PDBsum" id="4AGN"/>
<dbReference type="PDBsum" id="4AGO"/>
<dbReference type="PDBsum" id="4AGP"/>
<dbReference type="PDBsum" id="4AGQ"/>
<dbReference type="PDBsum" id="4BUZ"/>
<dbReference type="PDBsum" id="4BV2"/>
<dbReference type="PDBsum" id="4HFZ"/>
<dbReference type="PDBsum" id="4HJE"/>
<dbReference type="PDBsum" id="4IBQ"/>
<dbReference type="PDBsum" id="4IBS"/>
<dbReference type="PDBsum" id="4IBT"/>
<dbReference type="PDBsum" id="4IBU"/>
<dbReference type="PDBsum" id="4IBV"/>
<dbReference type="PDBsum" id="4IBW"/>
<dbReference type="PDBsum" id="4IBY"/>
<dbReference type="PDBsum" id="4IBZ"/>
<dbReference type="PDBsum" id="4IJT"/>
<dbReference type="PDBsum" id="4KVP"/>
<dbReference type="PDBsum" id="4LO9"/>
<dbReference type="PDBsum" id="4LOE"/>
<dbReference type="PDBsum" id="4LOF"/>
<dbReference type="PDBsum" id="4MZI"/>
<dbReference type="PDBsum" id="4MZR"/>
<dbReference type="PDBsum" id="4QO1"/>
<dbReference type="PDBsum" id="4RP6"/>
<dbReference type="PDBsum" id="4RP7"/>
<dbReference type="PDBsum" id="4X34"/>
<dbReference type="PDBsum" id="4XR8"/>
<dbReference type="PDBsum" id="4ZZJ"/>
<dbReference type="PDBsum" id="5A7B"/>
<dbReference type="PDBsum" id="5AB9"/>
<dbReference type="PDBsum" id="5ABA"/>
<dbReference type="PDBsum" id="5AOI"/>
<dbReference type="PDBsum" id="5AOJ"/>
<dbReference type="PDBsum" id="5AOK"/>
<dbReference type="PDBsum" id="5AOL"/>
<dbReference type="PDBsum" id="5AOM"/>
<dbReference type="PDBsum" id="5BUA"/>
<dbReference type="PDBsum" id="5ECG"/>
<dbReference type="PDBsum" id="5G4M"/>
<dbReference type="PDBsum" id="5G4N"/>
<dbReference type="PDBsum" id="5G4O"/>
<dbReference type="PDBsum" id="5HOU"/>
<dbReference type="PDBsum" id="5HP0"/>
<dbReference type="PDBsum" id="5HPD"/>
<dbReference type="PDBsum" id="5LAP"/>
<dbReference type="PDBsum" id="5LGY"/>
<dbReference type="PDBsum" id="5MHC"/>
<dbReference type="PDBsum" id="5MOC"/>
<dbReference type="PDBsum" id="5UN8"/>
<dbReference type="DisProt" id="DP00086"/>
<dbReference type="ProteinModelPortal" id="P04637"/>
<dbReference type="SMR" id="P04637"/>
<dbReference type="BioGrid" id="113010">
<property type="interactions" value="1032"/>
</dbReference>
<dbReference type="CORUM" id="P04637"/>
<dbReference type="DIP" id="DIP-368N"/>
<dbReference type="ELM" id="P04637"/>
<dbReference type="IntAct" id="P04637">
<property type="interactions" value="463"/>
</dbReference>
<dbReference type="MINT" id="MINT-91013"/>
<dbReference type="STRING" id="9606.ENSP00000269305"/>
<dbReference type="BindingDB" id="P04637"/>
<dbReference type="ChEMBL" id="CHEMBL4096"/>
<dbReference type="DrugBank" id="DB08363">
<property type="generic name" value="1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00945">
<property type="generic name" value="Acetylsalicylic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB05404">
<property type="generic name" value="AZD 3355"/>
</dbReference>
<dbReference type="TCDB" id="1.C.110.1.1">
<property type="family name" value="the pore-forming pnc-27 peptide of 32 aas from the p53 tumor suppressor protein (pnc-27) family"/>
</dbReference>
<dbReference type="iPTMnet" id="P04637"/>
<dbReference type="PhosphoSitePlus" id="P04637"/>
<dbReference type="BioMuta" id="TP53"/>
<dbReference type="DMDM" id="269849759"/>
<dbReference type="SWISS-2DPAGE" id="P04637"/>
<dbReference type="EPD" id="P04637"/>
<dbReference type="MaxQB" id="P04637"/>
<dbReference type="PaxDb" id="P04637"/>
<dbReference type="PeptideAtlas" id="P04637"/>
<dbReference type="PRIDE" id="P04637"/>
<dbReference type="DNASU" id="7157"/>
<dbReference type="Ensembl" id="ENST00000269305">
<molecule id="P04637-1"/>
<property type="protein sequence ID" value="ENSP00000269305"/>
<property type="gene ID" value="ENSG00000141510"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000420246">
<molecule id="P04637-2"/>
<property type="protein sequence ID" value="ENSP00000391127"/>
<property type="gene ID" value="ENSG00000141510"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000445888">
<molecule id="P04637-1"/>
<property type="protein sequence ID" value="ENSP00000391478"/>
<property type="gene ID" value="ENSG00000141510"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000455263">
<molecule id="P04637-3"/>
<property type="protein sequence ID" value="ENSP00000398846"/>
<property type="gene ID" value="ENSG00000141510"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000504290">
<molecule id="P04637-9"/>
<property type="protein sequence ID" value="ENSP00000484409"/>
<property type="gene ID" value="ENSG00000141510"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000504937">
<molecule id="P04637-7"/>
<property type="protein sequence ID" value="ENSP00000481179"/>
<property type="gene ID" value="ENSG00000141510"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000510385">
<molecule id="P04637-8"/>
<property type="protein sequence ID" value="ENSP00000478499"/>
<property type="gene ID" value="ENSG00000141510"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000610292">
<molecule id="P04637-4"/>
<property type="protein sequence ID" value="ENSP00000478219"/>
<property type="gene ID" value="ENSG00000141510"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000610538">
<molecule id="P04637-6"/>
<property type="protein sequence ID" value="ENSP00000480868"/>
<property type="gene ID" value="ENSG00000141510"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000617185">
<molecule id="P04637-2"/>
<property type="protein sequence ID" value="ENSP00000482258"/>
<property type="gene ID" value="ENSG00000141510"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000619485">
<molecule id="P04637-4"/>
<property type="protein sequence ID" value="ENSP00000482537"/>
<property type="gene ID" value="ENSG00000141510"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000620739">
<molecule id="P04637-4"/>
<property type="protein sequence ID" value="ENSP00000481638"/>
<property type="gene ID" value="ENSG00000141510"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000622645">
<molecule id="P04637-5"/>
<property type="protein sequence ID" value="ENSP00000482222"/>
<property type="gene ID" value="ENSG00000141510"/>
</dbReference>
<dbReference type="GeneID" id="7157"/>
<dbReference type="KEGG" id="hsa:7157"/>
<dbReference type="UCSC" id="uc002gij.4">
<molecule id="P04637-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7157"/>
<dbReference type="DisGeNET" id="7157"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000141510.16"/>
<dbReference type="GeneCards" id="TP53"/>
<dbReference type="GeneReviews" id="TP53"/>
<dbReference type="HGNC" id="HGNC:11998">
<property type="gene designation" value="TP53"/>
</dbReference>
<dbReference type="HPA" id="CAB002973"/>
<dbReference type="HPA" id="CAB039238"/>
<dbReference type="HPA" id="CAB039239"/>
<dbReference type="HPA" id="CAB072876"/>
<dbReference type="HPA" id="HPA051244"/>
<dbReference type="MalaCards" id="TP53"/>
<dbReference type="MIM" id="133239">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="151623">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="191170">
<property type="type" value="gene+phenotype"/>
</dbReference>
<dbReference type="MIM" id="202300">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="211980">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="260500">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="275355">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="614740">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P04637"/>
<dbReference type="OpenTargets" id="ENSG00000141510"/>
<dbReference type="Orphanet" id="1501">
<property type="disease" value="Adrenocortical carcinoma"/>
</dbReference>
<dbReference type="Orphanet" id="67038">
<property type="disease" value="B-cell chronic lymphocytic leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="3318">
<property type="disease" value="Essential thrombocythemia"/>
</dbReference>
<dbReference type="Orphanet" id="1333">
<property type="disease" value="Familial pancreatic carcinoma"/>
</dbReference>
<dbReference type="Orphanet" id="251579">
<property type="disease" value="Giant cell glioblastoma"/>
</dbReference>
<dbReference type="Orphanet" id="251576">
<property type="disease" value="Gliosarcoma"/>
</dbReference>
<dbReference type="Orphanet" id="524">
<property type="disease" value="Li-Fraumeni syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="2807">
<property type="disease" value="Papilloma of choroid plexus"/>
</dbReference>
<dbReference type="Orphanet" id="99860">
<property type="disease" value="Precursor B-cell acute lymphoblastic leukemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36679"/>
<dbReference type="eggNOG" id="ENOG410IITK">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410ZSWV">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000015092"/>
<dbReference type="HOVERGEN" id="HBG005201"/>
<dbReference type="InParanoid" id="P04637"/>
<dbReference type="KO" id="K04451"/>
<dbReference type="OMA" id="PATSWPL"/>
<dbReference type="OrthoDB" id="EOG091G0XY5"/>
<dbReference type="PhylomeDB" id="P04637"/>
<dbReference type="TreeFam" id="TF106101"/>
<dbReference type="Reactome" id="R-HSA-111448">
<property type="pathway name" value="Activation of NOXA and translocation to mitochondria"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-139915">
<property type="pathway name" value="Activation of PUMA and translocation to mitochondria"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1912408">
<property type="pathway name" value="Pre-NOTCH Transcription and Translation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559580">
<property type="pathway name" value="Oxidative Stress Induced Senescence"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559584">
<property type="pathway name" value="Formation of Senescence-Associated Heterochromatin Foci (SAHF)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559585">
<property type="pathway name" value="Oncogene Induced Senescence"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559586">
<property type="pathway name" value="DNA Damage/Telomere Stress Induced Senescence"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3232118">
<property type="pathway name" value="SUMOylation of transcription factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-349425">
<property type="pathway name" value="Autodegradation of the E3 ubiquitin ligase COP1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-390471">
<property type="pathway name" value="Association of TriC/CCT with target proteins during biosynthesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5628897">
<property type="pathway name" value="TP53 Regulates Metabolic Genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689896">
<property type="pathway name" value="Ovarian tumor domain proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693565">
<property type="pathway name" value="Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and 13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6796648">
<property type="pathway name" value="TP53 Regulates Transcription of DNA Repair Genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6803204">
<property type="pathway name" value="TP53 Regulates Transcription of Genes Involved in Cytochrome C Release"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6803205">
<property type="pathway name" value="TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6803207">
<property type="pathway name" value="TP53 Regulates Transcription of Caspase Activators and Caspases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6803211">
<property type="pathway name" value="TP53 Regulates Transcription of Death Receptors and Ligands"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804114">
<property type="pathway name" value="TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804115">
<property type="pathway name" value="TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804116">
<property type="pathway name" value="TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804754">
<property type="pathway name" value="Regulation of TP53 Expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804756">
<property type="pathway name" value="Regulation of TP53 Activity through Phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804757">
<property type="pathway name" value="Regulation of TP53 Degradation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804758">
<property type="pathway name" value="Regulation of TP53 Activity through Acetylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804759">
<property type="pathway name" value="Regulation of TP53 Activity through Association with Co-factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804760">
<property type="pathway name" value="Regulation of TP53 Activity through Methylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811555">
<property type="pathway name" value="PI5P Regulates TP53 Acetylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69473">
<property type="pathway name" value="G2/M DNA damage checkpoint"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69481">
<property type="pathway name" value="G2/M Checkpoints"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69541">
<property type="pathway name" value="Stabilization of p53"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69895">
<property type="pathway name" value="Transcriptional activation of cell cycle inhibitor p21"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8852276">
<property type="pathway name" value="The role of GTSE1 in G2/M progression after G2 checkpoint"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8941855">
<property type="pathway name" value="RUNX3 regulates CDKN1A transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8943724">
<property type="pathway name" value="Regulation of PTEN gene transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983231">
<property type="pathway name" value="Factors involved in megakaryocyte development and platelet production"/>
</dbReference>
<dbReference type="SignaLink" id="P04637"/>
<dbReference type="SIGNOR" id="P04637"/>
<dbReference type="ChiTaRS" id="TP53">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P04637"/>
<dbReference type="GeneWiki" id="P53"/>
<dbReference type="GenomeRNAi" id="7157"/>
<dbReference type="PMAP-CutDB" id="P04637"/>
<dbReference type="PRO" id="PR:P04637"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000141510"/>
<dbReference type="ExpressionAtlas" id="P04637">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P04637">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005622">
<property type="term" value="C:intracellular"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005759">
<property type="term" value="C:mitochondrial matrix"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016363">
<property type="term" value="C:nuclear matrix"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005657">
<property type="term" value="C:replication fork"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051087">
<property type="term" value="F:chaperone binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005507">
<property type="term" value="F:copper ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001046">
<property type="term" value="F:core promoter sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0003684">
<property type="term" value="F:damaged DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0097718">
<property type="term" value="F:disordered domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035035">
<property type="term" value="F:histone acetyltransferase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0003730">
<property type="term" value="F:mRNA 3'-UTR binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0002039">
<property type="term" value="F:p53 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0002020">
<property type="term" value="F:protease binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0047485">
<property type="term" value="F:protein N-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051721">
<property type="term" value="F:protein phosphatase 2A binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043621">
<property type="term" value="F:protein self-association"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0030971">
<property type="term" value="F:receptor tyrosine kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:RNA polymerase II transcription factor activity, sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001085">
<property type="term" value="F:RNA polymerase II transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000990">
<property type="term" value="F:transcription factor activity, core RNA polymerase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:transcription factor activity, sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044212">
<property type="term" value="F:transcription regulatory region DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006914">
<property type="term" value="P:autophagy"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006284">
<property type="term" value="P:base-excision repair"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007569">
<property type="term" value="P:cell aging"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007050">
<property type="term" value="P:cell cycle arrest"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034613">
<property type="term" value="P:cellular protein localization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072717">
<property type="term" value="P:cellular response to actinomycin D"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035690">
<property type="term" value="P:cellular response to drug"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071480">
<property type="term" value="P:cellular response to gamma radiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0042149">
<property type="term" value="P:cellular response to glucose starvation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071456">
<property type="term" value="P:cellular response to hypoxia"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071479">
<property type="term" value="P:cellular response to ionizing radiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034644">
<property type="term" value="P:cellular response to UV"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0031497">
<property type="term" value="P:chromatin assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048512">
<property type="term" value="P:circadian behavior"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008340">
<property type="term" value="P:determination of adult lifespan"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030330">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006977">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006978">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0000733">
<property type="term" value="P:DNA strand renaturation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043153">
<property type="term" value="P:entrainment of circadian clock by photoperiod"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006983">
<property type="term" value="P:ER overload response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0097193">
<property type="term" value="P:intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0072332">
<property type="term" value="P:intrinsic apoptotic signaling pathway by p53 class mediator"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042771">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031571">
<property type="term" value="P:mitotic G1 DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009299">
<property type="term" value="P:mRNA transcription"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007275">
<property type="term" value="P:multicellular organism development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030308">
<property type="term" value="P:negative regulation of cell growth"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0048147">
<property type="term" value="P:negative regulation of fibroblast proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051097">
<property type="term" value="P:negative regulation of helicase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051974">
<property type="term" value="P:negative regulation of telomerase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006289">
<property type="term" value="P:nucleotide-excision repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097252">
<property type="term" value="P:oligodendrocyte apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090403">
<property type="term" value="P:oxidative stress-induced premature senescence"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071158">
<property type="term" value="P:positive regulation of cell cycle arrest"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:1900119">
<property type="term" value="P:positive regulation of execution phase of apoptosis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0031065">
<property type="term" value="P:positive regulation of histone deacetylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:2001244">
<property type="term" value="P:positive regulation of intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043525">
<property type="term" value="P:positive regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050731">
<property type="term" value="P:positive regulation of peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902895">
<property type="term" value="P:positive regulation of pri-miRNA transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046827">
<property type="term" value="P:positive regulation of protein export from nucleus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1900740">
<property type="term" value="P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032461">
<property type="term" value="P:positive regulation of protein oligomerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000379">
<property type="term" value="P:positive regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090200">
<property type="term" value="P:positive regulation of release of cytochrome c from mitochondria"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070245">
<property type="term" value="P:positive regulation of thymocyte apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990440">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006461">
<property type="term" value="P:protein complex assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051289">
<property type="term" value="P:protein homotetramerization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0008104">
<property type="term" value="P:protein localization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051262">
<property type="term" value="P:protein tetramerization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007265">
<property type="term" value="P:Ras protein signal transduction"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:1902749">
<property type="term" value="P:regulation of cell cycle G2/M phase transition"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046902">
<property type="term" value="P:regulation of mitochondrial membrane permeability"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090399">
<property type="term" value="P:replicative senescence"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046677">
<property type="term" value="P:response to antibiotic"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010332">
<property type="term" value="P:response to gamma radiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010165">
<property type="term" value="P:response to X-ray"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0072331">
<property type="term" value="P:signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="CDD" id="cd08367">
<property type="entry name" value="P53"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.720">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="4.10.170.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR008967">
<property type="entry name" value="p53-like_TF_DNA-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR012346">
<property type="entry name" value="p53/RUNT-type_TF_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR011615">
<property type="entry name" value="p53_DNA-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR036674">
<property type="entry name" value="p53_tetramer_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR010991">
<property type="entry name" value="p53_tetrameristn"/>
</dbReference>
<dbReference type="InterPro" id="IPR013872">
<property type="entry name" value="p53_transactivation_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR002117">
<property type="entry name" value="p53_tumour_suppressor"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11447">
<property type="entry name" value="PTHR11447"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00870">
<property type="entry name" value="P53"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08563">
<property type="entry name" value="P53_TAD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07710">
<property type="entry name" value="P53_tetramer"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00386">
<property type="entry name" value="P53SUPPRESSR"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47719">
<property type="entry name" value="SSF47719"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49417">
<property type="entry name" value="SSF49417"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00348">
<property type="entry name" value="P53"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0877">Alternative promoter usage</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0435">Li-Fraumeni syndrome</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-1210">Necrosis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="chain" description="Cellular tumor antigen p53" id="PRO_0000185703">
<location>
<begin position="1"/>
<end position="393"/>
</location>
</feature>
<feature type="DNA-binding region">
<location>
<begin position="102"/>
<end position="292"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CCAR2" evidence="148">
<location>
<begin position="1"/>
<end position="320"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with HRMT1L2" evidence="58">
<location>
<begin position="1"/>
<end position="83"/>
</location>
</feature>
<feature type="region of interest" description="Transcription activation (acidic)">
<location>
<begin position="1"/>
<end position="44"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with WWOX">
<location>
<begin position="66"/>
<end position="110"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with HIPK1" evidence="20">
<location>
<begin position="100"/>
<end position="370"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with ZNF385A" evidence="98">
<location>
<begin position="100"/>
<end position="300"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with FBXO42" evidence="110">
<location>
<begin position="113"/>
<end position="236"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with AXIN1" evidence="20">
<location>
<begin position="116"/>
<end position="292"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with the 53BP2 SH3 domain">
<location>
<begin position="241"/>
<end position="248"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with E4F1" evidence="26">
<location>
<begin position="256"/>
<end position="294"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DNA">
<location>
<begin position="273"/>
<end position="280"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CARM1" evidence="58">
<location>
<begin position="300"/>
<end position="393"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with HIPK2">
<location>
<begin position="319"/>
<end position="360"/>
</location>
</feature>
<feature type="region of interest" description="Oligomerization">
<location>
<begin position="325"/>
<end position="356"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with USP7">
<location>
<begin position="359"/>
<end position="363"/>
</location>
</feature>
<feature type="region of interest" description="Basic (repression of DNA-binding)">
<location>
<begin position="368"/>
<end position="387"/>
</location>
</feature>
<feature type="short sequence motif" description="TADI">
<location>
<begin position="17"/>
<end position="25"/>
</location>
</feature>
<feature type="short sequence motif" description="TADII">
<location>
<begin position="48"/>
<end position="56"/>
</location>
</feature>
<feature type="short sequence motif" description="Bipartite nuclear localization signal">
<location>
<begin position="305"/>
<end position="321"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal">
<location>
<begin position="339"/>
<end position="350"/>
</location>
</feature>
<feature type="short sequence motif" description="[KR]-[STA]-K motif">
<location>
<begin position="370"/>
<end position="372"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc">
<location>
<position position="176"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc">
<location>
<position position="179"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc">
<location>
<position position="238"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc">
<location>
<position position="242"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA">
<location>
<position position="120"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by HIPK4" evidence="101">
<location>
<position position="9"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK5, PRPK, AMPK, NUAK1 and ATM" evidence="24 39 63 65 83 96 100 132">
<location>
<position position="15"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CK1, VRK1 and VRK2" evidence="25 30 75">
<location>
<position position="18"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CHEK2, CK1 and PLK3" evidence="24 35 38 45 119">
<location>
<position position="20"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK5 and CDK7" evidence="96 161">
<location>
<position position="33"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPKAPK5" evidence="90">
<location>
<position position="37"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK5, DYRK2, HIPK2 and PKC/PRKCG" evidence="40 41 71 93 96">
<location>
<position position="46"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by TAF1 and GRK5" evidence="54 122">
<location>
<position position="55"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by KAT6A" evidence="144">
<location>
<position position="120"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by AURKB" evidence="131">
<location>
<position position="183"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by AURKB" evidence="131">
<location>
<position position="269"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by AURKB" evidence="131">
<location>
<position position="284"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="43">
<location>
<position position="305"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by AURKA, CDK1 and CDK2" evidence="29 53">
<location>
<position position="315"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="21">
<location>
<position position="321"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine; alternate" evidence="84 142">
<location>
<position position="370"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine; by SMYD2; alternate" evidence="84 142">
<location>
<position position="370"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine; by SETD7" evidence="61 73">
<location>
<position position="372"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine; by EHMT1 and EHMT2; alternate" evidence="121">
<location>
<position position="373"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="27">
<location>
<position position="373"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="19">
<location>
<position position="381"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine; alternate" evidence="97 130 142">
<location>
<position position="382"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by KAT6A; alternate" evidence="19 27 125 144">
<location>
<position position="382"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine; by KMT5A; alternate" evidence="97 130 142">
<location>
<position position="382"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2, CDK2 and NUAK1" evidence="29 34 83 132 137">
<location>
<position position="392"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="112">
<location>
<position position="291"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="112">
<location>
<position position="292"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="33 137 171">
<location>
<position position="386"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7, isoform 8 and isoform 9." id="VSP_040833" evidence="172">
<location>
<begin position="1"/>
<end position="132"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4, isoform 5 and isoform 6." id="VSP_040832" evidence="173">
<location>
<begin position="1"/>
<end position="39"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3, isoform 6 and isoform 9." id="VSP_040560" evidence="172">
<original>IRGRERFEMFRELNE</original>
<variation>MLLDLRWCYFLINSS</variation>
<location>
<begin position="332"/>
<end position="346"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform 5 and isoform 8." id="VSP_006535" evidence="172">
<original>IRGRERFEMF</original>
<variation>DQTSFQKENC</variation>
<location>
<begin position="332"/>
<end position="341"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform 5 and isoform 8." id="VSP_006536" evidence="172">
<location>
<begin position="342"/>
<end position="393"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3, isoform 6 and isoform 9." id="VSP_040561" evidence="172">
<location>
<begin position="347"/>
<end position="393"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; abolishes strongly phosphorylation." id="VAR_044543">
<original>Q</original>
<variation>H</variation>
<location>
<position position="5"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; reduces interaction with ZNF385A." id="VAR_044544">
<original>S</original>
<variation>L</variation>
<location>
<position position="6"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs587782646." id="VAR_005851">
<original>D</original>
<variation>H</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044545">
<original>P</original>
<variation>S</variation>
<location>
<position position="8"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs535274413." id="VAR_044546">
<original>V</original>
<variation>I</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs201382018." id="VAR_044547">
<original>E</original>
<variation>K</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs201382018." id="VAR_044548">
<original>E</original>
<variation>Q</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044549">
<original>S</original>
<variation>R</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044550">
<original>Q</original>
<variation>L</variation>
<location>
<position position="16"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044551">
<original>E</original>
<variation>D</variation>
<location>
<position position="17"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044552">
<original>K</original>
<variation>N</variation>
<location>
<position position="24"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044553">
<original>E</original>
<variation>A</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047158">
<original>NN</original>
<variation>KD</variation>
<location>
<begin position="29"/>
<end position="30"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs201753350." id="VAR_044554">
<original>V</original>
<variation>I</variation>
<location>
<position position="31"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044555">
<original>S</original>
<variation>T</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044556">
<original>P</original>
<variation>L</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs121912661." id="VAR_005852">
<original>L</original>
<variation>F</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs587781866." id="VAR_044557">
<original>P</original>
<variation>L</variation>
<location>
<position position="36"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044558">
<original>S</original>
<variation>P</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044559">
<original>S</original>
<variation>T</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044560">
<original>A</original>
<variation>P</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044561">
<original>A</original>
<variation>V</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044562">
<original>D</original>
<variation>Y</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_005853">
<original>L</original>
<variation>S</variation>
<location>
<position position="43"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044563">
<original>M</original>
<variation>I</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044564">
<original>M</original>
<variation>T</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044565">
<original>M</original>
<variation>V</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044566">
<original>L</original>
<variation>M</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044567">
<original>S</original>
<variation>F</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs876659630." id="VAR_044568">
<original>S</original>
<variation>P</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044569">
<original>P</original>
<variation>L</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1800371." id="VAR_014632" evidence="166">
<original>P</original>
<variation>S</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044570">
<original>D</original>
<variation>G</variation>
<location>
<position position="48"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587780728." id="VAR_044571">
<original>D</original>
<variation>H</variation>
<location>
<position position="49"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs587780728." id="VAR_044572">
<original>D</original>
<variation>N</variation>
<location>
<position position="49"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044573">
<original>D</original>
<variation>Y</variation>
<location>
<position position="49"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044574">
<original>Q</original>
<variation>H</variation>
<location>
<position position="52"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005854">
<original>W</original>
<variation>C</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044575">
<original>W</original>
<variation>G</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044576">
<original>F</original>
<variation>L</variation>
<location>
<position position="54"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044577">
<original>F</original>
<variation>Y</variation>
<location>
<position position="54"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044578">
<original>E</original>
<variation>K</variation>
<location>
<position position="56"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044579">
<original>E</original>
<variation>V</variation>
<location>
<position position="56"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044580">
<original>P</original>
<variation>Q</variation>
<location>
<position position="58"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044581">
<original>P</original>
<variation>T</variation>
<location>
<position position="58"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044582">
<original>G</original>
<variation>C</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044583">
<original>G</original>
<variation>D</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045783">
<original>G</original>
<variation>N</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044584">
<original>P</original>
<variation>L</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044585">
<original>P</original>
<variation>Q</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_005855">
<original>P</original>
<variation>S</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044586">
<original>D</original>
<variation>G</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044587">
<original>D</original>
<variation>N</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044588">
<original>E</original>
<variation>D</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs876658902." id="VAR_044589">
<original>A</original>
<variation>T</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs372201428." id="VAR_044590">
<original>A</original>
<variation>V</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044591">
<original>R</original>
<variation>T</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044592">
<original>M</original>
<variation>I</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044593">
<original>M</original>
<variation>R</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044594">
<original>P</original>
<variation>L</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044595">
<original>P</original>
<variation>R</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044596">
<original>P</original>
<variation>S</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044597">
<original>E</original>
<variation>G</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044598">
<original>E</original>
<variation>Q</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044599">
<original>A</original>
<variation>D</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs756233241." id="VAR_044600">
<original>A</original>
<variation>G</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044601">
<original>A</original>
<variation>T</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs756233241." id="VAR_044602">
<original>A</original>
<variation>V</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044603">
<original>A</original>
<variation>T</variation>
<location>
<position position="70"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044604">
<original>P</original>
<variation>T</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; requires 2 nucleotide substitutions; dbSNP:rs730882014." id="VAR_045784">
<original>P</original>
<variation>C</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045785">
<original>P</original>
<variation>G</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs1042522." id="VAR_045786">
<original>P</original>
<variation>H</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045787">
<original>P</original>
<variation>L</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1042522." id="VAR_005856" evidence="52 66 118 168">
<original>P</original>
<variation>R</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044605">
<original>V</original>
<variation>E</variation>
<location>
<position position="73"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044606">
<original>V</original>
<variation>L</variation>
<location>
<position position="73"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587782423." id="VAR_044607">
<original>V</original>
<variation>M</variation>
<location>
<position position="73"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044608">
<original>A</original>
<variation>T</variation>
<location>
<position position="74"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044609">
<original>P</original>
<variation>L</variation>
<location>
<position position="75"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044610">
<original>P</original>
<variation>R</variation>
<location>
<position position="75"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044611">
<original>P</original>
<variation>S</variation>
<location>
<position position="75"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044612" evidence="151">
<original>A</original>
<variation>G</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044613">
<original>A</original>
<variation>T</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044614">
<original>P</original>
<variation>A</variation>
<location>
<position position="77"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044615">
<original>A</original>
<variation>V</variation>
<location>
<position position="78"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044616">
<original>A</original>
<variation>G</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_005857">
<original>A</original>
<variation>T</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044617">
<original>A</original>
<variation>V</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044618">
<original>P</original>
<variation>L</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044619">
<original>P</original>
<variation>S</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044620">
<original>T</original>
<variation>I</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs534447939." id="VAR_044621">
<original>P</original>
<variation>L</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044622">
<original>P</original>
<variation>S</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs201717599." id="VAR_044623">
<original>A</original>
<variation>E</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs201717599." id="VAR_044624">
<original>A</original>
<variation>V</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044625">
<original>A</original>
<variation>G</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044626">
<original>A</original>
<variation>V</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044627">
<original>P</original>
<variation>L</variation>
<location>
<position position="85"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044628">
<original>P</original>
<variation>S</variation>
<location>
<position position="85"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044629">
<original>A</original>
<variation>V</variation>
<location>
<position position="86"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005858">
<original>P</original>
<variation>Q</variation>
<location>
<position position="87"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044630">
<original>A</original>
<variation>T</variation>
<location>
<position position="88"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044631">
<original>A</original>
<variation>V</variation>
<location>
<position position="88"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs730881994." id="VAR_044632">
<original>P</original>
<variation>L</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044633">
<original>P</original>
<variation>S</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044634">
<original>S</original>
<variation>F</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044635">
<original>S</original>
<variation>Y</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044636">
<original>W</original>
<variation>C</variation>
<location>
<position position="91"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044637">
<original>P</original>
<variation>A</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044638">
<original>P</original>
<variation>L</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044639">
<original>P</original>
<variation>S</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044640">
<original>L</original>
<variation>M</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044641">
<original>L</original>
<variation>P</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044642">
<original>S</original>
<variation>L</variation>
<location>
<position position="94"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005859">
<original>S</original>
<variation>T</variation>
<location>
<position position="94"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044643">
<original>S</original>
<variation>F</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044644">
<original>S</original>
<variation>T</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044645">
<original>S</original>
<variation>C</variation>
<location>
<position position="96"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044646">
<original>S</original>
<variation>F</variation>
<location>
<position position="96"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044647">
<original>S</original>
<variation>P</variation>
<location>
<position position="96"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044648">
<original>V</original>
<variation>A</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044649">
<original>V</original>
<variation>F</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="sequence variant" description="In familial cancer not matching LFS; germline mutation and in a sporadic cancer; somatic mutation." id="VAR_044650">
<original>V</original>
<variation>I</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044651">
<original>P</original>
<variation>L</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044652">
<original>P</original>
<variation>S</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044653">
<original>S</original>
<variation>F</variation>
<location>
<position position="99"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044654">
<original>S</original>
<variation>P</variation>
<location>
<position position="99"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044655">
<original>Q</original>
<variation>R</variation>
<location>
<position position="100"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs878854069." id="VAR_044656">
<original>K</original>
<variation>N</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044657">
<original>K</original>
<variation>R</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786202717." id="VAR_044658">
<original>T</original>
<variation>I</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044659">
<original>Q</original>
<variation>H</variation>
<location>
<position position="104"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044660">
<original>Q</original>
<variation>L</variation>
<location>
<position position="104"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_044661">
<original>G</original>
<variation>C</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587781504." id="VAR_044662">
<original>G</original>
<variation>D</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044663">
<original>G</original>
<variation>R</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044664">
<original>G</original>
<variation>S</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044665">
<original>G</original>
<variation>V</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044666">
<original>S</original>
<variation>G</variation>
<location>
<position position="106"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_044667">
<original>S</original>
<variation>R</variation>
<location>
<position position="106"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs587782447." id="VAR_044668">
<original>Y</original>
<variation>C</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044669">
<original>Y</original>
<variation>D</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs368771578." id="VAR_044670">
<original>Y</original>
<variation>H</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044671">
<original>G</original>
<variation>D</variation>
<location>
<position position="108"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587782461." id="VAR_044672">
<original>G</original>
<variation>S</variation>
<location>
<position position="108"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044673">
<original>F</original>
<variation>C</variation>
<location>
<position position="109"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044674">
<original>F</original>
<variation>L</variation>
<location>
<position position="109"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044675">
<original>F</original>
<variation>S</variation>
<location>
<position position="109"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587781371." id="VAR_005860">
<original>R</original>
<variation>C</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044676">
<original>R</original>
<variation>G</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs11540654." id="VAR_044677">
<original>R</original>
<variation>H</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation; does not induce SNAI1 degradation; dbSNP:rs11540654." id="VAR_005861" evidence="127">
<original>R</original>
<variation>L</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs11540654." id="VAR_005862" evidence="88">
<original>R</original>
<variation>P</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs587781371." id="VAR_044678">
<original>R</original>
<variation>S</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044679">
<original>L</original>
<variation>M</variation>
<location>
<position position="111"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044680">
<original>L</original>
<variation>P</variation>
<location>
<position position="111"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044681">
<original>L</original>
<variation>Q</variation>
<location>
<position position="111"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044682">
<original>L</original>
<variation>R</variation>
<location>
<position position="111"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044683">
<original>G</original>
<variation>D</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044684">
<original>G</original>
<variation>S</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005863">
<original>F</original>
<variation>C</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045788">
<original>F</original>
<variation>G</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044685">
<original>F</original>
<variation>I</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044686">
<original>F</original>
<variation>L</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044687">
<original>F</original>
<variation>S</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587781642." id="VAR_033033" evidence="88">
<original>F</original>
<variation>V</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044688">
<original>H</original>
<variation>Y</variation>
<location>
<position position="115"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044689">
<original>S</original>
<variation>C</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044690">
<original>S</original>
<variation>F</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044691">
<original>S</original>
<variation>P</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs755238756." id="VAR_044692">
<original>G</original>
<variation>E</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044693">
<original>G</original>
<variation>R</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044694">
<original>T</original>
<variation>A</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044695">
<original>T</original>
<variation>I</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044696">
<original>T</original>
<variation>R</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044697">
<original>A</original>
<variation>D</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044698">
<original>A</original>
<variation>T</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs121912658." id="VAR_044699">
<original>K</original>
<variation>E</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044700">
<original>K</original>
<variation>M</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044701">
<original>K</original>
<variation>Q</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044702">
<original>K</original>
<variation>R</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044703">
<original>S</original>
<variation>F</variation>
<location>
<position position="121"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044704">
<original>V</original>
<variation>L</variation>
<location>
<position position="122"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044705">
<original>T</original>
<variation>I</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044706">
<original>T</original>
<variation>N</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs730881997." id="VAR_044707">
<original>C</original>
<variation>G</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044708">
<original>C</original>
<variation>R</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs730881997." id="VAR_044709">
<original>C</original>
<variation>S</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044710">
<original>C</original>
<variation>W</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044711">
<original>C</original>
<variation>Y</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044712">
<original>T</original>
<variation>A</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786201057." id="VAR_044713">
<original>T</original>
<variation>K</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786201057." id="VAR_005864">
<original>T</original>
<variation>M</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044714">
<original>T</original>
<variation>P</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044715">
<original>T</original>
<variation>R</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_044716">
<original>Y</original>
<variation>C</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs886039483." id="VAR_005865">
<original>Y</original>
<variation>D</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044717">
<original>Y</original>
<variation>F</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045789">
<original>Y</original>
<variation>G</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044718">
<original>Y</original>
<variation>H</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005866">
<original>Y</original>
<variation>N</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044719">
<original>Y</original>
<variation>S</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs730881999." id="VAR_044720">
<original>S</original>
<variation>C</variation>
<location>
<position position="127"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs730881999." id="VAR_005867">
<original>S</original>
<variation>F</variation>
<location>
<position position="127"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044721">
<original>S</original>
<variation>P</variation>
<location>
<position position="127"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044722">
<original>S</original>
<variation>T</variation>
<location>
<position position="127"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044723">
<original>S</original>
<variation>Y</variation>
<location>
<position position="127"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044724">
<original>P</original>
<variation>A</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044725">
<original>P</original>
<variation>L</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044726">
<original>P</original>
<variation>R</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005868">
<original>P</original>
<variation>S</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005869">
<original>A</original>
<variation>D</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044727">
<original>A</original>
<variation>G</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044728">
<original>A</original>
<variation>T</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs137852792." id="VAR_044729">
<original>A</original>
<variation>V</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs863224683." id="VAR_044730">
<original>L</original>
<variation>F</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044731">
<original>L</original>
<variation>H</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044732">
<original>L</original>
<variation>I</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044733">
<original>L</original>
<variation>P</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005870">
<original>L</original>
<variation>R</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs863224683." id="VAR_044734">
<original>L</original>
<variation>V</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044735">
<original>N</original>
<variation>D</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044736">
<original>N</original>
<variation>H</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044737">
<original>N</original>
<variation>I</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs769270327." id="VAR_005872">
<original>N</original>
<variation>K</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005871">
<original>N</original>
<variation>S</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044738">
<original>N</original>
<variation>T</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587782160." id="VAR_044739">
<original>N</original>
<variation>Y</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047159">
<original>KM</original>
<variation>NL</variation>
<location>
<begin position="132"/>
<end position="133"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs747342068." id="VAR_044740">
<original>K</original>
<variation>E</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045790">
<original>K</original>
<variation>L</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005873">
<original>K</original>
<variation>M</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs866775781." id="VAR_044741">
<original>K</original>
<variation>N</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005874" evidence="78">
<original>K</original>
<variation>Q</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044742">
<original>K</original>
<variation>R</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044743">
<original>K</original>
<variation>T</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045791">
<original>K</original>
<variation>W</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044744">
<original>M</original>
<variation>I</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044745">
<original>M</original>
<variation>K</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044746">
<original>M</original>
<variation>L</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_044747">
<original>M</original>
<variation>R</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs28934873." id="VAR_005875" evidence="108">
<original>M</original>
<variation>T</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs1057280220." id="VAR_044748">
<original>M</original>
<variation>V</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs780442292." id="VAR_044749">
<original>F</original>
<variation>C</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044750">
<original>F</original>
<variation>I</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs267605077." id="VAR_036504" evidence="79">
<original>F</original>
<variation>L</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044751">
<original>F</original>
<variation>S</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044752">
<original>F</original>
<variation>V</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005877">
<original>C</original>
<variation>F</variation>
<location>
<position position="135"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044753">
<original>C</original>
<variation>G</variation>
<location>
<position position="135"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044754">
<original>C</original>
<variation>R</variation>
<location>
<position position="135"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005876">
<original>C</original>
<variation>S</variation>
<location>
<position position="135"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045792">
<original>C</original>
<variation>T</variation>
<location>
<position position="135"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044755">
<original>C</original>
<variation>W</variation>
<location>
<position position="135"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; decreased E6-mediated binding to E6-AP; dbSNP:rs587781991." id="VAR_044756">
<original>C</original>
<variation>Y</variation>
<location>
<position position="135"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005878">
<original>Q</original>
<variation>E</variation>
<location>
<position position="136"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs758781593." id="VAR_044757">
<original>Q</original>
<variation>H</variation>
<location>
<position position="136"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_005879">
<original>Q</original>
<variation>K</variation>
<location>
<position position="136"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044758">
<original>Q</original>
<variation>P</variation>
<location>
<position position="136"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044759">
<original>Q</original>
<variation>R</variation>
<location>
<position position="136"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044760">
<original>L</original>
<variation>M</variation>
<location>
<position position="137"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044761">
<original>L</original>
<variation>P</variation>
<location>
<position position="137"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005880">
<original>L</original>
<variation>Q</variation>
<location>
<position position="137"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044762">
<original>L</original>
<variation>V</variation>
<location>
<position position="137"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044763">
<original>A</original>
<variation>D</variation>
<location>
<position position="138"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs28934875." id="VAR_005881">
<original>A</original>
<variation>P</variation>
<location>
<position position="138"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation." id="VAR_044764">
<original>A</original>
<variation>S</variation>
<location>
<position position="138"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044765">
<original>A</original>
<variation>T</variation>
<location>
<position position="138"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs750600586." id="VAR_033034" evidence="88">
<original>A</original>
<variation>V</variation>
<location>
<position position="138"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044766">
<original>K</original>
<variation>E</variation>
<location>
<position position="139"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005882" evidence="51">
<original>K</original>
<variation>N</variation>
<location>
<position position="139"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044767">
<original>K</original>
<variation>Q</variation>
<location>
<position position="139"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044768">
<original>K</original>
<variation>R</variation>
<location>
<position position="139"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044769">
<original>K</original>
<variation>T</variation>
<location>
<position position="139"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044770">
<original>T</original>
<variation>A</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044771">
<original>T</original>
<variation>I</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs786202561." id="VAR_044772">
<original>T</original>
<variation>N</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044773">
<original>T</original>
<variation>P</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044774">
<original>T</original>
<variation>S</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045793">
<original>C</original>
<variation>A</variation>
<location>
<position position="141"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005885">
<original>C</original>
<variation>F</variation>
<location>
<position position="141"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005884">
<original>C</original>
<variation>G</variation>
<location>
<position position="141"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044775">
<original>C</original>
<variation>R</variation>
<location>
<position position="141"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044776">
<original>C</original>
<variation>S</variation>
<location>
<position position="141"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044777">
<original>C</original>
<variation>W</variation>
<location>
<position position="141"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs587781288." id="VAR_005886">
<original>C</original>
<variation>Y</variation>
<location>
<position position="141"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044778">
<original>P</original>
<variation>A</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045794">
<original>P</original>
<variation>F</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044779">
<original>P</original>
<variation>H</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs779196500." id="VAR_044780">
<original>P</original>
<variation>L</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044781">
<original>P</original>
<variation>R</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044782">
<original>P</original>
<variation>S</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044783">
<original>P</original>
<variation>T</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; strong DNA binding ability at 32.5 degrees Celsius; strong reduction of transcriptional activity at 37.5 degrees Celsius; severely represses interaction with ZNF385A." id="VAR_005887" evidence="98 154">
<original>V</original>
<variation>A</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044784">
<original>V</original>
<variation>E</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044785">
<original>V</original>
<variation>G</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587782620." id="VAR_044786">
<original>V</original>
<variation>L</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587782620." id="VAR_044787">
<original>V</original>
<variation>M</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044788">
<original>Q</original>
<variation>H</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044789">
<original>Q</original>
<variation>K</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_044790">
<original>Q</original>
<variation>L</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786203071." id="VAR_005888">
<original>Q</original>
<variation>P</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044791">
<original>Q</original>
<variation>R</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044792">
<original>L</original>
<variation>M</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587782197." id="VAR_005889">
<original>L</original>
<variation>P</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005890">
<original>L</original>
<variation>Q</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044793">
<original>L</original>
<variation>R</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044794">
<original>L</original>
<variation>V</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044795">
<original>W</original>
<variation>C</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786203064." id="VAR_044796">
<original>W</original>
<variation>G</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044797">
<original>W</original>
<variation>L</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044798">
<original>W</original>
<variation>R</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044799">
<original>W</original>
<variation>S</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044800">
<original>V</original>
<variation>A</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005891">
<original>V</original>
<variation>D</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044801">
<original>V</original>
<variation>E</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044802">
<original>V</original>
<variation>F</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005892">
<original>V</original>
<variation>G</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044803">
<original>V</original>
<variation>I</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs1046611742." id="VAR_044804">
<original>D</original>
<variation>A</variation>
<location>
<position position="148"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044805">
<original>D</original>
<variation>E</variation>
<location>
<position position="148"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044806">
<original>D</original>
<variation>G</variation>
<location>
<position position="148"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044807">
<original>D</original>
<variation>N</variation>
<location>
<position position="148"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044808">
<original>D</original>
<variation>V</variation>
<location>
<position position="148"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044809">
<original>D</original>
<variation>Y</variation>
<location>
<position position="148"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044810">
<original>S</original>
<variation>F</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005893">
<original>S</original>
<variation>P</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044811">
<original>S</original>
<variation>T</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044812">
<original>T</original>
<variation>A</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044813">
<original>T</original>
<variation>I</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044814">
<original>T</original>
<variation>K</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044815">
<original>T</original>
<variation>N</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044816">
<original>T</original>
<variation>P</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044817">
<original>T</original>
<variation>R</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005894">
<original>P</original>
<variation>A</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044818">
<original>P</original>
<variation>H</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044819">
<original>P</original>
<variation>L</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044820">
<original>P</original>
<variation>R</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs28934874." id="VAR_005895" evidence="152">
<original>P</original>
<variation>S</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs28934874." id="VAR_005896">
<original>P</original>
<variation>T</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044821">
<original>P</original>
<variation>A</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs587782705." id="VAR_005897" evidence="106">
<original>P</original>
<variation>L</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044822">
<original>P</original>
<variation>Q</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044823">
<original>P</original>
<variation>R</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs767328513." id="VAR_005898" evidence="163">
<original>P</original>
<variation>S</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044824">
<original>P</original>
<variation>T</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044825">
<original>P</original>
<variation>A</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045795">
<original>P</original>
<variation>F</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044826">
<original>P</original>
<variation>H</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044827">
<original>P</original>
<variation>L</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044828">
<original>P</original>
<variation>R</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044829">
<original>P</original>
<variation>S</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005899">
<original>P</original>
<variation>T</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044830">
<original>G</original>
<variation>A</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044831">
<original>G</original>
<variation>C</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs762846821." id="VAR_044832">
<original>G</original>
<variation>D</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045796">
<original>G</original>
<variation>I</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs137852789." id="VAR_044833">
<original>G</original>
<variation>S</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="sequence variant" description="In a brain tumor with no family history; germline mutation and in sporadic cancers; somatic mutation." id="VAR_005900" evidence="140">
<original>G</original>
<variation>V</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs772683278." id="VAR_005901" evidence="106">
<original>T</original>
<variation>A</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044834">
<original>T</original>
<variation>I</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044835">
<original>T</original>
<variation>M</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_044836">
<original>T</original>
<variation>N</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; does not induce SNAI1 degradation." id="VAR_044837" evidence="51 127">
<original>T</original>
<variation>P</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786202752." id="VAR_044838">
<original>T</original>
<variation>S</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs563378859." id="VAR_044839">
<original>R</original>
<variation>C</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044840">
<original>R</original>
<variation>G</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs371524413." id="VAR_044841">
<original>R</original>
<variation>H</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044842">
<original>R</original>
<variation>L</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005902" evidence="152">
<original>R</original>
<variation>P</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044843">
<original>R</original>
<variation>S</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044844">
<original>V</original>
<variation>A</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005903">
<original>V</original>
<variation>D</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs121912654." id="VAR_005904" evidence="79">
<original>V</original>
<variation>F</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044845">
<original>V</original>
<variation>G</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs121912654." id="VAR_012977" evidence="162">
<original>V</original>
<variation>I</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044846">
<original>V</original>
<variation>L</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587780068." id="VAR_005905">
<original>R</original>
<variation>C</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045797">
<original>R</original>
<variation>F</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_005906">
<original>R</original>
<variation>G</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs587782144." id="VAR_005907">
<original>R</original>
<variation>H</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044847">
<original>R</original>
<variation>L</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587782144." id="VAR_044848">
<original>R</original>
<variation>P</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044849">
<original>R</original>
<variation>Q</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044850">
<original>R</original>
<variation>S</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045798">
<original>R</original>
<variation>Y</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044851">
<original>A</original>
<variation>D</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions; dbSNP:rs730882022." id="VAR_045799">
<original>A</original>
<variation>F</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044852">
<original>A</original>
<variation>G</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs730882000." id="VAR_044853">
<original>A</original>
<variation>P</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044854">
<original>A</original>
<variation>S</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044855">
<original>A</original>
<variation>T</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044856">
<original>A</original>
<variation>V</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047160">
<original>MA</original>
<variation>IP</variation>
<location>
<begin position="160"/>
<end position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_047161">
<original>MA</original>
<variation>IS</variation>
<location>
<begin position="160"/>
<end position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047162">
<original>MA</original>
<variation>IT</variation>
<location>
<begin position="160"/>
<end position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs772354334." id="VAR_005908">
<original>M</original>
<variation>I</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044857">
<original>M</original>
<variation>K</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044858">
<original>M</original>
<variation>T</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044859">
<original>M</original>
<variation>V</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044860">
<original>A</original>
<variation>D</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045800">
<original>A</original>
<variation>F</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044861">
<original>A</original>
<variation>G</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044862">
<original>A</original>
<variation>P</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005909">
<original>A</original>
<variation>S</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs193920817." id="VAR_044863">
<original>A</original>
<variation>T</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044864">
<original>A</original>
<variation>V</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044865">
<original>I</original>
<variation>F</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044866">
<original>I</original>
<variation>M</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer with no family history; germline mutation and in sporadic cancers; somatic mutation." id="VAR_044867">
<original>I</original>
<variation>N</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587780069." id="VAR_005910">
<original>I</original>
<variation>S</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044868">
<original>I</original>
<variation>T</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005911">
<original>I</original>
<variation>V</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs148924904." id="VAR_033035" evidence="79 88">
<original>Y</original>
<variation>C</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786203436." id="VAR_044869">
<original>Y</original>
<variation>D</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044870">
<original>Y</original>
<variation>F</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005912" evidence="88">
<original>Y</original>
<variation>H</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044871">
<original>Y</original>
<variation>N</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044872">
<original>Y</original>
<variation>S</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs879254249." id="VAR_044873">
<original>K</original>
<variation>E</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044874">
<original>K</original>
<variation>M</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005913">
<original>K</original>
<variation>N</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005914">
<original>K</original>
<variation>Q</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044875">
<original>K</original>
<variation>R</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044876">
<original>K</original>
<variation>T</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044877">
<original>Q</original>
<variation>E</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044878">
<original>Q</original>
<variation>H</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005915">
<original>Q</original>
<variation>L</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044879">
<original>Q</original>
<variation>P</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005916">
<original>Q</original>
<variation>R</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044880">
<original>S</original>
<variation>A</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044881">
<original>S</original>
<variation>G</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005917">
<original>S</original>
<variation>L</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044882">
<original>S</original>
<variation>P</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044883">
<original>S</original>
<variation>T</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047163">
<original>QH</original>
<variation>HD</variation>
<location>
<begin position="167"/>
<end position="168"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047164">
<original>QH</original>
<variation>YL</variation>
<location>
<begin position="167"/>
<end position="168"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044884">
<original>Q</original>
<variation>H</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in a sporadic cancer; somatic mutation." id="VAR_044885">
<original>Q</original>
<variation>K</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044886">
<original>Q</original>
<variation>L</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044887">
<original>Q</original>
<variation>R</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047165">
<original>HM</original>
<variation>LI</variation>
<location>
<begin position="168"/>
<end position="169"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044888">
<original>H</original>
<variation>D</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044889">
<original>H</original>
<variation>L</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044890">
<original>H</original>
<variation>N</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044891">
<original>H</original>
<variation>P</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044892">
<original>H</original>
<variation>Q</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs867114783." id="VAR_005918">
<original>H</original>
<variation>R</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045801">
<original>H</original>
<variation>V</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044893">
<original>H</original>
<variation>Y</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047166">
<original>MT</original>
<variation>IS</variation>
<location>
<begin position="169"/>
<end position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005919" evidence="163">
<original>M</original>
<variation>I</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044894">
<original>M</original>
<variation>K</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005920">
<original>M</original>
<variation>T</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044895">
<original>M</original>
<variation>V</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587780729." id="VAR_044896">
<original>T</original>
<variation>A</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044897">
<original>T</original>
<variation>K</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs779000871." id="VAR_005921">
<original>T</original>
<variation>M</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044898">
<original>T</original>
<variation>P</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005922">
<original>T</original>
<variation>S</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044899">
<original>E</original>
<variation>A</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044900">
<original>E</original>
<variation>D</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044901">
<original>E</original>
<variation>G</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587781845." id="VAR_044902">
<original>E</original>
<variation>K</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044903">
<original>E</original>
<variation>Q</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044904">
<original>E</original>
<variation>V</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005923">
<original>V</original>
<variation>A</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044905">
<original>V</original>
<variation>D</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_044906">
<original>V</original>
<variation>F</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044907">
<original>V</original>
<variation>G</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044908">
<original>V</original>
<variation>I</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044909">
<original>V</original>
<variation>A</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005924">
<original>V</original>
<variation>E</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044910">
<original>V</original>
<variation>G</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005925">
<original>V</original>
<variation>L</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs876660754." id="VAR_005926">
<original>V</original>
<variation>M</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045802">
<original>V</original>
<variation>W</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in a sporadic cancer; somatic mutation; dbSNP:rs864622115." id="VAR_044911">
<original>R</original>
<variation>G</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005927" evidence="152">
<original>R</original>
<variation>K</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044912">
<original>R</original>
<variation>M</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044913">
<original>R</original>
<variation>S</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044914">
<original>R</original>
<variation>T</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044915">
<original>R</original>
<variation>W</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs138729528." id="VAR_005928">
<original>R</original>
<variation>C</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs138729528." id="VAR_005929">
<original>R</original>
<variation>G</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; does not induce SNAI1 degradation; reduces interaction with ZNF385A; dbSNP:rs28934578." id="VAR_005932" evidence="79 98 106 127 153 157">
<original>R</original>
<variation>H</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs28934578." id="VAR_005930">
<original>R</original>
<variation>L</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005931" evidence="98">
<original>R</original>
<variation>P</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044916">
<original>R</original>
<variation>Q</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044917">
<original>R</original>
<variation>S</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047167">
<original>CP</original>
<variation>FS</variation>
<location>
<begin position="176"/>
<end position="177"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005933" evidence="48 106 158 163">
<original>C</original>
<variation>F</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044918">
<original>C</original>
<variation>G</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044919">
<original>C</original>
<variation>R</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs967461896." id="VAR_044920">
<original>C</original>
<variation>S</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005934">
<original>C</original>
<variation>W</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786202962." id="VAR_044921">
<original>C</original>
<variation>Y</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044922">
<original>P</original>
<variation>A</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045803">
<original>P</original>
<variation>F</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044923">
<original>P</original>
<variation>H</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045804">
<original>P</original>
<variation>I</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005935">
<original>P</original>
<variation>L</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs751477326." id="VAR_036505" evidence="79">
<original>P</original>
<variation>R</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs147002414." id="VAR_044924">
<original>P</original>
<variation>S</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044925">
<original>P</original>
<variation>T</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047168">
<original>HH</original>
<variation>QS</variation>
<location>
<begin position="178"/>
<end position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044926">
<original>H</original>
<variation>D</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In a Burkitt lymphoma." id="VAR_005936" evidence="47">
<original>H</original>
<variation>HPHP</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044927">
<original>H</original>
<variation>L</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044928">
<original>H</original>
<variation>N</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044929">
<original>H</original>
<variation>P</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044930">
<original>H</original>
<variation>Q</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044931">
<original>H</original>
<variation>R</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044932">
<original>H</original>
<variation>Y</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044933">
<original>H</original>
<variation>D</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044934">
<original>H</original>
<variation>L</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044935">
<original>H</original>
<variation>N</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044936">
<original>H</original>
<variation>P</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044937">
<original>H</original>
<variation>Q</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044938">
<original>H</original>
<variation>R</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs587780070." id="VAR_044939">
<original>H</original>
<variation>Y</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044940">
<original>E</original>
<variation>A</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044941">
<original>E</original>
<variation>D</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044942">
<original>E</original>
<variation>G</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs879253911." id="VAR_044943">
<original>E</original>
<variation>K</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044944">
<original>E</original>
<variation>Q</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044945">
<original>E</original>
<variation>V</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs587782596." id="VAR_044946">
<original>R</original>
<variation>C</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044947">
<original>R</original>
<variation>G</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs397514495." id="VAR_044948">
<original>R</original>
<variation>H</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs397514495." id="VAR_005937">
<original>R</original>
<variation>L</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_044949">
<original>R</original>
<variation>P</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587782596." id="VAR_044950">
<original>R</original>
<variation>S</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044951">
<original>C</original>
<variation>R</variation>
<location>
<position position="182"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005938">
<original>C</original>
<variation>S</variation>
<location>
<position position="182"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044952">
<original>C</original>
<variation>Y</variation>
<location>
<position position="182"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044953">
<original>S</original>
<variation>L</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044954">
<original>S</original>
<variation>P</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044955">
<original>D</original>
<variation>G</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044956">
<original>D</original>
<variation>H</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs72661117." id="VAR_047169">
<original>D</original>
<variation>N</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044957">
<original>D</original>
<variation>V</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005939">
<original>D</original>
<variation>Y</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044958">
<original>S</original>
<variation>C</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044959">
<original>S</original>
<variation>G</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044960">
<original>S</original>
<variation>I</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs150607408." id="VAR_044961">
<original>S</original>
<variation>N</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044962">
<original>S</original>
<variation>R</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044963">
<original>S</original>
<variation>T</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs375275361." id="VAR_044964">
<original>D</original>
<variation>E</variation>
<location>
<position position="186"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044965">
<original>D</original>
<variation>G</variation>
<location>
<position position="186"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044966">
<original>D</original>
<variation>H</variation>
<location>
<position position="186"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044967">
<original>D</original>
<variation>N</variation>
<location>
<position position="186"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044968">
<original>D</original>
<variation>V</variation>
<location>
<position position="186"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_005940">
<original>D</original>
<variation>Y</variation>
<location>
<position position="186"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005941">
<original>G</original>
<variation>C</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044969">
<original>G</original>
<variation>D</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045805">
<original>G</original>
<variation>N</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044970">
<original>G</original>
<variation>R</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs776167460." id="VAR_005942">
<original>G</original>
<variation>S</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044971">
<original>G</original>
<variation>V</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044972">
<original>L</original>
<variation>P</variation>
<location>
<position position="188"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044973">
<original>L</original>
<variation>V</variation>
<location>
<position position="188"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044974">
<original>A</original>
<variation>D</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044975">
<original>A</original>
<variation>G</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005943">
<original>A</original>
<variation>P</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044976">
<original>A</original>
<variation>S</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044977">
<original>A</original>
<variation>T</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs121912665." id="VAR_044978">
<original>A</original>
<variation>V</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044979">
<original>P</original>
<variation>A</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044980">
<original>P</original>
<variation>H</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005944">
<original>P</original>
<variation>L</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs876660825." id="VAR_044981">
<original>P</original>
<variation>R</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044982">
<original>P</original>
<variation>S</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs876660254." id="VAR_044983">
<original>P</original>
<variation>T</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044984">
<original>P</original>
<variation>H</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044985">
<original>P</original>
<variation>L</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587778718." id="VAR_044986">
<original>P</original>
<variation>R</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs868590738." id="VAR_044987">
<original>P</original>
<variation>S</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005945">
<original>P</original>
<variation>T</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047170">
<original>QH</original>
<variation>HN</variation>
<location>
<begin position="192"/>
<end position="193"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047171">
<original>QH</original>
<variation>HY</variation>
<location>
<begin position="192"/>
<end position="193"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044988">
<original>Q</original>
<variation>H</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_044989">
<original>Q</original>
<variation>K</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044990">
<original>Q</original>
<variation>L</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044991">
<original>Q</original>
<variation>P</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs730882002." id="VAR_005946">
<original>Q</original>
<variation>R</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005947">
<original>H</original>
<variation>D</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786201838." id="VAR_044992">
<original>H</original>
<variation>L</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044993">
<original>H</original>
<variation>N</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044994">
<original>H</original>
<variation>P</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044995">
<original>H</original>
<variation>Q</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs786201838." id="VAR_005948" evidence="79 153">
<original>H</original>
<variation>R</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs876658468." id="VAR_044996">
<original>H</original>
<variation>Y</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587780071." id="VAR_044997">
<original>L</original>
<variation>F</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044998">
<original>L</original>
<variation>H</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_044999">
<original>L</original>
<variation>I</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005949">
<original>L</original>
<variation>P</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005950" evidence="152">
<original>L</original>
<variation>R</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045000">
<original>L</original>
<variation>V</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs942158624." id="VAR_045001">
<original>I</original>
<variation>F</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047172">
<original>I</original>
<variation>L</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045002">
<original>I</original>
<variation>N</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045003">
<original>I</original>
<variation>S</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs760043106." id="VAR_005951" evidence="88 163">
<original>I</original>
<variation>T</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045004">
<original>I</original>
<variation>V</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045806">
<original>I</original>
<variation>Y</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs397516435." id="VAR_045005">
<original>R</original>
<variation>G</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs483352697." id="VAR_045006">
<original>R</original>
<variation>L</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs483352697." id="VAR_045007">
<original>R</original>
<variation>P</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs483352697." id="VAR_045008">
<original>R</original>
<variation>Q</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045009">
<original>R</original>
<variation>S</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_045010">
<original>V</original>
<variation>E</variation>
<location>
<position position="197"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045011">
<original>V</original>
<variation>G</variation>
<location>
<position position="197"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786204041." id="VAR_045012">
<original>V</original>
<variation>L</variation>
<location>
<position position="197"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs786204041." id="VAR_045013">
<original>V</original>
<variation>M</variation>
<location>
<position position="197"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045014">
<original>E</original>
<variation>D</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045015">
<original>E</original>
<variation>G</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005952">
<original>E</original>
<variation>K</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045016">
<original>E</original>
<variation>Q</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045017">
<original>E</original>
<variation>V</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045018">
<original>G</original>
<variation>A</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045019">
<original>G</original>
<variation>E</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045020">
<original>G</original>
<variation>R</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045021">
<original>G</original>
<variation>V</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045022">
<original>N</original>
<variation>D</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045023">
<original>N</original>
<variation>I</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045024">
<original>N</original>
<variation>K</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045807">
<original>N</original>
<variation>P</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045025">
<original>N</original>
<variation>S</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045026">
<original>N</original>
<variation>T</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047173">
<original>LR</original>
<variation>FC</variation>
<location>
<begin position="201"/>
<end position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs730882024." id="VAR_045027">
<original>L</original>
<variation>F</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045028">
<original>L</original>
<variation>P</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045029">
<original>L</original>
<variation>S</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587780072." id="VAR_045030">
<original>R</original>
<variation>C</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587780072." id="VAR_045031">
<original>R</original>
<variation>G</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587778719." id="VAR_045032">
<original>R</original>
<variation>H</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587778719." id="VAR_045033">
<original>R</original>
<variation>L</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045034">
<original>R</original>
<variation>P</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045035">
<original>R</original>
<variation>S</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047174">
<original>VE</original>
<variation>LV</variation>
<location>
<begin position="203"/>
<end position="204"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045036">
<original>V</original>
<variation>A</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045037">
<original>V</original>
<variation>E</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045038">
<original>V</original>
<variation>L</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs730882003." id="VAR_045039">
<original>V</original>
<variation>M</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045808">
<original>V</original>
<variation>W</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045040">
<original>E</original>
<variation>A</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045041">
<original>E</original>
<variation>D</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045042">
<original>E</original>
<variation>G</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045043">
<original>E</original>
<variation>K</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045044">
<original>E</original>
<variation>Q</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045045">
<original>E</original>
<variation>V</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005953" evidence="50">
<original>Y</original>
<variation>C</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005954">
<original>Y</original>
<variation>D</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_047175">
<original>Y</original>
<variation>F</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045046">
<original>Y</original>
<variation>H</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045047">
<original>Y</original>
<variation>N</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045048">
<original>Y</original>
<variation>S</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045049">
<original>L</original>
<variation>F</variation>
<location>
<position position="206"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045050">
<original>L</original>
<variation>M</variation>
<location>
<position position="206"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047176">
<original>DD</original>
<variation>EY</variation>
<location>
<begin position="207"/>
<end position="208"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045051">
<original>D</original>
<variation>E</variation>
<location>
<position position="207"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045052">
<original>D</original>
<variation>G</variation>
<location>
<position position="207"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045053">
<original>D</original>
<variation>H</variation>
<location>
<position position="207"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs923100890." id="VAR_045054">
<original>D</original>
<variation>N</variation>
<location>
<position position="207"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045055">
<original>D</original>
<variation>V</variation>
<location>
<position position="207"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045056">
<original>D</original>
<variation>Y</variation>
<location>
<position position="207"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045057">
<original>D</original>
<variation>E</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045058">
<original>D</original>
<variation>G</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045059">
<original>D</original>
<variation>H</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045809">
<original>D</original>
<variation>I</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045060">
<original>D</original>
<variation>N</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045061">
<original>D</original>
<variation>V</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045062">
<original>D</original>
<variation>Y</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045063">
<original>R</original>
<variation>I</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045064">
<original>R</original>
<variation>K</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045065">
<original>R</original>
<variation>S</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045066">
<original>R</original>
<variation>T</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045067">
<original>N</original>
<variation>D</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045068">
<original>N</original>
<variation>H</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045069">
<original>N</original>
<variation>I</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045070">
<original>N</original>
<variation>K</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045071">
<original>N</original>
<variation>S</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045072">
<original>N</original>
<variation>T</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation." id="VAR_045073">
<original>N</original>
<variation>Y</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045074">
<original>T</original>
<variation>A</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045075">
<original>T</original>
<variation>I</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045076">
<original>T</original>
<variation>N</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045077">
<original>T</original>
<variation>P</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045078">
<original>T</original>
<variation>S</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045079">
<original>F</original>
<variation>I</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045080">
<original>F</original>
<variation>L</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045081">
<original>F</original>
<variation>S</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045082">
<original>F</original>
<variation>V</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045083">
<original>F</original>
<variation>Y</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045084">
<original>R</original>
<variation>G</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045085">
<original>R</original>
<variation>L</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs587778720." id="VAR_036506" evidence="79">
<original>R</original>
<variation>P</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs587778720." id="VAR_005955">
<original>R</original>
<variation>Q</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045086">
<original>R</original>
<variation>W</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045087">
<original>H</original>
<variation>D</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045088">
<original>H</original>
<variation>P</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587781386." id="VAR_047177">
<original>H</original>
<variation>Q</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045089">
<original>H</original>
<variation>R</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045090">
<original>H</original>
<variation>Y</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045091">
<original>S</original>
<variation>C</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs886039484." id="VAR_045092">
<original>S</original>
<variation>G</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045093">
<original>S</original>
<variation>I</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045810">
<original>S</original>
<variation>K</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045094">
<original>S</original>
<variation>N</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045095">
<original>S</original>
<variation>R</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587782177." id="VAR_045096">
<original>S</original>
<variation>T</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045097">
<original>V</original>
<variation>A</variation>
<location>
<position position="216"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045098">
<original>V</original>
<variation>E</variation>
<location>
<position position="216"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045099">
<original>V</original>
<variation>G</variation>
<location>
<position position="216"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045100">
<original>V</original>
<variation>L</variation>
<location>
<position position="216"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs730882025." id="VAR_005956" evidence="88">
<original>V</original>
<variation>M</variation>
<location>
<position position="216"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045811">
<original>V</original>
<variation>W</variation>
<location>
<position position="216"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045101">
<original>V</original>
<variation>A</variation>
<location>
<position position="217"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045102">
<original>V</original>
<variation>E</variation>
<location>
<position position="217"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045103">
<original>V</original>
<variation>G</variation>
<location>
<position position="217"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045104">
<original>V</original>
<variation>I</variation>
<location>
<position position="217"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045105">
<original>V</original>
<variation>L</variation>
<location>
<position position="217"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35163653." id="VAR_047178">
<original>V</original>
<variation>M</variation>
<location>
<position position="217"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045106">
<original>V</original>
<variation>A</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045107">
<original>V</original>
<variation>E</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045108">
<original>V</original>
<variation>G</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045109">
<original>V</original>
<variation>L</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs878854072." id="VAR_045110">
<original>V</original>
<variation>M</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045812">
<original>P</original>
<variation>C</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045111">
<original>P</original>
<variation>H</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045112">
<original>P</original>
<variation>L</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045113">
<original>P</original>
<variation>R</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs879253894." id="VAR_045114">
<original>P</original>
<variation>S</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045115">
<original>P</original>
<variation>T</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs121912666." id="VAR_005957" evidence="152 163">
<original>Y</original>
<variation>C</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045116">
<original>Y</original>
<variation>D</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045117">
<original>Y</original>
<variation>F</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs530941076." id="VAR_005958">
<original>Y</original>
<variation>H</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045118">
<original>Y</original>
<variation>N</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="sequence variant" description="In a brain tumor with no family history; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs121912666." id="VAR_005959">
<original>Y</original>
<variation>S</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045119">
<original>E</original>
<variation>A</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045120">
<original>E</original>
<variation>D</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045121">
<original>E</original>
<variation>G</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786201592." id="VAR_045122">
<original>E</original>
<variation>K</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045123">
<original>E</original>
<variation>Q</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045124">
<original>P</original>
<variation>A</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs146340390." id="VAR_045125">
<original>P</original>
<variation>L</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045126">
<original>P</original>
<variation>Q</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045127">
<original>P</original>
<variation>R</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045128">
<original>P</original>
<variation>S</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045129">
<original>P</original>
<variation>T</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047179">
<original>P</original>
<variation>A</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs138983188." id="VAR_045130">
<original>P</original>
<variation>H</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs138983188." id="VAR_045131">
<original>P</original>
<variation>L</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045132">
<original>P</original>
<variation>R</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045133">
<original>P</original>
<variation>S</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045134">
<original>P</original>
<variation>T</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045135">
<original>E</original>
<variation>D</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045136">
<original>E</original>
<variation>G</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045137">
<original>E</original>
<variation>K</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045138">
<original>E</original>
<variation>V</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045139">
<original>V</original>
<variation>A</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045140">
<original>V</original>
<variation>D</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045141">
<original>V</original>
<variation>F</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045142">
<original>V</original>
<variation>G</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045143">
<original>V</original>
<variation>I</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs746504075." id="VAR_045144">
<original>V</original>
<variation>L</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045145">
<original>G</original>
<variation>A</variation>
<location>
<position position="226"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_047180">
<original>G</original>
<variation>D</variation>
<location>
<position position="226"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045844">
<original>G</original>
<variation>N</variation>
<location>
<position position="226"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045146">
<original>G</original>
<variation>S</variation>
<location>
<position position="226"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs970212462." id="VAR_045147">
<original>G</original>
<variation>V</variation>
<location>
<position position="226"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045148">
<original>S</original>
<variation>C</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045149">
<original>S</original>
<variation>F</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045150">
<original>S</original>
<variation>P</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in a sporadic cancer; somatic mutation." id="VAR_045151">
<original>S</original>
<variation>T</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045152">
<original>D</original>
<variation>A</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005960">
<original>D</original>
<variation>E</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045153">
<original>D</original>
<variation>G</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045154">
<original>D</original>
<variation>H</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045155">
<original>D</original>
<variation>N</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045845">
<original>D</original>
<variation>P</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045156">
<original>D</original>
<variation>V</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045157">
<original>D</original>
<variation>Y</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045158">
<original>C</original>
<variation>G</variation>
<location>
<position position="229"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045846">
<original>C</original>
<variation>N</variation>
<location>
<position position="229"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045159">
<original>C</original>
<variation>R</variation>
<location>
<position position="229"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045160">
<original>C</original>
<variation>S</variation>
<location>
<position position="229"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045161">
<original>C</original>
<variation>Y</variation>
<location>
<position position="229"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045162">
<original>T</original>
<variation>A</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005961" evidence="163">
<original>T</original>
<variation>I</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045163">
<original>T</original>
<variation>N</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045164">
<original>T</original>
<variation>P</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045165">
<original>T</original>
<variation>S</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045166">
<original>T</original>
<variation>A</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045167">
<original>T</original>
<variation>I</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045168">
<original>T</original>
<variation>N</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045169">
<original>T</original>
<variation>S</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045170">
<original>I</original>
<variation>F</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045171">
<original>I</original>
<variation>L</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045172">
<original>I</original>
<variation>N</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; does not induce SNAI1 degradation." id="VAR_045173" evidence="127">
<original>I</original>
<variation>S</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587781589." id="VAR_005962">
<original>I</original>
<variation>T</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045174">
<original>I</original>
<variation>V</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in a sporadic cancer; somatic mutation." id="VAR_045175">
<original>H</original>
<variation>D</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045176">
<original>H</original>
<variation>L</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045177">
<original>H</original>
<variation>P</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045178">
<original>H</original>
<variation>Q</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs879254233." id="VAR_047181">
<original>H</original>
<variation>R</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045179">
<original>H</original>
<variation>Y</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs587780073." id="VAR_005963">
<original>Y</original>
<variation>C</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs864622237." id="VAR_045180">
<original>Y</original>
<variation>D</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045181">
<original>Y</original>
<variation>F</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005964">
<original>Y</original>
<variation>H</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045847">
<original>Y</original>
<variation>K</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045182">
<original>Y</original>
<variation>N</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045848">
<original>Y</original>
<variation>Q</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045183">
<original>Y</original>
<variation>S</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In an adrenocortical carcinoma with no family history; germline mutation and in sporadic cancers; somatic mutation." id="VAR_047182">
<original>N</original>
<variation>D</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045184">
<original>N</original>
<variation>H</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045185">
<original>N</original>
<variation>I</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045849">
<original>N</original>
<variation>M</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs144340710." id="VAR_045186">
<original>N</original>
<variation>S</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045187">
<original>N</original>
<variation>T</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786204145." id="VAR_045188">
<original>N</original>
<variation>Y</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_045189">
<original>Y</original>
<variation>C</variation>
<location>
<position position="236"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587782289." id="VAR_045190">
<original>Y</original>
<variation>D</variation>
<location>
<position position="236"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045191">
<original>Y</original>
<variation>F</variation>
<location>
<position position="236"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587782289." id="VAR_045192">
<original>Y</original>
<variation>H</variation>
<location>
<position position="236"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045193">
<original>Y</original>
<variation>N</variation>
<location>
<position position="236"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs730882026." id="VAR_045194">
<original>Y</original>
<variation>S</variation>
<location>
<position position="236"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs587782664." id="VAR_005965">
<original>M</original>
<variation>I</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs765848205." id="VAR_045195">
<original>M</original>
<variation>K</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045196">
<original>M</original>
<variation>L</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045197">
<original>M</original>
<variation>R</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045198">
<original>M</original>
<variation>T</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs730882004." id="VAR_045199">
<original>M</original>
<variation>V</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005966">
<original>C</original>
<variation>F</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_045200">
<original>C</original>
<variation>G</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045850">
<original>C</original>
<variation>H</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045201">
<original>C</original>
<variation>R</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_045202">
<original>C</original>
<variation>S</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs193920789." id="VAR_045203">
<original>C</original>
<variation>W</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs730882005." id="VAR_005967">
<original>C</original>
<variation>Y</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs876660807." id="VAR_045204">
<original>N</original>
<variation>D</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045205">
<original>N</original>
<variation>H</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045206">
<original>N</original>
<variation>I</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045207">
<original>N</original>
<variation>K</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045208">
<original>N</original>
<variation>S</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045209">
<original>N</original>
<variation>T</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045210">
<original>N</original>
<variation>Y</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045211">
<original>S</original>
<variation>C</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045212">
<original>S</original>
<variation>G</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005968">
<original>S</original>
<variation>I</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045213">
<original>S</original>
<variation>N</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045214">
<original>S</original>
<variation>P</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045215">
<original>S</original>
<variation>R</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045216">
<original>S</original>
<variation>T</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_033036" evidence="88">
<original>S</original>
<variation>A</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs28934573." id="VAR_045217">
<original>S</original>
<variation>C</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs28934573." id="VAR_005969" evidence="79 80">
<original>S</original>
<variation>F</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045218">
<original>S</original>
<variation>P</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_047183">
<original>S</original>
<variation>T</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045219">
<original>S</original>
<variation>Y</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005970" evidence="48 79">
<original>C</original>
<variation>F</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045220">
<original>C</original>
<variation>G</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045221">
<original>C</original>
<variation>R</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs121912655." id="VAR_045222">
<original>C</original>
<variation>S</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045223">
<original>C</original>
<variation>W</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs121912655." id="VAR_045224">
<original>C</original>
<variation>Y</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047184">
<original>MG</original>
<variation>IC</variation>
<location>
<begin position="243"/>
<end position="244"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047185">
<original>MG</original>
<variation>IS</variation>
<location>
<begin position="243"/>
<end position="244"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045225">
<original>M</original>
<variation>I</variation>
<location>
<position position="243"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045226">
<original>M</original>
<variation>K</variation>
<location>
<position position="243"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786203117." id="VAR_045227">
<original>M</original>
<variation>L</variation>
<location>
<position position="243"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045228">
<original>M</original>
<variation>R</variation>
<location>
<position position="243"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs730882006." id="VAR_045229">
<original>M</original>
<variation>T</variation>
<location>
<position position="243"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045230">
<original>M</original>
<variation>V</variation>
<location>
<position position="243"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs985033810." id="VAR_047186">
<original>G</original>
<variation>A</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045231">
<original>G</original>
<variation>C</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs1057517983." id="VAR_045232">
<original>G</original>
<variation>D</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045233">
<original>G</original>
<variation>E</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045234">
<original>G</original>
<variation>R</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045235">
<original>G</original>
<variation>S</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_045236">
<original>G</original>
<variation>V</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs121912656." id="VAR_005971">
<original>G</original>
<variation>A</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs28934575." id="VAR_005972" evidence="48 115">
<original>G</original>
<variation>C</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs121912656." id="VAR_005973" evidence="139">
<original>G</original>
<variation>D</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045237">
<original>G</original>
<variation>E</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045851">
<original>G</original>
<variation>F</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045852">
<original>G</original>
<variation>H</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045853">
<original>G</original>
<variation>L</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045854">
<original>G</original>
<variation>N</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045238">
<original>G</original>
<variation>R</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs28934575." id="VAR_005974" evidence="158">
<original>G</original>
<variation>S</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs121912656." id="VAR_005975" evidence="140">
<original>G</original>
<variation>V</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs1019340046." id="VAR_045239">
<original>M</original>
<variation>I</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045240">
<original>M</original>
<variation>K</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs483352695." id="VAR_044020">
<original>M</original>
<variation>L</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587780074." id="VAR_005976">
<original>M</original>
<variation>R</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005977">
<original>M</original>
<variation>T</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs483352695." id="VAR_005978">
<original>M</original>
<variation>V</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047187">
<original>NR</original>
<variation>IP</variation>
<location>
<begin position="247"/>
<end position="248"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_047188">
<original>NR</original>
<variation>KW</variation>
<location>
<begin position="247"/>
<end position="248"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045241">
<original>N</original>
<variation>D</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045855">
<original>N</original>
<variation>F</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786201762." id="VAR_005980">
<original>N</original>
<variation>I</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045242">
<original>N</original>
<variation>K</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045243">
<original>N</original>
<variation>S</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_047189">
<original>N</original>
<variation>T</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045244">
<original>N</original>
<variation>Y</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045245">
<original>R</original>
<variation>C</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005981">
<original>R</original>
<variation>G</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs11540652." id="VAR_005982" evidence="48 152">
<original>R</original>
<variation>L</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs11540652." id="VAR_045246">
<original>R</original>
<variation>P</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs11540652." id="VAR_005983" evidence="79 140 152 153">
<original>R</original>
<variation>Q</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs121912651." id="VAR_005984" evidence="79 115 158">
<original>R</original>
<variation>W</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047190">
<original>RP</original>
<variation>SA</variation>
<location>
<begin position="249"/>
<end position="250"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_047191">
<original>RP</original>
<variation>SS</variation>
<location>
<begin position="249"/>
<end position="250"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005985">
<original>R</original>
<variation>G</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045247">
<original>R</original>
<variation>I</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587782329." id="VAR_045248">
<original>R</original>
<variation>K</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_033037" evidence="88">
<original>R</original>
<variation>M</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045856">
<original>R</original>
<variation>N</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; does not induce SNAI1 degradation; dbSNP:rs28934571." id="VAR_005986" evidence="78 79 127">
<original>R</original>
<variation>S</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045249">
<original>R</original>
<variation>T</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587782082." id="VAR_045250">
<original>R</original>
<variation>W</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045251">
<original>P</original>
<variation>A</variation>
<location>
<position position="250"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045857">
<original>P</original>
<variation>F</variation>
<location>
<position position="250"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045252">
<original>P</original>
<variation>H</variation>
<location>
<position position="250"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_047192">
<original>P</original>
<variation>L</variation>
<location>
<position position="250"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045858">
<original>P</original>
<variation>N</variation>
<location>
<position position="250"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045253">
<original>P</original>
<variation>Q</variation>
<location>
<position position="250"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045254">
<original>P</original>
<variation>S</variation>
<location>
<position position="250"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045255">
<original>P</original>
<variation>T</variation>
<location>
<position position="250"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045256">
<original>I</original>
<variation>F</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs730882007." id="VAR_045257">
<original>I</original>
<variation>L</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation." id="VAR_045258">
<original>I</original>
<variation>M</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005987">
<original>I</original>
<variation>N</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs730882027." id="VAR_033038" evidence="88">
<original>I</original>
<variation>S</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045259">
<original>I</original>
<variation>T</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045260">
<original>I</original>
<variation>V</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045261">
<original>L</original>
<variation>F</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045262">
<original>L</original>
<variation>H</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045263">
<original>L</original>
<variation>I</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs121912653." id="VAR_005988" evidence="115">
<original>L</original>
<variation>P</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045264">
<original>L</original>
<variation>V</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045265">
<original>T</original>
<variation>A</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045266">
<original>T</original>
<variation>I</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045267">
<original>T</original>
<variation>N</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_047193">
<original>T</original>
<variation>P</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045268">
<original>T</original>
<variation>S</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045859">
<original>I</original>
<variation>D</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045269">
<original>I</original>
<variation>F</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045270">
<original>I</original>
<variation>L</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045271">
<original>I</original>
<variation>M</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_017908">
<original>I</original>
<variation>N</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045272">
<original>I</original>
<variation>S</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_017909">
<original>I</original>
<variation>T</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs746601313." id="VAR_045273">
<original>I</original>
<variation>V</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045274">
<original>I</original>
<variation>F</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045275">
<original>I</original>
<variation>M</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs876659675." id="VAR_045276">
<original>I</original>
<variation>N</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045277">
<original>I</original>
<variation>S</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045278">
<original>I</original>
<variation>T</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045279">
<original>I</original>
<variation>V</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="sequence variant" description="In a brain tumor with no family history; germline mutation and in sporadic cancers; somatic mutation." id="VAR_045280">
<original>T</original>
<variation>I</variation>
<location>
<position position="256"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045281">
<original>T</original>
<variation>K</variation>
<location>
<position position="256"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045282">
<original>T</original>
<variation>P</variation>
<location>
<position position="256"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045283">
<original>T</original>
<variation>S</variation>
<location>
<position position="256"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005989">
<original>L</original>
<variation>P</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs28934577." id="VAR_045284">
<original>L</original>
<variation>Q</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs28934577." id="VAR_045285">
<original>L</original>
<variation>R</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045286">
<original>L</original>
<variation>V</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045287">
<original>E</original>
<variation>A</variation>
<location>
<position position="258"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005990">
<original>E</original>
<variation>D</variation>
<location>
<position position="258"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045288">
<original>E</original>
<variation>G</variation>
<location>
<position position="258"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs121912652." id="VAR_005991" evidence="115">
<original>E</original>
<variation>K</variation>
<location>
<position position="258"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045860">
<original>E</original>
<variation>L</variation>
<location>
<position position="258"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045289">
<original>E</original>
<variation>Q</variation>
<location>
<position position="258"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045290">
<original>E</original>
<variation>V</variation>
<location>
<position position="258"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047194">
<original>D</original>
<variation>A</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045291">
<original>D</original>
<variation>E</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs745425759." id="VAR_045292">
<original>D</original>
<variation>G</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045293">
<original>D</original>
<variation>H</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045294">
<original>D</original>
<variation>N</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045861">
<original>D</original>
<variation>P</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045862">
<original>D</original>
<variation>S</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045295">
<original>D</original>
<variation>V</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_033039" evidence="88">
<original>D</original>
<variation>Y</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045296">
<original>S</original>
<variation>A</variation>
<location>
<position position="260"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045297">
<original>S</original>
<variation>C</variation>
<location>
<position position="260"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045298">
<original>S</original>
<variation>F</variation>
<location>
<position position="260"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045299">
<original>S</original>
<variation>P</variation>
<location>
<position position="260"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045300">
<original>S</original>
<variation>T</variation>
<location>
<position position="260"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs876658916." id="VAR_045301">
<original>S</original>
<variation>Y</variation>
<location>
<position position="260"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045302">
<original>S</original>
<variation>C</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045303">
<original>S</original>
<variation>G</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045304">
<original>S</original>
<variation>I</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045305">
<original>S</original>
<variation>N</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045306">
<original>S</original>
<variation>R</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047195">
<original>GN</original>
<variation>PD</variation>
<location>
<begin position="262"/>
<end position="263"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs200579969." id="VAR_045307">
<original>G</original>
<variation>C</variation>
<location>
<position position="262"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_047196">
<original>G</original>
<variation>D</variation>
<location>
<position position="262"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045863">
<original>G</original>
<variation>H</variation>
<location>
<position position="262"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs200579969." id="VAR_045308">
<original>G</original>
<variation>S</variation>
<location>
<position position="262"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045309" evidence="170">
<original>G</original>
<variation>V</variation>
<location>
<position position="262"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs72661119." id="VAR_045310">
<original>N</original>
<variation>D</variation>
<location>
<position position="263"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045311">
<original>N</original>
<variation>H</variation>
<location>
<position position="263"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045312">
<original>N</original>
<variation>I</variation>
<location>
<position position="263"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045313">
<original>N</original>
<variation>K</variation>
<location>
<position position="263"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045314">
<original>N</original>
<variation>S</variation>
<location>
<position position="263"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045315">
<original>L</original>
<variation>I</variation>
<location>
<position position="264"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045316">
<original>L</original>
<variation>P</variation>
<location>
<position position="264"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045317">
<original>L</original>
<variation>Q</variation>
<location>
<position position="264"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045318">
<original>L</original>
<variation>R</variation>
<location>
<position position="264"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045319">
<original>L</original>
<variation>V</variation>
<location>
<position position="264"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045320">
<original>L</original>
<variation>M</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs879253942." id="VAR_045321">
<original>L</original>
<variation>P</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045322">
<original>L</original>
<variation>Q</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_047197">
<original>L</original>
<variation>R</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045323">
<original>G</original>
<variation>A</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs193920774." id="VAR_045324">
<original>G</original>
<variation>E</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045325">
<original>G</original>
<variation>R</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs193920774." id="VAR_045326">
<original>G</original>
<variation>V</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045327">
<original>R</original>
<variation>G</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045328">
<original>R</original>
<variation>H</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045329">
<original>R</original>
<variation>P</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs587780075." id="VAR_045330">
<original>R</original>
<variation>Q</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs55832599." id="VAR_036507" evidence="79">
<original>R</original>
<variation>W</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045864">
<original>N</original>
<variation>F</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045331">
<original>N</original>
<variation>H</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045332">
<original>N</original>
<variation>I</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045333">
<original>N</original>
<variation>K</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045334">
<original>N</original>
<variation>S</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045335">
<original>N</original>
<variation>Y</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045336">
<original>S</original>
<variation>C</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045337">
<original>S</original>
<variation>G</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047198">
<original>S</original>
<variation>I</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045338">
<original>S</original>
<variation>N</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045339">
<original>S</original>
<variation>R</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045340">
<original>S</original>
<variation>T</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045341">
<original>F</original>
<variation>C</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045342">
<original>F</original>
<variation>I</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045343">
<original>F</original>
<variation>L</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045344">
<original>F</original>
<variation>S</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045345">
<original>F</original>
<variation>V</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045346">
<original>F</original>
<variation>Y</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045347">
<original>E</original>
<variation>A</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045348">
<original>E</original>
<variation>D</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045349">
<original>E</original>
<variation>G</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_036508" evidence="79">
<original>E</original>
<variation>K</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045865">
<original>E</original>
<variation>P</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045350">
<original>E</original>
<variation>Q</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045866">
<original>E</original>
<variation>R</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In an osteosarcoma with no family history; germline mutation and in sporadic cancers; somatic mutation." id="VAR_047199">
<original>E</original>
<variation>V</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_045351">
<original>V</original>
<variation>A</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045352">
<original>V</original>
<variation>E</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs876660333." id="VAR_045353">
<original>V</original>
<variation>G</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs121912657." id="VAR_005992" evidence="94">
<original>V</original>
<variation>L</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs121912657." id="VAR_045354">
<original>V</original>
<variation>M</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs121913343." id="VAR_005993" evidence="79 88 153 163">
<original>R</original>
<variation>C</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_005994">
<original>R</original>
<variation>G</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; abolishes sequence-specific DNA binding; does not induce SNAI1 degradation; dbSNP:rs28934576." id="VAR_005995" evidence="24 48 62 79 80 106 127 152 167">
<original>R</original>
<variation>H</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs28934576." id="VAR_036509" evidence="79">
<original>R</original>
<variation>L</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045867">
<original>R</original>
<variation>N</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs28934576." id="VAR_045355">
<original>R</original>
<variation>P</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045356">
<original>R</original>
<variation>Q</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs121913343." id="VAR_045357">
<original>R</original>
<variation>S</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045868">
<original>R</original>
<variation>Y</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045358">
<original>V</original>
<variation>A</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045359">
<original>V</original>
<variation>D</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005997">
<original>V</original>
<variation>F</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_047200">
<original>V</original>
<variation>G</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045360">
<original>V</original>
<variation>I</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045361">
<original>V</original>
<variation>L</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045362">
<original>C</original>
<variation>F</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045363">
<original>C</original>
<variation>G</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045364">
<original>C</original>
<variation>R</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045365">
<original>C</original>
<variation>S</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_005999">
<original>C</original>
<variation>W</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs863224451." id="VAR_005998" evidence="153">
<original>C</original>
<variation>Y</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786202082." id="VAR_045366">
<original>A</original>
<variation>D</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786202082." id="VAR_045367">
<original>A</original>
<variation>G</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045368">
<original>A</original>
<variation>P</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045369">
<original>A</original>
<variation>S</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045370">
<original>A</original>
<variation>T</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045371">
<original>A</original>
<variation>V</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs763098116." id="VAR_045372">
<original>C</original>
<variation>F</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006000">
<original>C</original>
<variation>G</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045373">
<original>C</original>
<variation>R</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045374">
<original>C</original>
<variation>S</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_047201">
<original>C</original>
<variation>W</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="sequence variant" description="In an osteosarcoma with no family history; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs763098116." id="VAR_045375">
<original>C</original>
<variation>Y</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs17849781." id="VAR_006001" evidence="60">
<original>P</original>
<variation>A</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045869">
<original>P</original>
<variation>F</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006002">
<original>P</original>
<variation>H</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs876659802." id="VAR_006003" evidence="140">
<original>P</original>
<variation>L</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045376">
<original>P</original>
<variation>R</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_006004" evidence="79 140 163">
<original>P</original>
<variation>S</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_006005">
<original>P</original>
<variation>T</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006006">
<original>G</original>
<variation>E</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045377">
<original>G</original>
<variation>R</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045378">
<original>G</original>
<variation>V</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045379">
<original>G</original>
<variation>W</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045380">
<original>R</original>
<variation>G</variation>
<location>
<position position="280"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs121912660." id="VAR_006008" evidence="79">
<original>R</original>
<variation>I</variation>
<location>
<position position="280"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation; no effect on interaction with CCAR2." id="VAR_006007" evidence="78 148">
<original>R</original>
<variation>K</variation>
<location>
<position position="280"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045381">
<original>R</original>
<variation>P</variation>
<location>
<position position="280"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045382">
<original>R</original>
<variation>S</variation>
<location>
<position position="280"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs121912660." id="VAR_006009" evidence="68">
<original>R</original>
<variation>T</variation>
<location>
<position position="280"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_047203">
<original>DR</original>
<variation>EW</variation>
<location>
<begin position="281"/>
<end position="282"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006010">
<original>D</original>
<variation>A</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006011" evidence="50">
<original>D</original>
<variation>E</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="sequence variant" description="In a brain tumor with no family history; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs587781525." id="VAR_006012">
<original>D</original>
<variation>G</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006013" evidence="79">
<original>D</original>
<variation>H</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs764146326." id="VAR_047202">
<original>D</original>
<variation>N</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045870">
<original>D</original>
<variation>R</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs587781525." id="VAR_006014">
<original>D</original>
<variation>V</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs764146326." id="VAR_045383">
<original>D</original>
<variation>Y</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs28934574." id="VAR_045384">
<original>R</original>
<variation>G</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045385">
<original>R</original>
<variation>H</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs730882008." id="VAR_006015">
<original>R</original>
<variation>L</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045386">
<original>R</original>
<variation>P</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs730882008." id="VAR_045387" evidence="103 169">
<original>R</original>
<variation>Q</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; does not induce SNAI1 degradation; dbSNP:rs28934574." id="VAR_006016" evidence="127 158">
<original>R</original>
<variation>W</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs149633775." id="VAR_006017">
<original>R</original>
<variation>C</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006018">
<original>R</original>
<variation>G</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="sequence variant" description="In a brain tumor with no family history; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs371409680." id="VAR_006019">
<original>R</original>
<variation>H</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045388">
<original>R</original>
<variation>L</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006020">
<original>R</original>
<variation>P</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs149633775." id="VAR_045389">
<original>R</original>
<variation>S</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006021" evidence="131">
<original>T</original>
<variation>A</variation>
<location>
<position position="284"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs863224685." id="VAR_045390">
<original>T</original>
<variation>I</variation>
<location>
<position position="284"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045391">
<original>T</original>
<variation>K</variation>
<location>
<position position="284"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006022">
<original>T</original>
<variation>P</variation>
<location>
<position position="284"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045392">
<original>E</original>
<variation>A</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045393">
<original>E</original>
<variation>D</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045394">
<original>E</original>
<variation>G</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs112431538." id="VAR_006023" evidence="50 78">
<original>E</original>
<variation>K</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_006024">
<original>E</original>
<variation>Q</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs121912667." id="VAR_006025">
<original>E</original>
<variation>V</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_006026">
<original>E</original>
<variation>A</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006027">
<original>E</original>
<variation>D</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006028">
<original>E</original>
<variation>G</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs786201059." id="VAR_006029" evidence="31 155">
<original>E</original>
<variation>K</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045871">
<original>E</original>
<variation>L</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006030" evidence="158">
<original>E</original>
<variation>Q</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045395">
<original>E</original>
<variation>V</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047204">
<original>E</original>
<variation>A</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs748891343." id="VAR_045396">
<original>E</original>
<variation>D</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045397">
<original>E</original>
<variation>G</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587782006." id="VAR_045398">
<original>E</original>
<variation>K</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045399">
<original>E</original>
<variation>V</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045400">
<original>N</original>
<variation>D</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045401">
<original>N</original>
<variation>K</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045402">
<original>N</original>
<variation>S</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045403">
<original>N</original>
<variation>T</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045404">
<original>N</original>
<variation>Y</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045405">
<original>L</original>
<variation>F</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045406">
<original>L</original>
<variation>H</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045407">
<original>L</original>
<variation>P</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045408">
<original>L</original>
<variation>R</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045409">
<original>L</original>
<variation>V</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs770374782." id="VAR_045410">
<original>R</original>
<variation>C</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs55819519." id="VAR_045411">
<original>R</original>
<variation>H</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_045412">
<original>R</original>
<variation>L</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045413">
<original>K</original>
<variation>E</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045414">
<original>K</original>
<variation>M</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs372613518." id="VAR_045415">
<original>K</original>
<variation>N</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_047205">
<original>K</original>
<variation>Q</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs781490101." id="VAR_045416">
<original>K</original>
<variation>R</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045417">
<original>K</original>
<variation>T</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045418">
<original>K</original>
<variation>E</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045872">
<original>K</original>
<variation>G</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in a sporadic cancer; somatic mutation; dbSNP:rs121912663." id="VAR_015819" evidence="22">
<original>K</original>
<variation>I</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045419">
<original>K</original>
<variation>N</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045420">
<original>K</original>
<variation>Q</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045421">
<original>K</original>
<variation>R</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045422">
<original>K</original>
<variation>T</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045423">
<original>G</original>
<variation>A</variation>
<location>
<position position="293"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587780076." id="VAR_045424">
<original>G</original>
<variation>R</variation>
<location>
<position position="293"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045425">
<original>G</original>
<variation>V</variation>
<location>
<position position="293"/>
</location>
</feature>
<feature type="sequence variant" description="In a brain tumor with no family history; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs587780076." id="VAR_045426">
<original>G</original>
<variation>W</variation>
<location>
<position position="293"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045427">
<original>E</original>
<variation>A</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045428">
<original>E</original>
<variation>D</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045429">
<original>E</original>
<variation>G</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_047206">
<original>E</original>
<variation>K</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045430">
<original>E</original>
<variation>Q</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045431">
<original>E</original>
<variation>V</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045432">
<original>P</original>
<variation>H</variation>
<location>
<position position="295"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs751713111." id="VAR_045433">
<original>P</original>
<variation>L</variation>
<location>
<position position="295"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045434">
<original>P</original>
<variation>R</variation>
<location>
<position position="295"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045435">
<original>P</original>
<variation>S</variation>
<location>
<position position="295"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045873">
<original>H</original>
<variation>C</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045436">
<original>H</original>
<variation>D</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_047207">
<original>H</original>
<variation>L</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045437">
<original>H</original>
<variation>N</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_006031">
<original>H</original>
<variation>P</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045438">
<original>H</original>
<variation>Q</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs483352696." id="VAR_045439">
<original>H</original>
<variation>R</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs672601296." id="VAR_045440">
<original>H</original>
<variation>Y</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045441">
<original>H</original>
<variation>D</variation>
<location>
<position position="297"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045442">
<original>H</original>
<variation>N</variation>
<location>
<position position="297"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045443">
<original>H</original>
<variation>P</variation>
<location>
<position position="297"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs876659477." id="VAR_045444">
<original>H</original>
<variation>R</variation>
<location>
<position position="297"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045445">
<original>H</original>
<variation>Y</variation>
<location>
<position position="297"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045446">
<original>E</original>
<variation>A</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045447">
<original>E</original>
<variation>D</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs201744589." id="VAR_045448">
<original>E</original>
<variation>K</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045449">
<original>E</original>
<variation>Q</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045450">
<original>E</original>
<variation>V</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045451">
<original>L</original>
<variation>P</variation>
<location>
<position position="299"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045452">
<original>L</original>
<variation>Q</variation>
<location>
<position position="299"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045453">
<original>L</original>
<variation>R</variation>
<location>
<position position="299"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045454">
<original>L</original>
<variation>V</variation>
<location>
<position position="299"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045455">
<original>P</original>
<variation>A</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs909643864." id="VAR_045456">
<original>P</original>
<variation>L</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_006032">
<original>P</original>
<variation>R</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045457">
<original>P</original>
<variation>S</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045458">
<original>P</original>
<variation>A</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006033">
<original>P</original>
<variation>L</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045459">
<original>P</original>
<variation>Q</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045460">
<original>P</original>
<variation>S</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047208">
<original>P</original>
<variation>T</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045461">
<original>G</original>
<variation>A</variation>
<location>
<position position="302"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006034">
<original>G</original>
<variation>E</variation>
<location>
<position position="302"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs863224686." id="VAR_045462">
<original>G</original>
<variation>R</variation>
<location>
<position position="302"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_006035">
<original>G</original>
<variation>V</variation>
<location>
<position position="302"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045463">
<original>S</original>
<variation>C</variation>
<location>
<position position="303"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045464">
<original>S</original>
<variation>I</variation>
<location>
<position position="303"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs876658714." id="VAR_045465">
<original>S</original>
<variation>N</variation>
<location>
<position position="303"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045466">
<original>S</original>
<variation>T</variation>
<location>
<position position="303"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs587782654." id="VAR_045467">
<original>T</original>
<variation>A</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045468">
<original>T</original>
<variation>I</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045469">
<original>T</original>
<variation>N</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047209">
<original>T</original>
<variation>S</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045470">
<original>K</original>
<variation>E</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_045471">
<original>K</original>
<variation>M</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; loss of nuclear localization." id="VAR_045472" evidence="23">
<original>K</original>
<variation>N</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045473">
<original>K</original>
<variation>R</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045474">
<original>K</original>
<variation>T</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in a sporadic cancer; somatic mutation." id="VAR_045475">
<original>R</original>
<variation>P</variation>
<location>
<position position="306"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs1048095040." id="VAR_006036">
<original>R</original>
<variation>Q</variation>
<location>
<position position="306"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045476">
<original>A</original>
<variation>P</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045477">
<original>A</original>
<variation>S</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006037">
<original>A</original>
<variation>T</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045478">
<original>L</original>
<variation>M</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045479">
<original>L</original>
<variation>V</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045480">
<original>P</original>
<variation>R</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation." id="VAR_006038" evidence="167">
<original>P</original>
<variation>S</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045481">
<original>N</original>
<variation>I</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045482">
<original>N</original>
<variation>T</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045483">
<original>N</original>
<variation>H</variation>
<location>
<position position="311"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045484">
<original>N</original>
<variation>K</variation>
<location>
<position position="311"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs56184981." id="VAR_045485">
<original>N</original>
<variation>S</variation>
<location>
<position position="311"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs56184981." id="VAR_045486">
<original>N</original>
<variation>T</variation>
<location>
<position position="311"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045487">
<original>T</original>
<variation>I</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs145151284." id="VAR_045488">
<original>T</original>
<variation>S</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045489">
<original>S</original>
<variation>C</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045490">
<original>S</original>
<variation>I</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045491">
<original>S</original>
<variation>N</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045492">
<original>S</original>
<variation>R</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs751440465." id="VAR_045493">
<original>S</original>
<variation>F</variation>
<location>
<position position="314"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045494">
<original>S</original>
<variation>C</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045495">
<original>S</original>
<variation>F</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045496">
<original>S</original>
<variation>P</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045497">
<original>P</original>
<variation>L</variation>
<location>
<position position="316"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs772773208." id="VAR_045498">
<original>P</original>
<variation>T</variation>
<location>
<position position="316"/>
</location>
</feature>
<feature type="sequence variant" description="In a kidney cancer with no family history; germline mutation and in a sporadic cancer; somatic mutation." id="VAR_045499">
<original>Q</original>
<variation>H</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs764735889." id="VAR_045500">
<original>Q</original>
<variation>K</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047210">
<original>Q</original>
<variation>L</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045501">
<original>Q</original>
<variation>P</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045502">
<original>Q</original>
<variation>R</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045503">
<original>P</original>
<variation>L</variation>
<location>
<position position="318"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045504">
<original>K</original>
<variation>E</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045505">
<original>K</original>
<variation>N</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045506">
<original>K</original>
<variation>R</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045507">
<original>K</original>
<variation>N</variation>
<location>
<position position="320"/>
</location>
</feature>
<feature type="sequence variant" description="In kidney cancer; germline mutation." id="VAR_045508">
<original>K</original>
<variation>E</variation>
<location>
<position position="321"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045509">
<original>K</original>
<variation>R</variation>
<location>
<position position="321"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045510">
<original>P</original>
<variation>L</variation>
<location>
<position position="322"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045511">
<original>P</original>
<variation>R</variation>
<location>
<position position="322"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045874">
<original>L</original>
<variation>G</variation>
<location>
<position position="323"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045512">
<original>L</original>
<variation>M</variation>
<location>
<position position="323"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045513">
<original>L</original>
<variation>P</variation>
<location>
<position position="323"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045514">
<original>L</original>
<variation>R</variation>
<location>
<position position="323"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047211">
<original>L</original>
<variation>V</variation>
<location>
<position position="323"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045515">
<original>D</original>
<variation>E</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions." id="VAR_045875">
<original>D</original>
<variation>S</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045516">
<original>D</original>
<variation>Y</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045517">
<original>G</original>
<variation>A</variation>
<location>
<position position="325"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045518">
<original>G</original>
<variation>E</variation>
<location>
<position position="325"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation; dbSNP:rs121912659." id="VAR_006039" evidence="62">
<original>G</original>
<variation>V</variation>
<location>
<position position="325"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045519">
<original>E</original>
<variation>G</variation>
<location>
<position position="326"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045520">
<original>Y</original>
<variation>H</variation>
<location>
<position position="327"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045521">
<original>Y</original>
<variation>S</variation>
<location>
<position position="327"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045522">
<original>F</original>
<variation>L</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045523">
<original>F</original>
<variation>S</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045524">
<original>F</original>
<variation>V</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs969930693." id="VAR_045525">
<original>T</original>
<variation>I</variation>
<location>
<position position="329"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045526">
<original>T</original>
<variation>S</variation>
<location>
<position position="329"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045527">
<original>L</original>
<variation>H</variation>
<location>
<position position="330"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047212">
<original>L</original>
<variation>P</variation>
<location>
<position position="330"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045528">
<original>L</original>
<variation>R</variation>
<location>
<position position="330"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs11575996." id="VAR_045529">
<original>Q</original>
<variation>H</variation>
<location>
<position position="331"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045530">
<original>Q</original>
<variation>P</variation>
<location>
<position position="331"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045531">
<original>Q</original>
<variation>R</variation>
<location>
<position position="331"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045532">
<original>I</original>
<variation>V</variation>
<location>
<position position="332"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_006040">
<original>G</original>
<variation>V</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045533">
<original>G</original>
<variation>W</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045534">
<original>R</original>
<variation>G</variation>
<location>
<position position="335"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs771939956." id="VAR_045535">
<original>R</original>
<variation>H</variation>
<location>
<position position="335"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045536">
<original>R</original>
<variation>L</variation>
<location>
<position position="335"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs587782529." id="VAR_006041" evidence="164">
<original>R</original>
<variation>C</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs121912664." id="VAR_035016" evidence="36">
<original>R</original>
<variation>H</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs121912664." id="VAR_045537">
<original>R</original>
<variation>L</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs121912664." id="VAR_045538">
<original>R</original>
<variation>P</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045539">
<original>F</original>
<variation>I</variation>
<location>
<position position="338"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs150293825." id="VAR_045540">
<original>F</original>
<variation>L</variation>
<location>
<position position="338"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs17882252." id="VAR_022316" evidence="166">
<original>E</original>
<variation>K</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs17882252." id="VAR_045541">
<original>E</original>
<variation>Q</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045542">
<original>F</original>
<variation>C</variation>
<location>
<position position="341"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045543">
<original>R</original>
<variation>L</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs375338359." id="VAR_045544">
<original>R</original>
<variation>P</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs375338359." id="VAR_047213">
<original>R</original>
<variation>Q</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045545">
<original>E</original>
<variation>G</variation>
<location>
<position position="343"/>
</location>
</feature>
<feature type="sequence variant" description="In LFS; germline mutation and in a sporadic cancer; somatic mutation; dbSNP:rs121912662." id="VAR_045546">
<original>L</original>
<variation>P</variation>
<location>
<position position="344"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045547">
<original>L</original>
<variation>R</variation>
<location>
<position position="344"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045548">
<original>E</original>
<variation>A</variation>
<location>
<position position="346"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045549">
<original>A</original>
<variation>G</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation." id="VAR_045550">
<original>A</original>
<variation>T</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045551">
<original>L</original>
<variation>F</variation>
<location>
<position position="348"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045552">
<original>L</original>
<variation>S</variation>
<location>
<position position="348"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045553">
<original>E</original>
<variation>D</variation>
<location>
<position position="349"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045554">
<original>D</original>
<variation>H</variation>
<location>
<position position="352"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045555">
<original>A</original>
<variation>T</variation>
<location>
<position position="353"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045556">
<original>Q</original>
<variation>E</variation>
<location>
<position position="354"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs755394212." id="VAR_045557">
<original>Q</original>
<variation>K</variation>
<location>
<position position="354"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs752142489." id="VAR_047214">
<original>Q</original>
<variation>R</variation>
<location>
<position position="354"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045558">
<original>G</original>
<variation>A</variation>
<location>
<position position="356"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045559">
<original>G</original>
<variation>W</variation>
<location>
<position position="356"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045560">
<original>E</original>
<variation>D</variation>
<location>
<position position="358"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs587782237." id="VAR_045561">
<original>E</original>
<variation>K</variation>
<location>
<position position="358"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35993958." id="VAR_045562">
<original>G</original>
<variation>A</variation>
<location>
<position position="360"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs35993958." id="VAR_045563">
<original>G</original>
<variation>V</variation>
<location>
<position position="360"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs876660285." id="VAR_045564">
<original>R</original>
<variation>K</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045565">
<original>A</original>
<variation>P</variation>
<location>
<position position="364"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045566">
<original>A</original>
<variation>T</variation>
<location>
<position position="364"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045567">
<original>A</original>
<variation>V</variation>
<location>
<position position="364"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_047215">
<original>H</original>
<variation>R</variation>
<location>
<position position="365"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in a sporadic cancer; somatic mutation; dbSNP:rs267605075." id="VAR_045568">
<original>H</original>
<variation>Y</variation>
<location>
<position position="365"/>
</location>
</feature>
<feature type="sequence variant" description="In a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs17881470." id="VAR_022317" evidence="166">
<original>S</original>
<variation>A</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045569">
<original>K</original>
<variation>Q</variation>
<location>
<position position="370"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045570">
<original>S</original>
<variation>A</variation>
<location>
<position position="376"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045571">
<original>S</original>
<variation>T</variation>
<location>
<position position="376"/>
</location>
</feature>
<feature type="sequence variant" description="In sporadic cancers; somatic mutation; dbSNP:rs863224682." id="VAR_045572">
<original>R</original>
<variation>H</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045573">
<original>F</original>
<variation>L</variation>
<location>
<position position="385"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation; dbSNP:rs587783064." id="VAR_045574">
<original>G</original>
<variation>W</variation>
<location>
<position position="389"/>
</location>
</feature>
<feature type="sequence variant" description="In a sporadic cancer; somatic mutation." id="VAR_045575">
<original>S</original>
<variation>L</variation>
<location>
<position position="392"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with PPP2R5C, PPP2CA AND PPP2R1A." evidence="100">
<original>S</original>
<variation>A</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with MDM2 and increase in protein levels after DNA damage." evidence="24">
<original>T</original>
<variation>A</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation site. Abolishes increase in protein levels after DNA damage." evidence="24">
<original>S</original>
<variation>A</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutively increased TP53 protein levels." evidence="24">
<original>S</original>
<variation>D</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with MDM2, leading to constitutively increased TP53 protein levels." evidence="24">
<original>LW</original>
<variation>QS</variation>
<location>
<begin position="22"/>
<end position="23"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolihes phosphorylation by MAPKAPK5." evidence="90">
<original>S</original>
<variation>D</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation by DYRK2 and HIPK2 and acetylation of K-382 by CREBBP." evidence="40 67 93">
<original>S</original>
<variation>A</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="mutagenesis site" description="Alters interaction with WWOX." evidence="40 67 93">
<location>
<position position="46"/>
</location>
</feature>
<feature type="mutagenesis site" description="Blocks phosphorylation by TAF1." evidence="54">
<original>T</original>
<variation>A</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes strongly phosphorylation." evidence="131">
<original>S</original>
<variation>A</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits slightly its transcriptional activity." evidence="131">
<original>S</original>
<variation>E</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not induce SNAI1 degradation." evidence="127">
<original>R</original>
<variation>S</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation." evidence="131">
<original>S</original>
<variation>A</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits strongly its transcriptional activity." evidence="131">
<original>S</original>
<variation>E</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits strongly its transcriptional activity.">
<original>T</original>
<variation>E</variation>
<location>
<position position="284"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes polyubiquitination by MKRN1." evidence="112">
<original>KK</original>
<variation>RR</variation>
<location>
<begin position="291"/>
<end position="292"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of nuclear localization; when associated with A-320 and A-321." evidence="134">
<original>K</original>
<variation>A</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of nuclear localization; when associated with A-319 and A-321." evidence="134">
<original>K</original>
<variation>A</variation>
<location>
<position position="320"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of nuclear localization; when associated with A-319 and A-320." evidence="134">
<original>K</original>
<variation>A</variation>
<location>
<position position="321"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to USP7." evidence="72">
<original>P</original>
<variation>D</variation>
<location>
<position position="359"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to USP7." evidence="72">
<original>G</original>
<variation>E</variation>
<location>
<position position="361"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to USP7." evidence="72">
<original>S</original>
<variation>A</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="mutagenesis site" description="Induces a decrease in methylation by SMYD2." evidence="84">
<original>K</original>
<variation>R</variation>
<location>
<position position="370"/>
</location>
</feature>
<feature type="mutagenesis site" description="Induces a decrease in protein stabilization." evidence="61">
<original>K</original>
<variation>R</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes dimethylation by EHMT1 and EHMT2." evidence="121">
<original>K</original>
<variation>R</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes acetylation by CREBBP." evidence="29 40 97 130">
<original>K</original>
<variation>A</variation>
<location>
<position position="382"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes monomethylation by KMT5A." evidence="29 40 97 130">
<original>K</original>
<variation>R</variation>
<location>
<position position="382"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes S-315 phosphorylation by CDK2/cyclin A." evidence="29">
<original>L</original>
<variation>A</variation>
<location>
<position position="383"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced SUMO1 conjugation." evidence="29 33">
<original>F</original>
<variation>A</variation>
<location>
<position position="385"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes SUMO1 conjugation, in vitro and in vivo." evidence="33 171">
<original>K</original>
<variation>A</variation>
<location>
<position position="386"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect SUMO1 conjugation." evidence="33">
<original>T</original>
<variation>A</variation>
<location>
<position position="387"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes SUMO1 conjugation." evidence="33">
<original>E</original>
<variation>A</variation>
<location>
<position position="388"/>
</location>
</feature>
<feature type="helix" evidence="16">
<location>
<begin position="3"/>
<end position="6"/>
</location>
</feature>
<feature type="turn" evidence="16">
<location>
<begin position="8"/>
<end position="10"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="19"/>
<end position="23"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="27"/>
<end position="29"/>
</location>
</feature>
<feature type="helix" evidence="17">
<location>
<begin position="30"/>
<end position="32"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="33"/>
<end position="35"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="36"/>
<end position="38"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="41"/>
<end position="44"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="47"/>
<end position="55"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="105"/>
<end position="108"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="110"/>
<end position="112"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="119"/>
<end position="121"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="124"/>
<end position="127"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="128"/>
<end position="131"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="132"/>
<end position="135"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="141"/>
<end position="146"/>
</location>
</feature>
<feature type="strand" evidence="18">
<location>
<begin position="148"/>
<end position="150"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="156"/>
<end position="165"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="166"/>
<end position="168"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="177"/>
<end position="180"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="181"/>
<end position="183"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="187"/>
<end position="189"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="194"/>
<end position="199"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="204"/>
<end position="207"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="209"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="214"/>
<end position="219"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="225"/>
<end position="227"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="228"/>
<end position="236"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="240"/>
<end position="242"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="243"/>
<end position="248"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="251"/>
<end position="258"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="260"/>
<end position="262"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="264"/>
<end position="274"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="278"/>
<end position="287"/>
</location>
</feature>
<feature type="helix" evidence="12">
<location>
<begin position="288"/>
<end position="290"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="327"/>
<end position="334"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="335"/>
<end position="354"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="375"/>
<end position="380"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1AIE"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1GZH"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1YC5"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ADY"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2B3G"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2FEJ"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2K8F"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2L14"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3D06"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3D07"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3DAC"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4HJE"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KVP"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4MZI"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4MZR"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5HOU"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5HPD"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UN8"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000250"/>
<evidence key="21" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P02340"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10484981"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10551826"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10570149"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10606744"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10644996"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10656795"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10722742"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10884347"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10951572"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11023613"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11025664"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11124955"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11239457"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11447225"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11481490"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11546806"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11551930"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11554766"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11740489"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11780126"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12085209"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12724314"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12750254"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12810724"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12851404"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1303181"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1394225"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14534297"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1459726"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14660794"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702041"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15053879"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15053880"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15109303"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15136035"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15186775"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15340061"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15525938"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1565144"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15701641"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15855171"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15866171"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16131611"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16219768"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1631151"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16322561"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16376338"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16377624"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16402859"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16415881"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16474402"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16704422"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16793544"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16845383"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1694291"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1699228"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17015838"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1705009"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17108107"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17108971"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17121812"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17145718"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17170702"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17224074"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17245430"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17254968"/>
</source>
</evidence>
<evidence key="91" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17317671"/>
</source>
</evidence>
<evidence key="92" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17332504"/>
</source>
</evidence>
<evidence key="93" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17349958"/>
</source>
</evidence>
<evidence key="94" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1737852"/>
</source>
</evidence>
<evidence key="95" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17467953"/>
</source>
</evidence>
<evidence key="96" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17591690"/>
</source>
</evidence>
<evidence key="97" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17707234"/>
</source>
</evidence>
<evidence key="98" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17719541"/>
</source>
</evidence>
<evidence key="99" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17904127"/>
</source>
</evidence>
<evidence key="100" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17967874"/>
</source>
</evidence>
<evidence key="101" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18022393"/>
</source>
</evidence>
<evidence key="102" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18206965"/>
</source>
</evidence>
<evidence key="103" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18453682"/>
</source>
</evidence>
<evidence key="104" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18585004"/>
</source>
</evidence>
<evidence key="105" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18650397"/>
</source>
</evidence>
<evidence key="106" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1868473"/>
</source>
</evidence>
<evidence key="107" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18996393"/>
</source>
</evidence>
<evidence key="108" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1933902"/>
</source>
</evidence>
<evidence key="109" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19473992"/>
</source>
</evidence>
<evidence key="110" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19509332"/>
</source>
</evidence>
<evidence key="111" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19515728"/>
</source>
</evidence>
<evidence key="112" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19536131"/>
</source>
</evidence>
<evidence key="113" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19556538"/>
</source>
</evidence>
<evidence key="114" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19776115"/>
</source>
</evidence>
<evidence key="115" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1978757"/>
</source>
</evidence>
<evidence key="116" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19837670"/>
</source>
</evidence>
<evidence key="117" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19880522"/>
</source>
</evidence>
<evidence key="118" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1999338"/>
</source>
</evidence>
<evidence key="119" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20041275"/>
</source>
</evidence>
<evidence key="120" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20096447"/>
</source>
</evidence>
<evidence key="121" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20118233"/>
</source>
</evidence>
<evidence key="122" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20124405"/>
</source>
</evidence>
<evidence key="123" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20142040"/>
</source>
</evidence>
<evidence key="124" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20173098"/>
</source>
</evidence>
<evidence key="125" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20228809"/>
</source>
</evidence>
<evidence key="126" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20364130"/>
</source>
</evidence>
<evidence key="127" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20385133"/>
</source>
</evidence>
<evidence key="128" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20660729"/>
</source>
</evidence>
<evidence key="129" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20673990"/>
</source>
</evidence>
<evidence key="130" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20870725"/>
</source>
</evidence>
<evidence key="131" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20959462"/>
</source>
</evidence>
<evidence key="132" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21317932"/>
</source>
</evidence>
<evidence key="133" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2141171"/>
</source>
</evidence>
<evidence key="134" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2156209"/>
</source>
</evidence>
<evidence key="135" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21946351"/>
</source>
</evidence>
<evidence key="136" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21952639"/>
</source>
</evidence>
<evidence key="137" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22214662"/>
</source>
</evidence>
<evidence key="138" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22522597"/>
</source>
</evidence>
<evidence key="139" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2259385"/>
</source>
</evidence>
<evidence key="140" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2263646"/>
</source>
</evidence>
<evidence key="141" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22726440"/>
</source>
</evidence>
<evidence key="142" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22864287"/>
</source>
</evidence>
<evidence key="143" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22945289"/>
</source>
</evidence>
<evidence key="144" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23431171"/>
</source>
</evidence>
<evidence key="145" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24051492"/>
</source>
</evidence>
<evidence key="146" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25422469"/>
</source>
</evidence>
<evidence key="147" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25591766"/>
</source>
</evidence>
<evidence key="148" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25732823"/>
</source>
</evidence>
<evidence key="149" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25772236"/>
</source>
</evidence>
<evidence key="150" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27323408"/>
</source>
</evidence>
<evidence key="151" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2946935"/>
</source>
</evidence>
<evidence key="152" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7682763"/>
</source>
</evidence>
<evidence key="153" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7887414"/>
</source>
</evidence>
<evidence key="154" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8013454"/>
</source>
</evidence>
<evidence key="155" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8316628"/>
</source>
</evidence>
<evidence key="156" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8632915"/>
</source>
</evidence>
<evidence key="157" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8825920"/>
</source>
</evidence>
<evidence key="158" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8829627"/>
</source>
</evidence>
<evidence key="159" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8875926"/>
</source>
</evidence>
<evidence key="160" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8875929"/>
</source>
</evidence>
<evidence key="161" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9372954"/>
</source>
</evidence>
<evidence key="162" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9419979"/>
</source>
</evidence>
<evidence key="163" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9450901"/>
</source>
</evidence>
<evidence key="164" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9452042"/>
</source>
</evidence>
<evidence key="165" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9840937"/>
</source>
</evidence>
<evidence key="166" type="ECO:0000269">
<source ref="12"/>
</evidence>
<evidence key="167" type="ECO:0000269">
<source ref="14"/>
</evidence>
<evidence key="168" type="ECO:0000269">
<source ref="17"/>
</evidence>
<evidence key="169" type="ECO:0000269">
<source ref="22"/>
</evidence>
<evidence key="170" type="ECO:0000269">
<source ref="23"/>
</evidence>
<evidence key="171" type="ECO:0000269">
<source ref="35"/>
</evidence>
<evidence key="172" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16131611"/>
</source>
</evidence>
<evidence key="173" type="ECO:0000305"/>
<sequence length="393" mass="43653" checksum="AD5C149FD8106131" modified="2009-11-24" version="4">
MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGP
DEAPRMPEAAPPVAPAPAAPTPAAPAPAPSWPLSSSVPSQKTYQGSYGFRLGFLHSGTAK
SVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHE
RCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNS
SCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELP
PGSTKRALPNNTSSSPQPKKKPLDGEYFTLQIRGRERFEMFRELNEALELKDAQAGKEPG
GSRAHSSHLKSKKGQSTSRHKKLMFKTEGPDSD
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2017-12-20" version="247">
<accession>P00533</accession>
<accession>O00688</accession>
<accession>O00732</accession>
<accession>P06268</accession>
<accession>Q14225</accession>
<accession>Q68GS5</accession>
<accession>Q92795</accession>
<accession>Q9BZS2</accession>
<accession>Q9GZX1</accession>
<accession>Q9H2C9</accession>
<accession>Q9H3C9</accession>
<accession>Q9UMD7</accession>
<accession>Q9UMD8</accession>
<accession>Q9UMG5</accession>
<name>EGFR_HUMAN</name>
<protein>
<recommendedName>
<fullName>Epidermal growth factor receptor</fullName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Proto-oncogene c-ErbB-1</fullName>
</alternativeName>
<alternativeName>
<fullName>Receptor tyrosine-protein kinase erbB-1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">EGFR</name>
<name type="synonym">ERBB</name>
<name type="synonym">ERBB1</name>
<name type="synonym">HER1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1984" name="Nature" volume="309" first="418" last="425">
<title>Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.</title>
<authorList>
<person name="Ullrich A."/>
<person name="Coussens L."/>
<person name="Hayflick J.S."/>
<person name="Dull T.J."/>
<person name="Gray A."/>
<person name="Tam A.W."/>
<person name="Lee J."/>
<person name="Yarden Y."/>
<person name="Libermann T.A."/>
<person name="Schlessinger J."/>
<person name="Downward J."/>
<person name="Mayes E.L.V."/>
<person name="Whittle N."/>
<person name="Waterfield M.D."/>
<person name="Seeburg P.H."/>
</authorList>
<dbReference type="PubMed" id="6328312"/>
<dbReference type="DOI" id="10.1038/309418a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="Mol. Reprod. Dev." volume="41" first="149" last="156">
<title>Possible role of variant RNA transcripts in the regulation of epidermal growth factor receptor expression in human placenta.</title>
<authorList>
<person name="Ilekis J.V."/>
<person name="Stark B.C."/>
<person name="Scoccia B."/>
</authorList>
<dbReference type="PubMed" id="7654368"/>
<dbReference type="DOI" id="10.1002/mrd.1080410205"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="Nucleic Acids Res." volume="24" first="4050" last="4056">
<title>A 1.8 kb alternative transcript from the human epidermal growth factor receptor gene encodes a truncated form of the receptor.</title>
<authorList>
<person name="Reiter J.L."/>
<person name="Maihle N.J."/>
</authorList>
<dbReference type="PubMed" id="8918811"/>
<dbReference type="DOI" id="10.1093/nar/24.20.4050"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1997" name="Gynecol. Oncol." volume="65" first="36" last="41">
<title>Expression of a truncated epidermal growth factor receptor-like protein (TEGFR) in ovarian cancer.</title>
<authorList>
<person name="Ilekis J.V."/>
<person name="Gariti J."/>
<person name="Niederberger C."/>
<person name="Scoccia B."/>
</authorList>
<dbReference type="PubMed" id="9103388"/>
<dbReference type="DOI" id="10.1006/gyno.1996.4526"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2001" name="Genomics" volume="71" first="1" last="20">
<title>Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms.</title>
<authorList>
<person name="Reiter J.L."/>
<person name="Threadgill D.W."/>
<person name="Eley G.D."/>
<person name="Strunk K.E."/>
<person name="Danielsen A.J."/>
<person name="Schehl Sinclair C."/>
<person name="Pearsall R.S."/>
<person name="Green P.J."/>
<person name="Yee D."/>
<person name="Lampland A.L."/>
<person name="Balasubramaniam S."/>
<person name="Crossley T.D."/>
<person name="Magnuson T.R."/>
<person name="James C.D."/>
<person name="Maihle N.J."/>
</authorList>
<dbReference type="PubMed" id="11161793"/>
<dbReference type="DOI" id="10.1006/geno.2000.6341"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 3 AND 4)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2004-07" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of the cDNA for a short EGF receptor from human placenta.</title>
<authorList>
<person name="Xu L."/>
<person name="Hong A."/>
<person name="He X."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="7">
<citation type="submission" date="2004-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS GLN-98; ARG-266; LYS-521; ILE-674; GLY-962 AND PRO-988</scope>
</reference>
<reference key="8">
<citation type="submission" date="1999-02" db="EMBL/GenBank/DDBJ databases">
<title>Human and mouse alternative EGFR transcripts encoding only the extracellular domain of the receptor.</title>
<authorList>
<person name="Reiter J.L."/>
<person name="Threadgill D.W."/>
<person name="Danielsen A.J."/>
<person name="Schehl C.M."/>
<person name="Lampland A.L."/>
<person name="Balasubramaniam S."/>
<person name="Crossley T.O."/>
<person name="Magnuson T.R."/>
<person name="Maihle N.J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 575-687</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1984" name="Science" volume="224" first="843" last="848">
<title>Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells.</title>
<authorList>
<person name="Lin C.R."/>
<person name="Chen W.S."/>
<person name="Kruiger W."/>
<person name="Stolarsky L.S."/>
<person name="Weber W."/>
<person name="Evans R.M."/>
<person name="Verma I.M."/>
<person name="Gill G.N."/>
<person name="Rosenfeld M.G."/>
</authorList>
<dbReference type="PubMed" id="6326261"/>
<dbReference type="DOI" id="10.1126/science.6326261"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 713-924</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1984" name="Nature" volume="309" first="806" last="810">
<title>Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells.</title>
<authorList>
<person name="Xu Y.H."/>
<person name="Ishii S."/>
<person name="Clark A.J.L."/>
<person name="Sullivan M."/>
<person name="Wilson R.K."/>
<person name="Ma D.P."/>
<person name="Roe B.A."/>
<person name="Merlino G.T."/>
<person name="Pastan I."/>
</authorList>
<dbReference type="PubMed" id="6330563"/>
<dbReference type="DOI" id="10.1038/309806a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 150-962</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1984" name="Biochem. Biophys. Res. Commun." volume="124" first="125" last="132">
<title>Isolation of an evolutionarily conserved epidermal growth factor receptor cDNA from human A431 carcinoma cells.</title>
<authorList>
<person name="Simmen F.A."/>
<person name="Gope M.L."/>
<person name="Schulz T.Z."/>
<person name="Wright D.A."/>
<person name="Carpenter G."/>
<person name="O'Malley B.W."/>
</authorList>
<dbReference type="PubMed" id="6093780"/>
<dbReference type="DOI" id="10.1016/0006-291X(84)90926-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1028-1210</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1987" name="Oncogene Res." volume="1" first="375" last="396">
<title>The human EGF receptor gene: structure of the 110 kb locus and identification of sequences regulating its transcription.</title>
<authorList>
<person name="Haley J.D."/>
<person name="Whittle N."/>
<person name="Bennett P."/>
<person name="Kinchington D."/>
<person name="Ullrich A."/>
<person name="Waterfield M.D."/>
</authorList>
<dbReference type="PubMed" id="3329716"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="1746" last="1753">
<title>Contributory effects of de novo transcription and premature transcript termination in the regulation of human epidermal growth factor receptor proto-oncogene RNA synthesis.</title>
<authorList>
<person name="Haley J.D."/>
<person name="Waterfield M.D."/>
</authorList>
<dbReference type="PubMed" id="1988448"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1985" name="Proc. Natl. Acad. Sci. U.S.A." volume="82" first="4920" last="4924">
<title>Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene.</title>
<authorList>
<person name="Ishii S."/>
<person name="Xu Y.H."/>
<person name="Stratton R.H."/>
<person name="Roe B.A."/>
<person name="Merlino G.T."/>
<person name="Pastan I."/>
</authorList>
<dbReference type="PubMed" id="2991899"/>
<dbReference type="DOI" id="10.1073/pnas.82.15.4920"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1984" name="Science" volume="224" first="294" last="297">
<title>Production of an epidermal growth factor receptor-related protein.</title>
<authorList>
<person name="Weber W."/>
<person name="Gill G.N."/>
<person name="Spiess J."/>
</authorList>
<dbReference type="PubMed" id="6324343"/>
<dbReference type="DOI" id="10.1126/science.6324343"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 25-49</scope>
</reference>
<reference key="16">
<citation type="submission" date="1997-09" db="UniProtKB">
<authorList>
<person name="Kohda D."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 540</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1988" name="J. Biol. Chem." volume="263" first="13152" last="13158">
<title>Epidermal growth factor receptor threonine and serine residues phosphorylated in vivo.</title>
<authorList>
<person name="Heisermann G.J."/>
<person name="Gill G.N."/>
</authorList>
<dbReference type="PubMed" id="3138233"/>
</citation>
<scope>PROTEIN SEQUENCE OF 687-705; 986-998; 1000-1023; 1026-1030 AND 1068-1077</scope>
<scope>PHOSPHORYLATION AT THR-693; SER-695; SER-1070 AND SER-1071</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="Protein Sci." volume="13" first="2819" last="2824">
<title>Signal peptide prediction based on analysis of experimentally verified cleavage sites.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Henzel W.J."/>
</authorList>
<dbReference type="PubMed" id="15340161"/>
<dbReference type="DOI" id="10.1110/ps.04682504"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-39</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1985" name="J. Biol. Chem." volume="260" first="5205" last="5208">
<title>Identification of residues in the nucleotide binding site of the epidermal growth factor receptor/kinase.</title>
<authorList>
<person name="Russo M.W."/>
<person name="Lukas T.J."/>
<person name="Cohen S."/>
<person name="Staros J.V."/>
</authorList>
<dbReference type="PubMed" id="2985580"/>
</citation>
<scope>PROTEIN SEQUENCE OF 740-744 AND 746-747</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="Mol. Cell" volume="21" first="737" last="748">
<title>Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain.</title>
<authorList>
<person name="Huang F."/>
<person name="Kirkpatrick D."/>
<person name="Jiang X."/>
<person name="Gygi S.P."/>
<person name="Sorkin A."/>
</authorList>
<dbReference type="PubMed" id="16543144"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.02.018"/>
</citation>
<scope>PROTEIN SEQUENCE OF 861-875 AND 914-932</scope>
<scope>UBIQUITINATION AT LYS-716; LYS-737; LYS-754; LYS-867; LYS-929 AND LYS-970</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="11150" last="11157">
<title>Disulfide bond structure of human epidermal growth factor receptor.</title>
<authorList>
<person name="Abe Y."/>
<person name="Odaka M."/>
<person name="Inagaki F."/>
<person name="Lax I."/>
<person name="Schlessinger J."/>
<person name="Kohda D."/>
</authorList>
<dbReference type="PubMed" id="9556602"/>
<dbReference type="DOI" id="10.1074/jbc.273.18.11150"/>
</citation>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1984" name="Nature" volume="309" first="270" last="273">
<title>ATP-stimulated interaction between epidermal growth factor receptor and supercoiled DNA.</title>
<authorList>
<person name="Mroczkowski B."/>
<person name="Mosig G."/>
<person name="Cohen S."/>
</authorList>
<dbReference type="PubMed" id="6325948"/>
<dbReference type="DOI" id="10.1038/309270a0"/>
</citation>
<scope>RECEPTOR ACTIVITY</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1987" name="Annu. Rev. Biochem." volume="56" first="881" last="914">
<title>Receptors for epidermal growth factor and other polypeptide mitogens.</title>
<authorList>
<person name="Carpenter G."/>
</authorList>
<dbReference type="PubMed" id="3039909"/>
<dbReference type="DOI" id="10.1146/annurev.bi.56.070187.004313"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1989" name="Cell" volume="59" first="33" last="43">
<title>Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation.</title>
<authorList>
<person name="Chen W.S."/>
<person name="Lazar C.S."/>
<person name="Lund K.A."/>
<person name="Welsh J.B."/>
<person name="Chang C.P."/>
<person name="Walton G.M."/>
<person name="Der C.J."/>
<person name="Wiley H.S."/>
<person name="Gill G.N."/>
<person name="Rosenfeld M.G."/>
</authorList>
<dbReference type="PubMed" id="2790960"/>
<dbReference type="DOI" id="10.1016/0092-8674(89)90867-2"/>
</citation>
<scope>LIGAND-BINDING</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1989" name="J. Biol. Chem." volume="264" first="10667" last="10671">
<title>All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor.</title>
<authorList>
<person name="Margolis B.L."/>
<person name="Lax I."/>
<person name="Kris R."/>
<person name="Dombalagian M."/>
<person name="Honegger A.M."/>
<person name="Howk R."/>
<person name="Givol D."/>
<person name="Ullrich A."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="2543678"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-1110</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="2924" last="2931">
<title>Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells.</title>
<authorList>
<person name="Johnson G.R."/>
<person name="Kannan B."/>
<person name="Shoyab M."/>
<person name="Stromberg K."/>
</authorList>
<dbReference type="PubMed" id="7679104"/>
</citation>
<scope>IDENTIFICATION OF AMPHIREGULIN AS LIGAND</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1996" name="Science" volume="272" first="1797" last="1802">
<title>Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor.</title>
<authorList>
<person name="Galcheva-Gargova Z."/>
<person name="Konstantinov K.N."/>
<person name="Wu I.-H."/>
<person name="Klier F.G."/>
<person name="Barrett T."/>
<person name="Davis R.J."/>
</authorList>
<dbReference type="PubMed" id="8650580"/>
<dbReference type="DOI" id="10.1126/science.272.5269.1797"/>
</citation>
<scope>INTERACTION WITH ZPR1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1998" name="J. Cell Biol." volume="143" first="1471" last="1484">
<title>Interaction of ZPR1 with translation elongation factor-1alpha in proliferating cells.</title>
<authorList>
<person name="Gangwani L."/>
<person name="Mikrut M."/>
<person name="Galcheva-Gargova Z."/>
<person name="Davis R.J."/>
</authorList>
<dbReference type="PubMed" id="9852145"/>
<dbReference type="DOI" id="10.1083/jcb.143.6.1471"/>
</citation>
<scope>INTERACTION WITH ZPR1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="5567" last="5576">
<title>Cell-type specific phosphorylation of threonines T654 and T669 by PKD defines the signal capacity of the EGF receptor.</title>
<authorList>
<person name="Bagowski C.P."/>
<person name="Stein-Gerlach M."/>
<person name="Choidas A."/>
<person name="Ullrich A."/>
</authorList>
<dbReference type="PubMed" id="10523301"/>
<dbReference type="DOI" id="10.1093/emboj/18.20.5567"/>
</citation>
<scope>PHOSPHORYLATION AT THR-678 AND THR-693</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="9966" last="9973">
<title>Recombinant human betacellulin. Molecular structure, biological activities, and receptor interaction.</title>
<authorList>
<person name="Watanabe T."/>
<person name="Shintani A."/>
<person name="Nakata M."/>
<person name="Shing Y."/>
<person name="Folkman J."/>
<person name="Igarashi K."/>
<person name="Sasada R."/>
</authorList>
<dbReference type="PubMed" id="8144591"/>
</citation>
<scope>IDENTIFICATION OF BETACELLULIN/BTC AS LIGAND</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="20242" last="20245">
<title>Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation.</title>
<authorList>
<person name="Galisteo M.L."/>
<person name="Dikic I."/>
<person name="Batzer A.G."/>
<person name="Langdon W.Y."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="7657591"/>
<dbReference type="DOI" id="10.1074/jbc.270.35.20242"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CBL</scope>
<scope>INTERACTION WITH CBL</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1996" name="Growth Factors" volume="13" first="121" last="132">
<title>Analysis of the glycosylation patterns of the extracellular domain of the epidermal growth factor receptor expressed in Chinese hamster ovary fibroblasts.</title>
<authorList>
<person name="Smith K.D."/>
<person name="Davies M.J."/>
<person name="Bailey D."/>
<person name="Renouf D.V."/>
<person name="Hounsell E.F."/>
</authorList>
<dbReference type="PubMed" id="8962717"/>
<dbReference type="DOI" id="10.3109/08977199609034572"/>
</citation>
<scope>GLYCOSYLATION AT ASN-128; ASN-175; ASN-413; ASN-444 AND ASN-528</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1997" name="Oncogene" volume="15" first="2841" last="2848">
<title>Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4.</title>
<authorList>
<person name="Komurasaki T."/>
<person name="Toyoda H."/>
<person name="Uchida D."/>
<person name="Morimoto S."/>
</authorList>
<dbReference type="PubMed" id="9419975"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201458"/>
</citation>
<scope>IDENTIFICATION OF EPIREGULIN/EREG AS LIGAND</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="1622" last="1634">
<title>Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase.</title>
<authorList>
<person name="Tiganis T."/>
<person name="Bennett A.M."/>
<person name="Ravichandran K.S."/>
<person name="Tonks N.K."/>
</authorList>
<dbReference type="PubMed" id="9488479"/>
<dbReference type="DOI" id="10.1128/MCB.18.3.1622"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>DEPHOSPHORYLATION BY PTPN1 AND PTPN2</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="2489" last="2499">
<title>Inhibition of the receptor-binding function of clathrin adaptor protein AP-2 by dominant-negative mutant mu2 subunit and its effects on endocytosis.</title>
<authorList>
<person name="Nesterov A."/>
<person name="Carter R.E."/>
<person name="Sorkina T."/>
<person name="Gill G.N."/>
<person name="Sorkin A."/>
</authorList>
<dbReference type="PubMed" id="10228163"/>
<dbReference type="DOI" id="10.1093/emboj/18.9.2489"/>
</citation>
<scope>INTERACTION WITH AP2M1</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="5542" last="5549">
<title>Identification of Grb4/Nckbeta, a src homology 2 and 3 domain-containing adapter protein having similar binding and biological properties to Nck.</title>
<authorList>
<person name="Braverman L.E."/>
<person name="Quilliam L.A."/>
</authorList>
<dbReference type="PubMed" id="10026169"/>
<dbReference type="DOI" id="10.1074/jbc.274.9.5542"/>
</citation>
<scope>INTERACTION WITH GRB2; NCK1 AND NCK2</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2000" name="J. Biochem." volume="127" first="65" last="72">
<title>Characterization of the N-oligosaccharides attached to the atypical Asn-X-Cys sequence of recombinant human epidermal growth factor receptor.</title>
<authorList>
<person name="Sato C."/>
<person name="Kim J.-H."/>
<person name="Abe Y."/>
<person name="Saito K."/>
<person name="Yokoyama S."/>
<person name="Kohda D."/>
</authorList>
<dbReference type="PubMed" id="10731668"/>
<dbReference type="DOI" id="10.1093/oxfordjournals.jbchem.a022585"/>
</citation>
<scope>GLYCOSYLATION AT ASN-56; ASN-352; ASN-361; ASN-568 AND ASN-603</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="48532" last="48538">
<title>RGS16 function is regulated by epidermal growth factor receptor-mediated tyrosine phosphorylation.</title>
<authorList>
<person name="Derrien A."/>
<person name="Druey K.M."/>
</authorList>
<dbReference type="PubMed" id="11602604"/>
<dbReference type="DOI" id="10.1074/jbc.M108862200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF RGS16</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2003" name="Biochemistry" volume="42" first="5478" last="5492">
<title>Characterization of glycosylation sites of the epidermal growth factor receptor.</title>
<authorList>
<person name="Zhen Y."/>
<person name="Caprioli R.M."/>
<person name="Staros J.V."/>
</authorList>
<dbReference type="PubMed" id="12731890"/>
<dbReference type="DOI" id="10.1021/bi027101p"/>
</citation>
<scope>GLYCOSYLATION AT ASN-56; ASN-128; ASN-175; ASN-196; ASN-352; ASN-361; ASN-413; ASN-444; ASN-528; ASN-568; ASN-603 AND ASN-623</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="3923" last="3930">
<title>Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor.</title>
<authorList>
<person name="Shao H."/>
<person name="Cheng H.Y."/>
<person name="Cook R.G."/>
<person name="Tweardy D.J."/>
</authorList>
<dbReference type="PubMed" id="12873986"/>
</citation>
<scope>FUNCTION IN CELL PROLIFERATION</scope>
<scope>INTERACTION WITH STAT3</scope>
<scope>PHOSPHORYLATION AT TYR-1092 AND TYR-1110</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="3270" last="3281">
<title>LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation.</title>
<authorList>
<person name="Gur G."/>
<person name="Rubin C."/>
<person name="Katz M."/>
<person name="Amit I."/>
<person name="Citri A."/>
<person name="Nilsson J."/>
<person name="Amariglio N."/>
<person name="Henriksson R."/>
<person name="Rechavi G."/>
<person name="Hedman H."/>
<person name="Wides R."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="15282549"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600342"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH LRIG1</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="3817" last="3830">
<title>Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors.</title>
<authorList>
<person name="Arcaro A."/>
<person name="Zvelebil M.J."/>
<person name="Wallasch C."/>
<person name="Ullrich A."/>
<person name="Waterfield M.D."/>
<person name="Domin J."/>
</authorList>
<dbReference type="PubMed" id="10805725"/>
<dbReference type="DOI" id="10.1128/MCB.20.11.3817-3830.2000"/>
</citation>
<scope>FUNCTION IN EGFR SIGNALING</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH PIK3C2A AND ERBB2</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH PIK3C2B AND ERBB2</scope>
<scope>INTERACTION WITH PIK3C2B</scope>
<scope>MUTAGENESIS OF TYR-1016; TYR-1092; TYR-1110; TYR-1172 AND TYR-1197</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="8865" last="8874">
<title>The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome.</title>
<authorList>
<person name="Habib A.A."/>
<person name="Chatterjee S."/>
<person name="Park S.-K."/>
<person name="Ratan R.R."/>
<person name="Lefebvre S."/>
<person name="Vartanian T."/>
</authorList>
<dbReference type="PubMed" id="11116146"/>
<dbReference type="DOI" id="10.1074/jbc.M008458200"/>
</citation>
<scope>FUNCTION IN NF-KAPPA-B ACTIVATION</scope>
<scope>INTERACTION WITH RIPK1</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="35239" last="35242">
<title>The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin.</title>
<authorList>
<person name="Li Y."/>
<person name="Ren J."/>
<person name="Yu W."/>
<person name="Li Q."/>
<person name="Kuwahara H."/>
<person name="Yin L."/>
<person name="Carraway K.L. III"/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="11483589"/>
<dbReference type="DOI" id="10.1074/jbc.C100359200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF MUC1</scope>
<scope>INTERACTION WITH MUC1</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="7038" last="7048">
<title>Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling.</title>
<authorList>
<person name="Kario E."/>
<person name="Marmor M.D."/>
<person name="Adamsky K."/>
<person name="Citri A."/>
<person name="Amit I."/>
<person name="Amariglio N."/>
<person name="Rechavi G."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="15590694"/>
<dbReference type="DOI" id="10.1074/jbc.M408575200"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH SOCS5</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="8503" last="8512">
<title>Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity.</title>
<authorList>
<person name="Kochupurakkal B.S."/>
<person name="Harari D."/>
<person name="Di-Segni A."/>
<person name="Maik-Rachline G."/>
<person name="Lyass L."/>
<person name="Gur G."/>
<person name="Kerber G."/>
<person name="Citri A."/>
<person name="Lavi S."/>
<person name="Eilam R."/>
<person name="Chalifa-Caspi V."/>
<person name="Eshhar Z."/>
<person name="Pikarsky E."/>
<person name="Pinkas-Kramarski R."/>
<person name="Bacus S.S."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="15611079"/>
<dbReference type="DOI" id="10.1074/jbc.M413919200"/>
</citation>
<scope>IDENTIFICATION OF EPIGEN/EPGN AS A LIGAND</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="1155" last="1170">
<title>Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications-comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR).</title>
<authorList>
<person name="Wu S.L."/>
<person name="Kim J."/>
<person name="Hancock W.S."/>
<person name="Karger B."/>
</authorList>
<dbReference type="PubMed" id="16083266"/>
<dbReference type="DOI" id="10.1021/pr050113n"/>
</citation>
<scope>GLYCOSYLATION AT ASN-56; ASN-128; ASN-175; ASN-196; ASN-352; ASN-361; ASN-413; ASN-444; ASN-528; ASN-568 AND ASN-603</scope>
<scope>PHOSPHORYLATION AT THR-693; SER-991 AND SER-1026</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="7724" last="7732">
<title>Functional implications of altered subcellular localization of PELP1 in breast cancer cells.</title>
<authorList>
<person name="Vadlamudi R.K."/>
<person name="Manavathi B."/>
<person name="Balasenthil S."/>
<person name="Nair S.S."/>
<person name="Yang Z."/>
<person name="Sahin A.A."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="16140940"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-05-0614"/>
</citation>
<scope>INTERACTION WITH PELP1</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1172 AND TYR-1197</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="50">
<citation type="journal article" date="2006" name="Nat. Cell Biol." volume="8" first="1359" last="1368">
<title>Tyrosine phosphorylation controls PCNA function through protein stability.</title>
<authorList>
<person name="Wang S.C."/>
<person name="Nakajima Y."/>
<person name="Yu Y.L."/>
<person name="Xia W."/>
<person name="Chen C.T."/>
<person name="Yang C.C."/>
<person name="McIntush E.W."/>
<person name="Li L.Y."/>
<person name="Hawke D.H."/>
<person name="Kobayashi R."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="17115032"/>
<dbReference type="DOI" id="10.1038/ncb1501"/>
</citation>
<scope>FUNCTION IN CELL PROLIFERATION</scope>
<scope>FUNCTION IN PCNA PHOSPHORYLATION</scope>
<scope>INTERACTION WITH PCNA</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2007" name="J. Clin. Invest." volume="117" first="2260" last="2267">
<title>Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia.</title>
<authorList>
<person name="Groenestege W.M.T."/>
<person name="Thebault S."/>
<person name="van der Wijst J."/>
<person name="van den Berg D."/>
<person name="Janssen R."/>
<person name="Tejpar S."/>
<person name="van den Heuvel L.P."/>
<person name="van Cutsem E."/>
<person name="Hoenderop J.G."/>
<person name="Knoers N.V."/>
<person name="Bindels R.J."/>
</authorList>
<dbReference type="PubMed" id="17671655"/>
<dbReference type="DOI" id="10.1172/JCI31680"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2007" name="Mol. Biol. Cell" volume="18" first="732" last="742">
<title>Activated Cdc42-associated kinase 1 is a component of EGF receptor signaling complex and regulates EGF receptor degradation.</title>
<authorList>
<person name="Shen F."/>
<person name="Lin Q."/>
<person name="Gu Y."/>
<person name="Childress C."/>
<person name="Yang W."/>
</authorList>
<dbReference type="PubMed" id="17182860"/>
<dbReference type="DOI" id="10.1091/mbc.E06-02-0142"/>
</citation>
<scope>INTERACTION WITH TNF2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2008" name="Cell. Signal." volume="20" first="1725" last="1739">
<title>Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking.</title>
<authorList>
<person name="Nonis D."/>
<person name="Schmidt M.H."/>
<person name="van de Loo S."/>
<person name="Eich F."/>
<person name="Dikic I."/>
<person name="Nowock J."/>
<person name="Auburger G."/>
</authorList>
<dbReference type="PubMed" id="18602463"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2008.05.018"/>
</citation>
<scope>INTERACTION WITH ATX2</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2008" name="EMBO J." volume="27" first="2305" last="2316">
<title>Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein.</title>
<authorList>
<person name="Brummer T."/>
<person name="Larance M."/>
<person name="Herrera Abreu M.T."/>
<person name="Lyons R.J."/>
<person name="Timpson P."/>
<person name="Emmerich C.H."/>
<person name="Fleuren E.D.G."/>
<person name="Lehrbach G.M."/>
<person name="Schramek D."/>
<person name="Guilhaus M."/>
<person name="James D.E."/>
<person name="Daly R.J."/>
</authorList>
<dbReference type="PubMed" id="19172738"/>
<dbReference type="DOI" id="10.1038/emboj.2008.159"/>
</citation>
<scope>INTERACTION WITH GAB2</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="56">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-695; SER-1064; SER-1081; SER-1166 AND TYR-1197</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="57">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-991; SER-995; TYR-998; SER-1039; THR-1041; SER-1042; SER-1064 AND SER-1166</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="58">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2009" name="Curr. Biol." volume="19" first="1788" last="1798">
<title>An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis.</title>
<authorList>
<person name="Tarcic G."/>
<person name="Boguslavsky S.K."/>
<person name="Wakim J."/>
<person name="Kiuchi T."/>
<person name="Liu A."/>
<person name="Reinitz F."/>
<person name="Nathanson D."/>
<person name="Takahashi T."/>
<person name="Mischel P.S."/>
<person name="Ng T."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="19836242"/>
<dbReference type="DOI" id="10.1016/j.cub.2009.09.048"/>
</citation>
<scope>ENZYME REGULATION BY PTPRJ AND PTPRK</scope>
<scope>PHOSPHORYLATION AT TYR-1197</scope>
<scope>DEPHOSPHORYLATION BY PTPRJ</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CBL AND GRB2</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="20206" last="20214">
<title>GAREM, a novel adaptor protein for growth factor receptor-bound protein 2, contributes to cellular transformation through the activation of extracellular signal-regulated kinase signaling.</title>
<authorList>
<person name="Tashiro K."/>
<person name="Tsunematsu T."/>
<person name="Okubo H."/>
<person name="Ohta T."/>
<person name="Sano E."/>
<person name="Yamauchi E."/>
<person name="Taniguchi H."/>
<person name="Konishi H."/>
</authorList>
<dbReference type="PubMed" id="19509291"/>
<dbReference type="DOI" id="10.1074/jbc.M109.021139"/>
</citation>
<scope>INTERACTION WITH GAREM1</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-352; ASN-413 AND ASN-568</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="62">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2009" name="Mol. Endocrinol." volume="23" first="1815" last="1826">
<title>G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells.</title>
<authorList>
<person name="Vivacqua A."/>
<person name="Lappano R."/>
<person name="De Marco P."/>
<person name="Sisci D."/>
<person name="Aquila S."/>
<person name="De Amicis F."/>
<person name="Fuqua S.A."/>
<person name="Ando S."/>
<person name="Maggiolini M."/>
</authorList>
<dbReference type="PubMed" id="19749156"/>
<dbReference type="DOI" id="10.1210/me.2009-0120"/>
</citation>
<scope>INTERACTION WITH GPER1</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2010" name="Biochem. Biophys. Res. Commun." volume="399" first="498" last="504">
<title>COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport.</title>
<authorList>
<person name="Wang Y.N."/>
<person name="Wang H."/>
<person name="Yamaguchi H."/>
<person name="Lee H.J."/>
<person name="Lee H.H."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="20674546"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.07.096"/>
</citation>
<scope>INTERACTION WITH COPG1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TOPOLOGY</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2010" name="Cancer Res." volume="70" first="6036" last="6046">
<title>Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts.</title>
<authorList>
<person name="Madeo A."/>
<person name="Maggiolini M."/>
</authorList>
<dbReference type="PubMed" id="20551055"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-10-0408"/>
</citation>
<scope>INTERACTION WITH GPER1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-991; SER-1064 AND TYR-1197</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="67">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="20558" last="20568">
<title>Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells.</title>
<authorList>
<person name="Huang W.C."/>
<person name="Chen Y.J."/>
<person name="Li L.Y."/>
<person name="Wei Y.L."/>
<person name="Hsu S.C."/>
<person name="Tsai S.L."/>
<person name="Chiu P.C."/>
<person name="Huang W.P."/>
<person name="Wang Y.N."/>
<person name="Chen C.H."/>
<person name="Chang W.C."/>
<person name="Chang W.C."/>
<person name="Chen A.J."/>
<person name="Tsai C.H."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="21487020"/>
<dbReference type="DOI" id="10.1074/jbc.M111.240796"/>
</citation>
<scope>PHOSPHORYLATION AT SER-229</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2011" name="Nat. Cell Biol." volume="13" first="174" last="181">
<title>Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation.</title>
<authorList>
<person name="Hsu J.M."/>
<person name="Chen C.T."/>
<person name="Chou C.K."/>
<person name="Kuo H.P."/>
<person name="Li L.Y."/>
<person name="Lin C.Y."/>
<person name="Lee H.J."/>
<person name="Wang Y.N."/>
<person name="Liu M."/>
<person name="Liao H.W."/>
<person name="Shi B."/>
<person name="Lai C.C."/>
<person name="Bedford M.T."/>
<person name="Tsai C.H."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="21258366"/>
<dbReference type="DOI" id="10.1038/ncb2158"/>
</citation>
<scope>FUNCTION IN CELL PROLIFERATION AND CELL MIGRATION</scope>
<scope>METHYLATION AT ARG-1199 BY PRMT5</scope>
<scope>INTERACTION WITH PRMT5 AND PTPN6</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2011" name="Nat. Med." volume="17" first="589" last="595">
<title>EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.</title>
<authorList>
<person name="Lupberger J."/>
<person name="Zeisel M.B."/>
<person name="Xiao F."/>
<person name="Thumann C."/>
<person name="Fofana I."/>
<person name="Zona L."/>
<person name="Davis C."/>
<person name="Mee C.J."/>
<person name="Turek M."/>
<person name="Gorke S."/>
<person name="Royer C."/>
<person name="Fischer B."/>
<person name="Zahid M.N."/>
<person name="Lavillette D."/>
<person name="Fresquet J."/>
<person name="Cosset F.L."/>
<person name="Rothenberg S.M."/>
<person name="Pietschmann T."/>
<person name="Patel A.H."/>
<person name="Pessaux P."/>
<person name="Doffoel M."/>
<person name="Raffelsberger W."/>
<person name="Poch O."/>
<person name="McKeating J.A."/>
<person name="Brino L."/>
<person name="Baumert T.F."/>
</authorList>
<dbReference type="PubMed" id="21516087"/>
<dbReference type="DOI" id="10.1038/nm.2341"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="7968" last="7973">
<title>FER tyrosine kinase (FER) overexpression mediates resistance to quinacrine through EGF-dependent activation of NF-kappaB.</title>
<authorList>
<person name="Guo C."/>
<person name="Stark G.R."/>
</authorList>
<dbReference type="PubMed" id="21518868"/>
<dbReference type="DOI" id="10.1073/pnas.1105369108"/>
</citation>
<scope>INTERACTION WITH FER</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2012" name="Mol. Biol. Cell" volume="23" first="1343" last="1353">
<title>The Ankrd 13 family of UIM-bearing proteins regulates EGF receptor endocytosis from the plasma membrane.</title>
<authorList>
<person name="Tanno H."/>
<person name="Yamaguchi T."/>
<person name="Goto E."/>
<person name="Ishido S."/>
<person name="Komada M."/>
</authorList>
<dbReference type="PubMed" id="22298428"/>
<dbReference type="DOI" id="10.1091/mbc.E11-09-0817"/>
</citation>
<scope>INTERACTION WITH ANKRD13A; ANKRD13B AND ALKRD13D</scope>
<scope>UBIQUITINATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2012" name="Oncogene" volume="31" first="4599" last="4608">
<title>Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression.</title>
<authorList>
<person name="Pareja F."/>
<person name="Ferraro D.A."/>
<person name="Rubin C."/>
<person name="Cohen-Dvashi H."/>
<person name="Zhang F."/>
<person name="Aulmann S."/>
<person name="Ben-Chetrit N."/>
<person name="Pines G."/>
<person name="Navon R."/>
<person name="Crosetto N."/>
<person name="Kostler W."/>
<person name="Carvalho S."/>
<person name="Lavi S."/>
<person name="Schmitt F."/>
<person name="Dikic I."/>
<person name="Yakhini Z."/>
<person name="Sinn P."/>
<person name="Mills G.B."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="22179831"/>
<dbReference type="DOI" id="10.1038/onc.2011.587"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY OTUD7B</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2013" name="J. Cell Sci." volume="126" first="1366" last="1380">
<title>The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal sorting of the epidermal growth factor receptor.</title>
<authorList>
<person name="Smith C.J."/>
<person name="Berry D.M."/>
<person name="McGlade C.J."/>
</authorList>
<dbReference type="PubMed" id="23418353"/>
<dbReference type="DOI" id="10.1242/jcs.116129"/>
</citation>
<scope>INTERACTION WITH RNF115 AND RNF126</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693 AND SER-1064</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="76">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-991; SER-1026 AND SER-1166</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="77">
<citation type="journal article" date="2014" name="Mol. Cancer" volume="13" first="233" last="233">
<title>EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancer.</title>
<authorList>
<person name="Lin X."/>
<person name="Zhong S."/>
<person name="Ye X."/>
<person name="Liao Y."/>
<person name="Yao F."/>
<person name="Yang X."/>
<person name="Sun B."/>
<person name="Zhang J."/>
<person name="Li Q."/>
<person name="Gao Y."/>
<person name="Wang Y."/>
<person name="Liu J."/>
<person name="Han B."/>
<person name="Chin Y.E."/>
<person name="Zhou B.P."/>
<person name="Deng J."/>
</authorList>
<dbReference type="PubMed" id="25311788"/>
<dbReference type="DOI" id="10.1186/1476-4598-13-233"/>
</citation>
<scope>INTERACTION WITH GPRC5A</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2014" name="Oncogene" volume="33" first="3298" last="3306">
<title>Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B.</title>
<authorList>
<person name="Cipriano R."/>
<person name="Bryson B.L."/>
<person name="Miskimen K.L."/>
<person name="Bartel C.A."/>
<person name="Hernandez-Sanchez W."/>
<person name="Bruntz R.C."/>
<person name="Scott S.A."/>
<person name="Lindsley C.W."/>
<person name="Brown H.A."/>
<person name="Jackson M.W."/>
</authorList>
<dbReference type="PubMed" id="23912460"/>
<dbReference type="DOI" id="10.1038/onc.2013.293"/>
</citation>
<scope>INTERACTION WITH FAM83B</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2017" name="Gene" volume="626" first="48" last="53">
<title>Beclin1 antagonizes LAPTM4B-mediated EGFR overactivation in gastric cancer cells.</title>
<authorList>
<person name="Tian M."/>
<person name="Chen Y."/>
<person name="Tian D."/>
<person name="Qiao X."/>
<person name="Ma Z."/>
<person name="Li J."/>
</authorList>
<dbReference type="PubMed" id="28479384"/>
<dbReference type="DOI" id="10.1016/j.gene.2017.05.006"/>
</citation>
<scope>INTERACTION WITH LAPTM4B</scope>
</reference>
<reference key="80">
<citation type="journal article" date="2002" name="Cell" volume="110" first="775" last="787">
<title>Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.</title>
<authorList>
<person name="Ogiso H."/>
<person name="Ishitani R."/>
<person name="Nureki O."/>
<person name="Fukai S."/>
<person name="Yamanaka M."/>
<person name="Kim J.H."/>
<person name="Saito K."/>
<person name="Sakamoto A."/>
<person name="Inoue M."/>
<person name="Shirouzu M."/>
<person name="Yokoyama S."/>
</authorList>
<dbReference type="PubMed" id="12297050"/>
<dbReference type="DOI" id="10.1016/S0092-8674(02)00963-7"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 25-646 IN COMPLEX WITH EGF</scope>
<scope>FUNCTION IN MAPK1 AND/OR MAPK3 ACTIVATION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TYR-275; PHE-287; ARG-309 AND ARG-429</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-56; ASN-175; ASN-196; ASN-352; ASN-361 AND ASN-444</scope>
</reference>
<reference key="81">
<citation type="journal article" date="2003" name="Mol. Cell" volume="11" first="507" last="517">
<title>EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.</title>
<authorList>
<person name="Ferguson K.M."/>
<person name="Berger M.B."/>
<person name="Mendrola J.M."/>
<person name="Cho H.S."/>
<person name="Leahy D.J."/>
<person name="Lemmon M.A."/>
</authorList>
<dbReference type="PubMed" id="12620237"/>
<dbReference type="DOI" id="10.1016/S1097-2765(03)00047-9"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 25-642 IN COMPLEX WITH EGF</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF 587-ASP--HIS-590 AND LYS-609</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-352; ASN-361; ASN-444; ASN-528; ASN-568 AND ASN-603</scope>
</reference>
<reference key="82">
<citation type="journal article" date="2004" name="Cancer Res." volume="64" first="6652" last="6659">
<title>A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells.</title>
<authorList>
<person name="Wood E.R."/>
<person name="Truesdale A.T."/>
<person name="McDonald O.B."/>
<person name="Yuan D."/>
<person name="Hassell A."/>
<person name="Dickerson S.H."/>
<person name="Ellis B."/>
<person name="Pennisi C."/>
<person name="Horne E."/>
<person name="Lackey K."/>
<person name="Alligood K.J."/>
<person name="Rusnak D.W."/>
<person name="Gilmer T.M."/>
<person name="Shewchuk L."/>
</authorList>
<dbReference type="PubMed" id="15374980"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-04-1168"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 695-1022 IN COMPLEX WITH GW572016</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="83">
<citation type="journal article" date="2005" name="Cancer Cell" volume="7" first="301" last="311">
<title>Structural basis for inhibition of the epidermal growth factor receptor by cetuximab.</title>
<authorList>
<person name="Li S."/>
<person name="Schmitz K.R."/>
<person name="Jeffrey P.D."/>
<person name="Wiltzius J.J."/>
<person name="Kussie P."/>
<person name="Ferguson K.M."/>
</authorList>
<dbReference type="PubMed" id="15837620"/>
<dbReference type="DOI" id="10.1016/j.ccr.2005.03.003"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 25-642 IN COMPLEX WITH CETUXIMAB</scope>
</reference>
<reference key="84">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="24043" last="24052">
<title>A structural model for the membrane-bound form of the juxtamembrane domain of the epidermal growth factor receptor.</title>
<authorList>
<person name="Choowongkomon K."/>
<person name="Carlin C.R."/>
<person name="Sonnichsen F.D."/>
</authorList>
<dbReference type="PubMed" id="15840573"/>
<dbReference type="DOI" id="10.1074/jbc.M502698200"/>
</citation>
<scope>STRUCTURE BY NMR OF 669-721</scope>
</reference>
<reference key="85">
<citation type="journal article" date="2007" name="Cancer Cell" volume="11" first="217" last="227">
<title>Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity.</title>
<authorList>
<person name="Yun C.H."/>
<person name="Boggon T.J."/>
<person name="Li Y."/>
<person name="Woo M.S."/>
<person name="Greulich H."/>
<person name="Meyerson M."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="17349580"/>
<dbReference type="DOI" id="10.1016/j.ccr.2006.12.017"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.47 ANGSTROMS) OF 696-1022 OF WILD-TYPE AND VARIANTS SER-719 AND ARG-858 IN COMPLEXES WITH ATP ANALOGS AND SYNTHETIC INHIBITORS</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>CHARACTERIZATION OF VARIANTS SER-719 AND ARG-858</scope>
</reference>
<reference key="86">
<citation type="journal article" date="2007" name="Nature" volume="450" first="741" last="744">
<title>Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface.</title>
<authorList>
<person name="Zhang X."/>
<person name="Pickin K.A."/>
<person name="Bose R."/>
<person name="Jura N."/>
<person name="Cole P.A."/>
<person name="Kuriyan J."/>
</authorList>
<dbReference type="PubMed" id="18046415"/>
<dbReference type="DOI" id="10.1038/nature05998"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 702-1022 IN COMPLEX WITH ERRFI1</scope>
<scope>ENZYME REGULATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH ERRFI1</scope>
</reference>
<reference key="87">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="2070" last="2075">
<title>The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP.</title>
<authorList>
<person name="Yun C.H."/>
<person name="Mengwasser K.E."/>
<person name="Toms A.V."/>
<person name="Woo M.S."/>
<person name="Greulich H."/>
<person name="Wong K.K."/>
<person name="Meyerson M."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="18227510"/>
<dbReference type="DOI" id="10.1073/pnas.0709662105"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.05 ANGSTROMS) OF 695-1022 OF VARIANT MET-790</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>CHARACTERIZATION OF VARIANT MET-790</scope>
</reference>
<reference key="88">
<citation type="journal article" date="2009" name="Cell" volume="137" first="1293" last="1307">
<title>Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment.</title>
<authorList>
<person name="Jura N."/>
<person name="Endres N.F."/>
<person name="Engel K."/>
<person name="Deindl S."/>
<person name="Das R."/>
<person name="Lamers M.H."/>
<person name="Wemmer D.E."/>
<person name="Zhang X."/>
<person name="Kuriyan J."/>
</authorList>
<dbReference type="PubMed" id="19563760"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.04.025"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.96 ANGSTROMS) OF 696-1022</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PHOSPHORYLATION AT TYR-998; TYR-1016 AND TYR-1197</scope>
<scope>MUTAGENESIS OF LEU-688; GLU-690; LEU-692; ARG-977 AND 1005-GLU-ASP-1006</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="89">
<citation type="journal article" date="2009" name="Mol. Cell" volume="34" first="641" last="651">
<title>The juxtamembrane region of the EGF receptor functions as an activation domain.</title>
<authorList>
<person name="Red Brewer M."/>
<person name="Choi S.H."/>
<person name="Alvarado D."/>
<person name="Moravcevic K."/>
<person name="Pozzi A."/>
<person name="Lemmon M.A."/>
<person name="Carpenter G."/>
</authorList>
<dbReference type="PubMed" id="19560417"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.04.034"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 669-1022 OF MUTANT MET-745</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF LEU-688; VAL-689; GLU-690; LEU-692; THR-693; PRO-694; PRO-699; ASN-700; LEU-704; ARG-705; ILE-706 AND LYS-745</scope>
</reference>
<reference key="90">
<citation type="journal article" date="2010" name="J. Mol. Biol." volume="400" first="231" last="243">
<title>Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases.</title>
<authorList>
<person name="Mineev K.S."/>
<person name="Bocharov E.V."/>
<person name="Pustovalova Y.E."/>
<person name="Bocharova O.V."/>
<person name="Chupin V.V."/>
<person name="Arseniev A.S."/>
</authorList>
<dbReference type="PubMed" id="20471394"/>
<dbReference type="DOI" id="10.1016/j.jmb.2010.05.016"/>
</citation>
<scope>STRUCTURE BY NMR OF 634-677 IN COMPLEX WITH ERBB2</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="91">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="5432" last="5443">
<title>Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor.</title>
<authorList>
<person name="Lu C."/>
<person name="Mi L.Z."/>
<person name="Grey M.J."/>
<person name="Zhu J."/>
<person name="Graef E."/>
<person name="Yokoyama S."/>
<person name="Springer T.A."/>
</authorList>
<dbReference type="PubMed" id="20837704"/>
<dbReference type="DOI" id="10.1128/MCB.00742-10"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 25-638 IN COMPLEX WITH EGF</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-56; ASN-73; ASN-175; ASN-196; ASN-352; ASN-361; ASN-444 AND ASN-528</scope>
</reference>
<reference key="92">
<citation type="submission" date="2010-10" db="PDB data bank">
<title>Crystal structure of Cbl-b TKB domain in complex with EGFR pY1069 peptide.</title>
<authorList>
<consortium name="Structural genomics consortium"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.27 ANGSTROMS) OF 1066-1076 IN COMPLEX WITH CBLB</scope>
<scope>INTERACTION WITH CBLB</scope>
</reference>
<reference key="93">
<citation type="journal article" date="2012" name="J. Biochem." volume="152" first="487" last="495">
<title>Structural flexibility regulates phosphopeptide-binding activity of the tyrosine kinase binding domain of Cbl-c.</title>
<authorList>
<person name="Takeshita K."/>
<person name="Tezuka T."/>
<person name="Isozaki Y."/>
<person name="Yamashita E."/>
<person name="Suzuki M."/>
<person name="Kim M."/>
<person name="Yamanashi Y."/>
<person name="Yamamoto T."/>
<person name="Nakagawa A."/>
</authorList>
<dbReference type="PubMed" id="22888118"/>
<dbReference type="DOI" id="10.1093/jb/mvs085"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.52 ANGSTROMS) OF 1062-1074 IN COMPLEX WITH CBLC</scope>
<scope>PHOSPHORYLATION AT TYR-1069</scope>
<scope>INTERACTION WITH CBLC</scope>
<scope>MUTAGENESIS OF GLN-1067; ARG-1068 AND TYR-1069</scope>
</reference>
<reference key="94">
<citation type="journal article" date="2004" name="Clin. Cancer Res." volume="10" first="8195" last="8203">
<title>High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan.</title>
<authorList>
<person name="Huang S.F."/>
<person name="Liu H.P."/>
<person name="Li L.H."/>
<person name="Ku Y.C."/>
<person name="Fu Y.N."/>
<person name="Tsai H.Y."/>
<person name="Chen Y.T."/>
<person name="Lin Y.F."/>
<person name="Chang W.C."/>
<person name="Kuo H.P."/>
<person name="Wu Y.C."/>
<person name="Chen Y.R."/>
<person name="Tsai S.F."/>
</authorList>
<dbReference type="PubMed" id="15623594"/>
<dbReference type="DOI" id="10.1158/1078-0432.CCR-04-1245"/>
</citation>
<scope>VARIANTS ALA-709; GLY-709; CYS-719; SER-719; 746-GLU--ALA-750 DEL; 746-GLU--THR-751 DELINS ALA; 746-GLU--SER-752 DELINS ASP; 747-LEU--THR-751 DEL; ILE-768; MET-769; VAL-833; LEU-835; VAL-838; ARG-858 AND GLN-861</scope>
</reference>
<reference key="95">
<citation type="journal article" date="2004" name="Science" volume="304" first="1497" last="1500">
<title>EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.</title>
<authorList>
<person name="Paez J.G."/>
<person name="Janne P.A."/>
<person name="Lee J.C."/>
<person name="Tracy S."/>
<person name="Greulich H."/>
<person name="Gabriel S."/>
<person name="Herman P."/>
<person name="Kaye F.J."/>
<person name="Lindeman N."/>
<person name="Boggon T.J."/>
<person name="Naoki K."/>
<person name="Sasaki H."/>
<person name="Fujii Y."/>
<person name="Eck M.J."/>
<person name="Sellers W.R."/>
<person name="Johnson B.E."/>
<person name="Meyerson M."/>
</authorList>
<dbReference type="PubMed" id="15118125"/>
<dbReference type="DOI" id="10.1126/science.1099314"/>
</citation>
<scope>VARIANTS SER-719 AND ARG-858</scope>
<scope>POSSIBLE INVOLVEMENT IN LUNG CANCER</scope>
</reference>
<reference key="96">
<citation type="journal article" date="2006" name="Clin. Cancer Res." volume="12" first="1647" last="1653">
<title>Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.</title>
<authorList>
<person name="Tam I.Y.S."/>
<person name="Chung L.P."/>
<person name="Suen W.S."/>
<person name="Wang E."/>
<person name="Wong M.C.M."/>
<person name="Ho K.K."/>
<person name="Lam W.K."/>
<person name="Chiu S.W."/>
<person name="Girard L."/>
<person name="Minna J.D."/>
<person name="Gazdar A.F."/>
<person name="Wong M.P."/>
</authorList>
<dbReference type="PubMed" id="16533793"/>
<dbReference type="DOI" id="10.1158/1078-0432.CCR-05-1981"/>
</citation>
<scope>VARIANTS ALA-709; LYS-709; ALA-719; ASP-719; CYS-719; SER-719; SER-724; LYS-734; GLU-746 DEL; PHE-747; 747-LEU--GLU-749 DEL; PRO-748; 752-SER--ILE-759 DEL; ARG-787; MET-790; VAL-833; LEU-834; MET-858; ARG-858; GLN-861 AND GLU-873</scope>
<scope>POSSIBLE INVOLVEMENT IN LUNG CANCER</scope>
</reference>
<reference key="97">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="1205" last="1215">
<title>Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants.</title>
<authorList>
<person name="Chen Y.R."/>
<person name="Fu Y.N."/>
<person name="Lin C.H."/>
<person name="Yang S.T."/>
<person name="Hu S.F."/>
<person name="Chen Y.T."/>
<person name="Tsai S.F."/>
<person name="Huang S.F."/>
</authorList>
<dbReference type="PubMed" id="16205628"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209159"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS ALA-709; GLY-709; SER-719; ILE-768; VAL-833; LEU-835; VAL-838; ARG-858 AND GLN-861</scope>
</reference>
<reference key="98">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="7817" last="7822">
<title>Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors.</title>
<authorList>
<person name="Ji H."/>
<person name="Zhao X."/>
<person name="Yuza Y."/>
<person name="Shimamura T."/>
<person name="Li D."/>
<person name="Protopopov A."/>
<person name="Jung B.L."/>
<person name="McNamara K."/>
<person name="Xia H."/>
<person name="Glatt K.A."/>
<person name="Thomas R.K."/>
<person name="Sasaki H."/>
<person name="Horner J.W."/>
<person name="Eck M."/>
<person name="Mitchell A."/>
<person name="Sun Y."/>
<person name="Al-Hashem R."/>
<person name="Bronson R.T."/>
<person name="Rabindran S.K."/>
<person name="Discafani C.M."/>
<person name="Maher E."/>
<person name="Shapiro G.I."/>
<person name="Meyerson M."/>
<person name="Wong K.K."/>
</authorList>
<dbReference type="PubMed" id="16672372"/>
<dbReference type="DOI" id="10.1073/pnas.0510284103"/>
</citation>
<scope>VARIANT 30-VAL--ARG-297 DEL</scope>
<scope>POSSIBLE INVOLVEMENT IN LUNG CANCER</scope>
</reference>
<reference key="99">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] LYS-521; ARG-1034 AND VAL-1210</scope>
</reference>
<reference key="100">
<citation type="journal article" date="2014" name="J. Invest. Dermatol." volume="134" first="2570" last="2578">
<title>Epithelial inflammation resulting from an inherited loss-of-function mutation in EGFR.</title>
<authorList>
<person name="Campbell P."/>
<person name="Morton P.E."/>
<person name="Takeichi T."/>
<person name="Salam A."/>
<person name="Roberts N."/>
<person name="Proudfoot L.E."/>
<person name="Mellerio J.E."/>
<person name="Aminu K."/>
<person name="Wellington C."/>
<person name="Patil S.N."/>
<person name="Akiyama M."/>
<person name="Liu L."/>
<person name="McMillan J.R."/>
<person name="Aristodemou S."/>
<person name="Ishida-Yamamoto A."/>
<person name="Abdul-Wahab A."/>
<person name="Petrof G."/>
<person name="Fong K."/>
<person name="Harnchoowong S."/>
<person name="Stone K.L."/>
<person name="Harper J.I."/>
<person name="McLean W.H."/>
<person name="Simpson M.A."/>
<person name="Parsons M."/>
<person name="McGrath J.A."/>
</authorList>
<dbReference type="PubMed" id="24691054"/>
<dbReference type="DOI" id="10.1038/jid.2014.164"/>
</citation>
<scope>VARIANT NISBD2 ASP-428</scope>
<scope>CHARACTERIZATION OF VARIANT NISBD2 ASP-428</scope>
<scope>INVOLVEMENT IN NISBD2</scope>
</reference>
<comment type="function">
<text evidence="33">Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. Known ligands include EGF, TGFA/TGF-alpha, amphiregulin, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF. Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules. May also activate the NF-kappa-B signaling cascade. Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling. Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin. Plays a role in enhancing learning and memory performance (By similarity).</text>
</comment>
<comment type="function">
<text>Isoform 2 may act as an antagonist of EGF action.</text>
</comment>
<comment type="function">
<text evidence="82">(Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry. Mediates HCV entry by promoting the formation of the CD81-CLDN1 receptor complexes that are essential for HCV entry and by enhancing membrane fusion of cells expressing HCV envelope glycoproteins.</text>
</comment>
<comment type="catalytic activity">
<text evidence="36 51 64 66 67 72 73">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="49 52 66 75">Endocytosis and inhibition of the activated EGFR by phosphatases like PTPRJ and PTPRK constitute immediate regulatory mechanisms. Upon EGF-binding phosphorylates EPS15 that regulates EGFR endocytosis and activity. Moreover, inducible feedback inhibitors including LRIG1, SOCS4, SOCS5 and ERRFI1 constitute alternative regulatory mechanisms for the EGFR signaling.</text>
</comment>
<comment type="subunit">
<text evidence="37 38 41 42 43 44 45 47 49 51 52 54 56 61 62 66 68 70 71 72 73 74 75 76 77 78 79 80 83 85 86 87 88 90 92 94 95 97 100">Binding of the ligand triggers homo- and/or heterodimerization of the receptor triggering its autophosphorylation. Heterodimer with ERBB2. Interacts with ERRFI1; inhibits dimerization of the kinase domain and autophosphorylation. Part of a complex with ERBB2 and either PIK3C2A or PIK3C2B. Interacts with GRB2; an adapter protein coupling the receptor to downstream signaling pathways. Interacts with GAB2; involved in signaling downstream of EGFR. Interacts with STAT3; mediates EGFR downstream signaling in cell proliferation. Interacts with RIPK1; involved in NF-kappa-B activation. Interacts (autophosphorylated) with CBL, CBLB and CBLC; involved in EGFR ubiquitination and regulation. Interacts with SOCS5; regulates EGFR degradation through ELOC- and ELOB-mediated ubiquitination and proteasomal degradation. Interacts with PRMT5; methylates EGFR and enhances interaction with PTPN6. Interacts (phosphorylated) with PTPN6; inhibits EGFR-dependent activation of MAPK/ERK. Interacts with COPG1; essential for regulation of EGF-dependent nuclear transport of EGFR by retrograde trafficking from the Golgi to the ER. Interacts with TNK2; this interaction is dependent on EGF stimulation and kinase activity of EGFR. Interacts with PCNA; positively regulates PCNA. Interacts with PELP1. Interacts with MUC1. Interacts with AP2M1. Interacts with FER. May interact with EPS8; mediates EPS8 phosphorylation. Interacts (via SH2 domains) with GRB2, NCK1 and NCK2. Interacts with ATX2. Interacts with GAREM1. Interacts (ubiquitinated) with ANKRD13A/B/D; the interaction is direct and may regulate EGFR internalization after EGF stimulation. Interacts with GPER1; the interaction occurs in an estrogen-dependent manner. Interacts (via C-terminal cytoplasmic kinase domain) with ZPR1 (via zinc fingers). Interacts with RNF115 and RNF126. Interacts with GPRC5A (via its transmembrane domain)(PubMed:25311788). Interacts with FAM83B; positively regulates EGFR inducing its autophospharylation in absence of stimulation by EGF (PubMed:23912460). Interacts with LAPTM4B; positively correlates with EGFR activation (PubMed:28479384).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-297353"/>
<organismsDiffer>false</organismsDiffer>
<experiments>30</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-9356749">
<id>Q53FC7</id>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-9356686">
<id>Q96BE0</id>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-375543">
<id>P00519</id>
<label>ABL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1102694">
<id>P42684</id>
<label>ABL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1646426">
<id>Q15109</id>
<label>AGER</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-528269">
<id>Q9UKV8</id>
<label>AGO2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2555881">
<id>Q09666</id>
<label>AHNAK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2562430">
<id>Q02952</id>
<label>AKAP12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1048612">
<id>Q92625</id>
<label>ANKS1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-297683">
<id>Q96CW1</id>
<label>AP2M1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-81694">
<id>O00213</id>
<label>APBB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-79277">
<id>Q92870</id>
<label>APBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-286427">
<id>O95704</id>
<label>APBB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-741243">
<id>Q9UKG1</id>
<label>APPL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-448680">
<id>O14965</id>
<label>AURKA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2850927">
<id>P30530</id>
<label>AXL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-949378">
<id>Q14457</id>
<label>BECN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2105445">
<id>P51451</id>
<label>BLK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-397435">
<id>P62158</id>
<label>CALM3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-397530">
<id>P62161</id>
<label>Calm3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1748958">
<id>P49069</id>
<label>CAMLG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-603614">
<id>Q03135</id>
<label>CAV1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-518228">
<id>P22681</id>
<label>CBL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-640919">
<id>P22682</id>
<label>Cbl</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-295634">
<id>Q16543</id>
<label>CDC37</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-727477">
<id>P12830</id>
<label>CDH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-617866">
<id>Q9NSE2</id>
<label>CISH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-7878194">
<id>Q7Z7G1</id>
<label>CLNK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-886">
<id>P46108</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-287556">
<id>P46108-1</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-910">
<id>P46109</id>
<label>CRKL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-701918">
<id>P35221</id>
<label>CTNNA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-701927">
<id>O60716</id>
<label>CTNND1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-351886">
<id>Q14247</id>
<label>CTTN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-448974">
<id>Q99418</id>
<label>CYTH2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2880244">
<id>Q6PKX4</id>
<label>DOK6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-640857">
<id>P01133</id>
<label>EGF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-375576">
<id>Q12929</id>
<label>EPS8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>25</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-720706">
<id>P21860</id>
<label>ERBB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-80371">
<id>Q15303</id>
<label>ERBB4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-750962">
<id>P07992</id>
<label>ERCC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>21</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2941912">
<id>Q9UJM3</id>
<label>ERRFI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-4309277">
<id>P03372-4</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-355383">
<id>Q96A65</id>
<label>EXOC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1383732">
<id>P09769</id>
<label>FGR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-724839">
<id>Q14318</id>
<label>FKBP8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-517684">
<id>Q13480</id>
<label>GAB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-720116">
<id>P60520</id>
<label>GABARAPL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-354056">
<id>P04406</id>
<label>GAPDH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-7250369">
<id>Q14956</id>
<label>GPNMB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-16191078">
<id>Q14956-1</id>
<label>GPNMB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-740418">
<id>O75791</id>
<label>GRAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>36</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-346340">
<id>P08631</id>
<label>HCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-301697">
<id>Q9UBN7</id>
<label>HDAC6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1048378">
<id>Q8WUI4</id>
<label>HDAC7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-296047">
<id>P07900</id>
<label>HSP90AA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-9356629">
<id>Q6PK50</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-629985">
<id>P08107</id>
<label>HSPA1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-351896">
<id>P11142</id>
<label>HSPA8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-354932">
<id>P38646</id>
<label>HSPA9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-352682">
<id>P04792</id>
<label>HSPB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-715709">
<id>P17936</id>
<label>IGFBP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-297509">
<id>P46940</id>
<label>IQGAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-356594">
<id>O14654</id>
<label>IRS4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-3267258">
<id>Q86VI4</id>
<label>LAPTM4B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1222766">
<id>O43561</id>
<label>LAT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-346946">
<id>Q13094</id>
<label>LCP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-719955">
<id>Q96FE5</id>
<label>LINGO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1050422">
<id>Q38SD2</id>
<label>LRRK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-79452">
<id>P07948</id>
<label>LYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-6895930">
<id>P07948-1</id>
<label>LYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-78404">
<id>Q9UQF2</id>
<label>MAPK8IP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-722813">
<id>Q13387</id>
<label>MAPK8IP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-3385920">
<id>Q9Y2H9</id>
<label>MAST1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1039152">
<id>P08581</id>
<label>MET</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-372712">
<id>P14174</id>
<label>MIF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2804728">
<id>P15941</id>
<label>MUC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-389883">
<id>P16333</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-493507">
<id>P04150</id>
<label>NR3C1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2861522">
<id>P16234</id>
<label>PDGFRA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-641107">
<id>O00750</id>
<label>PIK3C2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-346930">
<id>O00459</id>
<label>PIK3R2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-79893">
<id>Q92569</id>
<label>PIK3R3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-617403">
<id>P16885</id>
<label>PLCG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1383528">
<id>P17252</id>
<label>PRKCA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2272005">
<id>P97313</id>
<label>Prkdc</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-702142">
<id>Q05397</id>
<label>PTK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-968788">
<id>P18031</id>
<label>PTPN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-916819">
<id>P20417</id>
<label>Ptpn1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2266035">
<id>Q05209</id>
<label>PTPN12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1211241">
<id>Q9Y2R2</id>
<label>PTPN22</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-913954">
<id>Q9UJ41</id>
<label>RABGEF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-3940924">
<id>Q70E73</id>
<label>RAPH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1026476">
<id>P20936</id>
<label>RASA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-366017">
<id>Q13671</id>
<label>RIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-6082337">
<id>Q01973</id>
<label>ROR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2952709">
<id>Q92622</id>
<label>RUBCN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-3506572">
<id>Q80U62</id>
<label>Rubcn</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-476295">
<id>P31947</id>
<label>SFN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-310491">
<id>Q9NRF2</id>
<label>SH2B1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-7879749">
<id>Q9UQQ2</id>
<label>SH2B3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2339271">
<id>Q9BRG2</id>
<label>SH2D3A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-78835">
<id>P29353</id>
<label>SHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>28</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-9691288">
<id>P29353-7</id>
<label>SHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-7256023">
<id>P98077</id>
<label>SHC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-9453524">
<id>Q6S5L8</id>
<label>SHC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-726214">
<id>Q13239</id>
<label>SLA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1772443">
<id>P13866</id>
<label>SLC5A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1057697">
<id>P42224</id>
<label>STAT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-518675">
<id>P40763</id>
<label>STAT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-749537">
<id>P42229</id>
<label>STAT5A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1054052">
<id>P31948</id>
<label>STIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-357085">
<id>Q9UNE7</id>
<label>STUB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-78302">
<id>P43405</id>
<label>SYK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1034374">
<id>P01135</id>
<label>TGFA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2462036">
<id>Q9Y490</id>
<label>TLN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-973722">
<id>O60603</id>
<label>TLR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1220488">
<id>Q68CZ2</id>
<label>TNS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-712991">
<id>O75674</id>
<label>TOM1L1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-355744">
<id>Q12933</id>
<label>TRAF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2650739">
<id>Q8K424</id>
<label>Trpv3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-302552">
<id>Q71U36</id>
<label>TUBA1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-594644">
<id>P10599</id>
<label>TXN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-714860">
<id>P09936</id>
<label>UCHL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1059156">
<id>Q9P0L0</id>
<label>VAPA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-515331">
<id>P07947</id>
<label>YES1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-359854">
<id>P27348</id>
<label>YWHAQ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1211276">
<id>P43403</id>
<label>ZAP70</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Endoplasmic reticulum membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Golgi apparatus membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Endosome</location>
</subcellularLocation>
<subcellularLocation>
<location>Endosome membrane</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>In response to EGF, translocated from the cell membrane to the nucleus via Golgi and ER. Endocytosed upon activation by ligand. Colocalized with GPER1 in the nucleus of estrogen agonist-induced cancer-associated fibroblasts (CAF).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P00533-1</id>
<name>1</name>
<name>p170</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P00533-2</id>
<name>2</name>
<name>p60</name>
<name>Truncated</name>
<name>TEGFR</name>
<sequence type="described" ref="VSP_002887 VSP_002888"/>
</isoform>
<isoform>
<id>P00533-3</id>
<name>3</name>
<name>p110</name>
<sequence type="described" ref="VSP_002889 VSP_002890"/>
</isoform>
<isoform>
<id>P00533-4</id>
<name>4</name>
<sequence type="described" ref="VSP_002891 VSP_002892"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="65">Ubiquitously expressed. Isoform 2 is also expressed in ovarian cancers.</text>
</comment>
<comment type="PTM">
<text evidence="39 47 55 73 75 80 91 93">Phosphorylation at Ser-695 is partial and occurs only if Thr-693 is phosphorylated. Phosphorylation at Thr-678 and Thr-693 by PRKD1 inhibits EGF-induced MAPK8/JNK1 activation. Dephosphorylation by PTPRJ prevents endocytosis and stabilizes the receptor at the plasma membrane. Autophosphorylation at Tyr-1197 is stimulated by methylation at Arg-1199 and enhances interaction with PTPN6. Autophosphorylation at Tyr-1092 and/or Tyr-1110 recruits STAT3. Dephosphorylated by PTPN1 and PTPN2.</text>
</comment>
<comment type="PTM">
<text evidence="33 59 84 85">Monoubiquitinated and polyubiquitinated upon EGF stimulation; which does not affect tyrosine kinase activity or signaling capacity but may play a role in lysosomal targeting. Polyubiquitin linkage is mainly through 'Lys-63', but linkage through 'Lys-48', 'Lys-11' and 'Lys-29' also occurs. Deubiquitination by OTUD7B prevents degradation. Ubiquitinated by RNF115 and RNF126 (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="73 75 80">Methylated. Methylation at Arg-1199 by PRMT5 stimulates phosphorylation at Tyr-1197.</text>
</comment>
<comment type="disease" evidence="48 58 60">
<disease id="DI-02205">
<name>Lung cancer</name>
<acronym>LNCR</acronym>
<description>A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis.</description>
<dbReference type="MIM" id="211980"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="89">
<disease id="DI-04271">
<name>Inflammatory skin and bowel disease, neonatal, 2</name>
<acronym>NISBD2</acronym>
<description>A disorder characterized by inflammatory features with neonatal onset, involving the skin, hair, and gut. The skin lesions involve perioral and perianal erythema, psoriasiform erythroderma, with flares of erythema, scaling, and widespread pustules. Gastrointestinal symptoms include malabsorptive diarrhea that is exacerbated by intercurrent gastrointestinal infections. The hair is short or broken, and the eyelashes and eyebrows are wiry and disorganized.</description>
<dbReference type="MIM" id="616069"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="35">Belongs to the protein kinase superfamily. Tyr protein kinase family. EGF receptor subfamily.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/egfr/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Epidermal_growth_factor_receptor"/>
<text>EGFR entry</text>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="X00588">
<property type="protein sequence ID" value="CAA25240.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U95089">
<property type="protein sequence ID" value="AAB53063.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U48722">
<property type="protein sequence ID" value="AAC50802.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U48723">
<property type="protein sequence ID" value="AAC50804.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48724">
<property type="protein sequence ID" value="AAC50796.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48725">
<property type="protein sequence ID" value="AAC50797.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48726">
<property type="protein sequence ID" value="AAC50798.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48727">
<property type="protein sequence ID" value="AAC50799.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48728">
<property type="protein sequence ID" value="AAC50800.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48729">
<property type="protein sequence ID" value="AAC50801.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF288738">
<property type="protein sequence ID" value="AAG35786.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF288738">
<property type="protein sequence ID" value="AAG35787.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF288738">
<property type="protein sequence ID" value="AAG35788.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF288738">
<property type="protein sequence ID" value="AAG35789.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF288738">
<property type="protein sequence ID" value="AAG35790.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY698024">
<property type="protein sequence ID" value="AAT97979.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY588246">
<property type="protein sequence ID" value="AAS83109.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF277897">
<property type="protein sequence ID" value="AAK01080.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF125253">
<property type="protein sequence ID" value="AAG43240.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF125539">
<property type="protein sequence ID" value="AAG43243.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF125538">
<property type="protein sequence ID" value="AAG43243.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X06370">
<property type="protein sequence ID" value="CAA29668.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X00663">
<property type="protein sequence ID" value="CAA25282.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M38425">
<property type="protein sequence ID" value="AAA63171.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M11234">
<property type="protein sequence ID" value="AAA52370.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47587.1">
<molecule id="P00533-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5514.1">
<molecule id="P00533-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5515.1">
<molecule id="P00533-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5516.1">
<molecule id="P00533-4"/>
</dbReference>
<dbReference type="PIR" id="A00641">
<property type="entry name" value="GQHUE"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005219.2">
<molecule id="P00533-1"/>
<property type="nucleotide sequence ID" value="NM_005228.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_958439.1">
<molecule id="P00533-4"/>
<property type="nucleotide sequence ID" value="NM_201282.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_958440.1">
<molecule id="P00533-2"/>
<property type="nucleotide sequence ID" value="NM_201283.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_958441.1">
<molecule id="P00533-3"/>
<property type="nucleotide sequence ID" value="NM_201284.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.488293"/>
<dbReference type="UniGene" id="Hs.605083"/>
<dbReference type="UniGene" id="Hs.731652"/>
<dbReference type="PDB" id="1DNQ">
<property type="method" value="Model"/>
<property type="chains" value="A=25-336"/>
</dbReference>
<dbReference type="PDB" id="1DNR">
<property type="method" value="Model"/>
<property type="chains" value="A=337-645"/>
</dbReference>
<dbReference type="PDB" id="1IVO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B=25-646"/>
</dbReference>
<dbReference type="PDB" id="1M14">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="1M17">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="1MOX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=25-525"/>
</dbReference>
<dbReference type="PDB" id="1NQL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=25-642"/>
</dbReference>
<dbReference type="PDB" id="1XKK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="1YY9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=25-642"/>
</dbReference>
<dbReference type="PDB" id="1Z9I">
<property type="method" value="NMR"/>
<property type="chains" value="A=669-721"/>
</dbReference>
<dbReference type="PDB" id="2EB2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="2EB3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.84"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="2EXP">
<property type="method" value="Model"/>
<property type="chains" value="A=311-326"/>
</dbReference>
<dbReference type="PDB" id="2EXQ">
<property type="method" value="Model"/>
<property type="chains" value="A=27-536"/>
</dbReference>
<dbReference type="PDB" id="2GS2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2GS6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2GS7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.47"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.74"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.68"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.73"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.47"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.88"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.98"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITY">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.42"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.72"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2J5E">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2J5F">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2J6M">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2JIT">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2JIU">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.05"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="2JIV">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="2KS1">
<property type="method" value="NMR"/>
<property type="chains" value="B=634-677"/>
</dbReference>
<dbReference type="PDB" id="2M0B">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=634-677"/>
</dbReference>
<dbReference type="PDB" id="2M20">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=642-697"/>
</dbReference>
<dbReference type="PDB" id="2N5S">
<property type="method" value="NMR"/>
<property type="chains" value="A=642-690"/>
</dbReference>
<dbReference type="PDB" id="2RF9">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2RFD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="A/B=702-1022"/>
</dbReference>
<dbReference type="PDB" id="2RFE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C/D=702-1022"/>
</dbReference>
<dbReference type="PDB" id="2RGP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=702-1016"/>
</dbReference>
<dbReference type="PDB" id="3B2U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.58"/>
<property type="chains" value="A/B/E/I/M/P/S/V=335-538"/>
</dbReference>
<dbReference type="PDB" id="3B2V">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A=25-642"/>
</dbReference>
<dbReference type="PDB" id="3BEL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=702-1016"/>
</dbReference>
<dbReference type="PDB" id="3BUO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/C=1063-1075"/>
</dbReference>
<dbReference type="PDB" id="3C09">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/D=336-538"/>
</dbReference>
<dbReference type="PDB" id="3G5V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="C=311-326"/>
</dbReference>
<dbReference type="PDB" id="3G5Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.59"/>
<property type="chains" value="E=311-326"/>
</dbReference>
<dbReference type="PDB" id="3GOP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=669-1022"/>
</dbReference>
<dbReference type="PDB" id="3GT8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.96"/>
<property type="chains" value="A/B/C/D=696-1022"/>
</dbReference>
<dbReference type="PDB" id="3IKA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=694-1022"/>
</dbReference>
<dbReference type="PDB" id="3LZB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B/C/D/E/F/G/H=696-983"/>
</dbReference>
<dbReference type="PDB" id="3NJP">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B=25-638"/>
</dbReference>
<dbReference type="PDB" id="3OB2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1063-1074"/>
</dbReference>
<dbReference type="PDB" id="3OP0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.52"/>
<property type="chains" value="C/D=1066-1076"/>
</dbReference>
<dbReference type="PDB" id="3P0Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=334-538"/>
</dbReference>
<dbReference type="PDB" id="3PFV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.27"/>
<property type="chains" value="C/D=1066-1076"/>
</dbReference>
<dbReference type="PDB" id="3POZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="3QWQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A=1-642"/>
</dbReference>
<dbReference type="PDB" id="3UG1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="3UG2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="3VJN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.34"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="3VJO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.64"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="3VRP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.52"/>
<property type="chains" value="B=1062-1074"/>
</dbReference>
<dbReference type="PDB" id="3VRR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="C=1062-1074"/>
</dbReference>
<dbReference type="PDB" id="3W2O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A=698-1022"/>
</dbReference>
<dbReference type="PDB" id="3W2P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A=698-1022"/>
</dbReference>
<dbReference type="PDB" id="3W2Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=698-1022"/>
</dbReference>
<dbReference type="PDB" id="3W2R">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A=698-1022"/>
</dbReference>
<dbReference type="PDB" id="3W2S">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="3W32">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="3W33">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4G5J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4G5P">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.17"/>
<property type="chains" value="A/B=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4HJO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4I1Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4I20">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.34"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4I21">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.37"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4I22">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.71"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4I23">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4I24">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4JQ7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.73"/>
<property type="chains" value="A=696-1021"/>
</dbReference>
<dbReference type="PDB" id="4JQ8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.83"/>
<property type="chains" value="A=696-1021"/>
</dbReference>
<dbReference type="PDB" id="4JR3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=696-1021"/>
</dbReference>
<dbReference type="PDB" id="4JRV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1021"/>
</dbReference>
<dbReference type="PDB" id="4KRL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A=335-538"/>
</dbReference>
<dbReference type="PDB" id="4KRM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.66"/>
<property type="chains" value="A/C/E/G/I/K=335-538"/>
</dbReference>
<dbReference type="PDB" id="4KRO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.05"/>
<property type="chains" value="A=25-642"/>
</dbReference>
<dbReference type="PDB" id="4KRP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.82"/>
<property type="chains" value="A=25-642"/>
</dbReference>
<dbReference type="PDB" id="4LI5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.64"/>
<property type="chains" value="A=696-1020"/>
</dbReference>
<dbReference type="PDB" id="4LL0">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.00"/>
<property type="chains" value="A/B=694-1022"/>
</dbReference>
<dbReference type="PDB" id="4LQM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=694-1022"/>
</dbReference>
<dbReference type="PDB" id="4LRM">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.53"/>
<property type="chains" value="A/B/C/D/E=694-1022"/>
</dbReference>
<dbReference type="PDB" id="4R3P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=696-1018"/>
</dbReference>
<dbReference type="PDB" id="4R3R">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="A=696-1018"/>
</dbReference>
<dbReference type="PDB" id="4R5S">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4RIW">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="B/D=682-1022"/>
</dbReference>
<dbReference type="PDB" id="4RIX">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="B/D=682-1022"/>
</dbReference>
<dbReference type="PDB" id="4RIY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.98"/>
<property type="chains" value="B/D=682-1022"/>
</dbReference>
<dbReference type="PDB" id="4RJ4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.78"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4RJ5">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4RJ6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4RJ7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4RJ8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4TKS">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4UIP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A=26-637"/>
</dbReference>
<dbReference type="PDB" id="4UV7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=25-645"/>
</dbReference>
<dbReference type="PDB" id="4WD5">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B=694-1022"/>
</dbReference>
<dbReference type="PDB" id="4WKQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4WRG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4ZAU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4ZJV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4ZSE">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.97"/>
<property type="chains" value="A/B/C/D=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5C8K">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5C8M">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5C8N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.73"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CNN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=696-1042"/>
</dbReference>
<dbReference type="PDB" id="5CNO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A/B/X=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5CZH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=694-1022"/>
</dbReference>
<dbReference type="PDB" id="5CZI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=694-1022"/>
</dbReference>
<dbReference type="PDB" id="5D41">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EDP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EDQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EDR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EM5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EM6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.78"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EM7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.81"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EM8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5FED">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5FEE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5FEQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5GMP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5GNK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=696-988"/>
</dbReference>
<dbReference type="PDB" id="5GTY">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.14"/>
<property type="chains" value="A/B/C/D/E/F/G/H=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5GTZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5HCX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5HCY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.46"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5HCZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.62"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5HG5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.52"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5HG7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5HG8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.42"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5HG9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5HIB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5HIC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5J9Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=697-1019"/>
</dbReference>
<dbReference type="PDB" id="5J9Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=696-1020"/>
</dbReference>
<dbReference type="PDB" id="5JEB">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5LV6">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=634-677"/>
</dbReference>
<dbReference type="PDB" id="5SX4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="M/N=335-525"/>
</dbReference>
<dbReference type="PDB" id="5SX5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="M/N=335-525"/>
</dbReference>
<dbReference type="PDB" id="5U8L">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UG8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.46"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UG9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.33"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UGA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.82"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UGB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.53"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UGC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.58"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UWD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.06"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5WB7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.94"/>
<property type="chains" value="A/B/C/D=25-525"/>
</dbReference>
<dbReference type="PDB" id="5WB8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/D=25-525"/>
</dbReference>
<dbReference type="PDB" id="5XGM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5XGN">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=696-1022"/>
</dbReference>
<dbReference type="PDBsum" id="1DNQ"/>
<dbReference type="PDBsum" id="1DNR"/>
<dbReference type="PDBsum" id="1IVO"/>
<dbReference type="PDBsum" id="1M14"/>
<dbReference type="PDBsum" id="1M17"/>
<dbReference type="PDBsum" id="1MOX"/>
<dbReference type="PDBsum" id="1NQL"/>
<dbReference type="PDBsum" id="1XKK"/>
<dbReference type="PDBsum" id="1YY9"/>
<dbReference type="PDBsum" id="1Z9I"/>
<dbReference type="PDBsum" id="2EB2"/>
<dbReference type="PDBsum" id="2EB3"/>
<dbReference type="PDBsum" id="2EXP"/>
<dbReference type="PDBsum" id="2EXQ"/>
<dbReference type="PDBsum" id="2GS2"/>
<dbReference type="PDBsum" id="2GS6"/>
<dbReference type="PDBsum" id="2GS7"/>
<dbReference type="PDBsum" id="2ITN"/>
<dbReference type="PDBsum" id="2ITO"/>
<dbReference type="PDBsum" id="2ITP"/>
<dbReference type="PDBsum" id="2ITQ"/>
<dbReference type="PDBsum" id="2ITT"/>
<dbReference type="PDBsum" id="2ITU"/>
<dbReference type="PDBsum" id="2ITV"/>
<dbReference type="PDBsum" id="2ITW"/>
<dbReference type="PDBsum" id="2ITX"/>
<dbReference type="PDBsum" id="2ITY"/>
<dbReference type="PDBsum" id="2ITZ"/>
<dbReference type="PDBsum" id="2J5E"/>
<dbReference type="PDBsum" id="2J5F"/>
<dbReference type="PDBsum" id="2J6M"/>
<dbReference type="PDBsum" id="2JIT"/>
<dbReference type="PDBsum" id="2JIU"/>
<dbReference type="PDBsum" id="2JIV"/>
<dbReference type="PDBsum" id="2KS1"/>
<dbReference type="PDBsum" id="2M0B"/>
<dbReference type="PDBsum" id="2M20"/>
<dbReference type="PDBsum" id="2N5S"/>
<dbReference type="PDBsum" id="2RF9"/>
<dbReference type="PDBsum" id="2RFD"/>
<dbReference type="PDBsum" id="2RFE"/>
<dbReference type="PDBsum" id="2RGP"/>
<dbReference type="PDBsum" id="3B2U"/>
<dbReference type="PDBsum" id="3B2V"/>
<dbReference type="PDBsum" id="3BEL"/>
<dbReference type="PDBsum" id="3BUO"/>
<dbReference type="PDBsum" id="3C09"/>
<dbReference type="PDBsum" id="3G5V"/>
<dbReference type="PDBsum" id="3G5Y"/>
<dbReference type="PDBsum" id="3GOP"/>
<dbReference type="PDBsum" id="3GT8"/>
<dbReference type="PDBsum" id="3IKA"/>
<dbReference type="PDBsum" id="3LZB"/>
<dbReference type="PDBsum" id="3NJP"/>
<dbReference type="PDBsum" id="3OB2"/>
<dbReference type="PDBsum" id="3OP0"/>
<dbReference type="PDBsum" id="3P0Y"/>
<dbReference type="PDBsum" id="3PFV"/>
<dbReference type="PDBsum" id="3POZ"/>
<dbReference type="PDBsum" id="3QWQ"/>
<dbReference type="PDBsum" id="3UG1"/>
<dbReference type="PDBsum" id="3UG2"/>
<dbReference type="PDBsum" id="3VJN"/>
<dbReference type="PDBsum" id="3VJO"/>
<dbReference type="PDBsum" id="3VRP"/>
<dbReference type="PDBsum" id="3VRR"/>
<dbReference type="PDBsum" id="3W2O"/>
<dbReference type="PDBsum" id="3W2P"/>
<dbReference type="PDBsum" id="3W2Q"/>
<dbReference type="PDBsum" id="3W2R"/>
<dbReference type="PDBsum" id="3W2S"/>
<dbReference type="PDBsum" id="3W32"/>
<dbReference type="PDBsum" id="3W33"/>
<dbReference type="PDBsum" id="4G5J"/>
<dbReference type="PDBsum" id="4G5P"/>
<dbReference type="PDBsum" id="4HJO"/>
<dbReference type="PDBsum" id="4I1Z"/>
<dbReference type="PDBsum" id="4I20"/>
<dbReference type="PDBsum" id="4I21"/>
<dbReference type="PDBsum" id="4I22"/>
<dbReference type="PDBsum" id="4I23"/>
<dbReference type="PDBsum" id="4I24"/>
<dbReference type="PDBsum" id="4JQ7"/>
<dbReference type="PDBsum" id="4JQ8"/>
<dbReference type="PDBsum" id="4JR3"/>
<dbReference type="PDBsum" id="4JRV"/>
<dbReference type="PDBsum" id="4KRL"/>
<dbReference type="PDBsum" id="4KRM"/>
<dbReference type="PDBsum" id="4KRO"/>
<dbReference type="PDBsum" id="4KRP"/>
<dbReference type="PDBsum" id="4LI5"/>
<dbReference type="PDBsum" id="4LL0"/>
<dbReference type="PDBsum" id="4LQM"/>
<dbReference type="PDBsum" id="4LRM"/>
<dbReference type="PDBsum" id="4R3P"/>
<dbReference type="PDBsum" id="4R3R"/>
<dbReference type="PDBsum" id="4R5S"/>
<dbReference type="PDBsum" id="4RIW"/>
<dbReference type="PDBsum" id="4RIX"/>
<dbReference type="PDBsum" id="4RIY"/>
<dbReference type="PDBsum" id="4RJ4"/>
<dbReference type="PDBsum" id="4RJ5"/>
<dbReference type="PDBsum" id="4RJ6"/>
<dbReference type="PDBsum" id="4RJ7"/>
<dbReference type="PDBsum" id="4RJ8"/>
<dbReference type="PDBsum" id="4TKS"/>
<dbReference type="PDBsum" id="4UIP"/>
<dbReference type="PDBsum" id="4UV7"/>
<dbReference type="PDBsum" id="4WD5"/>
<dbReference type="PDBsum" id="4WKQ"/>
<dbReference type="PDBsum" id="4WRG"/>
<dbReference type="PDBsum" id="4ZAU"/>
<dbReference type="PDBsum" id="4ZJV"/>
<dbReference type="PDBsum" id="4ZSE"/>
<dbReference type="PDBsum" id="5C8K"/>
<dbReference type="PDBsum" id="5C8M"/>
<dbReference type="PDBsum" id="5C8N"/>
<dbReference type="PDBsum" id="5CAL"/>
<dbReference type="PDBsum" id="5CAN"/>
<dbReference type="PDBsum" id="5CAO"/>
<dbReference type="PDBsum" id="5CAP"/>
<dbReference type="PDBsum" id="5CAQ"/>
<dbReference type="PDBsum" id="5CAS"/>
<dbReference type="PDBsum" id="5CAU"/>
<dbReference type="PDBsum" id="5CAV"/>
<dbReference type="PDBsum" id="5CNN"/>
<dbReference type="PDBsum" id="5CNO"/>
<dbReference type="PDBsum" id="5CZH"/>
<dbReference type="PDBsum" id="5CZI"/>
<dbReference type="PDBsum" id="5D41"/>
<dbReference type="PDBsum" id="5EDP"/>
<dbReference type="PDBsum" id="5EDQ"/>
<dbReference type="PDBsum" id="5EDR"/>
<dbReference type="PDBsum" id="5EM5"/>
<dbReference type="PDBsum" id="5EM6"/>
<dbReference type="PDBsum" id="5EM7"/>
<dbReference type="PDBsum" id="5EM8"/>
<dbReference type="PDBsum" id="5FED"/>
<dbReference type="PDBsum" id="5FEE"/>
<dbReference type="PDBsum" id="5FEQ"/>
<dbReference type="PDBsum" id="5GMP"/>
<dbReference type="PDBsum" id="5GNK"/>
<dbReference type="PDBsum" id="5GTY"/>
<dbReference type="PDBsum" id="5GTZ"/>
<dbReference type="PDBsum" id="5HCX"/>
<dbReference type="PDBsum" id="5HCY"/>
<dbReference type="PDBsum" id="5HCZ"/>
<dbReference type="PDBsum" id="5HG5"/>
<dbReference type="PDBsum" id="5HG7"/>
<dbReference type="PDBsum" id="5HG8"/>
<dbReference type="PDBsum" id="5HG9"/>
<dbReference type="PDBsum" id="5HIB"/>
<dbReference type="PDBsum" id="5HIC"/>
<dbReference type="PDBsum" id="5J9Y"/>
<dbReference type="PDBsum" id="5J9Z"/>
<dbReference type="PDBsum" id="5JEB"/>
<dbReference type="PDBsum" id="5LV6"/>
<dbReference type="PDBsum" id="5SX4"/>
<dbReference type="PDBsum" id="5SX5"/>
<dbReference type="PDBsum" id="5U8L"/>
<dbReference type="PDBsum" id="5UG8"/>
<dbReference type="PDBsum" id="5UG9"/>
<dbReference type="PDBsum" id="5UGA"/>
<dbReference type="PDBsum" id="5UGB"/>
<dbReference type="PDBsum" id="5UGC"/>
<dbReference type="PDBsum" id="5UWD"/>
<dbReference type="PDBsum" id="5WB7"/>
<dbReference type="PDBsum" id="5WB8"/>
<dbReference type="PDBsum" id="5XGM"/>
<dbReference type="PDBsum" id="5XGN"/>
<dbReference type="DisProt" id="DP00309"/>
<dbReference type="ProteinModelPortal" id="P00533"/>
<dbReference type="SMR" id="P00533"/>
<dbReference type="BioGrid" id="108276">
<property type="interactions" value="1200"/>
</dbReference>
<dbReference type="CORUM" id="P00533"/>
<dbReference type="DIP" id="DIP-405N"/>
<dbReference type="ELM" id="P00533"/>
<dbReference type="IntAct" id="P00533">
<property type="interactions" value="492"/>
</dbReference>
<dbReference type="MINT" id="MINT-206389"/>
<dbReference type="STRING" id="9606.ENSP00000275493"/>
<dbReference type="BindingDB" id="P00533"/>
<dbReference type="ChEMBL" id="CHEMBL203"/>
<dbReference type="DrugBank" id="DB08916">
<property type="generic name" value="Afatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00002">
<property type="generic name" value="Cetuximab"/>
</dbReference>
<dbReference type="DrugBank" id="DB05424">
<property type="generic name" value="CI-1033"/>
</dbReference>
<dbReference type="DrugBank" id="DB00530">
<property type="generic name" value="Erlotinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB03496">
<property type="generic name" value="Flavopiridol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00317">
<property type="generic name" value="Gefitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05324">
<property type="generic name" value="HuMax-EGFr"/>
</dbReference>
<dbReference type="DrugBank" id="DB11737">
<property type="generic name" value="Icotinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB04988">
<property type="generic name" value="IGN311"/>
</dbReference>
<dbReference type="DrugBank" id="DB05774">
<property type="generic name" value="IMC-11F8"/>
</dbReference>
<dbReference type="DrugBank" id="DB05900">
<property type="generic name" value="INSM-18"/>
</dbReference>
<dbReference type="DrugBank" id="DB01259">
<property type="generic name" value="Lapatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00281">
<property type="generic name" value="Lidocaine"/>
</dbReference>
<dbReference type="DrugBank" id="DB05101">
<property type="generic name" value="Matuzumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB07662">
<property type="generic name" value="N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE"/>
</dbReference>
<dbReference type="DrugBank" id="DB09559">
<property type="generic name" value="Necitumumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB13164">
<property type="generic name" value="Olmutinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB09330">
<property type="generic name" value="Osimertinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01269">
<property type="generic name" value="Panitumumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB05374">
<property type="generic name" value="Rindopepimut"/>
</dbReference>
<dbReference type="DrugBank" id="DB07602">
<property type="generic name" value="S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB00072">
<property type="generic name" value="Trastuzumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB05294">
<property type="generic name" value="Vandetanib"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1797"/>
<dbReference type="iPTMnet" id="P00533"/>
<dbReference type="PhosphoSitePlus" id="P00533"/>
<dbReference type="SwissPalm" id="P00533"/>
<dbReference type="UniCarbKB" id="P00533"/>
<dbReference type="BioMuta" id="EGFR"/>
<dbReference type="DMDM" id="2811086"/>
<dbReference type="SWISS-2DPAGE" id="P00533"/>
<dbReference type="EPD" id="P00533"/>
<dbReference type="MaxQB" id="P00533"/>
<dbReference type="PaxDb" id="P00533"/>
<dbReference type="PeptideAtlas" id="P00533"/>
<dbReference type="PRIDE" id="P00533"/>
<dbReference type="DNASU" id="1956"/>
<dbReference type="Ensembl" id="ENST00000275493">
<molecule id="P00533-1"/>
<property type="protein sequence ID" value="ENSP00000275493"/>
<property type="gene ID" value="ENSG00000146648"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000342916">
<molecule id="P00533-4"/>
<property type="protein sequence ID" value="ENSP00000342376"/>
<property type="gene ID" value="ENSG00000146648"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000344576">
<molecule id="P00533-3"/>
<property type="protein sequence ID" value="ENSP00000345973"/>
<property type="gene ID" value="ENSG00000146648"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000420316">
<molecule id="P00533-2"/>
<property type="protein sequence ID" value="ENSP00000413843"/>
<property type="gene ID" value="ENSG00000146648"/>
</dbReference>
<dbReference type="GeneID" id="1956"/>
<dbReference type="KEGG" id="hsa:1956"/>
<dbReference type="UCSC" id="uc003tqh.4">
<molecule id="P00533-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1956"/>
<dbReference type="DisGeNET" id="1956"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000146648.15"/>
<dbReference type="GeneCards" id="EGFR"/>
<dbReference type="HGNC" id="HGNC:3236">
<property type="gene designation" value="EGFR"/>
</dbReference>
<dbReference type="HPA" id="CAB000035"/>
<dbReference type="HPA" id="CAB068186"/>
<dbReference type="HPA" id="CAB073534"/>
<dbReference type="HPA" id="HPA001200"/>
<dbReference type="HPA" id="HPA018530"/>
<dbReference type="MalaCards" id="EGFR"/>
<dbReference type="MIM" id="131550">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="211980">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616069">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P00533"/>
<dbReference type="OpenTargets" id="ENSG00000146648"/>
<dbReference type="Orphanet" id="251579">
<property type="disease" value="Giant cell glioblastoma"/>
</dbReference>
<dbReference type="Orphanet" id="251576">
<property type="disease" value="Gliosarcoma"/>
</dbReference>
<dbReference type="Orphanet" id="294023">
<property type="disease" value="Neonatal inflammatory skin and bowel disease"/>
</dbReference>
<dbReference type="Orphanet" id="357191">
<property type="disease" value="Selection of therapeutic option in non-small cell lung carcinoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA7360"/>
<dbReference type="eggNOG" id="KOG1025">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XNSR">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118799"/>
<dbReference type="HOVERGEN" id="HBG000490"/>
<dbReference type="InParanoid" id="P00533"/>
<dbReference type="KO" id="K04361"/>
<dbReference type="OMA" id="VCRKCHP"/>
<dbReference type="OrthoDB" id="EOG091G00NO"/>
<dbReference type="PhylomeDB" id="P00533"/>
<dbReference type="TreeFam" id="TF106002"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1227986">
<property type="pathway name" value="Signaling by ERBB2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1236382">
<property type="pathway name" value="Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1236394">
<property type="pathway name" value="Signaling by ERBB4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1250196">
<property type="pathway name" value="SHC1 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1251932">
<property type="pathway name" value="PLCG1 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-177929">
<property type="pathway name" value="Signaling by EGFR"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-179812">
<property type="pathway name" value="GRB2 events in EGFR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-180292">
<property type="pathway name" value="GAB1 signalosome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-180336">
<property type="pathway name" value="SHC1 events in EGFR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-182971">
<property type="pathway name" value="EGFR downregulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1963640">
<property type="pathway name" value="GRB2 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1963642">
<property type="pathway name" value="PI3K events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-212718">
<property type="pathway name" value="EGFR interacts with phospholipase C-gamma"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2179392">
<property type="pathway name" value="EGFR Transactivation by Gastrin"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445144">
<property type="pathway name" value="Signal transduction by L1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5637810">
<property type="pathway name" value="Constitutive Signaling by EGFRvIII"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5638303">
<property type="pathway name" value="Inhibition of Signaling by Overexpressed EGFR"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785631">
<property type="pathway name" value="ERBB2 Regulates Cell Motility"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8847993">
<property type="pathway name" value="ERBB2 Activates PTK6 Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856825">
<property type="pathway name" value="Cargo recognition for clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856828">
<property type="pathway name" value="Clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8857538">
<property type="pathway name" value="PTK6 promotes HIF1A stabilization"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8863795">
<property type="pathway name" value="Downregulation of ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866910">
<property type="pathway name" value="TFAP2 (AP-2) family regulates transcription of growth factors and their receptors"/>
</dbReference>
<dbReference type="SignaLink" id="P00533"/>
<dbReference type="SIGNOR" id="P00533"/>
<dbReference type="ChiTaRS" id="EGFR">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P00533"/>
<dbReference type="GeneWiki" id="Epidermal_growth_factor_receptor"/>
<dbReference type="GenomeRNAi" id="1956"/>
<dbReference type="PMAP-CutDB" id="P00533"/>
<dbReference type="PRO" id="PR:P00533"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 7"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000146648"/>
<dbReference type="ExpressionAtlas" id="P00533">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P00533">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016323">
<property type="term" value="C:basolateral plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030665">
<property type="term" value="C:clathrin-coated vesicle membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031901">
<property type="term" value="C:early endosome membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030139">
<property type="term" value="C:endocytic vesicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000139">
<property type="term" value="C:Golgi membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097489">
<property type="term" value="C:multivesicular body, internal vesicle lumen"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031965">
<property type="term" value="C:nuclear membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070435">
<property type="term" value="C:Shc-EGFR complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045202">
<property type="term" value="C:synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051015">
<property type="term" value="F:actin filament binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005516">
<property type="term" value="F:calmodulin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003690">
<property type="term" value="F:double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048408">
<property type="term" value="F:epidermal growth factor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005006">
<property type="term" value="F:epidermal growth factor-activated receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0005178">
<property type="term" value="F:integrin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004709">
<property type="term" value="F:MAP kinase kinase kinase activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046934">
<property type="term" value="F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005088">
<property type="term" value="F:Ras guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004716">
<property type="term" value="F:signal transducer, downstream of receptor, with protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0004714">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001618">
<property type="term" value="F:virus receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0043006">
<property type="term" value="P:activation of phospholipase A2 activity by calcium-mediated signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007202">
<property type="term" value="P:activation of phospholipase C activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048143">
<property type="term" value="P:astrocyte activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0098609">
<property type="term" value="P:cell-cell adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071230">
<property type="term" value="P:cellular response to amino acid stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071276">
<property type="term" value="P:cellular response to cadmium ion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0071549">
<property type="term" value="P:cellular response to dexamethasone stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035690">
<property type="term" value="P:cellular response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071364">
<property type="term" value="P:cellular response to epidermal growth factor stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071392">
<property type="term" value="P:cellular response to estradiol stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071260">
<property type="term" value="P:cellular response to mechanical stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034614">
<property type="term" value="P:cellular response to reactive oxygen species"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0021795">
<property type="term" value="P:cerebral cortex cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007623">
<property type="term" value="P:circadian rhythm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048546">
<property type="term" value="P:digestive tract morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016101">
<property type="term" value="P:diterpenoid metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001892">
<property type="term" value="P:embryonic placenta development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007173">
<property type="term" value="P:epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038128">
<property type="term" value="P:ERBB2 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0061029">
<property type="term" value="P:eyelid development in camera-type eye"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001942">
<property type="term" value="P:hair follicle development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042743">
<property type="term" value="P:hydrogen peroxide metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007611">
<property type="term" value="P:learning or memory"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097421">
<property type="term" value="P:liver regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030324">
<property type="term" value="P:lung development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010960">
<property type="term" value="P:magnesium ion homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0061024">
<property type="term" value="P:membrane organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007494">
<property type="term" value="P:midgut development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060571">
<property type="term" value="P:morphogenesis of an epithelial fold"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1905208">
<property type="term" value="P:negative regulation of cardiocyte differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042059">
<property type="term" value="P:negative regulation of epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1901185">
<property type="term" value="P:negative regulation of ERBB signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045930">
<property type="term" value="P:negative regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042177">
<property type="term" value="P:negative regulation of protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048812">
<property type="term" value="P:neuron projection morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001503">
<property type="term" value="P:ossification"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042698">
<property type="term" value="P:ovulation cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038083">
<property type="term" value="P:peptidyl-tyrosine autophosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097755">
<property type="term" value="P:positive regulation of blood vessel diameter"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045780">
<property type="term" value="P:positive regulation of bone resorption"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035413">
<property type="term" value="P:positive regulation of catenin import into nucleus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030307">
<property type="term" value="P:positive regulation of cell growth"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0031659">
<property type="term" value="P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045739">
<property type="term" value="P:positive regulation of DNA repair"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045740">
<property type="term" value="P:positive regulation of DNA replication"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050679">
<property type="term" value="P:positive regulation of epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048146">
<property type="term" value="P:positive regulation of fibroblast proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043406">
<property type="term" value="P:positive regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901224">
<property type="term" value="P:positive regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0045429">
<property type="term" value="P:positive regulation of nitric oxide biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033138">
<property type="term" value="P:positive regulation of peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042327">
<property type="term" value="P:positive regulation of phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903800">
<property type="term" value="P:positive regulation of production of miRNAs involved in gene silencing by miRNA"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902722">
<property type="term" value="P:positive regulation of prolactin secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900020">
<property type="term" value="P:positive regulation of protein kinase C activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903078">
<property type="term" value="P:positive regulation of protein localization to plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048661">
<property type="term" value="P:positive regulation of smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032930">
<property type="term" value="P:positive regulation of superoxide anion generation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051968">
<property type="term" value="P:positive regulation of synaptic transmission, glutamatergic"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0045907">
<property type="term" value="P:positive regulation of vasoconstriction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051205">
<property type="term" value="P:protein insertion into membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000145">
<property type="term" value="P:regulation of cell motility"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070372">
<property type="term" value="P:regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0046328">
<property type="term" value="P:regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0050999">
<property type="term" value="P:regulation of nitric-oxide synthase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050730">
<property type="term" value="P:regulation of peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014066">
<property type="term" value="P:regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051592">
<property type="term" value="P:response to calcium ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033590">
<property type="term" value="P:response to cobalamin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033594">
<property type="term" value="P:response to hydroxyisoflavone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006970">
<property type="term" value="P:response to osmotic stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006950">
<property type="term" value="P:response to stress"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070141">
<property type="term" value="P:response to UV-A"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007435">
<property type="term" value="P:salivary gland morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043586">
<property type="term" value="P:tongue development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006412">
<property type="term" value="P:translation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042060">
<property type="term" value="P:wound healing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.5.100">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.20.20">
<property type="match status" value="4"/>
</dbReference>
<dbReference type="InterPro" id="IPR021157">
<property type="entry name" value="Cyt_c1_TM_anchor_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR006211">
<property type="entry name" value="Furin-like_Cys-rich_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR006212">
<property type="entry name" value="Furin_repeat"/>
</dbReference>
<dbReference type="InterPro" id="IPR032778">
<property type="entry name" value="GF_recep_IV"/>
</dbReference>
<dbReference type="InterPro" id="IPR009030">
<property type="entry name" value="Growth_fac_rcpt_cys_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR000494">
<property type="entry name" value="Rcpt_L-dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036941">
<property type="entry name" value="Rcpt_L-dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016245">
<property type="entry name" value="Tyr_kinase_EGF/ERB/XmrK_rcpt"/>
</dbReference>
<dbReference type="Pfam" id="PF00757">
<property type="entry name" value="Furin-like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF14843">
<property type="entry name" value="GF_recep_IV"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01030">
<property type="entry name" value="Recep_L_domain"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000619">
<property type="entry name" value="TyrPK_EGF-R"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00261">
<property type="entry name" value="FU"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52058">
<property type="entry name" value="SSF52058"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57184">
<property type="entry name" value="SSF57184"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-1183">Host cell receptor for virus entry</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="50 98">
<location>
<begin position="1"/>
<end position="24"/>
</location>
</feature>
<feature type="chain" description="Epidermal growth factor receptor" id="PRO_0000016665">
<location>
<begin position="25"/>
<end position="1210"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="34">
<location>
<begin position="25"/>
<end position="645"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="34">
<location>
<begin position="646"/>
<end position="668"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="34">
<location>
<begin position="669"/>
<end position="1210"/>
</location>
</feature>
<feature type="repeat" description="Approximate">
<location>
<begin position="75"/>
<end position="300"/>
</location>
</feature>
<feature type="repeat" description="Approximate">
<location>
<begin position="390"/>
<end position="600"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="35">
<location>
<begin position="712"/>
<end position="979"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="718"/>
<end position="726"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="790"/>
<end position="791"/>
</location>
</feature>
<feature type="region of interest" description="Important for dimerization, phosphorylation and activation">
<location>
<begin position="688"/>
<end position="704"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="35 36">
<location>
<position position="837"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="745"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="855"/>
</location>
</feature>
<feature type="site" description="Important for interaction with PIK3C2B">
<location>
<position position="1016"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="81">
<location>
<position position="229"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKC and PKD/PRKD1" evidence="39">
<location>
<position position="678"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKD/PRKD1" evidence="29 30 31 32 39 55 93">
<location>
<position position="693"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29 93">
<location>
<position position="695"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="28 30 32 55">
<location>
<position position="991"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="28">
<location>
<position position="995"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="28 73">
<location>
<position position="998"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="73">
<location>
<position position="1016"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="32 55">
<location>
<position position="1026"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="28">
<location>
<position position="1039"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="28">
<location>
<position position="1041"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="28">
<location>
<position position="1042"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="28 29 30 31">
<location>
<position position="1064"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="108">
<location>
<position position="1069"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="93">
<location>
<position position="1070"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="93">
<location>
<position position="1071"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29">
<location>
<position position="1081"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="47">
<location>
<position position="1092"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="47 91">
<location>
<position position="1110"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="28 29 32">
<location>
<position position="1166"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="27">
<location>
<position position="1172"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="27 29 30 73 75">
<location>
<position position="1197"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="80">
<location>
<position position="1199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine; atypical; partial" id="CAR_000227" evidence="40 44 46 55 79">
<location>
<position position="56"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine; atypical" evidence="79">
<location>
<position position="73"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="46 55 96">
<location>
<position position="128"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="44 46 55 79 96">
<location>
<position position="175"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="44 46 55 79">
<location>
<position position="196"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="40 44 45 46 55 69 79">
<location>
<position position="352"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="40 44 45 46 55 79">
<location>
<position position="361"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="46 55 69 96">
<location>
<position position="413"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="44 45 46 55 79 96">
<location>
<position position="444"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="45 46 55 79 96">
<location>
<position position="528"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine; partial" evidence="40 45 46 55 69">
<location>
<position position="568"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine; partial" evidence="40 45 46 55">
<location>
<position position="603"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (high mannose) asparagine" evidence="107">
<location>
<position position="623"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="31"/>
<end position="58"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="157"/>
<end position="187"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="190"/>
<end position="199"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="194"/>
<end position="207"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="215"/>
<end position="223"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="219"/>
<end position="231"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="232"/>
<end position="240"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="236"/>
<end position="248"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="251"/>
<end position="260"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="264"/>
<end position="291"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="295"/>
<end position="307"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="311"/>
<end position="326"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="329"/>
<end position="333"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="337"/>
<end position="362"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="470"/>
<end position="499"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="506"/>
<end position="515"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="510"/>
<end position="523"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="526"/>
<end position="535"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="539"/>
<end position="555"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="558"/>
<end position="571"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="562"/>
<end position="579"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="582"/>
<end position="591"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="595"/>
<end position="617"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="620"/>
<end position="628"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="624"/>
<end position="636"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="59">
<location>
<position position="716"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="59">
<location>
<position position="737"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="59">
<location>
<position position="754"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="59">
<location>
<position position="867"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="59">
<location>
<position position="929"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="59">
<location>
<position position="970"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002887" evidence="102 103 104 105">
<original>FL</original>
<variation>LS</variation>
<location>
<begin position="404"/>
<end position="405"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002888" evidence="102 103 104 105">
<location>
<begin position="406"/>
<end position="1210"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_002889" evidence="101">
<original>CTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLR</original>
<variation>PGNESLKAMLFCLFKLSSCNQSNDGSVSHQSGSPAAQESCLGWIPSLLPSEFQLGWGGCSHLHAWPSASVIITASSCH</variation>
<location>
<begin position="628"/>
<end position="705"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_002891" evidence="101">
<original>C</original>
<variation>S</variation>
<location>
<position position="628"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_002892" evidence="101">
<location>
<begin position="629"/>
<end position="1210"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_002890" evidence="101">
<location>
<begin position="706"/>
<end position="1210"/>
</location>
</feature>
<feature type="sequence variant" description="Variant EGFR vIII; found in a lung cancer sample; somatic mutation; induces lung cancer when exogenously expressed." id="VAR_066493" evidence="60">
<location>
<begin position="30"/>
<end position="297"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17289589." id="VAR_019293" evidence="99">
<original>R</original>
<variation>Q</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17336639." id="VAR_019294" evidence="99">
<original>P</original>
<variation>R</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence variant" description="In NISBD2; loss of function; the mutant does not localize to the cell membrane; has diffuse cytoplasmic localization; dbSNP:rs606231253." id="VAR_072435" evidence="89">
<original>G</original>
<variation>D</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2227983." id="VAR_019295" evidence="63 99">
<original>R</original>
<variation>K</variation>
<location>
<position position="521"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17337079." id="VAR_019296" evidence="99">
<original>V</original>
<variation>I</variation>
<location>
<position position="674"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs397517085." id="VAR_026084" evidence="53 57 58">
<original>E</original>
<variation>A</variation>
<location>
<position position="709"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs397517085." id="VAR_069498" evidence="53 57">
<original>E</original>
<variation>G</variation>
<location>
<position position="709"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs727504256." id="VAR_026085" evidence="58">
<original>E</original>
<variation>K</variation>
<location>
<position position="709"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs121913428." id="VAR_026086" evidence="58">
<original>G</original>
<variation>A</variation>
<location>
<position position="719"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs28929495." id="VAR_026087" evidence="53 58">
<original>G</original>
<variation>C</variation>
<location>
<position position="719"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs121913428." id="VAR_026088" evidence="58">
<original>G</original>
<variation>D</variation>
<location>
<position position="719"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; somatic mutation; strongly increased kinase activity; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs28929495." id="VAR_019297" evidence="48 53 57 58 64">
<original>G</original>
<variation>S</variation>
<location>
<position position="719"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs1051753269." id="VAR_026089" evidence="58">
<original>G</original>
<variation>S</variation>
<location>
<position position="724"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs121913420." id="VAR_026090" evidence="58">
<original>E</original>
<variation>K</variation>
<location>
<position position="734"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_069499" evidence="53">
<original>ELREATS</original>
<variation>D</variation>
<location>
<begin position="746"/>
<end position="752"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_069500" evidence="53">
<original>ELREAT</original>
<variation>A</variation>
<location>
<begin position="746"/>
<end position="751"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026092" evidence="53">
<location>
<begin position="746"/>
<end position="750"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026091" evidence="58">
<location>
<position position="746"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_069501" evidence="53">
<location>
<begin position="747"/>
<end position="751"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026094" evidence="58">
<location>
<begin position="747"/>
<end position="749"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026093" evidence="58">
<original>L</original>
<variation>F</variation>
<location>
<position position="747"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026095" evidence="58">
<original>R</original>
<variation>P</variation>
<location>
<position position="748"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026096" evidence="58">
<location>
<begin position="752"/>
<end position="759"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs121913465." id="VAR_069502" evidence="53 57">
<original>S</original>
<variation>I</variation>
<location>
<position position="768"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs147149347." id="VAR_069503" evidence="53">
<original>V</original>
<variation>M</variation>
<location>
<position position="769"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026097" evidence="58">
<original>Q</original>
<variation>R</variation>
<location>
<position position="787"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; increased kinase activity; dbSNP:rs121434569." id="VAR_026098" evidence="58 67">
<original>T</original>
<variation>M</variation>
<location>
<position position="790"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs397517126." id="VAR_026099" evidence="53 57 58">
<original>L</original>
<variation>V</variation>
<location>
<position position="833"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs397517127." id="VAR_026100" evidence="58">
<original>V</original>
<variation>L</variation>
<location>
<position position="834"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs397517128." id="VAR_069504" evidence="53 57">
<original>H</original>
<variation>L</variation>
<location>
<position position="835"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs864621996." id="VAR_069505" evidence="53 57">
<original>L</original>
<variation>V</variation>
<location>
<position position="838"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs121913443." id="VAR_026101" evidence="58">
<original>L</original>
<variation>M</variation>
<location>
<position position="858"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; somatic mutation; constitutively activated enzyme with strongly increased kinase activity; more sensitive to gefitinib than wild-type; dbSNP:rs121434568." id="VAR_019298" evidence="48 53 57 58 64">
<original>L</original>
<variation>R</variation>
<location>
<position position="858"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs121913444." id="VAR_026102" evidence="53 57 58">
<original>L</original>
<variation>Q</variation>
<location>
<position position="861"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026103" evidence="58">
<original>G</original>
<variation>E</variation>
<location>
<position position="873"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17337451." id="VAR_019299" evidence="99">
<original>R</original>
<variation>G</variation>
<location>
<position position="962"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17290699." id="VAR_019300" evidence="99">
<original>H</original>
<variation>P</variation>
<location>
<position position="988"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34352568." id="VAR_042095" evidence="63">
<original>L</original>
<variation>R</variation>
<location>
<position position="1034"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35918369." id="VAR_042096" evidence="63">
<original>A</original>
<variation>V</variation>
<location>
<position position="1210"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-309." evidence="44">
<original>Y</original>
<variation>A</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-309." evidence="44">
<original>F</original>
<variation>A</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-275. Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-287." evidence="44">
<original>R</original>
<variation>S</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes autophosphorylation and activation of downstream kinases." evidence="44">
<original>R</original>
<variation>E</variation>
<location>
<position position="429"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases intramolecular interactions and facilitates EGF binding." evidence="45">
<original>DGPH</original>
<variation>AGPA</variation>
<location>
<begin position="587"/>
<end position="590"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases intramolecular interactions and facilitates EGF binding." evidence="45">
<original>K</original>
<variation>A</variation>
<location>
<position position="609"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation." evidence="72 73">
<original>L</original>
<variation>A</variation>
<location>
<position position="688"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced autophosphorylation." evidence="72">
<original>V</original>
<variation>A</variation>
<location>
<position position="689"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutively activated kinase." evidence="72">
<original>V</original>
<variation>M</variation>
<location>
<position position="689"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced phosphorylation." evidence="72 73">
<original>E</original>
<variation>A</variation>
<location>
<position position="690"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation." evidence="72 73">
<original>L</original>
<variation>A</variation>
<variation>P</variation>
<location>
<position position="692"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased phosphorylation." evidence="72">
<original>T</original>
<variation>A</variation>
<location>
<position position="693"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation." evidence="72">
<original>T</original>
<variation>D</variation>
<location>
<position position="693"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation." evidence="72">
<original>P</original>
<variation>A</variation>
<location>
<position position="694"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced phosphorylation." evidence="72">
<original>P</original>
<variation>A</variation>
<location>
<position position="699"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation." evidence="72">
<original>N</original>
<variation>A</variation>
<location>
<position position="700"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation." evidence="72">
<original>L</original>
<variation>A</variation>
<location>
<position position="704"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation." evidence="72">
<original>R</original>
<variation>A</variation>
<location>
<position position="705"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation." evidence="72">
<original>I</original>
<variation>A</variation>
<location>
<position position="706"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="72">
<original>K</original>
<variation>A</variation>
<variation>M</variation>
<location>
<position position="745"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation.">
<original>D</original>
<variation>A</variation>
<location>
<position position="974"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced phosphorylation." evidence="73">
<original>R</original>
<variation>A</variation>
<location>
<position position="977"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutively activated kinase." evidence="73">
<original>ED</original>
<variation>RK</variation>
<location>
<begin position="1005"/>
<end position="1006"/>
</location>
</feature>
<feature type="mutagenesis site" description="50% decrease in interaction with PIK3C2B. 65% decrease in interaction with PIK3C2B; when associated with F-1197. Abolishes interaction with PIK3C2B; when associated with F-1197 and F-1092." evidence="41">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1016"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with CBLC." evidence="86">
<original>Q</original>
<variation>G</variation>
<location>
<position position="1067"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreases interaction with CBLC." evidence="86">
<original>R</original>
<variation>G</variation>
<location>
<position position="1068"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CBLC." evidence="86">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1069"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in interaction with PIK3C2B. Abolishes interaction with PIK3C2B; when associated with F-1197 and F-1016." evidence="41">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1092"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in interaction with PIK3C2B." evidence="41">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1110"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in interaction with PIK3C2B." evidence="41">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1172"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in interaction with PIK3C2B. 65% decrease in interaction with PIK3C2B; when associated with F-1016. Abolishes interaction with PIK3C2B; when associated with F-1092 and F-1016." evidence="41">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1197"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA25240." ref="1" evidence="106">
<original>N</original>
<variation>K</variation>
<location>
<position position="540"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="40"/>
<end position="43"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="44"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="60"/>
<end position="69"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="77"/>
<end position="81"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="84"/>
<end position="87"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="89"/>
<end position="93"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="101"/>
<end position="103"/>
</location>
</feature>
<feature type="turn" evidence="21">
<location>
<begin position="114"/>
<end position="116"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="117"/>
<end position="122"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="125"/>
<end position="129"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="145"/>
<end position="152"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="159"/>
<end position="161"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="164"/>
<end position="166"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="170"/>
<end position="173"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="195"/>
<end position="197"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="199"/>
<end position="204"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="211"/>
<end position="214"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="223"/>
<end position="227"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="228"/>
<end position="230"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="236"/>
<end position="238"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="240"/>
<end position="244"/>
</location>
</feature>
<feature type="turn" evidence="21">
<location>
<begin position="245"/>
<end position="247"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="248"/>
<end position="256"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="259"/>
<end position="263"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="267"/>
<end position="271"/>
</location>
</feature>
<feature type="turn" evidence="21">
<location>
<begin position="272"/>
<end position="275"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="276"/>
<end position="279"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="285"/>
<end position="287"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="290"/>
<end position="294"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="296"/>
<end position="298"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="299"/>
<end position="301"/>
</location>
</feature>
<feature type="strand" evidence="20">
<location>
<begin position="303"/>
<end position="305"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="306"/>
<end position="310"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="313"/>
<end position="315"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="318"/>
<end position="320"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="323"/>
<end position="325"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="330"/>
<end position="332"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="336"/>
<end position="338"/>
</location>
</feature>
<feature type="turn" evidence="14">
<location>
<begin position="340"/>
<end position="342"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="343"/>
<end position="345"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="349"/>
<end position="351"/>
</location>
</feature>
<feature type="turn" evidence="11">
<location>
<begin position="353"/>
<end position="355"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="356"/>
<end position="359"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="363"/>
<end position="367"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="369"/>
<end position="371"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="373"/>
<end position="377"/>
</location>
</feature>
<feature type="turn" evidence="11">
<location>
<begin position="380"/>
<end position="383"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="389"/>
<end position="397"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="400"/>
<end position="403"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="405"/>
<end position="407"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="418"/>
<end position="420"/>
</location>
</feature>
<feature type="turn" evidence="11">
<location>
<begin position="433"/>
<end position="435"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="436"/>
<end position="442"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="458"/>
<end position="464"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="472"/>
<end position="474"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="477"/>
<end position="480"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="481"/>
<end position="483"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="488"/>
<end position="494"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="496"/>
<end position="501"/>
</location>
</feature>
<feature type="strand" evidence="25">
<location>
<begin position="508"/>
<end position="510"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="515"/>
<end position="519"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="520"/>
<end position="522"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="523"/>
<end position="526"/>
</location>
</feature>
<feature type="strand" evidence="18">
<location>
<begin position="531"/>
<end position="533"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="535"/>
<end position="537"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="540"/>
<end position="546"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="548"/>
<end position="551"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="554"/>
<end position="557"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="560"/>
<end position="562"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="566"/>
<end position="568"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="570"/>
<end position="575"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="578"/>
<end position="587"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="590"/>
<end position="594"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="597"/>
<end position="602"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="606"/>
<end position="611"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="615"/>
<end position="619"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="629"/>
<end position="632"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="633"/>
<end position="635"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="643"/>
<end position="646"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="648"/>
<end position="669"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="671"/>
<end position="673"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="679"/>
<end position="684"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="685"/>
<end position="687"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="688"/>
<end position="692"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="694"/>
<end position="697"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="703"/>
<end position="706"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="709"/>
<end position="711"/>
</location>
</feature>
<feature type="strand" evidence="26">
<location>
<begin position="712"/>
<end position="721"/>
</location>
</feature>
<feature type="strand" evidence="26">
<location>
<begin position="724"/>
<end position="731"/>
</location>
</feature>
<feature type="turn" evidence="26">
<location>
<begin position="734"/>
<end position="736"/>
</location>
</feature>
<feature type="strand" evidence="26">
<location>
<begin position="740"/>
<end position="747"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="748"/>
<end position="750"/>
</location>
</feature>
<feature type="turn" evidence="15">
<location>
<begin position="753"/>
<end position="755"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="756"/>
<end position="767"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="772"/>
<end position="774"/>
</location>
</feature>
<feature type="strand" evidence="26">
<location>
<begin position="777"/>
<end position="791"/>
</location>
</feature>
<feature type="strand" evidence="16">
<location>
<begin position="794"/>
<end position="797"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="798"/>
<end position="804"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="806"/>
<end position="808"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="811"/>
<end position="830"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="840"/>
<end position="842"/>
</location>
</feature>
<feature type="strand" evidence="26">
<location>
<begin position="843"/>
<end position="847"/>
</location>
</feature>
<feature type="strand" evidence="26">
<location>
<begin position="850"/>
<end position="853"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="858"/>
<end position="862"/>
</location>
</feature>
<feature type="turn" evidence="13">
<location>
<begin position="863"/>
<end position="865"/>
</location>
</feature>
<feature type="strand" evidence="26">
<location>
<begin position="867"/>
<end position="870"/>
</location>
</feature>
<feature type="strand" evidence="22">
<location>
<begin position="873"/>
<end position="876"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="878"/>
<end position="880"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="883"/>
<end position="888"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="893"/>
<end position="908"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="909"/>
<end position="911"/>
</location>
</feature>
<feature type="turn" evidence="26">
<location>
<begin position="914"/>
<end position="917"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="920"/>
<end position="922"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="923"/>
<end position="928"/>
</location>
</feature>
<feature type="strand" evidence="24">
<location>
<begin position="937"/>
<end position="939"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="941"/>
<end position="950"/>
</location>
</feature>
<feature type="strand" evidence="24">
<location>
<begin position="951"/>
<end position="953"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="955"/>
<end position="957"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="961"/>
<end position="972"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="975"/>
<end position="977"/>
</location>
</feature>
<feature type="helix" evidence="23">
<location>
<begin position="984"/>
<end position="986"/>
</location>
</feature>
<feature type="turn" evidence="23">
<location>
<begin position="992"/>
<end position="998"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="1004"/>
<end position="1010"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="1013"/>
<end position="1016"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="1068"/>
<end position="1070"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1IVO"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1MOX"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1YY9"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1Z9I"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2GS7"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ITU"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KS1"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3B2V"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3G5Y"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GOP"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3P0Y"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3PFV"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3POZ"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3QWQ"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3W2S"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4G5P"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4I21"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KRL"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KRO"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KRP"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4UV7"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5CZI"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5HG8"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5JEB"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5SX4"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UG9"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q01279"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000255"/>
<evidence key="35" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10026169"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10228163"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10523301"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10731668"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10805725"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11116146"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11483589"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12297050"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12620237"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12731890"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12873986"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15118125"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15282549"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15340161"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15374980"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15590694"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15623594"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15837620"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16083266"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16140940"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16205628"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16533793"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16543144"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16672372"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17115032"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17182860"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17349580"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17671655"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18046415"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18227510"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18602463"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19172738"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19509291"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19560417"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19563760"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19749156"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19836242"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20471394"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20551055"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20674546"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20837704"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21258366"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21487020"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21516087"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21518868"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22179831"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22298428"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22888118"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23418353"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23912460"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24691054"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25311788"/>
</source>
</evidence>
<evidence key="91" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2543678"/>
</source>
</evidence>
<evidence key="92" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28479384"/>
</source>
</evidence>
<evidence key="93" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3138233"/>
</source>
</evidence>
<evidence key="94" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7657591"/>
</source>
</evidence>
<evidence key="95" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8650580"/>
</source>
</evidence>
<evidence key="96" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8962717"/>
</source>
</evidence>
<evidence key="97" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9852145"/>
</source>
</evidence>
<evidence key="98" type="ECO:0000269">
<source ref="16"/>
</evidence>
<evidence key="99" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="100" type="ECO:0000269">
<source ref="92"/>
</evidence>
<evidence key="101" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11161793"/>
</source>
</evidence>
<evidence key="102" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7654368"/>
</source>
</evidence>
<evidence key="103" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8918811"/>
</source>
</evidence>
<evidence key="104" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9103388"/>
</source>
</evidence>
<evidence key="105" type="ECO:0000303">
<source ref="6"/>
</evidence>
<evidence key="106" type="ECO:0000305"/>
<evidence key="107" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12731890"/>
</source>
</evidence>
<evidence key="108" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22888118"/>
</source>
</evidence>
<sequence length="1210" mass="134277" checksum="D8A2A50B4EFB6ED2" modified="1997-11-01" version="2" precursor="true">
MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEV
VLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALA
VLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDF
QNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGC
TGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYV
VTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFK
NCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAF
ENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKL
FGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCN
LLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVM
GENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVV
ALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGS
GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI
CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA
RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY
GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPK
FRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQ
QGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTED
SIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLN
TVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRV
APQSSEFIGA
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1989-07-01" modified="2017-12-20" version="257">
<accession>P10275</accession>
<accession>A0A0B4J1T2</accession>
<accession>A2RUN2</accession>
<accession>B1AKD7</accession>
<accession>C0JKD3</accession>
<accession>C0JKD4</accession>
<accession>E7EVX6</accession>
<accession>Q9UD95</accession>
<name>ANDR_HUMAN</name>
<protein>
<recommendedName>
<fullName>Androgen receptor</fullName>
</recommendedName>
<alternativeName>
<fullName>Dihydrotestosterone receptor</fullName>
</alternativeName>
<alternativeName>
<fullName>Nuclear receptor subfamily 3 group C member 4</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">AR</name>
<name type="synonym">DHTR</name>
<name type="synonym">NR3C4</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="Mol. Endocrinol." volume="2" first="1265" last="1275">
<title>The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate.</title>
<authorList>
<person name="Lubahn D.B."/>
<person name="Joseph D.R."/>
<person name="Sar M."/>
<person name="Tan J."/>
<person name="Higgs H.N."/>
<person name="Larson R.E."/>
<person name="French F.S."/>
<person name="Wilson E.M."/>
</authorList>
<dbReference type="PubMed" id="3216866"/>
<dbReference type="DOI" id="10.1210/mend-2-12-1265"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1988" name="Proc. Natl. Acad. Sci. U.S.A." volume="85" first="7211" last="7215">
<title>Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors.</title>
<authorList>
<person name="Chang C."/>
<person name="Kokontis J."/>
<person name="Liao S."/>
</authorList>
<dbReference type="PubMed" id="3174628"/>
<dbReference type="DOI" id="10.1073/pnas.85.19.7211"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="327" last="331">
<title>Characterization and expression of a cDNA encoding the human androgen receptor.</title>
<authorList>
<person name="Tilley W.D."/>
<person name="Marcelli M."/>
<person name="Wilson J.D."/>
<person name="McPhaul M.J."/>
</authorList>
<dbReference type="PubMed" id="2911578"/>
<dbReference type="DOI" id="10.1073/pnas.86.1.327"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="9534" last="9538">
<title>Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity.</title>
<authorList>
<person name="Lubahn D.B."/>
<person name="Brown T.R."/>
<person name="Simental J.A."/>
<person name="Higgs H.N."/>
<person name="Migeon C.J."/>
<person name="Wilson E.M."/>
<person name="French F.S."/>
</authorList>
<dbReference type="PubMed" id="2594783"/>
<dbReference type="DOI" id="10.1073/pnas.86.23.9534"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT AIS MET-867</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1990" name="Mol. Endocrinol." volume="4" first="417" last="427">
<title>Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor.</title>
<authorList>
<person name="Govindan M.V."/>
</authorList>
<dbReference type="PubMed" id="2342476"/>
<dbReference type="DOI" id="10.1210/mend-4-3-417"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1990" name="Mol. Endocrinol." volume="4" first="1105" last="1116">
<title>Definition of the human androgen receptor gene structure permits the identification of mutations that cause androgen resistance: premature termination of the receptor protein at amino acid residue 588 causes complete androgen resistance.</title>
<authorList>
<person name="Marcelli M."/>
<person name="Tilley W.D."/>
<person name="Wilson C.M."/>
<person name="Griffin J.E."/>
<person name="Wilson J.D."/>
<person name="McPhaul M.J."/>
</authorList>
<dbReference type="PubMed" id="2293020"/>
<dbReference type="DOI" id="10.1210/mend-4-8-1105"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2005" name="FEBS J." volume="272" first="74" last="84">
<title>Androgen receptor function is modulated by the tissue-specific AR45 variant.</title>
<authorList>
<person name="Ahrens-Fath I."/>
<person name="Politz O."/>
<person name="Geserick C."/>
<person name="Haendler B."/>
</authorList>
<dbReference type="PubMed" id="15634333"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.2004.04395.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING (ISOFORM 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2009" name="Cancer Res." volume="69" first="2305" last="2313">
<title>A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.</title>
<authorList>
<person name="Guo Z."/>
<person name="Yang X."/>
<person name="Sun F."/>
<person name="Jiang R."/>
<person name="Linn D.E."/>
<person name="Chen H."/>
<person name="Chen H."/>
<person name="Kong X."/>
<person name="Melamed J."/>
<person name="Tepper C.G."/>
<person name="Kung H.J."/>
<person name="Brodie A.M."/>
<person name="Edwards J."/>
<person name="Qiu Y."/>
</authorList>
<dbReference type="PubMed" id="19244107"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-08-3795"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4)</scope>
<scope>VARIANT GLN-57</scope>
<scope>FUNCTION (ISOFORMS 3 AND 4)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM 3)</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2005" name="Nature" volume="434" first="325" last="337">
<title>The DNA sequence of the human X chromosome.</title>
<authorList>
<person name="Ross M.T."/>
<person name="Grafham D.V."/>
<person name="Coffey A.J."/>
<person name="Scherer S."/>
<person name="McLay K."/>
<person name="Muzny D."/>
<person name="Platzer M."/>
<person name="Howell G.R."/>
<person name="Burrows C."/>
<person name="Bird C.P."/>
<person name="Frankish A."/>
<person name="Lovell F.L."/>
<person name="Howe K.L."/>
<person name="Ashurst J.L."/>
<person name="Fulton R.S."/>
<person name="Sudbrak R."/>
<person name="Wen G."/>
<person name="Jones M.C."/>
<person name="Hurles M.E."/>
<person name="Andrews T.D."/>
<person name="Scott C.E."/>
<person name="Searle S."/>
<person name="Ramser J."/>
<person name="Whittaker A."/>
<person name="Deadman R."/>
<person name="Carter N.P."/>
<person name="Hunt S.E."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Gunaratne P."/>
<person name="Havlak P."/>
<person name="Hodgson A."/>
<person name="Metzker M.L."/>
<person name="Richards S."/>
<person name="Scott G."/>
<person name="Steffen D."/>
<person name="Sodergren E."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Ainscough R."/>
<person name="Ambrose K.D."/>
<person name="Ansari-Lari M.A."/>
<person name="Aradhya S."/>
<person name="Ashwell R.I."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Ballabio A."/>
<person name="Banerjee R."/>
<person name="Barker G.E."/>
<person name="Barlow K.F."/>
<person name="Barrett I.P."/>
<person name="Bates K.N."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Beck A."/>
<person name="Bethel G."/>
<person name="Blechschmidt K."/>
<person name="Brady N."/>
<person name="Bray-Allen S."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Brown M.J."/>
<person name="Bonnin D."/>
<person name="Bruford E.A."/>
<person name="Buhay C."/>
<person name="Burch P."/>
<person name="Burford D."/>
<person name="Burgess J."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Bye J.M."/>
<person name="Carder C."/>
<person name="Carrel L."/>
<person name="Chako J."/>
<person name="Chapman J.C."/>
<person name="Chavez D."/>
<person name="Chen E."/>
<person name="Chen G."/>
<person name="Chen Y."/>
<person name="Chen Z."/>
<person name="Chinault C."/>
<person name="Ciccodicola A."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Clerc-Blankenburg K."/>
<person name="Clifford K."/>
<person name="Cobley V."/>
<person name="Cole C.G."/>
<person name="Conquer J.S."/>
<person name="Corby N."/>
<person name="Connor R.E."/>
<person name="David R."/>
<person name="Davies J."/>
<person name="Davis C."/>
<person name="Davis J."/>
<person name="Delgado O."/>
<person name="Deshazo D."/>
<person name="Dhami P."/>
<person name="Ding Y."/>
<person name="Dinh H."/>
<person name="Dodsworth S."/>
<person name="Draper H."/>
<person name="Dugan-Rocha S."/>
<person name="Dunham A."/>
<person name="Dunn M."/>
<person name="Durbin K.J."/>
<person name="Dutta I."/>
<person name="Eades T."/>
<person name="Ellwood M."/>
<person name="Emery-Cohen A."/>
<person name="Errington H."/>
<person name="Evans K.L."/>
<person name="Faulkner L."/>
<person name="Francis F."/>
<person name="Frankland J."/>
<person name="Fraser A.E."/>
<person name="Galgoczy P."/>
<person name="Gilbert J."/>
<person name="Gill R."/>
<person name="Gloeckner G."/>
<person name="Gregory S.G."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gu Y."/>
<person name="Gwilliam R."/>
<person name="Hamilton C."/>
<person name="Hart E.A."/>
<person name="Hawes A."/>
<person name="Heath P.D."/>
<person name="Heitmann K."/>
<person name="Hennig S."/>
<person name="Hernandez J."/>
<person name="Hinzmann B."/>
<person name="Ho S."/>
<person name="Hoffs M."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hume J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Isherwood J."/>
<person name="Jacob L."/>
<person name="Johnson D."/>
<person name="Jones S."/>
<person name="de Jong P.J."/>
<person name="Joseph S.S."/>
<person name="Keenan S."/>
<person name="Kelly S."/>
<person name="Kershaw J.K."/>
<person name="Khan Z."/>
<person name="Kioschis P."/>
<person name="Klages S."/>
<person name="Knights A.J."/>
<person name="Kosiura A."/>
<person name="Kovar-Smith C."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leversha M."/>
<person name="Lewis L."/>
<person name="Liu W."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loulseged H."/>
<person name="Loveland J.E."/>
<person name="Lovell J.D."/>
<person name="Lozado R."/>
<person name="Lu J."/>
<person name="Lyne R."/>
<person name="Ma J."/>
<person name="Maheshwari M."/>
<person name="Matthews L.H."/>
<person name="McDowall J."/>
<person name="McLaren S."/>
<person name="McMurray A."/>
<person name="Meidl P."/>
<person name="Meitinger T."/>
<person name="Milne S."/>
<person name="Miner G."/>
<person name="Mistry S.L."/>
<person name="Morgan M."/>
<person name="Morris S."/>
<person name="Mueller I."/>
<person name="Mullikin J.C."/>
<person name="Nguyen N."/>
<person name="Nordsiek G."/>
<person name="Nyakatura G."/>
<person name="O'dell C.N."/>
<person name="Okwuonu G."/>
<person name="Palmer S."/>
<person name="Pandian R."/>
<person name="Parker D."/>
<person name="Parrish J."/>
<person name="Pasternak S."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Pearson D.M."/>
<person name="Pelan S.E."/>
<person name="Perez L."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Reichwald K."/>
<person name="Rhodes S."/>
<person name="Ridler K.A."/>
<person name="Schlessinger D."/>
<person name="Schueler M.G."/>
<person name="Sehra H.K."/>
<person name="Shaw-Smith C."/>
<person name="Shen H."/>
<person name="Sheridan E.M."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Sotheran E.C."/>
<person name="Steingruber H.E."/>
<person name="Steward C.A."/>
<person name="Storey R."/>
<person name="Swann R.M."/>
<person name="Swarbreck D."/>
<person name="Tabor P.E."/>
<person name="Taudien S."/>
<person name="Taylor T."/>
<person name="Teague B."/>
<person name="Thomas K."/>
<person name="Thorpe A."/>
<person name="Timms K."/>
<person name="Tracey A."/>
<person name="Trevanion S."/>
<person name="Tromans A.C."/>
<person name="d'Urso M."/>
<person name="Verduzco D."/>
<person name="Villasana D."/>
<person name="Waldron L."/>
<person name="Wall M."/>
<person name="Wang Q."/>
<person name="Warren J."/>
<person name="Warry G.L."/>
<person name="Wei X."/>
<person name="West A."/>
<person name="Whitehead S.L."/>
<person name="Whiteley M.N."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams G."/>
<person name="Williams L."/>
<person name="Williamson A."/>
<person name="Williamson H."/>
<person name="Wilming L."/>
<person name="Woodmansey R.L."/>
<person name="Wray P.W."/>
<person name="Yen J."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Zoghbi H."/>
<person name="Zorilla S."/>
<person name="Buck D."/>
<person name="Reinhardt R."/>
<person name="Poustka A."/>
<person name="Rosenthal A."/>
<person name="Lehrach H."/>
<person name="Meindl A."/>
<person name="Minx P.J."/>
<person name="Hillier L.W."/>
<person name="Willard H.F."/>
<person name="Wilson R.K."/>
<person name="Waterston R.H."/>
<person name="Rice C.M."/>
<person name="Vaudin M."/>
<person name="Coulson A."/>
<person name="Nelson D.L."/>
<person name="Weinstock G."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Gibbs R.A."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="15772651"/>
<dbReference type="DOI" id="10.1038/nature03440"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1989" name="Mol. Cell. Endocrinol." volume="61" first="257" last="262">
<title>The N-terminal domain of the human androgen receptor is encoded by one, large exon.</title>
<authorList>
<person name="Faber P.W."/>
<person name="Kuiper G.G.J.M."/>
<person name="van Rooij H.C.J."/>
<person name="van der Korput J.A.G.M."/>
<person name="Brinkmann A.O."/>
<person name="Trapman J."/>
</authorList>
<dbReference type="PubMed" id="2917688"/>
<dbReference type="DOI" id="10.1016/0303-7207(89)90137-8"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-539</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1988" name="Science" volume="240" first="324" last="326">
<title>Molecular cloning of human and rat complementary DNA encoding androgen receptors.</title>
<authorList>
<person name="Chang C."/>
<person name="Kokontis J."/>
<person name="Liao S."/>
</authorList>
<dbReference type="PubMed" id="3353726"/>
<dbReference type="DOI" id="10.1126/science.3353726"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 191-920 (ISOFORM 1)</scope>
</reference>
<reference key="14">
<citation type="submission" date="1995-02" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Lu J."/>
<person name="Danielsen M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 448-476</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="1988" name="Biochem. Biophys. Res. Commun." volume="153" first="241" last="248">
<title>Cloning, structure and expression of a cDNA encoding the human androgen receptor.</title>
<authorList>
<person name="Trapman J."/>
<person name="Klaassen P."/>
<person name="Kuiper G.G.J.M."/>
<person name="van der Korput J.A.G.M."/>
<person name="Faber P.W."/>
<person name="van Rooij H.C.J."/>
<person name="Geurts van Kessel A."/>
<person name="Voorhorst M.M."/>
<person name="Mulder E."/>
<person name="Brinkmann A.O."/>
</authorList>
<dbReference type="PubMed" id="3377788"/>
<dbReference type="DOI" id="10.1016/S0006-291X(88)81214-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 470-920 (ISOFORM 1)</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1989" name="J. Mol. Endocrinol." volume="2" first="R1" last="R4">
<title>Structural organization of the human androgen receptor gene.</title>
<authorList>
<person name="Kuiper G.G."/>
<person name="Faber P.W."/>
<person name="van Rooij H.C."/>
<person name="van der Korput J.A."/>
<person name="Ris-Stalpers C."/>
<person name="Klaassen P."/>
<person name="Trapman J."/>
<person name="Brinkmann A.O."/>
</authorList>
<dbReference type="PubMed" id="2546571"/>
<dbReference type="DOI" id="10.1677/jme.0.002R001"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 537-541; 587-591; 626-630; 722-726; 770-774; 814-817 AND 866-870</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1993" name="Mol. Endocrinol." volume="7" first="861" last="869">
<title>A point mutation in the second zinc finger of the DNA-binding domain of the androgen receptor gene causes complete androgen insensitivity in two siblings with receptor-positive androgen resistance.</title>
<authorList>
<person name="Mowszowicz I."/>
<person name="Lee H.-J."/>
<person name="Chen H.-T."/>
<person name="Mestayer C."/>
<person name="Portois M.-C."/>
<person name="Cabrol S."/>
<person name="Mauvais-Jarvis P."/>
<person name="Chang C."/>
</authorList>
<dbReference type="PubMed" id="8413310"/>
<dbReference type="DOI" id="10.1210/mend.7.7.8413310"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 558-625 (ISOFORMS 1/2)</scope>
<scope>VARIANT AIS HIS-616</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="1988" name="Science" volume="240" first="327" last="330">
<title>Cloning of human androgen receptor complementary DNA and localization to the X chromosome.</title>
<authorList>
<person name="Lubahn D.B."/>
<person name="Joseph D.R."/>
<person name="Sullivan P.M."/>
<person name="Willard H.F."/>
<person name="French F.S."/>
<person name="Wilson E.M."/>
</authorList>
<dbReference type="PubMed" id="3353727"/>
<dbReference type="DOI" id="10.1126/science.3353727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 560-625 (ISOFORMS 1/2)</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1991" name="Mol. Endocrinol." volume="5" first="1562" last="1569">
<title>Substitution of aspartic acid-686 by histidine or asparagine in the human androgen receptor leads to a functionally inactive protein with altered hormone-binding characteristics.</title>
<authorList>
<person name="Ris-Stalpers C."/>
<person name="Trifiro M.A."/>
<person name="Kuiper G.G.J.M."/>
<person name="Jenster G."/>
<person name="Romalo G."/>
<person name="Sai T."/>
<person name="van Rooij H.C.J."/>
<person name="Kaufman M."/>
<person name="Rosenfield R.L."/>
<person name="Liao S."/>
<person name="Schweikert H.-U."/>
<person name="Trapman J."/>
<person name="Pinsky L."/>
<person name="Brinkmann A.O."/>
</authorList>
<dbReference type="PubMed" id="1775137"/>
<dbReference type="DOI" id="10.1210/mend-5-10-1562"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 630-724</scope>
<scope>VARIANTS AIS ASN-696 AND HIS-696</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1992" name="Nucleic Acids Res." volume="20" first="1427" last="1427">
<title>Trinucleotide repeat polymorphism in the androgen receptor gene (AR).</title>
<authorList>
<person name="Sleddens H.F.B.M."/>
<person name="Oostra B.A."/>
<person name="Brinkmann A.O."/>
<person name="Trapman J."/>
</authorList>
<dbReference type="PubMed" id="1561105"/>
<dbReference type="DOI" id="10.1093/nar/20.6.1427-a"/>
</citation>
<scope>POLYMORPHISM OF POLY-GLN REGION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="3320" last="3323">
<title>The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.</title>
<authorList>
<person name="Giovannucci E."/>
<person name="Stampfer M.J."/>
<person name="Krithivas K."/>
<person name="Brown M."/>
<person name="Dahl D."/>
<person name="Brufsky A."/>
<person name="Talcott J."/>
<person name="Hennekens C.H."/>
<person name="Kantoff P.W."/>
</authorList>
<dbReference type="PubMed" id="9096391"/>
<dbReference type="DOI" id="10.1073/pnas.94.7.3320"/>
</citation>
<scope>POLYMORPHISM OF POLY-GLN REGION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="8272" last="8272">
<authorList>
<person name="Giovannucci E."/>
<person name="Stampfer M.J."/>
<person name="Krithivas K."/>
<person name="Brown M."/>
<person name="Dahl D."/>
<person name="Brufsky A."/>
<person name="Talcott J."/>
<person name="Hennekens C.H."/>
<person name="Kantoff P.W."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="977" last="987">
<title>PQBP-1, a novel polyglutamine tract binding protein, inhibits transcription activation by Brn-2 and affects cell survival.</title>
<authorList>
<person name="Waragai M."/>
<person name="Lammers C.-H."/>
<person name="Takeuchi S."/>
<person name="Imafuku I."/>
<person name="Udagawa Y."/>
<person name="Kanazawa I."/>
<person name="Kawabata M."/>
<person name="Mouradian M.M."/>
<person name="Okazawa H."/>
</authorList>
<dbReference type="PubMed" id="10332029"/>
<dbReference type="DOI" id="10.1093/hmg/8.6.977"/>
</citation>
<scope>INTERACTION WITH PQBP1</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="8316" last="8321">
<title>Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate.</title>
<authorList>
<person name="Fujimoto N."/>
<person name="Yeh S."/>
<person name="Kang H.-Y."/>
<person name="Inui S."/>
<person name="Chang H.-C."/>
<person name="Mizokami A."/>
<person name="Chang C."/>
</authorList>
<dbReference type="PubMed" id="10075738"/>
<dbReference type="DOI" id="10.1074/jbc.274.12.8316"/>
</citation>
<scope>INTERACTION WITH TGFB1I1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="19441" last="19446">
<title>Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription.</title>
<authorList>
<person name="Poukka H."/>
<person name="Aarnisalo P."/>
<person name="Karvonen U."/>
<person name="Palvimo J.J."/>
<person name="Jaenne O.A."/>
</authorList>
<dbReference type="PubMed" id="10383460"/>
<dbReference type="DOI" id="10.1074/jbc.274.27.19441"/>
</citation>
<scope>INTERACTION WITH UBE2I</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="20229" last="20234">
<title>The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator.</title>
<authorList>
<person name="Hsiao P.-W."/>
<person name="Lin D.-L."/>
<person name="Nakao R."/>
<person name="Chang C."/>
</authorList>
<dbReference type="PubMed" id="10400640"/>
<dbReference type="DOI" id="10.1074/jbc.274.29.20229"/>
</citation>
<scope>INTERACTION WITH RAN</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="1216" last="1225">
<title>PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression.</title>
<authorList>
<person name="Oettgen P."/>
<person name="Finger E."/>
<person name="Sun Z."/>
<person name="Akbarali Y."/>
<person name="Thamrongsak U."/>
<person name="Boltax J."/>
<person name="Grall F."/>
<person name="Dube A."/>
<person name="Weiss A."/>
<person name="Brown L."/>
<person name="Quinn G."/>
<person name="Kas K."/>
<person name="Endress G."/>
<person name="Kunsch C."/>
<person name="Libermann T.A."/>
</authorList>
<dbReference type="PubMed" id="10625666"/>
<dbReference type="DOI" id="10.1074/jbc.275.2.1216"/>
</citation>
<scope>INTERACTION WITH SPDEF</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="35200" last="35208">
<title>Androgen receptor interacts with a novel MYST protein, HBO1.</title>
<authorList>
<person name="Sharma M."/>
<person name="Zarnegar M."/>
<person name="Li X."/>
<person name="Lim B."/>
<person name="Sun Z."/>
</authorList>
<dbReference type="PubMed" id="10930412"/>
<dbReference type="DOI" id="10.1074/jbc.M004838200"/>
</citation>
<scope>INTERACTION WITH KAT7</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="14145" last="14150">
<title>Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).</title>
<authorList>
<person name="Poukka H."/>
<person name="Karvonen U."/>
<person name="Jaenne O.A."/>
<person name="Palvimo J.J."/>
</authorList>
<dbReference type="PubMed" id="11121022"/>
<dbReference type="DOI" id="10.1073/pnas.97.26.14145"/>
</citation>
<scope>SUMOYLATION AT LYS-388 AND LYS-521</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="48020" last="48027">
<title>RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor.</title>
<authorList>
<person name="Rao M.A."/>
<person name="Cheng H."/>
<person name="Quayle A.N."/>
<person name="Nishitani H."/>
<person name="Nelson C.C."/>
<person name="Rennie P.S."/>
</authorList>
<dbReference type="PubMed" id="12361945"/>
<dbReference type="DOI" id="10.1074/jbc.M209741200"/>
</citation>
<scope>INTERACTION WITH RANBP9</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="30031" last="30039">
<title>Activation function-1 domain of androgen receptor contributes to the interaction between subnuclear splicing factor compartment and nuclear receptor compartment. Identification of the p102 U5 small nuclear ribonucleoprotein particle-binding protein as a coactivator for the receptor.</title>
<authorList>
<person name="Zhao Y."/>
<person name="Goto K."/>
<person name="Saitoh M."/>
<person name="Yanase T."/>
<person name="Nomura M."/>
<person name="Okabe T."/>
<person name="Takayanagi R."/>
<person name="Nawata H."/>
</authorList>
<dbReference type="PubMed" id="12039962"/>
<dbReference type="DOI" id="10.1074/jbc.M203811200"/>
</citation>
<scope>INTERACTION WITH PRPF6</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="14783" last="14788">
<title>Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade.</title>
<authorList>
<person name="Wong C.-W."/>
<person name="McNally C."/>
<person name="Nickbarg E."/>
<person name="Komm B.S."/>
<person name="Cheskis B.J."/>
</authorList>
<dbReference type="PubMed" id="12415108"/>
<dbReference type="DOI" id="10.1073/pnas.192569699"/>
</citation>
<scope>INTERACTION WITH PELP1</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2003" name="EMBO J." volume="22" first="6101" last="6114">
<title>hZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci.</title>
<authorList>
<person name="Sharma M."/>
<person name="Li X."/>
<person name="Wang Y."/>
<person name="Zarnegar M."/>
<person name="Huang C.-Y."/>
<person name="Palvimo J.J."/>
<person name="Lim B."/>
<person name="Sun Z."/>
</authorList>
<dbReference type="PubMed" id="14609956"/>
<dbReference type="DOI" id="10.1093/emboj/cdg585"/>
</citation>
<scope>INTERACTION WITH ZMIZ1</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="46087" last="46093">
<title>The scaffolding protein RACK1 interacts with androgen receptor and promotes cross-talk through a protein kinase C signaling pathway.</title>
<authorList>
<person name="Rigas A.C."/>
<person name="Ozanne D.M."/>
<person name="Neal D.E."/>
<person name="Robson C.N."/>
</authorList>
<dbReference type="PubMed" id="12958311"/>
<dbReference type="DOI" id="10.1074/jbc.M306219200"/>
</citation>
<scope>INTERACTION WITH RACK1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2003" name="J. Mol. Endocrinol." volume="31" first="583" last="596">
<title>The retinoblastoma protein-associated transcription repressor RBaK interacts with the androgen receptor and enhances its transcriptional activity.</title>
<authorList>
<person name="Hofman K."/>
<person name="Swinnen J.V."/>
<person name="Claessens F."/>
<person name="Verhoeven G."/>
<person name="Heyns W."/>
</authorList>
<dbReference type="PubMed" id="14664718"/>
<dbReference type="DOI" id="10.1677/jme.0.0310583"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RBAK</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2003" name="Mol. Cancer Res." volume="1" first="247" last="261">
<title>DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex.</title>
<authorList>
<person name="Niki T."/>
<person name="Takahashi-Niki K."/>
<person name="Taira T."/>
<person name="Iguchi-Ariga S.M.M."/>
<person name="Ariga H."/>
</authorList>
<dbReference type="PubMed" id="12612053"/>
</citation>
<scope>INTERACTION WITH EFCAB6</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="1922" last="1931">
<title>Mechanism of p21-activated kinase 6-mediated inhibition of androgen receptor signaling.</title>
<authorList>
<person name="Schrantz N."/>
<person name="da Silva Correia J."/>
<person name="Fowler B."/>
<person name="Ge Q."/>
<person name="Sun Z."/>
<person name="Bokoch G.M."/>
</authorList>
<dbReference type="PubMed" id="14573606"/>
<dbReference type="DOI" id="10.1074/jbc.M311145200"/>
</citation>
<scope>PHOSPHORYLATION BY PAK6</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2005" name="J. Cell Biol." volume="170" first="191" last="200">
<title>Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors.</title>
<authorList>
<person name="Mills I.G."/>
<person name="Gaughan L."/>
<person name="Robson C."/>
<person name="Ross T."/>
<person name="McCracken S."/>
<person name="Kelly J."/>
<person name="Neal D.E."/>
</authorList>
<dbReference type="PubMed" id="16027218"/>
<dbReference type="DOI" id="10.1083/jcb.200503106"/>
</citation>
<scope>INTERACTION WITH HIP1</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2005" name="Mol. Endocrinol." volume="19" first="2915" last="2929">
<title>hZimp7, a novel PIAS-like protein, enhances androgen receptor-mediated transcription and interacts with SWI/SNF-like BAF complexes.</title>
<authorList>
<person name="Huang C.-Y."/>
<person name="Beliakoff J."/>
<person name="Li X."/>
<person name="Lee J."/>
<person name="Li X."/>
<person name="Sharma M."/>
<person name="Lim B."/>
<person name="Sun Z."/>
</authorList>
<dbReference type="PubMed" id="16051670"/>
<dbReference type="DOI" id="10.1210/me.2005-0097"/>
</citation>
<scope>INTERACTION WITH ZMIZ2</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2006" name="Cancer Cell" volume="10" first="309" last="319">
<title>Regulation of androgen receptor activity by tyrosine phosphorylation.</title>
<authorList>
<person name="Guo Z."/>
<person name="Dai B."/>
<person name="Jiang T."/>
<person name="Xu K."/>
<person name="Xie Y."/>
<person name="Kim O."/>
<person name="Nesheiwat I."/>
<person name="Kong X."/>
<person name="Melamed J."/>
<person name="Handratta V.D."/>
<person name="Njar V.C."/>
<person name="Brodie A.M."/>
<person name="Yu L.-R."/>
<person name="Veenstra T.D."/>
<person name="Chen H."/>
<person name="Qiu Y."/>
</authorList>
<dbReference type="PubMed" id="17045208"/>
<dbReference type="DOI" id="10.1016/j.ccr.2006.08.021"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-225; TYR-269; TYR-309; TYR-348; TYR-359; TYR-364; TYR-365; TYR-395; TYR-535; TYR-552 AND TYR-916</scope>
<scope>MUTAGENESIS OF TYR-225; TYR-269; TYR-309; TYR-348; TYR-359; TYR-364; TYR-365; TYR-395; TYR-535; TYR-552 AND TYR-916</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2007" name="Cancer Cell" volume="11" first="97" last="97">
<authorList>
<person name="Guo Z."/>
<person name="Dai B."/>
<person name="Jiang T."/>
<person name="Xu K."/>
<person name="Xie Y."/>
<person name="Kim O."/>
<person name="Nesheiwat I."/>
<person name="Kong X."/>
<person name="Melamed J."/>
<person name="Handratta V.D."/>
<person name="Njar V.C."/>
<person name="Brodie A.M."/>
<person name="Yu L.-R."/>
<person name="Veenstra T.D."/>
<person name="Chen H."/>
<person name="Qiu Y."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="8439" last="8447">
<title>Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells.</title>
<authorList>
<person name="Ma A.H."/>
<person name="Xia L."/>
<person name="Desai S.J."/>
<person name="Boucher D.L."/>
<person name="Guan Y."/>
<person name="Shih H.M."/>
<person name="Shi X.B."/>
<person name="deVere White R.W."/>
<person name="Chen H.W."/>
<person name="Tepper C.G."/>
<person name="Kung H.J."/>
</authorList>
<dbReference type="PubMed" id="16951154"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-06-1636"/>
</citation>
<scope>INTERACTION WITH MAK</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2007" name="J. Steroid Biochem. Mol. Biol." volume="107" first="1" last="14">
<title>PRMT2, a member of the protein arginine methyltransferase family, is a coactivator of the androgen receptor.</title>
<authorList>
<person name="Meyer R."/>
<person name="Wolf S.S."/>
<person name="Obendorf M."/>
</authorList>
<dbReference type="PubMed" id="17587566"/>
<dbReference type="DOI" id="10.1016/j.jsbmb.2007.05.006"/>
</citation>
<scope>INTERACTION WITH PRMT2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2007" name="Mol. Endocrinol." volume="21" first="2056" last="2070">
<title>The zinc finger protein Ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer.</title>
<authorList>
<person name="Mukhopadhyay N.K."/>
<person name="Cinar B."/>
<person name="Mukhopadhyay L."/>
<person name="Lutchman M."/>
<person name="Ferdinand A.S."/>
<person name="Kim J."/>
<person name="Chung L.W.K."/>
<person name="Adam R.M."/>
<person name="Ray S.K."/>
<person name="Leiter A.B."/>
<person name="Richie J.P."/>
<person name="Liu B.C.-S."/>
<person name="Freeman M.R."/>
</authorList>
<dbReference type="PubMed" id="17550981"/>
<dbReference type="DOI" id="10.1210/me.2006-0503"/>
</citation>
<scope>INTERACTION WITH RREB1</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2008" name="Biochem. Biophys. Res. Commun." volume="368" first="121" last="125">
<title>RanBP10 acts as a novel coactivator for the androgen receptor.</title>
<authorList>
<person name="Harada N."/>
<person name="Yokoyama T."/>
<person name="Yamaji R."/>
<person name="Nakano Y."/>
<person name="Inui H."/>
</authorList>
<dbReference type="PubMed" id="18222118"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2008.01.072"/>
</citation>
<scope>INTERACTION WITH RANBP10</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="8438" last="8443">
<title>Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.</title>
<authorList>
<person name="Mahajan N.P."/>
<person name="Liu Y."/>
<person name="Majumder S."/>
<person name="Warren M.R."/>
<person name="Parker C.E."/>
<person name="Mohler J.L."/>
<person name="Earp H.S."/>
<person name="Whang Y.E."/>
</authorList>
<dbReference type="PubMed" id="17494760"/>
<dbReference type="DOI" id="10.1073/pnas.0700420104"/>
</citation>
<scope>INTERACTION WITH TNK2</scope>
<scope>PHOSPHORYLATION AT TYR-269 AND TYR-365 BY TNK2</scope>
<scope>MUTAGENESIS OF TYR-269 AND TYR-365</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2008" name="Cancer Res." volume="68" first="3486" last="3494">
<title>TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells.</title>
<authorList>
<person name="Miyajima N."/>
<person name="Maruyama S."/>
<person name="Bohgaki M."/>
<person name="Kano S."/>
<person name="Shigemura M."/>
<person name="Shinohara N."/>
<person name="Nonomura K."/>
<person name="Hatakeyama S."/>
</authorList>
<dbReference type="PubMed" id="18451177"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-07-6059"/>
</citation>
<scope>INTERACTION WITH TRIM68</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2008" name="Mol. Endocrinol." volume="22" first="1606" last="1621">
<title>Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells.</title>
<authorList>
<person name="Kaulfuss S."/>
<person name="Grzmil M."/>
<person name="Hemmerlein B."/>
<person name="Thelen P."/>
<person name="Schweyer S."/>
<person name="Neesen J."/>
<person name="Bubendorf L."/>
<person name="Glass A.G."/>
<person name="Jarry H."/>
<person name="Auber B."/>
<person name="Burfeind P."/>
</authorList>
<dbReference type="PubMed" id="18451096"/>
<dbReference type="DOI" id="10.1210/me.2006-0546"/>
</citation>
<scope>INTERACTION WITH LPXN</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2008" name="Oncogene" volume="27" first="3292" last="3300">
<title>ZIP kinase plays a crucial role in androgen receptor-mediated transcription.</title>
<authorList>
<person name="Leister P."/>
<person name="Felten A."/>
<person name="Chasan A.I."/>
<person name="Scheidtmann K.H."/>
</authorList>
<dbReference type="PubMed" id="18084323"/>
<dbReference type="DOI" id="10.1038/sj.onc.1210995"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ZIPK/DAPK3</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2009" name="Biochim. Biophys. Acta" volume="1793" first="1828" last="1836">
<title>TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.</title>
<authorList>
<person name="Kikuchi M."/>
<person name="Okumura F."/>
<person name="Tsukiyama T."/>
<person name="Watanabe M."/>
<person name="Miyajima N."/>
<person name="Tanaka J."/>
<person name="Imamura M."/>
<person name="Hatakeyama S."/>
</authorList>
<dbReference type="PubMed" id="19909775"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2009.11.001"/>
</citation>
<scope>INTERACTION WITH TRIM24</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2009" name="Cancer Cell" volume="15" first="270" last="282">
<title>Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination.</title>
<authorList>
<person name="Xu K."/>
<person name="Shimelis H."/>
<person name="Linn D.E."/>
<person name="Jiang R."/>
<person name="Yang X."/>
<person name="Sun F."/>
<person name="Guo Z."/>
<person name="Chen H."/>
<person name="Li W."/>
<person name="Chen H."/>
<person name="Kong X."/>
<person name="Melamed J."/>
<person name="Fang S."/>
<person name="Xiao Z."/>
<person name="Veenstra T.D."/>
<person name="Qiu Y."/>
</authorList>
<dbReference type="PubMed" id="19345326"/>
<dbReference type="DOI" id="10.1016/j.ccr.2009.02.021"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>POLYUBIQUITINATION AT LYS-846 AND LYS-848 BY RNF6</scope>
<scope>MUTAGENESIS OF LYS-846 AND LYS-848</scope>
<scope>INTERACTION WITH RNF14 AND RNF6</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2010" name="Mol. Endocrinol." volume="24" first="2267" last="2280">
<title>CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation.</title>
<authorList>
<person name="Gordon V."/>
<person name="Bhadel S."/>
<person name="Wunderlich W."/>
<person name="Zhang J."/>
<person name="Ficarro S.B."/>
<person name="Mollah S.A."/>
<person name="Shabanowitz J."/>
<person name="Hunt D.F."/>
<person name="Xenarios I."/>
<person name="Hahn W.C."/>
<person name="Conaway M."/>
<person name="Carey M.F."/>
<person name="Gioeli D."/>
</authorList>
<dbReference type="PubMed" id="20980437"/>
<dbReference type="DOI" id="10.1210/me.2010-0238"/>
</citation>
<scope>FUNCTION IN AR KINASE</scope>
<scope>PHOSPHORYLATION AT SER-83 BY CDK9</scope>
<scope>MUTAGENESIS OF SER-83</scope>
<scope>INTERACTION WITH CDK9</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2010" name="Mol. Cancer Res." volume="8" first="844" last="854">
<title>The deubiquitinating enzyme USP26 is a regulator of androgen receptor signaling.</title>
<authorList>
<person name="Dirac A.M."/>
<person name="Bernards R."/>
</authorList>
<dbReference type="PubMed" id="20501646"/>
<dbReference type="DOI" id="10.1158/1541-7786.MCR-09-0424"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION</scope>
<scope>INTERACTION WITH USP26</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2010" name="Prostate" volume="70" first="1274" last="1285">
<title>Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity.</title>
<authorList>
<person name="Mahajan K."/>
<person name="Challa S."/>
<person name="Coppola D."/>
<person name="Lawrence H."/>
<person name="Luo Y."/>
<person name="Gevariya H."/>
<person name="Zhu W."/>
<person name="Chen Y.A."/>
<person name="Lawrence N.J."/>
<person name="Mahajan N.P."/>
</authorList>
<dbReference type="PubMed" id="20623637"/>
<dbReference type="DOI" id="10.1002/pros.21163"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-269</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2011" name="Cancer Res." volume="71" first="4303" last="4313">
<title>MST1 is a multifunctional caspase-independent inhibitor of androgenic signaling.</title>
<authorList>
<person name="Cinar B."/>
<person name="Collak F.K."/>
<person name="Lopez D."/>
<person name="Akgul S."/>
<person name="Mukhopadhyay N.K."/>
<person name="Kilicarslan M."/>
<person name="Gioeli D.G."/>
<person name="Freeman M.R."/>
</authorList>
<dbReference type="PubMed" id="21512132"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-10-4532"/>
</citation>
<scope>PHOSPHORYLATION AT SER-651</scope>
<scope>INTERACTION WITH STK4/MST1</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2011" name="Nature" volume="480" first="552" last="556">
<title>Cryptochromes mediate rhythmic repression of the glucocorticoid receptor.</title>
<authorList>
<person name="Lamia K.A."/>
<person name="Papp S.J."/>
<person name="Yu R.T."/>
<person name="Barish G.D."/>
<person name="Uhlenhaut N.H."/>
<person name="Jonker J.W."/>
<person name="Downes M."/>
<person name="Evans R.M."/>
</authorList>
<dbReference type="PubMed" id="22170608"/>
<dbReference type="DOI" id="10.1038/nature10700"/>
</citation>
<scope>INTERACTION WITH CRY1</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2012" name="Mol. Biol. Cell" volume="23" first="188" last="199">
<title>DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors.</title>
<authorList>
<person name="Pedram A."/>
<person name="Razandi M."/>
<person name="Deschenes R.J."/>
<person name="Levin E.R."/>
</authorList>
<dbReference type="PubMed" id="22031296"/>
<dbReference type="DOI" id="10.1091/mbc.E11-07-0638"/>
</citation>
<scope>PALMITOYLATION</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2013" name="Nucleic Acids Res." volume="41" first="8526" last="8536">
<title>CCAR1 promotes chromatin loading of androgen receptor (AR) transcription complex by stabilizing the association between AR and GATA2.</title>
<authorList>
<person name="Seo W.Y."/>
<person name="Jeong B.C."/>
<person name="Yu E.J."/>
<person name="Kim H.J."/>
<person name="Kim S.H."/>
<person name="Lim J.E."/>
<person name="Kwon G.Y."/>
<person name="Lee H.M."/>
<person name="Kim J.H."/>
</authorList>
<dbReference type="PubMed" id="23887938"/>
<dbReference type="DOI" id="10.1093/nar/gkt644"/>
</citation>
<scope>INTERACTION WITH CCAR1 AND GATA2</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96 AND SER-258</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="61">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="26164" last="26171">
<title>Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations.</title>
<authorList>
<person name="Matias P.M."/>
<person name="Donner P."/>
<person name="Coelho R."/>
<person name="Thomaz M."/>
<person name="Peixoto C."/>
<person name="Macedo S."/>
<person name="Otto N."/>
<person name="Joschko S."/>
<person name="Scholz P."/>
<person name="Wegg A."/>
<person name="Baesler S."/>
<person name="Schaefer M."/>
<person name="Egner U."/>
<person name="Carrondo M.A."/>
</authorList>
<dbReference type="PubMed" id="10840043"/>
<dbReference type="DOI" id="10.1074/jbc.M004571200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 658-920</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2002" name="J. Med. Chem." volume="45" first="1439" last="1446">
<title>Structural basis for the glucocorticoid response in a mutant human androgen receptor (AR(ccr)) derived from an androgen-independent prostate cancer.</title>
<authorList>
<person name="Matias P.M."/>
<person name="Carrondo M.A."/>
<person name="Coelho R."/>
<person name="Thomaz M."/>
<person name="Zhao X.Y."/>
<person name="Wegg A."/>
<person name="Crusius K."/>
<person name="Egner U."/>
<person name="Donner P."/>
</authorList>
<dbReference type="PubMed" id="11906285"/>
<dbReference type="DOI" id="10.1021/jm011072j"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 671-918</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2004" name="Mol. Cell" volume="16" first="425" last="438">
<title>Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance.</title>
<authorList>
<person name="He B."/>
<person name="Gampe R.T. Jr."/>
<person name="Kole A.J."/>
<person name="Hnat A.T."/>
<person name="Stanley T.B."/>
<person name="An G."/>
<person name="Stewart E.L."/>
<person name="Kalman R.I."/>
<person name="Minges J.T."/>
<person name="Wilson E.M."/>
</authorList>
<dbReference type="PubMed" id="15525515"/>
<dbReference type="DOI" id="10.1016/j.molcel.2004.09.036"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.89 ANGSTROMS) OF 672-920 IN COMPLEXES WITH N-TERMINAL MODULATING DOMAIN AND NCOA2</scope>
<scope>INTERACTION WITH NCOA1</scope>
<scope>CHARACTERIZATION OF VARIANT PROSTATE CANCER MET-731</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="8060" last="8068">
<title>The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor.</title>
<authorList>
<person name="Estebanez-Perpina E."/>
<person name="Moore J.M.R."/>
<person name="Mar E."/>
<person name="Delgado-Rodrigues E."/>
<person name="Nguyen P."/>
<person name="Baxter J.D."/>
<person name="Buehrer B.M."/>
<person name="Webb P."/>
<person name="Fletterick R.J."/>
<person name="Guy R.K."/>
</authorList>
<dbReference type="PubMed" id="15563469"/>
<dbReference type="DOI" id="10.1074/jbc.M407046200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.66 ANGSTROMS) OF 670-920 IN COMPLEXES WITH DIHYDROTESTOSTERONE AND NCOA1; NCOA2; NCOA3 AND NCOA4</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NCOA1; NCOA2; NCOA3 AND NCOA4</scope>
<scope>MUTAGENESIS OF LYS-721 AND GLU-898</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="37747" last="37754">
<title>Structural basis for accommodation of nonsteroidal ligands in the androgen receptor.</title>
<authorList>
<person name="Bohl C.E."/>
<person name="Miller D.D."/>
<person name="Chen J."/>
<person name="Bell C.E."/>
<person name="Dalton J.T."/>
</authorList>
<dbReference type="PubMed" id="16129672"/>
<dbReference type="DOI" id="10.1074/jbc.M507464200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 665-920 IN COMPLEXES WITH NONSTEROIDAL LIGANDS</scope>
<scope>MUTAGENESIS OF TRP-742</scope>
<scope>CHARACTERIZATION OF VARIANT PROSTATE CANCER ALA-878</scope>
<scope>CHARACTERIZATION OF VARIANT AIS THR-896</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2006" name="Protein Sci." volume="15" first="987" last="999">
<title>Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity.</title>
<authorList>
<person name="Pereira de Jesus-Tran K."/>
<person name="Cote P.-L."/>
<person name="Cantin L."/>
<person name="Blanchet J."/>
<person name="Labrie F."/>
<person name="Breton R."/>
</authorList>
<dbReference type="PubMed" id="16641486"/>
<dbReference type="DOI" id="10.1110/ps.051905906"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.64 ANGSTROMS) OF 655-920 IN COMPLEXES WITH TESTOSTERONE; DIHYDROTESTOSTERONE AND TETRAHYDROGESTRINONE</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2007" name="Acta Crystallogr. D" volume="63" first="1198" last="1200">
<title>Interaction between the androgen receptor and a segment of its corepressor SHP.</title>
<authorList>
<person name="Jouravel N."/>
<person name="Sablin E."/>
<person name="Arnold L.A."/>
<person name="Guy R.K."/>
<person name="Fletterick R.J."/>
</authorList>
<dbReference type="PubMed" id="18007036"/>
<dbReference type="DOI" id="10.1107/S0907444907045702"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 672-919 IN COMPLEX WITH NR0B2</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="13648" last="13655">
<title>Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design.</title>
<authorList>
<person name="Bohl C.E."/>
<person name="Wu Z."/>
<person name="Miller D.D."/>
<person name="Bell C.E."/>
<person name="Dalton J.T."/>
</authorList>
<dbReference type="PubMed" id="17311914"/>
<dbReference type="DOI" id="10.1074/jbc.M611711200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 671-919 OF MUTANT ALA-878 IN COMPLEX WITH THE ANTIANDROGEN CYPROTERONE ACETATE</scope>
<scope>CHARACTERIZATION OF VARIANT PROSTATE CANCER ALA-878</scope>
<scope>MUTAGENESIS OF LEU-702</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="25801" last="25816">
<title>Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone.</title>
<authorList>
<person name="Askew E.B."/>
<person name="Gampe R.T. Jr."/>
<person name="Stanley T.B."/>
<person name="Faggart J.L."/>
<person name="Wilson E.M."/>
</authorList>
<dbReference type="PubMed" id="17591767"/>
<dbReference type="DOI" id="10.1074/jbc.M703268200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 663-919 OF WILD-TYPE AND MUTANT TYR-875 IN COMPLEX WITH TESTOSTERONE AND NCOA2</scope>
<scope>ACTIVATION BY THE N-TERMINAL MODULATING DOMAIN</scope>
<scope>INTERACTION WITH NCOA2 AND MAGEA11</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-721 AND GLU-898</scope>
<scope>CHARACTERIZATION OF VARIANT PROSTATE CANCER TYR-875</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="30910" last="30919">
<title>Structural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally designed steroidal ligand bearing a bulky chain directed toward helix 12.</title>
<authorList>
<person name="Cantin L."/>
<person name="Faucher F."/>
<person name="Couture J.-F."/>
<person name="de Jesus-Tran K.P."/>
<person name="Legrand P."/>
<person name="Ciobanu L.C."/>
<person name="Frechette Y."/>
<person name="Labrecque R."/>
<person name="Singh S.M."/>
<person name="Labrie F."/>
<person name="Breton R."/>
</authorList>
<dbReference type="PubMed" id="17711855"/>
<dbReference type="DOI" id="10.1074/jbc.M705524200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 655-920 IN COMPLEX WITH EM5744</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="16074" last="16079">
<title>A surface on the androgen receptor that allosterically regulates coactivator binding.</title>
<authorList>
<person name="Estebanez-Perpina E."/>
<person name="Arnold L.A."/>
<person name="Nguyen P."/>
<person name="Rodrigues E.D."/>
<person name="Mar E."/>
<person name="Bateman R."/>
<person name="Pallai P."/>
<person name="Shokat K.M."/>
<person name="Baxter J.D."/>
<person name="Guy R.K."/>
<person name="Webb P."/>
<person name="Fletterick R.J."/>
</authorList>
<dbReference type="PubMed" id="17911242"/>
<dbReference type="DOI" id="10.1073/pnas.0708036104"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.76 ANGSTROMS) OF 670-920 IN COMPLEXES WITH SYNTHETIC LIGANDS</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NCOA2</scope>
</reference>
<reference key="72">
<citation type="journal article" date="1992" name="Clin. Invest. Med." volume="15" first="456" last="472">
<title>Androgen resistance due to mutation of the androgen receptor.</title>
<authorList>
<person name="Pinsky L."/>
<person name="Trifiro M.A."/>
<person name="Kaufman M."/>
<person name="Beitel L.K."/>
<person name="Mhatre A."/>
<person name="Kazemi-Esfarjani P."/>
<person name="Sabbaghian N."/>
<person name="Lumbroso R."/>
<person name="Alvarado C."/>
<person name="Vasiliou M."/>
<person name="Gottlieb B."/>
</authorList>
<dbReference type="PubMed" id="1458719"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="73">
<citation type="journal article" date="1993" name="Eur. J. Pediatr. 152 Suppl." volume="2" first="S62" last="S69">
<title>Molecular genetics of human androgen insensitivity.</title>
<authorList>
<person name="Brown T.R."/>
<person name="Scherer P.A."/>
<person name="Chang Y.-T."/>
<person name="Migeon C.J."/>
<person name="Ghirri P."/>
<person name="Murono K."/>
<person name="Zhou Z."/>
</authorList>
<dbReference type="PubMed" id="8339746"/>
<dbReference type="DOI" id="10.1007/BF02125442"/>
</citation>
<scope>REVIEW ON VARIANTS AIS</scope>
</reference>
<reference key="74">
<citation type="journal article" date="1993" name="J. Steroid Biochem. Mol. Biol." volume="46" first="519" last="530">
<title>Mutations of androgen receptor gene in androgen insensitivity syndromes.</title>
<authorList>
<person name="Sultan C."/>
<person name="Lumbroso S."/>
<person name="Poujol N."/>
<person name="Belon C."/>
<person name="Boudon C."/>
<person name="Lobaccaro J.-M."/>
</authorList>
<dbReference type="PubMed" id="8240973"/>
<dbReference type="DOI" id="10.1016/0960-0760(93)90178-Y"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="75">
<citation type="journal article" date="1994" name="Nucleic Acids Res." volume="22" first="3560" last="3562">
<title>The androgen receptor gene mutations database.</title>
<authorList>
<person name="Patterson M.N."/>
<person name="Hughes I.A."/>
<person name="Gottlieb B."/>
<person name="Pinsky L."/>
</authorList>
<dbReference type="PubMed" id="7937057"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="76">
<citation type="journal article" date="1995" name="J. Steroid Biochem. Mol. Biol." volume="53" first="443" last="448">
<title>Androgen receptor mutations.</title>
<authorList>
<person name="Brinkmann A.O."/>
<person name="Jenster G."/>
<person name="Ris-Stalpers C."/>
<person name="van der Korput J.A.G.M."/>
<person name="Bruggenwirth H.T."/>
<person name="Boehmer A.L.M."/>
<person name="Trapman J."/>
</authorList>
<dbReference type="PubMed" id="7626493"/>
<dbReference type="DOI" id="10.1016/0960-0760(95)00090-M"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="77">
<citation type="journal article" date="1997" name="Nucleic Acids Res." volume="25" first="158" last="162">
<title>The androgen receptor gene mutations database.</title>
<authorList>
<person name="Gottlieb B."/>
<person name="Trifiro M.A."/>
<person name="Lumbroso R."/>
<person name="Vasiliou D.M."/>
<person name="Pinsky L."/>
</authorList>
<dbReference type="PubMed" id="9016528"/>
<dbReference type="DOI" id="10.1093/nar/25.1.158"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2012" name="Hum. Mutat." volume="33" first="887" last="894">
<title>The androgen receptor gene mutations database: 2012 update.</title>
<authorList>
<person name="Gottlieb B."/>
<person name="Beitel L.K."/>
<person name="Nadarajah A."/>
<person name="Paliouras M."/>
<person name="Trifiro M."/>
</authorList>
<dbReference type="PubMed" id="22334387"/>
<dbReference type="DOI" id="10.1002/humu.22046"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="79">
<citation type="journal article" date="1990" name="Biochem. Biophys. Res. Commun." volume="173" first="534" last="540">
<title>A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens.</title>
<authorList>
<person name="Veldscholte J."/>
<person name="Ris-Stalpers C."/>
<person name="Kuiper G.G.J.M."/>
<person name="Jenster G."/>
<person name="Berrevoets C.A."/>
<person name="Claassen E."/>
<person name="van Rooij H.C.J."/>
<person name="Trapman J."/>
<person name="Brinkmann A.O."/>
<person name="Mulder E."/>
</authorList>
<dbReference type="PubMed" id="2260966"/>
<dbReference type="DOI" id="10.1016/S0006-291X(05)80067-1"/>
</citation>
<scope>VARIANT LNCAP ALA-878</scope>
</reference>
<reference key="80">
<citation type="journal article" date="1990" name="Mol. Endocrinol." volume="4" first="1759" last="1772">
<title>Functional characterization of naturally occurring mutant androgen receptors from subjects with complete androgen insensitivity.</title>
<authorList>
<person name="Brown T.R."/>
<person name="Lubahn D.B."/>
<person name="Wilson E.M."/>
<person name="French F.S."/>
<person name="Migeon C.J."/>
<person name="Corfen J.L."/>
</authorList>
<dbReference type="PubMed" id="2082179"/>
<dbReference type="DOI" id="10.1210/mend-4-12-1759"/>
</citation>
<scope>VARIANTS AIS CYS-775; GLN-832 AND MET-867</scope>
</reference>
<reference key="81">
<citation type="journal article" date="1991" name="J. Clin. Endocrinol. Metab." volume="73" first="318" last="325">
<title>Androgen resistance associated with a mutation of the androgen receptor at amino acid 772 (Arg-->Cys) results from a combination of decreased messenger ribonucleic acid levels and impairment of receptor function.</title>
<authorList>
<person name="Marcelli M."/>
<person name="Tilley W.D."/>
<person name="Zoppi S."/>
<person name="Griffin J.E."/>
<person name="Wilson J.D."/>
<person name="McPhaul M.J."/>
</authorList>
<dbReference type="PubMed" id="1856263"/>
<dbReference type="DOI" id="10.1210/jcem-73-2-318"/>
</citation>
<scope>VARIANT CYS-775</scope>
</reference>
<reference key="82">
<citation type="journal article" date="1991" name="J. Clin. Invest." volume="87" first="1123" last="1126">
<title>A mutation in the DNA-binding domain of the androgen receptor gene causes complete testicular feminization in a patient with receptor-positive androgen resistance.</title>
<authorList>
<person name="Marcelli M."/>
<person name="Zoppi S."/>
<person name="Grino P.B."/>
<person name="Griffin J.E."/>
<person name="Wilson J.D."/>
<person name="McPhaul M.J."/>
</authorList>
<dbReference type="PubMed" id="1999491"/>
<dbReference type="DOI" id="10.1172/JCI115076"/>
</citation>
<scope>VARIANT AIS PRO-618</scope>
</reference>
<reference key="83">
<citation type="journal article" date="1991" name="J. Clin. Invest." volume="87" first="1413" last="1421">
<title>Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy.</title>
<authorList>
<person name="McPhaul M.J."/>
<person name="Marcelli M."/>
<person name="Tilley W.D."/>
<person name="Griffin J.E."/>
<person name="Isidro-Gutierrez R.F."/>
<person name="Wilson J.D."/>
</authorList>
<dbReference type="PubMed" id="2010552"/>
<dbReference type="DOI" id="10.1172/JCI115147"/>
</citation>
<scope>VARIANT PAIS CYS-764</scope>
</reference>
<reference key="84">
<citation type="journal article" date="1991" name="Nature" volume="352" first="77" last="79">
<title>Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy.</title>
<authorList>
<person name="la Spada A.R."/>
<person name="Wilson E.M."/>
<person name="Lubahn D.B."/>
<person name="Harding A.E."/>
<person name="Fischbeck K.H."/>
</authorList>
<dbReference type="PubMed" id="2062380"/>
<dbReference type="DOI" id="10.1038/352077a0"/>
</citation>
<scope>POLY-GLN REGION EXPANSION</scope>
<scope>INVOLVEMENT IN SPINAL AND BULBAR MUSCULAR ATROPHY</scope>
</reference>
<reference key="85">
<citation type="journal article" date="1992" name="Am. J. Hum. Genet." volume="51" first="143" last="155">
<title>Replacement of arginine 773 by cysteine or histidine in the human androgen receptor causes complete androgen insensitivity with different receptor phenotypes.</title>
<authorList>
<person name="Prior L."/>
<person name="Bordet S."/>
<person name="Trifiro M.A."/>
<person name="Mhatre A."/>
<person name="Kaufman M."/>
<person name="Pinsky L."/>
<person name="Wrogemann K."/>
<person name="Belsham D.D."/>
<person name="Pereira F."/>
<person name="Greenberg C.R."/>
<person name="Trapman J."/>
<person name="Brinkmann A.O."/>
<person name="Chang C."/>
<person name="Liao S."/>
</authorList>
<dbReference type="PubMed" id="1609793"/>
</citation>
<scope>VARIANTS AIS CYS-775 AND HIS-775</scope>
</reference>
<reference key="86">
<citation type="journal article" date="1992" name="Clin. Endocrinol. (Oxf.)" volume="37" first="214" last="220">
<title>Point mutations detected in the androgen receptor gene of three men with partial androgen insensitivity syndrome.</title>
<authorList>
<person name="Saunders P.T."/>
<person name="Padayachi T."/>
<person name="Tincello D.G."/>
<person name="Shalet S.M."/>
<person name="Wu F.C."/>
</authorList>
<dbReference type="PubMed" id="1424203"/>
<dbReference type="DOI" id="10.1111/j.1365-2265.1992.tb02313.x"/>
</citation>
<scope>VARIANTS PAIS LYS-609 AND LEU-867</scope>
</reference>
<reference key="87">
<citation type="journal article" date="1992" name="Fertil. Steril." volume="58" first="703" last="707">
<title>A unique point mutation in the androgen receptor gene in a family with complete androgen insensitivity syndrome.</title>
<authorList>
<person name="Sweet C.R."/>
<person name="Behzadian M.A."/>
<person name="McDonough P.G."/>
</authorList>
<dbReference type="PubMed" id="1426313"/>
</citation>
<scope>VARIANT AIS THR-766</scope>
</reference>
<reference key="88">
<citation type="journal article" date="1992" name="Hum. Genet." volume="90" first="311" last="312">
<title>Point mutation in the steroid-binding domain of the androgen receptor gene in a family with complete androgen insensitivity syndrome (CAIS).</title>
<authorList>
<person name="Jakubiczka S."/>
<person name="Werder E.A."/>
<person name="Wieacker P."/>
</authorList>
<dbReference type="PubMed" id="1487249"/>
<dbReference type="DOI" id="10.1007/BF00220088"/>
</citation>
<scope>VARIANT AIS VAL-750</scope>
</reference>
<reference key="89">
<citation type="journal article" date="1992" name="Hum. Mol. Genet." volume="1" first="497" last="503">
<title>Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome.</title>
<authorList>
<person name="Batch J.A."/>
<person name="Williams D.M."/>
<person name="Davies H.R."/>
<person name="Brown B.D."/>
<person name="Evans B.A.J."/>
<person name="Hughes I.A."/>
<person name="Patterson M.N."/>
</authorList>
<dbReference type="PubMed" id="1307250"/>
<dbReference type="DOI" id="10.1093/hmg/1.7.497"/>
</citation>
<scope>VARIANTS AIS</scope>
<scope>VARIANTS PAIS</scope>
</reference>
<reference key="90">
<citation type="journal article" date="1992" name="J. Clin. Endocrinol. Metab." volume="74" first="1152" last="1157">
<title>A single amino acid substitution (Met-786-->Val) in the steroid-binding domain of human androgen receptor leads to complete androgen insensitivity syndrome.</title>
<authorList>
<person name="Nakao R."/>
<person name="Haji M."/>
<person name="Yanase T."/>
<person name="Ogo A."/>
<person name="Takayanagi R."/>
<person name="Katsube T."/>
<person name="Fukumaki Y."/>
<person name="Nawata H."/>
</authorList>
<dbReference type="PubMed" id="1569163"/>
<dbReference type="DOI" id="10.1210/jcem.74.5.1569163"/>
</citation>
<scope>VARIANT AIS VAL-788</scope>
</reference>
<reference key="91">
<citation type="journal article" date="1992" name="J. Clin. Endocrinol. Metab." volume="75" first="1474" last="1478">
<title>Immunoreactive androgen receptor expression in subjects with androgen resistance.</title>
<authorList>
<person name="Wilson C.M."/>
<person name="Griffin J.E."/>
<person name="Wilson J.D."/>
<person name="Marcelli M."/>
<person name="Zoppi S."/>
<person name="McPhaul M.J."/>
</authorList>
<dbReference type="PubMed" id="1464650"/>
<dbReference type="DOI" id="10.1210/jcem.75.6.1464650"/>
</citation>
<scope>VARIANTS AIS ARG-742 AND CYS-835</scope>
</reference>
<reference key="92">
<citation type="journal article" date="1992" name="J. Clin. Invest." volume="90" first="2097" last="2101">
<title>Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene.</title>
<authorList>
<person name="McPhaul M.J."/>
<person name="Marcelli M."/>
<person name="Zoppi S."/>
<person name="Wilson C.M."/>
<person name="Griffin J.E."/>
<person name="Wilson J.D."/>
</authorList>
<dbReference type="PubMed" id="1430233"/>
<dbReference type="DOI" id="10.1172/JCI116093"/>
</citation>
<scope>VARIANTS AIS</scope>
<scope>VARIANTS PAIS</scope>
</reference>
<reference key="93">
<citation type="journal article" date="1992" name="J. Steroid Biochem. Mol. Biol." volume="41" first="665" last="669">
<title>The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens.</title>
<authorList>
<person name="Veldscholte J."/>
<person name="Berrevoets C.A."/>
<person name="Ris-Stalpers C."/>
<person name="Kuiper G.G.J.M."/>
<person name="Jenster G."/>
<person name="Trapman J."/>
<person name="Brinkmann A.O."/>
<person name="Mulder E."/>
</authorList>
<dbReference type="PubMed" id="1562539"/>
<dbReference type="DOI" id="10.1016/0960-0760(92)90401-4"/>
</citation>
<scope>VARIANT PROSTATE CANCER ALA-878</scope>
</reference>
<reference key="94">
<citation type="journal article" date="1992" name="Mol. Endocrinol." volume="6" first="409" last="415">
<title>Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance.</title>
<authorList>
<person name="Zoppi S."/>
<person name="Marcelli M."/>
<person name="Deslypere J.-P."/>
<person name="Griffin J.E."/>
<person name="Wilson J.D."/>
<person name="McPhaul M.J."/>
</authorList>
<dbReference type="PubMed" id="1316540"/>
<dbReference type="DOI" id="10.1210/mend.6.3.1316540"/>
</citation>
<scope>VARIANTS AIS TYR-560 AND ARG-577</scope>
<scope>VARIANTS PAIS GLY-598 AND PRO-618</scope>
</reference>
<reference key="95">
<citation type="journal article" date="1992" name="Mol. Endocrinol." volume="6" first="1909" last="1920">
<title>Single base mutations in the human androgen receptor gene causing complete androgen insensitivity: rapid detection by a modified denaturing gradient gel electrophoresis technique.</title>
<authorList>
<person name="De Bellis A."/>
<person name="Quigley C.A."/>
<person name="Cariello N.F."/>
<person name="el-Awady M.K."/>
<person name="Sar M."/>
<person name="Lane M.V."/>
<person name="Wilson E.M."/>
<person name="French F.S."/>
</authorList>
<dbReference type="PubMed" id="1480178"/>
<dbReference type="DOI" id="10.1210/me.6.11.1909"/>
</citation>
<scope>VARIANTS AIS SER-706; VAL-750; PHE-760; HIS-775; CYS-856 AND GLY-865</scope>
</reference>
<reference key="96">
<citation type="journal article" date="1992" name="Nat. Genet." volume="2" first="132" last="134">
<title>A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome.</title>
<authorList>
<person name="Wooster R."/>
<person name="Mangion J."/>
<person name="Eeles R."/>
<person name="Smith S."/>
<person name="Dowsett M."/>
<person name="Averill D."/>
<person name="Barrett-Lee P."/>
<person name="Easton D.F."/>
<person name="Ponder B.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="1303262"/>
<dbReference type="DOI" id="10.1038/ng1092-132"/>
</citation>
<scope>VARIANT PAIS/BREAST CANCER GLN-608</scope>
</reference>
<reference key="97">
<citation type="journal article" date="1992" name="Proc. Natl. Acad. Sci. U.S.A." volume="89" first="6319" last="6323">
<title>Androgen receptor gene mutations in human prostate cancer.</title>
<authorList>
<person name="Newmark J.R."/>
<person name="Hardy D.O."/>
<person name="Tonb D.C."/>
<person name="Carter B.S."/>
<person name="Epstein J.I."/>
<person name="Isaacs W.B."/>
<person name="Brown T.R."/>
<person name="Barrack E.R."/>
</authorList>
<dbReference type="PubMed" id="1631125"/>
<dbReference type="DOI" id="10.1073/pnas.89.14.6319"/>
</citation>
<scope>VARIANT MET-731</scope>
</reference>
<reference key="98">
<citation type="journal article" date="1993" name="Am. J. Hum. Genet." volume="53" first="844" last="852">
<title>Sequence variation in the androgen receptor gene is not a common determinant of male sexual orientation.</title>
<authorList>
<person name="Macke J.P."/>
<person name="Hu N."/>
<person name="Hu S."/>
<person name="Bailey M."/>
<person name="King V.L."/>
<person name="Brown T."/>
<person name="Hamer D."/>
<person name="Nathans J."/>
</authorList>
<dbReference type="PubMed" id="8213813"/>
</citation>
<scope>VARIANTS ARG-207 AND ASP-794</scope>
</reference>
<reference key="99">
<citation type="journal article" date="1993" name="Fertil. Steril." volume="60" first="814" last="819">
<title>A new mutation within the deoxyribonucleic acid-binding domain of the androgen receptor gene in a family with complete androgen insensitivity syndrome.</title>
<authorList>
<person name="Lumbroso S."/>
<person name="Lobaccaro J.-M."/>
<person name="Belon C."/>
<person name="Martin D."/>
<person name="Chaussain J.-L."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="8224266"/>
</citation>
<scope>VARIANT AIS PHE-582</scope>
</reference>
<reference key="100">
<citation type="journal article" date="1993" name="Hum. Mol. Genet." volume="2" first="1041" last="1043">
<title>An exonic point mutation creates a MaeIII site in the androgen receptor gene of a family with complete androgen insensitivity syndrome.</title>
<authorList>
<person name="Lobaccaro J.-M."/>
<person name="Lumbroso S."/>
<person name="Ktari R."/>
<person name="Dumas R."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="8103398"/>
<dbReference type="DOI" id="10.1093/hmg/2.7.1041"/>
</citation>
<scope>VARIANT AIS VAL-755</scope>
</reference>
<reference key="101">
<citation type="journal article" date="1993" name="Hum. Mol. Genet." volume="2" first="1799" last="1802">
<title>Androgen receptor gene mutation in male breast cancer.</title>
<authorList>
<person name="Lobaccaro J.-M."/>
<person name="Lumbroso S."/>
<person name="Belon C."/>
<person name="Galtier-Dereure F."/>
<person name="Bringer J."/>
<person name="Lesimple T."/>
<person name="Namer M."/>
<person name="Cutuli B.F."/>
<person name="Pujol H."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="8281139"/>
<dbReference type="DOI" id="10.1093/hmg/2.11.1799"/>
</citation>
<scope>VARIANT PAIS/BREAST CANCER LYS-609</scope>
</reference>
<reference key="102">
<citation type="journal article" date="1993" name="Hum. Mol. Genet." volume="2" first="1809" last="1812">
<title>A single-base substitution in exon 6 of the androgen receptor gene causing complete androgen insensitivity: the mutated receptor fails to transactivate but binds to DNA in vitro.</title>
<authorList>
<person name="Adeyemo O."/>
<person name="Kallio P.J."/>
<person name="Palvimo J.J."/>
<person name="Kontula K."/>
<person name="Jaenne O.A."/>
</authorList>
<dbReference type="PubMed" id="8281140"/>
<dbReference type="DOI" id="10.1093/hmg/2.11.1809"/>
</citation>
<scope>VARIANT AIS ARG-808</scope>
</reference>
<reference key="103">
<citation type="journal article" date="1993" name="J. Clin. Endocrinol. Metab." volume="77" first="103" last="107">
<title>A single amino acid substitution (Gly743 --> Val) in the steroid-binding domain of the human androgen receptor leads to Reifenstein syndrome.</title>
<authorList>
<person name="Nakao R."/>
<person name="Yanase T."/>
<person name="Sakai Y."/>
<person name="Haji M."/>
<person name="Nawata H."/>
</authorList>
<dbReference type="PubMed" id="8325932"/>
<dbReference type="DOI" id="10.1210/jcem.77.1.8325932"/>
</citation>
<scope>VARIANT PAIS VAL-744</scope>
</reference>
<reference key="104">
<citation type="journal article" date="1993" name="J. Clin. Endocrinol. Metab." volume="77" first="262" last="266">
<title>Single strand conformation polymorphism analysis of androgen receptor gene mutations in patients with androgen insensitivity syndromes: application for diagnosis, genetic counseling, and therapy.</title>
<authorList>
<person name="Hiort O."/>
<person name="Huang Q."/>
<person name="Sinnecker G.H."/>
<person name="Sadeghi-Nejad A."/>
<person name="Kruse K."/>
<person name="Wolfe H.J."/>
<person name="Yandell D.W."/>
</authorList>
<dbReference type="PubMed" id="8325950"/>
<dbReference type="DOI" id="10.1210/jcem.77.1.8325950"/>
</citation>
<scope>VARIANTS AIS LYS-682 AND THR-843</scope>
<scope>VARIANTS PAIS HIS-841 AND LEU-867</scope>
</reference>
<reference key="105">
<citation type="journal article" date="1993" name="J. Med. Genet." volume="30" first="198" last="201">
<title>Mutations of the androgen receptor gene identified in perineal hypospadias.</title>
<authorList>
<person name="Batch J.A."/>
<person name="Evans B.A.J."/>
<person name="Hughes I.A."/>
<person name="Patterson M.N."/>
</authorList>
<dbReference type="PubMed" id="8097257"/>
<dbReference type="DOI" id="10.1136/jmg.30.3.198"/>
</citation>
<scope>VARIANTS PAIS HIS-856 AND MET-870</scope>
</reference>
<reference key="106">
<citation type="journal article" date="1993" name="J. Steroid Biochem. Mol. Biol." volume="44" first="211" last="216">
<title>Complete androgen insensitivity syndrome associated with a de novo mutation of the androgen receptor gene detected by single strand conformation polymorphism.</title>
<authorList>
<person name="Lobaccaro J.-M."/>
<person name="Lumbroso S."/>
<person name="Berta P."/>
<person name="Chaussain J.-L."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="8096390"/>
<dbReference type="DOI" id="10.1016/0960-0760(93)90081-7"/>
</citation>
<scope>VARIANT AIS VAL-744</scope>
</reference>
<reference key="107">
<citation type="journal article" date="1993" name="J. Steroid Biochem. Mol. Biol." volume="46" first="759" last="765">
<title>Androgen receptor gene mutations in human prostate cancer.</title>
<authorList>
<person name="Suzuki H."/>
<person name="Sato N."/>
<person name="Watabe Y."/>
<person name="Masai M."/>
<person name="Seino S."/>
<person name="Shimazaki J."/>
</authorList>
<dbReference type="PubMed" id="8274409"/>
<dbReference type="DOI" id="10.1016/0960-0760(93)90316-O"/>
</citation>
<scope>VARIANTS PROSTATE CANCER HIS-702 AND ALA-878</scope>
</reference>
<reference key="108">
<citation type="journal article" date="1993" name="Mol. Endocrinol." volume="7" first="37" last="46">
<title>Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes.</title>
<authorList>
<person name="Kazemi-Esfarjani P."/>
<person name="Beitel L.K."/>
<person name="Trifiro M.A."/>
<person name="Kaufman M."/>
<person name="Rennie P."/>
<person name="Sheppard P."/>
<person name="Matusik R."/>
<person name="Pinsky L."/>
</authorList>
<dbReference type="PubMed" id="8446106"/>
<dbReference type="DOI" id="10.1210/mend.7.1.8446106"/>
</citation>
<scope>VARIANT AIS MET-867</scope>
<scope>VARIANT PAIS LEU-867</scope>
</reference>
<reference key="109">
<citation type="journal article" date="1993" name="Mol. Endocrinol." volume="7" first="1541" last="1550">
<title>Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.</title>
<authorList>
<person name="Culig Z."/>
<person name="Hobisch A."/>
<person name="Cronauer M.V."/>
<person name="Cato A.C.B."/>
<person name="Hittmair A."/>
<person name="Radmayr C."/>
<person name="Eberle J."/>
<person name="Bartsch G."/>
<person name="Klocker H."/>
</authorList>
<dbReference type="PubMed" id="8145761"/>
<dbReference type="DOI" id="10.1210/mend.7.12.8145761"/>
</citation>
<scope>VARIANT PROSTATE CANCER MET-716</scope>
</reference>
<reference key="110">
<citation type="journal article" date="1993" name="Pediatr. Res. Suppl." volume="33" first="S22" last="S22">
<title>Androgen receptor (AR) gene mutations in 6 families with androgen insensitivity syndrome (Abstract #114).</title>
<authorList>
<person name="Lobaccaro J.-M."/>
<person name="Lumbroso S."/>
<person name="Belon C."/>
<person name="Chaussain J.L."/>
<person name="Toublanc J.E."/>
<person name="Leheup B."/>
<person name="Sultan C."/>
</authorList>
</citation>
<scope>VARIANTS AIS PHE-582; VAL-744; VAL-755; GLU-768 AND CYS-856</scope>
</reference>
<reference key="111">
<citation type="journal article" date="1993" name="Verh. Dtsch. Ges. Pathol." volume="77" first="119" last="123">
<title>Androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer.</title>
<authorList>
<person name="Castagnaro M."/>
<person name="Yandell D.W."/>
<person name="Dockhorn-Dworniczak B."/>
<person name="Wolfe H.J."/>
<person name="Poremba C."/>
</authorList>
<dbReference type="PubMed" id="7511268"/>
</citation>
<scope>VARIANTS PROSTATE CANCER LEU-342 AND GLU-799</scope>
</reference>
<reference key="112">
<citation type="journal article" date="1994" name="Biochem. Biophys. Res. Commun." volume="198" first="74" last="80">
<title>Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancer.</title>
<authorList>
<person name="Schoenberg M.P."/>
<person name="Hakimi J.M."/>
<person name="Wang S."/>
<person name="Bova G.S."/>
<person name="Epstein J.I."/>
<person name="Fischbeck K.H."/>
<person name="Isaacs W.B."/>
<person name="Walsh P.C."/>
<person name="Barrack E.R."/>
</authorList>
<dbReference type="PubMed" id="8292051"/>
<dbReference type="DOI" id="10.1006/bbrc.1994.1011"/>
</citation>
<scope>POLY-GLN REGION CONTRACTION</scope>
<scope>INVOLVEMENT IN PROSTATE CANCER</scope>
</reference>
<reference key="113">
<citation type="journal article" date="1994" name="Cancer Res." volume="54" first="2861" last="2864">
<title>Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers.</title>
<authorList>
<person name="Gaddipati J.P."/>
<person name="McLeod D.G."/>
<person name="Heidenberg H.B."/>
<person name="Sesterhenn I.A."/>
<person name="Finger M.J."/>
<person name="Moul J.W."/>
<person name="Srivastava S."/>
</authorList>
<dbReference type="PubMed" id="8187068"/>
</citation>
<scope>VARIANT PROSTATE CANCER ALA-878</scope>
</reference>
<reference key="114">
<citation type="journal article" date="1994" name="Clin. Endocrinol. (Oxf.)" volume="40" first="297" last="302">
<title>Molecular prenatal diagnosis of partial androgen insensitivity syndrome based on the Hind III polymorphism of the androgen receptor gene.</title>
<authorList>
<person name="Lobaccaro J.-M."/>
<person name="Belon C."/>
<person name="Lumbroso S."/>
<person name="Olewniczack G."/>
<person name="Carre-Pigeon F."/>
<person name="Job J.C."/>
<person name="Chaussain J.L."/>
<person name="Toublanc J.E."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="7910529"/>
</citation>
<scope>VARIANT PAIS TRP-569</scope>
</reference>
<reference key="115">
<citation type="journal article" date="1994" name="Eur. J. Endocrinol." volume="130" first="327" last="332">
<title>Molecular prenatal exclusion of familial partial androgen insensitivity (Reifenstein syndrome).</title>
<authorList>
<person name="Lumbroso S."/>
<person name="Lobaccaro J.-M."/>
<person name="Belon C."/>
<person name="Amram S."/>
<person name="Bachelard B."/>
<person name="Garandeau P."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="7909256"/>
<dbReference type="DOI" id="10.1530/eje.0.1300327"/>
</citation>
<scope>VARIANT PAIS HIS-841</scope>
</reference>
<reference key="116">
<citation type="journal article" date="1994" name="Eur. J. Endocrinol." volume="130" first="569" last="574">
<title>Single amino acid substitution (840Arg-->His) in the hormone-binding domain of the androgen receptor leads to incomplete androgen insensitivity syndrome associated with a thermolabile androgen receptor.</title>
<authorList>
<person name="Imasaki K."/>
<person name="Hasegawa T."/>
<person name="Okabe T."/>
<person name="Sakai Y."/>
<person name="Haji M."/>
<person name="Takayanagi R."/>
<person name="Nawata H."/>
</authorList>
<dbReference type="PubMed" id="8205256"/>
<dbReference type="DOI" id="10.1530/eje.0.1300569"/>
</citation>
<scope>VARIANT PAIS HIS-841</scope>
</reference>
<reference key="117">
<citation type="journal article" date="1994" name="Eur. J. Pediatr." volume="153" first="317" last="321">
<title>Molecular characterization of the androgen receptor gene in boys with hypospadias.</title>
<authorList>
<person name="Hiort O."/>
<person name="Klauber G."/>
<person name="Cendron M."/>
<person name="Sinnecker G.H."/>
<person name="Keim L."/>
<person name="Schwinger E."/>
<person name="Wolfe H.J."/>
<person name="Yandell D.W."/>
</authorList>
<dbReference type="PubMed" id="8033918"/>
<dbReference type="DOI" id="10.1007/BF01956409"/>
</citation>
<scope>VARIANT PAIS VAL-871</scope>
</reference>
<reference key="118">
<citation type="journal article" date="1994" name="Horm. Res." volume="41" first="117" last="117">
<title>Partial androgen insensitivity (PAIS) in a large eskimo kindred caused by a delD690 mutation in the androgen receptor (AR) gene (Abstract #244).</title>
<authorList>
<person name="Schwartz M."/>
<person name="Skovby F."/>
<person name="Mueller J."/>
<person name="Nielsen O."/>
<person name="Skakkebaek N.E."/>
</authorList>
</citation>
<scope>VARIANT PAIS ASP-691 DEL</scope>
</reference>
<reference key="119">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="21" last="27">
<title>Complete androgen insensitivity due to mutations in the probable alpha-helical segments of the DNA-binding domain in the human androgen receptor.</title>
<authorList>
<person name="Beitel L.K."/>
<person name="Prior L."/>
<person name="Vasiliou D.M."/>
<person name="Gottlieb B."/>
<person name="Kaufman M."/>
<person name="Lumbroso R."/>
<person name="Alvarado C."/>
<person name="McGillivray B."/>
<person name="Trifiro M.A."/>
<person name="Pinsky L."/>
</authorList>
<dbReference type="PubMed" id="8162033"/>
<dbReference type="DOI" id="10.1093/hmg/3.1.21"/>
</citation>
<scope>VARIANTS AIS PHE-583 DEL; ARG-616 DEL AND HIS-616</scope>
</reference>
<reference key="120">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="1163" last="1166">
<title>Detection of point mutations in the androgen receptor gene using non-isotopic single strand conformation polymorphism analysis.</title>
<authorList>
<person name="Hiort O."/>
<person name="Wodtke A."/>
<person name="Struve D."/>
<person name="Zoellner A."/>
<person name="Sinnecker G.H."/>
</authorList>
<dbReference type="PubMed" id="7981687"/>
<dbReference type="DOI" id="10.1093/hmg/3.7.1163"/>
</citation>
<scope>VARIANTS PAIS SER-583; TYR-605; ALA-709; LEU-755 AND HIS-772</scope>
<scope>VARIANT AIS TRP-780</scope>
</reference>
<reference key="121">
<citation type="journal article" date="1994" name="Hum. Mol. Genet." volume="3" first="1169" last="1170">
<title>Two mutations causing complete androgen insensitivity: a frame-shift in the steroid binding domain and a Cys-->Phe substitution in the second zinc finger of the androgen receptor.</title>
<authorList>
<person name="Baldazzi L."/>
<person name="Baroncini C."/>
<person name="Pirazzoli P."/>
<person name="Balsamo A."/>
<person name="Capelli M."/>
<person name="Marchetti G."/>
<person name="Bernardi F."/>
<person name="Cacciari E."/>
</authorList>
<dbReference type="PubMed" id="7981689"/>
<dbReference type="DOI" id="10.1093/hmg/3.7.1169"/>
</citation>
<scope>VARIANT AIS PHE-602</scope>
</reference>
<reference key="122">
<citation type="journal article" date="1994" name="J. Clin. Endocrinol. Metab." volume="78" first="513" last="522">
<title>Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome.</title>
<authorList>
<person name="De Bellis A."/>
<person name="Quigley C.A."/>
<person name="Marschke K.B."/>
<person name="el-Awady M.K."/>
<person name="Lane M.V."/>
<person name="Smith E.P."/>
<person name="Sar M."/>
<person name="Wilson E.M."/>
<person name="French F.S."/>
</authorList>
<dbReference type="PubMed" id="8126121"/>
<dbReference type="DOI" id="10.1210/jc.78.3.513"/>
</citation>
<scope>VARIANTS PAIS ARG-617; HIS-841 AND MET-890</scope>
</reference>
<reference key="123">
<citation type="journal article" date="1994" name="J. Clin. Endocrinol. Metab." volume="79" first="1202" last="1207">
<title>An androgen receptor mutation causing androgen resistance in undervirilized male syndrome.</title>
<authorList>
<person name="Tsukada T."/>
<person name="Inoue M."/>
<person name="Tachibana S."/>
<person name="Nakai Y."/>
<person name="Takebe H."/>
</authorList>
<dbReference type="PubMed" id="7962294"/>
<dbReference type="DOI" id="10.1210/jcem.79.4.7962294"/>
</citation>
<scope>VARIANT AIS PHE-791</scope>
</reference>
<reference key="124">
<citation type="journal article" date="1994" name="J. Clin. Invest." volume="94" first="546" last="554">
<title>Substitution of arginine-839 by cysteine or histidine in the androgen receptor causes different receptor phenotypes in cultured cells and coordinate degrees of clinical androgen resistance.</title>
<authorList>
<person name="Beitel L.K."/>
<person name="Kazemi-Esfarjani P."/>
<person name="Kaufman M."/>
<person name="Lumbroso R."/>
<person name="DiGeorge A.M."/>
<person name="Killinger D.W."/>
<person name="Trifiro M.A."/>
<person name="Pinsky L."/>
</authorList>
<dbReference type="PubMed" id="8040309"/>
<dbReference type="DOI" id="10.1172/JCI117368"/>
</citation>
<scope>VARIANTS AIS CYS-841 AND HIS-841</scope>
</reference>
<reference key="125">
<citation type="journal article" date="1994" name="J. Clin. Invest." volume="94" first="1642" last="1650">
<title>Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex.</title>
<authorList>
<person name="Marcelli M."/>
<person name="Zoppi S."/>
<person name="Wilson C.M."/>
<person name="Griffin J.E."/>
<person name="McPhaul M.J."/>
</authorList>
<dbReference type="PubMed" id="7929841"/>
<dbReference type="DOI" id="10.1172/JCI117507"/>
</citation>
<scope>VARIANTS AIS</scope>
<scope>VARIANTS PAIS</scope>
</reference>
<reference key="126">
<citation type="journal article" date="1994" name="Lancet" volume="344" first="826" last="827">
<title>Pregnancy after hormonal correction of severe spermatogenic defect due to mutation in androgen receptor gene.</title>
<authorList>
<person name="Yong E.L."/>
<person name="Ng S.C."/>
<person name="Roy A.C."/>
<person name="Yun G."/>
<person name="Ratnam S.S."/>
</authorList>
<dbReference type="PubMed" id="7993455"/>
<dbReference type="DOI" id="10.1016/S0140-6736(94)92385-X"/>
</citation>
<scope>VARIANT AIS LYS-728</scope>
</reference>
<reference key="127">
<citation type="journal article" date="1994" name="Pediatr. Res." volume="36" first="227" last="234">
<title>A practical approach to the detection of androgen receptor gene mutations and pedigree analysis in families with X-linked androgen insensitivity.</title>
<authorList>
<person name="Ris-Stalpers C."/>
<person name="Hoogenboezem T."/>
<person name="Sleddens H.F.B.M."/>
<person name="Verleun-Mooijman M.C.T."/>
<person name="Degenhart H.J."/>
<person name="Drop S.L.S."/>
<person name="Halley D.J.J."/>
<person name="Oosterwijk J.C."/>
<person name="Hodgins M.B."/>
<person name="Trapman J."/>
<person name="Brinkmann A.O."/>
</authorList>
<dbReference type="PubMed" id="7970939"/>
<dbReference type="DOI" id="10.1203/00006450-199408000-00015"/>
</citation>
<scope>VARIANTS AIS HIS-616 AND LEU-765</scope>
<scope>VARIANTS PAIS VAL-743 AND THR-746</scope>
</reference>
<reference key="128">
<citation type="journal article" date="1995" name="Ann. Clin. Biochem." volume="32" first="482" last="486">
<title>A frame-shift mutation of the androgen receptor gene in a patient with receptor-negative complete testicular feminization: comparison with a single base substitution in a receptor-reduced incomplete form.</title>
<authorList>
<person name="Imai A."/>
<person name="Ohno T."/>
<person name="Iida K."/>
<person name="Ohsuye K."/>
<person name="Okano Y."/>
<person name="Tamaya T."/>
</authorList>
<dbReference type="PubMed" id="8830623"/>
</citation>
<scope>VARIANT AIS HIS-841</scope>
</reference>
<reference key="129">
<citation type="journal article" date="1995" name="Cancer Res." volume="55" first="1621" last="1624">
<title>Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men.</title>
<authorList>
<person name="Takahashi H."/>
<person name="Furusato M."/>
<person name="Allsbrook W.C. Jr."/>
<person name="Nishii H."/>
<person name="Wakui S."/>
<person name="Barrett J.C."/>
<person name="Boyd J."/>
</authorList>
<dbReference type="PubMed" id="7712463"/>
</citation>
<scope>VARIANTS PROSTATE CANCER</scope>
</reference>
<reference key="130">
<citation type="journal article" date="1995" name="Clin. Endocrinol. (Oxf.)" volume="43" first="69" last="77">
<title>Genetic counselling in complete androgen insensitivity syndrome: trinucleotide repeat polymorphisms, single-strand conformation polymorphism and direct detection of two novel mutations in the androgen receptor gene.</title>
<authorList>
<person name="Davies H.R."/>
<person name="Hughes I.A."/>
<person name="Patterson M.N."/>
</authorList>
<dbReference type="PubMed" id="7641413"/>
<dbReference type="DOI" id="10.1111/j.1365-2265.1995.tb01895.x"/>
</citation>
<scope>VARIANT AIS VAL-882</scope>
</reference>
<reference key="131">
<citation type="journal article" date="1995" name="Endocr. Rev." volume="16" first="271" last="321">
<title>Androgen receptor defects: historical, clinical, and molecular perspectives.</title>
<authorList>
<person name="Quigley C.A."/>
<person name="De Bellis A."/>
<person name="Marschke K.B."/>
<person name="el-Awady M.K."/>
<person name="Wilson E.M."/>
<person name="French F.S."/>
</authorList>
<dbReference type="PubMed" id="7671849"/>
<dbReference type="DOI" id="10.1210/edrv-16-3-271"/>
</citation>
<scope>VARIANTS AIS SER-706 AND HIS-764</scope>
<scope>VARIANTS PAIS LEU-726; THR-738; HIS-775 AND GLU-799</scope>
</reference>
<reference key="132">
<citation type="journal article" date="1995" name="Endocr. Rev." volume="16" first="546" last="546">
<authorList>
<person name="Quigley C.A."/>
<person name="De Bellis A."/>
<person name="Marschke K.B."/>
<person name="el-Awady M.K."/>
<person name="Wilson E.M."/>
<person name="French F.S."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="133">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="515" last="521">
<title>Characterization of alternative amino acid substitutions at arginine 830 of the androgen receptor that cause complete androgen insensitivity in three families.</title>
<authorList>
<person name="Shkolny D.L."/>
<person name="Brown T.R."/>
<person name="Punnett H.H."/>
<person name="Kaufman M."/>
<person name="Trifiro M.A."/>
<person name="Pinsky L."/>
</authorList>
<dbReference type="PubMed" id="7633398"/>
<dbReference type="DOI" id="10.1093/hmg/4.4.515"/>
</citation>
<scope>VARIANTS AIS LEU-832 AND GLN-832</scope>
</reference>
<reference key="134">
<citation type="journal article" date="1995" name="Hum. Mutat." volume="5" first="28" last="33">
<title>Leu-676-Pro mutation of the androgen receptor causes complete androgen insensitivity syndrome in a large Hutterite kindred.</title>
<authorList>
<person name="Belsham D.D."/>
<person name="Pereira F."/>
<person name="Greenberg C.R."/>
<person name="Liao S."/>
<person name="Wrogemann K."/>
</authorList>
<dbReference type="PubMed" id="7537149"/>
<dbReference type="DOI" id="10.1002/humu.1380050104"/>
</citation>
<scope>VARIANT AIS PRO-678</scope>
</reference>
<reference key="135">
<citation type="journal article" date="1995" name="Hum. Mutat." volume="6" first="152" last="162">
<title>Human androgen insensitivity due to point mutations encoding amino acid substitutions in the androgen receptor steroid-binding domain.</title>
<authorList>
<person name="Murono K."/>
<person name="Mendonca B.B."/>
<person name="Arnhold I.J.P."/>
<person name="Rigon A.C.M.M."/>
<person name="Migeon C.J."/>
<person name="Brown T.R."/>
</authorList>
<dbReference type="PubMed" id="7581399"/>
<dbReference type="DOI" id="10.1002/humu.1380060208"/>
</citation>
<scope>VARIANT PAIS CYS-764</scope>
<scope>VARIANTS AIS TRP-780; VAL-808 AND CYS-856</scope>
</reference>
<reference key="136">
<citation type="journal article" date="1995" name="Int. J. Cancer" volume="63" first="544" last="550">
<title>Mutant androgen receptors in prostatic tumors distinguish between amino-acid-sequence requirements for transactivation and ligand binding.</title>
<authorList>
<person name="Peterziel H."/>
<person name="Culig Z."/>
<person name="Stober J."/>
<person name="Hobisch A."/>
<person name="Radmayr C."/>
<person name="Bartsch G."/>
<person name="Klocker H."/>
<person name="Cato A.C.B."/>
</authorList>
<dbReference type="PubMed" id="7591265"/>
<dbReference type="DOI" id="10.1002/ijc.2910630415"/>
</citation>
<scope>VARIANT PROSTATE CANCER MET-731</scope>
</reference>
<reference key="137">
<citation type="journal article" date="1995" name="J. Clin. Endocrinol. Metab." volume="80" first="2697" last="2699">
<title>Mutations of the androgen receptor coding sequence are infrequent in patients with isolated hypospadias.</title>
<authorList>
<person name="Allera A."/>
<person name="Herbst M.A."/>
<person name="Griffin J.E."/>
<person name="Wilson J.D."/>
<person name="Schweikert H.-U."/>
<person name="McPhaul M.J."/>
</authorList>
<dbReference type="PubMed" id="7673412"/>
<dbReference type="DOI" id="10.1210/jcem.80.9.7673412"/>
</citation>
<scope>VARIANT VAL-569</scope>
</reference>
<reference key="138">
<citation type="journal article" date="1995" name="J. Clin. Endocrinol. Metab." volume="80" first="3494" last="3500">
<title>Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol.</title>
<authorList>
<person name="Elo J.P."/>
<person name="Kvist L."/>
<person name="Leinonen K."/>
<person name="Isomaa V."/>
<person name="Henttu P."/>
<person name="Lukkarinen O."/>
<person name="Vihko P."/>
</authorList>
<dbReference type="PubMed" id="8530589"/>
<dbReference type="DOI" id="10.1210/jcem.80.12.8530589"/>
</citation>
<scope>VARIANT PROSTATE CANCER LEU-727</scope>
</reference>
<reference key="139">
<citation type="journal article" date="1995" name="Mol. Cell. Endocrinol." volume="111" first="93" last="98">
<title>A single amino acid exchange abolishes dimerization of the androgen receptor and causes Reifenstein syndrome.</title>
<authorList>
<person name="Gast A."/>
<person name="Neuschmid-Kaspar F."/>
<person name="Klocker H."/>
<person name="Cato A.C.B."/>
</authorList>
<dbReference type="PubMed" id="7649358"/>
<dbReference type="DOI" id="10.1016/0303-7207(95)03554-K"/>
</citation>
<scope>VARIANT PAIS THR-597</scope>
</reference>
<reference key="140">
<citation type="journal article" date="1995" name="N. Engl. J. Med." volume="332" first="1393" last="1398">
<title>Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.</title>
<authorList>
<person name="Taplin M.-E."/>
<person name="Bubley G.J."/>
<person name="Shuster T.D."/>
<person name="Frantz M.E."/>
<person name="Spooner A.E."/>
<person name="Ogata G.K."/>
<person name="Keer H.N."/>
<person name="Balk S.P."/>
</authorList>
<dbReference type="PubMed" id="7723794"/>
<dbReference type="DOI" id="10.1056/NEJM199505253322101"/>
</citation>
<scope>VARIANTS PROSTATE CANCER</scope>
</reference>
<reference key="141">
<citation type="journal article" date="1996" name="Am. J. Med. Genet." volume="63" first="218" last="222">
<title>The clinical and molecular spectrum of androgen insensitivity syndromes.</title>
<authorList>
<person name="Hiort O."/>
<person name="Sinnecker G.H."/>
<person name="Holterhus P.M."/>
<person name="Nitsche E.M."/>
<person name="Kruse K."/>
</authorList>
<dbReference type="PubMed" id="8723113"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19960503)63:1&lt;218::AID-AJMG38>3.0.CO;2-P"/>
</citation>
<scope>VARIANTS AIS AND PAIS</scope>
</reference>
<reference key="142">
<citation type="journal article" date="1996" name="Clin. Cancer Res." volume="2" first="277" last="285">
<title>Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.</title>
<authorList>
<person name="Tilley W.D."/>
<person name="Buchanan G."/>
<person name="Hickey T.E."/>
<person name="Bentel J.M."/>
</authorList>
<dbReference type="PubMed" id="9816170"/>
</citation>
<scope>VARIANTS PROSTATE CANCER</scope>
</reference>
<reference key="143">
<citation type="journal article" date="1996" name="Clin. Endocrinol. (Oxf.)" volume="45" first="733" last="739">
<title>Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene.</title>
<authorList>
<person name="Weidemann W."/>
<person name="Linck B."/>
<person name="Haupt H."/>
<person name="Mentrup B."/>
<person name="Romalo G."/>
<person name="Stockklauser K."/>
<person name="Brinkmann A.O."/>
<person name="Schweikert H.-U."/>
<person name="Spindler K.D."/>
</authorList>
<dbReference type="PubMed" id="9039340"/>
<dbReference type="DOI" id="10.1046/j.1365-2265.1996.8600869.x"/>
</citation>
<scope>VARIANTS PAIS GLN-608; THR-611; LEU-755; HIS-841; THR-843 AND HIS-856</scope>
<scope>VARIANT AIS MET-867</scope>
</reference>
<reference key="144">
<citation type="journal article" date="1996" name="Clin. Genet." volume="50" first="202" last="205">
<title>Rapid detection of a mutation hot-spot in the human androgen receptor.</title>
<authorList>
<person name="Malmgren H."/>
<person name="Gustavsson J."/>
<person name="Tuvemo T."/>
<person name="Dahl N."/>
</authorList>
<dbReference type="PubMed" id="9001799"/>
</citation>
<scope>VARIANT AIS CYS-856</scope>
</reference>
<reference key="145">
<citation type="journal article" date="1996" name="Hum. Mol. Genet." volume="5" first="265" last="273">
<title>Functional analysis of six androgen receptor mutations identified in patients with partial androgen insensitivity syndrome.</title>
<authorList>
<person name="Bevan C.L."/>
<person name="Brown B.B."/>
<person name="Davies H.R."/>
<person name="Evans B.A.J."/>
<person name="Hughes I.A."/>
<person name="Patterson M.N."/>
</authorList>
<dbReference type="PubMed" id="8824883"/>
<dbReference type="DOI" id="10.1093/hmg/5.2.265"/>
</citation>
<scope>VARIANTS PAIS ILE-743; ILE-781; GLU-799; CYS-841; HIS-856 AND MET-870</scope>
</reference>
<reference key="146">
<citation type="journal article" date="1996" name="J. Clin. Endocrinol. Metab." volume="81" first="236" last="243">
<title>Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels.</title>
<authorList>
<person name="Choong C.S."/>
<person name="Sturm M.J."/>
<person name="Strophair J.A."/>
<person name="McCulloch R.K."/>
<person name="Tilley W.D."/>
<person name="Leedman P.J."/>
<person name="Hurley D.M."/>
</authorList>
<dbReference type="PubMed" id="8550758"/>
<dbReference type="DOI" id="10.1210/jcem.81.1.8550758"/>
</citation>
<scope>VARIANT PAIS ARG-910</scope>
</reference>
<reference key="147">
<citation type="journal article" date="1996" name="J. Clin. Endocrinol. Metab." volume="81" first="1984" last="1988">
<title>A novel substitution (Leu707Arg) in exon 4 of the androgen receptor gene causes complete androgen resistance.</title>
<authorList>
<person name="Lumbroso S."/>
<person name="Lobaccaro J.-M."/>
<person name="Georget V."/>
<person name="Leger J."/>
<person name="Poujol N."/>
<person name="Terouanne B."/>
<person name="Evain-Brion D."/>
<person name="Czernichow P."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="8626869"/>
<dbReference type="DOI" id="10.1210/jcem.81.5.8626869"/>
</citation>
<scope>VARIANT AIS ARG-708</scope>
</reference>
<reference key="148">
<citation type="journal article" date="1996" name="J. Clin. Endocrinol. Metab." volume="81" first="2994" last="2998">
<title>Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene.</title>
<authorList>
<person name="Rodien P."/>
<person name="Mebarki F."/>
<person name="Mowszowicz I."/>
<person name="Chaussain J.L."/>
<person name="Young J."/>
<person name="Morel Y."/>
<person name="Schaison G."/>
</authorList>
<dbReference type="PubMed" id="8768864"/>
<dbReference type="DOI" id="10.1210/jcem.81.8.8768864"/>
</citation>
<scope>VARIANT AIS ILE-781</scope>
</reference>
<reference key="149">
<citation type="journal article" date="1996" name="J. Clin. Invest." volume="98" first="1423" last="1431">
<title>A novel missense mutation in the amino-terminal domain of the human androgen receptor gene in a family with partial androgen insensitivity syndrome causes reduced efficiency of protein translation.</title>
<authorList>
<person name="Choong C.S."/>
<person name="Quigley C.A."/>
<person name="French F.S."/>
<person name="Wilson E.M."/>
</authorList>
<dbReference type="PubMed" id="8823308"/>
<dbReference type="DOI" id="10.1172/JCI118930"/>
</citation>
<scope>VARIANT PAIS LYS-2</scope>
</reference>
<reference key="150">
<citation type="journal article" date="1996" name="J. Steroid Biochem. Mol. Biol." volume="58" first="569" last="575">
<title>Molecular basis of androgen insensitivity.</title>
<authorList>
<person name="Bruggenwirth H.T."/>
<person name="Boehmer A.L.M."/>
<person name="Verleun-Mooijman M.C.T."/>
<person name="Hoogenboezem T."/>
<person name="Kleijer W.J."/>
<person name="Otten B.J."/>
<person name="Trapman J."/>
<person name="Brinkmann A.O."/>
</authorList>
<dbReference type="PubMed" id="8918984"/>
<dbReference type="DOI" id="10.1016/0960-0760(96)00095-7"/>
</citation>
<scope>VARIANT AIS ASP-574</scope>
</reference>
<reference key="151">
<citation type="journal article" date="1996" name="J. Urol." volume="156" first="828" last="831">
<title>Androgen receptor gene mutations are rarely associated with isolated penile hypospadias.</title>
<authorList>
<person name="Sutherland R.W."/>
<person name="Wiener J.S."/>
<person name="Hicks J.P."/>
<person name="Marcelli M."/>
<person name="Gonzales E.T. Jr."/>
<person name="Roth D.R."/>
<person name="Lamb D.J."/>
</authorList>
<dbReference type="PubMed" id="8683794"/>
<dbReference type="DOI" id="10.1097/00005392-199608001-00077"/>
</citation>
<scope>VARIANT AIS SER-549</scope>
</reference>
<reference key="152">
<citation type="journal article" date="1996" name="Mol. Cell. Endocrinol." volume="116" first="137" last="147">
<title>Molecular modeling and in vitro investigations of the human androgen receptor DNA-binding domain: application for the study of two mutations.</title>
<authorList>
<person name="Lobaccaro J.-M."/>
<person name="Poujol N."/>
<person name="Chiche L."/>
<person name="Lumbroso S."/>
<person name="Brown T.R."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="8647313"/>
<dbReference type="DOI" id="10.1016/0303-7207(95)03709-8"/>
</citation>
<scope>VARIANT AIS PRO-617</scope>
</reference>
<reference key="153">
<citation type="journal article" date="1996" name="Mol. Cell. Endocrinol." volume="120" first="15" last="24">
<title>Androgen insensitivity syndrome due to new mutations in the DNA-binding domain of the androgen receptor.</title>
<authorList>
<person name="Imasaki K."/>
<person name="Okabe T."/>
<person name="Murakami H."/>
<person name="Tanaka Y."/>
<person name="Haji M."/>
<person name="Takayanagi R."/>
<person name="Nawata H."/>
</authorList>
<dbReference type="PubMed" id="8809734"/>
<dbReference type="DOI" id="10.1016/0303-7207(96)03812-9"/>
</citation>
<scope>VARIANT AIS PHE-580</scope>
<scope>VARIANT PAIS TYR-583</scope>
</reference>
<reference key="154">
<citation type="journal article" date="1996" name="Prostate" volume="28" first="162" last="171">
<title>Low incidence of androgen receptor gene mutations in human prostatic tumors using single strand conformation polymorphism analysis.</title>
<authorList>
<person name="Evans B.A.J."/>
<person name="Harper M.E."/>
<person name="Daniells C.E."/>
<person name="Watts C.E."/>
<person name="Matenhelia S."/>
<person name="Green J."/>
<person name="Griffiths K."/>
</authorList>
<dbReference type="PubMed" id="8628719"/>
<dbReference type="DOI" id="10.1002/(SICI)1097-0045(199603)28:3&lt;162::AID-PROS3>3.0.CO;2-H"/>
</citation>
<scope>VARIANT PROSTATE CANCER GLU-799</scope>
</reference>
<reference key="155">
<citation type="journal article" date="1996" name="Prostate" volume="29" first="153" last="158">
<title>Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome.</title>
<authorList>
<person name="Suzuki H."/>
<person name="Akakura K."/>
<person name="Komiya A."/>
<person name="Aida S."/>
<person name="Akimoto S."/>
<person name="Shimazaki J."/>
</authorList>
<dbReference type="PubMed" id="8827083"/>
<dbReference type="DOI" id="10.1002/1097-0045(199609)29:3&lt;153::AID-PROS2990290303>3.0.CO;2-5"/>
</citation>
<scope>VARIANT PROSTATE CANCER ALA-878</scope>
</reference>
<reference key="156">
<citation type="journal article" date="1997" name="Am. J. Hum. Genet." volume="60" first="1003" last="1006">
<title>Germ-line and somatic mosaicism in the androgen insensitivity syndrome: implications for genetic counseling.</title>
<authorList>
<person name="Boehmer A.L.M."/>
<person name="Brinkmann A.O."/>
<person name="Niermeijer M.F."/>
<person name="Bakker L."/>
<person name="Halley D.J.J."/>
<person name="Drop S.L.S."/>
</authorList>
<dbReference type="PubMed" id="9106550"/>
</citation>
<scope>VARIANT AIS HIS-856</scope>
</reference>
<reference key="157">
<citation type="journal article" date="1997" name="Cancer Res." volume="57" first="314" last="319">
<title>Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.</title>
<authorList>
<person name="Koivisto P."/>
<person name="Kononen J."/>
<person name="Palmberg C."/>
<person name="Tammela T."/>
<person name="Hyytinen E."/>
<person name="Isola J."/>
<person name="Trapman J."/>
<person name="Cleutjens K."/>
<person name="Noordzij A."/>
<person name="Visakorpi T."/>
<person name="Kallioniemi O.-P."/>
</authorList>
<dbReference type="PubMed" id="9000575"/>
</citation>
<scope>VARIANT PROSTATE CANCER ALA-684</scope>
</reference>
<reference key="158">
<citation type="journal article" date="1997" name="Clin. Endocrinol. (Oxf.)" volume="46" first="497" last="506">
<title>Correlation of clinical, endocrine and molecular abnormalities with in vivo responses to high-dose testosterone in patients with partial androgen insensitivity syndrome.</title>
<authorList>
<person name="Tincello D.G."/>
<person name="Saunders P.T."/>
<person name="Hodgins M.B."/>
<person name="Simpson N.B."/>
<person name="Edwards C.R."/>
<person name="Hargreaves T.B."/>
<person name="Wu F.C."/>
</authorList>
<dbReference type="PubMed" id="9196614"/>
<dbReference type="DOI" id="10.1046/j.1365-2265.1997.1140927.x"/>
</citation>
<scope>VARIANTS PAIS LYS-609 AND GLY-773</scope>
</reference>
<reference key="159">
<citation type="journal article" date="1997" name="Dis. Markers" volume="13" first="99" last="105">
<title>Molecular analysis of androgen resistance syndromes in Egyptian patients.</title>
<authorList>
<person name="Essawi M."/>
<person name="Gad Y.Z."/>
<person name="el-Rouby O."/>
<person name="Temtamy S.A."/>
<person name="Sabour Y.A."/>
<person name="el-Awady M.K."/>
</authorList>
<dbReference type="PubMed" id="9160185"/>
</citation>
<scope>VARIANT AIS MET-890</scope>
</reference>
<reference key="160">
<citation type="journal article" date="1997" name="Eur. J. Pediatr." volume="156" first="7" last="14">
<title>Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene.</title>
<authorList>
<person name="Sinnecker G.H."/>
<person name="Hiort O."/>
<person name="Nitsche E.M."/>
<person name="Holterhus P.M."/>
<person name="Kruse K."/>
</authorList>
<dbReference type="PubMed" id="9007482"/>
<dbReference type="DOI" id="10.1007/s004310050542"/>
</citation>
<scope>VARIANT AIS TRP-780</scope>
</reference>
<reference key="161">
<citation type="journal article" date="1997" name="Hum. Mutat." volume="9" first="57" last="61">
<title>Mutations of the androgen receptor gene in patients with complete androgen insensitivity.</title>
<authorList>
<person name="Jakubiczka S."/>
<person name="Nedel S."/>
<person name="Werder E.A."/>
<person name="Schleiermacher E."/>
<person name="Theile U."/>
<person name="Wolff G."/>
<person name="Wieacker P."/>
</authorList>
<dbReference type="PubMed" id="8990010"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1997)9:1&lt;57::AID-HUMU10>3.3.CO;2-0"/>
</citation>
<scope>VARIANTS AIS VAL-750; CYS-775; ILE-781 AND SER-795</scope>
</reference>
<reference key="162">
<citation type="journal article" date="1997" name="Jpn. J. Clin. Oncol." volume="27" first="389" last="393">
<title>Genetic alterations of androgen receptor gene in Japanese human prostate cancer.</title>
<authorList>
<person name="Watanabe M."/>
<person name="Ushijima T."/>
<person name="Shiraishi T."/>
<person name="Yatani R."/>
<person name="Shimazaki J."/>
<person name="Kotake T."/>
<person name="Sugimura T."/>
<person name="Nagao M."/>
</authorList>
<dbReference type="PubMed" id="9438000"/>
<dbReference type="DOI" id="10.1093/jjco/27.6.389"/>
</citation>
<scope>VARIANTS PROSTATE CANCER IN POLY-GLN REGION; HIS-702 AND ARG-911</scope>
</reference>
<reference key="163">
<citation type="journal article" date="1997" name="Nihon Hinyokika Gakkai Zasshi" volume="88" first="550" last="556">
<title>Androgen receptor gene mutations in prostate cancer.</title>
<authorList>
<person name="Wang C."/>
<person name="Uchida T."/>
</authorList>
<dbReference type="PubMed" id="9184448"/>
<dbReference type="DOI" id="10.5980/jpnjurol1989.88.550"/>
</citation>
<scope>VARIANT PROSTATE CANCER GLN-630</scope>
</reference>
<reference key="164">
<citation type="journal article" date="1997" name="J. Obstet. Gynaecol. Res." volume="23" first="277" last="281">
<title>DNA analysis of the androgen receptor gene in two cases with complete androgen insensitivity syndrome.</title>
<authorList>
<person name="Komori S."/>
<person name="Sakata K."/>
<person name="Tanaka H."/>
<person name="Shima H."/>
<person name="Koyama K."/>
</authorList>
<dbReference type="PubMed" id="9255042"/>
<dbReference type="DOI" id="10.1111/j.1447-0756.1997.tb00845.x"/>
</citation>
<scope>VARIANTS AIS ARG-196 AND CYS-856</scope>
</reference>
<reference key="165">
<citation type="journal article" date="1997" name="J. Pediatr." volume="131" first="386" last="392">
<title>Etiologic classification of severe hypospadias: implications for prognosis and management.</title>
<authorList>
<person name="Albers N."/>
<person name="Ulrichs C."/>
<person name="Gluer S."/>
<person name="Hiort O."/>
<person name="Sinnecker G.H."/>
<person name="Mildenberger H."/>
<person name="Brodehl J."/>
</authorList>
<dbReference type="PubMed" id="9329414"/>
<dbReference type="DOI" id="10.1016/S0022-3476(97)80063-7"/>
</citation>
<scope>VARIANTS PAIS ALA-709 AND GLY-871</scope>
</reference>
<reference key="166">
<citation type="journal article" date="1997" name="J. Reprod. Med." volume="42" first="424" last="428">
<title>Complete androgen insensitivity syndrome. Molecular characterization in two Chinese women.</title>
<authorList>
<person name="Ko T.M."/>
<person name="Yang Y.S."/>
<person name="Wu M.Y."/>
<person name="Kao C.H."/>
<person name="Hsu P.M."/>
<person name="Chuang S.M."/>
<person name="Lee T.Y."/>
</authorList>
<dbReference type="PubMed" id="9252933"/>
</citation>
<scope>VARIANTS AIS ASN-733 AND THR-766</scope>
</reference>
<reference key="167">
<citation type="journal article" date="1997" name="J. Steroid Biochem. Mol. Biol." volume="61" first="19" last="26">
<title>Wide variation in androgen receptor dysfunction in complete androgen insensitivity syndrome.</title>
<authorList>
<person name="Bevan C.L."/>
<person name="Hughes I.A."/>
<person name="Patterson M.N."/>
</authorList>
<dbReference type="PubMed" id="9328206"/>
<dbReference type="DOI" id="10.1016/S0960-0760(97)00001-0"/>
</citation>
<scope>VARIANTS AIS ASP-751; PHE-763; THR-766; ASN-865 AND PHE-908</scope>
</reference>
<reference key="168">
<citation type="journal article" date="1997" name="J. Urol." volume="158" first="1553" last="1556">
<title>Androgen receptor point mutations as the underlying molecular defect in 2 patients with androgen insensitivity syndrome.</title>
<authorList>
<person name="Radmayr C."/>
<person name="Culig Z."/>
<person name="Glatzl J."/>
<person name="Neuschmid-Kaspar F."/>
<person name="Bartsch G."/>
<person name="Klocker H."/>
</authorList>
<dbReference type="PubMed" id="9302173"/>
<dbReference type="DOI" id="10.1016/S0022-5347(01)64279-4"/>
</citation>
<scope>VARIANT PAIS GLY-704</scope>
<scope>VARIANT AIS LEU-917</scope>
</reference>
<reference key="169">
<citation type="journal article" date="1998" name="Arch. Gynecol. Obstet." volume="261" first="95" last="100">
<title>Molecular analysis of the androgen receptor gene in 4 patients with complete androgen insensitivity.</title>
<authorList>
<person name="Komori S."/>
<person name="Kasumi H."/>
<person name="Sakata K."/>
<person name="Tanaka H."/>
<person name="Hamada K."/>
<person name="Koyama K."/>
</authorList>
<dbReference type="PubMed" id="9544375"/>
<dbReference type="DOI" id="10.1007/s004040050206"/>
</citation>
<scope>VARIANTS AIS CYS-572; GLN-753 AND CYS-775</scope>
</reference>
<reference key="170">
<citation type="journal article" date="1998" name="Braz. J. Med. Biol. Res." volume="31" first="775" last="778">
<title>Mutations of androgen receptor gene in Brazilian patients with male pseudohermaphroditism.</title>
<authorList>
<person name="Cabral D.F."/>
<person name="Maciel-Guerra A.T."/>
<person name="Hackel C."/>
</authorList>
<dbReference type="PubMed" id="9698822"/>
<dbReference type="DOI" id="10.1590/S0100-879X1998000600008"/>
</citation>
<scope>VARIANTS AIS HIS-616 AND GLN-753</scope>
</reference>
<reference key="171">
<citation type="journal article" date="1998" name="Clin. Genet." volume="54" first="185" last="192">
<title>Analysis of the transactivation domain of the androgen receptor in patients with male infertility.</title>
<authorList>
<person name="Wang Q."/>
<person name="Ghadessy F.J."/>
<person name="Yong E.L."/>
</authorList>
<dbReference type="PubMed" id="9788719"/>
</citation>
<scope>VARIANT ARG-216</scope>
<scope>CHARACTERIZATION OF VARIANT ARG-216</scope>
</reference>
<reference key="172">
<citation type="journal article" date="1998" name="Gynecol. Endocrinol." volume="12" first="75" last="82">
<title>One additional mutation at exon A amplifies thermolability of androgen receptor in a case with complete androgen insensitivity syndrome.</title>
<authorList>
<person name="Tanaka H."/>
<person name="Komori S."/>
<person name="Sakata K."/>
<person name="Shima H."/>
<person name="Koyama K."/>
</authorList>
<dbReference type="PubMed" id="9610419"/>
<dbReference type="DOI" id="10.3109/09513599809024954"/>
</citation>
<scope>VARIANTS AIS PRO-257 AND ALA-821</scope>
</reference>
<reference key="173">
<citation type="journal article" date="1998" name="Hum. Genet." volume="103" first="529" last="531">
<title>Functional characterisation of mutations in the ligand-binding domain of the androgen receptor gene in patients with androgen insensitivity syndrome.</title>
<authorList>
<person name="Lundberg Giwercman Y."/>
<person name="Nikoshkov A."/>
<person name="Lindsten K."/>
<person name="Bystroem B."/>
<person name="Pousette A."/>
<person name="Chibalin A.V."/>
<person name="Arvidsson S."/>
<person name="Tiulpakov A."/>
<person name="Semitcheva T.V."/>
<person name="Peterkova V."/>
<person name="Hagenfeldt K."/>
<person name="Ritzen E.M."/>
<person name="Wedell A."/>
</authorList>
<dbReference type="PubMed" id="9856504"/>
<dbReference type="DOI" id="10.1007/s004390050864"/>
</citation>
<scope>VARIANTS AIS THR-766; TYR-785 AND THR-896</scope>
<scope>VARIANT PAIS GLY-841</scope>
</reference>
<reference key="174">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="11" first="337" last="339">
<title>A new missense substitution at a mutational hot spot of the androgen receptor in siblings with complete androgen insensitivity syndrome.</title>
<authorList>
<person name="Doerk T."/>
<person name="Schnieders F."/>
<person name="Jakubiczka S."/>
<person name="Wieacker P."/>
<person name="Schroeder-Kurth T."/>
<person name="Schmidtke J."/>
</authorList>
<dbReference type="PubMed" id="9554754"/>
</citation>
<scope>VARIANT AIS VAL-696</scope>
</reference>
<reference key="175">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="11" first="339" last="339">
<title>An androgen receptor gene mutation (A645D) in a boy with a normal phenotype.</title>
<authorList>
<person name="Nordenskjoeld A."/>
<person name="Soederhaell S."/>
</authorList>
<dbReference type="PubMed" id="9554755"/>
</citation>
<scope>VARIANT ASP-646</scope>
</reference>
<reference key="176">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="12" first="220" last="220">
<title>Single amino acid substitution in the hormone-binding domain of the androgen receptor in a family with complete androgen insensitivity syndrome (CAIS).</title>
<authorList>
<person name="Knoke I."/>
<person name="Jakubiczka S."/>
<person name="Rohrer T."/>
<person name="Hanimann B."/>
<person name="Werder E.A."/>
<person name="Wieacker P."/>
</authorList>
</citation>
<scope>VARIANT AIS LEU-893</scope>
</reference>
<reference key="177">
<citation type="journal article" date="1998" name="J. Clin. Endocrinol. Metab." volume="83" first="1173" last="1176">
<title>Response to androgen treatment in a patient with partial androgen insensitivity and a mutation in the deoxyribonucleic acid-binding domain of the androgen receptor.</title>
<authorList>
<person name="Weidemann W."/>
<person name="Peters B."/>
<person name="Romalo G."/>
<person name="Spindler K.D."/>
<person name="Schweikert H.-U."/>
</authorList>
<dbReference type="PubMed" id="9543136"/>
<dbReference type="DOI" id="10.1210/jcem.83.4.4704"/>
</citation>
<scope>VARIANT PAIS GLN-608</scope>
</reference>
<reference key="178">
<citation type="journal article" date="1998" name="J. Clin. Endocrinol. Metab." volume="83" first="3597" last="3603">
<title>Trafficking of androgen receptor mutants fused to green fluorescent protein: a new investigation of partial androgen insensitivity syndrome.</title>
<authorList>
<person name="Georget V."/>
<person name="Terouanne B."/>
<person name="Lumbroso S."/>
<person name="Nicolas J.C."/>
<person name="Sultan C."/>
</authorList>
<dbReference type="PubMed" id="9768671"/>
<dbReference type="DOI" id="10.1210/jcem.83.10.5201"/>
</citation>
<scope>VARIANTS PAIS VAL-744 AND CYS-841</scope>
</reference>
<reference key="179">
<citation type="journal article" date="1998" name="J. Clin. Endocrinol. Metab." volume="83" first="4303" last="4309">
<title>Azoospermia associated with a mutation in the ligand-binding domain of an androgen receptor displaying normal ligand binding, but defective trans-activation.</title>
<authorList>
<person name="Wang Q."/>
<person name="Ghadessy F.J."/>
<person name="Trounson A."/>
<person name="de Kretser D."/>
<person name="McLachlan R."/>
<person name="Ng S.C."/>
<person name="Yong E.L."/>
</authorList>
<dbReference type="PubMed" id="9851768"/>
<dbReference type="DOI" id="10.1210/jcem.83.12.5358"/>
</citation>
<scope>VARIANT AIS GLU-799</scope>
</reference>
<reference key="180">
<citation type="journal article" date="1998" name="J. Pediatr." volume="132" first="939" last="943">
<title>Inherited and de novo androgen receptor gene mutations: investigation of single-case families.</title>
<authorList>
<person name="Hiort O."/>
<person name="Sinnecker G.H."/>
<person name="Holterhus P.M."/>
<person name="Nitsche E.M."/>
<person name="Kruse K."/>
</authorList>
<dbReference type="PubMed" id="9627582"/>
<dbReference type="DOI" id="10.1016/S0022-3476(98)70387-7"/>
</citation>
<scope>VARIANTS AIS</scope>
</reference>
<reference key="181">
<citation type="journal article" date="1998" name="Mol. Cell. Endocrinol." volume="137" first="41" last="50">
<title>Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.</title>
<authorList>
<person name="Yong E.L."/>
<person name="Tut T.G."/>
<person name="Ghadessy F.J."/>
<person name="Prins G."/>
<person name="Ratnam S.S."/>
</authorList>
<dbReference type="PubMed" id="9607727"/>
<dbReference type="DOI" id="10.1016/S0303-7207(97)00229-3"/>
</citation>
<scope>VARIANT PAIS THR-759</scope>
</reference>
<reference key="182">
<citation type="journal article" date="1999" name="Andrologia" volume="31" first="199" last="201">
<title>A new point mutation of the androgen receptor gene in a patient with partial androgen resistance and severe oligozoospermia.</title>
<authorList>
<person name="Knoke I."/>
<person name="Jakubiczka S."/>
<person name="Lehnert H."/>
<person name="Wieacker P."/>
</authorList>
<dbReference type="PubMed" id="10470409"/>
<dbReference type="DOI" id="10.1046/j.1439-0272.1999.00278.x"/>
</citation>
<scope>VARIANT PAIS LEU-912</scope>
</reference>
<reference key="183">
<citation type="journal article" date="1999" name="Cancer Res." volume="59" first="2511" last="2515">
<title>Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.</title>
<authorList>
<person name="Taplin M.-E."/>
<person name="Bubley G.J."/>
<person name="Ko Y.J."/>
<person name="Small E.J."/>
<person name="Upton M."/>
<person name="Rajeshkumar B."/>
<person name="Balk S.P."/>
</authorList>
<dbReference type="PubMed" id="10363963"/>
</citation>
<scope>VARIANTS PROSTATE CANCER ALA-878 AND ASN-891</scope>
</reference>
<reference key="184">
<citation type="journal article" date="1999" name="Hum. Mutat." volume="14" first="353" last="353">
<title>A novel point mutation (R840S) in the androgen receptor in a Brazilian family with partial androgen insensitivity syndrome.</title>
<authorList>
<person name="Melo K.F.S."/>
<person name="Latronico A.C."/>
<person name="Costa E.M.F."/>
<person name="Billerbeck A.E.C."/>
<person name="Mendonca B.B."/>
<person name="Arnhold I.J.P."/>
</authorList>
<dbReference type="PubMed" id="10502786"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(199910)14:4&lt;353::AID-HUMU16>3.0.CO;2-7"/>
</citation>
<scope>VARIANT PAIS SER-841</scope>
</reference>
<reference key="185">
<citation type="journal article" date="1999" name="Hum. Mutat." volume="14" first="527" last="539">
<title>Analysis of exon 1 mutations in the androgen receptor gene.</title>
<authorList>
<person name="Gottlieb B."/>
<person name="Vasiliou D.M."/>
<person name="Lumbroso R."/>
<person name="Beitel L.K."/>
<person name="Pinsky L."/>
<person name="Trifiro M.A."/>
</authorList>
<dbReference type="PubMed" id="10571951"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(199912)14:6&lt;527::AID-HUMU12>3.0.CO;2-X"/>
</citation>
<scope>VARIANTS AIS ARG-392 AND ARG-445</scope>
</reference>
<reference key="186">
<citation type="journal article" date="1999" name="Hum. Reprod." volume="14" first="664" last="670">
<title>Androgen receptor gene mutations in 46,XY females with germ cell tumours.</title>
<authorList>
<person name="Chen C.P."/>
<person name="Chern S.R."/>
<person name="Wang T.Y."/>
<person name="Wang W."/>
<person name="Wang K.L."/>
<person name="Jeng C.J."/>
</authorList>
<dbReference type="PubMed" id="10221692"/>
<dbReference type="DOI" id="10.1093/humrep/14.3.664"/>
</citation>
<scope>VARIANT PAIS GLN-608</scope>
<scope>VARIANT AIS LYS-682</scope>
</reference>
<reference key="187">
<citation type="journal article" date="1999" name="Int. J. Urol." volume="6" first="327" last="330">
<title>A case of complete testicular feminization: laparoscopic orchiectomy and analysis of androgen receptor gene mutation.</title>
<authorList>
<person name="Kanayama H."/>
<person name="Naroda T."/>
<person name="Inoue Y."/>
<person name="Kurokawa Y."/>
<person name="Kagawa S."/>
</authorList>
<dbReference type="PubMed" id="10404311"/>
<dbReference type="DOI" id="10.1046/j.1442-2042.1999.00065.x"/>
</citation>
<scope>VARIANT AIS LEU-893</scope>
</reference>
<reference key="188">
<citation type="journal article" date="1999" name="J. Clin. Endocrinol. Metab." volume="84" first="805" last="810">
<title>Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively.</title>
<authorList>
<person name="Shkolny D.L."/>
<person name="Beitel L.K."/>
<person name="Ginsberg J."/>
<person name="Pekeles G."/>
<person name="Arbour L."/>
<person name="Pinsky L."/>
<person name="Trifiro M.A."/>
</authorList>
<dbReference type="PubMed" id="10022458"/>
<dbReference type="DOI" id="10.1210/jcem.84.2.5453"/>
</citation>
<scope>VARIANT PAIS ALA-773</scope>
<scope>VARIANT AIS GLY-872</scope>
</reference>
<reference key="189">
<citation type="journal article" date="1999" name="J. Pathol." volume="189" first="559" last="563">
<title>Androgen receptor gene mutations in hormone-refractory prostate cancer.</title>
<authorList>
<person name="Wallen M.J."/>
<person name="Linja M."/>
<person name="Kaartinen K."/>
<person name="Schleutker J."/>
<person name="Visakorpi T."/>
</authorList>
<dbReference type="PubMed" id="10629558"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-9896(199912)189:4&lt;559::AID-PATH471>3.0.CO;2-Y"/>
</citation>
<scope>VARIANTS PROSTATE CANCER IN POLY-GLN REGION AND ALA-684</scope>
</reference>
<reference key="190">
<citation type="journal article" date="1999" name="J. Urol." volume="162" first="2192" last="2199">
<title>Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.</title>
<authorList>
<person name="Zhao X.Y."/>
<person name="Boyle B."/>
<person name="Krishnan A.V."/>
<person name="Navone N.M."/>
<person name="Peehl D.M."/>
<person name="Feldman D."/>
</authorList>
<dbReference type="PubMed" id="10569618"/>
<dbReference type="DOI" id="10.1016/S0022-5347(05)68158-X"/>
</citation>
<scope>VARIANTS PROSTATE CANCER HIS-702 AND ALA-878</scope>
</reference>
<reference key="191">
<citation type="journal article" date="1999" name="Lancet" volume="354" first="1444" last="1445">
<title>Directed pharmacological therapy of ambiguous genitalia due to an androgen receptor gene mutation.</title>
<authorList>
<person name="Ong Y.C."/>
<person name="Wong H.B."/>
<person name="Adaikan G."/>
<person name="Yong E.L."/>
</authorList>
<dbReference type="PubMed" id="10543676"/>
<dbReference type="DOI" id="10.1016/S0140-6736(99)03205-5"/>
</citation>
<scope>VARIANT PAIS THR-808</scope>
</reference>
<reference key="192">
<citation type="journal article" date="1999" name="Mol. Cell. Endocrinol." volume="148" first="47" last="53">
<title>An androgen receptor mutation in the direct vicinity of the proposed C-terminal alpha-helix of the ligand binding domain containing the AF-2 transcriptional activating function core is associated with complete androgen insensitivity.</title>
<authorList>
<person name="Peters I."/>
<person name="Weidemann W."/>
<person name="Romalo G."/>
<person name="Knorr D."/>
<person name="Schweikert H.-U."/>
<person name="Spindler K.D."/>
</authorList>
<dbReference type="PubMed" id="10221770"/>
<dbReference type="DOI" id="10.1016/S0303-7207(98)00237-8"/>
</citation>
<scope>VARIANT AIS LEU-893</scope>
</reference>
<reference key="193">
<citation type="journal article" date="1999" name="Mol. Endocrinol." volume="13" first="2065" last="2075">
<title>A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1.</title>
<authorList>
<person name="Nazareth L.V."/>
<person name="Stenoien D.L."/>
<person name="Bingman W.E. III"/>
<person name="James A.J."/>
<person name="Wu C."/>
<person name="Zhang Y."/>
<person name="Edwards D.P."/>
<person name="Mancini M."/>
<person name="Marcelli M."/>
<person name="Lamb D.J."/>
<person name="Weigel N.L."/>
</authorList>
<dbReference type="PubMed" id="10598582"/>
<dbReference type="DOI" id="10.1210/mend.13.12.0382"/>
</citation>
<scope>VARIANT PROSTATE CANCER TYR-620</scope>
</reference>
<reference key="194">
<citation type="journal article" date="2000" name="Mol. Endocrinol." volume="14" first="544" last="544">
<authorList>
<person name="Nazareth L.V."/>
<person name="Stenoien D.L."/>
<person name="Bingman W.E. III"/>
<person name="James A.J."/>
<person name="Wu C."/>
<person name="Zhang Y."/>
<person name="Edwards D.P."/>
<person name="Mancini M."/>
<person name="Marcelli M."/>
<person name="Lamb D.J."/>
<person name="Weigel N.L."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="195">
<citation type="journal article" date="1999" name="Pediatr. Res." volume="46" first="684" last="690">
<title>Clinical and molecular spectrum of somatic mosaicism in androgen insensitivity syndrome.</title>
<authorList>
<person name="Holterhus P.M."/>
<person name="Wiebel J."/>
<person name="Sinnecker G.H."/>
<person name="Bruggenwirth H.T."/>
<person name="Sippell W.G."/>
<person name="Brinkmann A.O."/>
<person name="Kruse K."/>
<person name="Hiort O."/>
</authorList>
<dbReference type="PubMed" id="10590024"/>
<dbReference type="DOI" id="10.1203/00006450-199912000-00008"/>
</citation>
<scope>VARIANT AIS THR-597</scope>
</reference>
<reference key="196">
<citation type="journal article" date="1999" name="Tohoku J. Exp. Med." volume="187" first="263" last="272">
<title>Point mutations in the steroid-binding domain of the androgen receptor gene of five Japanese patients with androgen insensitivity syndrome.</title>
<authorList>
<person name="Yaegashi N."/>
<person name="Uehara S."/>
<person name="Senoo M."/>
<person name="Sato J."/>
<person name="Fujiwara J."/>
<person name="Funato T."/>
<person name="Sasaki T."/>
<person name="Yajima A."/>
</authorList>
<dbReference type="PubMed" id="10458483"/>
<dbReference type="DOI" id="10.1620/tjem.187.263"/>
</citation>
<scope>VARIANTS AIS PHE-813 AND GLN-832</scope>
</reference>
<reference key="197">
<citation type="journal article" date="1999" name="Urol. Res." volume="27" first="49" last="55">
<title>Screening for mutations in candidate genes for hypospadias.</title>
<authorList>
<person name="Nordenskjoeld A."/>
<person name="Friedman E."/>
<person name="Tapper-Persson M."/>
<person name="Soederhaell C."/>
<person name="Leviav A."/>
<person name="Svensson J."/>
<person name="Anvret M."/>
</authorList>
<dbReference type="PubMed" id="10092153"/>
<dbReference type="DOI" id="10.1007/s002400050088"/>
</citation>
<scope>VARIANTS THR-598 AND LEU-726</scope>
</reference>
<reference key="198">
<citation type="journal article" date="2000" name="Cancer Res." volume="60" first="944" last="949">
<title>Androgen receptor mutations in prostate cancer.</title>
<authorList>
<person name="Marcelli M."/>
<person name="Ittmann M."/>
<person name="Mariani S."/>
<person name="Sutherland R.W."/>
<person name="Nigam R."/>
<person name="Murthy L."/>
<person name="Zhao Y."/>
<person name="DiConcini D."/>
<person name="Puxeddu E."/>
<person name="Esen A."/>
<person name="Eastham J."/>
<person name="Weigel N.L."/>
<person name="Lamb D.J."/>
</authorList>
<dbReference type="PubMed" id="10706109"/>
</citation>
<scope>VARIANTS PROSTATE CANCER ALA-576; ARG-581; VAL-587; TYR-620; ALA-758 AND GLY-847</scope>
</reference>
<reference key="199">
<citation type="journal article" date="2000" name="J. Clin. Endocrinol. Metab." volume="85" first="658" last="665">
<title>Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome.</title>
<authorList>
<person name="Ahmed S.F."/>
<person name="Cheng A."/>
<person name="Dovey L."/>
<person name="Hawkins J.R."/>
<person name="Martin H."/>
<person name="Rowland J."/>
<person name="Shimura N."/>
<person name="Tait A.D."/>
<person name="Hughes I.A."/>
</authorList>
<dbReference type="PubMed" id="10690872"/>
<dbReference type="DOI" id="10.1210/jcem.85.2.6337"/>
</citation>
<scope>VARIANTS AIS AND PAIS</scope>
</reference>
<reference key="200">
<citation type="journal article" date="2001" name="J. Hum. Genet." volume="46" first="560" last="565">
<title>Eight novel mutations of the androgen receptor gene in patients with androgen insensitivity syndrome.</title>
<authorList>
<person name="Chavez B."/>
<person name="Mendez J.P."/>
<person name="Ulloa-Aguirre A."/>
<person name="Larrea F."/>
<person name="Vilchis F."/>
</authorList>
<dbReference type="PubMed" id="11587068"/>
<dbReference type="DOI" id="10.1007/s100380170021"/>
</citation>
<scope>VARIANTS PAIS THR-683 AND GLU-712</scope>
<scope>VARIANTS AIS GLU-744; VAL-828; ARG-875 AND TYR-880</scope>
</reference>
<reference key="201">
<citation type="journal article" date="2001" name="J. Invest. Dermatol." volume="116" first="452" last="455">
<title>Polymorphism of the androgen receptor gene is associated with male pattern baldness.</title>
<authorList>
<person name="Ellis J.A."/>
<person name="Stebbing M."/>
<person name="Harrap S.B."/>
</authorList>
<dbReference type="PubMed" id="11231320"/>
<dbReference type="DOI" id="10.1046/j.1523-1747.2001.01261.x"/>
</citation>
<scope>INVOLVEMENT IN ANDROGENETIC ALOPECIA</scope>
<scope>POLYMORPHISM OF POLY-GLY REGION</scope>
</reference>
<reference key="202">
<citation type="journal article" date="2002" name="Int. J. Mol. Med." volume="9" first="45" last="48">
<title>Characterization of a novel receptor mutation A->T at exon 4 in complete androgen insensitivity syndrome and a carrier sibling via bidirectional polymorphism sequence analysis.</title>
<authorList>
<person name="Sills E.S."/>
<person name="Sholes T.E."/>
<person name="Perloe M."/>
<person name="Kaplan C.R."/>
<person name="Davis J.G."/>
<person name="Tucker M.J."/>
</authorList>
<dbReference type="PubMed" id="11744994"/>
</citation>
<scope>VARIANT AIS TYR-706</scope>
</reference>
<reference key="203">
<citation type="journal article" date="2005" name="Am. J. Hum. Genet." volume="77" first="140" last="148">
<title>Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia.</title>
<authorList>
<person name="Hillmer A.M."/>
<person name="Hanneken S."/>
<person name="Ritzmann S."/>
<person name="Becker T."/>
<person name="Freudenberg J."/>
<person name="Brockschmidt F.F."/>
<person name="Flaquer A."/>
<person name="Freudenberg-Hua Y."/>
<person name="Jamra R.A."/>
<person name="Metzen C."/>
<person name="Heyn U."/>
<person name="Schweiger N."/>
<person name="Betz R.C."/>
<person name="Blaumeiser B."/>
<person name="Hampe J."/>
<person name="Schreiber S."/>
<person name="Schulze T.G."/>
<person name="Hennies H.C."/>
<person name="Schumacher J."/>
<person name="Propping P."/>
<person name="Ruzicka T."/>
<person name="Cichon S."/>
<person name="Wienker T.F."/>
<person name="Kruse R."/>
<person name="Noethen M.M."/>
</authorList>
<dbReference type="PubMed" id="15902657"/>
<dbReference type="DOI" id="10.1086/431425"/>
</citation>
<scope>INVOLVEMENT IN ANDROGENETIC ALOPECIA</scope>
<scope>POLYMORPHISM OF POLY-GLY REGION</scope>
</reference>
<reference key="204">
<citation type="journal article" date="2005" name="Neurology" volume="64" first="1458" last="1460">
<title>A family with early-onset and rapidly progressive X-linked spinal and bulbar muscular atrophy.</title>
<authorList>
<person name="Echaniz-Laguna A."/>
<person name="Rousso E."/>
<person name="Anheim M."/>
<person name="Cossee M."/>
<person name="Tranchant C."/>
</authorList>
<dbReference type="PubMed" id="15851746"/>
<dbReference type="DOI" id="10.1212/01.WNL.0000158617.41819.F3"/>
</citation>
<scope>INVOLVEMENT IN SMAX1</scope>
</reference>
<reference key="205">
<citation type="journal article" date="2004" name="Clin. Genet." volume="65" first="183" last="190">
<title>Concordance of phenotypic expression and gender identity in a large kindred with a mutation in the androgen receptor.</title>
<authorList>
<person name="Hooper H.T."/>
<person name="Figueiredo B.C."/>
<person name="Pavan-Senn C.C."/>
<person name="De Lacerda L."/>
<person name="Sandrini R."/>
<person name="Mengarelli J.K."/>
<person name="Japp K."/>
<person name="Karaviti L.P."/>
</authorList>
<dbReference type="PubMed" id="14756668"/>
<dbReference type="DOI" id="10.1111/j.0009-9163.2004.00197.x"/>
</citation>
<scope>VARIANT AIS PHE-577</scope>
</reference>
<reference key="206">
<citation type="journal article" date="2006" name="J. Mol. Endocrinol." volume="36" first="361" last="368">
<title>Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains.</title>
<authorList>
<person name="Jaeaeskelaeinen J."/>
<person name="Deeb A."/>
<person name="Schwabe J.W."/>
<person name="Mongan N.P."/>
<person name="Martin H."/>
<person name="Hughes I.A."/>
</authorList>
<dbReference type="PubMed" id="16595706"/>
<dbReference type="DOI" id="10.1677/jme.1.01885"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS AIS ASN-696; CYS-764; HIS-775; GLU-799; HIS-856 AND PHE-908</scope>
</reference>
<reference key="207">
<citation type="journal article" date="2016" name="Nature" volume="536" first="285" last="291">
<title>Analysis of protein-coding genetic variation in 60,706 humans.</title>
<authorList>
<consortium name="Exome Aggregation Consortium"/>
<person name="Lek M."/>
<person name="Karczewski K.J."/>
<person name="Minikel E.V."/>
<person name="Samocha K.E."/>
<person name="Banks E."/>
<person name="Fennell T."/>
<person name="O'Donnell-Luria A.H."/>
<person name="Ware J.S."/>
<person name="Hill A.J."/>
<person name="Cummings B.B."/>
<person name="Tukiainen T."/>
<person name="Birnbaum D.P."/>
<person name="Kosmicki J.A."/>
<person name="Duncan L.E."/>
<person name="Estrada K."/>
<person name="Zhao F."/>
<person name="Zou J."/>
<person name="Pierce-Hoffman E."/>
<person name="Berghout J."/>
<person name="Cooper D.N."/>
<person name="Deflaux N."/>
<person name="DePristo M."/>
<person name="Do R."/>
<person name="Flannick J."/>
<person name="Fromer M."/>
<person name="Gauthier L."/>
<person name="Goldstein J."/>
<person name="Gupta N."/>
<person name="Howrigan D."/>
<person name="Kiezun A."/>
<person name="Kurki M.I."/>
<person name="Moonshine A.L."/>
<person name="Natarajan P."/>
<person name="Orozco L."/>
<person name="Peloso G.M."/>
<person name="Poplin R."/>
<person name="Rivas M.A."/>
<person name="Ruano-Rubio V."/>
<person name="Rose S.A."/>
<person name="Ruderfer D.M."/>
<person name="Shakir K."/>
<person name="Stenson P.D."/>
<person name="Stevens C."/>
<person name="Thomas B.P."/>
<person name="Tiao G."/>
<person name="Tusie-Luna M.T."/>
<person name="Weisburd B."/>
<person name="Won H.H."/>
<person name="Yu D."/>
<person name="Altshuler D.M."/>
<person name="Ardissino D."/>
<person name="Boehnke M."/>
<person name="Danesh J."/>
<person name="Donnelly S."/>
<person name="Elosua R."/>
<person name="Florez J.C."/>
<person name="Gabriel S.B."/>
<person name="Getz G."/>
<person name="Glatt S.J."/>
<person name="Hultman C.M."/>
<person name="Kathiresan S."/>
<person name="Laakso M."/>
<person name="McCarroll S."/>
<person name="McCarthy M.I."/>
<person name="McGovern D."/>
<person name="McPherson R."/>
<person name="Neale B.M."/>
<person name="Palotie A."/>
<person name="Purcell S.M."/>
<person name="Saleheen D."/>
<person name="Scharf J.M."/>
<person name="Sklar P."/>
<person name="Sullivan P.F."/>
<person name="Tuomilehto J."/>
<person name="Tsuang M.T."/>
<person name="Watkins H.C."/>
<person name="Wilson J.G."/>
<person name="Daly M.J."/>
<person name="MacArthur D.G."/>
</authorList>
<dbReference type="PubMed" id="27535533"/>
<dbReference type="DOI" id="10.1038/nature19057"/>
</citation>
<scope>VARIANT ARG-216</scope>
</reference>
<comment type="function">
<text evidence="52 57 76 79 81 87 95">Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription factor activity is modulated by bound coactivator and corepressor proteins. Transcription activation is down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3.</text>
</comment>
<comment type="function">
<text evidence="86">Isoform 3 and isoform 4 lack the C-terminal ligand-binding domain and may therefore constitutively activate the transcription of a specific set of genes independently of steroid hormones.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="92">AIM-100 (4-amino-5,6-biaryl-furo[2,3-d]pyrimidine) suppresses TNK2-mediated phosphorylation at Tyr-269. Inhibits the binding of the Tyr-269 phosphorylated form to androgen-responsive enhancers (AREs) and its transcriptional activity.</text>
</comment>
<comment type="subunit">
<text evidence="12 16 18 19 29 33 38 39 40 41 42 50 52 56 57 64 65 70 72 73 74 75 76 77 79 80 81 82 83 84 87 88 91 95 96 98 100">Binds DNA as a homodimer. Part of a ternary complex containing AR, EFCAB6/DJBP and PARK7. Interacts with HIPK3 and NR0B2 in the presence of androgen. The ligand binding domain interacts with KAT7/HBO1 in the presence of dihydrotestosterone. Interacts with EFCAB6/DJBP, PELP1, PQBP1, RANBP9, RBAK, SPDEF, SRA1, TGFB1I1, ZNF318 and RREB1. Interacts with ZMIZ1/ZIMP10 and ZMIZ2/ZMIP7 which both enhance its transactivation activity. Interacts with SLC30A9 and RAD54L2/ARIP4. Interacts via the ligand-binding domain with LXXLL and FXXLF motifs from NCOA1, NCOA2, NCOA3, NCOA4 and MAGEA11. The AR N-terminal poly-Gln region binds Ran resulting in enhancement of AR-mediated transactivation. Ran-binding decreases as the poly-Gln length increases. Interacts with HIP1 (via coiled coil domain). Interacts (via ligand-binding domain) with TRIM68. Interacts with TNK2. Interacts with USP26. Interacts with RNF6. Interacts (regulated by RNF6 probably through polyubiquitination) with RNF14; regulates AR transcriptional activity. Interacts with PRMT2 and TRIM24. Interacts with RACK1. Interacts with RANBP10; this interaction enhances dihydrotestosterone-induced AR transcriptional activity. Interacts with PRPF6 in a hormone-independent way; this interaction enhances dihydrotestosterone-induced AR transcriptional activity. Interacts with STK4/MST1. Interacts with ZIPK/DAPK3. Interacts with LPXN. Interacts with MAK. Part of a complex containing AR, MAK and NCOA3. Interacts with CRY1. Interacts with CCAR1 and GATA2.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-375543">
<id>P00519</id>
<label>ABL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-540797">
<id>Q9UBL3</id>
<label>ASH2L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-2105445">
<id>P51451</id>
<label>BLK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-2623522">
<id>Q8WV28</id>
<label>BLNK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-9345088">
<id>O60885-1</id>
<label>BRD4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1047576">
<id>P78543</id>
<label>BTG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-78060">
<id>Q14790</id>
<label>CASP8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-375001">
<id>P24385</id>
<label>CCND1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-81215">
<id>Q92793</id>
<label>CREBBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-2802973">
<id>O14595</id>
<label>CTDSP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-491549">
<id>P35222</id>
<label>CTNNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-77321">
<id>Q9UER7</id>
<label>DAXX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1632155">
<id>P20711</id>
<label>DDC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-79704">
<id>P11308</id>
<label>ERG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1055635">
<id>P07332</id>
<label>FES</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1383732">
<id>P09769</id>
<label>FGR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1047444">
<id>Q02790</id>
<label>FKBP4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-3918034">
<id>P55317</id>
<label>FOXA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1759806">
<id>O75593</id>
<label>FOXH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1371343">
<id>Q9R1E0</id>
<label>Foxo1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-970191">
<id>Q14451</id>
<label>GRB7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-351506">
<id>P06396</id>
<label>GSN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-308629">
<id>P56524</id>
<label>HDAC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-447269">
<id>Q16665</id>
<label>HIF1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-2867186">
<id>Q16666</id>
<label>IFI16</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1384248">
<id>O15357</id>
<label>INPPL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1224969">
<id>Q15652</id>
<label>JMJD1C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-2682803">
<id>P17535</id>
<label>JUND</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-473199">
<id>O95251</id>
<label>KAT7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1246860">
<id>Q9BY66</id>
<label>KDM5D</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-12559887">
<id>Q9BY66-3</id>
<label>KDM5D</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1220791">
<id>P07288</id>
<label>KLK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-591370">
<id>Q03164</id>
<label>KMT2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-996065">
<id>O14686</id>
<label>KMT2D</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1348">
<id>P06239</id>
<label>LCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-79452">
<id>P07948</id>
<label>LYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-3911321">
<id>P20794</id>
<label>MAK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-751664">
<id>P42679</id>
<label>MATK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-389668">
<id>Q00987</id>
<label>MDM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-81236">
<id>Q15596</id>
<label>NCOA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-78670">
<id>Q14686</id>
<label>NCOA6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-2693298">
<id>O96028</id>
<label>NSD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1164361">
<id>Q99497</id>
<label>PARK7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-346930">
<id>O00459</id>
<label>PIK3R2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-79893">
<id>Q92569</id>
<label>PIK3R3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>37</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-617403">
<id>P16885</id>
<label>PLCG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-353193">
<id>Q06830</id>
<label>PRDX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-352053">
<id>P78527</id>
<label>PRKDC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-297779">
<id>Q06124</id>
<label>PTPN11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1026476">
<id>P20936</id>
<label>RASA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-2130308">
<id>Q9UBS8</id>
<label>RNF14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-2341483">
<id>Q9Y252</id>
<label>RNF6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-3923013">
<id>O14796</id>
<label>SH2D1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-490630">
<id>Q9NP31</id>
<label>SH2D2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-78835">
<id>P29353</id>
<label>SHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-9453524">
<id>Q6S5L8</id>
<label>SHC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-3956977">
<id>Q5VZ18</id>
<label>SHE</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-957413">
<id>Q06986</id>
<label>Siah2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-1567153">
<id>Q15797</id>
<label>SMAD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-3929549">
<id>O14544</id>
<label>SOCS6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-6083058">
<id>Q9ULZ2</id>
<label>STAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-80140">
<id>P63165</id>
<label>SUMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-3389814">
<id>Q9HBL0</id>
<label>TNS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-15888922">
<id>Q01534-1</id>
<label>TSPY1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-608057"/>
<interactant intactId="EBI-515331">
<id>P07947</id>
<label>YES1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="42 60 75 86 87">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="42 75 86">Cytoplasm</location>
</subcellularLocation>
<text evidence="42 75">Predominantly cytoplasmic in unligated form but translocates to the nucleus upon ligand-binding. Can also translocate to the nucleus in unligated form in the presence of RACK1.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P10275-1</id>
<name>1</name>
<name>AR-B</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P10275-2</id>
<name>2</name>
<name>AR-A</name>
<name>Variant AR45</name>
<sequence type="described" ref="VSP_036889 VSP_036890"/>
</isoform>
<isoform>
<id>P10275-3</id>
<name>3</name>
<name>AR3</name>
<sequence type="described" ref="VSP_058166 VSP_058168"/>
<text evidence="86">Minor isoform up-regulated in prostate cancer cells.</text>
</isoform>
<isoform>
<id>P10275-4</id>
<name>4</name>
<name>AR4</name>
<sequence type="described" ref="VSP_058167 VSP_058169"/>
<text evidence="86">Minor isoform identified in prostate cancer cells.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="60 86">Isoform 2 is mainly expressed in heart and skeletal muscle (PubMed:15634333). Isoform 3 is expressed by basal and stromal cells of prostate (at protein level) (PubMed:19244107).</text>
</comment>
<comment type="domain">
<text>Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain. In the presence of bound steroid the ligand-binding domain interacts with the N-terminal modulating domain, and thereby activates AR transcription factor activity. Agonist binding is required for dimerization and binding to target DNA. The transcription factor activity of the complex formed by ligand-activated AR and DNA is modulated by interactions with coactivator and corepressor proteins. Interaction with RANBP9 is mediated by both the N-terminal domain and the DNA-binding domain. Interaction with EFCAB6/DJBP is mediated by the DNA-binding domain.</text>
</comment>
<comment type="PTM">
<text evidence="34 87 91">Sumoylated on Lys-388 (major) and Lys-521. Ubiquitinated. Deubiquitinated by USP26. 'Lys-6' and 'Lys-27'-linked polyubiquitination by RNF6 modulates AR transcriptional activity and specificity.</text>
</comment>
<comment type="PTM">
<text evidence="49 71 73 92 95 96">Phosphorylated in prostate cancer cells in response to several growth factors including EGF. Phosphorylation is induced by c-Src kinase (CSK). Tyr-535 is one of the major phosphorylation sites and an increase in phosphorylation and Src kinase activity is associated with prostate cancer progression. Phosphorylation by TNK2 enhances the DNA-binding and transcriptional activity and may be responsible for androgen-independent progression of prostate cancer. Phosphorylation at Ser-83 by CDK9 regulates AR promoter selectivity and cell growth. Phosphorylation by PAK6 leads to AR-mediated transcription inhibition.</text>
</comment>
<comment type="PTM">
<text evidence="97">Palmitoylated by ZDHHC7 and ZDHHC21. Palmitoylation is required for plasma membrane targeting and for rapid intracellular signaling via ERK and AKT kinases and cAMP generation.</text>
</comment>
<comment type="polymorphism">
<text evidence="58 93 135 160">The poly-Gln region of AR is highly polymorphic and the number of Gln varies in the population (from 17 to 26). A smaller size of the poly-Gln region may be associated with the development of prostate cancer.</text>
</comment>
<comment type="polymorphism">
<text evidence="35 63">The poly-Gly region of AR is polymorphic and ranges from 24 to 31 Gly. A poly-Gly region shorter or equal to 23 may be associated with the development of androgenetic alopecia.</text>
</comment>
<comment type="disease" evidence="11 14 15 20 21 26 27 31 36 37 44 45 47 48 51 53 54 55 61 66 67 69 78 89 94 101 104 105 107 108 110 114 115 116 117 118 119 121 122 124 127 131 134 137 138 139 140 143 145 146 147 148 149 153 154 155 157 158 159 161 162 165 166 167 168 172 173 176 177 178 181 182 183 185">
<disease id="DI-00116">
<name>Androgen insensitivity syndrome</name>
<acronym>AIS</acronym>
<description>An X-linked recessive form of pseudohermaphroditism due end-organ resistance to androgen. Affected males have female external genitalia, female breast development, blind vagina, absent uterus and female adnexa, and abdominal or inguinal testes, despite a normal 46,XY karyotype.</description>
<dbReference type="MIM" id="300068"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="62">
<disease id="DI-01053">
<name>Spinal and bulbar muscular atrophy X-linked 1</name>
<acronym>SMAX1</acronym>
<description>An X-linked recessive form of spinal muscular atrophy. Spinal muscular atrophy refers to a group of neuromuscular disorders characterized by degeneration of the anterior horn cells of the spinal cord, leading to symmetrical muscle weakness and atrophy. SMAX1 occurs only in men. Age at onset is usually in the third to fifth decade of life, but earlier involvement has been reported. It is characterized by slowly progressive limb and bulbar muscle weakness with fasciculations, muscle atrophy, and gynecomastia. The disorder is clinically similar to classic forms of autosomal spinal muscular atrophy.</description>
<dbReference type="MIM" id="313200"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry. Caused by trinucleotide CAG repeat expansion. In SMAX1 patients the number of Gln ranges from 38 to 62. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.</text>
</comment>
<comment type="disease">
<text>Defects in AR may play a role in metastatic prostate cancer. The mutated receptor stimulates prostate growth and metastases development despite of androgen ablation. This treatment can reduce primary and metastatic lesions probably by inducing apoptosis of tumor cells when they express the wild-type receptor.</text>
</comment>
<comment type="disease" evidence="11 14 22 23 24 36 43 44 45 46 48 53 90 105 109 110 112 113 114 116 117 120 123 125 129 133 136 137 140 142 149 150 151 159 164 167 169 171 175 179 182 184">
<disease id="DI-00117">
<name>Androgen insensitivity, partial</name>
<acronym>PAIS</acronym>
<description>A disorder that is characterized by hypospadias, hypogonadism, gynecomastia, genital ambiguity, normal XY karyotype, and a pedigree pattern consistent with X-linked recessive inheritance. Some patients present azoospermia or severe oligospermia without other clinical manifestations.</description>
<dbReference type="MIM" id="312300"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>In the absence of ligand, steroid hormone receptors are thought to be weakly associated with nuclear components; hormone binding greatly increases receptor affinity. The hormone-receptor complex appears to recognize discrete DNA sequences upstream of transcriptional start sites.</text>
</comment>
<comment type="miscellaneous">
<text>Transcriptional activity is enhanced by binding to RANBP9.</text>
</comment>
<comment type="miscellaneous">
<text>The level of tyrosine phosphorylation may serve as a diagnostic tool to predict patient outcome in response to hormone-ablation therapy. Inhibition of tyrosine phosphorylation may be an effective intervention target for hormone-refractory prostate cancer.</text>
</comment>
<comment type="similarity">
<text evidence="186">Belongs to the nuclear hormone receptor family. NR3 subfamily.</text>
</comment>
<comment type="online information" name="Androgen receptor gene mutations database">
<link uri="http://androgendb.mcgill.ca"/>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/ARID685chXq12.html"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Androgen_receptor"/>
<text>Androgen receptor entry</text>
</comment>
<comment type="online information" name="X-chromosome gene database, androgen receptor (AR)">
<link uri="http://www.lovd.nl/AR"/>
<text>Leiden Open Variation Database (LOVD)</text>
</comment>
<dbReference type="EMBL" id="M20132">
<property type="protein sequence ID" value="AAA51729.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M23263">
<property type="protein sequence ID" value="AAA51775.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M27430">
<property type="protein sequence ID" value="AAA51886.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M27423">
<property type="protein sequence ID" value="AAA51886.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M27424">
<property type="protein sequence ID" value="AAA51886.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M27425">
<property type="protein sequence ID" value="AAA51886.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M27426">
<property type="protein sequence ID" value="AAA51886.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M27427">
<property type="protein sequence ID" value="AAA51886.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M27428">
<property type="protein sequence ID" value="AAA51886.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M27429">
<property type="protein sequence ID" value="AAA51886.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M34233">
<property type="protein sequence ID" value="AAA51780.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M21748">
<property type="protein sequence ID" value="AAA51771.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M35851">
<property type="protein sequence ID" value="AAA51772.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M35844">
<property type="protein sequence ID" value="AAA51772.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M35845">
<property type="protein sequence ID" value="AAA51772.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M35846">
<property type="protein sequence ID" value="AAA51772.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M35847">
<property type="protein sequence ID" value="AAA51772.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M35848">
<property type="protein sequence ID" value="AAA51772.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M35849">
<property type="protein sequence ID" value="AAA51772.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M35850">
<property type="protein sequence ID" value="AAA51772.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AX453758">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Unassigned_DNA"/>
</dbReference>
<dbReference type="EMBL" id="FJ235916">
<property type="protein sequence ID" value="ACN39559.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="FJ235917">
<property type="protein sequence ID" value="ACN39560.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL049564">
<property type="protein sequence ID" value="CAI43080.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL158016">
<property type="protein sequence ID" value="CAI43080.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL356358">
<property type="protein sequence ID" value="CAI43080.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL158016">
<property type="protein sequence ID" value="CAI40853.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL049564">
<property type="protein sequence ID" value="CAI40853.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL356358">
<property type="protein sequence ID" value="CAI40853.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL356358">
<property type="protein sequence ID" value="CAI40496.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL049564">
<property type="protein sequence ID" value="CAI40496.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL158016">
<property type="protein sequence ID" value="CAI40496.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471132">
<property type="protein sequence ID" value="EAX05380.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC132975">
<property type="protein sequence ID" value="AAI32976.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L29496">
<property type="protein sequence ID" value="AAA51770.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U16371">
<property type="protein sequence ID" value="AAB60346.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M20260">
<property type="protein sequence ID" value="AAA51774.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S79366">
<property type="protein sequence ID" value="AAB21256.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S79366">
<property type="protein sequence ID" value="AAB21257.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS14387.1">
<molecule id="P10275-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS43965.1">
<molecule id="P10275-2"/>
</dbReference>
<dbReference type="PIR" id="A39248">
<property type="entry name" value="A39248"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000035.2">
<molecule id="P10275-1"/>
<property type="nucleotide sequence ID" value="NM_000044.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001011645.1">
<molecule id="P10275-2"/>
<property type="nucleotide sequence ID" value="NM_001011645.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001334990.1">
<molecule id="P10275-3"/>
<property type="nucleotide sequence ID" value="NM_001348061.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001334992.1">
<molecule id="P10275-4"/>
<property type="nucleotide sequence ID" value="NM_001348063.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001334993.1">
<property type="nucleotide sequence ID" value="NM_001348064.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.76704"/>
<dbReference type="PDB" id="1E3G">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=658-920"/>
</dbReference>
<dbReference type="PDB" id="1GS4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=671-918"/>
</dbReference>
<dbReference type="PDB" id="1T5Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=670-920"/>
</dbReference>
<dbReference type="PDB" id="1T63">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.07"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="1T65">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.66"/>
<property type="chains" value="A=670-920"/>
</dbReference>
<dbReference type="PDB" id="1XJ7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=664-920"/>
</dbReference>
<dbReference type="PDB" id="1XOW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=672-920, B=20-30"/>
</dbReference>
<dbReference type="PDB" id="1XQ3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=672-920"/>
</dbReference>
<dbReference type="PDB" id="1Z95">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=673-918"/>
</dbReference>
<dbReference type="PDB" id="2AM9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.64"/>
<property type="chains" value="A=655-920"/>
</dbReference>
<dbReference type="PDB" id="2AMA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=655-920"/>
</dbReference>
<dbReference type="PDB" id="2AMB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=655-920"/>
</dbReference>
<dbReference type="PDB" id="2AO6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.89"/>
<property type="chains" value="A=672-920"/>
</dbReference>
<dbReference type="PDB" id="2AX6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=665-920"/>
</dbReference>
<dbReference type="PDB" id="2AX7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=665-920"/>
</dbReference>
<dbReference type="PDB" id="2AX8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=665-920"/>
</dbReference>
<dbReference type="PDB" id="2AX9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=665-920"/>
</dbReference>
<dbReference type="PDB" id="2AXA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=665-920"/>
</dbReference>
<dbReference type="PDB" id="2HVC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=670-919"/>
</dbReference>
<dbReference type="PDB" id="2OZ7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=672-920"/>
</dbReference>
<dbReference type="PDB" id="2PIO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="A=670-920"/>
</dbReference>
<dbReference type="PDB" id="2PIP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="L=670-920"/>
</dbReference>
<dbReference type="PDB" id="2PIQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=670-920"/>
</dbReference>
<dbReference type="PDB" id="2PIR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=670-920"/>
</dbReference>
<dbReference type="PDB" id="2PIT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.76"/>
<property type="chains" value="A=670-920"/>
</dbReference>
<dbReference type="PDB" id="2PIU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.12"/>
<property type="chains" value="A=670-920"/>
</dbReference>
<dbReference type="PDB" id="2PIV">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=670-920"/>
</dbReference>
<dbReference type="PDB" id="2PIW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.58"/>
<property type="chains" value="A=670-920"/>
</dbReference>
<dbReference type="PDB" id="2PIX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=670-920"/>
</dbReference>
<dbReference type="PDB" id="2PKL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.49"/>
<property type="chains" value="A=670-920"/>
</dbReference>
<dbReference type="PDB" id="2PNU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=655-920"/>
</dbReference>
<dbReference type="PDB" id="2Q7I">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.87"/>
<property type="chains" value="A=664-920, B=20-30"/>
</dbReference>
<dbReference type="PDB" id="2Q7J">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=664-920"/>
</dbReference>
<dbReference type="PDB" id="2Q7K">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=664-920, B=20-30"/>
</dbReference>
<dbReference type="PDB" id="2Q7L">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.92"/>
<property type="chains" value="A=664-920"/>
</dbReference>
<dbReference type="PDB" id="2YHD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=672-920"/>
</dbReference>
<dbReference type="PDB" id="2YLO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=665-920"/>
</dbReference>
<dbReference type="PDB" id="2YLP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=665-920"/>
</dbReference>
<dbReference type="PDB" id="2YLQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=665-920"/>
</dbReference>
<dbReference type="PDB" id="2Z4J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=672-919"/>
</dbReference>
<dbReference type="PDB" id="3B5R">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=672-920"/>
</dbReference>
<dbReference type="PDB" id="3B65">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=672-920"/>
</dbReference>
<dbReference type="PDB" id="3B66">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=672-920"/>
</dbReference>
<dbReference type="PDB" id="3B67">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=672-920"/>
</dbReference>
<dbReference type="PDB" id="3B68">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=672-920"/>
</dbReference>
<dbReference type="PDB" id="3BTR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="B=622-636"/>
</dbReference>
<dbReference type="PDB" id="3L3X">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A=671-919"/>
</dbReference>
<dbReference type="PDB" id="3L3Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=671-919"/>
</dbReference>
<dbReference type="PDB" id="3RLJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=672-918"/>
</dbReference>
<dbReference type="PDB" id="3RLL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=672-918"/>
</dbReference>
<dbReference type="PDB" id="3V49">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=655-920, B=21-31"/>
</dbReference>
<dbReference type="PDB" id="3V4A">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=672-920, B=21-31"/>
</dbReference>
<dbReference type="PDB" id="3ZQT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.29"/>
<property type="chains" value="A=665-920"/>
</dbReference>
<dbReference type="PDB" id="4HLW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=665-920"/>
</dbReference>
<dbReference type="PDB" id="4K7A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.44"/>
<property type="chains" value="A=671-919"/>
</dbReference>
<dbReference type="PDB" id="4OEA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.12"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OED">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.79"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OEY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.83"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OEZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OFR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.26"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OFU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.12"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OGH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.98"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OH5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OH6">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.56"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OHA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.42"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OIL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.51"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OIU">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.01"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OJ9">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.31"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OJB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OK1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.09"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OKB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OKT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OKW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OKX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4OLM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=671-920"/>
</dbReference>
<dbReference type="PDB" id="4QL8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=663-920"/>
</dbReference>
<dbReference type="PDB" id="5CJ6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.07"/>
<property type="chains" value="A=642-920, B=21-30"/>
</dbReference>
<dbReference type="PDB" id="5JJM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A/B/C/D=669-920"/>
</dbReference>
<dbReference type="PDB" id="5T8E">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.71"/>
<property type="chains" value="A=672-920"/>
</dbReference>
<dbReference type="PDB" id="5T8J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=672-920"/>
</dbReference>
<dbReference type="PDB" id="5V8Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.44"/>
<property type="chains" value="A=672-920"/>
</dbReference>
<dbReference type="PDBsum" id="1E3G"/>
<dbReference type="PDBsum" id="1GS4"/>
<dbReference type="PDBsum" id="1T5Z"/>
<dbReference type="PDBsum" id="1T63"/>
<dbReference type="PDBsum" id="1T65"/>
<dbReference type="PDBsum" id="1XJ7"/>
<dbReference type="PDBsum" id="1XOW"/>
<dbReference type="PDBsum" id="1XQ3"/>
<dbReference type="PDBsum" id="1Z95"/>
<dbReference type="PDBsum" id="2AM9"/>
<dbReference type="PDBsum" id="2AMA"/>
<dbReference type="PDBsum" id="2AMB"/>
<dbReference type="PDBsum" id="2AO6"/>
<dbReference type="PDBsum" id="2AX6"/>
<dbReference type="PDBsum" id="2AX7"/>
<dbReference type="PDBsum" id="2AX8"/>
<dbReference type="PDBsum" id="2AX9"/>
<dbReference type="PDBsum" id="2AXA"/>
<dbReference type="PDBsum" id="2HVC"/>
<dbReference type="PDBsum" id="2OZ7"/>
<dbReference type="PDBsum" id="2PIO"/>
<dbReference type="PDBsum" id="2PIP"/>
<dbReference type="PDBsum" id="2PIQ"/>
<dbReference type="PDBsum" id="2PIR"/>
<dbReference type="PDBsum" id="2PIT"/>
<dbReference type="PDBsum" id="2PIU"/>
<dbReference type="PDBsum" id="2PIV"/>
<dbReference type="PDBsum" id="2PIW"/>
<dbReference type="PDBsum" id="2PIX"/>
<dbReference type="PDBsum" id="2PKL"/>
<dbReference type="PDBsum" id="2PNU"/>
<dbReference type="PDBsum" id="2Q7I"/>
<dbReference type="PDBsum" id="2Q7J"/>
<dbReference type="PDBsum" id="2Q7K"/>
<dbReference type="PDBsum" id="2Q7L"/>
<dbReference type="PDBsum" id="2YHD"/>
<dbReference type="PDBsum" id="2YLO"/>
<dbReference type="PDBsum" id="2YLP"/>
<dbReference type="PDBsum" id="2YLQ"/>
<dbReference type="PDBsum" id="2Z4J"/>
<dbReference type="PDBsum" id="3B5R"/>
<dbReference type="PDBsum" id="3B65"/>
<dbReference type="PDBsum" id="3B66"/>
<dbReference type="PDBsum" id="3B67"/>
<dbReference type="PDBsum" id="3B68"/>
<dbReference type="PDBsum" id="3BTR"/>
<dbReference type="PDBsum" id="3L3X"/>
<dbReference type="PDBsum" id="3L3Z"/>
<dbReference type="PDBsum" id="3RLJ"/>
<dbReference type="PDBsum" id="3RLL"/>
<dbReference type="PDBsum" id="3V49"/>
<dbReference type="PDBsum" id="3V4A"/>
<dbReference type="PDBsum" id="3ZQT"/>
<dbReference type="PDBsum" id="4HLW"/>
<dbReference type="PDBsum" id="4K7A"/>
<dbReference type="PDBsum" id="4OEA"/>
<dbReference type="PDBsum" id="4OED"/>
<dbReference type="PDBsum" id="4OEY"/>
<dbReference type="PDBsum" id="4OEZ"/>
<dbReference type="PDBsum" id="4OFR"/>
<dbReference type="PDBsum" id="4OFU"/>
<dbReference type="PDBsum" id="4OGH"/>
<dbReference type="PDBsum" id="4OH5"/>
<dbReference type="PDBsum" id="4OH6"/>
<dbReference type="PDBsum" id="4OHA"/>
<dbReference type="PDBsum" id="4OIL"/>
<dbReference type="PDBsum" id="4OIU"/>
<dbReference type="PDBsum" id="4OJ9"/>
<dbReference type="PDBsum" id="4OJB"/>
<dbReference type="PDBsum" id="4OK1"/>
<dbReference type="PDBsum" id="4OKB"/>
<dbReference type="PDBsum" id="4OKT"/>
<dbReference type="PDBsum" id="4OKW"/>
<dbReference type="PDBsum" id="4OKX"/>
<dbReference type="PDBsum" id="4OLM"/>
<dbReference type="PDBsum" id="4QL8"/>
<dbReference type="PDBsum" id="5CJ6"/>
<dbReference type="PDBsum" id="5JJM"/>
<dbReference type="PDBsum" id="5T8E"/>
<dbReference type="PDBsum" id="5T8J"/>
<dbReference type="PDBsum" id="5V8Q"/>
<dbReference type="DisProt" id="DP00492"/>
<dbReference type="ProteinModelPortal" id="P10275"/>
<dbReference type="SMR" id="P10275"/>
<dbReference type="BioGrid" id="106862">
<property type="interactions" value="265"/>
</dbReference>
<dbReference type="CORUM" id="P10275"/>
<dbReference type="DIP" id="DIP-125N"/>
<dbReference type="ELM" id="P10275"/>
<dbReference type="IntAct" id="P10275">
<property type="interactions" value="132"/>
</dbReference>
<dbReference type="MINT" id="MINT-94801"/>
<dbReference type="STRING" id="9606.ENSP00000363822"/>
<dbReference type="BindingDB" id="P10275"/>
<dbReference type="ChEMBL" id="CHEMBL1871"/>
<dbReference type="DrugBank" id="DB02932">
<property type="generic name" value="(2r)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-3-[(4-Fluorophenyl)Sulfonyl]-2-Hydroxy-2-Methylpropanamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB07422">
<property type="generic name" value="(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB07419">
<property type="generic name" value="(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB07423">
<property type="generic name" value="(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB07039">
<property type="generic name" value="(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB07454">
<property type="generic name" value="(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE"/>
</dbReference>
<dbReference type="DrugBank" id="DB01128">
<property type="generic name" value="Bicalutamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01541">
<property type="generic name" value="Boldenone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01564">
<property type="generic name" value="Calusterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB04839">
<property type="generic name" value="Cyproterone acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB01406">
<property type="generic name" value="Danazol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01481">
<property type="generic name" value="Delta1-dihydrotestosterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB02901">
<property type="generic name" value="Dihydrotestosterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01395">
<property type="generic name" value="Drospirenone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00858">
<property type="generic name" value="Drostanolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB08899">
<property type="generic name" value="Enzalutamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB13155">
<property type="generic name" value="Esculin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00687">
<property type="generic name" value="Fludrocortisone"/>
</dbReference>
<dbReference type="DrugBank" id="DB02266">
<property type="generic name" value="Flufenamic Acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01185">
<property type="generic name" value="Fluoxymesterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00499">
<property type="generic name" value="Flutamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01026">
<property type="generic name" value="Ketoconazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00367">
<property type="generic name" value="Levonorgestrel"/>
</dbReference>
<dbReference type="DrugBank" id="DB05234">
<property type="generic name" value="LGD2941"/>
</dbReference>
<dbReference type="DrugBank" id="DB05094">
<property type="generic name" value="MDV3100"/>
</dbReference>
<dbReference type="DrugBank" id="DB06710">
<property type="generic name" value="Methyltestosterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB02998">
<property type="generic name" value="Methyltrienolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB08804">
<property type="generic name" value="Nandrolone decanoate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00984">
<property type="generic name" value="Nandrolone phenpropionate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00665">
<property type="generic name" value="Nilutamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB09389">
<property type="generic name" value="Norgestrel"/>
</dbReference>
<dbReference type="DrugBank" id="DB00621">
<property type="generic name" value="Oxandrolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB06412">
<property type="generic name" value="Oxymetholone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01708">
<property type="generic name" value="Prasterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB07769">
<property type="generic name" value="S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE"/>
</dbReference>
<dbReference type="DrugBank" id="DB00421">
<property type="generic name" value="Spironolactone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00624">
<property type="generic name" value="Testosterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01420">
<property type="generic name" value="Testosterone Propionate"/>
</dbReference>
<dbReference type="DrugBank" id="DB08867">
<property type="generic name" value="Ulipristal"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="628"/>
<dbReference type="SwissLipids" id="SLP:000001553"/>
<dbReference type="iPTMnet" id="P10275"/>
<dbReference type="PhosphoSitePlus" id="P10275"/>
<dbReference type="SwissPalm" id="P10275"/>
<dbReference type="BioMuta" id="AR"/>
<dbReference type="DMDM" id="113830"/>
<dbReference type="EPD" id="P10275"/>
<dbReference type="MaxQB" id="P10275"/>
<dbReference type="PaxDb" id="P10275"/>
<dbReference type="PeptideAtlas" id="P10275"/>
<dbReference type="PRIDE" id="P10275"/>
<dbReference type="TopDownProteomics" id="P10275-1">
<molecule id="P10275-1"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000374690">
<molecule id="P10275-1"/>
<property type="protein sequence ID" value="ENSP00000363822"/>
<property type="gene ID" value="ENSG00000169083"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000396043">
<molecule id="P10275-2"/>
<property type="protein sequence ID" value="ENSP00000379358"/>
<property type="gene ID" value="ENSG00000169083"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000504326">
<molecule id="P10275-3"/>
<property type="protein sequence ID" value="ENSP00000421155"/>
<property type="gene ID" value="ENSG00000169083"/>
</dbReference>
<dbReference type="GeneID" id="367"/>
<dbReference type="KEGG" id="hsa:367"/>
<dbReference type="UCSC" id="uc004dwv.3">
<molecule id="P10275-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc011mpf.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="367"/>
<dbReference type="DisGeNET" id="367"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000169083.15"/>
<dbReference type="GeneCards" id="AR"/>
<dbReference type="GeneReviews" id="AR"/>
<dbReference type="H-InvDB" id="HIX0056152"/>
<dbReference type="HGNC" id="HGNC:644">
<property type="gene designation" value="AR"/>
</dbReference>
<dbReference type="HPA" id="CAB000001"/>
<dbReference type="HPA" id="CAB065764"/>
<dbReference type="HPA" id="HPA065701"/>
<dbReference type="MalaCards" id="AR"/>
<dbReference type="MIM" id="300068">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="312300">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="313200">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="313700">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P10275"/>
<dbReference type="OpenTargets" id="ENSG00000169083"/>
<dbReference type="Orphanet" id="99429">
<property type="disease" value="Complete androgen insensitivity syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="440">
<property type="disease" value="Familial hypospadias"/>
</dbReference>
<dbReference type="Orphanet" id="481">
<property type="disease" value="Kennedy disease"/>
</dbReference>
<dbReference type="Orphanet" id="90797">
<property type="disease" value="Partial androgen insensitivity syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA57"/>
<dbReference type="eggNOG" id="KOG3575">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XRZC">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118887"/>
<dbReference type="HOVERGEN" id="HBG007583"/>
<dbReference type="InParanoid" id="P10275"/>
<dbReference type="KO" id="K08557"/>
<dbReference type="OMA" id="YGDMRLE"/>
<dbReference type="OrthoDB" id="EOG091G032J"/>
<dbReference type="PhylomeDB" id="P10275"/>
<dbReference type="TreeFam" id="TF350286"/>
<dbReference type="Reactome" id="R-HSA-3371497">
<property type="pathway name" value="HSP90 chaperone cycle for steroid hormone receptors (SHR)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-383280">
<property type="pathway name" value="Nuclear Receptor transcription pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5625886">
<property type="pathway name" value="Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8940973">
<property type="pathway name" value="RUNX2 regulates osteoblast differentiation"/>
</dbReference>
<dbReference type="SignaLink" id="P10275"/>
<dbReference type="SIGNOR" id="P10275"/>
<dbReference type="ChiTaRS" id="AR">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P10275"/>
<dbReference type="GeneWiki" id="Androgen_receptor"/>
<dbReference type="GenomeRNAi" id="367"/>
<dbReference type="PMAP-CutDB" id="B1AKD7"/>
<dbReference type="PRO" id="PR:P10275"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000169083"/>
<dbReference type="CleanEx" id="HS_AR"/>
<dbReference type="ExpressionAtlas" id="P10275">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P10275">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005497">
<property type="term" value="F:androgen binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004882">
<property type="term" value="F:androgen receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051117">
<property type="term" value="F:ATPase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0008013">
<property type="term" value="F:beta-catenin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004879">
<property type="term" value="F:nuclear receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070974">
<property type="term" value="F:POU domain binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046983">
<property type="term" value="F:protein dimerization activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II core promoter proximal region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0001085">
<property type="term" value="F:RNA polymerase II transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005496">
<property type="term" value="F:steroid binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:transcription factor activity, sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044212">
<property type="term" value="F:transcription regulatory region DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001077">
<property type="term" value="F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0060520">
<property type="term" value="P:activation of prostate induction by androgen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030521">
<property type="term" value="P:androgen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048645">
<property type="term" value="P:animal organ formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016049">
<property type="term" value="P:cell growth"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007267">
<property type="term" value="P:cell-cell signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0071383">
<property type="term" value="P:cellular response to steroid hormone stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0071394">
<property type="term" value="P:cellular response to testosterone stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060742">
<property type="term" value="P:epithelial cell differentiation involved in prostate gland development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003382">
<property type="term" value="P:epithelial cell morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001701">
<property type="term" value="P:in utero embryonic development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030522">
<property type="term" value="P:intracellular receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060599">
<property type="term" value="P:lateral sprouting involved in mammary gland duct morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033327">
<property type="term" value="P:Leydig cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048808">
<property type="term" value="P:male genitalia morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019102">
<property type="term" value="P:male somatic sex determination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060749">
<property type="term" value="P:mammary gland alveolus development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060571">
<property type="term" value="P:morphogenesis of an epithelial fold"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035264">
<property type="term" value="P:multicellular organism growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050680">
<property type="term" value="P:negative regulation of epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2001237">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045720">
<property type="term" value="P:negative regulation of integrin biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0045597">
<property type="term" value="P:positive regulation of cell differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060769">
<property type="term" value="P:positive regulation of epithelial cell proliferation involved in prostate gland development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043568">
<property type="term" value="P:positive regulation of insulin-like growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045726">
<property type="term" value="P:positive regulation of integrin biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033148">
<property type="term" value="P:positive regulation of intracellular estrogen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043410">
<property type="term" value="P:positive regulation of MAPK cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042327">
<property type="term" value="P:positive regulation of phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045945">
<property type="term" value="P:positive regulation of transcription from RNA polymerase III promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030850">
<property type="term" value="P:prostate gland development"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060740">
<property type="term" value="P:prostate gland epithelium morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060736">
<property type="term" value="P:prostate gland growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051259">
<property type="term" value="P:protein oligomerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0050790">
<property type="term" value="P:regulation of catalytic activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048638">
<property type="term" value="P:regulation of developmental growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1903076">
<property type="term" value="P:regulation of protein localization to plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003073">
<property type="term" value="P:regulation of systemic arterial blood pressure"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0072520">
<property type="term" value="P:seminiferous tubule development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007548">
<property type="term" value="P:sex differentiation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007338">
<property type="term" value="P:single fertilization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060748">
<property type="term" value="P:tertiary branching involved in mammary gland duct morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006810">
<property type="term" value="P:transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.565.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.130.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001103">
<property type="entry name" value="Andrgn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR035500">
<property type="entry name" value="NHR_like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000536">
<property type="entry name" value="Nucl_hrmn_rcpt_lig-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR015943">
<property type="entry name" value="WD40/YVTN_repeat-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001628">
<property type="entry name" value="Znf_hrmn_rcpt"/>
</dbReference>
<dbReference type="Pfam" id="PF02166">
<property type="entry name" value="Androgen_recep"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00104">
<property type="entry name" value="Hormone_recep"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00105">
<property type="entry name" value="zf-C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00521">
<property type="entry name" value="ANDROGENR"/>
</dbReference>
<dbReference type="PRINTS" id="PR00047">
<property type="entry name" value="STROIDFINGER"/>
</dbReference>
<dbReference type="SMART" id="SM00430">
<property type="entry name" value="HOLI"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00399">
<property type="entry name" value="ZnF_C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48508">
<property type="entry name" value="SSF48508"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51843">
<property type="entry name" value="NR_LBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00031">
<property type="entry name" value="NUCLEAR_REC_DBD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51030">
<property type="entry name" value="NUCLEAR_REC_DBD_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0446">Lipid-binding</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0657">Pseudohermaphroditism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0754">Steroid-binding</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0818">Triplet repeat expansion</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Androgen receptor" id="PRO_0000053704">
<location>
<begin position="1"/>
<end position="920"/>
</location>
</feature>
<feature type="domain" description="NR LBD" evidence="10">
<location>
<begin position="669"/>
<end position="900"/>
</location>
</feature>
<feature type="DNA-binding region" description="Nuclear receptor" evidence="9">
<location>
<begin position="560"/>
<end position="632"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="9">
<location>
<begin position="560"/>
<end position="580"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="9">
<location>
<begin position="596"/>
<end position="620"/>
</location>
</feature>
<feature type="region of interest" description="Modulating">
<location>
<begin position="1"/>
<end position="559"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with LPXN" evidence="83">
<location>
<begin position="552"/>
<end position="919"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with HIPK3" evidence="8">
<location>
<begin position="572"/>
<end position="662"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CCAR1" evidence="100">
<location>
<begin position="592"/>
<end position="919"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with KAT7" evidence="33">
<location>
<begin position="625"/>
<end position="919"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gln-rich">
<location>
<begin position="58"/>
<end position="120"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="58"/>
<end position="80"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="86"/>
<end position="91"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="195"/>
<end position="199"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="374"/>
<end position="383"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="398"/>
<end position="404"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="451"/>
<end position="473"/>
</location>
</feature>
<feature type="binding site" description="Androgen">
<location>
<position position="706"/>
</location>
</feature>
<feature type="binding site" description="Androgen">
<location>
<position position="753"/>
</location>
</feature>
<feature type="binding site" description="Androgen">
<location>
<position position="878"/>
</location>
</feature>
<feature type="site" description="Interaction with coactivator LXXL motif">
<location>
<position position="721"/>
</location>
</feature>
<feature type="site" description="Interaction with coactivator FXXLF motif">
<location>
<position position="898"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK9" evidence="95">
<location>
<position position="83"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 7">
<location>
<position position="96"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="71">
<location>
<position position="225"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="258"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK and TNK2" evidence="71 73 92">
<location>
<position position="269"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="71">
<location>
<position position="309"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="71">
<location>
<position position="348"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="71">
<location>
<position position="359"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="71">
<location>
<position position="364"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK and TNK2" evidence="71 73">
<location>
<position position="365"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="71">
<location>
<position position="395"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="71">
<location>
<position position="535"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="71">
<location>
<position position="552"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by STK4/MST1" evidence="96">
<location>
<position position="651"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="71">
<location>
<position position="916"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="34">
<location>
<position position="388"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="34">
<location>
<position position="521"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="87">
<location>
<position position="846"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="87">
<location>
<position position="848"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_036889" evidence="186">
<location>
<begin position="1"/>
<end position="532"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_036890" evidence="186">
<original>GPYGDMR</original>
<variation>MILWLHS</variation>
<location>
<begin position="533"/>
<end position="539"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_058166">
<original>ARKLKKLGNLKLQEEG</original>
<variation>EKFRVGNCKHLKMTRP</variation>
<location>
<begin position="629"/>
<end position="644"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_058167">
<original>RKLKKLGNLKLQEEGEASS</original>
<variation>AVVVSERILRVFGVSEWLP</variation>
<location>
<begin position="630"/>
<end position="648"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_058168">
<location>
<begin position="645"/>
<end position="920"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_058169">
<location>
<begin position="649"/>
<end position="920"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS; dbSNP:rs104894742." id="VAR_004679" evidence="150">
<original>E</original>
<variation>K</variation>
<location>
<position position="2"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_004680">
<original>L</original>
<variation>S</variation>
<location>
<position position="54"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; dbSNP:rs78686797." id="VAR_004681" evidence="86">
<original>L</original>
<variation>Q</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009711">
<original>Q</original>
<variation>R</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009712">
<original>Q</original>
<variation>H</variation>
<location>
<position position="114"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009713">
<original>K</original>
<variation>R</variation>
<location>
<position position="182"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009224" evidence="166">
<original>Q</original>
<variation>R</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs374549047." id="VAR_009714" evidence="130">
<original>S</original>
<variation>R</variation>
<location>
<position position="207"/>
</location>
</feature>
<feature type="sequence variant" description="Functional polymorphism; 20% lower transactivation capacity; dbSNP:rs199554641." id="VAR_009715" evidence="102 180">
<original>G</original>
<variation>R</variation>
<location>
<position position="216"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009225" evidence="176">
<original>L</original>
<variation>P</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009716">
<original>M</original>
<variation>T</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009717">
<original>P</original>
<variation>S</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; dbSNP:rs138454018." id="VAR_009718" evidence="103">
<original>P</original>
<variation>L</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; dbSNP:rs773996740." id="VAR_009226" evidence="26">
<original>P</original>
<variation>R</variation>
<location>
<position position="392"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; dbSNP:rs201934623." id="VAR_009227">
<original>P</original>
<variation>S</variation>
<location>
<position position="392"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; unknown pathological significance." id="VAR_009228" evidence="26">
<original>Q</original>
<variation>R</variation>
<location>
<position position="445"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009719">
<original>G</original>
<variation>S</variation>
<location>
<position position="492"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009720">
<original>D</original>
<variation>G</variation>
<location>
<position position="529"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS; dbSNP:rs139524801." id="VAR_009721">
<original>L</original>
<variation>F</variation>
<location>
<position position="548"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; dbSNP:rs137852588." id="VAR_009722" evidence="146">
<original>P</original>
<variation>S</variation>
<location>
<position position="549"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009723" evidence="45">
<original>C</original>
<variation>Y</variation>
<location>
<position position="560"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with isolated hypospadias." id="VAR_009725" evidence="111">
<original>G</original>
<variation>V</variation>
<location>
<position position="569"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009726" evidence="113">
<original>G</original>
<variation>W</variation>
<location>
<position position="569"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009727" evidence="172">
<original>Y</original>
<variation>C</variation>
<location>
<position position="572"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009728">
<original>A</original>
<variation>D</variation>
<location>
<position position="574"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009729">
<original>L</original>
<variation>P</variation>
<location>
<position position="575"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009730" evidence="32">
<original>T</original>
<variation>A</variation>
<location>
<position position="576"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009731" evidence="53">
<original>C</original>
<variation>F</variation>
<location>
<position position="577"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009732" evidence="45">
<original>C</original>
<variation>R</variation>
<location>
<position position="577"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; reduced transcription and DNA binding; dbSNP:rs137852586." id="VAR_009733" evidence="149">
<original>C</original>
<variation>F</variation>
<location>
<position position="580"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009734">
<original>C</original>
<variation>Y</variation>
<location>
<position position="580"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009735" evidence="32">
<original>K</original>
<variation>R</variation>
<location>
<position position="581"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009736" evidence="131 183">
<original>V</original>
<variation>F</variation>
<location>
<position position="582"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009737" evidence="117">
<original>F</original>
<variation>S</variation>
<location>
<position position="583"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS; dbSNP:rs137852587." id="VAR_009738" evidence="149">
<original>F</original>
<variation>Y</variation>
<location>
<position position="583"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009739" evidence="127">
<location>
<position position="583"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009740">
<original>R</original>
<variation>K</variation>
<location>
<position position="586"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation." id="VAR_009741" evidence="32">
<original>A</original>
<variation>V</variation>
<location>
<position position="587"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation." id="VAR_009742">
<original>A</original>
<variation>S</variation>
<location>
<position position="588"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; abolishes dimerization; dbSNP:rs137852569." id="VAR_009743" evidence="27 109">
<original>A</original>
<variation>T</variation>
<location>
<position position="597"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS; associated with P-618 in a PAIS patient; normal androgen binding; does not activate transcription; impairs DNA binding; dbSNP:rs142280455." id="VAR_009744" evidence="45">
<original>S</original>
<variation>G</variation>
<location>
<position position="598"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with severe hypospadias." id="VAR_009745" evidence="13">
<original>S</original>
<variation>T</variation>
<location>
<position position="598"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009746" evidence="118">
<original>C</original>
<variation>F</variation>
<location>
<position position="602"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009747" evidence="117">
<original>D</original>
<variation>Y</variation>
<location>
<position position="605"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS and breast cancer; dbSNP:rs137852573." id="VAR_004684" evidence="14 43 159 171">
<original>R</original>
<variation>Q</variation>
<location>
<position position="608"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS and breast cancer; defective nuclear localization; dbSNP:rs137852576." id="VAR_004685" evidence="46 133 164">
<original>R</original>
<variation>K</variation>
<location>
<position position="609"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009748" evidence="159">
<original>N</original>
<variation>T</variation>
<location>
<position position="611"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009749">
<original>C</original>
<variation>Y</variation>
<location>
<position position="612"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and PAIS; dbSNP:rs754201976." id="VAR_009751" evidence="116 127 139 178">
<original>R</original>
<variation>H</variation>
<location>
<position position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009752">
<original>R</original>
<variation>P</variation>
<location>
<position position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009750" evidence="127">
<location>
<position position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009753" evidence="145">
<original>L</original>
<variation>P</variation>
<location>
<position position="617"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009754" evidence="125">
<original>L</original>
<variation>R</variation>
<location>
<position position="617"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and PAIS; associated with G-598 in a PAIS patient; loss of DNA-binding activity." id="VAR_009755" evidence="45 89">
<original>R</original>
<variation>P</variation>
<location>
<position position="618"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; loss of DNA binding; somatic mutation." id="VAR_009756" evidence="28 32">
<original>C</original>
<variation>Y</variation>
<location>
<position position="620"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009757" evidence="163">
<original>R</original>
<variation>Q</variation>
<location>
<position position="630"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009758">
<original>K</original>
<variation>T</variation>
<location>
<position position="631"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1800053." id="VAR_004686" evidence="174">
<original>A</original>
<variation>D</variation>
<location>
<position position="646"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; dbSNP:rs137852584." id="VAR_009760">
<original>S</original>
<variation>N</variation>
<location>
<position position="648"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and PAIS." id="VAR_004687">
<original>I</original>
<variation>N</variation>
<location>
<position position="665"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009761">
<original>Q</original>
<variation>R</variation>
<location>
<position position="671"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009762">
<original>P</original>
<variation>H</variation>
<location>
<position position="672"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009763">
<original>I</original>
<variation>T</variation>
<location>
<position position="673"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; dbSNP:rs137852579." id="VAR_004688" evidence="104">
<original>L</original>
<variation>P</variation>
<location>
<position position="678"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009764" evidence="14 137">
<original>E</original>
<variation>K</variation>
<location>
<position position="682"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_013474" evidence="36">
<original>P</original>
<variation>T</variation>
<location>
<position position="683"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009765" evidence="30 156">
<original>G</original>
<variation>A</variation>
<location>
<position position="684"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009766">
<original>V</original>
<variation>I</variation>
<location>
<position position="685"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009767">
<original>C</original>
<variation>R</variation>
<location>
<position position="687"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009768">
<original>A</original>
<variation>V</variation>
<location>
<position position="688"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009769">
<original>G</original>
<variation>E</variation>
<location>
<position position="689"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009770" evidence="184">
<location>
<position position="691"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004689">
<location>
<position position="693"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004690" evidence="78">
<original>D</original>
<variation>H</variation>
<location>
<position position="696"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; almost complete loss of androgen binding and transcription activation." id="VAR_004691" evidence="69 78">
<original>D</original>
<variation>N</variation>
<location>
<position position="696"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004692" evidence="173">
<original>D</original>
<variation>V</variation>
<location>
<position position="696"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009771">
<original>L</original>
<variation>M</variation>
<location>
<position position="701"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009772">
<original>L</original>
<variation>F</variation>
<location>
<position position="702"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and prostate cancer; dbSNP:rs864622007." id="VAR_009773" evidence="25 132 170">
<original>L</original>
<variation>H</variation>
<location>
<position position="702"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009774">
<original>S</original>
<variation>A</variation>
<location>
<position position="703"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009775">
<original>S</original>
<variation>C</variation>
<location>
<position position="704"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS and AIS." id="VAR_004693" evidence="167">
<original>S</original>
<variation>G</variation>
<location>
<position position="704"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009776" evidence="54 110">
<original>N</original>
<variation>S</variation>
<location>
<position position="706"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_013475" evidence="37">
<original>N</original>
<variation>Y</variation>
<location>
<position position="706"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; dbSNP:rs137852585." id="VAR_004694" evidence="143">
<original>L</original>
<variation>R</variation>
<location>
<position position="708"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009777" evidence="117 169">
<original>G</original>
<variation>A</variation>
<location>
<position position="709"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009778">
<original>G</original>
<variation>V</variation>
<location>
<position position="709"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009779">
<original>R</original>
<variation>T</variation>
<location>
<position position="711"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_013476" evidence="36">
<original>Q</original>
<variation>E</variation>
<location>
<position position="712"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS; dbSNP:rs137852595." id="VAR_009780">
<original>L</original>
<variation>F</variation>
<location>
<position position="713"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; gain in function." id="VAR_009781" evidence="126">
<original>V</original>
<variation>M</variation>
<location>
<position position="716"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009782">
<original>K</original>
<variation>E</variation>
<location>
<position position="718"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; found in bone metastases." id="VAR_009783">
<original>K</original>
<variation>E</variation>
<location>
<position position="721"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation; dbSNP:rs137852583." id="VAR_009784">
<original>A</original>
<variation>T</variation>
<location>
<position position="722"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009785">
<original>L</original>
<variation>F</variation>
<location>
<position position="723"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009786">
<original>P</original>
<variation>S</variation>
<location>
<position position="724"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and prostate cancer." id="VAR_009787">
<original>G</original>
<variation>D</variation>
<location>
<position position="725"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with severe hypospadias." id="VAR_009788" evidence="13 110">
<original>F</original>
<variation>L</variation>
<location>
<position position="726"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; dbSNP:rs137852593." id="VAR_009789" evidence="141">
<original>R</original>
<variation>L</variation>
<location>
<position position="727"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; dbSNP:rs768869912." id="VAR_009790" evidence="119">
<original>N</original>
<variation>K</variation>
<location>
<position position="728"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009791">
<original>L</original>
<variation>S</variation>
<location>
<position position="729"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; increases transcription activation; dbSNP:rs137852571." id="VAR_004695" evidence="56 68 106">
<original>V</original>
<variation>M</variation>
<location>
<position position="731"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004696" evidence="165">
<original>D</original>
<variation>N</variation>
<location>
<position position="733"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004697">
<original>D</original>
<variation>Y</variation>
<location>
<position position="733"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009792">
<original>Q</original>
<variation>H</variation>
<location>
<position position="734"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009793" evidence="110">
<original>I</original>
<variation>T</variation>
<location>
<position position="738"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009794" evidence="51">
<original>W</original>
<variation>R</variation>
<location>
<position position="742"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_004698" evidence="151">
<original>M</original>
<variation>I</variation>
<location>
<position position="743"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009795" evidence="116">
<original>M</original>
<variation>V</variation>
<location>
<position position="743"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; dbSNP:rs137852600." id="VAR_013477" evidence="36">
<original>G</original>
<variation>E</variation>
<location>
<position position="744"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS and AIS; dbSNP:rs137852600." id="VAR_004699" evidence="122 136 179 183">
<original>G</original>
<variation>V</variation>
<location>
<position position="744"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and prostate cancer." id="VAR_009796">
<original>L</original>
<variation>F</variation>
<location>
<position position="745"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009797" evidence="116">
<original>M</original>
<variation>T</variation>
<location>
<position position="746"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009798">
<original>V</original>
<variation>M</variation>
<location>
<position position="747"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009799">
<original>A</original>
<variation>D</variation>
<location>
<position position="749"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009800">
<original>A</original>
<variation>T</variation>
<location>
<position position="749"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009801">
<original>A</original>
<variation>V</variation>
<location>
<position position="749"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009802">
<original>M</original>
<variation>I</variation>
<location>
<position position="750"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS and AIS." id="VAR_004700" evidence="54 55 155">
<original>M</original>
<variation>V</variation>
<location>
<position position="750"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of androgen binding." id="VAR_004701" evidence="168">
<original>G</original>
<variation>D</variation>
<location>
<position position="751"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009803">
<original>G</original>
<variation>S</variation>
<location>
<position position="751"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009804">
<original>W</original>
<variation>R</variation>
<location>
<position position="752"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004702" evidence="172 178">
<original>R</original>
<variation>Q</variation>
<location>
<position position="753"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS and prostate cancer." id="VAR_009805" evidence="117 159">
<original>F</original>
<variation>L</variation>
<location>
<position position="755"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004703" evidence="124 183">
<original>F</original>
<variation>V</variation>
<location>
<position position="755"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009806">
<original>T</original>
<variation>A</variation>
<location>
<position position="756"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS; dbSNP:rs141425171." id="VAR_009807">
<original>N</original>
<variation>S</variation>
<location>
<position position="757"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009808" evidence="32">
<original>V</original>
<variation>A</variation>
<location>
<position position="758"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS; 50% reduction in transactivation." id="VAR_009809" evidence="175">
<original>N</original>
<variation>T</variation>
<location>
<position position="759"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009810" evidence="54">
<original>S</original>
<variation>F</variation>
<location>
<position position="760"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009811">
<original>S</original>
<variation>P</variation>
<location>
<position position="760"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of androgen binding." id="VAR_004704" evidence="168">
<original>L</original>
<variation>F</variation>
<location>
<position position="763"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS and prostate cancer; partial loss of androgen binding; dbSNP:rs137852567." id="VAR_004705" evidence="69 90 105">
<original>Y</original>
<variation>C</variation>
<location>
<position position="764"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009812" evidence="110">
<original>Y</original>
<variation>H</variation>
<location>
<position position="764"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009813" evidence="116">
<original>F</original>
<variation>L</variation>
<location>
<position position="765"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of androgen binding." id="VAR_004707" evidence="47 165 168 182">
<original>A</original>
<variation>T</variation>
<location>
<position position="766"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009814">
<original>A</original>
<variation>V</variation>
<location>
<position position="766"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009815">
<original>P</original>
<variation>S</variation>
<location>
<position position="767"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009816" evidence="183">
<original>D</original>
<variation>E</variation>
<location>
<position position="768"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009817">
<original>L</original>
<variation>P</variation>
<location>
<position position="769"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS; dbSNP:rs886041352." id="VAR_009818" evidence="117">
<original>N</original>
<variation>H</variation>
<location>
<position position="772"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009819" evidence="11">
<original>E</original>
<variation>A</variation>
<location>
<position position="773"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009820" evidence="164">
<original>E</original>
<variation>G</variation>
<location>
<position position="773"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; frequent mutation; loss of androgen binding; dbSNP:rs137852562." id="VAR_004709" evidence="66 85 94 155 172">
<original>R</original>
<variation>C</variation>
<location>
<position position="775"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and PAIS; almost complete loss of androgen binding; dbSNP:rs137852572." id="VAR_004708" evidence="54 66 69 110">
<original>R</original>
<variation>H</variation>
<location>
<position position="775"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004710" evidence="105 117 158">
<original>R</original>
<variation>W</variation>
<location>
<position position="780"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS and AIS; dbSNP:rs137852589." id="VAR_004711" evidence="148 151 155">
<original>M</original>
<variation>I</variation>
<location>
<position position="781"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; somatic mutation." id="VAR_009821">
<original>S</original>
<variation>N</variation>
<location>
<position position="783"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of androgen binding and of transactivation." id="VAR_004712" evidence="182">
<original>C</original>
<variation>Y</variation>
<location>
<position position="785"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; dbSNP:rs137852570." id="VAR_004713" evidence="61">
<original>M</original>
<variation>V</variation>
<location>
<position position="788"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009822">
<original>R</original>
<variation>S</variation>
<location>
<position position="789"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009823" evidence="115">
<original>L</original>
<variation>F</variation>
<location>
<position position="791"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009824">
<original>S</original>
<variation>P</variation>
<location>
<position position="792"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_009825" evidence="130">
<original>E</original>
<variation>D</variation>
<location>
<position position="794"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004714" evidence="155">
<original>F</original>
<variation>S</variation>
<location>
<position position="795"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS, AIS and prostate cancer; reduced transcription activation; dbSNP:rs137852591." id="VAR_004715" evidence="69 103 110 144 151 181">
<original>Q</original>
<variation>E</variation>
<location>
<position position="799"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009826">
<original>C</original>
<variation>Y</variation>
<location>
<position position="807"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of transactivation." id="VAR_004716" evidence="134">
<original>M</original>
<variation>R</variation>
<location>
<position position="808"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS; dbSNP:rs137852592." id="VAR_009827" evidence="24">
<original>M</original>
<variation>T</variation>
<location>
<position position="808"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; 25% androgen binding." id="VAR_004717" evidence="105">
<original>M</original>
<variation>V</variation>
<location>
<position position="808"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009828" evidence="21">
<original>L</original>
<variation>F</variation>
<location>
<position position="813"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and PAIS." id="VAR_004718">
<original>S</original>
<variation>N</variation>
<location>
<position position="815"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009829" evidence="176">
<original>G</original>
<variation>A</variation>
<location>
<position position="821"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009830">
<original>L</original>
<variation>V</variation>
<location>
<position position="822"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_013478" evidence="36">
<original>F</original>
<variation>V</variation>
<location>
<position position="828"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009831">
<original>L</original>
<variation>P</variation>
<location>
<position position="831"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004719" evidence="107">
<original>R</original>
<variation>L</variation>
<location>
<position position="832"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of androgen binding." id="VAR_004720" evidence="21 94 107">
<original>R</original>
<variation>Q</variation>
<location>
<position position="832"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of androgen binding." id="VAR_009832" evidence="51">
<original>Y</original>
<variation>C</variation>
<location>
<position position="835"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; dbSNP:rs137852577." id="VAR_004721" evidence="121 151 179">
<original>R</original>
<variation>C</variation>
<location>
<position position="841"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_004722" evidence="182">
<original>R</original>
<variation>G</variation>
<location>
<position position="841"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; dbSNP:rs9332969." id="VAR_004723" evidence="112 121 125 129 137 153 159">
<original>R</original>
<variation>H</variation>
<location>
<position position="841"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009229" evidence="23">
<original>R</original>
<variation>S</variation>
<location>
<position position="841"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009833">
<original>I</original>
<variation>S</variation>
<location>
<position position="842"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; dbSNP:rs9332970." id="VAR_004724" evidence="137 159">
<original>I</original>
<variation>T</variation>
<location>
<position position="843"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009834" evidence="32">
<original>R</original>
<variation>G</variation>
<location>
<position position="847"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009835">
<original>R</original>
<variation>K</variation>
<location>
<position position="855"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; dbSNP:rs886041132." id="VAR_004725" evidence="54 105 157 166 183">
<original>R</original>
<variation>C</variation>
<location>
<position position="856"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; strongly reduced transcription activation; dbSNP:rs9332971." id="VAR_004726" evidence="69 123 151 159 161">
<original>R</original>
<variation>H</variation>
<location>
<position position="856"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; dbSNP:rs137852598." id="VAR_009836">
<original>F</original>
<variation>L</variation>
<location>
<position position="857"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009837">
<original>L</original>
<variation>R</variation>
<location>
<position position="864"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009838" evidence="54">
<original>D</original>
<variation>G</variation>
<location>
<position position="865"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; loss of androgen binding." id="VAR_004727" evidence="168">
<original>D</original>
<variation>N</variation>
<location>
<position position="865"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; dbSNP:rs137852597." id="VAR_009839">
<original>S</original>
<variation>P</variation>
<location>
<position position="866"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004728">
<original>V</original>
<variation>E</variation>
<location>
<position position="867"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS; dbSNP:rs137852564." id="VAR_004729" evidence="46 137 140">
<original>V</original>
<variation>L</variation>
<location>
<position position="867"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and prostate cancer; dbSNP:rs137852564." id="VAR_004730" evidence="94 101 140 159">
<original>V</original>
<variation>M</variation>
<location>
<position position="867"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS; dbSNP:rs137852574." id="VAR_004731" evidence="123 151">
<original>I</original>
<variation>M</variation>
<location>
<position position="870"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009840" evidence="169">
<original>A</original>
<variation>G</variation>
<location>
<position position="871"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS; dbSNP:rs143040492." id="VAR_009841" evidence="120">
<original>A</original>
<variation>V</variation>
<location>
<position position="871"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009842" evidence="11">
<original>R</original>
<variation>G</variation>
<location>
<position position="872"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_013479" evidence="36">
<original>H</original>
<variation>R</variation>
<location>
<position position="875"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; increases affinity for testosterone and androgen sensitivity; increased transcription activation; dbSNP:rs137852581." id="VAR_009843" evidence="76">
<original>H</original>
<variation>Y</variation>
<location>
<position position="875"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; found in bone metastases; alters receptor specificity so that transcription is activated by antiandrogens such as cyproterone acetate; dbSNP:rs137852578." id="VAR_004732" evidence="17 25 59 67 72 99 128 132 152">
<original>T</original>
<variation>A</variation>
<location>
<position position="878"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; dbSNP:rs137852580." id="VAR_009844">
<original>T</original>
<variation>S</variation>
<location>
<position position="878"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_013480" evidence="36">
<original>D</original>
<variation>Y</variation>
<location>
<position position="880"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009845">
<original>L</original>
<variation>Q</variation>
<location>
<position position="881"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009846" evidence="108">
<original>L</original>
<variation>V</variation>
<location>
<position position="882"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; dbSNP:rs755226547." id="VAR_009847">
<original>M</original>
<variation>V</variation>
<location>
<position position="887"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS and PAIS; dbSNP:rs886041133." id="VAR_009848" evidence="125 162">
<original>V</original>
<variation>M</variation>
<location>
<position position="890"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009849" evidence="17">
<original>D</original>
<variation>N</variation>
<location>
<position position="891"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009850">
<original>F</original>
<variation>L</variation>
<location>
<position position="892"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_004733" evidence="15 20 185">
<original>P</original>
<variation>L</variation>
<location>
<position position="893"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; low androgen binding and transactivation." id="VAR_004734" evidence="67 182">
<original>M</original>
<variation>T</variation>
<location>
<position position="896"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009851">
<original>A</original>
<variation>T</variation>
<location>
<position position="897"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009852">
<original>I</original>
<variation>T</variation>
<location>
<position position="899"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer; dbSNP:rs137852582." id="VAR_009853">
<original>Q</original>
<variation>R</variation>
<location>
<position position="903"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009854">
<original>V</original>
<variation>M</variation>
<location>
<position position="904"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009855">
<original>P</original>
<variation>H</variation>
<location>
<position position="905"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009856">
<original>P</original>
<variation>S</variation>
<location>
<position position="905"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS; almost complete loss of transcription activation." id="VAR_004735" evidence="69 168">
<original>L</original>
<variation>F</variation>
<location>
<position position="908"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009857">
<original>G</original>
<variation>E</variation>
<location>
<position position="910"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009858" evidence="142">
<original>G</original>
<variation>R</variation>
<location>
<position position="910"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009859" evidence="170">
<original>K</original>
<variation>R</variation>
<location>
<position position="911"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_009860" evidence="22">
<original>V</original>
<variation>L</variation>
<location>
<position position="912"/>
</location>
</feature>
<feature type="sequence variant" description="In PAIS." id="VAR_004736">
<original>P</original>
<variation>S</variation>
<location>
<position position="914"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009861" evidence="167">
<original>F</original>
<variation>L</variation>
<location>
<position position="917"/>
</location>
</feature>
<feature type="sequence variant" description="In AIS." id="VAR_009862">
<original>H</original>
<variation>R</variation>
<location>
<position position="918"/>
</location>
</feature>
<feature type="sequence variant" description="In prostate cancer." id="VAR_009863">
<original>Q</original>
<variation>R</variation>
<location>
<position position="920"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced cell growth." evidence="95">
<original>S</original>
<variation>A</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of CSK-induced phosphorylation." evidence="71">
<original>Y</original>
<variation>F</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of CSK-induced phosphorylation and phosphorylation by TNK2. Complete loss of TNK2-dependent phosphorylation; when associated with F-365." evidence="71 73">
<original>Y</original>
<variation>F</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of CSK-induced phosphorylation." evidence="71">
<original>Y</original>
<variation>F</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of CSK-induced phosphorylation." evidence="71">
<original>Y</original>
<variation>F</variation>
<location>
<position position="348"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of CSK-induced phosphorylation." evidence="71">
<original>Y</original>
<variation>F</variation>
<location>
<position position="359"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of CSK-induced phosphorylation." evidence="71">
<original>Y</original>
<variation>F</variation>
<location>
<position position="364"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of CSK-induced phosphorylation and phosphorylation by TNK2. Complete loss of TNK2-dependent phosphorylation; when associated with F-269." evidence="71 73">
<original>Y</original>
<variation>F</variation>
<location>
<position position="365"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease of CSK-induced phosphorylation." evidence="71">
<original>Y</original>
<variation>F</variation>
<location>
<position position="395"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatest decrease of CSK-induced phosphorylation and inhibition of transcriptional activity induced by EGF." evidence="71">
<original>Y</original>
<variation>F</variation>
<location>
<position position="535"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in CSK-induced phosphorylation." evidence="71">
<original>Y</original>
<variation>F</variation>
<location>
<position position="552"/>
</location>
</feature>
<feature type="mutagenesis site" description="Alters receptor specificity, so that transcription is activated by the antiandrogen cyproterone acetate." evidence="72">
<original>L</original>
<variation>A</variation>
<location>
<position position="702"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of transcription activation in the presence of androgen and of interaction with NCOA2." evidence="57 76">
<original>K</original>
<variation>A</variation>
<location>
<position position="721"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreased transcription activation in the presence of androgen." evidence="67">
<original>W</original>
<variation>L</variation>
<location>
<position position="742"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents ubiquitination by RNF6. Prevents AR transcriptional activation by RNF14 in absence of hormone." evidence="87">
<original>K</original>
<variation>R</variation>
<location>
<position position="846"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partially prevents ubiquitination by RNF6." evidence="87">
<original>K</original>
<variation>R</variation>
<location>
<position position="848"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced transcription activation in the presence of androgen." evidence="57 76">
<original>E</original>
<variation>A</variation>
<variation>Q</variation>
<location>
<position position="898"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of transcription activation in the presence of androgen." evidence="57 76">
<original>E</original>
<variation>K</variation>
<variation>R</variation>
<location>
<position position="898"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in CSK-induced phosphorylation." evidence="71">
<original>Y</original>
<variation>F</variation>
<location>
<position position="916"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA51780." ref="5" evidence="186">
<original>G</original>
<variation>A</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3 and 6; AAA51771/AAA51772." ref="3 6" evidence="186">
<original>A</original>
<variation>R</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA51775 and 13; AAA51770." ref="2 13" evidence="186">
<original>G</original>
<variation>E</variation>
<location>
<position position="476"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 15; AAA51774." ref="15" evidence="186">
<original>E</original>
<variation>K</variation>
<location>
<position position="566"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 19; AAB21256/AAB21257." ref="19" evidence="186">
<original>L</original>
<variation>P</variation>
<location>
<position position="635"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 19; AAB21256/AAB21257." ref="19" evidence="186">
<original>N</original>
<variation>I</variation>
<location>
<position position="676"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA51780." ref="5" evidence="186">
<original>L</original>
<variation>M</variation>
<location>
<position position="811"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="22"/>
<end position="29"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="667"/>
<end position="669"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="673"/>
<end position="681"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="692"/>
<end position="694"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="698"/>
<end position="721"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="726"/>
<end position="728"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="731"/>
<end position="758"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="761"/>
<end position="766"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="769"/>
<end position="771"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="773"/>
<end position="778"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="782"/>
<end position="797"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="802"/>
<end position="812"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="815"/>
<end position="818"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="825"/>
<end position="843"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="844"/>
<end position="846"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="850"/>
<end position="852"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="853"/>
<end position="883"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="885"/>
<end position="888"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="894"/>
<end position="902"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="904"/>
<end position="908"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="911"/>
<end position="914"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1XJ7"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2PIV"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2PKL"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3V49"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4OHA"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250"/>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00407"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01189"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10022458"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10075738"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10092153"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10221692"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10221770"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10332029"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10363963"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10383460"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10400640"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10404311"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10458483"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10470409"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10502786"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10543676"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10569618"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10571951"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10590024"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10598582"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10625666"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10629558"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10690872"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10706109"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10930412"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11121022"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11231320"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11587068"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11744994"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12039962"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12361945"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12415108"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12612053"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12958311"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1303262"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1307250"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1316540"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1424203"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1426313"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1430233"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14573606"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14609956"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1464650"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14664718"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14756668"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1480178"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1487249"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15525515"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15563469"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1561105"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1562539"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15634333"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1569163"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15851746"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15902657"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16027218"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16051670"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1609793"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16129672"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1631125"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16595706"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16951154"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17045208"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17311914"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17494760"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17550981"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17587566"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17591767"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17711855"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1775137"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17911242"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18007036"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18084323"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18222118"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18451096"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18451177"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1856263"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19244107"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19345326"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19909775"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1999491"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2010552"/>
</source>
</evidence>
<evidence key="91" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20501646"/>
</source>
</evidence>
<evidence key="92" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20623637"/>
</source>
</evidence>
<evidence key="93" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2062380"/>
</source>
</evidence>
<evidence key="94" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2082179"/>
</source>
</evidence>
<evidence key="95" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20980437"/>
</source>
</evidence>
<evidence key="96" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21512132"/>
</source>
</evidence>
<evidence key="97" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22031296"/>
</source>
</evidence>
<evidence key="98" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22170608"/>
</source>
</evidence>
<evidence key="99" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2260966"/>
</source>
</evidence>
<evidence key="100" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23887938"/>
</source>
</evidence>
<evidence key="101" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2594783"/>
</source>
</evidence>
<evidence key="102" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27535533"/>
</source>
</evidence>
<evidence key="103" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7511268"/>
</source>
</evidence>
<evidence key="104" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7537149"/>
</source>
</evidence>
<evidence key="105" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7581399"/>
</source>
</evidence>
<evidence key="106" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7591265"/>
</source>
</evidence>
<evidence key="107" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7633398"/>
</source>
</evidence>
<evidence key="108" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7641413"/>
</source>
</evidence>
<evidence key="109" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7649358"/>
</source>
</evidence>
<evidence key="110" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7671849"/>
</source>
</evidence>
<evidence key="111" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7673412"/>
</source>
</evidence>
<evidence key="112" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7909256"/>
</source>
</evidence>
<evidence key="113" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7910529"/>
</source>
</evidence>
<evidence key="114" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7929841"/>
</source>
</evidence>
<evidence key="115" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7962294"/>
</source>
</evidence>
<evidence key="116" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7970939"/>
</source>
</evidence>
<evidence key="117" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7981687"/>
</source>
</evidence>
<evidence key="118" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7981689"/>
</source>
</evidence>
<evidence key="119" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7993455"/>
</source>
</evidence>
<evidence key="120" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8033918"/>
</source>
</evidence>
<evidence key="121" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8040309"/>
</source>
</evidence>
<evidence key="122" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8096390"/>
</source>
</evidence>
<evidence key="123" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8097257"/>
</source>
</evidence>
<evidence key="124" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8103398"/>
</source>
</evidence>
<evidence key="125" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8126121"/>
</source>
</evidence>
<evidence key="126" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8145761"/>
</source>
</evidence>
<evidence key="127" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8162033"/>
</source>
</evidence>
<evidence key="128" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8187068"/>
</source>
</evidence>
<evidence key="129" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8205256"/>
</source>
</evidence>
<evidence key="130" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8213813"/>
</source>
</evidence>
<evidence key="131" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8224266"/>
</source>
</evidence>
<evidence key="132" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8274409"/>
</source>
</evidence>
<evidence key="133" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8281139"/>
</source>
</evidence>
<evidence key="134" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8281140"/>
</source>
</evidence>
<evidence key="135" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8292051"/>
</source>
</evidence>
<evidence key="136" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8325932"/>
</source>
</evidence>
<evidence key="137" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8325950"/>
</source>
</evidence>
<evidence key="138" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8339746"/>
</source>
</evidence>
<evidence key="139" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8413310"/>
</source>
</evidence>
<evidence key="140" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8446106"/>
</source>
</evidence>
<evidence key="141" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8530589"/>
</source>
</evidence>
<evidence key="142" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8550758"/>
</source>
</evidence>
<evidence key="143" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8626869"/>
</source>
</evidence>
<evidence key="144" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8628719"/>
</source>
</evidence>
<evidence key="145" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8647313"/>
</source>
</evidence>
<evidence key="146" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8683794"/>
</source>
</evidence>
<evidence key="147" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8723113"/>
</source>
</evidence>
<evidence key="148" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8768864"/>
</source>
</evidence>
<evidence key="149" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8809734"/>
</source>
</evidence>
<evidence key="150" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8823308"/>
</source>
</evidence>
<evidence key="151" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8824883"/>
</source>
</evidence>
<evidence key="152" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8827083"/>
</source>
</evidence>
<evidence key="153" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8830623"/>
</source>
</evidence>
<evidence key="154" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8918984"/>
</source>
</evidence>
<evidence key="155" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8990010"/>
</source>
</evidence>
<evidence key="156" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9000575"/>
</source>
</evidence>
<evidence key="157" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9001799"/>
</source>
</evidence>
<evidence key="158" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9007482"/>
</source>
</evidence>
<evidence key="159" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9039340"/>
</source>
</evidence>
<evidence key="160" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9096391"/>
</source>
</evidence>
<evidence key="161" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9106550"/>
</source>
</evidence>
<evidence key="162" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9160185"/>
</source>
</evidence>
<evidence key="163" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9184448"/>
</source>
</evidence>
<evidence key="164" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9196614"/>
</source>
</evidence>
<evidence key="165" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9252933"/>
</source>
</evidence>
<evidence key="166" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9255042"/>
</source>
</evidence>
<evidence key="167" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9302173"/>
</source>
</evidence>
<evidence key="168" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9328206"/>
</source>
</evidence>
<evidence key="169" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9329414"/>
</source>
</evidence>
<evidence key="170" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9438000"/>
</source>
</evidence>
<evidence key="171" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9543136"/>
</source>
</evidence>
<evidence key="172" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9544375"/>
</source>
</evidence>
<evidence key="173" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9554754"/>
</source>
</evidence>
<evidence key="174" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9554755"/>
</source>
</evidence>
<evidence key="175" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9607727"/>
</source>
</evidence>
<evidence key="176" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9610419"/>
</source>
</evidence>
<evidence key="177" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9627582"/>
</source>
</evidence>
<evidence key="178" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9698822"/>
</source>
</evidence>
<evidence key="179" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9768671"/>
</source>
</evidence>
<evidence key="180" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9788719"/>
</source>
</evidence>
<evidence key="181" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9851768"/>
</source>
</evidence>
<evidence key="182" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9856504"/>
</source>
</evidence>
<evidence key="183" type="ECO:0000269">
<source ref="110"/>
</evidence>
<evidence key="184" type="ECO:0000269">
<source ref="118"/>
</evidence>
<evidence key="185" type="ECO:0000269">
<source ref="176"/>
</evidence>
<evidence key="186" type="ECO:0000305"/>
<sequence length="920" mass="99188" checksum="A73432C55D39AE06" modified="2016-03-16" version="3">
MEVQLGLGRVYPRPPSKTYRGAFQNLFQSVREVIQNPGPRHPEAASAAPPGASLLLLQQQ
QQQQQQQQQQQQQQQQQQQQETSPRQQQQQQGEDGSPQAHRRGPTGYLVLDEEQQPSQPQ
SALECHPERGCVPEPGAAVAASKGLPQQLPAPPDEDDSAAPSTLSLLGPTFPGLSSCSAD
LKDILSEASTMQLLQQQQQEAVSEGSSSGRAREASGAPTSSKDNYLGGTSTISDNAKELC
KAVSVSMGLGVEALEHLSPGEQLRGDCMYAPLLGVPPAVRPTPCAPLAECKGSLLDDSAG
KSTEDTAEYSPFKGGYTKGLEGESLGCSGSAAAGSSGTLELPSTLSLYKSGALDEAAAYQ
SRDYYNFPLALAGPPPPPPPPHPHARIKLENPLDYGSAWAAAAAQCRYGDLASLHGAGAA
GPGSGSPSAAASSSWHTLFTAEEGQLYGPCGGGGGGGGGGGGGGGGGGGGGGGEAGAVAP
YGYTRPPQGLAGQESDFTAPDVWYPGGMVSRVPYPSPTCVKSEMGPWMDSYSGPYGDMRL
ETARDHVLPIDYYFPPQKTCLICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRN
DCTIDKFRRKNCPSCRLRKCYEAGMTLGARKLKKLGNLKLQEEGEASSTTSPTEETTQKL
TVSHIEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWA
KALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSR
MYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELD
RIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEII
SVQVPKILSGKVKPIYFHTQ
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1994-10-01" modified="2017-12-20" version="232">
<accession>P38398</accession>
<accession>E9PFZ0</accession>
<accession>O15129</accession>
<accession>Q1RMC1</accession>
<accession>Q3LRJ0</accession>
<accession>Q3LRJ6</accession>
<accession>Q6IN79</accession>
<accession>Q7KYU9</accession>
<name>BRCA1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Breast cancer type 1 susceptibility protein</fullName>
<ecNumber evidence="23 41 42 58 64 74">2.3.2.27</ecNumber>
</recommendedName>
<alternativeName>
<fullName>RING finger protein 53</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="107">RING-type E3 ubiquitin transferase BRCA1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">BRCA1</name>
<name type="synonym">RNF53</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Science" volume="266" first="66" last="71">
<title>A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.</title>
<authorList>
<person name="Miki Y."/>
<person name="Swensen J."/>
<person name="Shattuck-Eidens D."/>
<person name="Futreal P.A."/>
<person name="Harshman K."/>
<person name="Tavtigian S."/>
<person name="Liu Q."/>
<person name="Cochran C."/>
<person name="Bennett L.M."/>
<person name="Ding W."/>
<person name="Bell R."/>
<person name="Rosenthal J."/>
<person name="Hussey C."/>
<person name="Tran T."/>
<person name="McClure M."/>
<person name="Frye C."/>
<person name="Hattier T."/>
<person name="Phelps R."/>
<person name="Haugen-Strano A."/>
<person name="Katcher H."/>
<person name="Yakumo K."/>
<person name="Gholami Z."/>
<person name="Shaffer D."/>
<person name="Stone S."/>
<person name="Bayer S."/>
<person name="Wray C."/>
<person name="Bogden R."/>
<person name="Dayananth P."/>
<person name="Ward J."/>
<person name="Tonin P."/>
<person name="Narod S."/>
<person name="Bristow P.K."/>
<person name="Norris F.H."/>
<person name="Helvering L."/>
<person name="Morrison P."/>
<person name="Rosteck P."/>
<person name="Lai M."/>
<person name="Barrett J.C."/>
<person name="Lewis C."/>
<person name="Neuhausen S."/>
<person name="Cannon-Albright L."/>
<person name="Godlgar D."/>
<person name="Wiseman R."/>
<person name="Kamb A."/>
<person name="Skolnick M.H."/>
</authorList>
<dbReference type="PubMed" id="7545954"/>
<dbReference type="DOI" id="10.1126/science.7545954"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT BC ARG-1775</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Genome Res." volume="6" first="1029" last="1049">
<title>Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1.</title>
<authorList>
<person name="Smith T.M."/>
<person name="Lee M.K."/>
<person name="Szabo C.I."/>
<person name="Jerome N."/>
<person name="McEuen M."/>
<person name="Taylor M."/>
<person name="Hood L."/>
<person name="King M.-C."/>
</authorList>
<dbReference type="PubMed" id="8938427"/>
<dbReference type="DOI" id="10.1101/gr.6.11.1029"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Oncogene" volume="14" first="1" last="16">
<title>Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b.</title>
<authorList>
<person name="Wilson C.A."/>
<person name="Payton M.N."/>
<person name="Elliott G.S."/>
<person name="Buaas F.W."/>
<person name="Cajulis E.E."/>
<person name="Grosshans D."/>
<person name="Ramos L."/>
<person name="Reese D.M."/>
<person name="Slamon D.J."/>
<person name="Calzone F.J."/>
</authorList>
<dbReference type="PubMed" id="9010228"/>
<dbReference type="DOI" id="10.1038/sj.onc.1200924"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM 2)</scope>
<scope>VARIANTS ARG-239 AND GLY-1613</scope>
<scope>TISSUE SPECIFICITY (ISOFORMS 1 AND 3)</scope>
<source>
<tissue>Mammary gland</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="1997-05" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Holt J.T."/>
<person name="Robinson-Benion C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Raymond C.K."/>
<person name="Paddock M."/>
<person name="Subramanian S."/>
<person name="Deodato C."/>
<person name="Zhou Y."/>
<person name="Haugen E."/>
<person name="Kaul R."/>
<person name="Olson M.V."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT ARG-356</scope>
</reference>
<reference key="6">
<citation type="submission" date="2003-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS SER-275; ARG-356; ASN-693; LEU-871; GLY-1038; ASN-1040; GLY-1140; ARG-1183; GLY-1613 AND ALA-1620</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1045" last="1049">
<title>DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Adams D.J."/>
<person name="Sharpe T."/>
<person name="Harrow J."/>
<person name="Lupski J.R."/>
<person name="Nicholson C."/>
<person name="Searle S.M."/>
<person name="Wilming L."/>
<person name="Young S.K."/>
<person name="Abouelleil A."/>
<person name="Allen N.R."/>
<person name="Bi W."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Bugalter B.E."/>
<person name="Butler J."/>
<person name="Chang J.L."/>
<person name="Chen C.-K."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="Cuomo C.A."/>
<person name="de Jong P.J."/>
<person name="DeCaprio D."/>
<person name="Dewar K."/>
<person name="FitzGerald M."/>
<person name="Gilbert J."/>
<person name="Gibson R."/>
<person name="Gnerre S."/>
<person name="Goldstein S."/>
<person name="Grafham D.V."/>
<person name="Grocock R."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hart E."/>
<person name="Norman C.H."/>
<person name="Humphray S."/>
<person name="Jaffe D.B."/>
<person name="Jones M."/>
<person name="Kamal M."/>
<person name="Khodiyar V.K."/>
<person name="LaButti K."/>
<person name="Laird G."/>
<person name="Lehoczky J."/>
<person name="Liu X."/>
<person name="Lokyitsang T."/>
<person name="Loveland J."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews L."/>
<person name="Mauceli E."/>
<person name="McCarroll S.A."/>
<person name="Mihalev A.H."/>
<person name="Mudge J."/>
<person name="Nguyen C."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Osoegawa K."/>
<person name="Schwartz D.C."/>
<person name="Shaw-Smith C."/>
<person name="Stankiewicz P."/>
<person name="Steward C."/>
<person name="Swarbreck D."/>
<person name="Venkataraman V."/>
<person name="Whittaker C.A."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Bradley A."/>
<person name="Hubbard T."/>
<person name="Birren B.W."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16625196"/>
<dbReference type="DOI" id="10.1038/nature04689"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 6 AND 7)</scope>
<scope>VARIANTS LEU-871; GLY-1038; ARG-1183; GLY-1613 AND ILE-1652</scope>
<source>
<tissue>PNS</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="Oncogene" volume="19" first="2767" last="2773">
<title>Initiation of translation from a downstream in-frame AUG codon on BRCA1 can generate the novel isoform protein DeltaBRCA1(17aa).</title>
<authorList>
<person name="Liu J."/>
<person name="Prolla G."/>
<person name="Rostagno A."/>
<person name="Chiarle R."/>
<person name="Feiner H."/>
<person name="Inghirami G."/>
</authorList>
<dbReference type="PubMed" id="10851077"/>
<dbReference type="DOI" id="10.1038/sj.onc.1203599"/>
</citation>
<scope>PROTEIN SEQUENCE OF 6-18 (ISOFORM 1)</scope>
<scope>PROTEIN SEQUENCE OF 18-26 (ISOFORM 4)</scope>
<scope>ALTERNATIVE INITIATION (ISOFORM 4)</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1997" name="Mol. Cell. Biol." volume="17" first="444" last="452">
<title>Localization of BRCA1 and a splice variant identifies the nuclear localization signal.</title>
<authorList>
<person name="Thakur S."/>
<person name="Zhang H.B."/>
<person name="Peng Y."/>
<person name="Le H."/>
<person name="Carroll B."/>
<person name="Ward T."/>
<person name="Yao J."/>
<person name="Farid L.M."/>
<person name="Couch F.J."/>
<person name="Wilson R.B."/>
<person name="Weber B.L."/>
</authorList>
<dbReference type="PubMed" id="8972225"/>
<dbReference type="DOI" id="10.1128/MCB.17.1.444"/>
</citation>
<scope>ALTERNATIVE SPLICING (ISOFORM 5)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM 5)</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1998" name="Nat. Genet." volume="19" first="254" last="256">
<title>BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A.</title>
<authorList>
<person name="Anderson S.F."/>
<person name="Schlegel B.P."/>
<person name="Nakajima T."/>
<person name="Wolpin E.S."/>
<person name="Parvin J.D."/>
</authorList>
<dbReference type="PubMed" id="9662397"/>
<dbReference type="DOI" id="10.1038/930"/>
</citation>
<scope>INTERACTION WITH DHX9</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1998" name="Oncogene" volume="16" first="1097" last="1112">
<title>BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.</title>
<authorList>
<person name="Jensen D.E."/>
<person name="Proctor M."/>
<person name="Marquis S.T."/>
<person name="Gardner H.P."/>
<person name="Ha S.I."/>
<person name="Chodosh L.A."/>
<person name="Ishov A.M."/>
<person name="Tommerup N."/>
<person name="Vissing H."/>
<person name="Sekido Y."/>
<person name="Minna J."/>
<person name="Borodovsky A."/>
<person name="Schultz D.C."/>
<person name="Wilkinson K.D."/>
<person name="Maul G.G."/>
<person name="Barlev N."/>
<person name="Berger S."/>
<person name="Prendergast G.C."/>
<person name="Rauscher F.J. III"/>
</authorList>
<dbReference type="PubMed" id="9528852"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201861"/>
</citation>
<scope>INTERACTION WITH BAP1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>VARIANTS GLY-61 AND GLY-64</scope>
<scope>MUTAGENESIS OF ARG-71</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1998" name="Oncogene" volume="17" first="2279" last="2285">
<title>Characterization of a carboxy-terminal BRCA1 interacting protein.</title>
<authorList>
<person name="Wong A.K."/>
<person name="Ormonde P.A."/>
<person name="Pero R."/>
<person name="Chen Y."/>
<person name="Lian L."/>
<person name="Salada G."/>
<person name="Berry S."/>
<person name="Lawrence Q."/>
<person name="Dayananth P."/>
<person name="Ha P."/>
<person name="Tavtigian S.V."/>
<person name="Teng D.H."/>
<person name="Bartel P.L."/>
</authorList>
<dbReference type="PubMed" id="9811458"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202150"/>
</citation>
<scope>INTERACTION WITH RBBP8</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="11364" last="11369">
<title>RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination.</title>
<authorList>
<person name="Lorick K.L."/>
<person name="Jensen J.P."/>
<person name="Fang S."/>
<person name="Ong A.M."/>
<person name="Hatakeyama S."/>
<person name="Weissman A.M."/>
</authorList>
<dbReference type="PubMed" id="10500182"/>
<dbReference type="DOI" id="10.1073/pnas.96.20.11364"/>
</citation>
<scope>FUNCTION AS AN E2-DEPENDENT UBIQUITIN-PROTEIN LIGASE</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="Genes Dev." volume="14" first="927" last="939">
<title>BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.</title>
<authorList>
<person name="Wang Y."/>
<person name="Cortez D."/>
<person name="Yazdi P."/>
<person name="Neff N."/>
<person name="Elledge S.J."/>
<person name="Qin J."/>
</authorList>
<dbReference type="PubMed" id="10783165"/>
</citation>
<scope>IDENTIFICATION IN THE BASC COMPLEX</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2000" name="Genes Dev." volume="14" first="2989" last="3002">
<title>Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.</title>
<authorList>
<person name="Tibbetts R.S."/>
<person name="Cortez D."/>
<person name="Brumbaugh K.M."/>
<person name="Scully R."/>
<person name="Livingston D."/>
<person name="Elledge S.J."/>
<person name="Abraham R.T."/>
</authorList>
<dbReference type="PubMed" id="11114888"/>
<dbReference type="DOI" id="10.1101/gad.851000"/>
</citation>
<scope>PHOSPHORYLATION AT SER-1143; SER-1280; SER-1387; THR-1394; SER-1423 AND SER-1457</scope>
<scope>MUTAGENESIS OF SER-1143; SER-1239; SER-1280; SER-1298; SER-1330; SER-1387; THR-1394; SER-1423; SER-1457; SER-1466; SER-1524 AND SER-1755</scope>
<scope>CHARACTERIZATION OF VARIANT BC ALA-1720</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="Nature" volume="404" first="201" last="204">
<title>hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response.</title>
<authorList>
<person name="Lee J.S."/>
<person name="Collins K.M."/>
<person name="Brown A.L."/>
<person name="Lee C.H."/>
<person name="Chung J.H."/>
</authorList>
<dbReference type="PubMed" id="10724175"/>
<dbReference type="DOI" id="10.1038/35004614"/>
</citation>
<scope>FUNCTION IN DNA DAMAGE RESPONSE</scope>
<scope>PHOSPHORYLATION AT SER-988 BY CHEK2</scope>
<scope>INTERACTION WITH CHEK2</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="Cell" volume="105" first="149" last="160">
<title>BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.</title>
<authorList>
<person name="Cantor S.B."/>
<person name="Bell D.W."/>
<person name="Ganesan S."/>
<person name="Kass E.M."/>
<person name="Drapkin R."/>
<person name="Grossman S."/>
<person name="Wahrer D.C.R."/>
<person name="Sgroi D.C."/>
<person name="Lane W.S."/>
<person name="Haber D.A."/>
<person name="Livingston D.M."/>
</authorList>
<dbReference type="PubMed" id="11301010"/>
<dbReference type="DOI" id="10.1016/S0092-8674(01)00304-X"/>
</citation>
<scope>INTERACTION WITH BRIP1</scope>
<scope>CHARACTERIZATION OF VARIANT OVARIAN CANCER ARG-1749</scope>
<scope>CHARACTERIZATION OF VARIANT BC ARG-1775</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="J. Cell Biol." volume="155" first="911" last="921">
<title>BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations.</title>
<authorList>
<person name="Ye Q."/>
<person name="Hu Y.-F."/>
<person name="Zhong H."/>
<person name="Nye A.C."/>
<person name="Belmont A.S."/>
<person name="Li R."/>
</authorList>
<dbReference type="PubMed" id="11739404"/>
<dbReference type="DOI" id="10.1083/jcb.200108049"/>
</citation>
<scope>INTERACTION WITH NELFB</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2001" name="Mol. Cell" volume="7" first="249" last="262">
<title>Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.</title>
<authorList>
<person name="Garcia-Higuera I."/>
<person name="Taniguchi T."/>
<person name="Ganesan S."/>
<person name="Meyn M.S."/>
<person name="Timmers C."/>
<person name="Hejna J."/>
<person name="Grompe M."/>
<person name="D'Andrea A.D."/>
</authorList>
<dbReference type="PubMed" id="11239454"/>
<dbReference type="DOI" id="10.1016/S1097-2765(01)00173-3"/>
</citation>
<scope>INTERACTION WITH FANCD2</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="Cancer Res." volume="62" first="4588" last="4591">
<title>Phosphorylation of serine 1387 in BRCA1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation.</title>
<authorList>
<person name="Xu B."/>
<person name="O'Donnell A.H."/>
<person name="Kim S.-T."/>
<person name="Kastan M.B."/>
</authorList>
<dbReference type="PubMed" id="12183412"/>
</citation>
<scope>PHOSPHORYLATION BY ATM</scope>
<scope>MUTAGENESIS OF SER-1387; SER-1423 AND SER-1524</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2002" name="Curr. Biol." volume="12" first="1846" last="1851">
<title>NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain.</title>
<authorList>
<person name="Kobayashi J."/>
<person name="Tauchi H."/>
<person name="Sakamoto S."/>
<person name="Nakamura A."/>
<person name="Morishima K."/>
<person name="Matsuura S."/>
<person name="Kobayashi T."/>
<person name="Tamai K."/>
<person name="Tanimoto K."/>
<person name="Komatsu K."/>
</authorList>
<dbReference type="PubMed" id="12419185"/>
<dbReference type="DOI" id="10.1016/S0960-9822(02)01259-9"/>
</citation>
<scope>INTERACTION WITH H2AFX</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2002" name="Genes Dev." volume="16" first="571" last="582">
<title>SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint.</title>
<authorList>
<person name="Yazdi P.T."/>
<person name="Wang Y."/>
<person name="Zhao S."/>
<person name="Patel N."/>
<person name="Lee E.Y.-H.P."/>
<person name="Qin J."/>
</authorList>
<dbReference type="PubMed" id="11877377"/>
<dbReference type="DOI" id="10.1101/gad.970702"/>
</citation>
<scope>INTERACTION WITH SMC1A</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="7849" last="7856">
<title>The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity.</title>
<authorList>
<person name="Sum E.Y."/>
<person name="Peng B."/>
<person name="Yu X."/>
<person name="Chen J."/>
<person name="Byrne J."/>
<person name="Lindeman G.J."/>
<person name="Visvader J.E."/>
</authorList>
<dbReference type="PubMed" id="11751867"/>
<dbReference type="DOI" id="10.1074/jbc.M110603200"/>
</citation>
<scope>INTERACTION WITH LMO4</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2002" name="Nat. Genet." volume="30" first="285" last="289">
<title>BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage.</title>
<authorList>
<person name="Yarden R.I."/>
<person name="Pardo-Reoyo S."/>
<person name="Sgagias M."/>
<person name="Cowan K.H."/>
<person name="Brody L.C."/>
</authorList>
<dbReference type="PubMed" id="11836499"/>
<dbReference type="DOI" id="10.1038/ng837"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CHEK1</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="6729" last="6739">
<title>BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains.</title>
<authorList>
<person name="Magnard C."/>
<person name="Bachelier R."/>
<person name="Vincent A."/>
<person name="Jaquinod M."/>
<person name="Kieffer S."/>
<person name="Lenoir G.M."/>
<person name="Venezia N.D."/>
</authorList>
<dbReference type="PubMed" id="12360400"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205915"/>
</citation>
<scope>INTERACTION WITH ACACA</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="34743" last="34746">
<title>The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin.</title>
<authorList>
<person name="Wu-Baer F."/>
<person name="Lagrazon K."/>
<person name="Yuan W."/>
<person name="Baer R."/>
</authorList>
<dbReference type="PubMed" id="12890688"/>
<dbReference type="DOI" id="10.1074/jbc.C300249200"/>
</citation>
<scope>FUNCTION</scope>
<scope>UBIQUITINATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH BARD1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2003" name="Mol. Cell" volume="12" first="247" last="254">
<title>BRCA1-independent ubiquitination of FANCD2.</title>
<authorList>
<person name="Vandenberg C.J."/>
<person name="Gergely F."/>
<person name="Ong C.Y."/>
<person name="Pace P."/>
<person name="Mallery D.L."/>
<person name="Hiom K."/>
<person name="Patel K.J."/>
</authorList>
<dbReference type="PubMed" id="12887909"/>
<dbReference type="DOI" id="10.1016/S1097-2765(03)00281-8"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2003" name="Mol. Cell" volume="12" first="1087" last="1099">
<title>Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair.</title>
<authorList>
<person name="Dong Y."/>
<person name="Hakimi M.-A."/>
<person name="Chen X."/>
<person name="Kumaraswamy E."/>
<person name="Cooch N.S."/>
<person name="Godwin A.K."/>
<person name="Shiekhattar R."/>
</authorList>
<dbReference type="PubMed" id="14636569"/>
<dbReference type="DOI" id="10.1016/S1097-2765(03)00424-6"/>
</citation>
<scope>INTERACTION WITH BRCC3</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2004" name="Hum. Mol. Genet." volume="13" first="807" last="817">
<title>BRCA1:BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair.</title>
<authorList>
<person name="Morris J.R."/>
<person name="Solomon E."/>
</authorList>
<dbReference type="PubMed" id="14976165"/>
<dbReference type="DOI" id="10.1093/hmg/ddh095"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BARD1</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="19643" last="19648">
<title>BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition.</title>
<authorList>
<person name="Ouchi M."/>
<person name="Fujiuchi N."/>
<person name="Sasai K."/>
<person name="Katayama H."/>
<person name="Minamishima Y.A."/>
<person name="Ongusaha P.P."/>
<person name="Deng C."/>
<person name="Sen S."/>
<person name="Lee S.W."/>
<person name="Ouchi T."/>
</authorList>
<dbReference type="PubMed" id="14990569"/>
<dbReference type="DOI" id="10.1074/jbc.M311780200"/>
</citation>
<scope>INTERACTION WITH AURKA</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF SER-308</scope>
<scope>PHOSPHORYLATION AT SER-308</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="9207" last="9220">
<title>Artemis is a phosphorylation target of ATM and ATR and is involved in the G2/M DNA damage checkpoint response.</title>
<authorList>
<person name="Zhang X."/>
<person name="Succi J."/>
<person name="Feng Z."/>
<person name="Prithivirajsingh S."/>
<person name="Story M.D."/>
<person name="Legerski R.J."/>
</authorList>
<dbReference type="PubMed" id="15456891"/>
<dbReference type="DOI" id="10.1128/MCB.24.20.9207-9220.2004"/>
</citation>
<scope>INTERACTION WITH DCLRE1C</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="6484" last="6489">
<title>Human claspin works with BRCA1 to both positively and negatively regulate cell proliferation.</title>
<authorList>
<person name="Lin S.-Y."/>
<person name="Li K."/>
<person name="Stewart G.S."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="15096610"/>
<dbReference type="DOI" id="10.1073/pnas.0401847101"/>
</citation>
<scope>INTERACTION WITH CLSPN</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1336</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2006" name="Genes Dev." volume="20" first="1721" last="1726">
<title>BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP.</title>
<authorList>
<person name="Yu X."/>
<person name="Fu S."/>
<person name="Lai M."/>
<person name="Baer R."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="16818604"/>
<dbReference type="DOI" id="10.1101/gad.1431006"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH RBBP8</scope>
<scope>MUTAGENESIS OF ILE-26</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="3172" last="3181">
<title>BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase.</title>
<authorList>
<person name="Moreau K."/>
<person name="Dizin E."/>
<person name="Ray H."/>
<person name="Luquain C."/>
<person name="Lefai E."/>
<person name="Foufelle F."/>
<person name="Billaud M."/>
<person name="Lenoir G.M."/>
<person name="Venezia N.D."/>
</authorList>
<dbReference type="PubMed" id="16326698"/>
<dbReference type="DOI" id="10.1074/jbc.M504652200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ACACA</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2006" name="J. Mol. Biol." volume="359" first="973" last="982">
<title>ACCA phosphopeptide recognition by the BRCT repeats of BRCA1.</title>
<authorList>
<person name="Ray H."/>
<person name="Moreau K."/>
<person name="Dizin E."/>
<person name="Callebaut I."/>
<person name="Venezia N.D."/>
</authorList>
<dbReference type="PubMed" id="16698035"/>
<dbReference type="DOI" id="10.1016/j.jmb.2006.04.010"/>
</citation>
<scope>INTERACTION WITH ACACA</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="11186" last="11194">
<title>Aurora-A kinase regulates breast cancer associated gene 1 inhibition of centrosome-dependent microtubule nucleation.</title>
<authorList>
<person name="Sankaran S."/>
<person name="Crone D.E."/>
<person name="Palazzo R.E."/>
<person name="Parvin J.D."/>
</authorList>
<dbReference type="PubMed" id="18056443"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-07-2578"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PHOSPHORYLATION BY AURKA</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2007" name="Nat. Struct. Mol. Biol." volume="14" first="710" last="715">
<title>CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response.</title>
<authorList>
<person name="Kim H."/>
<person name="Huang J."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="17643122"/>
<dbReference type="DOI" id="10.1038/nsmb1277"/>
</citation>
<scope>INTERACTION WITH ABRAXAS1</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2007" name="Nat. Struct. Mol. Biol." volume="14" first="716" last="720">
<title>CCDC98 targets BRCA1 to DNA damage sites.</title>
<authorList>
<person name="Liu Z."/>
<person name="Wu J."/>
<person name="Yu X."/>
</authorList>
<dbReference type="PubMed" id="17643121"/>
<dbReference type="DOI" id="10.1038/nsmb1279"/>
</citation>
<scope>INTERACTION WITH ABRAXAS1</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2007" name="Science" volume="316" first="1194" last="1198">
<title>Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response.</title>
<authorList>
<person name="Wang B."/>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Zhang D."/>
<person name="Smogorzewska A."/>
<person name="Giyi S."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525340"/>
<dbReference type="DOI" id="10.1126/science.1139476"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ABRAXAS1</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2008" name="Hum. Genet." volume="124" first="271" last="278">
<title>Germline BRCA1 mutations predispose to pancreatic adenocarcinoma.</title>
<authorList>
<person name="Al-Sukhni W."/>
<person name="Rothenmund H."/>
<person name="Borgida A.E."/>
<person name="Zogopoulos G."/>
<person name="O'Shea A.M."/>
<person name="Pollett A."/>
<person name="Gallinger S."/>
</authorList>
<dbReference type="PubMed" id="18762988"/>
<dbReference type="DOI" id="10.1007/s00439-008-0554-0"/>
</citation>
<scope>INVOLVEMENT IN PNCA4</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-395; SER-398; SER-753; SER-1211; SER-1217 AND SER-1218</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="45">
<citation type="journal article" date="2009" name="Genes Dev." volume="23" first="719" last="728">
<title>MERIT40 facilitates BRCA1 localization and DNA damage repair.</title>
<authorList>
<person name="Feng L."/>
<person name="Huang J."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="19261748"/>
<dbReference type="DOI" id="10.1101/gad.1770609"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE BRCA1-A COMPLEX</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2009" name="Genes Dev." volume="23" first="729" last="739">
<title>NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control.</title>
<authorList>
<person name="Wang B."/>
<person name="Hurov K."/>
<person name="Hofmann K."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="19261749"/>
<dbReference type="DOI" id="10.1101/gad.1770309"/>
</citation>
<scope>IDENTIFICATION IN THE BRCA1-A COMPLEX</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2009" name="Genes Dev." volume="23" first="740" last="754">
<title>MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks.</title>
<authorList>
<person name="Shao G."/>
<person name="Patterson-Fortin J."/>
<person name="Messick T.E."/>
<person name="Feng D."/>
<person name="Shanbhag N."/>
<person name="Wang Y."/>
<person name="Greenberg R.A."/>
</authorList>
<dbReference type="PubMed" id="19261746"/>
<dbReference type="DOI" id="10.1101/gad.1739609"/>
</citation>
<scope>IDENTIFICATION IN THE BRCA1-A COMPLEX</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="7155" last="7160">
<title>PALB2 is an integral component of the BRCA complex required for homologous recombination repair.</title>
<authorList>
<person name="Sy S.M."/>
<person name="Huen M.S."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="19369211"/>
<dbReference type="DOI" id="10.1073/pnas.0811159106"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PALB2</scope>
<scope>IDENTIFICATION IN A BRCA COMPLEX WITH BRCA1 AND PALB2</scope>
<scope>CHARACTERIZATION OF VARIANT OVARIAN CANCER 1411-THR</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-395 AND SER-398</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="50">
<citation type="journal article" date="2010" name="Br. J. Cancer" volume="102" first="1061" last="1067">
<title>Identification of DBC1 as a transcriptional repressor for BRCA1.</title>
<authorList>
<person name="Hiraike H."/>
<person name="Wada-Hiraike O."/>
<person name="Nakagawa S."/>
<person name="Koyama S."/>
<person name="Miyamoto Y."/>
<person name="Sone K."/>
<person name="Tanikawa M."/>
<person name="Tsuruga T."/>
<person name="Nagasaka K."/>
<person name="Matsumoto Y."/>
<person name="Oda K."/>
<person name="Shoji K."/>
<person name="Fukuhara H."/>
<person name="Saji S."/>
<person name="Nakagawa K."/>
<person name="Kato S."/>
<person name="Yano T."/>
<person name="Taketani Y."/>
</authorList>
<dbReference type="PubMed" id="20160719"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6605577"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CCAR2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="2787" last="2798">
<title>The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.</title>
<authorList>
<person name="Wu-Baer F."/>
<person name="Ludwig T."/>
<person name="Baer R."/>
</authorList>
<dbReference type="PubMed" id="20351172"/>
<dbReference type="DOI" id="10.1128/MCB.01056-09"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH BARD1 AND UBXN1</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF ILE-26</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2010" name="Nat. Cell Biol." volume="12" first="492" last="499">
<title>The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells.</title>
<authorList>
<person name="Stolz A."/>
<person name="Ertych N."/>
<person name="Kienitz A."/>
<person name="Vogel C."/>
<person name="Schneider V."/>
<person name="Fritz B."/>
<person name="Jacob R."/>
<person name="Dittmar G."/>
<person name="Weichert W."/>
<person name="Petersen I."/>
<person name="Bastians H."/>
</authorList>
<dbReference type="PubMed" id="20364141"/>
<dbReference type="DOI" id="10.1038/ncb2051"/>
</citation>
<scope>FUNCTION IN CHROMOSOMAL STABILITY</scope>
<scope>PHOSPHORYLATION AT SER-988 BY CHEK2</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114; SER-423; SER-694; SER-1328; SER-1336 AND SER-1342</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="54">
<citation type="journal article" date="2011" name="Biochem. Biophys. Res. Commun." volume="404" first="476" last="481">
<title>Protein phosphatase 5 is necessary for ATR-mediated DNA repair.</title>
<authorList>
<person name="Kang Y."/>
<person name="Cheong H.M."/>
<person name="Lee J.H."/>
<person name="Song P.I."/>
<person name="Lee K.H."/>
<person name="Kim S.Y."/>
<person name="Jun J.Y."/>
<person name="You H.J."/>
</authorList>
<dbReference type="PubMed" id="21144835"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.12.005"/>
</citation>
<scope>PHOSPHORYLATION AT SER-1524</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2011" name="Mol. Cancer Res." volume="9" first="1091" last="1099">
<title>KIAA0101 interacts with BRCA1 and regulates centrosome number.</title>
<authorList>
<person name="Kais Z."/>
<person name="Barsky S.H."/>
<person name="Mathsyaraja H."/>
<person name="Zha A."/>
<person name="Ransburgh D.J."/>
<person name="He G."/>
<person name="Pilarski R.T."/>
<person name="Shapiro C.L."/>
<person name="Huang K."/>
<person name="Parvin J.D."/>
</authorList>
<dbReference type="PubMed" id="21673012"/>
<dbReference type="DOI" id="10.1158/1541-7786.MCR-10-0503"/>
</citation>
<scope>INTERACTION WITH PCLAF</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114; SER-1218; SER-1336 AND SER-1342</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114; SER-434; SER-551; SER-694; SER-708; SER-1009; SER-1189; SER-1191 AND SER-1542</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="59">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-339; LYS-459; LYS-583; LYS-654; LYS-734 AND LYS-739</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.O114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-339; LYS-443 AND LYS-583</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2016" name="Nat. Cell Biol." volume="18" first="271" last="280">
<title>EXD2 promotes homologous recombination by facilitating DNA end resection.</title>
<authorList>
<person name="Broderick R."/>
<person name="Nieminuszczy J."/>
<person name="Baddock H.T."/>
<person name="Deshpande R.A."/>
<person name="Gileadi O."/>
<person name="Paull T.T."/>
<person name="McHugh P.J."/>
<person name="Niedzwiedz W."/>
</authorList>
<dbReference type="PubMed" id="26807646"/>
<dbReference type="DOI" id="10.1038/ncb3303"/>
</citation>
<scope>INTERACTION WITH EXD2</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-109; LYS-301; LYS-339; LYS-443; LYS-459; LYS-519; LYS-583; LYS-918; LYS-987 AND LYS-1079</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2017" name="Oncogene" volume="36" first="4161" last="4170">
<title>Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.</title>
<authorList>
<person name="Foo T.K."/>
<person name="Tischkowitz M."/>
<person name="Simhadri S."/>
<person name="Boshari T."/>
<person name="Zayed N."/>
<person name="Burke K.A."/>
<person name="Berman S.H."/>
<person name="Blecua P."/>
<person name="Riaz N."/>
<person name="Huo Y."/>
<person name="Ding Y.C."/>
<person name="Neuhausen S.L."/>
<person name="Weigelt B."/>
<person name="Reis-Filho J.S."/>
<person name="Foulkes W.D."/>
<person name="Xia B."/>
</authorList>
<dbReference type="PubMed" id="28319063"/>
<dbReference type="DOI" id="10.1038/onc.2017.46"/>
</citation>
<scope>INTERACTION WITH PALB2</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2001" name="Nat. Struct. Biol." volume="8" first="833" last="837">
<title>Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.</title>
<authorList>
<person name="Brzovic P.S."/>
<person name="Rajagopal P."/>
<person name="Hoyt D.W."/>
<person name="King M.C."/>
<person name="Klevit R.E."/>
</authorList>
<dbReference type="PubMed" id="11573085"/>
<dbReference type="DOI" id="10.1038/nsb1001-833"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-110 IN COMPLEX WITH ZINC IONS AND BARD1</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2001" name="Nat. Struct. Biol." volume="8" first="838" last="842">
<title>Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.</title>
<authorList>
<person name="Williams R.S."/>
<person name="Green R."/>
<person name="Glover J.N."/>
</authorList>
<dbReference type="PubMed" id="11573086"/>
<dbReference type="DOI" id="10.1038/nsb1001-838"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1646-1859</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="2630" last="2635">
<title>Structural consequences of a cancer-causing BRCA1-BRCT missense mutation.</title>
<authorList>
<person name="Williams R.S."/>
<person name="Glover J.N."/>
</authorList>
<dbReference type="PubMed" id="12427738"/>
<dbReference type="DOI" id="10.1074/jbc.M210019200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1646-1859 OF VARIANT BC ARG-1775</scope>
<scope>CHARACTERIZATION OF VARIANT BC ARG-1775</scope>
<scope>CIRCULAR DICHROISM</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2004" name="Biochemistry" volume="43" first="15983" last="15995">
<title>Solution structure, backbone dynamics, and association behavior of the C-terminal BRCT domain from the breast cancer-associated protein BRCA1.</title>
<authorList>
<person name="Gaiser O.J."/>
<person name="Ball L.J."/>
<person name="Schmieder P."/>
<person name="Leitner D."/>
<person name="Strauss H."/>
<person name="Wahl M."/>
<person name="Kuhne R."/>
<person name="Oschkinat H."/>
<person name="Heinemann U."/>
</authorList>
<dbReference type="PubMed" id="15609993"/>
<dbReference type="DOI" id="10.1021/bi049550q"/>
</citation>
<scope>STRUCTURE BY NMR OF 1755-1863</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2004" name="Nat. Struct. Mol. Biol." volume="11" first="512" last="518">
<title>Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.</title>
<authorList>
<person name="Clapperton J.A."/>
<person name="Manke I.A."/>
<person name="Lowery D.M."/>
<person name="Ho T."/>
<person name="Haire L.F."/>
<person name="Yaffe M.B."/>
<person name="Smerdon S.J."/>
</authorList>
<dbReference type="PubMed" id="15133502"/>
<dbReference type="DOI" id="10.1038/nsmb775"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 1649-1859 IN COMPLEX WITH WITH PHOSPHORYLATED BRIP1 PEPTIDE</scope>
<scope>MUTAGENESIS OF SER-1655; LYS-1702 AND GLY-1738</scope>
<scope>CHARACTERIZATION OF VARIANT OVARIAN CANCER ARG-1749</scope>
<scope>CHARACTERIZATION OF VARIANT BC ARG-1775</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PHOSPHORYLATED BRIP1</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2005" name="Biochemistry" volume="44" first="10941" last="10946">
<title>Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex.</title>
<authorList>
<person name="Varma A.K."/>
<person name="Brown R.S."/>
<person name="Birrane G."/>
<person name="Ladias J.A."/>
</authorList>
<dbReference type="PubMed" id="16101277"/>
<dbReference type="DOI" id="10.1021/bi0509651"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1646-1859 IN COMPLEX WITH PHOSPHORYLATED RBBP8 PEPTIDE</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2008" name="Biochemistry" volume="47" first="5767" last="5773">
<title>Structural evidence for direct interactions between the BRCT domains of human BRCA1 and a phospho-peptide from human ACC1.</title>
<authorList>
<person name="Shen Y."/>
<person name="Tong L."/>
</authorList>
<dbReference type="PubMed" id="18452305"/>
<dbReference type="DOI" id="10.1021/bi800314m"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.21 ANGSTROMS) OF 1646-1859 IN COMPLEX WITH PHOSPHORYLATED ACACA PEPTIDE</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2008" name="Eur. J. Hum. Genet." volume="16" first="820" last="832">
<title>Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.</title>
<authorList>
<person name="Tischkowitz M."/>
<person name="Hamel N."/>
<person name="Carvalho M.A."/>
<person name="Birrane G."/>
<person name="Soni A."/>
<person name="van Beers E.H."/>
<person name="Joosse S.A."/>
<person name="Wong N."/>
<person name="Novak D."/>
<person name="Quenneville L.A."/>
<person name="Grist S.A."/>
<person name="Nederlof P.M."/>
<person name="Goldgar D.E."/>
<person name="Tavtigian S.V."/>
<person name="Monteiro A.N."/>
<person name="Ladias J.A."/>
<person name="Foulkes W.D."/>
</authorList>
<dbReference type="PubMed" id="18285836"/>
<dbReference type="DOI" id="10.1038/ejhg.2008.13"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.6 ANGSTROMS) OF 1649-1859 OF VARIANT BC LYS-1775</scope>
<scope>VARIANT BC LYS-1775</scope>
<scope>CHARACTERIZATION OF VARIANT BC LYS-1775</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2010" name="Structure" volume="18" first="167" last="176">
<title>Comparison of the structures and peptide binding specificities of the BRCT domains of MDC1 and BRCA1.</title>
<authorList>
<person name="Campbell S.J."/>
<person name="Edwards R.A."/>
<person name="Glover J.N."/>
</authorList>
<dbReference type="PubMed" id="20159462"/>
<dbReference type="DOI" id="10.1016/j.str.2009.12.008"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 1646-1859 IN COMPLEX WITH PHOSPHORYLATED PEPTIDES</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2011" name="Biochemistry" volume="50" first="4579" last="4589">
<title>Impact of BRCA1 BRCT domain missense substitutions on phosphopeptide recognition.</title>
<authorList>
<person name="Coquelle N."/>
<person name="Green R."/>
<person name="Glover J.N."/>
</authorList>
<dbReference type="PubMed" id="21473589"/>
<dbReference type="DOI" id="10.1021/bi2003795"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 1646-1859 IN COMPLEX WITH PHOSPHORYLATED BRIP1 PEPTIDE</scope>
<scope>INTERACTION WITH BRIP1</scope>
<scope>MUTAGENESIS OF GLY-1656; THR-1700; ARG-1835 AND GLU-1836</scope>
<scope>CHARACTERIZATION OF VARIANTS BC GLN-1699 AND TRP-1699</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2013" name="Acta Crystallogr. F" volume="69" first="1401" last="1404">
<title>Preliminary crystallographic studies of BRCA1 BRCT-ABRAXAS complex.</title>
<authorList>
<person name="Badgujar D.C."/>
<person name="Sawant U."/>
<person name="Vikrant X."/>
<person name="Yadav L."/>
<person name="Hosur M.V."/>
<person name="Varma A.K."/>
</authorList>
<dbReference type="PubMed" id="24316840"/>
<dbReference type="DOI" id="10.1107/S1744309113030649"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.50 ANGSTROMS) OF 1649-1859 IN COMPLEX WITH ABRAXAS1</scope>
<scope>INTERACTION WITH ABRAXAS1</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2016" name="Mol. Cell" volume="61" first="434" last="448">
<title>Structure of BRCA1-BRCT/Abraxas complex reveals phosphorylation-dependent BRCT dimerization at DNA damage sites.</title>
<authorList>
<person name="Wu Q."/>
<person name="Paul A."/>
<person name="Su D."/>
<person name="Mehmood S."/>
<person name="Foo T.K."/>
<person name="Ochi T."/>
<person name="Bunting E.L."/>
<person name="Xia B."/>
<person name="Robinson C.V."/>
<person name="Wang B."/>
<person name="Blundell T.L."/>
</authorList>
<dbReference type="PubMed" id="26778126"/>
<dbReference type="DOI" id="10.1016/j.molcel.2015.12.017"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 1646-1859 IN COMPLEX WITH ABRAXAS1</scope>
<scope>INTERACTION WITH ABRAXAS1</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF PHE-1662; MET-1663; TYR-1666; ARG-1670 AND LYS-1671</scope>
</reference>
<reference key="76">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="8" first="8" last="18">
<title>Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene.</title>
<authorList>
<person name="Couch F.J."/>
<person name="Weber B.L."/>
</authorList>
<dbReference type="PubMed" id="8807330"/>
<dbReference type="DOI" id="10.1002/humu.1380080102"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="77">
<citation type="journal article" date="1994" name="Science" volume="266" first="120" last="122">
<title>BRCA1 mutations in primary breast and ovarian carcinomas.</title>
<authorList>
<person name="Futreal P.A."/>
<person name="Liu Q."/>
<person name="Shattuck-Eidens D."/>
<person name="Cochran C."/>
<person name="Harshman K."/>
<person name="Tavtigian S."/>
<person name="Bennett L.M."/>
<person name="Haugen-Strano A."/>
<person name="Swensen J."/>
<person name="Miki Y."/>
<person name="Eddington K."/>
<person name="McClure M."/>
<person name="Frye C."/>
<person name="Weaver-Felhaus J."/>
<person name="Ding W."/>
<person name="Gholami Z."/>
<person name="Soederkvist P."/>
<person name="Terry L."/>
<person name="Jhanwar S."/>
<person name="Berchuk A."/>
<person name="Iglehart J.D."/>
<person name="Marks J."/>
<person name="Ballinger D.G."/>
<person name="Barrett J.C."/>
<person name="Skolnick M.H."/>
<person name="Kamb A."/>
<person name="Wiseman R."/>
</authorList>
<dbReference type="PubMed" id="7939630"/>
<dbReference type="DOI" id="10.1126/science.7939630"/>
</citation>
<scope>VARIANT BC ARG-1775</scope>
<scope>VARIANTS LEU-1637 AND GLU-1708</scope>
</reference>
<reference key="78">
<citation type="journal article" date="1994" name="Nat. Genet." volume="8" first="387" last="391">
<title>Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer.</title>
<authorList>
<person name="Castilla L.H."/>
<person name="Couch F.J."/>
<person name="Erdos M.R."/>
<person name="Hoskins K.F."/>
<person name="Calzone K."/>
<person name="Garber J.E."/>
<person name="Boyd J."/>
<person name="Lubin M.B."/>
<person name="Deshano M.L."/>
<person name="Brody L.C."/>
<person name="Collins F.S."/>
<person name="Weber B.L."/>
</authorList>
<dbReference type="PubMed" id="7894491"/>
<dbReference type="DOI" id="10.1038/ng1294-387"/>
</citation>
<scope>VARIANT BC GLY-64</scope>
<scope>VARIANTS ALA-772; ASN-1040 AND GLY-1443</scope>
</reference>
<reference key="79">
<citation type="journal article" date="1994" name="Nat. Genet." volume="8" first="399" last="404">
<title>Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.</title>
<authorList>
<person name="Friedman L.S."/>
<person name="Ostermeyer E.A."/>
<person name="Szabo C.I."/>
<person name="Dowd P."/>
<person name="Lynch E.D."/>
<person name="Rowell S.E."/>
<person name="King M.-C."/>
</authorList>
<dbReference type="PubMed" id="7894493"/>
<dbReference type="DOI" id="10.1038/ng1294-399"/>
</citation>
<scope>VARIANT BC GLY-61</scope>
<scope>VARIANTS ARG-356; GLY-1038; ASN-1040; ARG-1183 AND GLY-1613</scope>
</reference>
<reference key="80">
<citation type="journal article" date="1996" name="Am. J. Hum. Genet." volume="58" first="42" last="51">
<title>A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.</title>
<authorList>
<person name="Serova O."/>
<person name="Montagna M."/>
<person name="Torchard D."/>
<person name="Narod S.A."/>
<person name="Tonin P."/>
<person name="Sylla B."/>
<person name="Lynch H.T."/>
<person name="Feunteun J."/>
<person name="Lenoir G.M."/>
</authorList>
<dbReference type="PubMed" id="8554067"/>
</citation>
<scope>VARIANT BC GLY-61</scope>
</reference>
<reference key="81">
<citation type="journal article" date="1996" name="Genet. Epidemiol." volume="13" first="595" last="604">
<title>BRCA1 R841W: a strong candidate for a common mutation with moderate phenotype.</title>
<authorList>
<person name="Barker D.F."/>
<person name="Almeida E.F.A."/>
<person name="Casey G."/>
<person name="Fain P.R."/>
<person name="Liao S.-Y."/>
<person name="Masunaka I."/>
<person name="Noble B."/>
<person name="Kurosaki T."/>
<person name="Anton-Culver H."/>
</authorList>
<dbReference type="PubMed" id="8968716"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-2272(1996)13:6&lt;595::AID-GEPI5>3.3.CO;2-0"/>
</citation>
<scope>VARIANT BROVCA1 TRP-841</scope>
</reference>
<reference key="82">
<citation type="journal article" date="1996" name="Hum. Mol. Genet." volume="5" first="835" last="842">
<title>Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations.</title>
<authorList>
<person name="Durocher F."/>
<person name="Shattuck-Eidens D."/>
<person name="McClure M."/>
<person name="Labrie F."/>
<person name="Skolnick M.H."/>
<person name="Goldgar D.E."/>
<person name="Simard J."/>
</authorList>
<dbReference type="PubMed" id="8776600"/>
<dbReference type="DOI" id="10.1093/hmg/5.6.835"/>
</citation>
<scope>VARIANTS BC AND BROVCA1</scope>
</reference>
<reference key="83">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="7" first="334" last="339">
<title>Mutations in the BRCA1 gene in Japanese breast cancer patients.</title>
<authorList>
<person name="Katagiri T."/>
<person name="Emi M."/>
<person name="Ito I."/>
<person name="Kobayashi K."/>
<person name="Yoshimoto M."/>
<person name="Iwase T."/>
<person name="Kasumi F."/>
<person name="Miki Y."/>
<person name="Skolnick M.H."/>
<person name="Nakamura Y."/>
</authorList>
<dbReference type="PubMed" id="8723683"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)7:4&lt;334::AID-HUMU7>3.3.CO;2-K"/>
</citation>
<scope>VARIANTS BC MET-271 AND SER-1150</scope>
</reference>
<reference key="84">
<citation type="journal article" date="1998" name="Hum. Genet." volume="103" first="154" last="161">
<title>A high proportion of mutations in the BRCA1 gene in German breast/ovarian cancer families with clustering of mutations in the 3' third of the gene.</title>
<authorList>
<person name="Dong J."/>
<person name="Chang-Claude J."/>
<person name="Wu Y."/>
<person name="Schumacher V."/>
<person name="Debatin I."/>
<person name="Tonin P."/>
<person name="Royer-Pokora B."/>
</authorList>
<dbReference type="PubMed" id="9760198"/>
<dbReference type="DOI" id="10.1007/s004390050799"/>
</citation>
<scope>VARIANT BC GLY-61</scope>
<scope>VARIANTS ARG-239; TRP-841 AND ILE-1512</scope>
</reference>
<reference key="85">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="11" first="166" last="174">
<title>Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening.</title>
<authorList>
<person name="Andersen T.I."/>
<person name="Eiken H.G."/>
<person name="Couch F."/>
<person name="Kaada G."/>
<person name="Skrede M."/>
<person name="Johnsen H."/>
<person name="Aloysius T.A."/>
<person name="Tveit K.M."/>
<person name="Tranebjaerg L."/>
<person name="Doerum A."/>
<person name="Moeller P."/>
<person name="Weber B.L."/>
<person name="Boerresen-Dale A.-L."/>
</authorList>
<dbReference type="PubMed" id="9482581"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1998)11:2&lt;166::AID-HUMU10>3.0.CO;2-X"/>
</citation>
<scope>VARIANT BC GLY-64</scope>
<scope>VARIANTS ALA-772; GLU-820; ASN-1040; GLY-1443; ILE-1512; LEU-1637 AND ILE-1652</scope>
</reference>
<reference key="86">
<citation type="journal article" date="1998" name="J. Hum. Genet." volume="43" first="42" last="48">
<title>High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families.</title>
<authorList>
<person name="Katagiri T."/>
<person name="Kasumi F."/>
<person name="Yoshimoto M."/>
<person name="Nomizu T."/>
<person name="Asaishi K."/>
<person name="Abe R."/>
<person name="Tsuchiya A."/>
<person name="Sugano M."/>
<person name="Takai S."/>
<person name="Yoneda M."/>
<person name="Fukutomi T."/>
<person name="Nanba K."/>
<person name="Makita M."/>
<person name="Okazaki H."/>
<person name="Hirata K."/>
<person name="Okazaki M."/>
<person name="Furutsuma Y."/>
<person name="Morishita Y."/>
<person name="Iino Y."/>
<person name="Karino T."/>
<person name="Ayabe H."/>
<person name="Hara S."/>
<person name="Kajiwara T."/>
<person name="Houga S."/>
<person name="Shimizu T."/>
<person name="Toda M."/>
<person name="Yamazaki Y."/>
<person name="Uchida T."/>
<person name="Kunitomo K."/>
<person name="Sonoo H."/>
<person name="Kurebayashi J."/>
<person name="Shimotsuma K."/>
<person name="Nakamura Y."/>
<person name="Miki Y."/>
</authorList>
<dbReference type="PubMed" id="9609997"/>
<dbReference type="DOI" id="10.1007/s100380050035"/>
</citation>
<scope>VARIANTS BC SER-22; LEU-461; ASP-465; VAL-552; SER-892; ASP-960; ILE-1025 AND ALA-1047</scope>
</reference>
<reference key="87">
<citation type="journal article" date="1999" name="Am. J. Hum. Genet." volume="65" first="1021" last="1029">
<title>The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.</title>
<authorList>
<person name="Gayther S.A."/>
<person name="Russell P."/>
<person name="Harrington P."/>
<person name="Antoniou A.C."/>
<person name="Easton D.F."/>
<person name="Ponder B.A.J."/>
</authorList>
<dbReference type="PubMed" id="10486320"/>
<dbReference type="DOI" id="10.1086/302583"/>
</citation>
<scope>VARIANT OVARIAN CANCER ARG-1749</scope>
</reference>
<reference key="88">
<citation type="journal article" date="1999" name="Hum. Genet." volume="104" first="201" last="204">
<title>Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan.</title>
<authorList>
<person name="Li S.S.-L."/>
<person name="Tseng H.-M."/>
<person name="Yang T.-P."/>
<person name="Liu C.-H."/>
<person name="Teng S.-J."/>
<person name="Huang H.-W."/>
<person name="Chen L.-M."/>
<person name="Kao H.-W."/>
<person name="Chen J.H."/>
<person name="Tseng J.-N."/>
<person name="Chen A."/>
<person name="Hou M.-F."/>
<person name="Huang T.-J."/>
<person name="Chang H.-T."/>
<person name="Mok K.-T."/>
<person name="Tsai J.-H."/>
</authorList>
<dbReference type="PubMed" id="10323242"/>
<dbReference type="DOI" id="10.1007/s004390050936"/>
</citation>
<scope>VARIANT BC SER-346</scope>
<scope>VARIANTS LEU-871; GLY-1038; ARG-1183 AND GLY-1613</scope>
</reference>
<reference key="89">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="889" last="897">
<title>Germline BRCA1 alterations in a population-based series of ovarian cancer cases.</title>
<authorList>
<person name="Janezic S.A."/>
<person name="Ziogas A."/>
<person name="Krumroy L.M."/>
<person name="Krasner M."/>
<person name="Plummer S.J."/>
<person name="Cohen P."/>
<person name="Gildea M."/>
<person name="Barker D."/>
<person name="Haile R."/>
<person name="Casey G."/>
<person name="Anton-Culver H."/>
</authorList>
<dbReference type="PubMed" id="10196379"/>
<dbReference type="DOI" id="10.1093/hmg/8.5.889"/>
</citation>
<scope>VARIANTS OVARIAN CANCER</scope>
<scope>VARIANTS</scope>
</reference>
<reference key="90">
<citation type="journal article" date="2002" name="Genet. Test." volume="6" first="119" last="121">
<title>Characterization of common BRCA1 and BRCA2 variants.</title>
<authorList>
<person name="Deffenbaugh A.M."/>
<person name="Frank T.S."/>
<person name="Hoffman M."/>
<person name="Cannon-Albright L."/>
<person name="Neuhausen S.L."/>
</authorList>
<dbReference type="PubMed" id="12215251"/>
<dbReference type="DOI" id="10.1089/10906570260199375"/>
</citation>
<scope>VARIANTS GLY-1347; ILE-1512 AND ILE-1652</scope>
</reference>
<reference key="91">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="20" first="474" last="474">
<title>BRCA1 and BRCA2 sequence variants in Chinese breast cancer families.</title>
<authorList>
<person name="Zhi X."/>
<person name="Szabo C."/>
<person name="Chopin S."/>
<person name="Suter N."/>
<person name="Wang Q.-S."/>
<person name="Ostrander E.A."/>
<person name="Sinilnikova O.M."/>
<person name="Lenoir G.M."/>
<person name="Goldgar D."/>
<person name="Shi Y.-R."/>
</authorList>
<dbReference type="PubMed" id="12442274"/>
<dbReference type="DOI" id="10.1002/humu.9083"/>
</citation>
<scope>VARIANTS ILE-656; LEU-871 AND GLY-1613</scope>
</reference>
<reference key="92">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="20" first="474" last="475">
<title>BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico.</title>
<authorList>
<person name="Ruiz-Flores P."/>
<person name="Sinilnikova O.M."/>
<person name="Badzioch M."/>
<person name="Calderon-Garciduenas A.L."/>
<person name="Chopin S."/>
<person name="Fabrice O."/>
<person name="Gonzalez-Guerrero J.F."/>
<person name="Szabo C."/>
<person name="Lenoir G."/>
<person name="Goldgar D.E."/>
<person name="Barrera-Saldana H.A."/>
</authorList>
<dbReference type="PubMed" id="12442275"/>
<dbReference type="DOI" id="10.1002/humu.9084"/>
</citation>
<scope>VARIANT BC TYR-749</scope>
</reference>
<reference key="93">
<citation type="journal article" date="2003" name="Hum. Mutat." volume="22" first="259" last="259">
<title>Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.</title>
<authorList>
<person name="Meyer P."/>
<person name="Voigtlaender T."/>
<person name="Bartram C.R."/>
<person name="Klaes R."/>
</authorList>
<dbReference type="PubMed" id="12938098"/>
<dbReference type="DOI" id="10.1002/humu.9174"/>
</citation>
<scope>VARIANTS BC GLY-61; LYS-71; GLN-866; TYR-888; ILE-1139; GLY-1210 AND PRO-1297</scope>
<scope>VARIANTS BROVCA1 TYR-835 AND PRO-1786</scope>
</reference>
<reference key="94">
<citation type="journal article" date="2004" name="Br. J. Cancer" volume="90" first="1244" last="1251">
<title>BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families.</title>
<authorList>
<person name="Claes K."/>
<person name="Poppe B."/>
<person name="Coene I."/>
<person name="De Paepe A."/>
<person name="Messiaen L."/>
</authorList>
<dbReference type="PubMed" id="15026808"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6601656"/>
</citation>
<scope>VARIANTS ASN-693; ASN-1040; ALA-1060 AND MET-1665</scope>
</reference>
<reference key="95">
<citation type="journal article" date="2004" name="Eur. J. Cancer" volume="40" first="422" last="428">
<title>One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden.</title>
<authorList>
<person name="Malander S."/>
<person name="Ridderheim M."/>
<person name="Masbaeck A."/>
<person name="Loman N."/>
<person name="Kristoffersson U."/>
<person name="Olsson H."/>
<person name="Nilbert M."/>
<person name="Borg A."/>
</authorList>
<dbReference type="PubMed" id="14746861"/>
<dbReference type="DOI" id="10.1016/j.ejca.2003.09.016"/>
</citation>
<scope>VARIANTS OVARIAN CANCER GLY-61; THR-1411; ARG-1697 AND TRP-1699</scope>
</reference>
<reference key="96">
<citation type="journal article" date="2004" name="Hum. Mutat." volume="23" first="205" last="205">
<title>Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families.</title>
<authorList>
<person name="Valarmathi M.T."/>
<person name="Sawhney M."/>
<person name="Deo S.S.V."/>
<person name="Shukla N.K."/>
<person name="Das S.N."/>
</authorList>
<dbReference type="PubMed" id="14722926"/>
<dbReference type="DOI" id="10.1002/humu.9213"/>
</citation>
<scope>VARIANTS BC/BROVCA1 LYS-10; LYS-23; ILE-1187; HIS-1200 AND TYR-1217</scope>
<scope>VARIANTS BC ILE-1204 AND ASN-1207</scope>
<scope>VARIANTS BROVCA1 LEU-1226 AND GLY-1243</scope>
<scope>VARIANT ARG-1183</scope>
</reference>
<reference key="97">
<citation type="journal article" date="2004" name="Hum. Mutat." volume="24" first="350" last="350">
<title>BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.</title>
<authorList>
<person name="Seo J.H."/>
<person name="Cho D.-Y."/>
<person name="Ahn S.-H."/>
<person name="Yoon K.-S."/>
<person name="Kang C.-S."/>
<person name="Cho H.M."/>
<person name="Lee H.S."/>
<person name="Choe J.J."/>
<person name="Choi C.W."/>
<person name="Kim B.S."/>
<person name="Shin S.W."/>
<person name="Kim Y.H."/>
<person name="Kim J.S."/>
<person name="Son G.-S."/>
<person name="Lee J.-B."/>
<person name="Koo B.H."/>
</authorList>
<dbReference type="PubMed" id="15365993"/>
<dbReference type="DOI" id="10.1002/humu.9275"/>
</citation>
<scope>VARIANTS HIS-856; LEU-871; GLY-1038; ARG-1183; THR-1628; GLN-1690 AND GLY-1713</scope>
</reference>
<reference key="98">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] PHE-30; PHE-758 AND CYS-778</scope>
</reference>
<reference key="99">
<citation type="journal article" date="2007" name="Am. J. Hum. Genet." volume="81" first="873" last="883">
<title>A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.</title>
<authorList>
<person name="Easton D.F."/>
<person name="Deffenbaugh A.M."/>
<person name="Pruss D."/>
<person name="Frye C."/>
<person name="Wenstrup R.J."/>
<person name="Allen-Brady K."/>
<person name="Tavtigian S.V."/>
<person name="Monteiro A.N.A."/>
<person name="Iversen E.S."/>
<person name="Couch F.J."/>
<person name="Goldgar D.E."/>
</authorList>
<dbReference type="PubMed" id="17924331"/>
<dbReference type="DOI" id="10.1086/521032"/>
</citation>
<scope>VARIANTS THR-18; MET-1495; GLY-1623; ILE-1685; ALA-1685; ARG-1689; TRP-1699; GLU-1706; GLU-1708; ARG-1715; ARG-1738; PRO-1764; SER-1766 AND VAL-1788</scope>
</reference>
<reference key="100">
<citation type="journal article" date="2010" name="Hum. Mutat." volume="31" first="E1484" last="E1505">
<title>Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicity.</title>
<authorList>
<person name="Walker L.C."/>
<person name="Whiley P.J."/>
<person name="Couch F.J."/>
<person name="Farrugia D.J."/>
<person name="Healey S."/>
<person name="Eccles D.M."/>
<person name="Lin F."/>
<person name="Butler S.A."/>
<person name="Goff S.A."/>
<person name="Thompson B.A."/>
<person name="Lakhani S.R."/>
<person name="Da Silva L.M."/>
<person name="Tavtigian S.V."/>
<person name="Goldgar D.E."/>
<person name="Brown M.A."/>
<person name="Spurdle A.B."/>
</authorList>
<dbReference type="PubMed" id="20513136"/>
<dbReference type="DOI" id="10.1002/humu.21267"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS GLY-1623 AND ILE-1685</scope>
</reference>
<reference key="101">
<citation type="journal article" date="2013" name="Cancer Discov." volume="3" first="1142" last="1155">
<title>A high-throughput functional complementation assay for classification of BRCA1 missense variants.</title>
<authorList>
<person name="Bouwman P."/>
<person name="van der Gulden H."/>
<person name="van der Heijden I."/>
<person name="Drost R."/>
<person name="Klijn C.N."/>
<person name="Prasetyanti P."/>
<person name="Pieterse M."/>
<person name="Wientjens E."/>
<person name="Seibler J."/>
<person name="Hogervorst F.B."/>
<person name="Jonkers J."/>
</authorList>
<dbReference type="PubMed" id="23867111"/>
<dbReference type="DOI" id="10.1158/2159-8290.CD-13-0094"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS BC PHE-4; THR-18; GLN-45; GLY-61; GLY-64; TYR-67; LYS-132; HIS-142; PHE-147; PRO-165; TRP-170; TYR-186; ILE-191; MET-231; VAL-245; VAL-246; LEU-271; PHE-668; ASN-695; LEU-798; TYR-810; LYS-826; GLN-841; HIS-856; ASN-1101; ASN-1140; GLY-1140; LYS-1214; LYS-1236; SER-1267; VAL-1282; SER-1297 DEL; ARG-1301; LYS-1346; ILE-1378; VAL-1400; PRO-1407; THR-1411; GLY-1443; GLY-1448; CYS-1486; MET-1534; PRO-1589; THR-1628; PRO-1651; PHE-1651; PHE-1655; ARG-1686; GLN-1686; VAL-1688 DEL; ILE-1691; TRP-1699; GLN-1699; GLU-1706; ALA-1706; GLU-1708; CYS-1718; ALA-1720; LYS-1735; ALA-1736; GLY-1739; VAL-1739; GLN-1746; THR-1753; PRO-1764; SER-1767; VAL-1770; CYS-1782; THR-1789; ASP-1794; ASP-1804; ARG-1812; ARG-1837 AND LEU-1862</scope>
<scope>VARIANTS CYS-105; CYS-866; ALA-1060; LYS-1250 AND ILE-1652</scope>
</reference>
<reference key="102">
<citation type="journal article" date="2017" name="Breast" volume="33" first="109" last="116">
<title>Suggestion of BRCA1 c.5339T>C (p.L1780P) variant confer from 'unknown significance' to 'Likely pathogenic' based on clinical evidence in Korea.</title>
<authorList>
<person name="Ryu J.M."/>
<person name="Kang G."/>
<person name="Nam S.J."/>
<person name="Kim S.W."/>
<person name="Yu J."/>
<person name="Lee S.K."/>
<person name="Bae S.Y."/>
<person name="Park S."/>
<person name="Paik H.J."/>
<person name="Kim J.W."/>
<person name="Park S.S."/>
<person name="Lee J.E."/>
<person name="Kim S.W."/>
</authorList>
<dbReference type="PubMed" id="28364669"/>
<dbReference type="DOI" id="10.1016/j.breast.2017.03.006"/>
</citation>
<scope>VARIANT BC PRO-1780</scope>
<scope>VARIANT BROVCA1 PRO-1780</scope>
<scope>VARIANT OC PRO-1780</scope>
</reference>
<comment type="function">
<text evidence="23 24 32 41 42 47 48 56 58 60 64 69 71 73 74 75">E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719).</text>
</comment>
<comment type="catalytic activity">
<text evidence="23 41 42 58 64 74">S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="64">The E3 ubiquitin-protein ligase activity is inhibited by phosphorylation by AURKA. Activity is increased by phosphatase treatment.</text>
</comment>
<comment type="pathway">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="24 25 27 28 29 30 31 32 33 36 37 42 44 47 48 50 51 53 55 56 57 58 60 61 62 66 68 69 70 71 72 73 74 78 79 81 82 83 84 97 99 101">Heterodimer with BARD1 (PubMed:11573085, PubMed:12890688, PubMed:14976165). Part of the BRCA1-associated genome surveillance complex (BASC), which contains BRCA1, MSH2, MSH6, MLH1, ATM, BLM, PMS2 and the MRE11-RAD50-NBN protein (MRN) complex (PubMed:10783165). This association could be a dynamic process changing throughout the cell cycle and within subnuclear domains (PubMed:10783165). Component of the BRCA1-A complex, at least composed of BRCA1, BARD1, UIMC1/RAP80, ABRAXAS1, BRCC3/BRCC36, BABAM2 and BABAM1/NBA1 (PubMed:19261746, PubMed:19261748, PubMed:19261749, PubMed:20351172). Interacts (via the BRCT domains) with ABRAXAS1 (phosphorylated form); this is important for recruitment to sites of DNA damage (PubMed:17525340, PubMed:17643121, PubMed:17643122, PubMed:24316840, PubMed:26778126). Can form a heterotetramer with two molecules of ABRAXAS1 (phosphorylated form) (PubMed:26778126). Component of the BRCA1-RBBP8 complex (PubMed:16101277). Interacts (via the BRCT domains) with RBBP8 ('Ser-327' phosphorylated form); the interaction ubiquitinates RBBP8, regulates CHEK1 activation, and involves RBBP8 in BRCA1-dependent G2/M checkpoint control on DNA damage (PubMed:16818604, PubMed:9811458). Associates with RNA polymerase II holoenzyme (PubMed:9662397). Interacts with SMC1A, COBRA1, DCLRE1C, CLSPN (PubMed:11877377, PubMed:15096610, PubMed:15456891). Interacts with CHEK1, CHEK2, BAP1, BRCC3, AURKA, UBXN1 and PCLAF (PubMed:10724175, PubMed:11836499, PubMed:14636569, PubMed:14990569, PubMed:20351172, PubMed:21673012). Interacts (via BRCT domains) with BRIP1 (phosphorylated form) (PubMed:11301010, PubMed:15133502, PubMed:21473589). Interacts with FANCD2 (ubiquitinated form) (PubMed:11239454). Interacts with H2AFX (phosphorylated on 'Ser-140') (PubMed:12419185). Interacts (via the BRCT domains) with ACACA (phosphorylated form); the interaction prevents dephosphorylation of ACACA (PubMed:12360400, PubMed:16326698, PubMed:16698035, PubMed:18452305). Part of a BRCA complex containing BRCA1, BRCA2 and PALB2 (PubMed:19369211). Interacts directly with PALB2; the interaction is essential for its function in HRR (PubMed:19369211, PubMed:28319063). Interacts directly with BRCA2; the interaction occurs only in the presence of PALB2 which serves as the bridging protein (PubMed:19369211). Interacts (via the BRCT domains) with LMO4; the interaction represses the transcriptional activity of BRCA1 (PubMed:11751867). Interacts (via the BRCT domains) with CCAR2 (via N-terminus); the interaction represses the transcriptional activator activity of BRCA1 (PubMed:20160719). Interacts with EXD2 (PubMed:26807646). Interacts (via C-terminus) with DHX9; this interaction is direct and links BRCA1 to the RNA polymerase II holoenzyme (PubMed:9662397).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-1263451">
<id>Q6UWZ7</id>
<label>ABRAXAS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-717681">
<id>Q13085</id>
<label>ACACA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-1791447">
<id>Q92560</id>
<label>BAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-473181">
<id>Q99728</id>
<label>BARD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-77694">
<id>P10415</id>
<label>BCL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-349900">
<id>Q7Z569</id>
<label>BRAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-10826195">
<id>Q6PJG6</id>
<label>BRAT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-3509650">
<id>Q9BX63</id>
<label>BRIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-375001">
<id>P24385</id>
<label>CCND1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-519526">
<id>P24864</id>
<label>CCNE1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-974488">
<id>O14757</id>
<label>CHEK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-904311">
<id>Q61188</id>
<label>Ezh2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-701903">
<id>Q14192</id>
<label>FHL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-359622">
<id>P78347</id>
<label>GTF2I</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-494830">
<id>P16104</id>
<label>H2AFX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-2556203">
<id>O75330</id>
<label>HMMR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-352528">
<id>P10809</id>
<label>HSPD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-2867186">
<id>Q16666</id>
<label>IFI16</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-349938">
<id>P52292</id>
<label>KPNA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-347721">
<id>Q8WX92</id>
<label>NELFB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-1222653">
<id>Q86YC2</id>
<label>PALB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>23</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-357253">
<id>P62136</id>
<label>PPP1CA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-352350">
<id>P62140</id>
<label>PPP1CB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-356283">
<id>P36873</id>
<label>PPP1CC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-745715">
<id>Q99708</id>
<label>RBBP8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-80140">
<id>P63165</id>
<label>SUMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-473220">
<id>P61956</id>
<label>SUMO2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-539628">
<id>P11388</id>
<label>TOP2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-399128">
<id>Q9Y4A5</id>
<label>TRRAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-725300">
<id>Q96RL1</id>
<label>UIMC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-9640371">
<id>Q96RL1-1</id>
<label>UIMC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-1263058">
<id>Q6NZY4</id>
<label>ZCCHC8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-349905"/>
<interactant intactId="EBI-396421">
<id>Q9GZX5</id>
<label>ZNF350</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="51 60 73 77 82 97">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="17">Chromosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="73">Cytoplasm</location>
</subcellularLocation>
<text evidence="73 82">Localizes at sites of DNA damage at double-strand breaks (DSBs); recruitment to DNA damage sites is mediated by ABRAXAS1 and the BRCA1-A complex (PubMed:26778126). Translocated to the cytoplasm during UV-induced apoptosis (PubMed:20160719).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 5</molecule>
<subcellularLocation>
<location evidence="94">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<event type="alternative initiation"/>
<isoform>
<id>P38398-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P38398-2</id>
<name>2</name>
<sequence type="described" ref="VSP_047891"/>
<text>May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.</text>
</isoform>
<isoform>
<id>P38398-3</id>
<name>3</name>
<name>Delta11b</name>
<sequence type="described" ref="VSP_035399 VSP_043797"/>
</isoform>
<isoform>
<id>P38398-4</id>
<name>4</name>
<name>DeltaBRCA1(17aa)</name>
<sequence type="described" ref="VSP_035396"/>
<text>Produced by alternative initiation at Met-18 of isoform 1.</text>
</isoform>
<isoform>
<id>P38398-5</id>
<name>5</name>
<name>Delta11</name>
<name>Delta772-3095</name>
<sequence type="described" ref="VSP_035398"/>
</isoform>
<isoform>
<id>P38398-6</id>
<name>6</name>
<sequence type="described" ref="VSP_035399 VSP_043797 VSP_043798"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>P38398-7</id>
<name>7</name>
<sequence type="described" ref="VSP_055404"/>
<text evidence="107">No experimental confirmation available. Ref.8 (AAI15038) sequence is in conflict in position: 1461:N->D.</text>
</isoform>
<isoform>
<id>P38398-8</id>
<name>8</name>
<sequence type="described" ref="VSP_057569"/>
<text evidence="107">No experimental confirmation available. The N-terminus is confirmed by several cDNAs.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.</text>
</comment>
<comment type="domain">
<text evidence="72">The BRCT domains recognize and bind phosphorylated pSXXF motif on proteins. The interaction with the phosphorylated pSXXF motif of ABRAXAS1, recruits BRCA1 at DNA damage sites.</text>
</comment>
<comment type="domain">
<text evidence="72">The RING-type zinc finger domain interacts with BAP1.</text>
</comment>
<comment type="PTM">
<text evidence="24 26 34 48 64 75 77">Phosphorylation at Ser-308 by AURKA is required for normal cell cycle progression from G2 to mitosis. Phosphorylated in response to IR, UV, and various stimuli that cause checkpoint activation, probably by ATM or ATR. Phosphorylation at Ser-988 by CHEK2 regulates mitotic spindle assembly.</text>
</comment>
<comment type="PTM">
<text evidence="42 74">Autoubiquitinated, undergoes 'Lys-6'-linked polyubiquitination. 'Lys-6'-linked polyubiquitination does not promote degradation.</text>
</comment>
<comment type="polymorphism">
<text>There is evidence that the presence of the rare form of Gln-356-Arg and Leu-871-Pro polymorphisms may be associated with an increased risk for developing ovarian cancer.</text>
</comment>
<comment type="disease" evidence="21 26 28 38 40 43 45 51 65 78 80 85 86 87 88 89 90 91 92 96 98 100">
<disease id="DI-02602">
<name>Breast cancer</name>
<acronym>BC</acronym>
<description>A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.</description>
<dbReference type="MIM" id="114480"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3-fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.</text>
</comment>
<comment type="disease" evidence="43 45 85 93">
<disease id="DI-01559">
<name>Breast-ovarian cancer, familial, 1</name>
<acronym>BROVCA1</acronym>
<description>A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate.</description>
<dbReference type="MIM" id="604370"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.</text>
</comment>
<comment type="disease" evidence="20 22 46 85">
<disease id="DI-01655">
<name>Ovarian cancer</name>
<acronym>OC</acronym>
<description>The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease.</description>
<dbReference type="MIM" id="167000"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="67">
<disease id="DI-03281">
<name>Pancreatic cancer 4</name>
<acronym>PNCA4</acronym>
<description>A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue.</description>
<dbReference type="MIM" id="614320"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="sequence caution" evidence="107">
<conflict type="erroneous translation">
<sequence resource="EMBL-CDS" id="AAB61673" version="1"/>
</conflict>
<text>Wrong choice of CDS.</text>
</comment>
<comment type="sequence caution" evidence="107">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAI15038" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<comment type="sequence caution" evidence="107">
<conflict type="erroneous termination">
<sequence resource="EMBL-CDS" id="AAI15038" version="1"/>
</conflict>
<location>
<position position="526"/>
</location>
<text>Translated as Gln.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/BRCA1ID163ch17q21.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/brca1/"/>
</comment>
<comment type="online information" name="SHMPD">
<link uri="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&amp;genename=BRCA1"/>
<text>The Singapore human mutation and polymorphism database</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/BRCA1"/>
<text>BRCA1 entry</text>
</comment>
<dbReference type="EC" id="2.3.2.27" evidence="23 41 42 58 64 74"/>
<dbReference type="EMBL" id="U14680">
<property type="protein sequence ID" value="AAA73985.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L78833">
<property type="protein sequence ID" value="AAC37594.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U64805">
<property type="protein sequence ID" value="AAC00049.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF005068">
<property type="protein sequence ID" value="AAB61673.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ190450">
<property type="protein sequence ID" value="ABA29208.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ190451">
<property type="protein sequence ID" value="ABA29211.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ190452">
<property type="protein sequence ID" value="ABA29214.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ190453">
<property type="protein sequence ID" value="ABA29217.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ190454">
<property type="protein sequence ID" value="ABA29220.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ190455">
<property type="protein sequence ID" value="ABA29223.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ190456">
<property type="protein sequence ID" value="ABA29226.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY273801">
<property type="protein sequence ID" value="AAP12647.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC060780">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC135721">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC072418">
<property type="protein sequence ID" value="AAH72418.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC115037">
<property type="protein sequence ID" value="AAI15038.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11453.1">
<molecule id="P38398-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11454.2">
<molecule id="P38398-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11455.2">
<molecule id="P38398-6"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11456.2">
<molecule id="P38398-7"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11459.2">
<molecule id="P38398-8"/>
</dbReference>
<dbReference type="PIR" id="A58881">
<property type="entry name" value="A58881"/>
</dbReference>
<dbReference type="RefSeq" id="NP_009225.1">
<molecule id="P38398-1"/>
<property type="nucleotide sequence ID" value="NM_007294.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_009228.2">
<molecule id="P38398-8"/>
<property type="nucleotide sequence ID" value="NM_007297.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_009229.2">
<molecule id="P38398-3"/>
<property type="nucleotide sequence ID" value="NM_007298.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_009230.2">
<molecule id="P38398-6"/>
<property type="nucleotide sequence ID" value="NM_007299.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_009231.2">
<molecule id="P38398-7"/>
<property type="nucleotide sequence ID" value="NM_007300.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.194143"/>
<dbReference type="PDB" id="1JM7">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-110"/>
</dbReference>
<dbReference type="PDB" id="1JNX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="X=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="1N5O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="X=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="1OQA">
<property type="method" value="NMR"/>
<property type="chains" value="A=1755-1863"/>
</dbReference>
<dbReference type="PDB" id="1T15">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="1T29">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="1T2U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="1T2V">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B/C/D/E=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="1Y98">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="2ING">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="X=1649-1859"/>
</dbReference>
<dbReference type="PDB" id="3COJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.21"/>
<property type="chains" value="A/B/C/D/E/F/G/X=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3K0H">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3K0K">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3K15">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3K16">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3PXA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3PXB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3PXC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="X=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3PXD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="3PXE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A/B/C/D=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="4IFI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="4IGK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A/B=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="4JLU">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A=1649-1859"/>
</dbReference>
<dbReference type="PDB" id="4OFB">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.05"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="4U4A">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.51"/>
<property type="chains" value="A/B/C=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="4Y18">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B/C/D/E/F/G/H=1646-1859"/>
</dbReference>
<dbReference type="PDB" id="4Y2G">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1646-1859"/>
</dbReference>
<dbReference type="PDBsum" id="1JM7"/>
<dbReference type="PDBsum" id="1JNX"/>
<dbReference type="PDBsum" id="1N5O"/>
<dbReference type="PDBsum" id="1OQA"/>
<dbReference type="PDBsum" id="1T15"/>
<dbReference type="PDBsum" id="1T29"/>
<dbReference type="PDBsum" id="1T2U"/>
<dbReference type="PDBsum" id="1T2V"/>
<dbReference type="PDBsum" id="1Y98"/>
<dbReference type="PDBsum" id="2ING"/>
<dbReference type="PDBsum" id="3COJ"/>
<dbReference type="PDBsum" id="3K0H"/>
<dbReference type="PDBsum" id="3K0K"/>
<dbReference type="PDBsum" id="3K15"/>
<dbReference type="PDBsum" id="3K16"/>
<dbReference type="PDBsum" id="3PXA"/>
<dbReference type="PDBsum" id="3PXB"/>
<dbReference type="PDBsum" id="3PXC"/>
<dbReference type="PDBsum" id="3PXD"/>
<dbReference type="PDBsum" id="3PXE"/>
<dbReference type="PDBsum" id="4IFI"/>
<dbReference type="PDBsum" id="4IGK"/>
<dbReference type="PDBsum" id="4JLU"/>
<dbReference type="PDBsum" id="4OFB"/>
<dbReference type="PDBsum" id="4U4A"/>
<dbReference type="PDBsum" id="4Y18"/>
<dbReference type="PDBsum" id="4Y2G"/>
<dbReference type="DisProt" id="DP00238"/>
<dbReference type="ProteinModelPortal" id="P38398"/>
<dbReference type="SMR" id="P38398"/>
<dbReference type="BioGrid" id="107140">
<property type="interactions" value="581"/>
</dbReference>
<dbReference type="CORUM" id="P38398"/>
<dbReference type="DIP" id="DIP-5971N"/>
<dbReference type="IntAct" id="P38398">
<property type="interactions" value="84"/>
</dbReference>
<dbReference type="MINT" id="MINT-90433"/>
<dbReference type="STRING" id="9606.ENSP00000418960"/>
<dbReference type="BindingDB" id="P38398"/>
<dbReference type="ChEMBL" id="CHEMBL5990"/>
<dbReference type="iPTMnet" id="P38398"/>
<dbReference type="PhosphoSitePlus" id="P38398"/>
<dbReference type="BioMuta" id="BRCA1"/>
<dbReference type="DMDM" id="728984"/>
<dbReference type="PaxDb" id="P38398"/>
<dbReference type="PeptideAtlas" id="P38398"/>
<dbReference type="PRIDE" id="P38398"/>
<dbReference type="DNASU" id="672"/>
<dbReference type="Ensembl" id="ENST00000352993">
<molecule id="P38398-5"/>
<property type="protein sequence ID" value="ENSP00000312236"/>
<property type="gene ID" value="ENSG00000012048"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000357654">
<molecule id="P38398-1"/>
<property type="protein sequence ID" value="ENSP00000350283"/>
<property type="gene ID" value="ENSG00000012048"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000461221">
<molecule id="P38398-2"/>
<property type="protein sequence ID" value="ENSP00000418548"/>
<property type="gene ID" value="ENSG00000012048"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000461798">
<molecule id="P38398-2"/>
<property type="protein sequence ID" value="ENSP00000417988"/>
<property type="gene ID" value="ENSG00000012048"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000468300">
<molecule id="P38398-6"/>
<property type="protein sequence ID" value="ENSP00000417148"/>
<property type="gene ID" value="ENSG00000012048"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000471181">
<molecule id="P38398-7"/>
<property type="protein sequence ID" value="ENSP00000418960"/>
<property type="gene ID" value="ENSG00000012048"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000491747">
<molecule id="P38398-3"/>
<property type="protein sequence ID" value="ENSP00000420705"/>
<property type="gene ID" value="ENSG00000012048"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000493795">
<molecule id="P38398-8"/>
<property type="protein sequence ID" value="ENSP00000418775"/>
<property type="gene ID" value="ENSG00000012048"/>
</dbReference>
<dbReference type="GeneID" id="672"/>
<dbReference type="KEGG" id="hsa:672"/>
<dbReference type="UCSC" id="uc002icq.4">
<molecule id="P38398-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc010cyx.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="672"/>
<dbReference type="DisGeNET" id="672"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000012048.20"/>
<dbReference type="GeneCards" id="BRCA1"/>
<dbReference type="GeneReviews" id="BRCA1"/>
<dbReference type="HGNC" id="HGNC:1100">
<property type="gene designation" value="BRCA1"/>
</dbReference>
<dbReference type="HPA" id="CAB001946"/>
<dbReference type="HPA" id="HPA034966"/>
<dbReference type="MalaCards" id="BRCA1"/>
<dbReference type="MIM" id="113705">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="114480">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="167000">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="604370">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="614320">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P38398"/>
<dbReference type="OpenTargets" id="ENSG00000012048"/>
<dbReference type="Orphanet" id="1333">
<property type="disease" value="Familial pancreatic carcinoma"/>
</dbReference>
<dbReference type="Orphanet" id="1331">
<property type="disease" value="Familial prostate cancer"/>
</dbReference>
<dbReference type="Orphanet" id="145">
<property type="disease" value="Hereditary breast and ovarian cancer syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="227535">
<property type="disease" value="Hereditary breast cancer"/>
</dbReference>
<dbReference type="Orphanet" id="213524">
<property type="disease" value="Hereditary site-specific ovarian cancer syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="168829">
<property type="disease" value="Primary peritoneal carcinoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA25411"/>
<dbReference type="eggNOG" id="ENOG410ITQ4">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4112BIH">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00440000034289"/>
<dbReference type="HOGENOM" id="HOG000230969"/>
<dbReference type="HOVERGEN" id="HBG050730"/>
<dbReference type="InParanoid" id="P38398"/>
<dbReference type="KO" id="K10605"/>
<dbReference type="OMA" id="FQHLLFG"/>
<dbReference type="OrthoDB" id="EOG091G0670"/>
<dbReference type="PhylomeDB" id="P38398"/>
<dbReference type="BRENDA" id="6.3.2.19">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1221632">
<property type="pathway name" value="Meiotic synapsis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3108214">
<property type="pathway name" value="SUMOylation of DNA damage response and repair proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5685938">
<property type="pathway name" value="HDR through Single Strand Annealing (SSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5685942">
<property type="pathway name" value="HDR through Homologous Recombination (HRR)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689901">
<property type="pathway name" value="Metalloprotease DUBs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693554">
<property type="pathway name" value="Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693565">
<property type="pathway name" value="Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693568">
<property type="pathway name" value="Resolution of D-loop Structures through Holliday Junction Intermediates"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693571">
<property type="pathway name" value="Nonhomologous End-Joining (NHEJ)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693579">
<property type="pathway name" value="Homologous DNA Pairing and Strand Exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693607">
<property type="pathway name" value="Processing of DNA double-strand break ends"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693616">
<property type="pathway name" value="Presynaptic phase of homologous DNA pairing and strand exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6796648">
<property type="pathway name" value="TP53 Regulates Transcription of DNA Repair Genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804756">
<property type="pathway name" value="Regulation of TP53 Activity through Phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69473">
<property type="pathway name" value="G2/M DNA damage checkpoint"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8953750">
<property type="pathway name" value="Transcriptional Regulation by E2F6"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912446">
<property type="pathway name" value="Meiotic recombination"/>
</dbReference>
<dbReference type="SignaLink" id="P38398"/>
<dbReference type="SIGNOR" id="P38398"/>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="ChiTaRS" id="BRCA1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P38398"/>
<dbReference type="GeneWiki" id="BRCA1"/>
<dbReference type="GenomeRNAi" id="672"/>
<dbReference type="PMAP-CutDB" id="P38398"/>
<dbReference type="PRO" id="PR:P38398"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000012048"/>
<dbReference type="CleanEx" id="HS_BRCA1"/>
<dbReference type="ExpressionAtlas" id="P38398">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P38398">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0070531">
<property type="term" value="C:BRCA1-A complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031436">
<property type="term" value="C:BRCA1-BARD1 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005694">
<property type="term" value="C:chromosome"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008274">
<property type="term" value="C:gamma-tubulin ring complex"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030529">
<property type="term" value="C:intracellular ribonucleoprotein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0000800">
<property type="term" value="C:lateral element"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000151">
<property type="term" value="C:ubiquitin ligase complex"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050681">
<property type="term" value="F:androgen receptor binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003684">
<property type="term" value="F:damaged DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070063">
<property type="term" value="F:RNA polymerase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001105">
<property type="term" value="F:RNA polymerase II transcription coactivator activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044212">
<property type="term" value="F:transcription regulatory region DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015631">
<property type="term" value="F:tubulin binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004842">
<property type="term" value="F:ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0030521">
<property type="term" value="P:androgen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0071681">
<property type="term" value="P:cellular response to indole-3-methanol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007098">
<property type="term" value="P:centrosome cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043009">
<property type="term" value="P:chordate embryonic development"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007059">
<property type="term" value="P:chromosome segregation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006978">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000729">
<property type="term" value="P:DNA double-strand break processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006260">
<property type="term" value="P:DNA replication"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000731">
<property type="term" value="P:DNA synthesis involved in DNA repair"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0009048">
<property type="term" value="P:dosage compensation by inactivation of X chromosome"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006302">
<property type="term" value="P:double-strand break repair"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0000724">
<property type="term" value="P:double-strand break repair via homologous recombination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0006303">
<property type="term" value="P:double-strand break repair via nonhomologous end joining"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006633">
<property type="term" value="P:fatty acid biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0031572">
<property type="term" value="P:G2 DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008630">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0044818">
<property type="term" value="P:mitotic G2/M transition checkpoint"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046600">
<property type="term" value="P:negative regulation of centriole replication"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902042">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045717">
<property type="term" value="P:negative regulation of fatty acid biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070317">
<property type="term" value="P:negative regulation of G0 to G1 transition"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035067">
<property type="term" value="P:negative regulation of histone acetylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051572">
<property type="term" value="P:negative regulation of histone H3-K4 methylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051573">
<property type="term" value="P:negative regulation of histone H3-K9 methylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033147">
<property type="term" value="P:negative regulation of intracellular estrogen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:2000378">
<property type="term" value="P:negative regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071158">
<property type="term" value="P:positive regulation of cell cycle arrest"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045739">
<property type="term" value="P:positive regulation of DNA repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035066">
<property type="term" value="P:positive regulation of histone acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051571">
<property type="term" value="P:positive regulation of histone H3-K4 methylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000617">
<property type="term" value="P:positive regulation of histone H3-K9 acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051574">
<property type="term" value="P:positive regulation of histone H3-K9 methylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000620">
<property type="term" value="P:positive regulation of histone H4-K16 acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070512">
<property type="term" value="P:positive regulation of histone H4-K20 methylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031398">
<property type="term" value="P:positive regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010575">
<property type="term" value="P:positive regulation of vascular endothelial growth factor production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006301">
<property type="term" value="P:postreplication repair"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0051865">
<property type="term" value="P:protein autoubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0085020">
<property type="term" value="P:protein K6-linked ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044030">
<property type="term" value="P:regulation of DNA methylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006349">
<property type="term" value="P:regulation of gene expression by genetic imprinting"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006359">
<property type="term" value="P:regulation of transcription from RNA polymerase III promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043627">
<property type="term" value="P:response to estrogen"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010212">
<property type="term" value="P:response to ionizing radiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000732">
<property type="term" value="P:strand displacement"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="CDD" id="cd00027">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.10190">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR011364">
<property type="entry name" value="BRCA1"/>
</dbReference>
<dbReference type="InterPro" id="IPR031099">
<property type="entry name" value="BRCA1-associated"/>
</dbReference>
<dbReference type="InterPro" id="IPR025994">
<property type="entry name" value="BRCA1_serine_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001357">
<property type="entry name" value="BRCT_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036420">
<property type="entry name" value="BRCT_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR018957">
<property type="entry name" value="Znf_C3HC4_RING-type"/>
</dbReference>
<dbReference type="InterPro" id="IPR001841">
<property type="entry name" value="Znf_RING"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR017907">
<property type="entry name" value="Znf_RING_CS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR13763">
<property type="entry name" value="PTHR13763"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR13763:SF0">
<property type="entry name" value="PTHR13763:SF0"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00533">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF12820">
<property type="entry name" value="BRCT_assoc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00097">
<property type="entry name" value="zf-C3HC4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF001734">
<property type="entry name" value="BRCA1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00493">
<property type="entry name" value="BRSTCANCERI"/>
</dbReference>
<dbReference type="SMART" id="SM00292">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00184">
<property type="entry name" value="RING"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52113">
<property type="entry name" value="SSF52113"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50172">
<property type="entry name" value="BRCT"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00518">
<property type="entry name" value="ZF_RING_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50089">
<property type="entry name" value="ZF_RING_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0233">DNA recombination</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0275">Fatty acid biosynthesis</keyword>
<keyword id="KW-0276">Fatty acid metabolism</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0444">Lipid biosynthesis</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Breast cancer type 1 susceptibility protein" id="PRO_0000055830">
<location>
<begin position="1"/>
<end position="1863"/>
</location>
</feature>
<feature type="domain" description="BRCT 1" evidence="18">
<location>
<begin position="1642"/>
<end position="1736"/>
</location>
</feature>
<feature type="domain" description="BRCT 2" evidence="18">
<location>
<begin position="1756"/>
<end position="1855"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type" evidence="19">
<location>
<begin position="24"/>
<end position="65"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PALB2" evidence="71">
<location>
<begin position="1397"/>
<end position="1424"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Lys">
<location>
<begin position="651"/>
<end position="654"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="12">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11 13">
<location>
<position position="114"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by AURKA" evidence="48">
<location>
<position position="308"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9">
<location>
<position position="395"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9">
<location>
<position position="398"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="423"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="434"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="551"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 13">
<location>
<position position="694"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="708"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="725"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="753"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="840"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CHEK2" evidence="24 75">
<location>
<position position="988"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="1009"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATR; in vitro" evidence="26">
<location>
<position position="1143"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="1189"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="1191"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="1211"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="1217"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 11">
<location>
<position position="1218"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATR; in vitro" evidence="26">
<location>
<position position="1280"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1328"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 10 11">
<location>
<position position="1336"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11">
<location>
<position position="1342"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATM and ATR" evidence="26">
<location>
<position position="1387"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by ATR; in vitro" evidence="26">
<location>
<position position="1394"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATM and ATR" evidence="26">
<location>
<position position="1423"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATR; in vitro" evidence="26">
<location>
<position position="1457"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ATM" evidence="77">
<location>
<position position="1524"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="1542"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16">
<location>
<position position="109"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16">
<location>
<position position="301"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14 15 16">
<location>
<position position="339"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="15 16">
<location>
<position position="443"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14 16">
<location>
<position position="459"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16">
<location>
<position position="519"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14 15 16">
<location>
<position position="583"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="654"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="734"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="739"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16">
<location>
<position position="918"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16">
<location>
<position position="987"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16">
<location>
<position position="1079"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 8." id="VSP_057569">
<location>
<begin position="1"/>
<end position="47"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_035396" evidence="107">
<location>
<begin position="1"/>
<end position="17"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_047891" evidence="106">
<location>
<begin position="64"/>
<end position="1863"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_035398" evidence="107">
<location>
<begin position="224"/>
<end position="1365"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 6." id="VSP_035399" evidence="104 105">
<location>
<begin position="264"/>
<end position="1366"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 6." id="VSP_043797" evidence="104 105">
<location>
<position position="1453"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_055404" evidence="104">
<original>A</original>
<variation>DSHIHGQRNNSMFSKRPREHIS</variation>
<location>
<position position="1453"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_043798" evidence="104">
<original>DQLEWMVQLCGASVVKELSSFTLGTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTREWVLDSVALYQCQELDTYLIPQIPHSHY</original>
<variation>GCPPNCGCAARCLDRGQWLPCNWADV</variation>
<location>
<begin position="1778"/>
<end position="1863"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs786203152." id="VAR_070458" evidence="80">
<original>S</original>
<variation>F</variation>
<location>
<position position="4"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and BROVCA1." id="VAR_020679" evidence="45">
<original>E</original>
<variation>K</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="sequence variant" description="Found in breast-ovarian cancer patients; unknown pathological significance; dbSNP:rs80357017." id="VAR_007754">
<original>V</original>
<variation>A</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80356929." id="VAR_063899" evidence="63 80">
<original>M</original>
<variation>T</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="sequence variant" description="Found in breast-ovarian cancer patients; unknown pathological significance; dbSNP:rs80357406." id="VAR_007755">
<original>I</original>
<variation>V</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs80357438." id="VAR_007756" evidence="98">
<original>L</original>
<variation>S</variation>
<location>
<position position="22"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and BROVCA1." id="VAR_020680" evidence="45">
<original>E</original>
<variation>K</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_035947" evidence="59">
<original>L</original>
<variation>F</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs769650474." id="VAR_070459" evidence="80">
<original>K</original>
<variation>Q</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and ovarian cancer; no interaction with BAP1; dbSNP:rs28897672." id="VAR_007757" evidence="43 46 80 88 90 97 100">
<original>C</original>
<variation>G</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; no interaction with BAP1; dbSNP:rs80357064." id="VAR_007758" evidence="80 87 96 97">
<original>C</original>
<variation>G</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55851803." id="VAR_007759">
<original>C</original>
<variation>Y</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357102." id="VAR_070460" evidence="80">
<original>D</original>
<variation>Y</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80356913." id="VAR_020681" evidence="43">
<original>R</original>
<variation>K</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897673." id="VAR_070461" evidence="80">
<original>Y</original>
<variation>C</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357413." id="VAR_070462" evidence="80">
<original>N</original>
<variation>K</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs55971303." id="VAR_070463" evidence="80">
<original>P</original>
<variation>H</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs748876625." id="VAR_070464" evidence="80">
<original>L</original>
<variation>F</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897674." id="VAR_052077">
<original>S</original>
<variation>R</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro." id="VAR_070465" evidence="80">
<original>L</original>
<variation>P</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357325." id="VAR_070466" evidence="80">
<original>R</original>
<variation>W</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs55688530." id="VAR_070467" evidence="80">
<original>S</original>
<variation>Y</variation>
<location>
<position position="186"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357090." id="VAR_070468" evidence="80">
<original>V</original>
<variation>I</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; unknown pathological significance." id="VAR_008759">
<original>E</original>
<variation>K</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357001." id="VAR_070469" evidence="80">
<original>T</original>
<variation>M</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs80357396." id="VAR_007760" evidence="95 100">
<original>H</original>
<variation>R</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80356865." id="VAR_070470" evidence="80">
<original>D</original>
<variation>V</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897675." id="VAR_070471" evidence="80">
<original>L</original>
<variation>V</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357244." id="VAR_070472" evidence="80">
<original>V</original>
<variation>L</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs80357244." id="VAR_007761" evidence="91">
<original>V</original>
<variation>M</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8176153." id="VAR_019944" evidence="103">
<original>G</original>
<variation>S</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80357015." id="VAR_008760" evidence="21">
<original>P</original>
<variation>S</variation>
<location>
<position position="346"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs1799950." id="VAR_007762" evidence="88 102 103">
<original>Q</original>
<variation>R</variation>
<location>
<position position="356"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_007763">
<location>
<position position="369"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56128296." id="VAR_007764">
<original>I</original>
<variation>M</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs56046357." id="VAR_007765" evidence="98">
<original>F</original>
<variation>L</variation>
<location>
<position position="461"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs397508869." id="VAR_007766" evidence="98">
<original>Y</original>
<variation>D</variation>
<location>
<position position="465"/>
</location>
</feature>
<feature type="sequence variant" description="Found in breast-ovarian cancer patients; unknown pathological significance; dbSNP:rs80357224." id="VAR_007767">
<original>R</original>
<variation>I</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs397508893." id="VAR_007768" evidence="98">
<original>G</original>
<variation>V</variation>
<location>
<position position="552"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_020682" evidence="39">
<original>N</original>
<variation>I</variation>
<location>
<position position="656"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357250." id="VAR_070473" evidence="80">
<original>L</original>
<variation>F</variation>
<location>
<position position="668"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; dbSNP:rs4986850." id="VAR_007769" evidence="49 103">
<original>D</original>
<variation>N</variation>
<location>
<position position="693"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897681." id="VAR_070474" evidence="80">
<original>D</original>
<variation>N</variation>
<location>
<position position="695"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4986845." id="VAR_020110">
<original>N</original>
<variation>D</variation>
<location>
<position position="723"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs80357114." id="VAR_020683" evidence="40">
<original>D</original>
<variation>Y</variation>
<location>
<position position="749"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_035948" evidence="59">
<original>L</original>
<variation>F</variation>
<location>
<position position="758"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; dbSNP:rs80357467." id="VAR_007770" evidence="87 96">
<original>V</original>
<variation>A</variation>
<location>
<position position="772"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_035949" evidence="59">
<original>G</original>
<variation>C</variation>
<location>
<position position="778"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs876660005." id="VAR_070475" evidence="80">
<original>P</original>
<variation>L</variation>
<location>
<position position="798"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897682." id="VAR_070476" evidence="80">
<original>N</original>
<variation>Y</variation>
<location>
<position position="810"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; dbSNP:rs56082113." id="VAR_007771" evidence="96">
<original>K</original>
<variation>E</variation>
<location>
<position position="820"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897683." id="VAR_007772" evidence="80">
<original>T</original>
<variation>K</variation>
<location>
<position position="826"/>
</location>
</feature>
<feature type="sequence variant" description="In BROVCA1; unknown pathological significance; dbSNP:rs751656678." id="VAR_020684" evidence="43">
<original>H</original>
<variation>Y</variation>
<location>
<position position="835"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357337." id="VAR_070477" evidence="80">
<original>R</original>
<variation>Q</variation>
<location>
<position position="841"/>
</location>
</feature>
<feature type="sequence variant" description="In BROVCA1; unknown pathological significance; dbSNP:rs1800709." id="VAR_007773" evidence="93 100">
<original>R</original>
<variation>W</variation>
<location>
<position position="841"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with sporadic breast cancer; unknown pathological significance; dbSNP:rs80356892." id="VAR_020685" evidence="52 80">
<original>Y</original>
<variation>H</variation>
<location>
<position position="856"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41286300." id="VAR_070478" evidence="80">
<original>R</original>
<variation>C</variation>
<location>
<position position="866"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020686" evidence="43">
<original>R</original>
<variation>Q</variation>
<location>
<position position="866"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs799917." id="VAR_007774" evidence="21 39 52 54 103">
<original>P</original>
<variation>L</variation>
<location>
<position position="871"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80357480." id="VAR_020687" evidence="43">
<original>H</original>
<variation>Y</variation>
<location>
<position position="888"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs397508994." id="VAR_007775" evidence="98">
<original>L</original>
<variation>S</variation>
<location>
<position position="892"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4986847." id="VAR_021913">
<original>I</original>
<variation>L</variation>
<location>
<position position="925"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs397509022." id="VAR_007776" evidence="98">
<original>G</original>
<variation>D</variation>
<location>
<position position="960"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4986848." id="VAR_020111">
<original>F</original>
<variation>S</variation>
<location>
<position position="989"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs1800704." id="VAR_007777">
<original>M</original>
<variation>I</variation>
<location>
<position position="1008"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs397509034." id="VAR_007778" evidence="98">
<original>T</original>
<variation>I</variation>
<location>
<position position="1025"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs16941." id="VAR_007779" evidence="21 52 54 88 103">
<original>E</original>
<variation>G</variation>
<location>
<position position="1038"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; dbSNP:rs4986852." id="VAR_007780" evidence="49 87 88 96 103">
<original>S</original>
<variation>N</variation>
<location>
<position position="1040"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs397509037." id="VAR_007781" evidence="98">
<original>V</original>
<variation>A</variation>
<location>
<position position="1047"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs80357184." id="VAR_020688" evidence="49 80">
<original>E</original>
<variation>A</variation>
<location>
<position position="1060"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs41293447." id="VAR_070479" evidence="80">
<original>S</original>
<variation>N</variation>
<location>
<position position="1101"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80357228." id="VAR_020689" evidence="43">
<original>S</original>
<variation>I</variation>
<location>
<position position="1139"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs2227945." id="VAR_019945" evidence="80 103">
<original>S</original>
<variation>G</variation>
<location>
<position position="1140"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro." id="VAR_070480" evidence="80">
<original>S</original>
<variation>N</variation>
<location>
<position position="1140"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs80357272." id="VAR_007782" evidence="91">
<original>P</original>
<variation>S</variation>
<location>
<position position="1150"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs16942." id="VAR_007783" evidence="21 45 52 54 88 103">
<original>K</original>
<variation>R</variation>
<location>
<position position="1183"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and BROVCA1." id="VAR_020690" evidence="45">
<original>S</original>
<variation>I</variation>
<location>
<position position="1187"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and BROVCA1; dbSNP:rs56214134." id="VAR_020691" evidence="45">
<original>Q</original>
<variation>H</variation>
<location>
<position position="1200"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020692" evidence="45">
<original>R</original>
<variation>I</variation>
<location>
<position position="1204"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020693" evidence="45">
<original>K</original>
<variation>N</variation>
<location>
<position position="1207"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020694" evidence="43">
<original>E</original>
<variation>G</variation>
<location>
<position position="1210"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80356923." id="VAR_070481" evidence="80">
<original>E</original>
<variation>K</variation>
<location>
<position position="1214"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and BROVCA1." id="VAR_020695" evidence="45">
<original>S</original>
<variation>Y</variation>
<location>
<position position="1217"/>
</location>
</feature>
<feature type="sequence variant" description="Found in breast-ovarian cancer patients; unknown pathological significance; dbSNP:rs80356876." id="VAR_007784">
<original>E</original>
<variation>D</variation>
<location>
<position position="1219"/>
</location>
</feature>
<feature type="sequence variant" description="In BROVCA1." id="VAR_020696" evidence="45">
<original>F</original>
<variation>L</variation>
<location>
<position position="1226"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897687." id="VAR_052078" evidence="80">
<original>N</original>
<variation>K</variation>
<location>
<position position="1236"/>
</location>
</feature>
<feature type="sequence variant" description="In BROVCA1." id="VAR_020697" evidence="45">
<original>R</original>
<variation>G</variation>
<location>
<position position="1243"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897686." id="VAR_052079" evidence="80">
<original>E</original>
<variation>K</variation>
<location>
<position position="1250"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs587782190." id="VAR_070482" evidence="80">
<original>L</original>
<variation>S</variation>
<location>
<position position="1267"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357217." id="VAR_070483" evidence="80">
<original>E</original>
<variation>V</variation>
<location>
<position position="1282"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020698" evidence="43">
<original>S</original>
<variation>P</variation>
<location>
<position position="1297"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro." id="VAR_070484" evidence="80">
<location>
<position position="1297"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs273900719." id="VAR_070485" evidence="80">
<original>S</original>
<variation>R</variation>
<location>
<position position="1301"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357407." id="VAR_070486" evidence="80">
<original>E</original>
<variation>K</variation>
<location>
<position position="1346"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897689." id="VAR_007785" evidence="35">
<original>R</original>
<variation>G</variation>
<location>
<position position="1347"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs28897690." id="VAR_070487" evidence="80">
<original>V</original>
<variation>I</variation>
<location>
<position position="1378"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357306." id="VAR_070488" evidence="80">
<original>M</original>
<variation>V</variation>
<location>
<position position="1400"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; dbSNP:rs1800707." id="VAR_008761">
<original>K</original>
<variation>N</variation>
<location>
<position position="1406"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357492." id="VAR_070489" evidence="80">
<original>L</original>
<variation>P</variation>
<location>
<position position="1407"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and ovarian cancer; unknown pathological significance; decreased interaction with PALB2; dbSNP:rs273900729." id="VAR_020699" evidence="46 71 80">
<original>M</original>
<variation>T</variation>
<location>
<position position="1411"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_007786">
<original>S</original>
<variation>P</variation>
<location>
<position position="1431"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs41293455." id="VAR_007787" evidence="80 87 96">
<original>R</original>
<variation>G</variation>
<location>
<position position="1443"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4986849." id="VAR_020112">
<original>R</original>
<variation>Q</variation>
<location>
<position position="1443"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357486." id="VAR_070490" evidence="80">
<original>S</original>
<variation>G</variation>
<location>
<position position="1448"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs397507232." id="VAR_070491" evidence="80">
<original>S</original>
<variation>C</variation>
<location>
<position position="1486"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80357389." id="VAR_063900" evidence="63">
<original>R</original>
<variation>M</variation>
<location>
<position position="1495"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1800744." id="VAR_007788" evidence="35 96 100">
<original>S</original>
<variation>I</variation>
<location>
<position position="1512"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs55815649." id="VAR_070492" evidence="80">
<original>V</original>
<variation>M</variation>
<location>
<position position="1534"/>
</location>
</feature>
<feature type="sequence variant" description="Found in breast cancer; unknown pathological significance; dbSNP:rs56158747." id="VAR_007789">
<original>T</original>
<variation>I</variation>
<location>
<position position="1561"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro." id="VAR_070493" evidence="80">
<original>R</original>
<variation>P</variation>
<location>
<position position="1589"/>
</location>
</feature>
<feature type="sequence variant" description="Found in breast cancer; unknown pathological significance; dbSNP:rs80356943." id="VAR_007790">
<original>K</original>
<variation>E</variation>
<location>
<position position="1606"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs1799966." id="VAR_007791" evidence="21 39 54 88 95 103">
<original>S</original>
<variation>G</variation>
<location>
<position position="1613"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8176219." id="VAR_019946" evidence="103">
<original>T</original>
<variation>A</variation>
<location>
<position position="1620"/>
</location>
</feature>
<feature type="sequence variant" description="Could be associated with cancer susceptibility; major splicing aberration identified with this mutant; dbSNP:rs80356862." id="VAR_063901" evidence="63 76">
<original>A</original>
<variation>G</variation>
<location>
<position position="1623"/>
</location>
</feature>
<feature type="sequence variant" description="In some patients with sporadic breast cancer; unknown pathological significance; dbSNP:rs4986854." id="VAR_007793" evidence="52 80">
<original>M</original>
<variation>T</variation>
<location>
<position position="1628"/>
</location>
</feature>
<feature type="sequence variant" description="Found in breast and ovarian cancer patients; unknown pathological significance; dbSNP:rs80357465." id="VAR_007792">
<original>M</original>
<variation>V</variation>
<location>
<position position="1628"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; dbSNP:rs80357048." id="VAR_007794" evidence="89 96">
<original>P</original>
<variation>L</variation>
<location>
<position position="1637"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; unknown pathological significance; dbSNP:rs1800726." id="VAR_008762">
<original>A</original>
<variation>P</variation>
<location>
<position position="1641"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80356938." id="VAR_070494" evidence="80">
<original>S</original>
<variation>F</variation>
<location>
<position position="1651"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs879254042." id="VAR_070495" evidence="80">
<original>S</original>
<variation>P</variation>
<location>
<position position="1651"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; dbSNP:rs1799967." id="VAR_007795" evidence="35 54 80 96">
<original>M</original>
<variation>I</variation>
<location>
<position position="1652"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357390." id="VAR_070496" evidence="80">
<original>S</original>
<variation>F</variation>
<location>
<position position="1655"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897695." id="VAR_052080">
<original>F</original>
<variation>C</variation>
<location>
<position position="1662"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs80357169." id="VAR_020700" evidence="49">
<original>V</original>
<variation>M</variation>
<location>
<position position="1665"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80356890." id="VAR_063902" evidence="63">
<original>T</original>
<variation>A</variation>
<location>
<position position="1685"/>
</location>
</feature>
<feature type="sequence variant" description="Could be associated with cancer susceptibility; multifactorial likelihood analysis provides evidence for pathogenicity; dbSNP:rs80357043." id="VAR_063903" evidence="63 76">
<original>T</original>
<variation>I</variation>
<location>
<position position="1685"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs397509218." id="VAR_070497" evidence="80">
<original>H</original>
<variation>Q</variation>
<location>
<position position="1686"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs730882166." id="VAR_070498" evidence="80">
<original>H</original>
<variation>R</variation>
<location>
<position position="1686"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro." id="VAR_070499" evidence="80">
<location>
<position position="1688"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80357061." id="VAR_063904" evidence="63">
<original>M</original>
<variation>R</variation>
<location>
<position position="1689"/>
</location>
</feature>
<feature type="sequence variant" description="In some patients with sporadic breast cancer; unknown pathological significance; dbSNP:rs397507239." id="VAR_020701" evidence="52">
<original>K</original>
<variation>Q</variation>
<location>
<position position="1690"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357034." id="VAR_070500" evidence="80">
<original>T</original>
<variation>I</variation>
<location>
<position position="1691"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; unknown pathological significance; dbSNP:rs80187739." id="VAR_008763">
<original>D</original>
<variation>N</variation>
<location>
<position position="1692"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; dbSNP:rs80356993." id="VAR_020702" evidence="46">
<original>C</original>
<variation>R</variation>
<location>
<position position="1697"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; strongly reduces affinity for a BRIP1 phosphopeptide; functionally impaired in vitro; dbSNP:rs41293459." id="VAR_070501" evidence="78 80">
<original>R</original>
<variation>Q</variation>
<location>
<position position="1699"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and ovarian cancer; impairs protein stability; functionally impaired in vitro; dbSNP:rs55770810." id="VAR_075666" evidence="46 63 78 80">
<original>R</original>
<variation>W</variation>
<location>
<position position="1699"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80356860." id="VAR_070502" evidence="80">
<original>G</original>
<variation>A</variation>
<location>
<position position="1706"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80356860." id="VAR_063905" evidence="63 80">
<original>G</original>
<variation>E</variation>
<location>
<position position="1706"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; abolishes ACACA binding; dbSNP:rs28897696." id="VAR_007796" evidence="63 80 89">
<original>A</original>
<variation>E</variation>
<location>
<position position="1708"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_007797" evidence="52">
<original>V</original>
<variation>G</variation>
<location>
<position position="1713"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80357094." id="VAR_063906" evidence="63">
<original>S</original>
<variation>R</variation>
<location>
<position position="1715"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357239." id="VAR_070503" evidence="80">
<original>W</original>
<variation>C</variation>
<location>
<position position="1718"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; no effect on in vitro phosphorylation by ATR; dbSNP:rs56195342." id="VAR_070504" evidence="26 80">
<original>T</original>
<variation>A</variation>
<location>
<position position="1720"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs397509238." id="VAR_070505" evidence="80">
<original>E</original>
<variation>K</variation>
<location>
<position position="1735"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs45553935." id="VAR_070506" evidence="80">
<original>V</original>
<variation>A</variation>
<location>
<position position="1736"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80356937." id="VAR_063907" evidence="63">
<original>G</original>
<variation>R</variation>
<location>
<position position="1738"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357227." id="VAR_070507" evidence="80">
<original>D</original>
<variation>G</variation>
<location>
<position position="1739"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357227." id="VAR_070508" evidence="80">
<original>D</original>
<variation>V</variation>
<location>
<position position="1739"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs786202389." id="VAR_070509" evidence="80">
<original>H</original>
<variation>Q</variation>
<location>
<position position="1746"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; unknown pathological significance; abolishes ACACA binding and strongly reduces BRIP1 binding; dbSNP:rs80357462." id="VAR_007798" evidence="22 28 51">
<original>P</original>
<variation>R</variation>
<location>
<position position="1749"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs397509246." id="VAR_070510" evidence="80">
<original>R</original>
<variation>T</variation>
<location>
<position position="1753"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357281." id="VAR_063908" evidence="63 80">
<original>L</original>
<variation>P</variation>
<location>
<position position="1764"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80357463." id="VAR_063909" evidence="63">
<original>I</original>
<variation>S</variation>
<location>
<position position="1766"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro." id="VAR_070511" evidence="80">
<original>C</original>
<variation>S</variation>
<location>
<position position="1767"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro." id="VAR_070512" evidence="80">
<original>G</original>
<variation>V</variation>
<location>
<position position="1770"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; strongly reduced transcription transactivation; abolishes interaction with BRIP1 and RBBP8; dbSNP:rs41293463." id="VAR_063212" evidence="65">
<original>M</original>
<variation>K</variation>
<location>
<position position="1775"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; alters protein stability and abolishes ACACA and BRIP1 binding; dbSNP:rs41293463." id="VAR_007799" evidence="28 38 51 86 89">
<original>M</original>
<variation>R</variation>
<location>
<position position="1775"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; unknown pathological significance; dbSNP:rs1800757." id="VAR_008764">
<original>P</original>
<variation>S</variation>
<location>
<position position="1776"/>
</location>
</feature>
<feature type="sequence variant" description="In BC, BROVCA1 and OC; unknown pathological significance." id="VAR_079607" evidence="85">
<original>L</original>
<variation>P</variation>
<location>
<position position="1780"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro." id="VAR_070513" evidence="80">
<original>W</original>
<variation>C</variation>
<location>
<position position="1782"/>
</location>
</feature>
<feature type="sequence variant" description="In BROVCA1; unknown pathological significance; dbSNP:rs398122697." id="VAR_020704" evidence="43">
<original>L</original>
<variation>P</variation>
<location>
<position position="1786"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80357069." id="VAR_063910" evidence="63">
<original>G</original>
<variation>V</variation>
<location>
<position position="1788"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80357078." id="VAR_070514" evidence="80">
<original>A</original>
<variation>T</variation>
<location>
<position position="1789"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs397509275." id="VAR_070515" evidence="80">
<original>E</original>
<variation>D</variation>
<location>
<position position="1794"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80356920." id="VAR_070516" evidence="80">
<original>V</original>
<variation>D</variation>
<location>
<position position="1804"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro." id="VAR_070517" evidence="80">
<original>P</original>
<variation>R</variation>
<location>
<position position="1812"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; unknown pathological significance; dbSNP:rs1800751." id="VAR_008765">
<original>P</original>
<variation>S</variation>
<location>
<position position="1812"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally impaired in vitro; dbSNP:rs80356959." id="VAR_070518" evidence="80">
<original>W</original>
<variation>R</variation>
<location>
<position position="1837"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; functionally neutral in vitro; dbSNP:rs80357183." id="VAR_070519" evidence="80">
<original>H</original>
<variation>L</variation>
<location>
<position position="1862"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts the interaction with E2 enzymes, thereby abolishing the E3 ubiquitin-protein ligase activity." evidence="58 74">
<original>I</original>
<variation>A</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="mutagenesis site" description="No ubiquitination of RBBP8. No restoration RBBP8-mediated focus formation or G2/M checkpoint control upon DNA damage." evidence="58 74">
<original>I</original>
<variation>E</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with BAP1." evidence="97">
<original>R</original>
<variation>G</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation by AURKA and interferes with cell cycle progression from G2 to mitosis." evidence="48">
<original>S</original>
<variation>N</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces in vitro phosphorylation by ATR." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="1143"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on in vitro phosphorylation by ATR." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="1239"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces in vitro phosphorylation by ATR." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="1280"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on in vitro phosphorylation by ATR." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="1298"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on in vitro phosphorylation by ATR." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="1330"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of IR-induced S-phase checkpoint. Reduces in vitro phosphorylation by ATR." evidence="26 34">
<original>S</original>
<variation>A</variation>
<location>
<position position="1387"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces in vitro phosphorylation by ATR." evidence="26">
<original>T</original>
<variation>A</variation>
<location>
<position position="1394"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibition of the infrared-induced G2 arrest. Reduces phosphorylation by ATR." evidence="26 34">
<original>S</original>
<variation>A</variation>
<location>
<position position="1423"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces in vitro phosphorylation by ATR." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="1457"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on in vitro phosphorylation by ATR." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="1466"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in infrared S-phase delay; when associated with A-1387. No effect on in vitro phosphorylation by ATR." evidence="26 34">
<original>S</original>
<variation>A</variation>
<location>
<position position="1524"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with BRIP1." evidence="51">
<original>S</original>
<variation>A</variation>
<location>
<position position="1655"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on affinity for a BRIP1 phosphopeptide." evidence="78">
<original>G</original>
<variation>D</variation>
<location>
<position position="1656"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not abolish ABRAXAS1 binding, but abolishes formation of a heterotetramer with ABRAXAS1." evidence="82">
<original>F</original>
<variation>S</variation>
<location>
<position position="1662"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not abolish ABRAXAS1 binding, but abolishes formation of a heterotetramer with ABRAXAS1." evidence="82">
<original>M</original>
<variation>K</variation>
<location>
<position position="1663"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not abolish ABRAXAS1 binding, but impairs formation of a heterotetramer with ABRAXAS1." evidence="82">
<original>Y</original>
<variation>A</variation>
<location>
<position position="1666"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs formation of a heterotetramer with ABRAXAS1." evidence="82">
<original>R</original>
<variation>E</variation>
<location>
<position position="1670"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs formation of a heterotetramer with ABRAXAS1." evidence="82">
<original>K</original>
<variation>E</variation>
<location>
<position position="1671"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces affinity for a BRIP1 phosphopeptide." evidence="78">
<original>T</original>
<variation>A</variation>
<location>
<position position="1700"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with BRIP1." evidence="51">
<original>K</original>
<variation>M</variation>
<location>
<position position="1702"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with BRIP1." evidence="51">
<original>G</original>
<variation>E</variation>
<location>
<position position="1738"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on in vitro phosphorylation by ATR." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="1755"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mildly reduces affinity for a BRIP1 phosphopeptide." evidence="78">
<original>R</original>
<variation>P</variation>
<location>
<position position="1835"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduces affinity for a BRIP1 phosphopeptide." evidence="78">
<original>E</original>
<variation>K</variation>
<location>
<position position="1836"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAB61673." ref="4" evidence="107">
<original>I</original>
<variation>T</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAB61673." ref="4" evidence="107">
<location>
<position position="148"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAC00049." ref="3" evidence="107">
<original>A</original>
<variation>V</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAI15038." ref="8" evidence="107">
<original>S</original>
<variation>P</variation>
<location>
<position position="713"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAB61673." ref="4" evidence="107">
<original>G</original>
<variation>R</variation>
<location>
<position position="1077"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAC00049." ref="3" evidence="107">
<original>S</original>
<variation>P</variation>
<location>
<position position="1426"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAI15038." ref="8" evidence="107">
<original>E</original>
<variation>G</variation>
<location>
<position position="1527"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="3"/>
<end position="5"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="8"/>
<end position="21"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="25"/>
<end position="27"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="46"/>
<end position="53"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="54"/>
<end position="58"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="62"/>
<end position="64"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="70"/>
<end position="72"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="78"/>
<end position="80"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="81"/>
<end position="96"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1651"/>
<end position="1656"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1659"/>
<end position="1671"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1675"/>
<end position="1679"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1686"/>
<end position="1689"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1695"/>
<end position="1697"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1701"/>
<end position="1708"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1712"/>
<end position="1715"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1717"/>
<end position="1725"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1731"/>
<end position="1734"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="1740"/>
<end position="1742"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="1743"/>
<end position="1745"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1748"/>
<end position="1754"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="1755"/>
<end position="1757"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="1760"/>
<end position="1763"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1765"/>
<end position="1768"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1770"/>
<end position="1772"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1773"/>
<end position="1775"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1777"/>
<end position="1786"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1790"/>
<end position="1794"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1795"/>
<end position="1797"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1801"/>
<end position="1803"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1806"/>
<end position="1810"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1812"/>
<end position="1814"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1817"/>
<end position="1819"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1820"/>
<end position="1822"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1824"/>
<end position="1827"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="1828"/>
<end position="1830"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1832"/>
<end position="1834"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1835"/>
<end position="1844"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1851"/>
<end position="1853"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1JM7"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1OQA"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1T29"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1T2V"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3PXE"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4IGK"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P48754"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00033"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00175"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10196379"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10323242"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10486320"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10500182"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10724175"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10783165"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11114888"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11239454"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11301010"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11573085"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11739404"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11751867"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11836499"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11877377"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12183412"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12215251"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12360400"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12419185"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12427738"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12442274"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12442275"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12887909"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12890688"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12938098"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14636569"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14722926"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14746861"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14976165"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14990569"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15026808"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15096610"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15133502"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15365993"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15456891"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16101277"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16326698"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16698035"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16818604"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17525340"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17643121"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17643122"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17924331"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18056443"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18285836"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18452305"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18762988"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19261746"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19261748"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19261749"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19369211"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20159462"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20160719"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20351172"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20364141"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20513136"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21144835"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21473589"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21673012"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23867111"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24316840"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26778126"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26807646"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28319063"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28364669"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7545954"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7894491"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7894493"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7939630"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8554067"/>
</source>
</evidence>
<evidence key="91" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8723683"/>
</source>
</evidence>
<evidence key="92" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8776600"/>
</source>
</evidence>
<evidence key="93" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8968716"/>
</source>
</evidence>
<evidence key="94" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8972225"/>
</source>
</evidence>
<evidence key="95" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9010228"/>
</source>
</evidence>
<evidence key="96" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9482581"/>
</source>
</evidence>
<evidence key="97" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9528852"/>
</source>
</evidence>
<evidence key="98" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9609997"/>
</source>
</evidence>
<evidence key="99" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9662397"/>
</source>
</evidence>
<evidence key="100" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9760198"/>
</source>
</evidence>
<evidence key="101" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9811458"/>
</source>
</evidence>
<evidence key="102" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="103" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="104" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="105" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9010228"/>
</source>
</evidence>
<evidence key="106" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="107" type="ECO:0000305"/>
<sequence length="1863" mass="207721" checksum="89C6D83FF56312AF" modified="1995-02-01" version="2">
MDLSALRVEEVQNVINAMQKILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQ
CPLCKNDITKRSLQESTRFSQLVEELLKIICAFQLDTGLEYANSYNFAKKENNSPEHLKD
EVSIIQSMGYRNRAKRLLQSEPENPSLQETSLSVQLSNLGTVRTLRTKQRIQPQKTSVYI
ELGSDSSEDTVNKATYCSVGDQELLQITPQGTRDEISLDSAKKAACEFSETDVTNTEHHQ
PSNNDLNTTEKRAAERHPEKYQGSSVSNLHVEPCGTNTHASSLQHENSSLLLTKDRMNVE
KAEFCNKSKQPGLARSQHNRWAGSKETCNDRRTPSTEKKVDLNADPLCERKEWNKQKLPC
SENPRDTEDVPWITLNSSIQKVNEWFSRSDELLGSDDSHDGESESNAKVADVLDVLNEVD
EYSGSSEKIDLLASDPHEALICKSERVHSKSVESNIEDKIFGKTYRKKASLPNLSHVTEN
LIIGAFVTEPQIIQERPLTNKLKRKRRPTSGLHPEDFIKKADLAVQKTPEMINQGTNQTE
QNGQVMNITNSGHENKTKGDSIQNEKNPNPIESLEKESAFKTKAEPISSSISNMELELNI
HNSKAPKKNRLRRKSSTRHIHALELVVSRNLSPPNCTELQIDSCSSSEEIKKKKYNQMPV
RHSRNLQLMEGKEPATGAKKSNKPNEQTSKRHDSDTFPELKLTNAPGSFTKCSNTSELKE
FVNPSLPREEKEEKLETVKVSNNAEDPKDLMLSGERVLQTERSVESSSISLVPGTDYGTQ
ESISLLEVSTLGKAKTEPNKCVSQCAAFENPKGLIHGCSKDNRNDTEGFKYPLGHEVNHS
RETSIEMEESELDAQYLQNTFKVSKRQSFAPFSNPGNAEEECATFSAHSGSLKKQSPKVT
FECEQKEENQGKNESNIKPVQTVNITAGFPVVGQKDKPVDNAKCSIKGGSRFCLSSQFRG
NETGLITPNKHGLLQNPYRIPPLFPIKSFVKTKCKKNLLEENFEEHSMSPEREMGNENIP
STVSTISRNNIRENVFKEASSSNINEVGSSTNEVGSSINEIGSSDENIQAELGRNRGPKL
NAMLRLGVLQPEVYKQSLPGSNCKHPEIKKQEYEEVVQTVNTDFSPYLISDNLEQPMGSS
HASQVCSETPDDLLDDGEIKEDTSFAENDIKESSAVFSKSVQKGELSRSPSPFTHTHLAQ
GYRRGAKKLESSEENLSSEDEELPCFQHLLFGKVNNIPSQSTRHSTVATECLSKNTEENL
LSLKNSLNDCSNQVILAKASQEHHLSEETKCSASLFSSQCSELEDLTANTNTQDPFLIGS
SKQMRHQSESQGVGLSDKELVSDDEERGTGLEENNQEEQSMDSNLGEAASGCESETSVSE
DCSGLSSQSDILTTQQRDTMQHNLIKLQQEMAELEAVLEQHGSQPSNSYPSIISDSSALE
DLRNPEQSTSEKAVLTSQKSSEYPISQNPEGLSADKFEVSADSSTSKNKEPGVERSSPSK
CPSLDDRWYMHSCSGSLQNRNYPSQEELIKVVDVEEQQLEESGPHDLTETSYLPRQDLEG
TPYLESGISLFSDDPESDPSEDRAPESARVGNIPSSTSALKVPQLKVAESAQSPAAAHTT
DTAGYNAMEESVSREKPELTASTERVNKRMSMVVSGLTPEEFMLVYKFARKHHITLTNLI
TEETTHVVMKTDAEFVCERTLKYFLGIAGGKWVVSYFWVTQSIKERKMLNEHDFEVRGDV
VNGRNHQGPKRARESQDRKIFRGLEICCYGPFTNMPTDQLEWMVQLCGASVVKELSSFTL
GTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTREWVLDSVALYQCQELDTYLIPQIPH
SHY
</sequence>
</entry>
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2017-12-20" version="201">
<accession>P51587</accession>
<accession>O00183</accession>
<accession>O15008</accession>
<accession>Q13879</accession>
<accession>Q5TBJ7</accession>
<name>BRCA2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Breast cancer type 2 susceptibility protein</fullName>
</recommendedName>
<alternativeName>
<fullName>Fanconi anemia group D1 protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">BRCA2</name>
<name type="synonym">FACD</name>
<name type="synonym">FANCD1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Nature" volume="378" first="789" last="792">
<title>Identification of the breast cancer susceptibility gene BRCA2.</title>
<authorList>
<person name="Wooster R."/>
<person name="Bignell G."/>
<person name="Lancaster J."/>
<person name="Swift S."/>
<person name="Seal S."/>
<person name="Mangion J."/>
<person name="Collins N."/>
<person name="Gregory S."/>
<person name="Gumbs C."/>
<person name="Micklem G."/>
<person name="Barfoot R."/>
<person name="Hamoudi R."/>
<person name="Patel S."/>
<person name="Rice C."/>
<person name="Biggs P."/>
<person name="Hashim Y."/>
<person name="Smith A."/>
<person name="Connor F."/>
<person name="Arason A."/>
<person name="Gudmundsson J."/>
<person name="Ficenec D."/>
<person name="Kelsell D."/>
<person name="Ford D."/>
<person name="Tonin P."/>
<person name="Bishop D.T."/>
<person name="Spurr N.K."/>
<person name="Ponder B.A.J."/>
<person name="Eeles R."/>
<person name="Peto J."/>
<person name="Devilee P."/>
<person name="Cornelisse C."/>
<person name="Lynch H."/>
<person name="Narod S."/>
<person name="Lenoir G."/>
<person name="Egilsson V."/>
<person name="Barkadottir R.B."/>
<person name="Easton D.F."/>
<person name="Bentley D.R."/>
<person name="Futreal P.A."/>
<person name="Ashworth A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="8524414"/>
<dbReference type="DOI" id="10.1038/378789a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Nat. Genet." volume="12" first="333" last="337">
<title>The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.</title>
<authorList>
<person name="Tavtigian S.V."/>
<person name="Simard J."/>
<person name="Rommens J."/>
<person name="Couch F."/>
<person name="Shattuck-Eidens D."/>
<person name="Neuhausen S."/>
<person name="Merajver S."/>
<person name="Thorlacius S."/>
<person name="Offit K."/>
<person name="Stoppa-Lyonnet D."/>
<person name="Belanger C."/>
<person name="Bell R."/>
<person name="Berry S."/>
<person name="Bogden R."/>
<person name="Chen Q."/>
<person name="Davis T."/>
<person name="Dumont M."/>
<person name="Frye C."/>
<person name="Hattier T."/>
<person name="Jammulapati S."/>
<person name="Janecki T."/>
<person name="Jiang P."/>
<person name="Kehrer R."/>
<person name="Leblanc J.-F."/>
<person name="Mitchell J.T."/>
<person name="McArthur-Morrison J."/>
<person name="Nguyen K."/>
<person name="Peng Y."/>
<person name="Samson C."/>
<person name="Schroeder M."/>
<person name="Snyder S.C."/>
<person name="Steele L."/>
<person name="Stringfellow M."/>
<person name="Stroup C."/>
<person name="Swedlund B."/>
<person name="Swensen J."/>
<person name="Teng D."/>
<person name="Thomas A."/>
<person name="Tran T."/>
<person name="Tran T."/>
<person name="Tranchant M."/>
<person name="Weaver-Feldhaus J."/>
<person name="Wong A.K.C."/>
<person name="Shizuya H."/>
<person name="Eyfjord J.E."/>
<person name="Cannon-Albright L."/>
<person name="Labrie F."/>
<person name="Skolnick M.H."/>
<person name="Weber B."/>
<person name="Kamb A."/>
<person name="Goldar D.E."/>
</authorList>
<dbReference type="PubMed" id="8589730"/>
<dbReference type="DOI" id="10.1038/ng0396-333"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS HIS-372 AND PHE-599</scope>
</reference>
<reference key="3">
<citation type="submission" date="2003-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS HIS-289; GLN-322; HIS-372; VAL-784; SER-929; PHE-976; ILE-987; ASP-991; ASN-1561; LYS-1880; MET-1915; PHE-2138; ARG-2162; ARG-2440; VAL-2466; THR-2490; PRO-2835; ALA-2856; PHE-2944; THR-2951; ILE-3244 AND VAL-3412</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nature" volume="428" first="522" last="528">
<title>The DNA sequence and analysis of human chromosome 13.</title>
<authorList>
<person name="Dunham A."/>
<person name="Matthews L.H."/>
<person name="Burton J."/>
<person name="Ashurst J.L."/>
<person name="Howe K.L."/>
<person name="Ashcroft K.J."/>
<person name="Beare D.M."/>
<person name="Burford D.C."/>
<person name="Hunt S.E."/>
<person name="Griffiths-Jones S."/>
<person name="Jones M.C."/>
<person name="Keenan S.J."/>
<person name="Oliver K."/>
<person name="Scott C.E."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Andrews D.T."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Bannerjee R."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burrill W."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clamp M.E."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S.C."/>
<person name="Cobley V."/>
<person name="Collins J.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Deloukas P."/>
<person name="Dhami P."/>
<person name="Dunham I."/>
<person name="Dunn M."/>
<person name="Earthrowl M.E."/>
<person name="Ellington A.G."/>
<person name="Faulkner L."/>
<person name="Frankish A.G."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gilbert J.G.R."/>
<person name="Gilson C.J."/>
<person name="Ghori J."/>
<person name="Grafham D.V."/>
<person name="Gribble S.M."/>
<person name="Griffiths C."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C.J."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Lloyd C."/>
<person name="Loveland J.E."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="McLaren S.J."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K.M."/>
<person name="Rice C.M."/>
<person name="Searle S."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thomas D.W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tubby B."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wright M.W."/>
<person name="Young L."/>
<person name="Coulson A."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Sulston J.E."/>
<person name="Beck S."/>
<person name="Bentley D.R."/>
<person name="Rogers J."/>
<person name="Ross M.T."/>
</authorList>
<dbReference type="PubMed" id="15057823"/>
<dbReference type="DOI" id="10.1038/nature02379"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1997" name="Nat. Genet." volume="16" first="17" last="18">
<title>Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients.</title>
<authorList>
<person name="Ozcelik H."/>
<person name="Schmocker B."/>
<person name="Di Nicola N."/>
<person name="Shi X.H."/>
<person name="Langer B."/>
<person name="Moore M."/>
<person name="Taylor B.R."/>
<person name="Narod S.A."/>
<person name="Darlington G."/>
<person name="Andrulis I.L."/>
<person name="Gallinger S."/>
<person name="Redston M."/>
</authorList>
<dbReference type="PubMed" id="9140390"/>
<dbReference type="DOI" id="10.1038/ng0597-17"/>
</citation>
<scope>INVOLVEMENT IN PNCA2</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="4633" last="4642">
<title>Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals.</title>
<authorList>
<person name="Marston N.J."/>
<person name="Richards W.J."/>
<person name="Hughes D."/>
<person name="Bertwistle D."/>
<person name="Marshall C.J."/>
<person name="Ashworth A."/>
</authorList>
<dbReference type="PubMed" id="10373512"/>
<dbReference type="DOI" id="10.1128/MCB.19.7.4633"/>
</citation>
<scope>INTERACTION WITH SEM1</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Hum. Mol. Genet." volume="13" first="1241" last="1248">
<title>Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways.</title>
<authorList>
<person name="Hussain S."/>
<person name="Wilson J.B."/>
<person name="Medhurst A.L."/>
<person name="Hejna J."/>
<person name="Witt E."/>
<person name="Ananth S."/>
<person name="Davies A."/>
<person name="Masson J.-Y."/>
<person name="Moses R."/>
<person name="West S.C."/>
<person name="de Winter J.P."/>
<person name="Ashworth A."/>
<person name="Jones N.J."/>
<person name="Mathew C.G."/>
</authorList>
<dbReference type="PubMed" id="15115758"/>
<dbReference type="DOI" id="10.1093/hmg/ddh135"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FANCD2</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="5850" last="5862">
<title>Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin.</title>
<authorList>
<person name="Wang X.Z."/>
<person name="Andreassen P.R."/>
<person name="D'Andrea A.D."/>
</authorList>
<dbReference type="PubMed" id="15199141"/>
<dbReference type="DOI" id="10.1128/MCB.24.13.5850-5862.2004"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH FANCD2</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="7444" last="7455">
<title>BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage.</title>
<authorList>
<person name="Schoenfeld A.R."/>
<person name="Apgar S."/>
<person name="Dolios G."/>
<person name="Wang R."/>
<person name="Aaronson S.A."/>
</authorList>
<dbReference type="PubMed" id="15314155"/>
<dbReference type="DOI" id="10.1128/MCB.24.17.7444-7455.2004"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION</scope>
<scope>INTERACTION WITH USP11</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="J. Med. Genet." volume="42" first="147" last="151">
<title>Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour.</title>
<authorList>
<consortium name="The famillial Wilms tumor collaboration"/>
<person name="Reid S."/>
<person name="Renwick A."/>
<person name="Seal S."/>
<person name="Baskcomb L."/>
<person name="Barfoot R."/>
<person name="Jayatilake H."/>
<person name="Pritchard-Jones K."/>
<person name="Stratton M.R."/>
<person name="Ridolfi-Luethy A."/>
<person name="Rahman N."/>
</authorList>
<dbReference type="PubMed" id="15689453"/>
<dbReference type="DOI" id="10.1136/jmg.2004.022673"/>
</citation>
<scope>INVOLVEMENT IN GLM3</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="14877" last="14883">
<title>FANCD2 functions independently of BRCA2 and RAD51 associated homologous recombination in response to DNA damage.</title>
<authorList>
<person name="Ohashi A."/>
<person name="Zdzienicka M.Z."/>
<person name="Chen J."/>
<person name="Couch F.J."/>
</authorList>
<dbReference type="PubMed" id="15671039"/>
<dbReference type="DOI" id="10.1074/jbc.M414669200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="Nature" volume="434" first="598" last="604">
<title>CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair.</title>
<authorList>
<person name="Esashi F."/>
<person name="Christ N."/>
<person name="Gannon J."/>
<person name="Liu Y."/>
<person name="Hunt T."/>
<person name="Jasin M."/>
<person name="West S.C."/>
</authorList>
<dbReference type="PubMed" id="15800615"/>
<dbReference type="DOI" id="10.1038/nature03404"/>
</citation>
<scope>PHOSPHORYLATION AT SER-3291 BY CDK2</scope>
<scope>INTERACTION WITH RAD51</scope>
<scope>MUTAGENESIS OF SER-3291</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="Neoplasia" volume="7" first="348" last="355">
<title>WDRPUH, a novel WD-repeat-containing protein, is highly expressed in human hepatocellular carcinoma and involved in cell proliferation.</title>
<authorList>
<person name="Silva F.P."/>
<person name="Hamamoto R."/>
<person name="Nakamura Y."/>
<person name="Furukawa Y."/>
</authorList>
<dbReference type="PubMed" id="15967112"/>
<dbReference type="DOI" id="10.1593/neo.04544"/>
</citation>
<scope>INTERACTION WITH WDR16</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Mol. Cell" volume="22" first="719" last="729">
<title>Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.</title>
<authorList>
<person name="Xia B."/>
<person name="Sheng Q."/>
<person name="Nakanishi K."/>
<person name="Ohashi A."/>
<person name="Wu J."/>
<person name="Christ N."/>
<person name="Liu X."/>
<person name="Jasin M."/>
<person name="Couch F.J."/>
<person name="Livingston D.M."/>
</authorList>
<dbReference type="PubMed" id="16793542"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.05.022"/>
</citation>
<scope>INTERACTION WITH PALB2</scope>
<scope>CHARACTERIZATION OF VARIANTS BC ARG-25; CYS-31 AND ARG-31</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="1186" last="1194">
<title>DSS1 is required for the stability of BRCA2.</title>
<authorList>
<person name="Li J."/>
<person name="Zou C."/>
<person name="Bai Y."/>
<person name="Wazer D.E."/>
<person name="Band V."/>
<person name="Gao Q."/>
</authorList>
<dbReference type="PubMed" id="16205630"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209153"/>
</citation>
<scope>INTERACTION WITH SEM1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-755</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Oncogene" volume="27" first="3641" last="3652">
<title>FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.</title>
<authorList>
<person name="Wilson J.B."/>
<person name="Yamamoto K."/>
<person name="Marriott A.S."/>
<person name="Hussain S."/>
<person name="Sung P."/>
<person name="Hoatlin M.E."/>
<person name="Mathew C.G."/>
<person name="Takata M."/>
<person name="Thompson L.H."/>
<person name="Kupfer G.M."/>
<person name="Jones N.J."/>
</authorList>
<dbReference type="PubMed" id="18212739"/>
<dbReference type="DOI" id="10.1038/sj.onc.1211034"/>
</citation>
<scope>INTERACTION WITH FANCD2; FANCG AND XRCC3</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Oncogene" volume="27" first="3977" last="3985">
<title>The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage.</title>
<authorList>
<person name="Bahassi E.M."/>
<person name="Ovesen J.L."/>
<person name="Riesenberg A.L."/>
<person name="Bernstein W.Z."/>
<person name="Hasty P.E."/>
<person name="Stambrook P.J."/>
</authorList>
<dbReference type="PubMed" id="18317453"/>
<dbReference type="DOI" id="10.1038/onc.2008.17"/>
</citation>
<scope>FUNCTION IN RAD51-DEPENDENT DNA REPAIR</scope>
<scope>PHOSPHORYLATION AT THR-3387 BY CHEK1 AND CHEK2</scope>
<scope>MUTAGENESIS OF THR-3387</scope>
<scope>INTERACTION WITH RAD51</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="7155" last="7160">
<title>PALB2 is an integral component of the BRCA complex required for homologous recombination repair.</title>
<authorList>
<person name="Sy S.M."/>
<person name="Huen M.S."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="19369211"/>
<dbReference type="DOI" id="10.1073/pnas.0811159106"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN A BRCA COMPLEX WITH BRCA1 AND PALB2</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Nat. Struct. Mol. Biol." volume="17" first="1260" last="1262">
<title>Human BRCA2 protein promotes RAD51 filament formation on RPA-covered single-stranded DNA.</title>
<authorList>
<person name="Liu J."/>
<person name="Doty T."/>
<person name="Gibson B."/>
<person name="Heyer W.D."/>
</authorList>
<dbReference type="PubMed" id="20729859"/>
<dbReference type="DOI" id="10.1038/nsmb.1904"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RAD51</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Nat. Struct. Mol. Biol." volume="17" first="1263" last="1265">
<title>The breast cancer tumor suppressor BRCA2 promotes the specific targeting of RAD51 to single-stranded DNA.</title>
<authorList>
<person name="Thorslund T."/>
<person name="McIlwraith M.J."/>
<person name="Compton S.A."/>
<person name="Lekomtsev S."/>
<person name="Petronczki M."/>
<person name="Griffith J.D."/>
<person name="West S.C."/>
</authorList>
<dbReference type="PubMed" id="20729858"/>
<dbReference type="DOI" id="10.1038/nsmb.1905"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="Nature" volume="467" first="678" last="683">
<title>Purified human BRCA2 stimulates RAD51-mediated recombination.</title>
<authorList>
<person name="Jensen R.B."/>
<person name="Carreira A."/>
<person name="Kowalczykowski S.C."/>
</authorList>
<dbReference type="PubMed" id="20729832"/>
<dbReference type="DOI" id="10.1038/nature09399"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RAD51 AND DMC1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="Cancer Res." volume="71" first="68" last="77">
<title>BRCA2 and nucleophosmin coregulate centrosome amplification and form a complex with the Rho effector kinase ROCK2.</title>
<authorList>
<person name="Wang H.F."/>
<person name="Takenaka K."/>
<person name="Nakanishi A."/>
<person name="Miki Y."/>
</authorList>
<dbReference type="PubMed" id="21084279"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-10-0030"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ROCK2 AND NPM1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="Exp. Cell Res." volume="317" first="1203" last="1213">
<title>Homologous recombination proteins are associated with centrosomes and are required for mitotic stability.</title>
<authorList>
<person name="Cappelli E."/>
<person name="Townsend S."/>
<person name="Griffin C."/>
<person name="Thacker J."/>
</authorList>
<dbReference type="PubMed" id="21276791"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2011.01.021"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; SER-445; SER-492; SER-1970; THR-2035; SER-2095 AND SER-3319</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2013" name="Nat. Struct. Mol. Biol." volume="20" first="1191" last="1198">
<title>A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization.</title>
<authorList>
<person name="Jeyasekharan A.D."/>
<person name="Liu Y."/>
<person name="Hattori H."/>
<person name="Pisupati V."/>
<person name="Jonsdottir A.B."/>
<person name="Rajendra E."/>
<person name="Lee M."/>
<person name="Sundaramoorthy E."/>
<person name="Schlachter S."/>
<person name="Kaminski C.F."/>
<person name="Ofir-Rosenfeld Y."/>
<person name="Sato K."/>
<person name="Savill J."/>
<person name="Ayoub N."/>
<person name="Venkitaraman A.R."/>
</authorList>
<dbReference type="PubMed" id="24013206"/>
<dbReference type="DOI" id="10.1038/nsmb.2666"/>
</citation>
<scope>INTERACTION WITH SEM1</scope>
<scope>CHARACTERIZATION OF VARIANT BC HIS-2723</scope>
<scope>MUTAGENESIS OF TRP-2725</scope>
<scope>NUCLEAR EXPORT SIGNAL</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2014" name="Oncogene" volume="33" first="4803" last="4812">
<title>Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair.</title>
<authorList>
<person name="Park J.Y."/>
<person name="Singh T.R."/>
<person name="Nassar N."/>
<person name="Zhang F."/>
<person name="Freund M."/>
<person name="Hanenberg H."/>
<person name="Meetei A.R."/>
<person name="Andreassen P.R."/>
</authorList>
<dbReference type="PubMed" id="24141787"/>
<dbReference type="DOI" id="10.1038/onc.2013.421"/>
</citation>
<scope>INTERACTION WITH PALB2</scope>
<scope>IDENTIFICATION IN A PALB2-CONTAINING HR COMPLEX</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2014" name="Cell Rep." volume="6" first="553" last="564">
<title>Breast cancer proteins PALB2 and BRCA2 stimulate polymerase eta in recombination-associated DNA synthesis at blocked replication forks.</title>
<authorList>
<person name="Buisson R."/>
<person name="Niraj J."/>
<person name="Pauty J."/>
<person name="Maity R."/>
<person name="Zhao W."/>
<person name="Coulombe Y."/>
<person name="Sung P."/>
<person name="Masson J.Y."/>
</authorList>
<dbReference type="PubMed" id="24485656"/>
<dbReference type="DOI" id="10.1016/j.celrep.2014.01.009"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH POLH</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2014" name="Nature" volume="511" first="362" last="365">
<title>BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2.</title>
<authorList>
<person name="Bhatia V."/>
<person name="Barroso S.I."/>
<person name="Garcia-Rubio M.L."/>
<person name="Tumini E."/>
<person name="Herrera-Moyano E."/>
<person name="Aguilera A."/>
</authorList>
<dbReference type="PubMed" id="24896180"/>
<dbReference type="DOI" id="10.1038/nature13374"/>
</citation>
<scope>FUNCTION IN R-LOOP PROCESSING</scope>
<scope>INTERACTION WITH SEM1 AND PCID2</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2017" name="Oncogene" volume="36" first="4161" last="4170">
<title>Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.</title>
<authorList>
<person name="Foo T.K."/>
<person name="Tischkowitz M."/>
<person name="Simhadri S."/>
<person name="Boshari T."/>
<person name="Zayed N."/>
<person name="Burke K.A."/>
<person name="Berman S.H."/>
<person name="Blecua P."/>
<person name="Riaz N."/>
<person name="Huo Y."/>
<person name="Ding Y.C."/>
<person name="Neuhausen S.L."/>
<person name="Weigelt B."/>
<person name="Reis-Filho J.S."/>
<person name="Foulkes W.D."/>
<person name="Xia B."/>
</authorList>
<dbReference type="PubMed" id="28319063"/>
<dbReference type="DOI" id="10.1038/onc.2017.46"/>
</citation>
<scope>INTERACTION WITH PALB2</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2002" name="Nature" volume="420" first="287" last="293">
<title>Insights into DNA recombination from the structure of a RAD51-BRCA2 complex.</title>
<authorList>
<person name="Pellegrini L."/>
<person name="Yu D.S."/>
<person name="Lo T."/>
<person name="Anand S."/>
<person name="Lee M."/>
<person name="Blundell T.L."/>
<person name="Venkitaraman A.R."/>
</authorList>
<dbReference type="PubMed" id="12442171"/>
<dbReference type="DOI" id="10.1038/nature01230"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 1519-1551 IN COMPLEX WITH RAD51</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="EMBO Rep." volume="10" first="990" last="996">
<title>Structural basis for recruitment of BRCA2 by PALB2.</title>
<authorList>
<person name="Oliver A.W."/>
<person name="Swift S."/>
<person name="Lord C.J."/>
<person name="Ashworth A."/>
<person name="Pearl L.H."/>
</authorList>
<dbReference type="PubMed" id="19609323"/>
<dbReference type="DOI" id="10.1038/embor.2009.126"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 21-39 IN COMPLEX WITH PALB2</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1996" name="Cancer Res." volume="56" first="2738" last="2741">
<title>Mutations of the BRCA2 gene in ovarian carcinomas.</title>
<authorList>
<person name="Takahashi H."/>
<person name="Chiu H.-C."/>
<person name="Bandera C.A."/>
<person name="Behbakht K."/>
<person name="Liu P.C."/>
<person name="Couch F.J."/>
<person name="Weber B.L."/>
<person name="LiVolsi V.A."/>
<person name="Furusato M."/>
<person name="Rebane B.A."/>
<person name="Cardonick A."/>
<person name="Benjamin I."/>
<person name="Morgan M.A."/>
<person name="King S.A."/>
<person name="Mikuta J.J."/>
<person name="Rubin S.C."/>
<person name="Boyd J."/>
</authorList>
<dbReference type="PubMed" id="8665505"/>
</citation>
<scope>VARIANT OVARIAN CANCER HIS-2787</scope>
<scope>VARIANTS HIS-372; MET-1915 AND VAL-2466</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1996" name="Nat. Genet." volume="13" first="123" last="125">
<title>BRCA2 germline mutations in male breast cancer cases and breast cancer families.</title>
<authorList>
<person name="Couch F.J."/>
<person name="Farid L.M."/>
<person name="Deshano M.L."/>
<person name="Tavtigian S.V."/>
<person name="Calzone K."/>
<person name="Campeau L."/>
<person name="Peng Y."/>
<person name="Bogden B."/>
<person name="Chen Q."/>
<person name="Neuhausen S."/>
<person name="Shattuck-Eidens D."/>
<person name="Godwin A.K."/>
<person name="Daly M."/>
<person name="Radford D.M."/>
<person name="Sedlacek S."/>
<person name="Rommens J."/>
<person name="Simard J."/>
<person name="Garber J."/>
<person name="Merajver S."/>
<person name="Weber B.L."/>
</authorList>
<dbReference type="PubMed" id="8673091"/>
<dbReference type="DOI" id="10.1038/ng0596-123"/>
</citation>
<scope>VARIANTS HIS-372; ASP-991; SER-1147; MET-1915 AND CYS-2034</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1996" name="Nat. Genet." volume="13" first="238" last="240">
<title>BRCA2 mutations in primary breast and ovarian cancers.</title>
<authorList>
<person name="Lancaster J.M."/>
<person name="Wooster R."/>
<person name="Mangion J."/>
<person name="Phelan C.M."/>
<person name="Cochran C."/>
<person name="Gumbs C."/>
<person name="Seal S."/>
<person name="Barfoot R."/>
<person name="Collins N."/>
<person name="Bignell G."/>
<person name="Patel S."/>
<person name="Hamoudi R."/>
<person name="Larsson C."/>
<person name="Wiseman R.W."/>
<person name="Berchuck A."/>
<person name="Iglehart J.D."/>
<person name="Marks J.R."/>
<person name="Ashworth A."/>
<person name="Stratton M.R."/>
<person name="Futreal P.A."/>
</authorList>
<dbReference type="PubMed" id="8640235"/>
<dbReference type="DOI" id="10.1038/ng0696-238"/>
</citation>
<scope>VARIANT GLU-3095</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1996" name="Nat. Genet." volume="13" first="241" last="244">
<title>Low incidence of BRCA2 mutations in breast carcinoma and other cancers.</title>
<authorList>
<person name="Teng D.H.-F."/>
<person name="Bogden R."/>
<person name="Mitchell J."/>
<person name="Baumgard M."/>
<person name="Bell R."/>
<person name="Berry S."/>
<person name="Davis T."/>
<person name="Ha P.C."/>
<person name="Kehrer R."/>
<person name="Jammulapati S."/>
<person name="Chen Q."/>
<person name="Offit K."/>
<person name="Skolnick M.H."/>
<person name="Tavtigian S.V."/>
<person name="Jhanwar S."/>
<person name="Swedlund B."/>
<person name="Wong A.K.C."/>
<person name="Kamb A."/>
</authorList>
<dbReference type="PubMed" id="8640236"/>
<dbReference type="DOI" id="10.1038/ng0696-241"/>
</citation>
<scope>VARIANTS</scope>
</reference>
<reference key="37">
<citation type="journal article" date="1996" name="Nat. Genet." volume="13" first="245" last="247">
<title>Mutation analysis in the BRCA2 gene in primary breast cancers.</title>
<authorList>
<person name="Miki Y."/>
<person name="Katagiri T."/>
<person name="Kasumi F."/>
<person name="Yoshimoto T."/>
<person name="Nakamura Y."/>
</authorList>
<dbReference type="PubMed" id="8640237"/>
<dbReference type="DOI" id="10.1038/ng0696-245"/>
</citation>
<scope>VARIANT BC ASN-2415</scope>
</reference>
<reference key="38">
<citation type="journal article" date="1997" name="Am. J. Hum. Genet." volume="60" first="1050" last="1058">
<title>A low proportion of BRCA2 mutations in Finnish breast cancer families.</title>
<authorList>
<person name="Vehmanen P."/>
<person name="Friedman L.S."/>
<person name="Eerola H."/>
<person name="Sarantaus L."/>
<person name="Pyrhoenen S."/>
<person name="Ponder B.A.J."/>
<person name="Muhonen T."/>
<person name="Nevanlinna H."/>
</authorList>
<dbReference type="PubMed" id="9150152"/>
</citation>
<scope>VARIANT BC ASP-2089</scope>
<scope>VARIANT VAL-3412</scope>
</reference>
<reference key="39">
<citation type="journal article" date="1998" name="Hum. Genet." volume="102" first="549" last="556">
<title>High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families.</title>
<authorList>
<person name="Ganguly T."/>
<person name="Dhulipala R."/>
<person name="Godmilow L."/>
<person name="Ganguly A."/>
</authorList>
<dbReference type="PubMed" id="9654203"/>
<dbReference type="DOI" id="10.1007/s004390050738"/>
</citation>
<scope>VARIANT BC/PANCREAS CANCER TRP-554</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1998" name="J. Hum. Genet." volume="43" first="42" last="48">
<title>High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families.</title>
<authorList>
<person name="Katagiri T."/>
<person name="Kasumi F."/>
<person name="Yoshimoto M."/>
<person name="Nomizu T."/>
<person name="Asaishi K."/>
<person name="Abe R."/>
<person name="Tsuchiya A."/>
<person name="Sugano M."/>
<person name="Takai S."/>
<person name="Yoneda M."/>
<person name="Fukutomi T."/>
<person name="Nanba K."/>
<person name="Makita M."/>
<person name="Okazaki H."/>
<person name="Hirata K."/>
<person name="Okazaki M."/>
<person name="Furutsuma Y."/>
<person name="Morishita Y."/>
<person name="Iino Y."/>
<person name="Karino T."/>
<person name="Ayabe H."/>
<person name="Hara S."/>
<person name="Kajiwara T."/>
<person name="Houga S."/>
<person name="Shimizu T."/>
<person name="Toda M."/>
<person name="Yamazaki Y."/>
<person name="Uchida T."/>
<person name="Kunitomo K."/>
<person name="Sonoo H."/>
<person name="Kurebayashi J."/>
<person name="Shimotsuma K."/>
<person name="Nakamura Y."/>
<person name="Miki Y."/>
</authorList>
<dbReference type="PubMed" id="9609997"/>
<dbReference type="DOI" id="10.1007/s100380050035"/>
</citation>
<scope>VARIANTS BC LEU-32; ARG-53; LEU-81; ARG-201; ALA-211; SER-222 AND THR-3118</scope>
</reference>
<reference key="41">
<citation type="journal article" date="1999" name="Am. J. Hum. Genet." volume="65" first="1021" last="1029">
<title>The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.</title>
<authorList>
<person name="Gayther S.A."/>
<person name="Russell P."/>
<person name="Harrington P."/>
<person name="Antoniou A.C."/>
<person name="Easton D.F."/>
<person name="Ponder B.A.J."/>
</authorList>
<dbReference type="PubMed" id="10486320"/>
<dbReference type="DOI" id="10.1086/302583"/>
</citation>
<scope>VARIANTS OVARIAN CANCER PRO-75; HIS-2502 AND HIS-3098</scope>
</reference>
<reference key="42">
<citation type="journal article" date="1999" name="Hum. Genet." volume="104" first="201" last="204">
<title>Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan.</title>
<authorList>
<person name="Li S.S.-L."/>
<person name="Tseng H.-M."/>
<person name="Yang T.-P."/>
<person name="Liu C.-H."/>
<person name="Teng S.-J."/>
<person name="Huang H.-W."/>
<person name="Chen L.-M."/>
<person name="Kao H.-W."/>
<person name="Chen J.H."/>
<person name="Tseng J.-N."/>
<person name="Chen A."/>
<person name="Hou M.-F."/>
<person name="Huang T.-J."/>
<person name="Chang H.-T."/>
<person name="Mok K.-T."/>
<person name="Tsai J.-H."/>
</authorList>
<dbReference type="PubMed" id="10323242"/>
<dbReference type="DOI" id="10.1007/s004390050936"/>
</citation>
<scope>VARIANTS HIS-289; HIS-372; ASP-991 AND VAL-3412</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="413" last="423">
<title>Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations.</title>
<authorList>
<person name="Wagner T.M.U."/>
<person name="Hirtenlehner K."/>
<person name="Shen P."/>
<person name="Moeslinger R."/>
<person name="Muhr D."/>
<person name="Fleischmann E."/>
<person name="Concin H."/>
<person name="Doeller W."/>
<person name="Haid A."/>
<person name="Lang A.H."/>
<person name="Mayer P."/>
<person name="Petru E."/>
<person name="Ropp E."/>
<person name="Langbauer G."/>
<person name="Kubista E."/>
<person name="Scheiner O."/>
<person name="Underhill P."/>
<person name="Mountain J."/>
<person name="Stierer M."/>
<person name="Zielinski C."/>
<person name="Oefner P."/>
</authorList>
<dbReference type="PubMed" id="9971877"/>
<dbReference type="DOI" id="10.1093/hmg/8.3.413"/>
</citation>
<scope>VARIANTS BC</scope>
<scope>VARIANTS</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1999" name="Int. J. Cancer" volume="82" first="325" last="328">
<title>Germline brca2 sequence variants in patients with ocular melanoma.</title>
<authorList>
<person name="Sinilnikova O.M."/>
<person name="Egan K.M."/>
<person name="Quinn J.L."/>
<person name="Boutrand L."/>
<person name="Lenoir G.M."/>
<person name="Stoppa-Lyonnet D."/>
<person name="Desjardins L."/>
<person name="Levy C."/>
<person name="Goldgar D."/>
<person name="Gragoudas E.S."/>
</authorList>
<dbReference type="PubMed" id="10399947"/>
<dbReference type="DOI" id="10.1002/(SICI)1097-0215(19990730)82:3&lt;325::AID-IJC3>3.0.CO;2-G"/>
</citation>
<scope>VARIANT BC ARG-326</scope>
<scope>VARIANT ILE-2728</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2000" name="Nat. Genet." volume="26" first="362" last="364">
<title>A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability.</title>
<authorList>
<person name="Healey C.S."/>
<person name="Dunning A.M."/>
<person name="Teare M.D."/>
<person name="Chase D."/>
<person name="Parker L."/>
<person name="Burn J."/>
<person name="Chang-Claude J."/>
<person name="Mannermaa A."/>
<person name="Kataja V."/>
<person name="Huntsman D.G."/>
<person name="Pharoah P.D.P."/>
<person name="Luben R.N."/>
<person name="Easton D.F."/>
<person name="Ponder B.A.J."/>
</authorList>
<dbReference type="PubMed" id="11062481"/>
<dbReference type="DOI" id="10.1038/81691"/>
</citation>
<scope>VARIANT HIS-372</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2000" name="J. Med. Genet." volume="37" first="E17" last="E17">
<title>BRCA2 germline mutations among early onset breast cancer patients unselected for family history of the disease.</title>
<authorList>
<person name="Plaschke J."/>
<person name="Commer T."/>
<person name="Jacobi C."/>
<person name="Schackert H.K."/>
<person name="Chang-Claude J."/>
</authorList>
<dbReference type="PubMed" id="10978364"/>
<dbReference type="DOI" id="10.1136/jmg.37.9.e17"/>
</citation>
<scope>VARIANTS BC MET-729; ILE-2515 AND ILE-2728</scope>
<scope>VARIANTS HIS-289; HIS-372; ASP-991; MET-1915 AND VAL-3412</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2001" name="Hum. Mutat." volume="17" first="73" last="73">
<title>BRCA2 germline mutations in male breast cancer patients in the Polish population.</title>
<authorList>
<person name="Kwiatkowska E."/>
<person name="Teresiak M."/>
<person name="Lamperska K.M."/>
<person name="Karczewska A."/>
<person name="Breborowicz D."/>
<person name="Stawicka M."/>
<person name="Godlewski D."/>
<person name="Krzyzosiak W.J."/>
<person name="Mackiewicz A."/>
</authorList>
<dbReference type="PubMed" id="11139248"/>
<dbReference type="DOI" id="10.1002/1098-1004(2001)17:1&lt;73::AID-HUMU12>3.3.CO;2-F"/>
</citation>
<scope>VARIANTS BC ASN-1179; ILE-3124 AND GLU-3196</scope>
<scope>VARIANT TYR-1420</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2001" name="Hum. Mutat." volume="17" first="220" last="232">
<title>An improved high throughput heteroduplex mutation detection system for screening BRCA2 mutations-fluorescent mutation detection (F-MD).</title>
<authorList>
<person name="Edwards S.M."/>
<person name="Kote-Jarai Z."/>
<person name="Hamoudi R."/>
<person name="Eeles R.A."/>
</authorList>
<dbReference type="PubMed" id="11241844"/>
<dbReference type="DOI" id="10.1002/humu.7"/>
</citation>
<scope>VARIANTS BC THR-505; TYR-1730; HIS-2135 AND CYS-2222</scope>
<scope>VARIANT LYS-1880</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2002" name="Am. J. Hum. Genet." volume="71" first="625" last="631">
<title>BRCA2 T2722R is a deleterious allele that causes exon skipping.</title>
<authorList>
<person name="Fackenthal J.D."/>
<person name="Cartegni L."/>
<person name="Krainer A.R."/>
<person name="Olopade O.I."/>
</authorList>
<dbReference type="PubMed" id="12145750"/>
<dbReference type="DOI" id="10.1086/342192"/>
</citation>
<scope>VARIANT BC ARG-2722</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2002" name="Am. J. Hum. Genet." volume="73" first="1477" last="1477">
<authorList>
<person name="Fackenthal J.D."/>
<person name="Cartegni L."/>
<person name="Krainer A.R."/>
<person name="Olopade O.I."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2002" name="Br. J. Cancer" volume="87" first="888" last="891">
<title>BRCA2 gene mutations in families with aggregations of breast and stomach cancers.</title>
<authorList>
<person name="Jakubowska A."/>
<person name="Nej K."/>
<person name="Huzarski T."/>
<person name="Scott R.J."/>
<person name="Lubinski J."/>
</authorList>
<dbReference type="PubMed" id="12373604"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6600562"/>
</citation>
<scope>VARIANTS BC CYS-2072; CYS-2094 AND ASN-2128</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2002" name="Cancer Res." volume="62" first="3789" last="3793">
<title>Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.</title>
<authorList>
<person name="Murphy K.M."/>
<person name="Brune K.A."/>
<person name="Griffin C."/>
<person name="Sollenberger J.E."/>
<person name="Petersen G.M."/>
<person name="Bansal R."/>
<person name="Hruban R.H."/>
<person name="Kern S.E."/>
</authorList>
<dbReference type="PubMed" id="12097290"/>
</citation>
<scope>VARIANT THR-192</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2002" name="Clin. Cancer Res." volume="8" first="1121" last="1126">
<title>Infrequent mutation in the BRCA2 gene in esophageal squamous cell carcinoma.</title>
<authorList>
<person name="Hu N."/>
<person name="Li G."/>
<person name="Li W.-J."/>
<person name="Wang C."/>
<person name="Goldstein A.M."/>
<person name="Tang Z.-Z."/>
<person name="Roth M.J."/>
<person name="Dawsey S.M."/>
<person name="Huang J."/>
<person name="Wang Q.-H."/>
<person name="Ding T."/>
<person name="Giffen C."/>
<person name="Taylor P.R."/>
<person name="Emmert-Buck M.R."/>
</authorList>
<dbReference type="PubMed" id="11948123"/>
</citation>
<scope>VARIANTS HIS-118; SER-315; ILE-1988; CYS-2842 AND SER-3300</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2002" name="Genet. Test." volume="6" first="119" last="121">
<title>Characterization of common BRCA1 and BRCA2 variants.</title>
<authorList>
<person name="Deffenbaugh A.M."/>
<person name="Frank T.S."/>
<person name="Hoffman M."/>
<person name="Cannon-Albright L."/>
<person name="Neuhausen S.L."/>
</authorList>
<dbReference type="PubMed" id="12215251"/>
<dbReference type="DOI" id="10.1089/10906570260199375"/>
</citation>
<scope>VARIANTS ALA-598; TYR-1420; CYS-2034; ILE-2728 AND THR-2951</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="20" first="473" last="474">
<title>BRCA1 and BRCA2 in Indian breast cancer patients.</title>
<authorList>
<person name="Saxena S."/>
<person name="Szabo C.I."/>
<person name="Chopin S."/>
<person name="Barjhoux L."/>
<person name="Sinilnikova O."/>
<person name="Lenoir G."/>
<person name="Goldgar D.E."/>
<person name="Bhatanager D."/>
</authorList>
<dbReference type="PubMed" id="12442273"/>
<dbReference type="DOI" id="10.1002/humu.9082"/>
</citation>
<scope>VARIANTS ASP-1593 AND SER-2706</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="20" first="474" last="474">
<title>BRCA1 and BRCA2 sequence variants in Chinese breast cancer families.</title>
<authorList>
<person name="Zhi X."/>
<person name="Szabo C."/>
<person name="Chopin S."/>
<person name="Suter N."/>
<person name="Wang Q.-S."/>
<person name="Ostrander E.A."/>
<person name="Sinilnikova O.M."/>
<person name="Lenoir G.M."/>
<person name="Goldgar D."/>
<person name="Shi Y.-R."/>
</authorList>
<dbReference type="PubMed" id="12442274"/>
<dbReference type="DOI" id="10.1002/humu.9083"/>
</citation>
<scope>VARIANT BC ASN-2729</scope>
<scope>VARIANT VAL-3412</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="20" first="474" last="475">
<title>BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico.</title>
<authorList>
<person name="Ruiz-Flores P."/>
<person name="Sinilnikova O.M."/>
<person name="Badzioch M."/>
<person name="Calderon-Garciduenas A.L."/>
<person name="Chopin S."/>
<person name="Fabrice O."/>
<person name="Gonzalez-Guerrero J.F."/>
<person name="Szabo C."/>
<person name="Lenoir G."/>
<person name="Goldgar D.E."/>
<person name="Barrera-Saldana H.A."/>
</authorList>
<dbReference type="PubMed" id="12442275"/>
<dbReference type="DOI" id="10.1002/humu.9084"/>
</citation>
<scope>VARIANTS BC CYS-42; ARG-613; LEU-2118; LEU-2293 AND ARG-2793</scope>
<scope>VARIANT ILE-3374</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2002" name="Int. J. Cancer" volume="98" first="943" last="945">
<title>Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer.</title>
<authorList>
<person name="Kwiatkowska E."/>
<person name="Teresiak M."/>
<person name="Breborowicz D."/>
<person name="Mackiewicz A."/>
</authorList>
<dbReference type="PubMed" id="11948477"/>
<dbReference type="DOI" id="10.1002/ijc.10289"/>
</citation>
<scope>VARIANTS BC TYR-1580 AND MET-1915</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2002" name="Science" volume="297" first="606" last="609">
<title>Biallelic inactivation of BRCA2 in Fanconi anemia.</title>
<authorList>
<person name="Howlett N.G."/>
<person name="Taniguchi T."/>
<person name="Olson S."/>
<person name="Cox B."/>
<person name="Waisfisz Q."/>
<person name="de Die-Smulders C."/>
<person name="Persky N."/>
<person name="Grompe M."/>
<person name="Joenje H."/>
<person name="Pals G."/>
<person name="Ikeda H."/>
<person name="Fox E.A."/>
<person name="D'Andrea A.D."/>
</authorList>
<dbReference type="PubMed" id="12065746"/>
<dbReference type="DOI" id="10.1126/science.1073834"/>
</citation>
<scope>INVOLVEMENT IN FANCD1</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2003" name="Hum. Mutat." volume="21" first="171" last="171">
<title>BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer.</title>
<authorList>
<person name="Hadjisavvas A."/>
<person name="Charalambous E."/>
<person name="Adamou A."/>
<person name="Christodoulou C.G."/>
<person name="Kyriacou K."/>
</authorList>
<dbReference type="PubMed" id="12552570"/>
<dbReference type="DOI" id="10.1002/humu.9110"/>
</citation>
<scope>VARIANTS HIS-289; HIS-372; GLY-462; ASP-991; SER-1279; TYR-1420; ASP-1771 AND VAL-2466</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2003" name="Hum. Mutat." volume="22" first="259" last="259">
<title>Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.</title>
<authorList>
<person name="Meyer P."/>
<person name="Voigtlaender T."/>
<person name="Bartram C.R."/>
<person name="Klaes R."/>
</authorList>
<dbReference type="PubMed" id="12938098"/>
<dbReference type="DOI" id="10.1002/humu.9174"/>
</citation>
<scope>VARIANTS BC ILE-431; LYS-1036; ARG-1106 AND VAL-1524</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2003" name="J. Hum. Genet." volume="48" first="130" last="137">
<title>Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1and BRCA2genes in familial breast cancer.</title>
<authorList>
<person name="Sakayori M."/>
<person name="Kawahara M."/>
<person name="Shiraishi K."/>
<person name="Nomizu T."/>
<person name="Shimada A."/>
<person name="Kudo T."/>
<person name="Abe R."/>
<person name="Ohuchi N."/>
<person name="Takenoshita S."/>
<person name="Kanamaru R."/>
<person name="Ishioka C."/>
</authorList>
<dbReference type="PubMed" id="12624724"/>
<dbReference type="DOI" id="10.1007/s100380300020"/>
</citation>
<scope>VARIANTS PRO-582; PHE-1522 AND VAL-2044</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2003" name="J. Natl. Cancer Inst." volume="95" first="214" last="221">
<title>BRCA2 germline mutations in familial pancreatic carcinoma.</title>
<authorList>
<person name="Hahn S.A."/>
<person name="Greenhalf B."/>
<person name="Ellis I."/>
<person name="Sina-Frey M."/>
<person name="Rieder H."/>
<person name="Korte B."/>
<person name="Gerdes B."/>
<person name="Kress R."/>
<person name="Ziegler A."/>
<person name="Raeburn J.A."/>
<person name="Campra D."/>
<person name="Gruetzmann R."/>
<person name="Rehder H."/>
<person name="Rothmund M."/>
<person name="Schmiegel W."/>
<person name="Neoptolemos J.P."/>
<person name="Bartsch D.K."/>
</authorList>
<dbReference type="PubMed" id="12569143"/>
<dbReference type="DOI" id="10.1093/jnci/95.3.214"/>
</citation>
<scope>VARIANTS CYS-2034 AND GLU-3076</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2004" name="Blood" volume="103" first="2554" last="2559">
<title>Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood.</title>
<authorList>
<person name="Hirsch B."/>
<person name="Shimamura A."/>
<person name="Moreau L."/>
<person name="Baldinger S."/>
<person name="Hag-alshiekh M."/>
<person name="Bostrom B."/>
<person name="Sencer S."/>
<person name="D'Andrea A.D."/>
</authorList>
<dbReference type="PubMed" id="14670928"/>
<dbReference type="DOI" id="10.1182/blood-2003-06-1970"/>
</citation>
<scope>VARIANT FANCD1 PRO-2510</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2004" name="Br. J. Cancer" volume="90" first="1244" last="1251">
<title>BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families.</title>
<authorList>
<person name="Claes K."/>
<person name="Poppe B."/>
<person name="Coene I."/>
<person name="De Paepe A."/>
<person name="Messiaen L."/>
</authorList>
<dbReference type="PubMed" id="15026808"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6601656"/>
</citation>
<scope>VARIANTS BC SER-60; ARG-405; HIS-448; GLY-462; GLY-2275; ARG-2353; LYS-2488; HIS-2723; ASN-2950; ILE-3013 AND HIS-3098</scope>
<scope>VARIANTS ASP-991; ALA-2856 AND VAL-3412</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2004" name="Cancer Genet. Cytogenet." volume="151" first="152" last="156">
<title>Hereditary breast and ovarian cancer in Cyprus: identification of a founder BRCA2 mutation.</title>
<authorList>
<person name="Hadjisavvas A."/>
<person name="Charalambous E."/>
<person name="Adamou A."/>
<person name="Neuhausen S.L."/>
<person name="Christodoulou C.G."/>
<person name="Kyriacou K."/>
</authorList>
<dbReference type="PubMed" id="15172753"/>
<dbReference type="DOI" id="10.1016/j.cancergencyto.2003.09.020"/>
</citation>
<scope>VARIANTS BC ILE-64; GLY-462; ASN-1690; ASP-1771; MET-1887; MET-1915 AND GLU-2456</scope>
<scope>VARIANTS HIS-289; HIS-372; ASP-991; SER-1279; TYR-1420; CYS-2108 AND VAL-2466</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2004" name="Eur. J. Cancer" volume="40" first="422" last="428">
<title>One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden.</title>
<authorList>
<person name="Malander S."/>
<person name="Ridderheim M."/>
<person name="Masbaeck A."/>
<person name="Loman N."/>
<person name="Kristoffersson U."/>
<person name="Olsson H."/>
<person name="Nilbert M."/>
<person name="Borg A."/>
</authorList>
<dbReference type="PubMed" id="14746861"/>
<dbReference type="DOI" id="10.1016/j.ejca.2003.09.016"/>
</citation>
<scope>VARIANT OVARIAN CANCER CYS-42</scope>
<scope>VARIANTS SER-3063 AND VAL-3412</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2004" name="Hum. Mutat." volume="23" first="205" last="205">
<title>Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families.</title>
<authorList>
<person name="Valarmathi M.T."/>
<person name="Sawhney M."/>
<person name="Deo S.S.V."/>
<person name="Shukla N.K."/>
<person name="Das S.N."/>
</authorList>
<dbReference type="PubMed" id="14722926"/>
<dbReference type="DOI" id="10.1002/humu.9213"/>
</citation>
<scope>VARIANTS BC ILE-1679; ALA-1804; LYS-1901 AND LEU-2096</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2004" name="Hum. Mutat." volume="24" first="272" last="272">
<title>RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1.</title>
<authorList>
<person name="Sharp A."/>
<person name="Pichert G."/>
<person name="Lucassen A."/>
<person name="Eccles D."/>
</authorList>
<dbReference type="PubMed" id="15300854"/>
<dbReference type="DOI" id="10.1002/humu.9267"/>
</citation>
<scope>VARIANT ALA-225</scope>
<scope>CHARACTERIZATION OF VARIANT ALA-225</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2004" name="Hum. Mutat." volume="24" first="350" last="350">
<title>BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.</title>
<authorList>
<person name="Seo J.H."/>
<person name="Cho D.-Y."/>
<person name="Ahn S.-H."/>
<person name="Yoon K.-S."/>
<person name="Kang C.-S."/>
<person name="Cho H.M."/>
<person name="Lee H.S."/>
<person name="Choe J.J."/>
<person name="Choi C.W."/>
<person name="Kim B.S."/>
<person name="Shin S.W."/>
<person name="Kim Y.H."/>
<person name="Kim J.S."/>
<person name="Son G.-S."/>
<person name="Lee J.-B."/>
<person name="Koo B.H."/>
</authorList>
<dbReference type="PubMed" id="15365993"/>
<dbReference type="DOI" id="10.1002/humu.9275"/>
</citation>
<scope>VARIANTS BC THR-1445; VAL-1929 AND ALA-2031</scope>
<scope>VARIANTS HIS-289; HIS-372; VAL-784; ASP-991 AND VAL-3412</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2005" name="J. Med. Genet." volume="42" first="E5" last="E5">
<title>Prevalence of BRCA2 mutations in a hospital based series of unselected breast cancer cases.</title>
<authorList>
<person name="Kim S.-W."/>
<person name="Lee C.S."/>
<person name="Fey J.V."/>
<person name="Borgen P.I."/>
<person name="Boyd J."/>
</authorList>
<dbReference type="PubMed" id="15635067"/>
<dbReference type="DOI" id="10.1136/jmg.2004.025056"/>
</citation>
<scope>VARIANTS LEU-1172; TYR-1420; PHE-2944; ASN-2950 AND ILE-3013</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2007" name="Am. J. Hum. Genet." volume="81" first="873" last="883">
<title>A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.</title>
<authorList>
<person name="Easton D.F."/>
<person name="Deffenbaugh A.M."/>
<person name="Pruss D."/>
<person name="Frye C."/>
<person name="Wenstrup R.J."/>
<person name="Allen-Brady K."/>
<person name="Tavtigian S.V."/>
<person name="Monteiro A.N.A."/>
<person name="Iversen E.S."/>
<person name="Couch F.J."/>
<person name="Goldgar D.E."/>
</authorList>
<dbReference type="PubMed" id="17924331"/>
<dbReference type="DOI" id="10.1086/521032"/>
</citation>
<scope>VARIANTS HIS-2336; CYS-2502; CYS-2626; PHE-2627; PRO-2653; LYS-2659; VAL-2663; ARG-2722; GLY-2723; ASP-2748 AND GLU-3095</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2007" name="J. Med. Genet." volume="44" first="1" last="9">
<title>Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.</title>
<authorList>
<person name="Alter B.P."/>
<person name="Rosenberg P.S."/>
<person name="Brody L.C."/>
</authorList>
<dbReference type="PubMed" id="16825431"/>
<dbReference type="DOI" id="10.1136/jmg.2006.043257"/>
</citation>
<scope>VARIANTS FANCD1 HIS-2336 AND CYS-2626</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2010" name="Hum. Mutat." volume="31" first="E1484" last="E1505">
<title>Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicity.</title>
<authorList>
<person name="Walker L.C."/>
<person name="Whiley P.J."/>
<person name="Couch F.J."/>
<person name="Farrugia D.J."/>
<person name="Healey S."/>
<person name="Eccles D.M."/>
<person name="Lin F."/>
<person name="Butler S.A."/>
<person name="Goff S.A."/>
<person name="Thompson B.A."/>
<person name="Lakhani S.R."/>
<person name="Da Silva L.M."/>
<person name="Tavtigian S.V."/>
<person name="Goldgar D.E."/>
<person name="Brown M.A."/>
<person name="Spurdle A.B."/>
</authorList>
<dbReference type="PubMed" id="20513136"/>
<dbReference type="DOI" id="10.1002/humu.21267"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS VAL-2663; GLY-2723 AND TRP-3052</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2011" name="Blood" volume="118" first="2430" last="2442">
<title>A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay.</title>
<authorList>
<person name="Biswas K."/>
<person name="Das R."/>
<person name="Alter B.P."/>
<person name="Kuznetsov S.G."/>
<person name="Stauffer S."/>
<person name="North S.L."/>
<person name="Burkett S."/>
<person name="Brody L.C."/>
<person name="Meyer S."/>
<person name="Byrd R.A."/>
<person name="Sharan S.K."/>
</authorList>
<dbReference type="PubMed" id="21719596"/>
<dbReference type="DOI" id="10.1182/blood-2010-12-324541"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS FANCD1 HIS-2336; PRO-2510 AND CYS-2626</scope>
<scope>CHARACTERIZATION OF VARIANTS THR-2490 AND ASN-2729</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SEM1</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2016" name="J. Med. Genet." volume="53" first="138" last="144">
<title>Homozygous missense mutation in the LMAN2L gene segregates with intellectual disability in a large consanguineous Pakistani family.</title>
<authorList>
<person name="Rafiullah R."/>
<person name="Aslamkhan M."/>
<person name="Paramasivam N."/>
<person name="Thiel C."/>
<person name="Mustafa G."/>
<person name="Wiemann S."/>
<person name="Schlesner M."/>
<person name="Wade R.C."/>
<person name="Rappold G.A."/>
<person name="Berkel S."/>
</authorList>
<dbReference type="PubMed" id="26566883"/>
<dbReference type="DOI" id="10.1136/jmedgenet-2015-103179"/>
</citation>
<scope>VARIANTS LEU-606 AND TYR-1420</scope>
</reference>
<comment type="function">
<text evidence="33 35 40 49 53 54 55 56 58 61 62">Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SEM1, and is required to prevent R-loop-associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination (PubMed:24896180).</text>
</comment>
<comment type="subunit">
<text evidence="6 20 33 35 37 42 43 44 45 48 49 50 51 53 54 55 56 58 59 60 61 62 64">Monomer and dimer (PubMed:20729858). Interacts with RAD51; regulates RAD51 recruitment and function at sites of DNA repair (PubMed:12442171, PubMed:15800615, PubMed:18317453, PubMed:20729832, PubMed:20729859). Interacts with WDR16, USP11, DMC1, ROCK2 and NPM1 (PubMed:15314155, PubMed:15967112, PubMed:20729832, PubMed:21084279). Interacts with SEM1; the interaction masks a nuclear export signal in BRCA2 (PubMed:10373512, PubMed:16205630, PubMed:21719596, PubMed:24013206). Interacts with both nonubiquitinated and monoubiquitinated FANCD2; this complex also includes XRCC3 and phosphorylated FANCG (PubMed:15115758, PubMed:15199141, PubMed:18212739). Part of a BRCA complex containing BRCA1, BRCA2 and PALB2 (PubMed:19369211). Interacts directly with PALB2 which may serve as a scaffold for a HR complex containing PALB2, BRCA2, RAD51C, RAD51 and XRCC3 (PubMed:19369211, PubMed:24141787, PubMed:28319063, PubMed:16793542, PubMed:19609323). Interacts with BRCA1 only in the presence of PALB2 which serves as the bridging protein (PubMed:19369211). Interacts with POLH; the interaction is direct (PubMed:24485656). Interacts with the TREX-2 complex subunits PCID2 and SEM1 (PubMed:24896180, PubMed:21719596).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-79792"/>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-930865">
<id>Q14565</id>
<label>DMC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-359343">
<id>Q9BXW9</id>
<label>FANCD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-596878">
<id>Q9BXW9-2</id>
<label>FANCD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-713401">
<id>Q9P0W2</id>
<label>HMG20B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-1222653">
<id>Q86YC2</id>
<label>PALB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-1175604">
<id>Q9NTI5</id>
<label>PDS5B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>26</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-2827270">
<id>Q9Y253</id>
<label>POLH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-297202">
<id>Q06609</id>
<label>RAD51</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>45</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-15557721">
<id>Q06609-1</id>
<label>RAD51</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-79819">
<id>P60896</id>
<label>SEM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-79792"/>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="59 77">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="57">Cytoplasm</location>
<location evidence="57">cytoskeleton</location>
<location evidence="57">microtubule organizing center</location>
<location evidence="57">centrosome</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text>Highest levels of expression in breast and thymus, with slightly lower levels in lung, ovary and spleen.</text>
</comment>
<comment type="PTM">
<text evidence="35 42 49">Phosphorylated by ATM upon irradiation-induced DNA damage. Phosphorylation by CHEK1 and CHEK2 regulates interaction with RAD51. Phosphorylation at Ser-3291 by CDK1 and CDK2 is low in S phase when recombination is active, but increases as cells progress towards mitosis; this phosphorylation prevents homologous recombination-dependent repair during S phase and G2 by inhibiting RAD51 binding.</text>
</comment>
<comment type="PTM">
<text evidence="37">Ubiquitinated in the absence of DNA damage; this does not lead to proteasomal degradation. In contrast, ubiquitination in response to DNA damage leads to proteasomal degradation.</text>
</comment>
<comment type="disease" evidence="7 9 11 12 14 17 19 22 23 27 29 31 34 38 45 59 67 71 72 73 74">
<disease id="DI-02602">
<name>Breast cancer</name>
<acronym>BC</acronym>
<description>A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.</description>
<dbReference type="MIM" id="114480"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="70">
<disease id="DI-02847">
<name>Pancreatic cancer 2</name>
<acronym>PNCA2</acronym>
<description>A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue.</description>
<dbReference type="MIM" id="613347"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-02603">
<name>Breast-ovarian cancer, familial, 2</name>
<acronym>BROVCA2</acronym>
<description>A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate.</description>
<dbReference type="MIM" id="612555"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="15 28 46 58">
<disease id="DI-01601">
<name>Fanconi anemia complementation group D1</name>
<acronym>FANCD1</acronym>
<description>A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.</description>
<dbReference type="MIM" id="605724"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="41">
<disease id="DI-02629">
<name>Glioma 3</name>
<acronym>GLM3</acronym>
<description>Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes.</description>
<dbReference type="MIM" id="613029"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="Fanconi Anemia Mutation Database">
<link uri="http://www2.rockefeller.edu/fanconi/genes/jumpd1"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/brca2/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/BRCA2"/>
<text>BRCA2 entry</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/BRCA2ID164ch13q13.html"/>
</comment>
<dbReference type="EMBL" id="X95152">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95153">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95154">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95155">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95156">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95157">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95158">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95159">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95160">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95161">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95162">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95163">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95164">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95165">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95166">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95167">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95168">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95169">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95170">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95171">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95172">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95173">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95174">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95175">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95176">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X95177">
<property type="protein sequence ID" value="CAA64484.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U43746">
<property type="protein sequence ID" value="AAB07223.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY436640">
<property type="protein sequence ID" value="AAQ97181.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL137247">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL445212">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z74739">
<property type="protein sequence ID" value="CAA98995.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z73359">
<property type="protein sequence ID" value="CAA97728.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS9344.1"/>
<dbReference type="PIR" id="G02334">
<property type="entry name" value="G02334"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000050.2">
<property type="nucleotide sequence ID" value="NM_000059.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.34012"/>
<dbReference type="PDB" id="1N0W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="B=1517-1551"/>
</dbReference>
<dbReference type="PDB" id="3EU7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="X=21-39"/>
</dbReference>
<dbReference type="PDBsum" id="1N0W"/>
<dbReference type="PDBsum" id="3EU7"/>
<dbReference type="ProteinModelPortal" id="P51587"/>
<dbReference type="SMR" id="P51587"/>
<dbReference type="BioGrid" id="107142">
<property type="interactions" value="98"/>
</dbReference>
<dbReference type="CORUM" id="P51587"/>
<dbReference type="DIP" id="DIP-24214N"/>
<dbReference type="ELM" id="P51587"/>
<dbReference type="IntAct" id="P51587">
<property type="interactions" value="32"/>
</dbReference>
<dbReference type="MINT" id="MINT-1540184"/>
<dbReference type="STRING" id="9606.ENSP00000369497"/>
<dbReference type="iPTMnet" id="P51587"/>
<dbReference type="PhosphoSitePlus" id="P51587"/>
<dbReference type="BioMuta" id="BRCA2"/>
<dbReference type="DMDM" id="14424438"/>
<dbReference type="EPD" id="P51587"/>
<dbReference type="PaxDb" id="P51587"/>
<dbReference type="PeptideAtlas" id="P51587"/>
<dbReference type="PRIDE" id="P51587"/>
<dbReference type="DNASU" id="675"/>
<dbReference type="Ensembl" id="ENST00000380152">
<property type="protein sequence ID" value="ENSP00000369497"/>
<property type="gene ID" value="ENSG00000139618"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000544455">
<property type="protein sequence ID" value="ENSP00000439902"/>
<property type="gene ID" value="ENSG00000139618"/>
</dbReference>
<dbReference type="GeneID" id="675"/>
<dbReference type="KEGG" id="hsa:675"/>
<dbReference type="UCSC" id="uc001uub.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="675"/>
<dbReference type="DisGeNET" id="675"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000139618.14"/>
<dbReference type="GeneCards" id="BRCA2"/>
<dbReference type="GeneReviews" id="BRCA2"/>
<dbReference type="HGNC" id="HGNC:1101">
<property type="gene designation" value="BRCA2"/>
</dbReference>
<dbReference type="HPA" id="HPA026815"/>
<dbReference type="MalaCards" id="BRCA2"/>
<dbReference type="MIM" id="114480">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="600185">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="605724">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="612555">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613029">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613347">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P51587"/>
<dbReference type="Orphanet" id="1333">
<property type="disease" value="Familial pancreatic carcinoma"/>
</dbReference>
<dbReference type="Orphanet" id="1331">
<property type="disease" value="Familial prostate cancer"/>
</dbReference>
<dbReference type="Orphanet" id="84">
<property type="disease" value="Fanconi anemia"/>
</dbReference>
<dbReference type="Orphanet" id="145">
<property type="disease" value="Hereditary breast and ovarian cancer syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="227535">
<property type="disease" value="Hereditary breast cancer"/>
</dbReference>
<dbReference type="Orphanet" id="213524">
<property type="disease" value="Hereditary site-specific ovarian cancer syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="319462">
<property type="disease" value="Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations"/>
</dbReference>
<dbReference type="PharmGKB" id="PA25412"/>
<dbReference type="eggNOG" id="KOG4751">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410Y06W">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="HOG000139693"/>
<dbReference type="HOVERGEN" id="HBG050731"/>
<dbReference type="InParanoid" id="P51587"/>
<dbReference type="KO" id="K08775"/>
<dbReference type="OrthoDB" id="EOG091G0C79"/>
<dbReference type="TreeFam" id="TF105041"/>
<dbReference type="Reactome" id="R-HSA-5685942">
<property type="pathway name" value="HDR through Homologous Recombination (HRR)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693554">
<property type="pathway name" value="Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693568">
<property type="pathway name" value="Resolution of D-loop Structures through Holliday Junction Intermediates"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693579">
<property type="pathway name" value="Homologous DNA Pairing and Strand Exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693616">
<property type="pathway name" value="Presynaptic phase of homologous DNA pairing and strand exchange"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912446">
<property type="pathway name" value="Meiotic recombination"/>
</dbReference>
<dbReference type="SignaLink" id="P51587"/>
<dbReference type="SIGNOR" id="P51587"/>
<dbReference type="EvolutionaryTrace" id="P51587"/>
<dbReference type="GeneWiki" id="BRCA2"/>
<dbReference type="GenomeRNAi" id="675"/>
<dbReference type="PRO" id="PR:P51587"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 13"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000139618"/>
<dbReference type="CleanEx" id="HS_BRCA2"/>
<dbReference type="ExpressionAtlas" id="P51587">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P51587">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0033593">
<property type="term" value="C:BRCA2-MAGE-D1 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000800">
<property type="term" value="C:lateral element"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0000784">
<property type="term" value="C:nuclear chromosome, telomeric region"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030141">
<property type="term" value="C:secretory granule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043015">
<property type="term" value="F:gamma-tubulin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010484">
<property type="term" value="F:H3 histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010485">
<property type="term" value="F:H4 histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0002020">
<property type="term" value="F:protease binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003697">
<property type="term" value="F:single-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007569">
<property type="term" value="P:cell aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051298">
<property type="term" value="P:centrosome duplication"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000910">
<property type="term" value="P:cytokinesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006978">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000731">
<property type="term" value="P:DNA synthesis involved in DNA repair"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006302">
<property type="term" value="P:double-strand break repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000724">
<property type="term" value="P:double-strand break repair via homologous recombination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070200">
<property type="term" value="P:establishment of protein localization to telomere"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008585">
<property type="term" value="P:female gonad development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030097">
<property type="term" value="P:hemopoiesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043966">
<property type="term" value="P:histone H3 acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043967">
<property type="term" value="P:histone H4 acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001833">
<property type="term" value="P:inner cell mass cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042771">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007141">
<property type="term" value="P:male meiosis I"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990426">
<property type="term" value="P:mitotic recombination-dependent replication fork processing"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033600">
<property type="term" value="P:negative regulation of mammary gland epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006289">
<property type="term" value="P:nucleotide-excision repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001556">
<property type="term" value="P:oocyte maturation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045931">
<property type="term" value="P:positive regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032465">
<property type="term" value="P:regulation of cytokinesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048478">
<property type="term" value="P:replication fork protection"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010332">
<property type="term" value="P:response to gamma radiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010225">
<property type="term" value="P:response to UV-C"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010165">
<property type="term" value="P:response to X-ray"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000732">
<property type="term" value="P:strand displacement"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000722">
<property type="term" value="P:telomere maintenance via recombination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd04493">
<property type="entry name" value="BRCA2DBD_OB1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd04495">
<property type="entry name" value="BRCA2DBD_OB3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR015525">
<property type="entry name" value="BRCA2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015252">
<property type="entry name" value="BRCA2_hlx"/>
</dbReference>
<dbReference type="InterPro" id="IPR036315">
<property type="entry name" value="BRCA2_hlx_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR015187">
<property type="entry name" value="BRCA2_OB_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR015188">
<property type="entry name" value="BRCA2_OB_3"/>
</dbReference>
<dbReference type="InterPro" id="IPR002093">
<property type="entry name" value="BRCA2_repeat"/>
</dbReference>
<dbReference type="InterPro" id="IPR012340">
<property type="entry name" value="NA-bd_OB-fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR015205">
<property type="entry name" value="Tower_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11289">
<property type="entry name" value="PTHR11289"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF09169">
<property type="entry name" value="BRCA-2_helical"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09103">
<property type="entry name" value="BRCA-2_OB1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09104">
<property type="entry name" value="BRCA-2_OB3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00634">
<property type="entry name" value="BRCA2"/>
<property type="match status" value="8"/>
</dbReference>
<dbReference type="Pfam" id="PF09121">
<property type="entry name" value="Tower"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF002397">
<property type="entry name" value="BRCA2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01341">
<property type="entry name" value="Tower"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50249">
<property type="entry name" value="SSF50249"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF81872">
<property type="entry name" value="SSF81872"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50138">
<property type="entry name" value="BRCA2_REPEAT"/>
<property type="match status" value="8"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0233">DNA recombination</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0923">Fanconi anemia</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Breast cancer type 2 susceptibility protein" id="PRO_0000064984">
<location>
<begin position="1"/>
<end position="3418"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 1">
<location>
<begin position="1002"/>
<end position="1036"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 2">
<location>
<begin position="1212"/>
<end position="1246"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 3">
<location>
<begin position="1421"/>
<end position="1455"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 4">
<location>
<begin position="1517"/>
<end position="1551"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 5">
<location>
<begin position="1664"/>
<end position="1698"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 6">
<location>
<begin position="1837"/>
<end position="1871"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 7">
<location>
<begin position="1971"/>
<end position="2005"/>
</location>
</feature>
<feature type="repeat" description="BRCA2 8">
<location>
<begin position="2051"/>
<end position="2085"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PALB2">
<location>
<begin position="1"/>
<end position="40"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with NPM1" evidence="56">
<location>
<begin position="639"/>
<end position="1000"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with POLH" evidence="61">
<location>
<begin position="1338"/>
<end position="1781"/>
</location>
</feature>
<feature type="region of interest" description="Required for stimulation of POLH DNA polymerization activity">
<location>
<begin position="1410"/>
<end position="1595"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with FANCD2">
<location>
<begin position="2350"/>
<end position="2545"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SEM1" evidence="6 44">
<location>
<begin position="2481"/>
<end position="2832"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal; masked by interaction with SEM1" evidence="59">
<location>
<begin position="2682"/>
<end position="2698"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="70"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="445"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="492"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="755"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1970"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="4">
<location>
<position position="2035"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="2095"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK1 and CDK2" evidence="42">
<location>
<position position="3291"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="3319"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CHEK1 and CHEK2" evidence="49">
<location>
<position position="3387"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; abolishes interaction with PALB2." id="VAR_028167" evidence="45">
<original>G</original>
<variation>R</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; abolishes interaction with PALB2." id="VAR_028168" evidence="45">
<original>W</original>
<variation>C</variation>
<location>
<position position="31"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; abolishes interaction with PALB2." id="VAR_028169" evidence="45">
<original>W</original>
<variation>R</variation>
<location>
<position position="31"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005085" evidence="72">
<original>F</original>
<variation>L</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and ovarian cancer; unknown pathological significance; dbSNP:rs4987046." id="VAR_020705" evidence="23 30">
<original>Y</original>
<variation>C</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005086" evidence="72">
<original>K</original>
<variation>R</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020706" evidence="31">
<original>N</original>
<variation>S</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_032712" evidence="34">
<original>T</original>
<variation>I</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer and renal cancer; unknown pathological significance; dbSNP:rs28897701." id="VAR_005087" evidence="8">
<original>A</original>
<variation>P</variation>
<location>
<position position="75"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005088" evidence="72">
<original>F</original>
<variation>L</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_008766">
<original>N</original>
<variation>H</variation>
<location>
<position position="108"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with esophageal carcinoma." id="VAR_032713" evidence="13">
<original>R</original>
<variation>H</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with pancreatic cancer." id="VAR_032714" evidence="16">
<original>M</original>
<variation>T</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005089" evidence="72">
<original>P</original>
<variation>R</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005090" evidence="72">
<original>V</original>
<variation>A</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005091" evidence="72">
<original>P</original>
<variation>S</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with BC; normal RNA expression and splicing." id="VAR_032715" evidence="36">
<original>T</original>
<variation>A</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; was originally thought to be linked to ovarian cancer; dbSNP:rs766173." id="VAR_005092" evidence="5 9 24 34 38 75">
<original>N</original>
<variation>H</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with esophageal carcinoma; dbSNP:rs79483201." id="VAR_032716" evidence="13">
<original>C</original>
<variation>S</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571640." id="VAR_018908" evidence="75">
<original>K</original>
<variation>Q</variation>
<location>
<position position="322"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs28897706." id="VAR_032717" evidence="7">
<original>S</original>
<variation>R</variation>
<location>
<position position="326"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_008767">
<original>K</original>
<variation>E</variation>
<location>
<position position="327"/>
</location>
</feature>
<feature type="sequence variant" description="In lung cancer." id="VAR_005093">
<original>V</original>
<variation>L</variation>
<location>
<position position="355"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; may be associated with an increased risk of breast cancer; dbSNP:rs144848." id="VAR_005094" evidence="5 9 10 24 32 34 38 68 69 75">
<original>N</original>
<variation>H</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020707" evidence="31">
<original>G</original>
<variation>R</variation>
<location>
<position position="405"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020708" evidence="27">
<original>T</original>
<variation>I</variation>
<location>
<position position="431"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020709" evidence="31">
<original>R</original>
<variation>H</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs56403624." id="VAR_020710" evidence="24 31 34">
<original>E</original>
<variation>G</variation>
<location>
<position position="462"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs28897708." id="VAR_032718" evidence="12">
<original>I</original>
<variation>T</variation>
<location>
<position position="505"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897709." id="VAR_056751">
<original>K</original>
<variation>R</variation>
<location>
<position position="513"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and pancreas cancer." id="VAR_005095" evidence="73">
<original>C</original>
<variation>W</variation>
<location>
<position position="554"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs80358457." id="VAR_008768" evidence="26">
<original>T</original>
<variation>P</variation>
<location>
<position position="582"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897710." id="VAR_020711" evidence="18">
<original>T</original>
<variation>A</variation>
<location>
<position position="598"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1046984." id="VAR_035436" evidence="65">
<original>S</original>
<variation>F</variation>
<location>
<position position="599"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_076440" evidence="63">
<original>P</original>
<variation>L</variation>
<location>
<position position="606"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020712" evidence="23">
<original>L</original>
<variation>R</variation>
<location>
<position position="613"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer." id="VAR_005096">
<original>T</original>
<variation>I</variation>
<location>
<position position="630"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs80358487." id="VAR_008769">
<original>D</original>
<variation>Y</variation>
<location>
<position position="707"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005097">
<original>D</original>
<variation>A</variation>
<location>
<position position="728"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_032719" evidence="9">
<original>I</original>
<variation>M</variation>
<location>
<position position="729"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571653." id="VAR_008770" evidence="38 75">
<original>M</original>
<variation>V</variation>
<location>
<position position="784"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_008771">
<original>N</original>
<variation>I</variation>
<location>
<position position="886"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2227943." id="VAR_018909" evidence="75">
<original>L</original>
<variation>S</variation>
<location>
<position position="929"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs28897716." id="VAR_008772">
<original>D</original>
<variation>N</variation>
<location>
<position position="935"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571656." id="VAR_018910" evidence="75">
<original>S</original>
<variation>F</variation>
<location>
<position position="976"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897717." id="VAR_056752">
<original>I</original>
<variation>L</variation>
<location>
<position position="982"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2227944." id="VAR_018911" evidence="75">
<original>N</original>
<variation>I</variation>
<location>
<position position="987"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs1799944." id="VAR_005098" evidence="5 9 24 31 34 38 69 75">
<original>N</original>
<variation>D</variation>
<location>
<position position="991"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020713" evidence="27">
<original>E</original>
<variation>K</variation>
<location>
<position position="1036"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020714" evidence="27">
<original>S</original>
<variation>R</variation>
<location>
<position position="1106"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1799951." id="VAR_005099" evidence="69">
<original>N</original>
<variation>S</variation>
<location>
<position position="1147"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_032720" evidence="39">
<original>S</original>
<variation>L</variation>
<location>
<position position="1172"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020715" evidence="11">
<original>S</original>
<variation>N</variation>
<location>
<position position="1179"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_020716" evidence="24 34">
<original>N</original>
<variation>S</variation>
<location>
<position position="1279"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_008773">
<location>
<position position="1286"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41293485." id="VAR_008774">
<original>C</original>
<variation>Y</variation>
<location>
<position position="1290"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005100">
<location>
<position position="1302"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs70953664." id="VAR_008775">
<original>T</original>
<variation>M</variation>
<location>
<position position="1414"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897727." id="VAR_008776" evidence="11 18 24 34 39 63">
<original>D</original>
<variation>Y</variation>
<location>
<position position="1420"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020717" evidence="38">
<original>K</original>
<variation>T</variation>
<location>
<position position="1445"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_008777">
<original>D</original>
<variation>N</variation>
<location>
<position position="1513"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with BC." id="VAR_032721" evidence="26">
<original>L</original>
<variation>F</variation>
<location>
<position position="1522"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020718" evidence="27">
<original>F</original>
<variation>V</variation>
<location>
<position position="1524"/>
</location>
</feature>
<feature type="sequence variant" description="In bladder cancer; dbSNP:rs28897728." id="VAR_005101">
<original>G</original>
<variation>R</variation>
<location>
<position position="1529"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897729." id="VAR_056753">
<original>V</original>
<variation>M</variation>
<location>
<position position="1542"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2219594." id="VAR_018912" evidence="75">
<original>H</original>
<variation>N</variation>
<location>
<position position="1561"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; somatic mutation." id="VAR_020719" evidence="14">
<original>C</original>
<variation>Y</variation>
<location>
<position position="1580"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_008778" evidence="21">
<original>E</original>
<variation>D</variation>
<location>
<position position="1593"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897731." id="VAR_056754">
<original>V</original>
<variation>A</variation>
<location>
<position position="1643"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020720" evidence="29">
<original>T</original>
<variation>I</variation>
<location>
<position position="1679"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_032722" evidence="34">
<original>K</original>
<variation>N</variation>
<location>
<position position="1690"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_032723" evidence="12">
<original>N</original>
<variation>Y</variation>
<location>
<position position="1730"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs80358755." id="VAR_008779" evidence="24 34">
<original>G</original>
<variation>D</variation>
<location>
<position position="1771"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020721" evidence="29">
<original>V</original>
<variation>A</variation>
<location>
<position position="1804"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs80358765." id="VAR_008780">
<original>N</original>
<variation>S</variation>
<location>
<position position="1805"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; was originally thought to be linked to breast cancer; dbSNP:rs11571657." id="VAR_005102" evidence="12 75">
<original>N</original>
<variation>K</variation>
<location>
<position position="1880"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_032724" evidence="34">
<original>T</original>
<variation>M</variation>
<location>
<position position="1887"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020722" evidence="29">
<original>E</original>
<variation>K</variation>
<location>
<position position="1901"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4987048." id="VAR_008781">
<original>D</original>
<variation>N</variation>
<location>
<position position="1902"/>
</location>
</feature>
<feature type="sequence variant" description="May be a rare polymorphism; somatic mutation; dbSNP:rs4987117." id="VAR_005103" evidence="9 14 34 68 69 75">
<original>T</original>
<variation>M</variation>
<location>
<position position="1915"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs79538375." id="VAR_020723" evidence="38">
<original>I</original>
<variation>V</variation>
<location>
<position position="1929"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897737." id="VAR_056755">
<original>S</original>
<variation>R</variation>
<location>
<position position="1979"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with esophageal carcinoma; somatic mutation." id="VAR_032725" evidence="13">
<original>V</original>
<variation>I</variation>
<location>
<position position="1988"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020724" evidence="38">
<original>T</original>
<variation>A</variation>
<location>
<position position="2031"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1799954." id="VAR_005104" evidence="18 25 69">
<original>R</original>
<variation>C</variation>
<location>
<position position="2034"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with BC; dbSNP:rs56191579." id="VAR_032726" evidence="26">
<original>G</original>
<variation>V</variation>
<location>
<position position="2044"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020725" evidence="19">
<original>S</original>
<variation>C</variation>
<location>
<position position="2072"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34309943." id="VAR_008782">
<original>H</original>
<variation>N</variation>
<location>
<position position="2074"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_008783" evidence="71">
<original>E</original>
<variation>D</variation>
<location>
<position position="2089"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020726" evidence="19">
<original>Y</original>
<variation>C</variation>
<location>
<position position="2094"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020727" evidence="29">
<original>P</original>
<variation>L</variation>
<location>
<position position="2096"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55794205." id="VAR_032727" evidence="34">
<original>R</original>
<variation>C</variation>
<location>
<position position="2108"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55953736." id="VAR_061563">
<original>H</original>
<variation>R</variation>
<location>
<position position="2116"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020728" evidence="23">
<original>V</original>
<variation>L</variation>
<location>
<position position="2118"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020729" evidence="19">
<original>K</original>
<variation>N</variation>
<location>
<position position="2128"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_032728" evidence="12">
<original>N</original>
<variation>H</variation>
<location>
<position position="2135"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571659." id="VAR_008784" evidence="75">
<original>V</original>
<variation>F</variation>
<location>
<position position="2138"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571660." id="VAR_018913" evidence="75">
<original>K</original>
<variation>R</variation>
<location>
<position position="2162"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_032729" evidence="12">
<original>Y</original>
<variation>C</variation>
<location>
<position position="2222"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897742." id="VAR_056756">
<original>D</original>
<variation>E</variation>
<location>
<position position="2238"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005105">
<original>G</original>
<variation>V</variation>
<location>
<position position="2274"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020730" evidence="31">
<original>E</original>
<variation>G</variation>
<location>
<position position="2275"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020731" evidence="23">
<original>F</original>
<variation>L</variation>
<location>
<position position="2293"/>
</location>
</feature>
<feature type="sequence variant" description="In FANCD1; affects protein splicing and expression; decreases homologous recombination-mediated DNA repair; dbSNP:rs28897743." id="VAR_032730" evidence="46 47 58">
<original>R</original>
<variation>H</variation>
<location>
<position position="2336"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897743." id="VAR_056757">
<original>R</original>
<variation>Q</variation>
<location>
<position position="2336"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020732" evidence="31">
<original>G</original>
<variation>R</variation>
<location>
<position position="2353"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005106" evidence="67">
<original>H</original>
<variation>N</variation>
<location>
<position position="2415"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005107">
<original>Q</original>
<variation>H</variation>
<location>
<position position="2421"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4986860." id="VAR_018914" evidence="75">
<original>H</original>
<variation>R</variation>
<location>
<position position="2440"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4986859." id="VAR_056758">
<original>N</original>
<variation>D</variation>
<location>
<position position="2447"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_032731" evidence="34">
<original>Q</original>
<variation>E</variation>
<location>
<position position="2456"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; was originally thought to be linked to ovarian cancer." id="VAR_008785" evidence="24 32 34 68 75">
<original>A</original>
<variation>V</variation>
<location>
<position position="2466"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs80358965." id="VAR_008786">
<original>L</original>
<variation>V</variation>
<location>
<position position="2480"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020733" evidence="31">
<original>R</original>
<variation>K</variation>
<location>
<position position="2488"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; no effect on homologous recombination-mediated DNA repair; no effect on interaction with SEM1; dbSNP:rs11571707." id="VAR_008787" evidence="58 75">
<original>I</original>
<variation>T</variation>
<location>
<position position="2490"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_063911" evidence="47">
<original>R</original>
<variation>C</variation>
<location>
<position position="2502"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; unknown pathological significance." id="VAR_008788" evidence="8">
<original>R</original>
<variation>H</variation>
<location>
<position position="2502"/>
</location>
</feature>
<feature type="sequence variant" description="In FANCD1; hypersensitive to DNA damage; disrupts interaction with SEM1." id="VAR_032732" evidence="28 58">
<original>L</original>
<variation>P</variation>
<location>
<position position="2510"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs28897744." id="VAR_008789" evidence="9">
<original>T</original>
<variation>I</variation>
<location>
<position position="2515"/>
</location>
</feature>
<feature type="sequence variant" description="In FANCD1; hypersensitive to DNA damage; no effect on interaction with SEM1." id="VAR_032733" evidence="46 47 58">
<original>W</original>
<variation>C</variation>
<location>
<position position="2626"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_063912" evidence="47">
<original>I</original>
<variation>F</variation>
<location>
<position position="2627"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_063913" evidence="47">
<original>L</original>
<variation>P</variation>
<location>
<position position="2653"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_063914" evidence="47">
<original>R</original>
<variation>K</variation>
<location>
<position position="2659"/>
</location>
</feature>
<feature type="sequence variant" description="Could be associated with cancer susceptibility; major splicing aberration identified with this mutant; multifactorial likelihood analysis provides evidence for pathogenicity." id="VAR_063915" evidence="47 52">
<original>E</original>
<variation>V</variation>
<location>
<position position="2663"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897746." id="VAR_056759">
<original>L</original>
<variation>P</variation>
<location>
<position position="2686"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_020734" evidence="21">
<original>N</original>
<variation>S</variation>
<location>
<position position="2706"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_018661" evidence="17 47">
<original>T</original>
<variation>R</variation>
<location>
<position position="2722"/>
</location>
</feature>
<feature type="sequence variant" description="Could be associated with cancer susceptibility; has abrogated function consistent with pathogenicity; major splicing aberration identified with this mutant." id="VAR_063916" evidence="47 52">
<original>D</original>
<variation>G</variation>
<location>
<position position="2723"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; disrupts interaction with SEM1 promoting interaction with XPO1 and BRCA2 cytoplasmic localization; in heterozygous state promotes RAD51 cytoplasmic localization." id="VAR_020735" evidence="31 59">
<original>D</original>
<variation>H</variation>
<location>
<position position="2723"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs28897749." id="VAR_020736" evidence="7 9 18">
<original>V</original>
<variation>I</variation>
<location>
<position position="2728"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; no effect on homologous recombination-mediated DNA repair; no effect on interaction with SEM1; dbSNP:rs80359065." id="VAR_020737" evidence="22 58">
<original>K</original>
<variation>N</variation>
<location>
<position position="2729"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_063917" evidence="47">
<original>G</original>
<variation>D</variation>
<location>
<position position="2748"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; somatic mutation." id="VAR_008790" evidence="68">
<original>R</original>
<variation>H</variation>
<location>
<position position="2787"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897751." id="VAR_056760">
<original>L</original>
<variation>P</variation>
<location>
<position position="2792"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_020738" evidence="23">
<original>G</original>
<variation>R</variation>
<location>
<position position="2793"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571746." id="VAR_018915" evidence="75">
<original>S</original>
<variation>P</variation>
<location>
<position position="2835"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with esophageal carcinoma; somatic mutation." id="VAR_032734" evidence="13">
<original>R</original>
<variation>C</variation>
<location>
<position position="2842"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571747." id="VAR_018916" evidence="31 75">
<original>E</original>
<variation>A</variation>
<location>
<position position="2856"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4987047." id="VAR_008791" evidence="39 75">
<original>I</original>
<variation>F</variation>
<location>
<position position="2944"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs28897754." id="VAR_020739" evidence="31 39">
<original>K</original>
<variation>N</variation>
<location>
<position position="2950"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571769." id="VAR_008792" evidence="18 75">
<original>A</original>
<variation>T</variation>
<location>
<position position="2951"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs59004709." id="VAR_008793">
<original>V</original>
<variation>M</variation>
<location>
<position position="2969"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance; dbSNP:rs28897755." id="VAR_020740" evidence="31 39">
<original>T</original>
<variation>I</variation>
<location>
<position position="3013"/>
</location>
</feature>
<feature type="sequence variant" description="Could be associated with cancer susceptibility; has abrogated function consistent with pathogenicity; multifactorial likelihood analysis provides evidence for pathogenicity." id="VAR_063918" evidence="52">
<original>R</original>
<variation>W</variation>
<location>
<position position="3052"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with ovarian cancer; unknown pathological significance." id="VAR_020741" evidence="30">
<original>P</original>
<variation>S</variation>
<location>
<position position="3063"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_020742" evidence="25">
<original>G</original>
<variation>E</variation>
<location>
<position position="3076"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; unknown pathological significance." id="VAR_005108" evidence="47 66">
<original>D</original>
<variation>E</variation>
<location>
<position position="3095"/>
</location>
</feature>
<feature type="sequence variant" description="In BC and ovarian cancer; unknown pathological significance; dbSNP:rs41293521." id="VAR_008794" evidence="8 31">
<original>Y</original>
<variation>H</variation>
<location>
<position position="3098"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs28897758." id="VAR_056761">
<original>L</original>
<variation>R</variation>
<location>
<position position="3101"/>
</location>
</feature>
<feature type="sequence variant" description="In melanoma." id="VAR_005109">
<original>I</original>
<variation>M</variation>
<location>
<position position="3103"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005110" evidence="72">
<original>M</original>
<variation>T</variation>
<location>
<position position="3118"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_020743" evidence="11">
<original>N</original>
<variation>I</variation>
<location>
<position position="3124"/>
</location>
</feature>
<feature type="sequence variant" description="In BC; dbSNP:rs80359228." id="VAR_020744" evidence="11">
<original>K</original>
<variation>E</variation>
<location>
<position position="3196"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11571831." id="VAR_018917" evidence="75">
<original>V</original>
<variation>I</variation>
<location>
<position position="3244"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_008795">
<original>K</original>
<variation>R</variation>
<location>
<position position="3257"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_008796">
<original>R</original>
<variation>S</variation>
<location>
<position position="3276"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with esophageal carcinoma." id="VAR_032735" evidence="13">
<original>P</original>
<variation>S</variation>
<location>
<position position="3300"/>
</location>
</feature>
<feature type="sequence variant" description="In BC." id="VAR_005111">
<original>T</original>
<variation>R</variation>
<location>
<position position="3357"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56309455." id="VAR_020745" evidence="23">
<original>T</original>
<variation>I</variation>
<location>
<position position="3374"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; was originally thought to be associated with breast cancer; dbSNP:rs1801426." id="VAR_005112" evidence="5 9 22 30 31 38 71 75">
<original>I</original>
<variation>V</variation>
<location>
<position position="3412"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with SEM1." evidence="59">
<original>W</original>
<variation>A</variation>
<location>
<position position="2725"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired interaction with RAD51." evidence="42">
<original>S</original>
<variation>E</variation>
<location>
<position position="3291"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation by CHEK1 and CHEK2 (in vitro)." evidence="49">
<original>T</original>
<variation>A</variation>
<location>
<position position="3387"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA64484." ref="1" evidence="76">
<original>S</original>
<variation>N</variation>
<location>
<position position="758"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA64484." ref="1" evidence="76">
<original>GY</original>
<variation>RI</variation>
<location>
<begin position="1761"/>
<end position="1762"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA64484." ref="1" evidence="76">
<original>K</original>
<variation>N</variation>
<location>
<position position="1767"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA98995." ref="4" evidence="76">
<original>S</original>
<variation>P</variation>
<location>
<position position="2536"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA97728." ref="4" evidence="76">
<original>L</original>
<variation>LVS</variation>
<location>
<position position="3216"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="31"/>
<end position="35"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1520"/>
<end position="1522"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1536"/>
<end position="1541"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1542"/>
<end position="1546"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1N0W"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3EU7"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17525332"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10323242"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10373512"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10399947"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10486320"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10978364"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11062481"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11139248"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11241844"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11948123"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11948477"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12065746"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12097290"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12145750"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12215251"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12373604"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12442171"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12442273"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12442274"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12442275"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12552570"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12569143"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12624724"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12938098"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14670928"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14722926"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14746861"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15026808"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15057823"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15115758"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15172753"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15199141"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15300854"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15314155"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15365993"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15635067"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15671039"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15689453"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15800615"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15967112"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16205630"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16793542"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16825431"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17924331"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18212739"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18317453"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19369211"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19609323"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20513136"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20729832"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20729858"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20729859"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21084279"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21276791"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21719596"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24013206"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24141787"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24485656"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24896180"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26566883"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28319063"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8589730"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8640235"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8640237"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8665505"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8673091"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9140390"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9150152"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9609997"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9654203"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9971877"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="76" type="ECO:0000305"/>
<evidence key="77" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21276791"/>
</source>
</evidence>
<sequence length="3418" mass="384202" checksum="6A0B3B7B332153EB" modified="2015-11-11" version="3">
MPIGSKERPTFFEIFKTRCNKADLGPISLNWFEELSSEAPPYNSEPAEESEHKNNNYEPN
LFKTPQRKPSYNQLASTPIIFKEQGLTLPLYQSPVKELDKFKLDLGRNVPNSRHKSLRTV
KTKMDQADDVSCPLLNSCLSESPVVLQCTHVTPQRDKSVVCGSLFHTPKFVKGRQTPKHI
SESLGAEVDPDMSWSSSLATPPTLSSTVLIVRNEEASETVFPHDTTANVKSYFSNHDESL
KKNDRFIASVTDSENTNQREAASHGFGKTSGNSFKVNSCKDHIGKSMPNVLEDEVYETVV
DTSEEDSFSLCFSKCRTKNLQKVRTSKTRKKIFHEANADECEKSKNQVKEKYSFVSEVEP
NDTDPLDSNVANQKPFESGSDKISKEVVPSLACEWSQLTLSGLNGAQMEKIPLLHISSCD
QNISEKDLLDTENKRKKDFLTSENSLPRISSLPKSEKPLNEETVVNKRDEEQHLESHTDC
ILAVKQAISGTSPVASSFQGIKKSIFRIRESPKETFNASFSGHMTDPNFKKETEASESGL
EIHTVCSQKEDSLCPNLIDNGSWPATTTQNSVALKNAGLISTLKKKTNKFIYAIHDETSY
KGKKIPKDQKSELINCSAQFEANAFEAPLTFANADSGLLHSSVKRSCSQNDSEEPTLSLT
SSFGTILRKCSRNETCSNNTVISQDLDYKEAKCNKEKLQLFITPEADSLSCLQEGQCEND
PKSKKVSDIKEEVLAAACHPVQHSKVEYSDTDFQSQKSLLYDHENASTLILTPTSKDVLS
NLVMISRGKESYKMSDKLKGNNYESDVELTKNIPMEKNQDVCALNENYKNVELLPPEKYM
RVASPSRKVQFNQNTNLRVIQKNQEETTSISKITVNPDSEELFSDNENNFVFQVANERNN
LALGNTKELHETDLTCVNEPIFKNSTMVLYGDTGDKQATQVSIKKDLVYVLAEENKNSVK
QHIKMTLGQDLKSDISLNIDKIPEKNNDYMNKWAGLLGPISNHSFGGSFRTASNKEIKLS
EHNIKKSKMFFKDIEEQYPTSLACVEIVNTLALDNQKKLSKPQSINTVSAHLQSSVVVSD
CKNSHITPQMLFSKQDFNSNHNLTPSQKAEITELSTILEESGSQFEFTQFRKPSYILQKS
TFEVPENQMTILKTTSEECRDADLHVIMNAPSIGQVDSSKQFEGTVEIKRKFAGLLKNDC
NKSASGYLTDENEVGFRGFYSAHGTKLNVSTEALQKAVKLFSDIENISEETSAEVHPISL
SSSKCHDSVVSMFKIENHNDKTVSEKNNKCQLILQNNIEMTTGTFVEEITENYKRNTENE
DNKYTAASRNSHNLEFDGSDSSKNDTVCIHKDETDLLFTDQHNICLKLSGQFMKEGNTQI
KEDLSDLTFLEVAKAQEACHGNTSNKEQLTATKTEQNIKDFETSDTFFQTASGKNISVAK
ESFNKIVNFFDQKPEELHNFSLNSELHSDIRKNKMDILSYEETDIVKHKILKESVPVGTG
NQLVTFQGQPERDEKIKEPTLLGFHTASGKKVKIAKESLDKVKNLFDEKEQGTSEITSFS
HQWAKTLKYREACKDLELACETIEITAAPKCKEMQNSLNNDKNLVSIETVVPPKLLSDNL
CRQTENLKTSKSIFLKVKVHENVEKETAKSPATCYTNQSPYSVIENSALAFYTSCSRKTS
VSQTSLLEAKKWLREGIFDGQPERINTADYVGNYLYENNSNSTIAENDKNHLSEKQDTYL
SNSSMSNSYSYHSDEVYNDSGYLSKNKLDSGIEPVLKNVEDQKNTSFSKVISNVKDANAY
PQTVNEDICVEELVTSSSPCKNKNAAIKLSISNSNNFEVGPPAFRIASGKIVCVSHETIK
KVKDIFTDSFSKVIKENNENKSKICQTKIMAGCYEALDDSEDILHNSLDNDECSTHSHKV
FADIQSEEILQHNQNMSGLEKVSKISPCDVSLETSDICKCSIGKLHKSVSSANTCGIFST
ASGKSVQVSDASLQNARQVFSEIEDSTKQVFSKVLFKSNEHSDQLTREENTAIRTPEHLI
SQKGFSYNVVNSSAFSGFSTASGKQVSILESSLHKVKGVLEEFDLIRTEHSLHYSPTSRQ
NVSKILPRVDKRNPEHCVNSEMEKTCSKEFKLSNNLNVEGGSSENNHSIKVSPYLSQFQQ
DKQQLVLGTKVSLVENIHVLGKEQASPKNVKMEIGKTETFSDVPVKTNIEVCSTYSKDSE
NYFETEAVEIAKAFMEDDELTDSKLPSHATHSLFTCPENEEMVLSNSRIGKRRGEPLILV
GEPSIKRNLLNEFDRIIENQEKSLKASKSTPDGTIKDRRLFMHHVSLEPITCVPFRTTKE
RQEIQNPNFTAPGQEFLSKSHLYEHLTLEKSSSNLAVSGHPFYQVSATRNEKMRHLITTG
RPTKVFVPPFKTKSHFHRVEQCVRNINLEENRQKQNIDGHGSDDSKNKINDNEIHQFNKN
NSNQAAAVTFTKCEEEPLDLITSLQNARDIQDMRIKKKQRQRVFPQPGSLYLAKTSTLPR
ISLKAAVGGQVPSACSHKQLYTYGVSKHCIKINSKNAESFQFHTEDYFGKESLWTGKGIQ
LADGGWLIPSNDGKAGKEEFYRALCDTPGVDPKLISRIWVYNHYRWIIWKLAAMECAFPK
EFANRCLSPERVLLQLKYRYDTEIDRSRRSAIKKIMERDDTAAKTLVLCVSDIISLSANI
SETSSNKTSSADTQKVAIIELTDGWYAVKAQLDPPLLAVLKNGRLTVGQKIILHGAELVG
SPDACTPLEAPESLMLKISANSTRPARWYTKLGFFPDPRPFPLPLSSLFSDGGNVGCVDV
IIQRAYPIQWMEKTSSGLYIFRNEREEEKEAAKYVEAQQKRLEALFTKIQEEFEEHEENT
TKPYLPSRALTRQQVRALQDGAELYEAVKNAADPAYLEGYFSEEQLRALNNHRQMLNDKK
QAQIQLEIRKAMESAEQKEQGLSRDVTTVWKLRIVSYSKKEKDSVILSIWRPSSDLYSLL
TEGKRYRIYHLATSKSKSKSERANIQLAATKKTQYQQLPVSDEILFQIYQPREPLHFSKF
LDPDFQPSCSEVDLIGFVVSVVKKTGLAPFVYLSDECYNLLAIKFWIDLNEDIIKPHMLI
AASNLQWRPESKSGLLTLFAGDFSVFSASPKEGHFQETFNKMKNTVENIDILCNEAENKL
MHILHANDPKWSTPTKDCTSGPYTAQIIPGTGNKLLMSSPNCEIYYQSPLSLCMAKRKSV
STPVSAQMTSKSCKGEKEIDDQKNCKKRRALDFLSRLPLPPPVSPICTFVSPAAQKAFQP
PRSCGTKYETPIKKKELNSPQMTPFKKFNEISLLESNSIADEELALINTQALLSGSTGEK
QFISVSESTRTAPTSSEDYLRLKRRCTTSLIKEQESSQASTEECEKNKQDTITTKKYI
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>